data_1jcu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jcu _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.932 0.305 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -37.47 80.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.4 t -71.31 -28.12 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.235 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.87 -48.03 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 20' ' ' ILE . 4.9 pt-20 -72.51 -20.92 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.81 -35.05 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -74.21 -40.18 62.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.457 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 17' ' ' GLU . 2.3 pp -75.65 -18.69 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 111.024 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 1.2 t -68.23 -53.87 21.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 4.9 p -63.78 -33.51 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 17.9 mtt -63.38 -30.32 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.8 -29.2 64.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.07 1.02 89.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.378 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.2 53.42 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.634 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.97 172.72 15.62 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.306 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.691 HG23 ' HD2' ' A' ' 51' ' ' ARG . 1.9 tp -96.38 136.3 27.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.748 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.8 131.63 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER -102.27 162.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.508 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -167.96 104.41 0.56 Allowed Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 93.7 Cg_endo -80.24 145.46 17.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.477 2.118 . . . . 0.0 111.888 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.643 HG23 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -123.05 -150.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.615 0.245 . . . . 0.0 111.224 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.715 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 3.0 m-20 -55.41 -22.43 20.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.603 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 95' ' ' PRO . 12.8 p -99.74 -112.79 0.18 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.945 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.726 HG22 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -161.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.726 0.298 . . . . 0.0 111.051 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -68.7 134.16 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.944 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 178.08 17.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.936 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.1 mt -133.42 139.17 46.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.644 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.83 124.53 2.09 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.989 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.62 165.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.558 0.218 . . . . 0.0 110.814 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.729 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -55.52 100.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 110.646 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -62.28 -42.15 99.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.159 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.5 mm? -77.53 15.6 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.34 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.42 146.23 36.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -24.36 67.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.26 -29.2 69.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.868 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.47 -40.28 70.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.188 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 t -65.35 -35.49 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.984 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -50.3 34.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.691 ' HD2' HG23 ' A' ' 28' ' ' ILE . 3.6 mmt180 -69.7 -13.71 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.503 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -75.25 -49.48 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.359 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -63.93 -25.55 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.19 -45.85 79.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.42 -52.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.347 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -74.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.218 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.73 40.59 98.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.562 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -112.37 -80.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.309 . . . . 0.0 110.925 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.08 129.22 16.93 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.31 22.1 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 112.487 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.89 -8.87 15.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.112 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -88.13 141.33 31.03 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.047 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.05 165.63 25.72 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.518 2.145 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -116.4 156.77 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.062 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 10.6 t -101.0 137.36 39.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.67 173.42 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.5 t -122.21 141.69 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.747 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 p -150.03 177.01 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.555 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -86.07 -46.82 10.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.674 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.25 175.85 9.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.008 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.579 ' HA ' HD12 ' A' ' 74' ' ' ILE . 16.4 t -59.48 -31.78 47.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.429 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 t70 -67.39 -26.03 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.107 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 23.6 mm-40 -80.39 -23.99 40.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.394 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.725 HG23 HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.54 54.81 0.61 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 77' ' ' PHE . 27.6 Cg_endo -61.74 -83.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.864 1.709 . . . . 0.0 111.743 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.49 19.89 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.368 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' H ' ' C ' ' A' ' 75' ' ' PRO . 8.2 m-85 -93.17 -44.13 8.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.801 0.334 . . . . 0.0 111.088 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -128.1 -175.45 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.638 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' HB3' ' CB ' ' A' ' 101' ' ' GLU . 10.1 ttt-85 -112.75 103.54 55.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.589 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -102.33 -178.77 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.223 2.615 . . . . 0.0 112.584 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 85' ' ' MET . 1.5 t -145.98 -176.17 5.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.05 -85.01 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.687 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 5.1 t70 -55.04 -26.31 36.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.754 0.312 . . . . 0.0 110.823 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.16 -51.53 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 81' ' ' SER . 13.7 mmt -69.55 -20.45 63.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.2 mt-10 -71.04 -41.36 70.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.667 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 2.7 tm? -60.08 -44.18 94.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.499 ' HB2' HD21 ' A' ' 182' ' ' LEU . 7.0 tpt -74.6 -35.98 62.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.155 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 92' ' ' LEU . 18.7 mt-10 -64.17 -12.5 40.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.859 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.718 ' HD2' ' HA ' ' A' ' 87' ' ' LEU . 23.8 mtt-85 -75.61 -55.13 5.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.672 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 57.52 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -132.1 154.51 81.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.615 0.245 . . . . 0.0 111.184 178.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.418 ' HB3' HG12 ' A' ' 121' ' ' VAL . 87.3 Cg_endo -78.92 -153.24 0.88 Allowed 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.712 -1.37 . . . . 0.0 112.007 -2.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.46 178.27 28.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.725 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.715 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 99.0 Cg_endo -79.58 32.57 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.673 2.249 . . . . 0.0 112.609 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.458 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -112.67 146.59 38.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.743 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.769 HG21 ' HA ' ' A' ' 179' ' ' VAL . 6.7 t -95.47 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.66 109.31 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.46 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.633 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 8.7 t -98.41 126.29 51.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.56 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.87 -174.9 3.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.714 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -74.6 -177.82 3.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.173 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.99 138.21 52.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.418 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.97 -165.56 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.029 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.65 43.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.602 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.809 HD21 ' HD2' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -80.54 124.72 29.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.518 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 3.4 mp -74.55 -50.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.948 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.809 ' HD2' HD21 ' A' ' 105' ' ' LEU . 86.9 Cg_exo -49.27 103.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.284 1.989 . . . . 0.0 112.554 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 81.2 m-20 -80.94 -4.57 55.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.176 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -70.45 -21.58 23.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.41 -35.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 64.1 p -76.95 -19.97 56.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.07 -167.69 51.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.55 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.72 5.72 73.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.59 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.7 m -122.69 -178.36 3.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.82 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.422 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 43.7 m -105.75 51.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -144.53 149.17 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 118' ' ' GLY . 87.6 t -139.65 142.55 32.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.574 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.538 ' N ' HG12 ' A' ' 117' ' ' VAL . . . -95.8 158.86 22.09 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.54 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.9 mt -142.62 162.62 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -146.63 128.23 15.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 111.321 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 93' ' ' PRO . 4.1 t -110.77 81.18 2.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' ' 33' ' ' THR . 72.1 Cg_endo -76.36 178.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.493 2.129 . . . . 0.0 112.551 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.38 9.74 35.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 9.1 m-20 -70.47 105.09 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.122 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.54 -49.96 74.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.411 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.18 -53.17 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.212 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -60.85 -18.35 55.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 2.6 mtp180 -74.69 -35.88 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.095 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -52.78 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.75 -49.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.747 ' HB3' ' HA ' ' A' ' 68' ' ' VAL . . . -63.29 -27.53 69.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.279 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.467 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . . . -54.67 -56.33 20.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -75.94 -87.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.159 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -77.0 126.75 85.12 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.188 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.08 154.6 66.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.309 2.006 . . . . 0.0 111.637 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.99 161.06 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.344 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.644 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 91.2 m -81.14 128.67 34.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -123.65 101.26 7.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 0.0 111.631 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.491 HG21 HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -124.91 146.4 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.669 178.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.1 m -82.35 120.92 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.149 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.899 179.539 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.415 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.1 Cg_exo . . . . . 0 CA--C 1.537 0.648 0 N-CA-C 113.554 0.559 . . . . 0.0 113.554 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 64.7 Cg_endo -73.25 118.67 5.62 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 121.893 1.729 . . . . 0.0 112.217 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.85 144.49 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -95.96 -13.63 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.927 2.418 . . . . 0.0 112.747 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 126.61 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -63.24 -40.01 96.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.155 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -18.9 62.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.61 -36.78 65.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.117 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.754 HD13 HG23 ' A' ' 165' ' ' VAL . 21.8 mt -68.78 -52.24 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.439 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.55 -27.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.0 -55.91 6.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.613 ' HB3' HD21 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.45 -55.83 13.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.33 -179.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.63 ' HB3' ' H ' ' A' ' 163' ' ' ASP . 2.3 mm? -91.14 73.93 6.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.929 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.13 -42.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.883 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.95 14.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 28' ' ' ILE . 3.0 t -80.67 -78.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.994 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.63 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -100.03 87.81 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.484 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.06 129.77 43.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.326 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.754 HG23 HD13 ' A' ' 155' ' ' ILE . 1.5 p -69.36 -169.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.791 HD21 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -125.91 154.53 42.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.399 . . . . 0.0 110.957 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.46 -21.9 19.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.3 -51.71 6.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.791 ' HA2' HD21 ' A' ' 166' ' ' LEU . . . 97.13 -155.58 20.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.744 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.9 -161.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.763 0.316 . . . . 0.0 111.086 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -146.2 -53.25 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.524 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.92 -128.63 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -85.64 144.56 27.77 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 120.84 0.353 . . . . 0.0 111.603 -178.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.726 ' HG2' HG22 ' A' ' 36' ' ' ILE . 2.5 ttp -65.29 -12.96 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.215 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.39 155.35 23.31 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.87 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.468 ' HB2' ' H ' ' A' ' 177' ' ' SER . 83.1 Cg_endo -91.93 -139.73 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.434 0.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 1.3 p -153.41 140.73 19.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.596 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 23.7 m -101.44 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.0 111.322 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.769 ' HA ' HG21 ' A' ' 97' ' ' THR . 67.5 t -129.25 112.15 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.649 HG12 ' HA ' ' A' ' 189' ' ' VAL . 58.0 mt -116.71 129.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.633 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.25 65.63 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 88' ' ' MET . 39.9 tp -69.9 89.38 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -80.08 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.832 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.45 -127.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.931 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.49 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -59.21 -51.06 84.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.485 ' HD3' HD21 ' A' ' 185' ' ' ASN . 97.8 Cg_endo -79.71 107.15 2.08 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.165 1.91 . . . . 0.0 112.403 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.662 ' HG3' ' HG ' ' A' ' 87' ' ' LEU . 82.1 Cg_endo -77.64 138.31 17.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.482 2.122 . . . . 0.0 111.961 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 181' ' ' ASP . 0.7 OUTLIER -101.08 41.63 1.17 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.374 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.649 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.8 p -56.95 105.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.015 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.1 94.63 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.541 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -83.67 140.1 32.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.756 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.697 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 42.8 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.932 0.305 . . . . 0.0 112.537 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -72.2 -35.31 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.797 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 48.8 t -61.35 -35.52 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.75 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.697 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -67.29 -56.51 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.624 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.62 -22.5 61.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.24 -34.91 61.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.006 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -69.46 -34.76 74.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.054 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.67 -39.67 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.721 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 t -72.85 -42.23 63.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 19' ' ' ALA . 8.6 p -68.37 -29.49 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.263 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.539 ' N ' HG11 ' A' ' 22' ' ' VAL . 11.1 mtt -74.24 -25.42 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.859 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -1.99 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.29 5.52 84.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.64 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.31 41.59 99.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.79 178.81 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.572 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.754 HG12 HG11 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -96.46 144.66 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.612 ' N ' HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.88 126.43 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.361 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.512 HG12 ' OD1' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -101.85 164.4 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.513 0.197 . . . . 0.0 110.488 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -165.29 103.76 0.77 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.588 ' HD3' HD13 ' A' ' 166' ' ' LEU . 90.9 Cg_endo -84.1 137.5 7.37 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.704 2.269 . . . . 0.0 111.735 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.501 HG21 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -116.93 -152.15 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.206 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 0.7 OUTLIER -54.73 -22.19 13.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.309 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -100.04 -116.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.49 HD13 ' HG3' ' A' ' 174' ' ' MET . 0.3 OUTLIER -112.2 -175.17 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.753 0.311 . . . . 0.0 111.141 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.449 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.1 m-85 -63.42 134.09 55.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.906 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.33 179.51 16.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.026 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 2.6 mp -122.27 143.57 49.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.971 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.22 117.39 0.96 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.101 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.754 HG11 HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -153.91 166.0 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 111.367 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -56.58 109.73 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.091 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.51 -46.25 84.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.202 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 44' ' ' LEU . 4.6 mm? -84.69 24.92 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.5 148.1 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 -24.66 60.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.83 -27.79 63.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.24 -28.39 59.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.23 -44.56 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.969 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -49.9 72.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.095 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 57.0 mmt-85 -62.29 -42.54 99.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.149 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.01 -25.71 68.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.903 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -30.51 64.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 54' ' ' ARG . 2.9 mmt85 -75.45 -49.9 17.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.309 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.71 -51.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.676 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -79.56 -5.96 56.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.293 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.15 -113.95 6.31 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.36 77.37 1.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 111.002 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -154.89 71.51 5.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 23.28 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.697 2.265 . . . . 0.0 112.531 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -122.5 -8.36 8.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 133.15 50.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.788 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.66 153.51 14.21 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.621 2.214 . . . . 0.0 112.52 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 142.54 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -97.22 148.55 22.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.625 HG13 ' HA ' ' A' ' 119' ' ' ILE . 0.9 OUTLIER -116.06 170.95 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.596 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 3.3 t -122.17 118.59 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.612 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.821 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 1.0 OUTLIER -138.46 177.51 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.799 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.839 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 2.1 t -86.95 -41.37 13.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.453 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -164.14 170.61 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.991 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.92 -34.03 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 21.9 t70 -67.03 -28.64 68.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.839 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 67.8 mm-40 -74.45 -23.36 58.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.749 HG21 HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.31 61.23 0.79 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.783 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 77' ' ' PHE . 34.8 Cg_endo -65.04 -72.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.063 1.842 . . . . 0.0 112.267 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.86 14.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.63 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' A' ' 75' ' ' PRO . 1.7 t80 -103.64 -54.34 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.406 ' OG ' HD13 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -120.09 172.69 7.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.751 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.52 111.49 41.77 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.933 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.14 175.29 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.948 2.432 . . . . 0.0 112.72 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.56 -177.02 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.896 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.36 -88.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.932 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -26.22 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.999 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.67 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.2 mmt -71.65 -16.22 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.055 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.56 -47.22 61.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.438 . . . . 0.0 110.401 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -57.31 -43.61 83.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.667 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.462 ' HE1' ' HB ' ' A' ' 98' ' ' VAL . 1.8 ttm -66.65 -36.73 83.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -67.96 -10.84 56.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.377 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.64 -51.69 13.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.8 65.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.228 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.627 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 3.1 tt -131.22 139.24 34.86 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 84.4 Cg_endo -79.03 -154.55 1.04 Allowed 'Cis proline' 0 C--N 1.35 0.65 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.548 -1.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 93' ' ' PRO . . . 158.71 160.47 10.36 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.686 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.67 42.37 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 112.271 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.613 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 55.3 p90 -112.18 149.9 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.6 m -96.19 141.78 29.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.156 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 182' ' ' LEU . 1.8 p -127.41 109.99 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.577 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.7 t -92.66 123.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.975 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.595 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 19.6 tp -127.26 172.27 10.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.599 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.595 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 2.8 pm0 -74.58 -176.17 2.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.521 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.784 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.07 139.43 51.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.975 0.417 . . . . 0.0 111.131 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.751 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.52 -157.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.94 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.489 ' H ' HD21 ' A' ' 103' ' ' ASN . 7.0 mm-40 -67.51 -31.85 72.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.505 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.7 tt -69.93 84.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.633 HG12 ' HE ' ' A' ' 102' ' ' ARG . 5.9 mt -80.9 104.48 2.78 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.734 ' HG2' ' HB ' ' A' ' 111' ' ' THR . 59.2 Cg_endo -70.69 154.8 63.85 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.33 2.02 . . . . 0.0 112.201 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.44 -84.04 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.752 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.5 m -81.88 7.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.985 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 6.8 mt -102.53 -35.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.295 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.734 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -83.12 -27.97 29.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.42 -140.55 37.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.383 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.05 -3.78 72.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.433 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -107.04 162.21 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.434 ' HB2' ' NH1' ' A' ' 102' ' ' ARG . 12.2 p -102.98 44.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -136.74 163.33 30.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 102' ' ' ARG . 80.2 t -139.78 133.71 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.652 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.494 ' O ' HD12 ' A' ' 119' ' ' ILE . . . -87.6 157.31 28.69 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.3 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.625 ' HA ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -135.28 167.98 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -154.97 119.46 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.354 . . . . 0.0 111.417 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' HG11 ' A' ' 121' ' ' VAL . 2.8 p -110.59 83.65 3.52 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.516 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.24 -178.86 4.73 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.632 2.221 . . . . 0.0 112.67 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.501 ' H ' HG21 ' A' ' 33' ' ' THR . 0.5 OUTLIER -93.02 -4.88 51.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.4 OUTLIER -62.04 110.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.989 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.06 -46.54 82.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' HB ' ' A' ' 15' ' ' VAL . 38.0 mm -62.03 -54.88 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.969 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.702 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 98.5 m -60.2 -19.78 55.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -75.63 -43.65 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -72.67 -54.45 9.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.654 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 tt -57.44 -45.35 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.504 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.821 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.52 -25.11 62.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.58 -56.5 18.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.024 0.44 . . . . 0.0 110.125 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -83.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.145 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 3.2 t80 -77.11 128.19 81.61 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.409 ' C ' HG22 ' A' ' 136' ' ' VAL . 58.5 Cg_endo -70.3 155.13 64.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.323 2.015 . . . . 0.0 111.603 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 41' ' ' VAL . 2.4 t -135.21 157.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.337 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.599 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.42 138.8 36.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.82 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.02 109.12 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 111.605 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.579 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -131.8 127.29 36.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.789 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.0 t -71.19 119.16 14.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 111.152 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.641 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.422 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.7 Cg_exo . . . . . 0 CA--C 1.537 0.637 0 N-CA-C 113.517 0.545 . . . . 0.0 113.517 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 65.6 Cg_endo -73.03 118.05 5.39 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.828 1.685 . . . . 0.0 112.378 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 143.77 26.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.817 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -96.0 -12.47 0.68 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.885 2.39 . . . . 0.0 112.863 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.59 122.45 27.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.31 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -30.88 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.841 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -29.18 60.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.124 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -67.43 -28.6 68.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.622 HD13 HG21 ' A' ' 165' ' ' VAL . 46.5 mt -75.04 -50.73 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.485 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.34 -33.82 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.925 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -75.6 -58.4 3.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.756 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.51 -34.05 77.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.821 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.675 ' HB3' HG11 ' A' ' 162' ' ' VAL . 85.0 mt -106.33 68.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.331 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 8.5 t70 -16.34 -63.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.778 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.02 22.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 111.121 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.721 HG11 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.77 -63.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.739 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.6 t70 -107.56 100.24 9.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.011 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.514 HD12 HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.61 124.7 25.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.601 -177.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.2 p -64.02 -166.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.843 HD21 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -125.62 160.04 30.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.01 -25.02 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.289 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.32 -55.85 3.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.843 ' HA2' HD21 ' A' ' 166' ' ' LEU . . . 101.18 -163.52 18.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.862 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.01 -165.97 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.405 ' HB2' ' C ' ' A' ' 33' ' ' THR . 22.1 m -144.64 -60.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.628 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -124.35 -130.85 0.26 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.1 m-20 -85.91 141.68 29.39 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.801 0.334 . . . . 0.0 111.465 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.49 ' HG3' HD13 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -56.96 -36.78 70.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -142.6 158.79 59.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.73 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 64.4 Cg_endo -91.46 -147.73 0.27 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.734 1.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 p -155.03 156.39 35.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.613 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.5 m -99.56 142.24 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.157 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.0 89.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 189' ' ' VAL . 12.2 mt -104.43 134.17 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -108.28 68.16 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.173 178.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.572 ' HB3' HG22 ' A' ' 98' ' ' VAL . 12.1 tp -69.75 87.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.358 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -77.25 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.66 0.267 . . . . 0.0 110.808 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.56 -126.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.453 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.7 OUTLIER -63.8 -53.42 50.11 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.19 108.22 2.46 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.161 1.907 . . . . 0.0 112.356 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.1 Cg_endo -76.22 139.2 20.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.451 2.1 . . . . 0.0 112.075 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.596 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.2 OUTLIER -99.42 49.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 180' ' ' ILE . 8.9 t -56.87 98.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.45 85.95 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.024 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.68 154.77 23.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.488 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.0 Cg_exo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.855 0.273 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.0 -34.59 73.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 167' ' ' ASP . 18.9 t -59.43 -53.64 45.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 13' ' ' PRO . 3.1 mm? -61.9 -35.98 79.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.407 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 21' ' ' SER . 2.8 mt-10 -57.72 -30.63 65.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.709 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -77.3 -32.89 55.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.286 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -71.15 -46.91 60.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.57 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.84 -17.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 13.0 t -66.12 -53.86 32.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 22' ' ' VAL . 9.7 p -69.78 -27.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.405 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.2 mtt -60.1 -37.15 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.09 -16.68 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.25 9.57 77.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.591 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.27 51.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.49 161.62 22.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.427 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.3 OUTLIER -96.24 143.21 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -117.04 146.08 21.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.828 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -111.19 165.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 178.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.9 92.0 0.46 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.816 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.9 Cg_endo -81.55 157.3 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.545 2.163 . . . . 0.0 111.127 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.625 ' HA ' ' CB ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.35 -150.88 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.24 -20.81 45.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.521 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.74 -98.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.036 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.571 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.2 OUTLIER -131.47 -166.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.874 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.816 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m-85 -72.68 131.12 41.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.781 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.2 178.59 17.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.136 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.75 HD12 HG23 ' A' ' 139' ' ' THR . 3.5 mt -133.96 144.49 48.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.351 . . . . 0.0 110.831 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.643 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.17 131.48 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.292 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 28' ' ' ILE . 1.1 m -156.53 163.35 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.5 m-20 -56.57 106.58 0.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.366 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.95 84.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.877 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 44' ' ' LEU . 4.5 mm? -81.53 18.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.552 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -110.62 146.77 35.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.24 -23.82 57.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.02 -26.77 68.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.21 -36.92 61.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.449 HG22 ' HB ' ' A' ' 109' ' ' VAL . 10.3 t -65.3 -43.64 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -70.05 -42.89 72.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.234 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -68.9 -29.39 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -67.59 -38.39 83.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.891 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -65.35 -37.73 87.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.69 -40.52 95.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.348 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.81 -57.92 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.288 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -81.89 -70.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.277 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.32 4.75 24.94 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.614 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.2 18.23 13.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -134.53 66.13 69.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.2 -54.38 5.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.79 2.327 . . . . 0.0 112.454 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -122.39 24.48 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -88.29 149.72 45.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.001 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.13 169.1 14.24 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.506 2.138 . . . . 0.0 112.289 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 110' ' ' ILE . 32.9 m -119.48 162.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.04 138.48 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.522 HG13 HG22 ' A' ' 119' ' ' ILE . 9.4 pt -116.01 165.95 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 41.9 t -122.06 130.45 53.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG21 HG22 ' A' ' 74' ' ' ILE . 1.4 p -138.34 -175.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.394 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.779 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 5.6 t -88.94 -45.85 9.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.49 168.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.831 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 74' ' ' ILE . 10.2 t -55.34 -35.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.631 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.63 -28.98 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.92 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.779 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 2.9 mp0 -75.23 -15.99 60.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.684 HG22 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.44 58.18 0.7 Allowed Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.934 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' PHE . 20.4 Cg_endo -60.02 -86.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.07 1.847 . . . . 0.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -73.32 22.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 75' ' ' PRO . 27.1 m-85 -96.99 -47.33 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 111.008 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.1 p -129.83 -175.0 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.25 99.84 51.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -102.69 -173.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.284 2.656 . . . . 0.0 112.508 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.648 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . 2.4 m -141.93 176.87 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.61 -87.9 0.2 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.839 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -33.76 64.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.648 ' HB1' ' HB2' ' A' ' 81' ' ' SER . . . -57.34 -46.57 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.78 ' HE1' ' HG ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -75.02 -25.5 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.246 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -46.99 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 0.0 110.924 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tp -66.41 -43.86 84.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.155 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.451 ' HE3' ' CE1' ' A' ' 96' ' ' TYR . 6.0 tpt -63.44 -57.42 10.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.529 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HA ' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -63.2 -11.81 23.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -67.12 -32.79 74.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.715 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.26 60.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -131.2 149.28 73.23 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.19 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 6.3 Cg_exo -78.54 -158.04 1.61 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.101 -1.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.24 162.08 11.31 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.829 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.401 ' HB2' HG23 ' A' ' 35' ' ' THR . 92.4 Cg_endo -82.25 46.5 2.21 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.847 2.365 . . . . 0.0 112.598 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.451 ' CE1' ' HE3' ' A' ' 88' ' ' MET . 35.8 p90 -112.11 -179.53 3.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.066 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 2.7 m -115.27 145.62 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.685 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.401 HG22 ' HE1' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -129.04 91.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.373 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.686 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 16.7 t -87.28 122.56 39.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.756 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.67 175.91 7.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.591 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.08 158.87 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.218 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.563 ' CZ ' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -119.83 145.47 46.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.208 0.527 . . . . 0.0 111.184 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.84 174.93 8.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -76.66 60.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.22 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.703 HD21 ' HD2' ' A' ' 107' ' ' PRO . 1.6 mt -71.37 154.01 41.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.577 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 mt -76.32 -51.28 2.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.728 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.703 ' HD2' HD21 ' A' ' 105' ' ' LEU . 16.5 Cg_endo -57.04 101.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.234 1.956 . . . . 0.0 112.243 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.427 ' HA ' ' HG1' ' A' ' 111' ' ' THR . 0.3 OUTLIER -82.22 4.56 23.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 49' ' ' VAL . 16.5 m -83.77 -17.63 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 64' ' ' VAL . 1.1 pt -113.03 -29.03 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.427 ' HG1' ' HA ' ' A' ' 108' ' ' ASP . 17.3 p -79.07 -35.43 42.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -169.2 46.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -70.47 -14.68 72.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p -117.64 -179.97 3.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.342 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.0 t -107.36 61.86 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mpp_? -141.2 141.5 34.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 102' ' ' ARG . 77.8 t -142.88 139.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.008 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.26 159.45 19.96 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.92 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.674 HG23 ' H ' ' A' ' 120' ' ' ARG . 1.1 mt -141.22 173.47 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.674 ' H ' HG23 ' A' ' 119' ' ' ILE . 7.1 ptp180 -162.64 131.13 4.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.7 t -110.97 86.82 6.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.514 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.4 -177.78 2.93 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.531 2.154 . . . . 0.0 112.423 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.42 8.97 25.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.068 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.5 OUTLIER -76.45 100.91 5.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.717 HD12 ' HB1' ' A' ' 168' ' ' ALA . 85.5 mt -57.84 -50.99 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.549 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -65.99 -18.34 65.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.714 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . 3.8 ttt180 -75.2 -37.66 61.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.999 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -51.21 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.475 ' HB ' HD12 ' A' ' 16' ' ' LEU . 2.0 tt -62.6 -43.69 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -68.06 -28.24 67.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.97 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.01 33.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.084 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -75.76 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.266 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -77.21 128.93 79.5 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.207 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.21 144.03 32.76 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.337 2.025 . . . . 0.0 111.514 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.538 HG11 ' H ' ' A' ' 137' ' ' THR . 3.1 t -125.54 157.02 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 111.462 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.643 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 36.2 m -79.14 143.45 35.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.835 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -139.19 110.1 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.964 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.75 HG23 HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -127.53 150.58 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.281 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.67 116.13 17.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.433 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.415 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.467 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 40.0 Cg_exo . . . . . 0 CA--C 1.538 0.719 0 N-CA-C 113.228 0.434 . . . . 0.0 113.228 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 7.4 Cg_exo -73.46 106.23 2.14 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.096 1.864 . . . . 0.0 112.291 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.08 155.95 36.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -95.41 -14.52 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.769 2.312 . . . . 0.0 112.775 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.7 mmt180 -134.38 128.86 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.935 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.757 HD22 ' HB ' ' A' ' 165' ' ' VAL . 5.7 mt -61.07 -45.46 94.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.066 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -23.52 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.79 -31.19 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.169 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.792 HD12 HG12 ' A' ' 165' ' ' VAL . 1.0 OUTLIER -75.49 -51.21 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.529 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.733 HG11 HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -59.0 -25.5 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.416 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -75.08 -48.99 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.15 -21.77 58.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.578 ' HB3' HG11 ' A' ' 162' ' ' VAL . 81.0 mt -111.23 68.05 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.03 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.5 t70 -16.26 -63.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.176 0.923 . . . . 0.0 112.724 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -159.26 23.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.235 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.658 HG11 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.88 -65.22 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.759 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.658 ' H ' HG11 ' A' ' 162' ' ' VAL . 47.5 t0 -111.37 102.34 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.575 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.49 131.15 40.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.573 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.828 ' HA ' HD11 ' A' ' 30' ' ' ILE . 17.1 m -65.33 -166.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.164 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.492 HD12 ' HA2' ' A' ' 169' ' ' GLY . 0.4 OUTLIER -126.3 167.39 15.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.456 ' HB3' HG13 ' A' ' 15' ' ' VAL . 3.2 t70 -92.47 -39.87 11.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.595 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.717 ' HB1' HD12 ' A' ' 126' ' ' ILE . . . -64.09 -70.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.305 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.492 ' HA2' HD12 ' A' ' 166' ' ' LEU . . . 89.37 51.26 2.98 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.837 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.625 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 3.7 m-20 -71.99 121.2 18.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.75 123.74 4.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.266 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.415 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -137.18 -113.85 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.415 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -85.38 127.53 34.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.571 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.08 -1.64 10.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.122 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.72 157.34 36.08 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.692 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -92.64 -151.66 0.36 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.737 1.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.8 p -156.91 115.1 3.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.1 m -102.31 143.58 31.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 111.499 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.414 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 19.8 t -129.5 105.87 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.54 HG21 HG22 ' A' ' 189' ' ' VAL . 13.7 mt -114.31 131.18 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.725 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.6 m-20 -99.42 73.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.718 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.78 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 0.2 OUTLIER -68.79 81.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.309 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -86.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.321 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.49 -128.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -59.82 -51.03 83.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 72.6 Cg_endo -76.53 108.67 2.71 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.203 1.936 . . . . 0.0 112.504 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 83.8 Cg_endo -83.96 121.92 2.89 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.645 2.23 . . . . 0.0 112.257 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.725 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.6 mtm180 -89.35 54.38 2.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.489 . . . . 0.0 111.149 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.54 HG22 HG21 ' A' ' 180' ' ' ILE . 48.3 t -59.33 106.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.8 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.47 86.86 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -89.75 140.65 29.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HG2' HD22 ' A' ' 16' ' ' LEU . 44.2 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.599 0.166 . . . . 0.0 112.052 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 m-20 -67.46 -28.12 67.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.87 -58.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.579 HD21 HG22 ' A' ' 126' ' ' ILE . 4.4 mm? -60.27 -42.48 95.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.685 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.27 -31.37 63.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.035 0.445 . . . . 0.0 110.485 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 5.1 mm-40 -76.29 -32.11 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.186 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -75.64 -41.73 53.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.907 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 16' ' ' LEU . 1.9 pp -71.7 -31.37 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.025 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.482 ' N ' HD12 ' A' ' 20' ' ' ILE . 5.7 p -75.18 -38.0 61.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.836 HG13 HD21 ' A' ' 164' ' ' LEU . 11.6 p -75.66 -29.39 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.083 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.521 ' N ' HG11 ' A' ' 22' ' ' VAL . 1.3 mtt -62.11 -42.7 99.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.634 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -4.97 26.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.813 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.76 78.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 51.69 37.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.812 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.17 165.24 22.57 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.427 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.723 ' HA ' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -96.5 148.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.592 HG12 HD12 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -116.39 127.42 74.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.733 -179.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -102.71 151.6 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.635 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.521 ' HH ' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -157.05 113.35 1.94 Allowed Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.63 134.26 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.721 2.281 . . . . 0.0 111.377 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.564 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -116.49 -149.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 111.191 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 11.7 m-20 -54.58 -22.08 12.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.194 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 36' ' ' ILE . 4.6 t -100.38 -121.82 0.16 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.52 -149.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.761 0.315 . . . . 0.0 111.454 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.524 ' HD2' ' HB2' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -64.96 129.59 40.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.446 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.72 170.68 15.36 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.959 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 139' ' ' THR . 1.6 mp -123.45 141.13 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.929 0.395 . . . . 0.0 111.263 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.34 111.5 0.58 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.696 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 28' ' ' ILE . 2.5 p -151.79 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.645 0.26 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 14.2 m120 -56.42 116.86 3.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 110.493 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.0 -56.02 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.988 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 44' ' ' LEU . 1.4 mm? -82.81 37.11 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.553 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -110.94 156.17 21.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 178.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -31.91 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.441 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.15 -28.15 68.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.518 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -72.25 -35.43 68.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.718 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.0 t -66.17 -48.28 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 50' ' ' ARG . 11.2 mtt180 -63.73 -45.17 91.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.529 ' HG3' HG13 ' A' ' 28' ' ' ILE . 11.0 mmm180 -65.25 -30.67 71.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -66.59 -46.48 75.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.6 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.89 -18.08 63.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.091 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -73.24 -67.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.701 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.28 -41.16 57.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -80.08 -11.32 59.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.626 0.251 . . . . 0.0 111.292 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 -139.0 39.05 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.416 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.2 85.48 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.82 67.45 23.21 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.88 9.31 2.03 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 0.0 112.511 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.404 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -105.21 -26.31 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.28 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.12 128.8 52.31 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.287 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.73 171.63 2.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.446 HG23 HG22 ' A' ' 110' ' ' ILE . 5.0 m -114.85 150.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.322 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -99.91 133.93 43.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.5 pt -113.94 172.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m -122.07 129.37 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.811 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 1.8 p -136.0 179.06 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.691 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 30.3 t -86.18 -42.54 13.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.261 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.5 166.22 20.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.422 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.575 ' HA ' HD12 ' A' ' 74' ' ' ILE . 26.8 t -57.68 -31.33 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.5 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 37.0 t70 -67.44 -27.59 67.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.812 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.691 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 0.6 OUTLIER -76.73 -21.04 55.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.119 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.784 HG21 HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.34 58.79 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 77' ' ' PHE . 34.7 Cg_endo -65.08 -74.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.007 1.804 . . . . 0.0 112.003 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.19 15.18 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.5 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 32.5 m-85 -100.52 -45.95 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 p -135.23 159.49 41.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.679 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.455 ' HG3' ' HB3' ' A' ' 101' ' ' GLU . 7.1 ptm180 -119.14 104.16 46.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.012 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -102.23 -166.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.14 2.56 . . . . 0.0 112.399 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 166.27 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.84 -73.47 0.68 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.586 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.621 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -55.33 -34.44 64.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.797 0.332 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.68 84.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.434 ' SD ' HG22 ' A' ' 71' ' ' VAL . 4.2 mmt -71.36 -17.99 62.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.095 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.621 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.6 mt-10 -71.58 -47.2 56.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.934 0.397 . . . . 0.0 110.573 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.471 HD12 HD11 ' A' ' 182' ' ' LEU . 2.6 tm? -58.23 -40.55 81.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.03 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.682 ' HB2' HD12 ' A' ' 182' ' ' LEU . 4.4 tpt -74.76 -46.12 39.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.507 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.83 -14.64 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.298 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -44.83 63.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.7 pt -108.81 53.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.535 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 6.3 tt -130.97 131.73 23.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 87.6 Cg_endo -78.08 -163.4 3.36 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.478 -0.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.62 167.11 16.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.95 37.22 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.748 2.299 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.17 144.31 41.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.628 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 1.3 m -94.74 148.77 21.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.71 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.544 HG11 ' SD ' ' A' ' 88' ' ' MET . 2.1 t -126.49 102.51 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.24 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.81 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 2.8 t -93.55 120.1 42.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 182' ' ' LEU . 1.1 mp -126.99 -168.5 1.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.576 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.455 ' HB3' ' HG3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -74.83 169.33 18.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.552 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.8 ' HB2' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.17 147.13 44.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.445 ' C ' ' H ' ' A' ' 105' ' ' LEU . 22.1 p-10 -73.72 -152.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.314 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 31.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.47 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.445 ' H ' ' C ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -69.53 94.85 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.725 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.591 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 6.1 mt -64.91 -50.79 61.0 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.71 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 76.5 Cg_exo -50.38 108.85 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.128 1.885 . . . . 0.0 112.316 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.22 -1.53 41.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.477 HG11 HG13 ' A' ' 110' ' ' ILE . 15.0 p -69.98 -21.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.477 HG13 HG11 ' A' ' 109' ' ' VAL . 5.1 mt -105.03 -52.25 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.037 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -68.2 -14.27 62.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.54 -154.75 40.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -87.62 6.25 83.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.362 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.9 169.93 9.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.769 0.318 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -99.0 39.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -136.92 158.99 43.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 102' ' ' ARG . 98.7 t -139.95 147.87 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.464 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -98.99 146.89 18.31 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.389 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.464 HG13 ' C ' ' A' ' 118' ' ' GLY . 24.8 mt -148.26 134.98 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -144.58 146.52 32.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.962 0.41 . . . . 0.0 111.438 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.505 HG23 ' HG ' ' A' ' 92' ' ' LEU . 1.7 m -110.22 96.82 27.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.14 -179.28 2.12 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.501 2.134 . . . . 0.0 112.449 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 5.2 47.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.97 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.3 104.54 6.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.35 -49.01 77.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.194 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.579 HG22 HD21 ' A' ' 16' ' ' LEU . 30.6 mm -59.83 -48.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.1 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.515 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 85.8 m -62.53 -20.89 65.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 128' ' ' ARG . 0.3 OUTLIER -75.19 -27.36 59.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.987 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -74.31 -60.4 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.172 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -58.27 -45.5 89.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.811 ' HB3' ' HA ' ' A' ' 68' ' ' VAL . . . -63.73 -28.25 69.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.006 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 129' ' ' ARG . . . -54.76 -53.4 55.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -75.28 -88.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.123 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -77.09 144.96 72.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.41 159.09 47.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.321 2.014 . . . . 0.0 111.603 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.568 HG21 ' HB2' ' A' ' 131' ' ' ALA . 7.5 t -133.65 150.25 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.526 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.607 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 m -80.9 140.47 35.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.824 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.7 107.13 8.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.494 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.12 122.24 22.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.905 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 110.54 5.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.017 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.544 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.8 Cg_exo . . . . . 0 CA--C 1.536 0.583 0 N-CA-C 113.322 0.47 . . . . 0.0 113.322 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 28.4 Cg_endo -62.1 129.66 27.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.781 1.654 . . . . 0.0 111.976 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.6 p -85.86 121.91 72.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -95.11 -28.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.882 2.388 . . . . 0.0 112.297 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 131.85 18.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.338 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.499 HD22 HG22 ' A' ' 165' ' ' VAL . 25.7 mt -59.95 -36.48 77.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.255 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -19.4 59.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.98 -44.83 79.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.761 HD11 HG21 ' A' ' 165' ' ' VAL . 11.6 mt -68.29 -44.1 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.17 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.96 -41.27 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -75.38 -53.31 8.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.498 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.615 ' HB3' HD22 ' A' ' 159' ' ' LEU . 9.6 t70 -56.6 -39.85 74.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.496 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 155' ' ' ILE . 2.6 mm? -111.37 77.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.934 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.43 -43.2 0.56 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.094 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.26 19.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 48.7 t -80.45 -97.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.658 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -94.72 92.25 6.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.46 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.836 HD21 HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -55.57 135.13 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.026 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 155' ' ' ILE . 0.7 OUTLIER -66.6 172.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.648 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -127.42 127.34 43.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.521 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -7.95 46.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.746 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.521 ' HB1' ' HH ' ' A' ' 31' ' ' TYR . . . -64.08 -38.21 90.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.388 . . . . 0.0 110.655 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.48 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 102.25 166.67 26.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.084 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -152.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.564 ' HB2' ' C ' ' A' ' 33' ' ' THR . 11.4 m -144.28 -63.22 0.37 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.57 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -130.47 -138.68 0.21 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.4 168.43 13.14 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.545 ' O ' HG12 ' A' ' 36' ' ' ILE . 61.9 mtp -71.01 1.39 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.012 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.17 160.17 26.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -97.02 -149.65 0.18 OUTLIER 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.737 1.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.77 120.45 5.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.484 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.452 ' HG1' ' HG3' ' A' ' 191' ' ' ARG . 5.8 m -99.73 137.21 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.398 . . . . 0.0 111.483 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.23 107.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.607 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 189' ' ' VAL . 3.1 mt -119.14 132.95 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.64 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.81 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 9.2 m-20 -97.88 69.24 2.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.163 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 88' ' ' MET . 3.5 tt -69.44 87.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.408 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -81.76 0.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.493 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.5 -126.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.864 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -60.58 -52.63 71.35 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.27 108.39 2.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.237 1.958 . . . . 0.0 112.626 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 1.0 OUTLIER -84.07 132.45 5.39 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.017 2.478 . . . . 0.0 112.071 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.635 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.1 mmm180 -91.88 59.18 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 110.897 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 180' ' ' ILE . 46.7 t -59.16 109.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.53 88.33 2.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.05 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.452 ' HG3' ' HG1' ' A' ' 178' ' ' THR . 5.6 ttt180 -90.94 127.77 36.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.819 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.654 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.819 0.258 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.08 -29.54 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.19 -31.77 25.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.599 HD23 HG23 ' A' ' 126' ' ' ILE . 1.4 mm? -72.92 -41.57 64.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' O ' HD13 ' A' ' 20' ' ' ILE . 1.4 pt-20 -74.87 -19.02 60.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.3 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.0 -36.73 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.82 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -72.77 -40.84 65.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.592 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 17' ' ' GLU . 2.2 pp -75.47 -17.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -71.94 -46.34 57.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.489 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 9.6 p -73.5 -27.78 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.481 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 15.2 mtt -59.76 -49.42 77.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.113 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.67 -12.96 61.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.57 1.03 89.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.503 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.14 44.26 87.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.9 170.43 19.38 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.362 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.654 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -96.45 143.84 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.428 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.63 140.03 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.701 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -105.46 165.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.445 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.2 103.32 0.31 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.779 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.459 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 83.3 Cg_endo -82.69 135.72 8.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.6 2.2 . . . . 0.0 111.744 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.552 HG21 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -120.21 -155.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.804 0.335 . . . . 0.0 111.414 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.8 OUTLIER -54.72 -21.17 10.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -98.42 -117.92 0.14 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.668 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.3 OUTLIER -112.6 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.723 0.297 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.37 131.38 47.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.714 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -123.11 176.47 16.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.482 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.788 HD13 HG21 ' A' ' 139' ' ' THR . 1.4 mt -133.32 142.99 48.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.741 0.305 . . . . 0.0 110.839 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.5 134.69 5.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.059 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.531 HG23 ' NH1' ' A' ' 51' ' ' ARG . 3.9 m -152.69 168.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.776 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -56.61 105.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.259 178.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -58.69 -50.12 75.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.278 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -79.89 22.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.87 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.776 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.25 161.71 15.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 178.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HA ' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -75.01 -25.18 58.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 110.426 178.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 6.5 m-20 -60.59 -28.82 68.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.806 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.09 -27.16 59.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.92 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 46' ' ' GLU . 46.2 t -65.66 -54.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -71.33 -22.19 61.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -68.01 -34.48 76.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.997 0.427 . . . . 0.0 110.754 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.57 HD22 ' HB2' ' A' ' 56' ' ' LYS . 0.8 OUTLIER -74.96 -44.44 48.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.391 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.52 -34.53 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.181 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -66.41 -61.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.439 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.76 -51.12 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.57 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -79.86 -70.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.454 -178.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.93 -11.7 0.62 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.08 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 56' ' ' LYS . 2.6 ptp180 -118.4 40.19 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.784 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 p -141.72 63.75 17.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.44 -66.85 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.652 2.235 . . . . 0.0 112.591 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.714 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 53.3 m80 -108.59 24.44 13.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -88.41 147.48 40.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.16 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.8 161.26 41.99 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.591 2.194 . . . . 0.0 112.269 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 110' ' ' ILE . 3.8 p -114.05 151.53 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.8 t -94.16 134.22 36.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.214 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -116.24 172.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.796 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 20.7 t -119.96 136.88 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -135.86 -179.57 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 1.2 t -76.09 -49.67 16.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.155 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.93 179.86 6.74 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.143 0.497 . . . . 0.0 111.664 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.743 HG23 HD13 ' A' ' 92' ' ' LEU . 60.9 t -52.44 -41.29 35.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.111 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.487 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -69.57 -27.82 65.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.905 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.821 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 1.4 tp10 -80.99 -8.22 59.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -90.86 -38.56 0.39 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.653 ' HG3' ' HG3' ' A' ' 80' ' ' PRO . 99.8 Cg_exo -44.03 -23.3 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.491 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -55.22 -59.33 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -107.51 3.89 25.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -118.05 179.7 4.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.511 ' HG2' HD21 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -131.5 94.44 26.26 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HA ' HD11 ' A' ' 100' ' ' LEU . 68.3 Cg_endo -102.49 -166.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.2 2.6 . . . . 0.0 112.687 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -143.53 177.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.15 -83.28 0.41 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.769 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.93 -33.25 62.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.842 0.353 . . . . 0.0 111.152 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.458 ' O ' HD22 ' A' ' 182' ' ' LEU . . . -60.41 -49.36 77.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.7 mmt -71.94 -14.91 62.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.255 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.0 mm-40 -66.59 -46.68 75.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.4 tm? -61.35 -38.4 86.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.201 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.605 ' HE3' HD12 ' A' ' 91' ' ' ILE . 5.9 tpt -66.29 -43.11 87.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.27 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -69.95 -39.69 75.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.058 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.605 HD12 ' HE3' ' A' ' 88' ' ' MET . 2.3 pt -115.12 51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.275 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -131.36 134.65 25.93 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.28 -162.34 2.95 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.277 -1.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.93 166.78 15.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.562 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.509 ' HB2' HG21 ' A' ' 35' ' ' THR . 86.9 Cg_endo -81.29 41.72 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.742 2.295 . . . . 0.0 112.482 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.419 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 1.2 m-85 -111.31 156.21 21.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.816 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 59.2 m -94.93 135.62 36.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.355 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.486 HG21 ' HE2' ' A' ' 88' ' ' MET . 6.5 t -122.49 98.94 6.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.292 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.775 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 18.9 t -95.48 128.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.623 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.697 HD11 ' HA ' ' A' ' 80' ' ' PRO . 2.3 mm? -126.96 -178.6 4.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -178.73 3.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.325 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.549 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.18 137.7 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.322 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.511 HD21 ' HG2' ' A' ' 79' ' ' ARG . 2.5 t-20 -74.25 -168.19 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.902 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 37.56 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.474 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.868 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 1.6 tp -72.11 132.25 43.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.572 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 19.9 mm -73.33 -50.6 6.22 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.665 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.868 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 72.8 Cg_exo -49.77 109.99 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.241 1.961 . . . . 0.0 112.353 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.09 -17.79 45.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.125 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.558 HG12 HG13 ' A' ' 110' ' ' ILE . 14.8 p -69.18 -22.6 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.247 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.558 HG13 HG12 ' A' ' 109' ' ' VAL . 45.0 mt -93.88 -43.58 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.025 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.629 ' HA ' HG21 ' A' ' 117' ' ' VAL . 22.1 p -81.28 -6.52 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.05 -169.8 50.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.714 ' HA3' ' HB3' ' A' ' 61' ' ' HIS . . . -78.23 -1.5 80.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.365 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.48 -172.75 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 111.017 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.429 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 3.4 p -106.22 39.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -136.77 153.1 50.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.047 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 111' ' ' THR . 93.8 t -139.81 144.53 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.468 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.48 ' N ' HG13 ' A' ' 117' ' ' VAL . . . -91.32 155.55 23.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.385 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 74' ' ' ILE . 3.8 mt -143.94 151.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.3 ttt180 -144.67 126.79 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.599 HG13 HD12 ' A' ' 92' ' ' LEU . 9.8 t -111.14 78.3 1.71 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 15.2 Cg_exo -69.71 -176.32 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.552 ' H ' HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -91.55 6.48 45.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.83 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 100.2 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -57.47 -45.71 84.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.032 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.599 HG23 HD23 ' A' ' 16' ' ' LEU . 41.9 mt -62.25 -53.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.185 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -24.01 62.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.445 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 1.7 ttm105 -68.95 -36.49 77.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -54.57 12.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.5 mt -60.47 -49.47 84.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 68' ' ' VAL . . . -60.29 -28.91 68.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.821 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.68 -56.7 16.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.35 -89.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -76.69 127.57 83.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.095 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 153.8 72.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.28 1.987 . . . . 0.0 111.628 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 137' ' ' THR . 4.1 t -132.03 155.82 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.119 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.646 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -80.56 139.5 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.031 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -143.24 111.52 6.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.882 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.788 HG21 HD13 ' A' ' 39' ' ' LEU . 2.1 t -140.24 138.15 34.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.545 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 15.0 p -70.6 126.78 30.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.338 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 46.2 Cg_exo . . . . . 0 CA--C 1.537 0.667 0 N-CA-C 113.474 0.529 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 40.6 Cg_endo -67.15 106.49 1.19 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.845 1.697 . . . . 0.0 112.327 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.09 136.5 21.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.511 ' HG2' ' HG2' ' A' ' 151' ' ' ARG . 69.3 Cg_endo -95.71 -12.25 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.865 2.377 . . . . 0.0 112.445 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.511 ' HG2' ' HG2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -128.29 112.34 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.777 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.832 ' HA ' HD12 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -56.49 -32.6 65.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.219 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -24.88 58.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.287 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 2.2 tt0 -72.51 -31.01 65.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.509 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -75.22 -51.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.313 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 157' ' ' ARG . 7.8 p -62.03 -36.32 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.54 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.506 ' N ' HG13 ' A' ' 156' ' ' VAL . 5.4 mmt85 -72.73 -51.15 20.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.338 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.18 -24.57 64.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.433 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.699 HD13 HG22 ' A' ' 155' ' ' ILE . 40.5 mt -111.22 79.46 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.143 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.2 t70 -28.15 -51.2 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.223 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -161.65 26.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.74 -92.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.654 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -89.95 88.51 7.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.489 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -56.26 129.39 40.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.388 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.82 ' HA ' HD12 ' A' ' 30' ' ' ILE . 35.4 m -66.37 -172.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.21 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.74 HD22 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.78 156.25 41.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -92.62 -19.6 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.4 -50.74 7.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.74 ' HA2' HD22 ' A' ' 166' ' ' LEU . . . 94.11 -157.02 22.52 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.909 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.07 -163.26 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.623 0.249 . . . . 0.0 111.105 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 m -150.18 -60.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.519 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -123.57 -130.19 0.26 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.519 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.6 OUTLIER -86.31 144.77 27.21 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.82 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.668 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.6 ttp -68.79 -15.71 63.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -154.51 160.83 30.53 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.582 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 70.2 Cg_endo -89.43 -142.41 0.16 OUTLIER 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.548 0.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 73.1 m -153.88 131.86 11.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.834 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 75.9 m -102.33 142.13 34.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.816 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 19.2 t -129.08 110.4 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.006 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.485 HG12 HG13 ' A' ' 189' ' ' VAL . 5.4 mt -120.69 125.08 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.182 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.775 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -102.32 66.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.473 ' CD2' ' HB2' ' A' ' 88' ' ' MET . 21.7 tp -69.58 83.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.527 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -80.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.447 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.2 t -120.73 -121.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.166 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.446 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -62.66 -52.86 61.7 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.1 109.61 2.73 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.208 1.938 . . . . 0.0 112.445 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 93.9 Cg_endo -80.45 127.83 6.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.615 2.21 . . . . 0.0 112.329 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.549 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -88.39 45.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.485 HG13 HG12 ' A' ' 180' ' ' ILE . 9.1 t -56.87 96.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.791 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.24 84.7 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.149 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.02 140.02 30.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 192' ' ' ARG . 1.2 mtt85 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.823 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.455 ' HB2' HD21 ' A' ' 16' ' ' LEU . 51.4 Cg_exo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.888 0.287 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -35.74 79.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.147 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.27 -53.21 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.167 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 126' ' ' ILE . 3.3 mm? -60.06 -32.62 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.623 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.98 67.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.788 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -36.6 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.34 -42.8 53.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -66.97 -30.14 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.114 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.8 p -66.5 -44.49 82.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.061 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 18' ' ' GLU . 35.7 t -65.32 -29.45 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.5 mmt -62.7 -44.6 95.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -17.74 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.86 89.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.98 39.78 93.29 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.51 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.84 171.93 15.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.67 ' HA ' HG11 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -96.17 140.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.61 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -116.55 130.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.197 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.623 ' HB ' ' HE1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -101.68 168.89 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.574 0.226 . . . . 0.0 110.756 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.595 ' HH ' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -169.48 102.4 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HG2' ' HA ' ' A' ' 170' ' ' ASP . 89.3 Cg_endo -83.06 143.74 11.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.544 2.163 . . . . 0.0 111.888 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -123.16 -160.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -66.83 -25.35 66.4 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.747 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -88.7 -89.9 0.14 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.257 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.405 HG13 ' HE1' ' A' ' 174' ' ' MET . 1.3 tt -133.68 174.99 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 111.06 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.623 ' HE1' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -68.21 143.16 55.43 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.82 177.13 19.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.745 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.788 ' HB2' HG22 ' A' ' 139' ' ' THR . 3.0 mt -125.55 144.38 50.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.87 0.367 . . . . 0.0 110.553 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.57 125.59 2.35 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.024 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -156.58 178.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 111.105 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.43 122.73 12.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.317 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.84 -60.67 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.05 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.4 mm? -81.07 37.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.1 149.76 30.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -75.14 -18.59 60.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -26.64 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.71 -44.55 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.997 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -35.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -38.87 78.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.671 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.58 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.3 -45.18 70.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.781 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.544 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.3 OUTLIER -60.83 -25.83 66.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.784 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -72.88 -34.82 66.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.27 -49.81 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.358 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 70.9 t -65.27 -49.85 76.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.588 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.587 ' HE2' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -79.75 -6.38 57.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 111.18 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.43 -92.05 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.64 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.86 116.05 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.458 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 60.8 p -155.11 57.44 1.65 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.09 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 59' ' ' SER . 50.7 Cg_exo -54.11 -57.18 1.98 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.411 2.074 . . . . 0.0 112.285 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.06 30.32 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HD3' ' HE2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.54 135.77 33.86 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.826 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.92 160.79 45.34 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 112.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 m -118.75 162.51 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 t -110.6 141.15 44.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.97 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.483 HG13 HG12 ' A' ' 119' ' ' ILE . 5.9 pt -116.49 167.34 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.01 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -119.78 135.7 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.714 ' HA ' ' HB2' ' A' ' 131' ' ' ALA . 1.3 p -141.53 -178.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.634 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.616 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 21.6 t -89.71 -41.86 11.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.564 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.18 170.69 16.02 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG13 ' SD ' ' A' ' 85' ' ' MET . 8.2 t -57.52 -37.63 59.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -67.41 -21.89 65.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.159 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -77.15 -26.27 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.527 HG22 HG21 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -113.48 58.81 0.74 Allowed Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 77' ' ' PHE . 21.5 Cg_endo -60.49 -84.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.066 1.844 . . . . 0.0 111.965 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.57 23.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.389 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' PRO . 26.0 m-85 -98.9 -31.78 11.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.673 0.273 . . . . 0.0 111.228 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.438 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -135.08 178.31 7.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.083 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -113.23 90.21 16.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 78' ' ' SER . 69.2 Cg_endo -102.23 176.39 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.049 2.499 . . . . 0.0 112.645 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -177.31 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.046 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.03 -75.23 0.74 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.516 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -59.19 -29.95 67.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.821 0.343 . . . . 0.0 110.856 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.74 -47.34 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.473 ' SD ' HG13 ' A' ' 71' ' ' VAL . 9.5 mmt -74.21 -18.63 60.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.161 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.4 mm-40 -63.01 -45.18 93.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.524 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.586 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.583 ' HG2' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.92 -58.24 8.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.306 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -4.0 16.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.321 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -56.33 4.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.048 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.45 71.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.583 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.587 ' H ' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.35 151.76 79.36 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.997 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.712 ' HB3' HG21 ' A' ' 121' ' ' VAL . 5.5 Cg_exo -78.36 -148.45 0.5 Allowed 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.175 -0.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.67 163.6 12.55 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.723 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.747 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 92.8 Cg_endo -81.6 35.2 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.756 2.304 . . . . 0.0 112.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.721 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 44.9 p90 -112.26 162.86 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.8 m -115.23 124.86 52.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 182' ' ' LEU . 2.4 p -108.31 109.01 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.131 0.491 . . . . 0.0 110.982 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.601 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 44.7 t -103.72 128.61 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.147 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.628 HD12 HD12 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -126.59 -165.87 1.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.308 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.69 -176.05 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.683 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.7 143.33 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.994 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -74.73 -170.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -76.49 55.2 0.99 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.207 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.784 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 24.1 tp -88.79 129.63 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.619 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 11.4 mm -72.02 -52.47 7.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.784 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 75.6 Cg_exo -50.88 100.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.304 2.003 . . . . 0.0 112.536 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.454 ' HA ' ' HG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -82.04 1.08 37.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 110' ' ' ILE . 10.4 p -70.8 -26.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.097 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -107.48 -29.51 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.454 ' HG1' ' HA ' ' A' ' 108' ' ' ASP . 19.8 p -78.76 -18.08 54.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.937 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.13 -169.21 54.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.375 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.08 -8.39 83.08 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.401 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.2 p -114.68 -175.46 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.513 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 74.8 m -111.63 62.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -143.22 138.21 29.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 102' ' ' ARG . 97.8 t -139.94 140.28 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.356 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.35 157.08 19.95 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.643 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.628 HD12 HD12 ' A' ' 100' ' ' LEU . 27.8 mt -146.23 151.74 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -146.39 137.71 24.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.459 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.712 HG21 ' HB3' ' A' ' 93' ' ' PRO . 2.7 p -110.6 87.72 6.88 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.489 ' HB2' HG22 ' A' ' 33' ' ' THR . 55.2 Cg_endo -70.39 -179.74 3.42 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.411 2.074 . . . . 0.0 112.628 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.29 -4.49 57.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.975 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 7.1 m-20 -62.33 103.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -45.98 83.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.546 HG22 HD13 ' A' ' 16' ' ' LEU . 41.5 mm -59.48 -50.8 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -63.56 -20.93 66.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.653 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -74.98 -27.21 60.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.492 ' O ' ' HB1' ' A' ' 132' ' ' ALA . 0.1 OUTLIER -75.05 -60.6 2.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.9 mt -57.79 -48.15 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.178 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -62.09 -29.87 70.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.358 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.6 -54.92 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 110.028 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -75.92 -89.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.26 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -77.04 141.07 67.03 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.09 153.77 46.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.303 2.002 . . . . 0.0 111.577 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.98 156.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.677 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.7 m -80.38 129.97 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.027 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.53 102.9 6.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.846 0.355 . . . . 0.0 111.856 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.788 HG22 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -130.28 141.76 50.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 p -61.72 125.52 24.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.692 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 111.373 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.456 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.4 Cg_exo . . . . . 0 CA--C 1.537 0.663 0 N-CA-C 113.246 0.441 . . . . 0.0 113.246 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 21.6 Cg_exo -65.24 100.22 0.37 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.008 1.805 . . . . 0.0 112.112 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.21 149.25 40.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.994 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -95.37 -18.03 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.858 2.372 . . . . 0.0 112.433 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -136.94 130.34 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.524 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.774 ' HA ' HD13 ' A' ' 155' ' ' ILE . 9.2 tp -56.78 -41.92 78.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.139 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.43 -38.01 88.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -58.66 -49.21 78.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -61.16 -39.32 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.493 ' HA ' HD11 ' A' ' 159' ' ' LEU . 57.7 t -52.46 -37.66 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.728 0.299 . . . . 0.0 111.399 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.39 86.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.495 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.85 -22.69 55.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.158 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.691 HD22 ' HB ' ' A' ' 155' ' ' ILE . 2.0 pp -108.65 43.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -16.8 -58.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.342 0.657 . . . . 0.0 112.535 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.38 10.06 0.43 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.52 HG11 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -80.87 -82.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.247 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.599 ' HA ' HG22 ' A' ' 28' ' ' ILE . 2.0 p-10 -100.51 92.7 5.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.796 0.331 . . . . 0.0 110.783 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 159' ' ' LEU . 0.6 OUTLIER -65.42 130.7 44.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.736 -178.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.597 HG12 HD12 ' A' ' 155' ' ' ILE . 27.0 m -59.98 -171.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.26 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.579 ' O ' HD21 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -126.76 156.05 41.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.51 -7.81 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.595 ' HB3' ' HH ' ' A' ' 31' ' ' TYR . . . -84.58 -40.12 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.892 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.88 -178.82 43.95 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.484 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.424 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 14.7 p-10 -70.73 -159.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.501 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 39.6 m -136.78 -59.66 0.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.262 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.71 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -135.85 -116.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.387 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 58.4 m-20 -86.13 150.63 24.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.405 ' HE1' HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.66 -15.07 62.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 178.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 6.2 pt-20 -153.07 160.6 30.75 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.668 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.519 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 66.0 Cg_endo -95.27 -139.56 0.13 OUTLIER 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.249 -1.146 . . . . 0.0 112.648 0.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.434 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 7.6 t -154.01 146.54 24.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.721 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 69.5 m -101.19 142.96 31.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.122 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.11 97.1 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.699 HG12 ' HA ' ' A' ' 189' ' ' VAL . 25.3 mt -109.94 131.58 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.211 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.6 ' HB3' ' HE ' ' A' ' 188' ' ' ARG . 0.2 OUTLIER -108.43 65.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.004 0.43 . . . . 0.0 110.571 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.669 ' HB3' HG23 ' A' ' 98' ' ' VAL . 19.0 tp -69.29 89.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -78.41 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 0.0 110.858 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -128.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.476 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 2.1 t-20 -59.68 -52.23 75.43 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.0 Cg_exo -76.92 108.9 2.74 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.497 2.131 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 94.1 Cg_endo -80.72 134.23 9.64 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.519 2.146 . . . . 0.0 112.037 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.6 ' HE ' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -96.31 45.91 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.274 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.699 ' HA ' HG12 ' A' ' 180' ' ' ILE . 20.2 t -56.63 103.81 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.21 93.26 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.452 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -85.07 149.54 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.769 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.038 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.823 0.259 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -69.81 -42.45 73.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.028 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -67.75 -25.22 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD22 HG22 ' A' ' 126' ' ' ILE . 2.0 mm? -70.98 -52.21 21.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.086 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -69.19 -14.53 63.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.25 -34.72 59.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.566 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.12 -42.98 55.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.776 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -75.55 -20.22 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.734 0.302 . . . . 0.0 111.274 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.422 ' N ' HD13 ' A' ' 20' ' ' ILE . 46.0 t -70.35 -48.5 56.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.52 -28.16 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.128 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 21.9 mtt -62.47 -38.57 90.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.064 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -70.29 -20.54 63.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.82 5.05 62.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.29 38.92 94.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.91 168.51 15.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.504 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.799 ' HA ' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -96.45 148.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.434 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.438 ' N ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -119.1 146.94 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER -114.78 164.85 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.272 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.91 103.42 0.32 Allowed Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD3' HD13 ' A' ' 166' ' ' LEU . 3.5 Cg_exo -79.79 137.03 12.38 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.769 2.312 . . . . 0.0 111.408 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.82 -151.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.738 0.304 . . . . 0.0 111.161 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -54.87 -20.95 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.606 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -100.1 -114.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.126 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.611 HG22 ' HG2' ' A' ' 174' ' ' MET . 0.0 OUTLIER -112.55 -163.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.353 . . . . 0.0 110.995 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.86 131.38 47.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.586 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.88 174.68 15.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.067 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.576 HD13 HG21 ' A' ' 139' ' ' THR . 2.5 mt -133.25 138.52 46.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.821 0.343 . . . . 0.0 111.132 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.1 121.16 1.48 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.836 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 28' ' ' ILE . 5.3 p -159.76 163.97 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.712 0.292 . . . . 0.0 111.221 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.721 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -55.25 102.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.01 0.434 . . . . 0.0 110.944 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -68.12 -41.74 81.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.938 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' HD21 ' A' ' 44' ' ' LEU . 4.3 mm? -76.26 12.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.306 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.721 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.46 150.46 28.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -19.53 60.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.77 -30.0 70.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.1 -22.89 57.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.22 -54.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -63.88 -40.25 96.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 8.2 mmt180 -64.18 -38.86 92.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -68.16 -18.4 64.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.798 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -36.76 62.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.2 -40.69 90.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.7 t -73.89 -52.96 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -79.38 -76.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.902 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 17.27 32.9 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.697 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -68.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.349 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.51 ' HB3' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -136.78 76.26 47.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.852 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.11 27.21 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 0.0 112.597 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.51 ' NE2' ' HB3' ' A' ' 59' ' ' SER . 23.7 p80 -105.28 -21.91 13.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.958 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.33 154.3 90.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.973 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HB3' ' O ' ' A' ' 116' ' ' ARG . 75.6 Cg_exo -50.62 154.88 5.96 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.597 2.198 . . . . 0.0 112.46 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 m -114.54 151.31 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -96.48 136.61 36.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.689 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.647 HD13 HD12 ' A' ' 74' ' ' ILE . 14.4 pt -116.27 172.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.27 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.676 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 12.5 t -117.87 135.57 54.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.974 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.24 174.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.604 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.47 -47.63 15.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.992 0.425 . . . . 0.0 110.462 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.17 176.3 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.449 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.573 HG12 ' HG3' ' A' ' 85' ' ' MET . 2.8 t -59.13 -33.74 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.764 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -67.54 -27.65 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.156 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.633 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 1.2 mp0 -80.43 -17.21 52.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.217 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.671 HG12 ' HB2' ' A' ' 78' ' ' SER . 21.5 tt -114.65 50.71 0.59 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.633 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 37.4 Cg_exo -59.07 -84.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.046 1.83 . . . . 0.0 113.182 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.42 12.27 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -177.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.654 ' HB3' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -107.77 -17.03 14.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.969 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.671 ' HB2' HG12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.5 177.22 7.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.889 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 12.4 mtp180 -129.81 85.43 58.05 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -101.96 -175.29 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.059 2.506 . . . . 0.0 112.853 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 85' ' ' MET . 1.3 m -140.4 179.9 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.878 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.25 -74.0 0.92 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.39 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.047 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.573 ' HG3' HG12 ' A' ' 71' ' ' VAL . 9.6 mmt -70.64 -16.32 62.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.169 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 41.3 mm-40 -64.89 -50.47 66.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.595 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.94 -35.98 80.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.6 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 36.3 mmm -65.6 -45.43 83.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.279 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.94 -16.89 62.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 111.117 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -39.1 63.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.38 40.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.798 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.692 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 4.8 tt -129.54 137.91 31.97 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.692 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 96.8 Cg_endo -78.45 -161.66 2.76 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.351 -0.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.98 167.06 16.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.928 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HB2' HG22 ' A' ' 35' ' ' THR . 92.2 Cg_endo -79.85 44.35 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.919 2.412 . . . . 0.0 112.359 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.432 ' OH ' HD11 ' A' ' 92' ' ' LEU . 10.6 p90 -112.19 141.24 46.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 m -102.55 112.51 25.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 180' ' ' ILE . 3.5 p -108.39 123.98 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.0 111.672 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.544 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 21.3 t -102.45 129.42 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.941 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.647 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 0.8 OUTLIER -126.88 177.17 6.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.802 -178.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.647 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 10.0 mt-10 -74.09 172.94 10.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.68 ' HB3' HG22 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -119.71 143.56 47.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.409 . . . . 0.0 111.477 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.472 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.13 -164.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.481 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.39 56.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.405 HD21 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -74.15 136.2 42.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.605 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.6 mt -80.16 -51.39 1.09 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.457 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 40.4 Cg_exo -57.75 103.35 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.328 2.019 . . . . 0.0 112.418 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.78 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 m -76.21 -17.39 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.2 -32.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.104 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 p -74.41 -26.79 60.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.5 -163.56 54.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.61 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.15 -3.06 80.87 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.483 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.9 m -114.68 171.32 7.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.426 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 33.5 p -103.87 59.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.585 ' HG2' ' HA ' ' A' ' 101' ' ' GLU . 9.6 mtm105 -152.31 149.1 28.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.022 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.68 HG22 ' HB3' ' A' ' 102' ' ' ARG . 77.7 t -139.8 131.81 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.589 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -78.68 167.6 53.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -147.04 162.48 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttt85 -149.14 125.62 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 111.463 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.03 77.79 1.52 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.706 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.641 ' HB2' HG23 ' A' ' 33' ' ' THR . 73.2 Cg_endo -75.34 -178.65 4.39 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.478 2.118 . . . . 0.0 112.605 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.28 -4.02 58.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 0.3 OUTLIER -62.8 99.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 45.3 mt-10 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.673 HG22 HD22 ' A' ' 16' ' ' LEU . 37.4 mt -60.08 -50.16 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.955 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -61.22 -24.57 66.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.819 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 15.9 mtm180 -70.12 -32.56 70.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.148 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -59.61 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 mt -58.92 -49.25 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.567 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 127' ' ' CYS . . . -61.61 -29.32 69.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.406 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 128' ' ' ARG . . . -54.64 -56.64 16.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 109.909 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.4 ' HB2' ' H ' ' A' ' 134' ' ' PHE . 2.5 mmt85 -76.44 -88.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.166 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.4 ' H ' ' HB2' ' A' ' 133' ' ' ARG . 27.1 m-85 -76.64 117.56 65.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.45 152.03 83.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.321 2.014 . . . . 0.0 111.319 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -134.46 169.55 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 111.472 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.659 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.2 m -80.85 138.8 36.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.492 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . . . -136.99 96.54 3.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.277 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.576 HG21 HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -125.72 145.33 50.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.32 117.07 22.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.186 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 179.514 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.479 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 36.0 Cg_exo . . . . . 0 CA--C 1.537 0.653 0 N-CA-C 113.404 0.502 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.1 Cg_exo -65.65 87.75 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.03 1.82 . . . . 0.0 112.175 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.451 ' HG ' HG21 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -96.62 142.97 25.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.911 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -95.74 -16.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.557 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -132.37 121.25 23.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.693 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.839 ' HA ' HD11 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -58.04 -38.7 76.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.195 -179.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.719 ' HA ' HG23 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -67.24 -41.48 85.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.29 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.0 -38.38 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.839 HD11 ' HA ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -71.94 -33.23 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 153' ' ' GLU . 21.6 t -53.42 -47.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.476 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -69.37 -32.45 71.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.861 0.363 . . . . 0.0 110.77 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -21.69 56.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.244 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.669 HD13 ' HA ' ' A' ' 164' ' ' LEU . 2.6 pp -98.76 43.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 159' ' ' LEU . 13.8 t0 -17.53 -54.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.709 0.63 . . . . 0.0 112.254 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -160.75 11.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.569 HG11 ' H ' ' A' ' 163' ' ' ASP . 1.4 p -81.84 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.859 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.657 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -108.24 96.19 6.19 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.743 0.306 . . . . 0.0 111.396 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.669 ' HA ' HD13 ' A' ' 159' ' ' LEU . 1.4 mm? -64.16 139.77 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.676 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.73 ' HB ' HD21 ' A' ' 152' ' ' LEU . 3.4 m -61.03 -174.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.508 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.698 HD23 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.32 145.6 50.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.739 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.85 -22.49 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.72 -52.79 5.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.138 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.698 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 96.64 -160.34 21.82 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.48 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.07 -163.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.415 ' HB3' ' N ' ' A' ' 34' ' ' ASP . 49.1 t -145.34 -57.4 0.33 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.612 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -126.16 -130.07 0.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.536 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.3 OUTLIER -86.16 147.63 26.05 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -177.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.611 ' HG2' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.21 -23.3 66.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 158.84 33.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.684 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 177' ' ' SER . 64.9 Cg_endo -90.95 -149.86 0.35 Allowed 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.024 -1.24 . . . . 0.0 112.663 1.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 89.1 p -154.67 153.74 31.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 191' ' ' ARG . 0.3 OUTLIER -99.91 141.58 32.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.0 t -129.05 78.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.754 HG12 ' HA ' ' A' ' 189' ' ' VAL . 23.2 mt -101.67 131.32 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.209 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 188' ' ' ARG . 6.9 t70 -108.78 61.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.3 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.492 ' HB3' HG22 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -70.14 100.15 1.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.333 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 -73.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.813 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.56 -109.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.028 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.488 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -74.63 -52.76 3.56 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.466 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 4.8 Cg_exo -77.68 108.0 2.48 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.496 2.131 . . . . 0.0 112.237 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 98.7 Cg_endo -79.46 131.15 9.34 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 3.8 mmt85 -86.65 53.12 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.973 0.416 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.754 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.93 107.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.12 82.73 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.795 ' HB3' HG21 ' A' ' 178' ' ' THR . 5.3 ptm180 -89.57 142.07 28.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.023 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.525 ' HD2' HD22 ' A' ' 16' ' ' LEU . 73.2 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.85 0.271 . . . . 0.0 112.352 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.05 -28.25 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.665 HG22 ' HB3' ' A' ' 167' ' ' ASP . 82.7 t -57.5 -62.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.18 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.767 HD13 HG12 ' A' ' 126' ' ' ILE . 2.9 mp -60.53 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.366 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.06 -29.61 67.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.482 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.97 -31.9 59.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.329 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.64 56.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.326 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 16' ' ' LEU . 2.2 pp -75.21 -22.05 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 0.0 111.224 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -69.08 -53.15 21.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG11 HD23 ' A' ' 164' ' ' LEU . 7.6 p -64.4 -28.62 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.4 mtt -57.09 -51.15 70.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.64 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.37 9.15 74.72 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.707 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 39.42 92.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.723 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.56 168.58 13.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.192 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.763 HD12 HG13 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -96.29 141.28 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.619 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -116.19 110.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.078 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER -100.49 151.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 111.247 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -154.33 114.12 2.48 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.171 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD3' HD12 ' A' ' 166' ' ' LEU . 68.4 Cg_endo -84.9 139.25 7.31 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.81 2.34 . . . . 0.0 111.391 176.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -119.2 -149.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.708 0.289 . . . . 0.0 111.457 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -54.82 -23.75 19.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.561 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.412 ' OG1' HG13 ' A' ' 36' ' ' ILE . 2.1 t -100.48 -114.94 0.17 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.011 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.71 -166.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.892 0.377 . . . . 0.0 111.592 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.59 138.57 55.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -130.98 168.71 21.86 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.116 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 139' ' ' THR . 8.3 mp -113.91 143.71 44.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.741 0.305 . . . . 0.0 110.863 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.13 112.97 0.68 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.763 HG13 HD12 ' A' ' 28' ' ' ILE . 18.6 m -151.52 172.41 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.748 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.87 95.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.233 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.54 84.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.998 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HG ' HD13 ' A' ' 110' ' ' ILE . 2.5 mp -67.38 -29.77 69.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 111.417 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -86.51 154.24 21.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.026 -177.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -60.58 -12.4 9.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.062 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -60.75 -34.03 73.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 110.262 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 41' ' ' VAL . . . -76.28 -49.32 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.493 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 46' ' ' GLU . 8.1 p -59.66 -20.9 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.195 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.07 -57.84 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 179.312 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -63.17 -25.43 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.721 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.879 HD23 HG21 ' A' ' 64' ' ' VAL . 1.7 mp -63.64 -54.43 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.768 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -54.57 -28.91 49.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.082 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -67.48 -57.26 6.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.605 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.9 t -75.55 -56.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.5 5.86 11.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.47 -121.85 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.353 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.04 109.24 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.0 111.015 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.609 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -148.25 66.8 9.53 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.82 -7.51 20.86 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.53 2.153 . . . . 0.0 112.306 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.544 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 21.7 m-70 -103.79 -19.14 14.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -85.96 132.51 43.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.8 166.22 27.01 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.433 2.089 . . . . 0.0 112.057 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.879 HG21 HD23 ' A' ' 52' ' ' LEU . 12.1 p -112.97 141.91 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.153 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.74 138.39 32.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.762 HD13 HG23 ' A' ' 119' ' ' ILE . 1.5 pp -115.99 174.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.534 ' SG ' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -122.23 132.68 54.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.538 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.769 HG21 HG22 ' A' ' 74' ' ' ILE . 1.2 p -138.47 179.83 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.731 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.819 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 3.0 t -90.09 -41.8 11.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.63 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.72 170.67 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.513 ' HA ' HD12 ' A' ' 74' ' ' ILE . 5.2 t -57.52 -38.54 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.13 -24.45 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.985 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.819 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 56.2 mm-40 -76.04 -20.89 57.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.775 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.769 HG22 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.55 61.84 0.9 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.729 178.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 28.9 Cg_exo -61.94 -79.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.086 1.858 . . . . 0.0 112.226 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -73.25 22.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 75' ' ' PRO . 1.1 t80 -100.56 -48.9 4.38 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.954 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.605 ' HG ' HD11 ' A' ' 74' ' ' ILE . 80.7 p -131.38 -179.98 5.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -129.14 101.61 19.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 88.2 Cg_endo -102.4 -172.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.143 2.562 . . . . 0.0 112.634 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.19 -171.86 3.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.14 -82.08 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.629 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 1.1 m-20 -56.43 -26.11 52.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.67 71.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.509 ' SD ' HG21 ' A' ' 71' ' ' VAL . 27.0 mmt -74.27 -12.89 60.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.75 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 1.8 mt-10 -70.68 -50.28 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.487 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.7 tp -63.96 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.833 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.629 ' HB2' HD12 ' A' ' 182' ' ' LEU . 7.9 tpt -75.01 -42.41 57.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.383 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.542 ' HA ' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -61.55 -23.7 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.715 -178.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.1 ptm180 -75.84 -36.21 59.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.472 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 pt -103.61 14.94 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.064 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' HG3' ' A' ' 88' ' ' MET . 0.3 OUTLIER -130.97 152.77 81.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.823 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.17 -174.38 14.66 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.563 -1.432 . . . . 0.0 112.67 0.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.61 -174.63 32.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.473 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 96.0 Cg_endo -79.87 39.29 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.597 2.198 . . . . 0.0 112.29 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.13 160.92 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.815 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 27.2 m -107.54 131.05 54.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.512 HG11 ' SD ' ' A' ' 88' ' ' MET . 3.8 t -114.29 107.34 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.828 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 5.5 t -102.89 131.02 52.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 182' ' ' LEU . 3.1 mm? -126.75 177.95 6.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.469 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 177.03 6.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.745 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -119.65 141.09 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.189 0.518 . . . . 0.0 111.429 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.553 ' H ' HD21 ' A' ' 103' ' ' ASN . 0.7 OUTLIER -74.8 -167.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.426 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -76.91 37.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.506 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.27 116.47 9.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.909 0.385 . . . . 0.0 110.786 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 25.5 mm -63.55 -48.55 80.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.159 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.5 Cg_exo -49.63 108.9 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.092 1.862 . . . . 0.0 112.483 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -2.62 48.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.858 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 110' ' ' ILE . 10.5 p -71.78 -27.03 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.73 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.62 HG13 HG13 ' A' ' 109' ' ' VAL . 4.4 mt -101.2 -35.6 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.686 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.549 HG23 ' HG2' ' A' ' 102' ' ' ARG . 2.0 m -73.88 -30.69 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.81 -143.01 27.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.357 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -89.98 -18.29 51.1 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.1 m -106.61 -172.08 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.704 0.288 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.2 m -113.12 42.44 1.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 116' ' ' ARG . 5.7 mtm-85 -136.63 156.36 48.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 102' ' ' ARG . 62.0 t -140.15 145.52 26.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -99.2 159.18 20.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.227 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.762 HG23 HD13 ' A' ' 66' ' ' ILE . 9.3 mt -142.57 159.89 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.621 ' H ' HG21 ' A' ' 119' ' ' ILE . 7.0 ttp85 -151.12 124.7 9.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 111.151 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.48 87.96 7.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.71 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HB2' HG22 ' A' ' 33' ' ' THR . 60.2 Cg_endo -72.25 -179.97 4.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.409 2.072 . . . . 0.0 112.47 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.506 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -93.0 17.92 9.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.182 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 109.77 15.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.01 -47.01 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.106 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.767 HG12 HD13 ' A' ' 16' ' ' LEU . 2.2 mp -64.39 -52.08 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.482 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 95.8 m -59.32 -16.15 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 69' ' ' SER . 31.7 ttt180 -74.94 -46.98 31.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -66.89 -48.88 67.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.388 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.616 HD13 HG21 ' A' ' 126' ' ' ILE . 37.9 mt -61.23 -55.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.192 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 127' ' ' CYS . . . -61.53 -26.42 67.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.228 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 128' ' ' ARG . . . -54.7 -57.1 12.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -76.0 -87.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.072 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.9 124.7 87.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.401 ' C ' HG21 ' A' ' 136' ' ' VAL . 59.6 Cg_endo -71.44 151.63 59.57 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.341 2.027 . . . . 0.0 111.879 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.534 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.6 t -131.42 157.71 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.046 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.689 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.4 OUTLIER -80.75 136.64 36.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.071 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -129.27 98.39 4.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 111.349 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -128.21 105.13 8.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.623 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.829 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 78.5 p -61.71 128.56 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.842 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 37.7 Cg_exo . . . . . 0 CA--C 1.537 0.669 0 N-CA-C 113.484 0.532 . . . . 0.0 113.484 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 57.1 Cg_endo -69.94 97.68 0.66 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.804 1.669 . . . . 0.0 112.198 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m -89.75 135.19 30.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -95.2 -43.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.752 2.301 . . . . 0.0 112.718 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.697 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 4.2 ttt180 -131.69 137.47 48.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.695 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.521 HD21 HG12 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -61.01 -40.67 94.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.427 ' HA ' HG13 ' A' ' 156' ' ' VAL . 0.2 OUTLIER -72.97 -19.93 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.697 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 3.7 tm-20 -67.29 -40.98 86.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.723 HD12 HG21 ' A' ' 165' ' ' VAL . 5.4 mt -70.06 -48.46 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.346 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 153' ' ' GLU . 4.5 p -61.76 -31.02 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.318 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ttt180 -75.36 -52.95 9.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.113 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.732 ' HB3' HD23 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -60.07 -38.62 83.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.179 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 158' ' ' ASP . 2.7 mm? -109.29 73.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -37.19 -39.83 0.29 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.25 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.84 11.88 0.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.606 0.241 . . . . 0.0 111.597 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 5.3 t -80.67 -81.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.755 ' HA ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -104.34 99.39 9.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.469 HD23 HG11 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -73.68 127.87 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -178.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.825 HG22 ' H ' ' A' ' 166' ' ' LEU . 3.5 p -65.19 -163.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.825 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.68 143.55 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.976 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.665 ' HB3' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -92.31 -14.96 28.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.24 -41.73 16.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.425 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.53 -167.67 28.8 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.163 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.428 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 3.0 p30 -73.1 -165.11 0.21 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.75 0.31 . . . . 0.0 111.022 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -61.4 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.724 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -126.33 -132.57 0.25 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -86.88 165.16 16.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.87 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.468 ' O ' HG12 ' A' ' 36' ' ' ILE . 1.8 ttp -70.33 -8.96 54.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.839 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.14 162.17 36.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -97.5 -148.97 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.71 1.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.27 110.31 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.423 HG23 HD11 ' A' ' 180' ' ' ILE . 95.6 m -101.46 138.72 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.198 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.815 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.0 t -129.24 109.24 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.69 HG12 HG13 ' A' ' 189' ' ' VAL . 4.5 mt -117.84 137.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.828 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.2 m-20 -108.0 67.44 0.68 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.629 HD12 ' HB2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -69.5 83.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.354 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.25 -83.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.523 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.96 -100.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.282 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.451 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -83.9 -51.82 0.6 Allowed Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -73.84 110.4 3.07 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.125 1.883 . . . . 0.0 112.259 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.5 Cg_endo -82.15 118.1 2.94 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.673 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -86.94 49.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.69 HG13 HG12 ' A' ' 180' ' ' ILE . 6.6 t -56.6 104.01 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.012 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.03 77.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.017 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -83.81 131.66 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.493 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.709 0.212 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -40.26 84.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 12.3 t -66.9 -34.01 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.014 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.724 HD23 HG21 ' A' ' 126' ' ' ILE . 1.2 mm? -68.95 -46.63 67.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -61.5 -21.55 64.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.161 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -75.18 -36.68 61.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.632 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.21 80.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.78 -32.26 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -59.99 -38.73 83.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 t -67.82 -34.68 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.566 ' HE2' ' HA ' ' A' ' 41' ' ' VAL . 15.0 mmt -56.06 -40.87 74.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.96 -23.14 58.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.21 -2.35 74.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.507 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.67 57.91 10.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.99 163.18 22.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.491 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.641 ' HA ' HG21 ' A' ' 41' ' ' VAL . 1.2 tp -96.21 143.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.772 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.44 120.32 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.543 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -101.58 149.96 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 0.0 110.981 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -153.18 100.08 2.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.005 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 2.5 Cg_endo -78.53 134.0 12.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.824 2.349 . . . . 0.0 110.791 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.531 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 93.9 m -138.35 -85.44 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.664 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 3.0 m-20 -74.46 -72.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.561 -177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 ' SD ' ' A' ' 174' ' ' MET . 1.0 OUTLIER -77.72 -86.89 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.047 -177.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.566 HG13 ' H ' ' A' ' 37' ' ' TYR . 3.9 tp -133.33 -155.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.672 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.566 ' H ' HG13 ' A' ' 36' ' ' ILE . 8.9 m-85 -63.27 131.5 48.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.37 172.85 14.42 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.177 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -118.2 135.85 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.96 0.41 . . . . 0.0 111.113 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.76 114.44 0.72 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.769 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 28' ' ' ILE . 1.5 p -158.12 175.88 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.638 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -56.35 118.55 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.592 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HA ' ' HG1' ' A' ' 137' ' ' THR . . . -59.85 -56.24 24.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.03 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 44' ' ' LEU . 2.6 mm? -82.29 37.52 0.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.926 0.393 . . . . 0.0 111.45 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.638 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.14 153.98 24.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.861 178.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -71.5 -29.16 64.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.833 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.04 -33.35 75.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.02 -35.99 74.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.78 -44.03 89.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.036 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -66.12 -43.11 88.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HA ' HH11 ' A' ' 51' ' ' ARG . 7.2 mmt-85 -70.96 -24.71 62.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.633 HD13 HG23 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -71.83 -44.99 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.985 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -20.47 62.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.41 -49.77 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.503 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 48.0 t -75.55 -40.36 41.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.439 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.95 -12.23 59.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.94 -108.0 2.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.533 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -118.19 90.6 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.049 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 m -153.79 70.7 6.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.12 14.98 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.566 2.177 . . . . 0.0 112.594 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -121.06 -19.02 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.951 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 131.68 49.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.01 175.34 1.01 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.555 2.17 . . . . 0.0 112.247 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.633 HG23 HD13 ' A' ' 52' ' ' LEU . 10.0 p -112.98 152.07 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 4.8 t -93.93 129.0 40.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.5 mm -107.98 161.51 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 51.4 t -122.23 127.44 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.71 HG21 ' HB2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -140.84 177.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.575 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.71 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -87.18 -41.76 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 110.462 179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.42 170.57 15.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.799 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.774 HG13 ' HE1' ' A' ' 85' ' ' MET . 5.1 t -59.03 -33.07 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -24.91 66.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.668 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.71 ' HB2' HG21 ' A' ' 68' ' ' VAL . 73.5 mm-40 -78.06 -21.04 51.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -113.66 56.52 0.69 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.625 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -58.68 -85.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.033 1.822 . . . . 0.0 112.11 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.458 ' H ' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -73.17 18.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.59 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 25.2 m-85 -92.34 -34.42 14.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.76 0.315 . . . . 0.0 110.958 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.673 ' HB2' HD21 ' A' ' 100' ' ' LEU . 57.1 p -135.37 -178.14 4.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.837 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.807 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 6.5 mmt180 -114.1 83.76 8.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.667 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 76.4 Cg_endo -102.46 178.46 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.111 2.541 . . . . 0.0 113.036 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -129.93 179.43 5.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.932 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.19 -78.63 0.63 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.762 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -55.08 -31.39 61.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 184' ' ' VAL . . . -60.73 -41.14 94.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.774 ' HE1' HG13 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -69.97 -25.95 63.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.279 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.3 mm-40 -57.99 -56.09 26.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.418 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.513 HD22 HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -55.04 -39.23 68.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.896 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.647 ' HB2' HD13 ' A' ' 182' ' ' LEU . 3.9 tpt -66.69 -41.34 88.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.343 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.23 -7.72 44.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.265 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.95 -37.92 61.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 pt -115.06 48.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.532 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 4.1 tp -131.21 138.52 33.04 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 97.0 Cg_endo -78.51 -162.95 3.14 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.481 -0.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.52 164.68 13.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.376 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.14 30.76 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.603 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -100.99 132.99 46.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.905 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.61 120.54 40.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.427 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.717 HG11 ' HB ' ' A' ' 180' ' ' ILE . 2.4 m -110.36 135.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 0.0 111.681 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -101.76 130.19 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.283 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -126.78 -179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.744 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 2.1 tt0 -74.27 175.71 7.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.508 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.53 ' HD3' ' HG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -119.24 144.77 46.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.417 . . . . 0.0 111.325 -179.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 105' ' ' LEU . 5.7 p-10 -74.34 -159.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.936 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 27.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.563 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -69.45 113.47 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.2 mt -68.58 -49.45 29.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.89 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 7.5 Cg_endo -49.93 110.08 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.444 2.096 . . . . 0.0 112.459 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.515 ' HA ' HG21 ' A' ' 111' ' ' THR . 3.9 m-20 -76.15 -5.06 44.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.872 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.442 HG12 HG12 ' A' ' 110' ' ' ILE . 7.7 p -69.77 -24.68 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.686 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 109' ' ' VAL . 26.0 mm -95.18 -51.71 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.168 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.53 ' HG1' ' HD3' ' A' ' 102' ' ' ARG . 11.7 t -77.93 -0.64 28.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.51 -160.17 51.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.588 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.37 83.89 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.473 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 m -113.82 -171.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.486 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 55.2 m -105.26 47.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -137.05 155.74 49.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.0 0.428 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.1 t -139.72 138.8 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.458 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.66 152.25 21.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.841 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 120' ' ' ARG . 42.9 mt -147.68 142.85 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' N ' HG21 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -148.76 137.94 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.943 0.401 . . . . 0.0 111.21 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 t -110.21 98.09 33.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.025 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.19 -179.1 4.92 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.459 2.106 . . . . 0.0 112.568 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.23 14.01 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 1.5 t0 -76.14 106.09 7.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -52.71 64.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.235 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.724 HG21 HD23 ' A' ' 16' ' ' LEU . 31.6 mt -59.2 -49.07 84.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -62.53 -23.66 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.891 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -67.04 -35.11 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.786 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -53.74 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 mt -60.58 -54.75 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.307 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 67' ' ' CYS . . . -58.32 -28.73 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.376 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.8 -55.27 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 109.904 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -75.48 -89.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.02 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.97 134.35 68.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.784 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.97 152.59 76.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.379 2.053 . . . . 0.0 111.811 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.3 153.61 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.204 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.621 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 6.8 m -80.68 137.55 36.32 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -133.91 108.47 8.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.707 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.91 136.04 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -79.43 113.88 17.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.577 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.402 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.9 Cg_exo . . . . . 0 CA--C 1.537 0.643 0 N-CA-C 113.352 0.482 . . . . 0.0 113.352 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 74.0 Cg_endo -74.81 115.81 4.41 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 112.358 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.4 152.69 38.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -95.86 -14.51 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.83 2.353 . . . . 0.0 113.004 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -135.88 136.88 40.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.856 0.36 . . . . 0.0 111.109 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.693 HD23 ' HB ' ' A' ' 165' ' ' VAL . 8.3 mt -65.3 -45.16 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.907 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -27.0 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.145 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -37.42 86.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.146 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.601 HD11 HG12 ' A' ' 165' ' ' VAL . 1.1 mt -72.7 -34.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.154 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 152' ' ' LEU . 16.0 t -64.17 -30.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.813 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -75.5 -53.02 9.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.444 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.41 -45.85 68.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.748 HD13 ' HB ' ' A' ' 162' ' ' VAL . 0.8 OUTLIER -90.83 64.22 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -37.05 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.186 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -171.51 16.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.748 ' HB ' HD13 ' A' ' 159' ' ' LEU . 47.1 t -80.78 -91.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.603 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -98.41 95.85 7.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.403 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.46 138.65 57.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.79 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.693 ' HB ' HD23 ' A' ' 152' ' ' LEU . 26.9 m -65.04 -169.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 166' ' ' LEU . 1.0 OUTLIER -125.84 135.76 52.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.211 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -2.16 54.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.01 -33.61 24.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.349 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.24 130.18 6.92 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.505 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 4.8 p-10 -73.41 -175.97 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.674 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.7 OUTLIER -136.72 -171.49 2.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.643 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -143.86 38.65 1.34 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.664 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 1.4 m-20 -85.08 56.89 4.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.111 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.443 ' SD ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -54.43 173.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.377 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.84 ' H ' ' HA ' ' A' ' 176' ' ' PRO . 2.1 tp10 -160.12 -47.77 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.84 ' HA ' ' H ' ' A' ' 175' ' ' GLU . 89.6 Cg_endo -83.45 -52.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.358 1.048 0 C-N-CA 124.653 -0.978 . . . . 0.0 113.495 3.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.96 144.82 22.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.664 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 96' ' ' TYR . 53.0 m -102.41 150.39 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.464 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.505 ' N ' HG23 ' A' ' 178' ' ' THR . 11.9 t -125.6 86.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.343 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.717 ' HB ' HG11 ' A' ' 98' ' ' VAL . 10.3 mt -100.71 131.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.65 ' HB3' ' HG3' ' A' ' 188' ' ' ARG . 7.3 t0 -98.84 64.53 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.953 0.406 . . . . 0.0 110.685 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.647 HD13 ' HB2' ' A' ' 88' ' ' MET . 1.3 tt -70.2 75.68 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.419 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.56 -79.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.444 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.498 ' CG1' ' H ' ' A' ' 185' ' ' ASN . 1.7 p -120.42 -95.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.546 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.511 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 2.2 t-20 -90.47 -51.31 0.33 Allowed Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 18.3 Cg_exo -67.52 107.26 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.571 2.18 . . . . 0.0 112.314 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 87.7 Cg_endo -84.55 116.51 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.683 2.255 . . . . 0.0 112.477 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.65 ' HG3' ' HB3' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -91.96 67.9 5.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.06 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 180' ' ' ILE . 2.5 t -63.71 112.77 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.3 94.08 2.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.585 ' HG2' HG22 ' A' ' 178' ' ' THR . 2.0 mtt180 -83.99 147.18 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.794 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 26.1 Cg_exo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.724 0.218 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -54.52 6.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.414 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.39 -45.95 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.607 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.794 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.7 mm? -58.94 -50.77 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.124 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -55.07 -27.57 45.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.839 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 1.8 mt-10 -75.82 -43.75 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.59 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.13 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.9 mm -67.41 -22.35 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 3.6 t -65.16 -58.9 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 23' ' ' MET . 14.6 p -62.41 -29.65 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.464 ' N ' HG11 ' A' ' 22' ' ' VAL . 3.7 mtt -64.57 -28.52 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.35 13.89 62.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.522 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.05 58.92 9.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.84 162.35 19.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.753 ' HA ' HG21 ' A' ' 41' ' ' VAL . 1.4 tp -95.05 140.0 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.721 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.39 131.99 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.571 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER -102.28 163.2 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.679 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -168.33 102.44 0.54 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.761 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.695 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 92.6 Cg_endo -84.27 155.47 12.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.745 2.297 . . . . 0.0 112.121 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.437 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 40.8 p -131.51 -155.28 0.68 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.553 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -55.34 -19.03 7.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.715 0.293 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -97.61 -118.64 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.795 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.652 HG13 ' HE3' ' A' ' 174' ' ' MET . 1.1 tt -111.94 -174.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 110.827 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.695 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -63.24 134.64 56.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.94 178.9 17.76 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.119 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 4.4 mt -133.25 138.01 46.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.174 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.46 122.61 1.73 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.609 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' A' ' 28' ' ' ILE . 1.7 p -159.77 177.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.723 0.296 . . . . 0.0 111.281 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 1.9 m120 -56.13 106.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.976 0.417 . . . . 0.0 110.669 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.14 -49.73 76.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.091 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.29 27.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.944 0.402 . . . . 0.0 111.748 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 147.77 34.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.815 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -73.32 -24.78 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 110.593 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -58.37 -30.14 66.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.809 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -65.88 -30.37 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 t -71.15 -46.07 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -65.15 -41.13 95.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.656 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mpt_? -67.01 -53.87 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.077 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -54.56 -25.76 27.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -73.76 -52.98 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -55.49 -35.88 66.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.68 -58.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -72.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.41 17.0 30.71 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.31 -16.16 9.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 110.93 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -140.05 67.65 33.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 -4.59 15.41 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.551 2.167 . . . . 0.0 112.213 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.91 -4.46 17.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 0.0 OUTLIER -86.43 145.36 39.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.993 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.442 ' HD2' ' HD2' ' A' ' 62' ' ' LYS . 24.2 Cg_endo -60.82 156.98 40.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.673 2.249 . . . . 0.0 112.147 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.9 p -112.59 147.26 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -94.18 145.03 25.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.2 161.83 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.819 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.486 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 10.8 t -111.73 131.55 55.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.723 HG23 ' HB2' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -137.74 170.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.798 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 4.1 t -86.47 -39.4 16.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.489 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.7 t -164.08 174.09 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG12 ' HG3' ' A' ' 85' ' ' MET . 37.9 t -59.93 -38.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.541 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m-20 -67.22 -23.4 65.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.798 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 24.5 mm-40 -80.62 -23.17 39.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.231 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.459 HG13 ' CB ' ' A' ' 77' ' ' PHE . 18.9 tt -114.22 50.66 0.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.029 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 20.8 Cg_endo -61.97 -78.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.099 1.866 . . . . 0.0 113.176 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 9.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.522 ' CE2' ' HG2' ' A' ' 135' ' ' PRO . 1.8 m-85 -108.21 -13.63 14.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.219 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.769 ' HB2' HD22 ' A' ' 100' ' ' LEU . 60.3 p -135.74 178.11 7.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.622 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.484 ' N ' ' HD3' ' A' ' 80' ' ' PRO . 3.8 mtp-105 -133.5 62.14 57.89 Favored Pre-proline 0 N--CA 1.464 0.232 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.485 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.514 ' HB3' HD23 ' A' ' 100' ' ' LEU . 65.6 Cg_endo -102.38 173.15 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.784 2.323 . . . . 0.0 113.203 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.5 -177.71 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.53 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.09 4.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.783 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -55.59 -41.28 73.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 0.0 111.211 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.557 ' HB3' ' HE3' ' A' ' 85' ' ' MET . . . -66.16 -51.6 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.643 ' HG3' HG12 ' A' ' 71' ' ' VAL . 24.0 mmt -71.74 -7.81 50.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -72.28 -54.58 9.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.342 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -37.49 74.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.695 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.499 ' HE1' HG21 ' A' ' 98' ' ' VAL . 3.4 tpt -73.76 -41.36 62.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.633 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -63.42 -13.82 43.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.05 -31.17 61.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.27 45.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.472 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 147.09 64.82 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.843 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.37 -172.08 10.76 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.953 -1.269 . . . . 0.0 112.14 -0.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.25 179.93 29.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.582 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 36.8 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.782 2.321 . . . . 0.0 112.279 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.403 ' HB2' ' HE2' ' A' ' 88' ' ' MET . 13.9 m-85 -106.86 114.42 28.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 26.0 m -96.99 117.29 30.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -108.83 108.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 ' HA2' ' A' ' 118' ' ' GLY . 7.1 t -84.93 124.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.769 HD22 ' HB2' ' A' ' 78' ' ' SER . 0.2 OUTLIER -128.13 162.3 27.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.394 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.584 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 3.6 mt-10 -59.08 174.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.724 ' HE ' ' HB3' ' A' ' 105' ' ' LEU . 18.8 ttt85 -118.57 159.06 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.151 0.501 . . . . 0.0 111.835 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.407 ' H ' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.13 -162.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.343 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 16.53 0.37 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.836 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.724 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 1.7 tm? -69.83 153.75 42.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.583 0.23 . . . . 0.0 110.459 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.65 HG13 ' H ' ' A' ' 108' ' ' ASP . 1.8 tp -59.54 106.41 0.73 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 74.3 Cg_endo -72.25 16.79 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.003 2.469 . . . . 0.0 113.431 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.65 ' H ' HG13 ' A' ' 106' ' ' ILE . 22.4 t0 -61.32 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.76 6.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.615 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.402 HG22 ' CZ ' ' A' ' 102' ' ' ARG . 10.1 mm -95.95 -59.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.297 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 p -87.5 -31.11 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.014 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 -89.8 0.29 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.19 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.93 -84.01 0.17 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.114 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -103.95 -167.71 1.4 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.558 0.218 . . . . 0.0 110.896 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.7 60.4 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 111.188 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 116' ' ' ARG . 9.5 mtt85 -136.44 143.6 43.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 102' ' ' ARG . 90.3 t -140.0 138.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.71 151.82 36.33 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.793 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 118' ' ' GLY . 26.0 mt -149.61 135.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.642 0.258 . . . . 0.0 110.453 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.596 ' HD2' ' HD3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -156.46 149.99 24.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 111.454 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.87 89.08 8.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.404 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.596 ' HD3' ' HD2' ' A' ' 120' ' ' ARG . 22.7 Cg_endo -61.75 -178.77 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.499 2.133 . . . . 0.0 112.721 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.428 ' H ' HG21 ' A' ' 33' ' ' THR . 3.5 t0 -85.72 7.46 23.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.3 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 127' ' ' CYS . 7.3 m-20 -80.2 94.86 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.868 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.26 -33.41 67.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.0 mt -69.67 -52.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.725 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -61.34 -13.93 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.754 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -75.15 -48.06 25.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.89 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.496 ' O ' ' HB1' ' A' ' 132' ' ' ALA . 7.2 mtp180 -59.65 -54.25 48.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mt -59.03 -49.05 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.064 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.4 -27.68 69.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 129' ' ' ARG . . . -54.42 -56.71 15.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -89.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.747 176.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -77.08 124.88 87.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.818 177.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.522 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 25.9 Cg_exo -64.78 157.72 54.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.283 1.989 . . . . 0.0 111.69 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 41' ' ' VAL . 12.3 t -128.94 155.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.646 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 8.0 m -80.51 132.51 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.927 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.23 104.29 7.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 111.548 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.4 HG22 HD11 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -133.22 163.32 29.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 t -81.31 131.22 35.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.483 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.044 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.426 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 45.5 Cg_exo . . . . . 0 CA--C 1.536 0.622 0 N-CA-C 113.228 0.434 . . . . 0.0 113.228 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 26.1 Cg_exo -62.0 91.24 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.899 1.733 . . . . 0.0 111.931 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.94 148.52 78.96 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -95.48 -15.53 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.994 2.462 . . . . 0.0 112.368 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -136.53 125.89 24.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.425 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.599 ' HA ' HD11 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -58.29 -40.8 82.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -70.22 -20.04 63.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 151' ' ' ARG . 15.2 tt0 -75.12 -28.68 60.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.777 HD13 HG12 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -74.95 -46.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 -179.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -60.09 -31.22 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.29 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -74.96 -47.02 31.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.071 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.14 -23.75 60.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.252 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.52 ' HB3' HG12 ' A' ' 162' ' ' VAL . 97.2 mt -111.34 67.13 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -16.19 -63.15 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.077 0.86 . . . . 0.0 112.776 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.18 22.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.005 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -81.13 -70.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.983 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.685 ' H ' HG12 ' A' ' 162' ' ' VAL . 38.6 t0 -107.98 96.7 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.578 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -67.51 135.77 53.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.777 HG12 HD13 ' A' ' 155' ' ' ILE . 18.8 m -67.4 -164.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.255 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.852 HD22 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.27 161.38 27.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.869 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -92.41 -25.08 18.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.59 -57.56 3.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.128 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.852 ' HA2' HD22 ' A' ' 166' ' ' LEU . . . 102.05 -161.87 17.33 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.934 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.65 -162.73 0.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.676 0.274 . . . . 0.0 110.915 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.437 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.73 -56.11 0.16 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.705 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.499 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -133.46 -133.15 0.17 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.499 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -85.89 142.6 28.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.873 0.368 . . . . 0.0 111.963 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.652 ' HE3' HG13 ' A' ' 36' ' ' ILE . 69.2 mmm -62.4 -25.36 67.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.319 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.4 159.17 42.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.741 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 177' ' ' SER . 75.3 Cg_endo -86.79 -149.59 0.44 Allowed 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.694 0.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.4 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.2 OUTLIER -153.98 157.12 38.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.75 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.45 132.23 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.87 90.33 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.946 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.71 HG12 ' HA ' ' A' ' 189' ' ' VAL . 22.6 mt -108.42 137.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 0.5 OUTLIER -106.49 67.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.042 178.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 31.8 tp -70.28 90.04 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.682 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -79.25 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.447 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 3.5 t -120.23 -123.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.059 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.492 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -62.51 -52.02 68.6 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.92 108.42 2.53 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.138 1.892 . . . . 0.0 112.645 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.521 ' HB3' HD12 ' A' ' 182' ' ' LEU . 84.6 Cg_endo -83.25 129.65 5.24 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.2 mmt85 -88.68 60.9 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.038 0.447 . . . . 0.0 111.001 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.71 ' HA ' HG12 ' A' ' 180' ' ' ILE . 32.6 t -62.38 92.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.949 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.55 87.04 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -83.56 145.93 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.722 179.687 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.863 0.276 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.672 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -75.07 -27.72 60.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.48 -49.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.725 HD23 HG21 ' A' ' 126' ' ' ILE . 4.1 mm? -66.22 -32.15 73.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.152 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.672 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -71.77 -31.3 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.575 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -75.54 -38.21 59.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.264 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.68 -45.44 58.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.8 -30.35 37.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.72 -40.81 88.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 164' ' ' LEU . 3.3 t -62.82 -31.03 50.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.0 mmt -61.5 -43.88 98.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.38 -23.21 58.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.809 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -19.0 63.8 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.44 36.34 88.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.687 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.74 170.57 14.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.142 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.654 HD12 HD23 ' A' ' 39' ' ' LEU . 1.5 tp -90.52 136.06 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.453 HG11 ' O ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER -116.7 133.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.665 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.516 HG12 ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -101.87 163.01 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.55 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.21 101.15 0.79 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.79 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.6 Cg_endo -82.61 144.64 12.67 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.592 2.195 . . . . 0.0 111.601 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.558 HG22 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -121.55 -152.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.717 0.294 . . . . 0.0 111.291 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -55.05 -21.99 14.29 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.457 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 1.8 t -100.02 -115.0 0.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.657 HG22 ' HG2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -112.34 -172.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.852 0.358 . . . . 0.0 111.173 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.646 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.8 m-85 -63.69 137.9 58.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.926 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.02 -176.66 14.77 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.014 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.654 HD23 HD12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -127.08 140.98 51.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.644 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.33 120.83 1.35 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.708 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 28' ' ' ILE . 1.5 p -165.98 177.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.775 0.321 . . . . 0.0 111.65 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.77 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t-20 -56.73 107.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -62.7 -52.09 64.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 33.1 0.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.6 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.77 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 159.69 17.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.833 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.13 -36.7 61.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.791 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 25.0 t70 -58.49 -26.54 63.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.109 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.83 -33.28 62.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.52 -52.69 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -65.01 -45.85 83.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.92 -31.95 63.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -27.9 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -42.91 53.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG23 HH21 ' A' ' 51' ' ' ARG . 48.1 t -74.72 -43.37 47.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.245 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.63 -17.9 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.012 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.93 -95.33 0.19 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -118.06 83.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.63 69.55 15.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.9 11.96 2.6 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.609 2.206 . . . . 0.0 112.526 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.17 -14.93 8.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -88.46 127.01 58.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.156 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.16 -166.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.692 2.261 . . . . 0.0 112.084 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 110' ' ' ILE . 12.6 p -118.68 135.64 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.138 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 8.6 t -96.24 131.69 42.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 32.3 pt -116.89 169.93 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -114.75 137.1 52.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.353 . . . . 0.0 110.603 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.612 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.2 p -145.84 173.91 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -80.17 -42.52 23.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.958 0.408 . . . . 0.0 110.371 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.41 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -163.45 168.51 20.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 74' ' ' ILE . 15.8 t -57.17 -29.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.943 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.46 -32.68 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.225 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.99 -13.24 59.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.489 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 74' ' ' ILE . 6.3 tt -114.16 44.52 0.32 Allowed Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 72.9 Cg_endo -76.39 -46.76 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.726 1.618 . . . . 0.0 112.634 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -72.42 -1.03 14.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.886 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.78 -56.07 2.28 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.652 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 p -114.55 171.03 7.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.347 . . . . 0.0 111.144 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -121.94 108.18 34.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.625 ' HA ' HD13 ' A' ' 100' ' ' LEU . 57.5 Cg_endo -102.45 -168.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.221 2.614 . . . . 0.0 113.007 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 85' ' ' MET . 3.2 t -138.82 -178.24 5.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.88 -83.72 0.37 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.843 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.783 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.96 -27.78 46.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.111 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.433 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -61.66 -46.43 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 81' ' ' SER . 19.5 mmt -74.92 -11.98 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.783 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -71.17 -48.28 52.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.992 0.425 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 5.0 tp -65.21 -35.99 82.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.79 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.752 ' HE2' HD23 ' A' ' 182' ' ' LEU . 7.7 tpp -68.41 -44.61 74.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.63 -13.82 61.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 5.7 tpt180 -73.43 -42.11 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.651 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 pt -110.55 43.79 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.041 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -131.2 143.5 49.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.766 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.4 Cg_exo -78.13 -165.14 4.37 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.174 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.81 173.33 23.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.588 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.537 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 93.0 Cg_endo -79.82 39.23 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.563 2.175 . . . . 0.0 112.358 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.62 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.3 m-85 -111.98 143.87 42.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.525 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 29.1 m -94.82 135.95 35.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.9 t -120.29 109.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.429 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.784 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 19.1 t -99.66 135.97 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.276 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HB2' HD13 ' A' ' 119' ' ' ILE . 2.4 mm? -126.45 -172.69 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.043 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.04 -165.84 0.43 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.733 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.485 ' HG2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.13 132.44 56.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.97 0.414 . . . . 0.0 111.106 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -74.87 -173.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.15 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 9.27 2.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.483 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.683 HD21 ' H ' ' A' ' 106' ' ' ILE . 1.3 mt -69.39 -174.39 0.67 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.711 0.291 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.683 ' H ' HD21 ' A' ' 105' ' ' LEU . 2.8 mt -79.53 107.47 6.55 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.283 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 65.4 Cg_endo -71.65 23.56 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.675 2.25 . . . . 0.0 112.941 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 106' ' ' ILE . 3.7 m-20 -61.55 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.683 0.278 . . . . 0.0 111.2 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 m -90.21 5.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.703 0.287 . . . . 0.0 111.202 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 ' HA ' HG11 ' A' ' 64' ' ' VAL . 4.1 mt -96.4 -35.01 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.4 OUTLIER -87.13 -37.27 17.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.622 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.78 -101.35 0.64 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.347 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.26 -60.42 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.631 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.78 -179.32 3.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.728 0.299 . . . . 0.0 110.906 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.532 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -92.78 70.1 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.995 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -136.75 163.69 30.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.322 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.485 HG21 ' HG2' ' A' ' 102' ' ' ARG . 95.3 t -139.54 125.07 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.377 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -78.92 152.71 37.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.899 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' HB2' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -144.87 156.06 14.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.653 0.263 . . . . 0.0 110.553 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -148.49 124.82 10.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.261 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.641 HG22 HD21 ' A' ' 92' ' ' LEU . 5.2 t -110.42 86.99 5.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.56 179.77 5.25 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.518 2.146 . . . . 0.0 112.65 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.558 ' H ' HG22 ' A' ' 33' ' ' THR . 0.3 OUTLIER -93.28 5.17 52.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.03 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.87 106.99 7.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.155 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -57.34 -39.44 75.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.771 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.725 HG21 HD23 ' A' ' 16' ' ' LEU . 45.2 mm -63.1 -54.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.873 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -61.87 -18.53 60.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -72.27 -36.46 69.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.404 ' O ' ' HB1' ' A' ' 132' ' ' ALA . 13.0 mtp180 -75.02 -52.53 10.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.239 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 mt -60.0 -53.72 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.84 -26.93 67.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.277 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 129' ' ' ARG . . . -54.63 -56.77 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.018 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -86.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.326 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.78 115.29 46.84 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.68 137.75 46.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.558 2.172 . . . . 0.0 111.602 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.74 170.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 120.943 0.402 . . . . 0.0 111.737 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.644 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 46.2 m -80.76 139.94 35.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.012 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.66 103.71 4.92 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.287 0.367 . . . . 0.0 111.37 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -130.28 126.31 36.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.7 p -70.93 110.86 5.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.959 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.449 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 39.5 Cg_exo . . . . . 0 CA--C 1.537 0.636 0 N-CA-C 113.178 0.415 . . . . 0.0 113.178 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 91.0 Cg_endo -78.99 103.05 1.59 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.898 1.732 . . . . 0.0 112.148 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.413 ' OG ' HG22 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -82.91 145.97 51.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -95.53 -11.22 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.916 2.411 . . . . 0.0 111.929 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.93 128.88 14.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.04 -27.36 66.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.578 ' O ' HG13 ' A' ' 156' ' ' VAL . 3.7 tt0 -71.07 -37.89 72.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.171 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -55.73 31.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.323 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.6 OUTLIER -63.47 -42.98 98.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -53.08 -30.1 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -39.21 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -26.79 57.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.257 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 155' ' ' ILE . 2.0 pp -94.98 46.8 1.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t70 -16.03 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.728 0.643 . . . . 0.0 112.551 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -157.32 10.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.761 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -81.39 -75.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.381 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.761 ' H ' HG13 ' A' ' 162' ' ' VAL . 4.2 t70 -95.79 109.07 21.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.791 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.567 ' HB2' HG13 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -73.85 120.65 19.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.99 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 155' ' ' ILE . 4.3 p -61.72 -179.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.779 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.632 HD13 ' HD2' ' A' ' 32' ' ' PRO . 1.3 pt? -125.28 149.28 48.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.828 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.19 -19.61 22.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.289 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.53 -48.0 61.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.945 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.56 -168.51 31.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.777 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -163.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.074 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.423 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 44.2 m -140.95 -56.94 0.5 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.48 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -129.43 -130.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.518 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -86.36 146.29 26.53 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.487 -178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.657 ' HG2' HG22 ' A' ' 36' ' ' ILE . 3.7 ttp -69.35 0.17 5.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.179 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.81 156.75 30.99 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.631 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.487 ' HB2' ' H ' ' A' ' 177' ' ' SER . 70.7 Cg_endo -88.71 -140.27 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.921 -1.283 . . . . 0.0 112.576 0.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.487 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -153.63 124.77 7.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.623 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.62 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 34.8 m -101.99 131.69 48.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.45 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.525 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -129.48 109.15 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.707 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.714 HG12 ' HA ' ' A' ' 189' ' ' VAL . 15.1 mt -120.9 137.14 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.474 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.784 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 6.0 t70 -107.99 66.91 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.589 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.752 HD23 ' HE2' ' A' ' 88' ' ' MET . 21.9 tp -69.77 88.26 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -79.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.437 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.64 -121.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.484 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.9 t-20 -63.48 -50.59 72.53 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 79.7 Cg_endo -77.87 108.75 2.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.24 1.96 . . . . 0.0 112.566 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.1 Cg_endo -82.44 128.6 5.52 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.558 2.172 . . . . 0.0 112.248 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 17.8 mtp180 -87.58 56.1 3.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.714 ' HA ' HG12 ' A' ' 180' ' ' ILE . 17.9 t -59.97 104.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.75 74.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -89.73 139.58 30.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.683 ' HG2' HD13 ' A' ' 16' ' ' LEU . 45.1 Cg_exo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.808 0.253 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.38 -28.74 68.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.066 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.6 t -65.31 -57.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.683 HD13 ' HG2' ' A' ' 13' ' ' PRO . 13.7 mt -62.01 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.15 -23.75 67.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.712 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.5 -32.69 58.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.165 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.27 -44.33 62.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.761 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -75.55 -18.37 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.182 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 t -75.52 -47.95 24.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.352 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -74.52 -26.93 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.656 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.612 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 15.7 ptp -73.97 -31.51 63.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 0.0 111.112 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -25.09 65.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.84 31.18 6.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.435 ' HA2' ' CG ' ' A' ' 47' ' ' ASP . . . 67.0 47.53 64.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 23' ' ' MET . . . -130.12 147.47 18.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -96.28 143.0 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.505 ' H ' HG13 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -117.94 145.26 24.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.766 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.844 HG22 HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -111.96 167.27 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.255 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.669 ' HH ' ' HB1' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -171.72 94.52 0.41 Allowed Pre-proline 0 C--N 1.332 -0.152 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.832 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.2 Cg_endo -84.14 142.71 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.872 2.381 . . . . 0.0 110.549 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.673 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 85.7 m -138.09 -97.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.047 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.12 -59.13 2.88 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.564 ' OG1' HG13 ' A' ' 36' ' ' ILE . 1.2 t -79.87 -104.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.564 HG13 ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -114.68 -146.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.62 0.248 . . . . 0.0 111.048 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.832 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.1 m-85 -81.84 134.39 35.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 111.038 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.4 -178.34 18.09 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.086 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.844 HD23 HG22 ' A' ' 30' ' ' ILE . 4.5 mt -133.65 142.68 48.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.638 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.39 132.2 4.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.881 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.564 HG13 HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -158.97 171.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.148 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.725 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 4.1 t-20 -56.58 122.2 11.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.131 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.49 -67.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -176.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.616 ' N ' HD21 ' A' ' 44' ' ' LEU . 4.3 mm? -80.5 37.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -110.41 146.67 35.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.681 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -73.99 -25.82 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.707 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.435 ' CG ' ' HA2' ' A' ' 26' ' ' GLY . 3.3 m-20 -61.63 -29.75 70.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.625 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB2' HG21 ' A' ' 41' ' ' VAL . . . -75.39 -36.11 60.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.09 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 46' ' ' GLU . 18.7 t -61.62 -46.77 95.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -48.69 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.126 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.504 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 1.9 mmp_? -63.79 -21.55 66.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -71.41 -40.92 70.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.79 -19.45 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' HG3' ' HA ' ' A' ' 51' ' ' ARG . 4.2 mmt180 -71.86 -56.4 5.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.357 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -75.36 -43.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.742 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.71 -3.17 46.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.303 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -113.75 5.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.19 90.12 3.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 t -144.8 71.37 15.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.66 7.37 4.58 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.763 2.309 . . . . 0.0 112.721 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -114.35 -14.41 12.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.14 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 122.03 70.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.24 171.47 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.594 2.196 . . . . 0.0 112.315 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 110' ' ' ILE . 10.5 p -112.8 145.02 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.008 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -93.6 146.49 23.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 136' ' ' VAL . 6.7 mm -116.39 154.31 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.8 t -105.02 122.93 46.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.761 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 1.8 p -147.51 177.68 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.765 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.536 ' HB2' ' HB1' ' A' ' 132' ' ' ALA . 2.5 t -86.74 -36.32 18.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.109 0.481 . . . . 0.0 110.23 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.486 ' O ' HG11 ' A' ' 68' ' ' VAL . 3.5 t -162.89 161.16 25.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.325 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 80' ' ' PRO . 17.8 t -55.58 -32.69 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.379 . . . . 0.0 111.099 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 2.0 m-20 -67.35 -29.36 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.001 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HB2' HG22 ' A' ' 68' ' ' VAL . 78.5 mm-40 -80.58 -15.27 57.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.371 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 119' ' ' ILE . 3.0 tt -114.34 47.9 0.44 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 98.8 Cg_endo -79.08 -32.67 1.74 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.778 1.652 . . . . 0.0 112.298 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -11.8 60.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.672 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.59 -49.44 3.24 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.483 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.9 p -114.83 178.23 4.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -117.22 116.63 37.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.023 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.563 ' HB3' HG11 ' A' ' 71' ' ' VAL . 68.2 Cg_endo -102.22 178.09 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.162 2.575 . . . . 0.0 112.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.76 177.35 8.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.89 -99.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.966 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.04 -25.49 30.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.158 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.16 87.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -27.93 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.003 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -57.88 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.578 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 11.8 tp -57.82 -26.2 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.884 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.544 ' SD ' HG12 ' A' ' 98' ' ' VAL . 6.9 tpt -72.39 -46.79 53.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.427 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.35 -4.03 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.273 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.59 -38.52 87.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.066 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.05 58.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -123.97 141.23 36.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.7 Cg_exo -78.66 -161.57 2.74 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.246 -1.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.45 163.1 11.65 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.748 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.17 38.55 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.2 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.426 ' OH ' ' HB2' ' A' ' 92' ' ' LEU . 30.6 p90 -99.96 158.03 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.08 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -110.51 137.67 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.545 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.544 HG12 ' SD ' ' A' ' 88' ' ' MET . 15.7 t -117.93 109.2 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.853 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 50.4 t -104.33 126.57 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.282 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.469 HD11 HG12 ' A' ' 71' ' ' VAL . 1.2 mt -126.33 -167.02 1.65 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.559 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.58 -167.94 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.687 178.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.547 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.45 137.44 53.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.252 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -74.43 -173.19 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.084 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -75.54 5.14 6.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.295 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.7 163.38 25.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.911 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -65.8 108.99 2.56 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 30.48 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.956 2.437 . . . . 0.0 113.051 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.429 ' HB2' HG12 ' A' ' 106' ' ' ILE . 37.8 t70 -61.46 -97.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.578 0.227 . . . . 0.0 111.559 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 109' ' ' VAL . 6.3 p -89.74 5.6 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.798 0.332 . . . . 0.0 111.618 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.415 ' HA ' HG12 ' A' ' 64' ' ' VAL . 1.4 mt -97.87 -36.27 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.313 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -87.11 -39.62 15.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.102 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.09 -96.53 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.44 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.45 -64.47 1.22 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.891 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.652 ' HB2' ' HE ' ' A' ' 116' ' ' ARG . 0.7 OUTLIER -104.56 176.27 5.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.681 0.277 . . . . 0.0 111.111 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.503 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -92.47 71.89 5.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.652 ' HE ' ' HB2' ' A' ' 114' ' ' SER . 64.2 mtm180 -136.32 160.36 38.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.547 HG23 ' HG2' ' A' ' 102' ' ' ARG . 21.6 t -139.26 125.92 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.411 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -85.61 161.55 35.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.514 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.539 HG12 HD12 ' A' ' 74' ' ' ILE . 30.5 mt -144.74 152.34 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.632 0.253 . . . . 0.0 110.452 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.61 120.23 9.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 92' ' ' LEU . 10.6 t -110.83 86.58 5.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.736 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.95 -178.02 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.516 2.144 . . . . 0.0 112.513 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 33' ' ' THR . 0.2 OUTLIER -83.54 -0.58 50.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.982 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.7 t0 -72.88 96.09 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -43.12 83.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.599 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.5 mt -67.48 -48.64 76.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.004 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 15.1 t -57.81 -29.02 64.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.546 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.8 mtp180 -67.35 -33.95 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.484 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -64.43 -58.77 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.973 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 tt -63.83 -35.08 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.376 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.761 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.43 -30.05 64.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.151 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 69' ' ' SER . . . -55.35 -55.36 32.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.178 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.441 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 12.9 ttm180 -75.9 -83.86 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.296 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.441 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 1.1 t80 -75.67 110.11 9.79 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' ARG . 17.1 Cg_exo -66.23 147.26 83.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.429 2.086 . . . . 0.0 111.768 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 41' ' ' VAL . 3.9 t -125.89 159.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.638 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 5.2 m -80.13 141.75 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.14 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.63 109.85 6.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 111.756 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.591 HG22 HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.75 157.06 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.508 178.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 p -78.52 126.51 30.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.055 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.07 179.766 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo . . . . . 0 CA--C 1.537 0.627 0 N-CA-C 113.459 0.523 . . . . 0.0 113.459 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.89 110.4 3.03 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.861 1.707 . . . . 0.0 112.279 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.37 151.94 38.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -95.88 -12.03 0.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.948 2.432 . . . . 0.0 112.934 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -131.48 137.39 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.208 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.442 HD22 ' CG2' ' A' ' 165' ' ' VAL . 64.2 mt -68.8 -33.39 73.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.717 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.1 -19.27 60.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.913 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -36.79 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.73 HD13 HG22 ' A' ' 165' ' ' VAL . 69.4 mt -67.62 -55.56 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.142 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.424 HG12 HG13 ' A' ' 165' ' ' VAL . 2.2 m -54.87 -33.85 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -59.46 2.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.626 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.45 -43.01 83.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.429 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.718 ' HG ' ' HB3' ' A' ' 163' ' ' ASP . 2.3 mm? -101.3 66.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 159' ' ' LEU . 33.8 t70 -16.87 -61.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.033 0.833 . . . . 0.0 112.706 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -152.15 11.56 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.241 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.447 ' H ' HG11 ' A' ' 162' ' ' VAL . 1.5 p -81.01 -63.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.837 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.718 ' HB3' ' HG ' ' A' ' 159' ' ' LEU . 40.4 t0 -109.34 91.33 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.477 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.67 139.81 53.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.473 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.73 HG22 HD13 ' A' ' 155' ' ' ILE . 1.4 p -74.62 -175.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.047 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.473 ' H ' HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.55 134.21 50.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -4.22 53.67 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB1' ' HH ' ' A' ' 31' ' ' TYR . . . -63.48 -43.14 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.755 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.436 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 86.71 28.82 25.55 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.995 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.673 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 25.7 m-20 -73.28 119.89 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.842 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.7 125.62 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.591 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -136.7 -138.64 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.216 -179.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.542 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -86.26 137.22 32.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.88 0.371 . . . . 0.0 111.598 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.6 ttt -68.83 -5.78 22.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.813 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -149.99 156.54 38.0 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.693 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 72.7 Cg_endo -90.63 -152.92 0.55 Allowed 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.864 -1.307 . . . . 0.0 112.633 0.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -155.52 122.25 5.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.521 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.681 HG22 HD11 ' A' ' 180' ' ' ILE . 0.2 OUTLIER -101.79 137.15 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.471 -179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.91 91.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.531 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.681 HD11 HG22 ' A' ' 178' ' ' THR . 2.2 mp -106.55 128.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.752 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.853 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -103.01 64.13 0.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.116 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.55 94.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.427 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -77.09 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.578 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.22 -123.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.589 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -63.39 -52.2 62.36 Favored Pre-proline 0 CA--C 1.532 0.253 0 O-C-N 122.423 -0.173 . . . . 0.0 111.256 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.4 Cg_exo -75.07 109.22 2.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.554 2.169 . . . . 0.0 112.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 93.2 Cg_endo -84.19 131.58 5.04 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.61 2.206 . . . . 0.0 112.405 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.585 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 23.8 mmm-85 -89.44 51.08 2.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.989 0.424 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.519 ' HA ' HG21 ' A' ' 180' ' ' ILE . 14.7 t -58.26 98.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.781 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.5 91.42 3.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.133 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 178.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.784 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 73.9 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 CA-C-O 120.966 0.319 . . . . 0.0 112.663 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.5 -32.51 68.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.77 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.71 HG22 ' HB3' ' A' ' 167' ' ' ASP . 58.8 t -60.43 -35.93 66.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.738 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.784 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -74.03 -39.13 63.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' O ' HD11 ' A' ' 20' ' ' ILE . 36.1 mt-10 -71.58 -21.34 61.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.981 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -35.68 58.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.777 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.77 75.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.285 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.506 ' H ' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -75.66 -21.35 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -66.9 -50.43 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.58 ' HB ' HD23 ' A' ' 164' ' ' LEU . 8.0 p -65.15 -32.99 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.447 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.4 mtt -61.48 -29.22 69.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.76 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.83 -30.54 62.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.01 5.11 77.88 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.577 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.16 36.6 93.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.692 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.9 169.65 13.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.19 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.733 HG21 ' HA ' ' A' ' 163' ' ' ASP . 0.3 OUTLIER -96.43 146.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -119.51 131.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.606 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -102.35 162.81 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' HA ' HD21 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -167.81 99.63 0.59 Allowed Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.638 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 79.1 Cg_endo -84.1 166.62 12.75 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.545 2.164 . . . . 0.0 110.922 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.723 ' HA ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.72 -157.61 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.937 178.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 10.4 p-10 -63.61 -13.19 39.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.819 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.755 ' HB ' ' HB3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -100.37 -94.49 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.996 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.475 ' HA ' ' HE2' ' A' ' 174' ' ' MET . 0.2 OUTLIER -133.13 173.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.661 0.267 . . . . 0.0 111.177 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.638 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m-85 -63.88 144.28 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.827 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.09 -174.83 13.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.334 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 mp -126.68 146.54 50.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.55 121.53 1.46 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.183 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.719 HG11 HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -157.75 171.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.744 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -56.76 123.43 14.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.055 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -57.24 -65.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.264 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 44' ' ' LEU . 4.1 mm? -82.95 40.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.762 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.744 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.38 149.41 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HA ' HG22 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -75.47 -28.76 59.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -65.23 -27.17 68.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.292 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.5 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.071 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.555 HG11 ' HB ' ' A' ' 109' ' ' VAL . 20.5 m -65.53 -28.83 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.219 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 4.8 mtp180 -72.39 -46.98 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.824 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -70.42 -27.09 64.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.733 HD11 HG21 ' A' ' 139' ' ' THR . 2.0 mp -67.12 -34.57 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -69.62 -39.74 77.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.953 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -65.19 -48.58 72.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.95 -40.04 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 5.6 mptt -83.0 -2.16 54.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.961 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.29 -102.78 0.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.326 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 71.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.036 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.02 70.25 70.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.11 -1.58 11.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.503 2.135 . . . . 0.0 112.425 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -121.12 -1.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -82.98 124.63 76.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.999 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.05 160.9 9.49 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.575 2.184 . . . . 0.0 112.431 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.28 148.67 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 t -95.38 149.86 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 111.074 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 mt -116.02 157.65 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.846 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 6.9 t -116.25 119.75 36.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -136.03 171.09 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.993 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -84.59 -38.83 19.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.103 0.477 . . . . 0.0 110.447 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.06 169.52 17.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.398 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.499 HG11 ' HG3' ' A' ' 85' ' ' MET . 22.2 t -59.2 -32.7 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.07 -26.62 66.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.755 ' HB2' HG22 ' A' ' 68' ' ' VAL . 17.8 mm-40 -81.12 -19.9 42.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.296 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.585 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 15.4 tt -114.74 47.49 0.45 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.637 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 21.7 Cg_exo -66.93 -65.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.832 1.688 . . . . 0.0 113.208 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -72.29 4.21 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' HB3' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -108.0 -24.03 11.77 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.571 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -129.31 159.27 36.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.37 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.539 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.57 87.12 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.69 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.35 -163.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.062 2.508 . . . . 0.0 112.83 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.76 -177.67 5.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.5 -77.2 0.73 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.645 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.761 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -56.2 -31.31 63.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.816 0.341 . . . . 0.0 111.066 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 184' ' ' VAL . . . -60.53 -46.07 91.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.119 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.499 ' HG3' HG11 ' A' ' 71' ' ' VAL . 20.2 mmt -71.41 -17.61 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.761 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -63.75 -50.35 69.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.263 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 2.5 tm? -60.58 -37.77 82.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.304 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.9 tpt -66.78 -33.31 75.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.016 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.14 -15.04 61.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.116 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 87' ' ' LEU . 1.2 mtp85 -67.0 -61.98 1.66 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 pt -98.68 57.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.051 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.725 HD12 HG22 ' A' ' 121' ' ' VAL . 3.9 tt -131.03 129.19 22.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.912 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.42 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 6.0 Cg_exo -78.14 -159.97 2.19 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.28 -0.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 156.83 163.04 11.97 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.626 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.755 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 4.6 Cg_exo -78.1 39.49 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.051 2.501 . . . . 0.0 112.371 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -112.3 130.97 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.337 -179.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.17 114.9 26.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.3 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.721 HG12 ' HB ' ' A' ' 180' ' ' ILE . 2.0 m -108.87 118.81 57.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.92 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.428 HG13 ' HD3' ' A' ' 116' ' ' ARG . 22.0 t -91.64 131.07 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.218 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 182' ' ' LEU . 0.3 OUTLIER -127.18 178.93 5.71 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.426 0.453 . . . . 0.0 111.121 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.75 176.08 7.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.679 ' HB3' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.05 137.14 53.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.979 0.419 . . . . 0.0 111.36 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.539 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 1.5 t-20 -74.59 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.024 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -75.55 15.8 0.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.477 HD11 ' H ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -69.51 153.98 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.679 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.477 ' H ' HD11 ' A' ' 105' ' ' LEU . 4.7 pt -59.67 109.61 2.1 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.24 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.599 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 59.2 Cg_endo -70.81 1.93 4.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.692 2.261 . . . . 0.0 112.785 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.13 -93.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.762 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.555 ' HB ' HG11 ' A' ' 49' ' ' VAL . 22.6 m -81.78 7.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.428 HG13 HD12 ' A' ' 105' ' ' LEU . 41.3 mm -103.2 -64.93 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 111.317 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.4 p -87.42 -26.97 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.39 -116.67 4.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.727 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.35 -20.2 42.58 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.019 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -104.83 179.8 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.575 0.226 . . . . 0.0 110.845 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -113.45 42.37 1.97 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.428 ' HD3' HG13 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -136.64 156.19 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.352 -179.352 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' A' ' 102' ' ' ARG . 58.8 t -139.51 144.6 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -84.04 160.08 36.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.96 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.511 ' O ' HG21 ' A' ' 98' ' ' VAL . 34.0 mt -149.15 141.14 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -148.91 134.11 18.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.946 0.403 . . . . 0.0 111.566 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.725 HG22 HD12 ' A' ' 92' ' ' LEU . 34.2 t -111.02 81.96 2.92 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.768 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.536 ' HG2' ' OD1' ' A' ' 124' ' ' ASP . 34.9 Cg_endo -64.38 -178.86 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.566 2.177 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.91 -0.98 55.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.72 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.536 ' OD1' ' HG2' ' A' ' 122' ' ' PRO . 0.8 OUTLIER -64.75 105.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 111.034 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.35 -42.88 82.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.437 HG21 HD22 ' A' ' 16' ' ' LEU . 38.5 mm -61.44 -58.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.218 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.65 -19.85 42.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 42.6 ttt-85 -70.11 -35.88 74.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.37 -51.89 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.05 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.38 -51.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -61.17 -29.41 69.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -55.08 -55.27 32.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.422 . . . . 0.0 110.039 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -75.78 -90.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.114 177.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 1.9 m-85 -77.17 127.34 83.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.935 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 23.1 Cg_exo -65.54 154.15 75.03 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 111.555 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 137' ' ' THR . 3.0 t -130.55 156.28 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.637 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 2.1 m -80.41 136.7 36.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.777 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . . . -133.02 108.05 8.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.868 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.733 HG21 HD11 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -127.76 118.54 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.582 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.43 112.17 2.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.982 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.21 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo . . . . . 0 CA--C 1.538 0.692 0 N-CA-C 113.336 0.476 . . . . 0.0 113.336 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.23 132.21 12.39 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.868 1.712 . . . . 0.0 112.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.413 ' CB ' HG21 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -97.16 156.56 36.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.897 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -95.06 -16.59 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.718 2.279 . . . . 0.0 112.382 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.686 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 12.5 ttm180 -141.7 129.13 21.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.319 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -58.07 -31.12 66.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.273 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.594 ' O ' HG13 ' A' ' 156' ' ' VAL . 2.1 tt0 -74.42 -34.74 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.396 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.686 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.6 -42.9 97.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.46 -178.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -74.17 -38.81 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.606 -178.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -53.37 -32.84 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.269 -177.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -75.92 -41.71 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.994 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -22.9 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.652 HD11 ' HA ' ' A' ' 164' ' ' LEU . 3.3 pp -93.22 37.41 1.04 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.101 -0.24 . . . . 0.0 111.643 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 159' ' ' LEU . 27.6 t70 -18.38 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.753 0.658 . . . . 0.0 112.517 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -154.64 7.95 0.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.417 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.442 ' CG1' ' H ' ' A' ' 163' ' ' ASP . 1.3 p -81.37 -80.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.618 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.733 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -104.64 89.44 3.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.652 ' HA ' HD11 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -57.22 121.18 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.679 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 152' ' ' LEU . 2.3 p -60.24 -170.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.391 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.571 HD12 ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -125.95 156.97 38.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.942 -179.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.71 ' HB3' HG22 ' A' ' 15' ' ' VAL . 2.3 t70 -91.77 -26.98 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.8 -59.21 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.797 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.523 ' H ' HD13 ' A' ' 166' ' ' LEU . . . 81.62 49.21 5.53 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.13 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.723 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -70.63 105.73 3.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.337 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -157.54 122.12 4.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.329 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -137.43 -104.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.4 m-20 -85.37 111.71 20.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.475 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 83.9 mmm -65.89 -16.8 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.175 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.97 154.64 39.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -91.67 -149.7 0.33 Allowed 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.681 0.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.0 p -158.27 146.35 18.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.494 HG22 HG13 ' A' ' 180' ' ' ILE . 40.5 m -101.87 145.19 29.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.899 0.38 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.98 96.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.721 ' HB ' HG12 ' A' ' 98' ' ' VAL . 12.5 mt -110.64 135.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.395 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.92 65.43 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.068 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.469 ' O ' HD13 ' A' ' 100' ' ' LEU . 18.6 tp -70.14 82.63 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.397 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.34 -75.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.336 . . . . 0.0 110.433 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.454 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 5.0 t -120.58 -120.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.562 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.1 m-80 -67.4 -52.83 26.4 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.0 109.05 2.26 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.38 2.053 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.3 Cg_endo -82.91 123.83 3.73 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.529 2.152 . . . . 0.0 112.162 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -88.01 54.4 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.598 ' HA ' HG23 ' A' ' 180' ' ' ILE . 11.6 t -57.56 104.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.904 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.39 89.9 2.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.074 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -86.95 141.01 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 192' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.649 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 19.0 Cg_exo . . . . . 0 C--O 1.232 0.2 0 CA-C-O 120.709 0.212 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 4.4 m-20 -74.24 -38.68 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -69.66 -26.5 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 mm? -70.87 -52.27 21.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -64.82 -20.06 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -67.65 -47.46 69.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.18 82.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.222 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 16' ' ' LEU . 28.2 mm -67.92 -33.26 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.81 -30.71 70.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.974 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.78 HG22 ' HG ' ' A' ' 164' ' ' LEU . 11.7 t -72.68 -33.38 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.5 mmt -64.03 -50.15 69.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.025 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.02 -17.57 64.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.252 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 0.91 84.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.2 35.02 90.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.59 165.06 12.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.663 ' HA ' HG21 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -96.19 146.59 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.511 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.15 129.87 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.701 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -102.42 163.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.677 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.432 ' HH ' ' HB2' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -163.68 88.42 1.19 Allowed Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.574 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 94.5 Cg_endo -78.22 119.94 4.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.498 2.132 . . . . 0.0 110.749 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.847 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 0.6 OUTLIER -116.46 -139.17 0.37 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.04 0.448 . . . . 0.0 111.961 -176.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB3' ' HG3' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -53.62 -47.77 69.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.52 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -79.0 -119.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.741 HG12 ' H ' ' A' ' 37' ' ' TYR . 8.3 tt -112.36 -168.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.282 -0.261 . . . . 0.0 110.846 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.741 ' H ' HG12 ' A' ' 36' ' ' ILE . 4.1 m-85 -63.43 127.89 33.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 110.353 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.43 170.58 13.34 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.368 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -120.12 139.58 52.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.36 117.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.869 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 28' ' ' ILE . 2.0 p -158.36 174.63 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.708 0.29 . . . . 0.0 111.331 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.799 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.22 114.36 1.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.653 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.48 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -66.17 -49.75 66.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.038 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 44' ' ' LEU . 1.2 mm? -80.97 28.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 111.564 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.799 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -111.02 152.23 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.71 178.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -75.36 -29.0 59.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.835 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -28.79 68.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.039 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.59 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.779 ' HA ' HD22 ' A' ' 52' ' ' LEU . 56.5 t -70.12 -48.67 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.135 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.32 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.245 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.98 -55.78 8.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.276 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.779 HD22 ' HA ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -60.13 -17.51 40.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.335 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -51.96 13.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.025 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -59.19 -38.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.218 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -70.71 -58.2 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -83.54 -76.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.18 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.03 27.68 51.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.55 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -108.48 -47.26 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 16.7 m -135.42 82.43 40.29 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.21 -3.39 10.7 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.812 2.342 . . . . 0.0 112.662 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -109.01 -19.94 13.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.246 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -68.0 147.39 98.44 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.487 ' HG3' ' HG ' ' A' ' 114' ' ' SER . 50.1 Cg_exo -53.47 158.64 7.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.52 2.147 . . . . 0.0 112.324 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 110' ' ' ILE . 9.0 p -112.8 153.54 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 136.0 34.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 12.0 mm -113.92 148.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.259 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.4 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -108.4 127.64 54.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 74' ' ' ILE . 1.5 p -141.96 179.99 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.589 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.891 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 12.5 t -86.32 -41.35 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 0.0 110.529 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.4 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -164.14 169.22 18.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.88 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' HA ' ' CD1' ' A' ' 74' ' ' ILE . 16.2 t -57.17 -34.61 45.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.29 -26.87 66.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.067 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.891 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 80.9 mm-40 -77.46 -20.02 55.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.767 HG21 HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.31 61.42 0.8 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.812 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 77' ' ' PHE . 37.1 Cg_endo -65.81 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.149 1.899 . . . . 0.0 112.421 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -73.02 16.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.976 -179.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CE1' HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -105.3 -49.53 3.43 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.135 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -126.4 165.38 19.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -113.0 96.97 40.58 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -102.29 -179.12 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.112 2.542 . . . . 0.0 112.567 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.443 ' HB3' ' CB ' ' A' ' 84' ' ' ALA . 47.4 t -133.59 169.96 16.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.45 -77.29 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.839 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.559 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -57.51 -29.62 64.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 81' ' ' SER . . . -61.44 -45.84 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.427 ' HE2' HD23 ' A' ' 100' ' ' LEU . 17.7 mmt -74.41 -11.65 60.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.334 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.559 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 4.4 mt-10 -72.43 -49.92 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.872 0.368 . . . . 0.0 110.603 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 8.3 tp -63.18 -36.37 83.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.949 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.828 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 3.7 tpt -70.67 -51.21 29.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.92 -14.98 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.465 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.98 -34.14 77.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 pt -115.04 52.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.46 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -131.03 140.56 39.05 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.75 -163.96 3.72 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.625 -1.406 . . . . 0.0 112.37 -1.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.85 166.39 15.2 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.625 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.495 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 5.7 Cg_exo -78.23 35.34 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.057 2.504 . . . . 0.0 112.043 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.531 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 25.0 p90 -99.0 164.86 12.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.969 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.707 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 36.8 m -115.29 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.698 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.828 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 1.7 p -123.6 104.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.444 . . . . 0.0 110.955 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 15.4 t -101.47 129.92 51.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.86 -175.11 3.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.595 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -178.79 3.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.747 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.76 141.27 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.969 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -74.28 -174.17 1.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 104' ' ' GLU . 2.5 pt-20 -76.56 43.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.491 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.406 HD21 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -73.97 146.16 44.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.804 0.335 . . . . 0.0 110.973 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.559 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.2 mp -80.02 -50.28 1.2 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 77.7 Cg_exo -51.07 100.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.186 1.924 . . . . 0.0 112.461 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.661 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.3 OUTLIER -82.38 1.98 34.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.407 HG21 HG23 ' A' ' 49' ' ' VAL . 9.0 p -80.92 -23.88 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.065 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 64' ' ' VAL . 15.0 pt -96.87 -39.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.151 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 108' ' ' ASP . 12.9 t -76.8 -15.51 59.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.953 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.24 -171.5 42.94 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.635 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -71.02 -6.67 60.83 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.487 ' HG ' ' HG3' ' A' ' 63' ' ' PRO . 4.2 p -106.24 -176.57 3.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.3 m -111.57 40.31 2.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -139.02 150.43 45.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 102' ' ' ARG . 93.0 t -139.7 144.56 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.497 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.569 ' HA2' HG11 ' A' ' 99' ' ' VAL . . . -91.77 158.3 25.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 120' ' ' ARG . 43.7 mt -145.82 151.16 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 97' ' ' THR . 13.3 mtp180 -147.67 134.06 19.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.617 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.8 87.26 6.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.551 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.55 -176.33 2.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.555 2.17 . . . . 0.0 112.586 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 11.55 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 13.4 t0 -76.83 97.89 4.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -47.92 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.09 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.2 mm -61.06 -50.98 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.027 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 6.9 t -61.35 -23.74 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 69' ' ' SER . 9.2 ttm180 -67.04 -31.85 72.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.591 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtt85 -75.09 -56.19 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.1 -50.9 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.371 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 127' ' ' CYS . . . -63.22 -26.96 69.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.391 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.58 -56.51 18.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 109.989 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -75.86 -86.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.998 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -76.59 125.56 87.21 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.717 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.45 147.19 82.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.283 1.988 . . . . 0.0 111.949 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 41' ' ' VAL . 3.1 t -120.52 155.1 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.209 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.657 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 11.3 m -80.22 133.84 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.228 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.71 104.97 7.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -134.15 161.18 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.3 m -76.87 123.33 26.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.789 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 -179.623 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 45.0 Cg_exo . . . . . 0 CA--C 1.538 0.682 0 N-CA-C 113.281 0.454 . . . . 0.0 113.281 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 24.0 Cg_exo -64.27 113.07 2.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.932 1.755 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -97.1 137.9 21.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 64.6 Cg_endo -96.09 -12.35 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.885 2.39 . . . . 0.0 112.983 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -133.05 134.85 44.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.551 HD23 HG22 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -67.0 -43.13 83.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.817 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.04 -18.0 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 158' ' ' ASP . 4.4 tt0 -73.44 -37.03 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 165' ' ' VAL . 6.1 mt -70.59 -46.4 70.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.593 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.58 -36.66 78.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.956 0.407 . . . . 0.0 111.403 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -75.61 -49.03 19.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.095 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -72.64 -41.96 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.302 . . . . 0.0 111.694 -177.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.611 HD22 HG22 ' A' ' 155' ' ' ILE . 2.9 mm? -93.77 72.28 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' A' ' 159' ' ' LEU . 11.3 t70 -15.97 -66.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.057 0.848 . . . . 0.0 112.925 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.14 25.94 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.281 . . . . 0.0 111.43 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.83 -67.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.661 ' H ' HG11 ' A' ' 162' ' ' VAL . 1.5 p-10 -111.12 94.19 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.413 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.78 ' HG ' HG22 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -60.01 127.76 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.608 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.72 HG21 ' H ' ' A' ' 166' ' ' LEU . 3.4 p -60.79 176.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.039 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.72 ' H ' HG21 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.79 125.54 41.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.135 0.493 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -4.34 52.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.67 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.432 ' HB2' ' HH ' ' A' ' 31' ' ' TYR . . . -63.39 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.71 65.62 1.49 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.996 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.847 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 5.6 m-20 -72.88 -116.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.73 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -149.89 -171.67 3.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.635 0.255 . . . . 0.0 111.112 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 9.11 1.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.4 94.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.42 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.73 -15.44 0.72 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 150.69 64.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.538 0.209 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.42 -160.87 2.41 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.663 0.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.0 t -160.9 112.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 3.4 m -102.16 136.18 42.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.707 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -128.93 98.9 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.795 HG22 HG22 ' A' ' 189' ' ' VAL . 36.9 mt -116.49 132.51 65.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.511 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.711 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -108.3 64.41 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 178.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 18.2 tp -69.91 100.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.533 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.42 -85.63 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.352 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.75 -94.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.213 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.522 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 23.0 t-20 -82.78 -53.15 0.63 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 85.5 Cg_endo -77.75 107.08 2.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.244 1.963 . . . . 0.0 112.231 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 86.9 Cg_endo -82.16 130.71 6.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.508 2.139 . . . . 0.0 112.367 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -90.42 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.982 0.42 . . . . 0.0 110.547 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.795 HG22 HG22 ' A' ' 180' ' ' ILE . 94.3 t -56.44 101.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.12 86.62 2.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.008 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -83.92 143.93 29.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.994 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.741 0.225 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.27 -48.47 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.14 -33.75 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -63.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.193 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.79 -20.01 60.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.276 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.02 -46.5 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.06 94.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.282 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' MET . 2.0 mp -72.26 -29.12 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -54.56 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.253 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.649 HG23 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.93 -26.79 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.571 ' HE2' ' HA ' ' A' ' 41' ' ' VAL . 10.8 mmt -56.56 -44.59 81.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -19.66 61.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.9 -0.43 64.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.694 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.52 27.23 71.52 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.36 170.75 13.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.676 HD12 ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -96.36 153.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.531 ' N ' HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.32 151.13 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 111.447 -178.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -108.3 154.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.22 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.79 106.93 0.45 Allowed Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.651 ' HD3' HD13 ' A' ' 166' ' ' LEU . 1.4 Cg_endo -84.55 162.59 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.292 2.661 . . . . 0.0 112.136 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -137.33 -150.34 0.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.637 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.765 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 5.9 m-20 -60.16 -20.36 58.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.725 0.297 . . . . 0.0 111.148 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 95' ' ' PRO . 7.9 p -100.18 -112.31 0.18 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.806 HG13 ' HE1' ' A' ' 174' ' ' MET . 1.3 tt -111.82 -179.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.665 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -84.2 128.89 34.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.197 0.522 . . . . 0.0 110.686 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -118.75 -167.98 14.03 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.676 ' HB3' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.799 0.333 . . . . 0.0 110.5 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -144.26 136.1 6.57 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.987 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.571 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 1.4 p -172.28 -169.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.792 -0.204 . . . . 0.0 110.743 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.8 t-20 -56.33 103.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.003 0.43 . . . . 0.0 110.327 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.84 -39.23 91.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.017 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.99 24.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.441 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.85 155.16 22.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.775 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -75.23 -21.74 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -72.89 -23.23 60.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.629 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.34 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 46' ' ' GLU . 11.5 p -72.27 -30.25 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.816 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -41.76 61.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -64.44 -44.38 91.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -40.69 95.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.13 -28.54 69.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.005 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -64.26 -45.72 86.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.247 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 t -72.51 -51.25 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.03 -78.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.86 7.41 16.14 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.851 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -118.35 11.8 13.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.721 0.296 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.61 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 1.6 m -147.11 65.35 9.56 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.104 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 59' ' ' SER . 8.9 Cg_exo -72.8 -2.63 12.21 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.728 2.286 . . . . 0.0 112.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -112.61 -24.33 9.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.2 OUTLIER -68.47 148.67 98.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 177.35 3.12 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.515 2.144 . . . . 0.0 112.344 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.599 HG13 HD13 ' A' ' 66' ' ' ILE . 14.6 p -112.92 149.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.798 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 134.27 35.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.599 HD13 HG13 ' A' ' 64' ' ' VAL . 4.1 mm -116.12 160.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.056 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 9.9 t -122.62 137.63 54.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.726 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.717 HG13 HG12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -139.35 -176.2 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.484 ' N ' HG11 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -73.3 -50.03 24.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.709 179.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.469 ' N ' HG11 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -164.71 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.265 0.555 . . . . 0.0 111.797 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.58 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 16.8 t -52.83 -22.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.85 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 2.2 t70 -67.92 -52.78 32.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.76 13.77 3.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.658 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.717 HG12 HG13 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.17 -42.88 0.41 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 72' ' ' ASP . 76.9 Cg_exo -51.62 -17.42 4.75 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.244 1.963 . . . . 0.0 112.935 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -72.2 -39.01 68.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.433 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 23.7 m-85 -97.44 -35.71 10.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.516 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.8 p -116.24 -173.81 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.957 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.39 100.7 28.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HA ' HD23 ' A' ' 100' ' ' LEU . 92.3 Cg_endo -102.74 -170.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.211 2.608 . . . . 0.0 112.677 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.5 ' H ' ' HE2' ' A' ' 85' ' ' MET . 0.3 OUTLIER -126.98 177.09 6.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.22 -88.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.857 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -55.72 -27.48 50.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.128 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.43 -44.12 97.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.918 0.39 . . . . 0.0 110.932 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.5 ' HE2' ' H ' ' A' ' 81' ' ' SER . 6.6 mmt -73.94 -16.13 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.307 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 mt-10 -67.44 -51.27 53.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.591 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.6 tp -62.61 -32.4 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.666 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.584 ' HG3' HD12 ' A' ' 92' ' ' LEU . 6.0 tpt -70.15 -48.12 58.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -65.42 -11.42 42.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.7 tpt180 -72.95 -31.08 64.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.09 32.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.474 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.584 HD12 ' HG3' ' A' ' 88' ' ' MET . 4.4 mt -131.11 152.93 81.5 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.815 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.94 -172.65 11.55 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.555 -1.435 . . . . 0.0 112.512 0.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.55 -177.81 31.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.687 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.765 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 87.8 Cg_endo -81.03 43.45 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.751 2.301 . . . . 0.0 112.239 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.52 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 5.6 m-85 -111.43 136.28 50.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 m -94.92 120.93 35.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.344 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.465 HG11 ' HG2' ' A' ' 88' ' ' MET . 3.2 t -108.86 116.52 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.675 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 3.5 t -104.1 127.47 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 80' ' ' PRO . 1.6 mt -126.87 -169.37 2.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.969 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -172.63 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.648 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.685 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.9 142.53 47.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 1.3 t-20 -74.38 -172.37 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.207 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -75.82 12.83 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.48 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 106' ' ' ILE . 1.0 OUTLIER -69.73 -172.93 0.55 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.807 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.655 ' H ' HD22 ' A' ' 105' ' ' LEU . 1.2 mt -80.25 105.12 3.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.128 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 65.9 Cg_endo -71.43 2.8 4.11 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.585 2.19 . . . . 0.0 112.611 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.82 -88.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.075 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 p -84.77 -0.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.0 mt -96.8 -63.59 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.648 0.261 . . . . 0.0 111.379 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.446 HG21 ' HA ' ' A' ' 107' ' ' PRO . 4.4 p -87.18 -23.75 24.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.59 -130.14 20.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.553 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.41 11.68 60.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.698 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -119.1 169.45 9.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.707 0.289 . . . . 0.0 111.035 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 39.8 m -113.44 31.95 6.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -136.6 166.58 23.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.685 HG23 ' HB2' ' A' ' 102' ' ' ARG . 77.2 t -139.93 142.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.479 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.65 155.75 41.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.366 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.593 HG22 HG13 ' A' ' 74' ' ' ILE . 8.4 mt -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.604 0.24 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.518 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER -146.1 127.34 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.387 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.37 80.13 2.47 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.597 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.595 ' HB3' HG23 ' A' ' 33' ' ' THR . 20.2 Cg_exo -66.6 179.08 2.28 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.505 2.137 . . . . 0.0 112.713 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.69 -0.9 55.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.2 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 83.5 m-20 -61.98 109.1 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.155 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.43 -56.59 19.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.438 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 126' ' ' ILE . 36.6 mm -58.66 -50.79 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -63.06 -17.24 62.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -75.14 -38.48 60.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -45.01 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.05 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.8 mm -62.91 -46.15 97.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 127' ' ' CYS . . . -64.38 -28.4 69.67 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.898 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 69' ' ' SER . . . -54.79 -55.0 34.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.041 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -75.48 -88.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.174 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -77.2 138.55 64.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.88 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.56 146.94 62.99 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.36 2.04 . . . . 0.0 111.849 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.31 133.32 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.47 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.703 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.2 m -67.35 141.47 57.1 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . . . -140.06 104.53 4.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.856 0.36 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.61 125.47 15.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.702 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.587 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -61.18 135.85 57.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.872 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 120.859 0.361 . . . . 0.0 111.171 -179.354 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 CA--C 1.536 0.597 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.46 94.98 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.847 1.698 . . . . 0.0 112.419 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.6 128.49 69.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.748 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -95.95 -8.24 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.886 2.39 . . . . 0.0 112.951 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -129.19 120.12 25.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.493 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.697 ' HG ' HG22 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -60.05 -36.31 77.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.518 178.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 156' ' ' VAL . 0.0 OUTLIER -71.47 -23.83 61.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.647 179.084 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -36.87 84.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.974 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.703 HD12 HG23 ' A' ' 165' ' ' VAL . 55.0 mt -68.77 -55.15 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.591 HG13 HG13 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -60.38 -32.51 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.46 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -75.67 -54.99 6.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.39 -24.08 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.585 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.53 ' HG ' ' OD2' ' A' ' 163' ' ' ASP . 3.2 mm? -111.25 70.69 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.818 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 16.4 t0 -15.94 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 124.049 0.843 . . . . 0.0 112.823 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -156.85 25.5 0.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.7 0.285 . . . . 0.0 111.469 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.61 -69.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.573 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.707 ' HB2' HD12 ' A' ' 30' ' ' ILE . 2.0 p-10 -111.29 102.65 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.488 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.649 ' HB2' HG23 ' A' ' 22' ' ' VAL . 3.2 mm? -71.45 131.52 43.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.703 HG23 HD12 ' A' ' 155' ' ' ILE . 2.0 p -62.98 -163.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.879 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.8 HD23 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.1 160.81 29.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 111.124 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.87 -25.8 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.68 -56.29 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.472 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.8 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 102.24 -163.28 16.86 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.792 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.63 ' HA ' ' HB2' ' A' ' 32' ' ' PRO . 7.2 p-10 -70.89 -164.72 0.1 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.829 0.347 . . . . 0.0 111.124 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.51 -57.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.563 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.505 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -124.17 -134.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.505 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.15 146.4 26.6 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.794 0.331 . . . . 0.0 111.841 -177.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.806 ' HE1' HG13 ' A' ' 36' ' ' ILE . 71.0 mmm -62.98 -27.47 69.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.71 154.28 47.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.655 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -91.39 -149.36 0.33 Allowed 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.867 -1.305 . . . . 0.0 112.67 1.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.82 158.29 39.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.2 m -102.27 139.0 38.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.1 t -129.1 88.8 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.048 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 189' ' ' VAL . 13.0 mt -108.87 129.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.373 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.675 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.55 66.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.414 178.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 187' ' ' PRO . 53.4 tp -69.71 93.67 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.318 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.51 -81.7 0.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.409 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 12.2 t -120.84 -115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.046 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.5 m-20 -66.41 -52.69 35.11 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 185' ' ' ASN . 3.5 Cg_exo -77.22 108.04 2.54 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.497 2.131 . . . . 0.0 112.093 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.4 Cg_endo -81.49 133.38 8.36 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.451 2.101 . . . . 0.0 112.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 188' ' ' ARG . 5.8 mtt180 -91.92 51.12 1.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.545 ' HA ' HG12 ' A' ' 180' ' ' ILE . 6.3 t -58.64 100.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 tp -126.54 86.64 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.426 ' NH1' HG12 ' A' ' 189' ' ' VAL . 8.5 ptt-85 -87.06 161.62 18.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.824 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 192' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.869 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 38.1 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.872 0.28 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.71 -39.88 66.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.28 -22.78 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.074 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.31 -43.62 66.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -75.23 -28.54 59.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.626 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.07 -38.9 69.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 111.018 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.626 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -74.08 -36.32 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.75 -30.0 48.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -68.84 -48.33 63.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.808 HG21 ' HG ' ' A' ' 164' ' ' LEU . 7.5 p -72.3 -21.8 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.412 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.8 OUTLIER -60.85 -48.4 81.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.809 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.37 -13.52 62.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.098 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.53 -2.87 76.57 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.453 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.29 53.84 33.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.552 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.37 161.6 23.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.516 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 163' ' ' ASP . 1.4 tp -90.89 136.05 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 110.568 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.74 140.96 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.958 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -101.99 150.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.053 178.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' HA ' ' HG ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -165.99 107.04 0.72 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 96.7 Cg_endo -84.26 159.29 13.13 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.763 2.309 . . . . 0.0 111.837 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -135.32 -149.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -54.81 -20.6 8.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.28 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 t -100.17 -117.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.651 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -157.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.117 0 O-C-N 122.198 -0.314 . . . . 0.0 111.202 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.608 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 3.9 m-85 -68.62 132.11 46.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.26 -176.76 15.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.265 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.673 HD12 HD12 ' A' ' 30' ' ' ILE . 1.7 mp -131.93 142.94 49.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.88 0.372 . . . . 0.0 111.172 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.89 115.46 0.82 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.595 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 42' ' ' ASN . 2.4 p -153.96 150.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.802 0.334 . . . . 0.0 111.067 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.571 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -55.87 104.65 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.397 . . . . 0.0 110.574 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -65.4 -34.53 78.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.942 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.4 mm? -76.7 13.92 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.946 0.403 . . . . 0.0 111.151 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -110.48 156.25 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.893 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -69.72 -25.22 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 31.1 t70 -66.5 -21.18 66.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.09 -38.14 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 50' ' ' ARG . 14.6 p -74.25 -35.86 41.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.778 0.323 . . . . 0.0 110.829 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.465 ' N ' HG12 ' A' ' 49' ' ' VAL . 1.1 ttp85 -69.89 -44.21 70.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.487 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.613 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.54 -37.43 84.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.453 179.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.613 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -60.05 -30.85 69.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.898 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.2 -32.01 66.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.762 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmt-85 -68.8 -48.71 62.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' HB ' HH21 ' A' ' 51' ' ' ARG . 29.7 t -75.05 -51.01 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.4 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.56 -67.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.296 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.06 33.03 82.48 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.446 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -100.4 -81.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 110.959 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 m -149.25 146.14 20.65 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.91 2.13 7.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.584 2.189 . . . . 0.0 112.489 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -1.55 26.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.099 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.77 145.29 50.04 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 158.28 54.6 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.517 2.145 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 m -117.04 163.21 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.6 136.6 46.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.623 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.27 168.32 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 8.3 t -122.57 133.35 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.949 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 74' ' ' ILE . 1.1 p -143.39 179.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.577 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -89.3 -42.99 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.931 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.3 t -164.21 170.21 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.089 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.537 ' HA ' HD11 ' A' ' 74' ' ' ILE . 6.8 t -56.94 -34.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.662 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -67.28 -29.84 69.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.936 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.601 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 58.8 mm-40 -73.53 -19.84 60.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 71' ' ' VAL . 0.4 OUTLIER -113.39 60.82 0.8 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.034 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.601 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 44.1 Cg_exo -56.08 -92.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.972 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.434 ' H ' ' HB2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -73.64 22.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.234 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 3.3 m-85 -92.89 -51.95 4.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -128.19 170.51 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.793 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.05 109.21 24.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HA ' HD22 ' A' ' 100' ' ' LEU . 81.1 Cg_endo -102.22 -169.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.108 2.539 . . . . 0.0 112.475 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 85' ' ' MET . 0.5 OUTLIER -127.61 170.26 12.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.009 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.85 -111.23 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.933 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -25.53 35.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 0.0 110.985 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 185' ' ' ASN . . . -59.97 -53.63 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.712 ' HE3' HG22 ' A' ' 98' ' ' VAL . 1.6 tpp -73.76 -24.16 59.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.098 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -55.55 -40.37 71.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -67.6 -40.54 84.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 178.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.83 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 12.0 tpt -61.69 -50.07 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.441 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.407 ' O ' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.83 -6.26 46.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.529 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.574 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.2 ttm180 -67.29 -24.88 65.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 pt -111.07 49.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.407 HD21 ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -128.05 150.37 73.54 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.18 179.06 32.11 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.392 0.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.15 174.34 26.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.72 39.91 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.671 2.248 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.446 ' HD2' HG22 ' A' ' 178' ' ' THR . 55.4 m-85 -98.74 138.43 35.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 7.7 m -97.92 141.45 30.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.654 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.83 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 2.5 p -126.18 99.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.18 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 65.3 t -96.7 117.13 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.63 HD21 HD13 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -126.12 -166.3 1.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.63 178.32 5.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.621 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.704 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -120.1 143.6 48.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.659 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -71.94 -170.56 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.19 -178.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.28 35.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.646 HD23 ' HD2' ' A' ' 107' ' ' PRO . 1.9 mt -69.86 146.3 51.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.852 0.358 . . . . 0.0 110.816 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 36.8 mm -80.1 -49.15 1.27 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.9 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.646 ' HD2' HD23 ' A' ' 105' ' ' LEU . 72.7 Cg_exo -50.22 94.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.482 2.121 . . . . 0.0 112.857 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.687 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.5 OUTLIER -82.45 -3.47 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.7 179.227 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 t -74.2 -24.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.292 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pt -98.27 -42.23 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.687 HG23 ' HA ' ' A' ' 108' ' ' ASP . 14.5 t -75.8 -14.54 60.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.814 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.8 -151.72 37.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.657 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.33 -26.4 57.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 m -106.29 175.54 5.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 111.001 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.49 67.65 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -142.12 131.49 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.704 HG23 ' HB2' ' A' ' 102' ' ' ARG . 59.8 t -139.85 140.89 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.786 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -98.95 162.4 20.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.384 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.444 ' HB ' HG12 ' A' ' 98' ' ' VAL . 10.3 mt -141.8 164.31 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.8 127.15 11.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 t -110.4 88.55 7.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.528 ' HB2' HG21 ' A' ' 33' ' ' THR . 78.6 Cg_endo -76.97 -179.35 5.34 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.59 2.193 . . . . 0.0 112.533 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.43 5.45 51.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -72.4 108.29 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -57.29 -43.05 82.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 130' ' ' ILE . 31.2 mm -64.16 -53.62 41.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -62.88 -17.68 61.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.883 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HG2' ' HG ' ' A' ' 69' ' ' SER . 7.6 ttt180 -75.49 -44.68 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -54.61 11.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.531 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.0 tt -57.31 -43.08 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.552 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 127' ' ' CYS . . . -71.36 -25.8 62.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.418 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.55 -58.05 8.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.013 0.435 . . . . 0.0 109.88 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -83.28 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.243 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.62 114.48 39.08 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.62 144.39 72.15 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.368 2.045 . . . . 0.0 111.565 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 41' ' ' VAL . 1.6 t -127.65 161.99 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.845 0.355 . . . . 0.0 111.267 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.47 139.26 36.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.063 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -131.07 107.48 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.381 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -132.75 141.41 48.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.9 p -80.72 115.74 20.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.86 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 -179.78 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 38.9 Cg_exo . . . . . 0 CA--C 1.537 0.649 0 N-CA-C 113.172 0.412 . . . . 0.0 113.172 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.6 Cg_exo -64.74 104.19 0.53 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.932 1.754 . . . . 0.0 111.862 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.7 t -77.08 149.54 79.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.211 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -95.21 -18.73 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.81 2.34 . . . . 0.0 112.403 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.64 141.41 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.494 HD21 ' O ' ' A' ' 166' ' ' LEU . 49.7 mt -64.47 -43.95 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.72 -17.18 63.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -75.06 -39.97 60.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.12 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.3 -56.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.201 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.409 HG12 ' HB ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -55.84 -40.86 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.32 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -65.41 -50.48 65.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.666 ' HB3' HD21 ' A' ' 159' ' ' LEU . 8.0 t0 -63.68 -35.17 79.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.823 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -110.88 75.32 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t0 -15.95 -64.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.117 0.886 . . . . 0.0 112.85 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -150.97 11.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.685 0.279 . . . . 0.0 111.35 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.823 HG13 ' HB3' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -81.15 -62.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.831 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.597 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 1.4 t0 -103.03 97.13 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.808 ' HG ' HG21 ' A' ' 22' ' ' VAL . 2.8 mm? -74.49 129.13 37.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.557 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.486 HG23 HD23 ' A' ' 152' ' ' LEU . 2.4 p -66.31 -179.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.306 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.509 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.31 147.33 49.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.484 179.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.9 -26.8 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.951 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.64 -54.08 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.88 0.372 . . . . 0.0 111.343 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.24 -165.64 21.76 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.945 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -71.94 -165.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.415 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -141.68 -51.74 0.42 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.322 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -132.33 -135.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 175' ' ' GLU . 4.4 t0 -86.57 154.81 20.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.778 0.323 . . . . 0.0 111.667 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.509 ' O ' HG12 ' A' ' 36' ' ' ILE . 19.3 ptm -70.9 17.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.434 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 173' ' ' ASP . 1.5 mt-10 -155.35 157.86 31.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.563 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -95.67 -151.89 0.28 Allowed 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.185 -1.173 . . . . 0.0 112.662 1.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.55 96.74 1.93 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 191' ' ' ARG . 97.0 m -100.97 135.51 42.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.231 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.517 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 21.0 t -127.64 104.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 189' ' ' VAL . 36.9 mt -109.11 127.71 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.462 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.2 m-20 -89.35 74.71 7.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.303 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.693 ' HG ' ' HE2' ' A' ' 85' ' ' MET . 0.8 OUTLIER -68.51 79.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -84.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.507 ' HA ' ' HG ' ' A' ' 81' ' ' SER . 3.1 t -121.0 -128.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.66 177.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.484 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 57.7 t30 -60.24 -51.74 78.09 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 68.3 Cg_endo -74.32 109.02 2.81 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.19 1.927 . . . . 0.0 112.637 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 84.7 Cg_endo -82.8 120.83 3.15 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.611 2.207 . . . . 0.0 112.157 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 1.2 mpp_? -87.87 53.17 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.131 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.804 HG21 HG23 ' A' ' 180' ' ' ILE . 21.5 t -56.73 97.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.71 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.96 89.41 3.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.269 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -91.17 131.9 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 -179.867 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 52.2 Cg_endo . . . . . 0 C--O 1.231 0.139 0 CA-C-O 120.854 0.272 . . . . 0.0 112.259 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.53 -32.98 73.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.402 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 15.6 t -68.14 -36.67 76.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.085 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.596 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.13 -39.77 71.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.15 -24.79 65.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.791 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -74.65 -33.93 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -67.67 -37.3 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.835 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 16' ' ' LEU . 7.8 mm -75.11 -18.71 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -73.41 -44.98 57.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.053 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 19' ' ' ALA . 14.1 p -68.46 -31.19 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 53.0 mtt -66.99 -31.24 71.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.861 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.12 -35.26 64.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.053 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.16 10.32 69.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.661 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.01 58.88 9.47 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.529 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.27 160.52 22.03 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.621 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -96.26 146.9 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.434 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.94 133.03 64.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.474 ' H ' HG13 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -102.58 154.14 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.62 0.248 . . . . 0.0 110.946 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.659 ' HH ' ' HB2' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -158.47 100.13 1.71 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.762 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 4.7 Cg_exo -78.01 142.29 19.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.975 2.45 . . . . 0.0 111.299 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 88.4 m -138.62 -82.4 0.3 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 112.304 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.541 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 6.0 m-20 -75.36 -78.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.722 ' HA ' ' HG3' ' A' ' 174' ' ' MET . 0.8 OUTLIER -79.4 -88.59 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.366 -177.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.626 HG21 ' HB3' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -118.59 -150.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 -178.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.529 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 7.4 m-85 -69.81 141.2 53.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.05 -177.22 17.77 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.911 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.592 ' HG ' HD11 ' A' ' 28' ' ' ILE . 1.5 mp -122.7 140.21 53.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -147.22 110.35 0.51 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.719 HG13 ' HB ' ' A' ' 137' ' ' THR . 2.6 p -153.48 156.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 111.099 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.537 ' N ' HG23 ' A' ' 41' ' ' VAL . 3.0 m120 -55.05 101.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.025 0.44 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.68 76.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.938 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.4 18.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.048 0.452 . . . . 0.0 111.238 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.84 156.97 20.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.565 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER -75.27 -30.32 60.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.973 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.486 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 6.9 m-20 -62.48 -32.32 73.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.093 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.65 -34.1 71.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG12 HG22 ' A' ' 109' ' ' VAL . 4.1 t -68.42 -44.79 83.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -66.88 -44.52 80.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.772 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.412 ' NH2' HG21 ' A' ' 162' ' ' VAL . 51.9 mmt-85 -67.01 -23.7 65.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.15 -53.58 19.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -65.86 -14.89 62.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -66.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.313 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -75.56 -38.48 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.408 ' N ' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -81.76 -1.54 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.385 -178.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.23 -148.57 50.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -98.61 117.6 33.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 3.2 p -153.35 69.65 6.72 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.822 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.25 1.36 5.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.772 2.314 . . . . 0.0 112.619 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.636 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.8 m80 -114.21 -21.68 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.206 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 8.7 mtpt -88.11 126.43 60.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.28 174.5 7.04 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.451 2.101 . . . . 0.0 112.069 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 110' ' ' ILE . 2.5 m -113.06 153.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.028 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 t -111.3 132.39 54.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -111.67 172.74 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.678 ' HB3' ' HB1' ' A' ' 138' ' ' ALA . 3.0 p -119.56 135.31 54.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.849 HG23 ' HB2' ' A' ' 73' ' ' GLU . 1.3 p -143.69 173.18 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.663 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -83.0 -39.94 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.996 0.427 . . . . 0.0 110.426 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.1 165.75 21.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 74' ' ' ILE . 18.5 t -55.41 -33.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.769 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.29 -31.36 71.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.116 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.849 ' HB2' HG23 ' A' ' 68' ' ' VAL . 9.2 mm-40 -71.07 -21.41 62.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.152 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.797 HG22 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.27 63.73 0.92 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.791 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.626 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 27.9 Cg_exo -62.29 -76.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.211 1.941 . . . . 0.0 112.38 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.21 23.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.143 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -102.5 -53.04 2.97 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.262 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.455 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 22.5 p -123.01 177.24 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 9.2 mtt-85 -113.64 88.76 14.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 78' ' ' SER . 94.2 Cg_endo -102.74 -169.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.241 2.627 . . . . 0.0 112.786 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.749 ' HB3' ' HB1' ' A' ' 84' ' ' ALA . 2.2 t -145.96 179.21 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.853 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.33 -86.46 0.3 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.046 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.595 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -54.96 -32.71 61.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.346 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.749 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -60.29 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.0 110.871 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.597 ' HE1' ' HG ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -72.5 -17.91 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.595 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 2.5 mm-40 -59.14 -51.63 69.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.279 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.5 OUTLIER -64.37 -32.81 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.273 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.708 ' HE1' ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -65.51 -49.39 69.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.463 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -70.22 -8.76 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.265 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -75.02 -20.21 59.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.407 HD13 ' CE1' ' A' ' 96' ' ' TYR . 1.7 mt -108.35 13.18 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.695 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 4.2 pp -131.2 166.07 30.52 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.544 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.695 ' HA ' ' HB2' ' A' ' 92' ' ' LEU . 97.2 Cg_endo -78.87 162.69 87.1 Favored 'Cis proline' 0 C--N 1.354 0.819 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.91 -0.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 96' ' ' TYR . . . 153.88 -151.04 22.81 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.982 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.407 ' HG3' ' HD2' ' A' ' 176' ' ' PRO . 85.6 Cg_endo -78.08 35.12 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.411 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.623 ' HE2' ' HG3' ' A' ' 88' ' ' MET . 16.9 t80 -92.62 135.35 34.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.592 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.703 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 13.2 m -114.02 120.23 39.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.708 ' HB ' ' HE1' ' A' ' 88' ' ' MET . 0.2 OUTLIER -115.92 108.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.224 0.535 . . . . 0.0 111.551 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.88 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -105.66 128.73 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.435 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.59 -172.44 2.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 1.7 tt0 -74.42 -176.65 2.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.296 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.795 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.71 141.36 49.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 111.279 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 7.7 t30 -74.54 -177.02 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.943 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.43 52.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.816 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 4.5 tp -79.97 134.84 36.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.588 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 27.4 mt -72.27 -50.58 8.51 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.428 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.816 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 71.0 Cg_exo -51.9 109.1 0.29 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.304 2.003 . . . . 0.0 112.327 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -81.98 -19.82 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.182 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.437 HG23 HG13 ' A' ' 110' ' ' ILE . 24.3 m -69.25 -15.38 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.197 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.519 HG23 HG21 ' A' ' 64' ' ' VAL . 48.1 mt -98.15 -43.08 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.3 t -77.0 -12.78 59.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.44 -155.73 49.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.455 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -82.44 -13.65 78.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.397 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.86 -175.06 2.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.782 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.409 ' CA ' ' HD2' ' A' ' 102' ' ' ARG . 3.0 m -112.91 44.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -137.22 159.91 40.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.063 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.795 HG23 ' HB2' ' A' ' 102' ' ' ARG . 84.1 t -139.79 143.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.459 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -99.33 152.49 19.56 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.328 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.732 HG12 HD13 ' A' ' 66' ' ' ILE . 19.4 mt -145.92 149.61 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.3 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 119' ' ' ILE . 3.5 ttm-85 -148.56 137.07 21.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.215 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.26 88.03 6.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.757 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.547 ' HD2' ' NH2' ' A' ' 128' ' ' ARG . 30.6 Cg_endo -63.95 -177.68 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.591 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.83 8.11 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.21 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.55 115.06 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.984 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -57.46 -56.37 22.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.663 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.457 HG23 HD23 ' A' ' 16' ' ' LEU . 66.7 mt -60.61 -48.47 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.444 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 7.2 t -57.49 -16.95 11.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.663 ' HE ' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -75.4 -55.04 6.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.149 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -51.09 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.652 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 tt -59.62 -40.22 81.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.597 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 127' ' ' CYS . . . -72.75 -26.49 61.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.13 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.45 -54.76 36.58 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -75.98 -88.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.2 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -77.85 119.18 76.38 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.456 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.64 156.41 63.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.405 2.07 . . . . 0.0 111.605 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.511 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.2 t -134.9 159.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.208 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.719 ' HB ' HG13 ' A' ' 41' ' ' VAL . 29.0 m -80.85 139.24 36.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.1 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 67' ' ' CYS . . . -133.42 106.38 7.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.801 0.334 . . . . 0.0 111.62 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -136.75 122.05 19.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.976 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.1 111.36 3.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.206 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo . . . . . 0 CA--C 1.537 0.662 0 N-CA-C 113.69 0.612 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.626 ' HB3' HG21 ' A' ' 36' ' ' ILE . 72.7 Cg_endo -76.36 121.23 5.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.906 1.737 . . . . 0.0 112.601 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -97.32 147.77 33.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.798 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -95.99 -13.72 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.913 2.408 . . . . 0.0 113.204 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -134.58 140.06 45.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.01 72.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.583 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.68 -17.43 63.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -75.27 -37.56 60.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.468 HG22 HD23 ' A' ' 159' ' ' LEU . 49.1 mt -67.48 -45.15 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.355 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.43 -28.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -75.7 -54.22 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.436 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.04 -43.96 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.722 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.58 ' HB3' HG11 ' A' ' 162' ' ' VAL . 2.7 mm? -90.5 66.59 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 159' ' ' LEU . 5.0 t70 -16.68 -64.35 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.062 0.851 . . . . 0.0 112.761 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.35 25.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.67 HG11 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.77 -68.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.722 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.67 ' H ' HG11 ' A' ' 162' ' ' VAL . 1.7 p-10 -111.1 96.55 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.676 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.68 130.42 46.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.199 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.67 HG23 ' H ' ' A' ' 166' ' ' LEU . 3.6 p -67.34 175.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.88 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.67 ' H ' HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.62 124.92 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 111.172 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 -7.54 45.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.274 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.659 ' HB2' ' HH ' ' A' ' 31' ' ' TYR . . . -63.83 -31.94 73.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.38 123.2 5.21 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 9.5 p-10 -73.25 -166.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.895 0.379 . . . . 0.0 111.259 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 5.1 m -136.49 -168.5 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.554 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.412 ' H ' ' HB3' ' A' ' 171' ' ' CYS . 0.0 OUTLIER -143.53 39.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.541 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -83.37 46.36 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.858 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.722 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 9.1 ttm -59.15 -17.97 31.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.467 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -139.92 136.05 16.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.407 ' HD2' ' HG3' ' A' ' 95' ' ' PRO . 84.1 Cg_endo -83.68 -151.93 0.73 Allowed 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.452 0.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.69 92.59 1.58 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.685 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -102.27 129.92 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.703 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 98.3 t -128.02 100.82 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.378 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.821 HG12 ' HA ' ' A' ' 189' ' ' VAL . 73.8 mt -116.29 139.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.827 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.88 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.8 m-20 -107.48 58.69 0.62 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 187' ' ' PRO . 9.7 tp -69.96 105.78 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.391 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.29 -88.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.242 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.7 t -120.96 -83.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.646 0.26 . . . . 0.0 111.371 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.522 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.0 OUTLIER -89.01 -52.14 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.67 -179.053 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.36 106.75 1.37 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.248 1.965 . . . . 0.0 112.491 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.647 ' HB3' HD11 ' A' ' 182' ' ' LEU . 98.2 Cg_endo -84.27 129.57 4.48 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.752 2.301 . . . . 0.0 112.499 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.599 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.2 mtt180 -90.48 50.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 180' ' ' ILE . 47.8 t -56.47 105.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.28 83.57 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.132 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 191' ' ' ARG . 8.1 ptt180 -85.95 174.1 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.737 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.803 0.251 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.86 -33.97 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.798 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.651 HG12 HG13 ' A' ' 126' ' ' ILE . 26.2 t -61.51 -40.14 85.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -68.43 -34.77 76.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.723 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.09 -26.58 63.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.554 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.65 -37.22 68.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.654 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -66.08 -37.25 85.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.814 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 16' ' ' LEU . 22.8 mm -75.3 -23.95 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 t -68.18 -47.75 67.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.53 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 7.3 p -69.72 -31.02 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 1.7 mtt -71.23 -27.91 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.075 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.84 -33.82 76.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.81 73.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.519 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.35 65.48 2.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.36 175.84 16.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.413 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 163' ' ' ASP . 2.2 tp -96.04 142.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.552 HG23 HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -116.69 121.15 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.678 HG21 ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -102.06 165.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.733 ' HH ' ' HB1' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -169.91 86.28 0.57 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.601 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 73.0 Cg_endo -75.09 118.97 5.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.265 1.977 . . . . 0.0 111.009 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.83 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 1.0 OUTLIER -116.31 -137.29 0.36 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.034 0.445 . . . . 0.0 111.68 -176.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -54.24 -46.56 72.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.202 -179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.8 -122.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.485 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.798 HG22 ' HG3' ' A' ' 174' ' ' MET . 0.0 OUTLIER -112.51 -158.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 110.9 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.455 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . 1.8 m-85 -69.99 115.46 9.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.468 ' HA3' HH22 ' A' ' 120' ' ' ARG . . . -116.16 126.48 7.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.525 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.678 ' HB3' HG21 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -111.17 138.77 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 111.199 -178.126 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 41' ' ' VAL . . . -145.18 160.52 28.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.987 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -158.95 -169.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.047 -178.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.722 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t30 -56.14 124.0 16.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.197 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.09 -67.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.226 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 44' ' ' LEU . 2.1 mm? -80.84 42.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 111.625 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.722 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.33 152.82 25.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.849 178.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.28 -30.28 60.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.89 -25.5 68.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -38.88 76.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 t -72.34 -37.63 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -67.66 -37.73 82.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.093 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -75.19 -20.29 59.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.036 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -44.92 66.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.956 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -75.26 -27.94 59.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -68.58 -56.52 7.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.72 -49.42 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.429 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -72.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.285 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.64 78.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.656 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.86 -69.31 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.91 98.7 11.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.73 14.72 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.567 2.178 . . . . 0.0 112.448 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -104.88 -7.35 19.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.6 148.5 44.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.978 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.56 165.13 1.78 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.662 2.241 . . . . 0.0 112.319 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.675 HG22 HG21 ' A' ' 110' ' ' ILE . 13.0 m -113.3 159.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.27 138.49 43.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.565 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 118' ' ' GLY . 22.6 pt -114.76 169.08 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.502 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 118.22 27.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 73' ' ' GLU . 1.5 p -135.86 -179.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.472 ' OG ' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -87.65 -40.1 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.042 0.449 . . . . 0.0 110.582 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 166.73 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.562 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -59.17 -29.38 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.752 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.31 -27.51 67.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.777 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.823 ' HB2' HG23 ' A' ' 68' ' ' VAL . 12.8 mm-40 -79.31 -22.87 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.74 56.67 0.71 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 42.8 Cg_endo -68.35 -62.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.857 1.705 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.404 ' H ' ' HG2' ' A' ' 75' ' ' PRO . 15.8 mtt180 -72.89 4.09 4.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.559 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -92.2 -64.54 1.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.736 0.303 . . . . 0.0 110.837 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.06 -178.03 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -116.59 116.62 38.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.956 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -102.07 -176.71 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.203 2.602 . . . . 0.0 112.558 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 85' ' ' MET . 29.5 t -143.4 173.08 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.99 -103.25 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.129 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 86' ' ' GLU . 1.5 m-20 -55.17 -26.54 39.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -60.61 -51.95 67.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.989 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.737 ' HE2' ' HG ' ' A' ' 182' ' ' LEU . 0.2 OUTLIER -74.26 -21.01 59.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -63.61 -44.83 92.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -44.65 95.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.621 ' HE3' ' HB ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -66.4 -29.98 70.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.555 ' HA ' HD22 ' A' ' 92' ' ' LEU . 3.7 mt-10 -72.39 -17.3 61.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.082 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -75.22 -13.82 60.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.179 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 41.95 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' A' ' 89' ' ' GLU . 1.8 pp -127.27 146.65 58.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.994 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.59 -171.95 10.59 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.37 -1.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.35 163.42 12.29 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.856 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.538 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.0 Cg_endo -81.06 48.78 3.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.413 ' HD2' ' HE1' ' A' ' 88' ' ' MET . 27.1 p90 -107.5 159.68 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.57 138.84 44.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.632 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.502 HG12 ' HG2' ' A' ' 88' ' ' MET . 0.4 OUTLIER -120.07 106.58 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.285 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.739 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 14.0 t -103.85 122.48 56.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 182' ' ' LEU . 1.2 mp -126.36 -167.66 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.442 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -177.53 3.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.314 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -119.8 147.87 44.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.091 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 8.7 t30 -74.28 -173.21 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.39 38.38 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.826 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 10.8 tp -76.63 127.77 33.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.79 0.329 . . . . 0.0 110.799 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.566 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.5 mt -75.68 -50.34 3.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.692 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.826 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 76.4 Cg_exo -50.58 108.32 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.267 1.978 . . . . 0.0 112.443 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.629 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.8 OUTLIER -80.82 1.37 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.73 -15.02 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.72 HD13 HD22 ' A' ' 105' ' ' LEU . 4.3 mt -109.5 -44.33 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 108' ' ' ASP . 8.8 t -77.26 -9.63 58.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.834 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.35 -150.25 38.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.7 -10.52 67.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.549 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.3 p -117.02 -171.35 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.757 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.558 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.4 p -109.67 64.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.702 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -140.42 152.59 45.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.012 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 102' ' ' ARG . 92.9 t -139.86 135.07 38.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.411 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 66' ' ' ILE . . . -99.21 155.99 19.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.563 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.505 HG23 HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -135.06 173.23 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.468 HH22 ' HA3' ' A' ' 38' ' ' GLY . 3.2 ttp180 -157.29 117.5 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 111.392 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.87 79.38 1.85 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.846 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.57 -170.47 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.594 2.196 . . . . 0.0 112.548 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.11 23.01 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.104 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.1 t0 -82.2 96.06 7.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.57 -44.99 85.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.651 HG13 HG12 ' A' ' 15' ' ' VAL . 30.6 mm -64.91 -53.42 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.947 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 14.5 t -63.11 -12.78 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 6.4 ttt85 -75.47 -42.85 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -73.25 -54.46 8.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.518 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.18 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.299 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.605 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.13 -26.6 63.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.36 -53.79 49.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -89.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.824 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 90.1 m-85 -77.74 123.16 86.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 20.7 Cg_exo -65.51 163.53 29.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 41' ' ' VAL . 21.0 t -134.06 146.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 111.517 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -74.47 151.24 39.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.29 114.87 8.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.952 0.406 . . . . 0.0 111.939 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.52 148.51 50.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.54 124.9 29.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.199 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.9 Cg_exo . . . . . 0 CA--C 1.537 0.674 0 N-CA-C 113.136 0.399 . . . . 0.0 113.136 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 86.3 Cg_endo -82.26 125.62 4.63 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.924 1.749 . . . . 0.0 112.571 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.08 154.63 38.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -95.85 -10.67 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.72 2.28 . . . . 0.0 112.972 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.35 139.54 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.389 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -65.53 -45.25 84.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.853 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.24 -18.5 65.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.611 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -40.92 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.748 HG22 HD23 ' A' ' 159' ' ' LEU . 24.0 mt -69.29 -37.87 76.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.217 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.11 -44.17 95.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.42 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -75.45 -46.9 29.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.753 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.655 ' HB3' HD21 ' A' ' 159' ' ' LEU . 6.3 t70 -70.18 -43.45 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.574 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.748 HD23 HG22 ' A' ' 155' ' ' ILE . 2.8 mm? -100.23 67.11 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -16.59 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.048 0.843 . . . . 0.0 112.848 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.44 25.09 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.649 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.55 -69.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.553 179.031 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.706 ' H ' HG12 ' A' ' 162' ' ' VAL . 1.2 p-10 -108.29 99.51 8.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.498 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.53 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.97 130.2 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.735 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 155' ' ' ILE . 1.9 p -64.33 -170.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.948 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.612 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.53 119.95 28.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.155 0.502 . . . . 0.0 111.426 -178.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.4 -0.69 57.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.076 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.733 ' HB1' ' HH ' ' A' ' 31' ' ' TYR . . . -75.75 -38.71 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.82 64.85 1.7 Allowed Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.767 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.83 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 7.3 m-20 -73.14 -124.0 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.859 -0.2 . . . . 0.0 110.744 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.809 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -141.72 -170.1 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.232 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.86 10.1 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -64.63 91.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.149 0.5 . . . . 0.0 111.364 -176.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.798 ' HG3' HG22 ' A' ' 36' ' ' ILE . 10.0 ttt -55.04 -15.79 2.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.857 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -139.68 150.58 63.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.055 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.417 ' HB2' ' H ' ' A' ' 177' ' ' SER . 94.8 Cg_endo -85.95 -151.92 0.66 Allowed 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 123.497 -1.46 . . . . 0.0 112.533 0.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.417 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 25.0 m -153.91 115.21 4.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.444 HG21 ' HB3' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -101.44 124.18 46.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.333 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.4 t -129.24 105.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.564 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.621 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 3.7 mp -121.2 132.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.739 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -95.3 71.86 3.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.737 ' HG ' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -68.37 84.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.299 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -88.0 0.08 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.414 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 2.4 t -120.72 -128.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.842 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.547 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.6 OUTLIER -59.33 -51.17 83.32 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.36 106.27 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.238 1.958 . . . . 0.0 112.371 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 96.1 Cg_endo -84.29 140.56 8.67 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.601 2.2 . . . . 0.0 112.401 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.2 mmm-85 -97.18 59.31 1.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.473 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 43.2 t -58.24 107.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.117 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.01 80.36 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.444 ' HB3' HG21 ' A' ' 178' ' ' THR . 0.0 OUTLIER -99.2 143.45 29.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.712 0.213 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -33.75 76.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.469 HG11 ' OE2' ' A' ' 18' ' ' GLU . 95.3 t -65.93 -35.67 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.135 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -47.08 70.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.87 -21.18 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.03 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.469 ' OE2' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.22 -34.21 61.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.661 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.68 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.058 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.6 mm -69.71 -31.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m -64.04 -47.54 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.47 -25.5 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.42 -47.24 86.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -23.71 61.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.983 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.35 -5.3 79.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.519 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.0 57.13 12.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.81 174.72 16.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.719 HD12 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -96.44 148.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.756 0.313 . . . . 0.0 110.67 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG13 HD11 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -117.8 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.614 ' HB ' HG12 ' A' ' 165' ' ' VAL . 2.5 mt -102.38 174.23 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.624 ' HH ' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -171.31 106.44 0.39 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' A' ' 170' ' ' ASP . 87.2 Cg_endo -84.28 125.39 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.602 2.201 . . . . 0.0 111.506 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.62 -154.84 0.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 6.8 m-20 -54.7 -30.1 54.89 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.255 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.579 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -93.54 -118.23 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.512 ' H ' ' HB ' ' A' ' 35' ' ' THR . 0.1 OUTLIER -112.18 -165.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.165 -179.593 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.468 ' HE2' HG13 ' A' ' 165' ' ' VAL . 33.6 m-85 -71.87 126.02 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.537 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.2 121.19 2.79 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.719 HD13 HD12 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -112.16 149.32 32.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 0.0 112.062 -176.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' HG11 ' A' ' 41' ' ' VAL . . . -144.93 169.04 26.8 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.946 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.583 HG11 HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -159.27 -170.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.909 0.385 . . . . 0.0 111.118 -179.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.674 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.5 t30 -56.75 119.74 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -58.56 -63.23 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.37 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 44' ' ' LEU . 1.2 mm? -78.33 33.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 111.863 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 1.1 m-20 -111.28 147.68 34.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.973 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -75.57 -29.63 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.305 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.71 -25.68 63.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -72.33 -31.48 65.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.145 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.13 -45.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.489 ' NH2' ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -67.75 -34.92 77.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 24.2 mmt180 -73.64 -35.1 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -67.23 -24.65 65.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.846 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -46.68 32.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.384 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -54.46 -48.21 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.391 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 140' ' ' SER . 10.7 t -75.21 -49.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.36 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.71 ' HE3' ' HB2' ' A' ' 58' ' ' ARG . 14.7 tptt -93.69 -71.25 0.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.411 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.85 15.33 34.32 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.697 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.71 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 76.7 mtp85 -118.23 22.91 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.521 ' HG ' ' HG2' ' A' ' 56' ' ' LYS . 2.4 p -149.7 66.21 8.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.93 -54.94 4.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.575 2.184 . . . . 0.0 112.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' HA3' ' A' ' 112' ' ' GLY . 32.2 p-80 -123.84 24.09 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.137 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HE3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -88.55 146.55 37.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.6 ' HD2' ' HE3' ' A' ' 62' ' ' LYS . 76.9 Cg_exo -51.74 148.32 22.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.662 2.241 . . . . 0.0 112.559 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.9 166.13 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.573 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 0.4 OUTLIER -106.92 140.22 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 118' ' ' GLY . 1.8 pt -116.21 171.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.6 t -122.8 125.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.504 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 131' ' ' ALA . 0.8 OUTLIER -135.97 -179.11 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.878 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 1.5 t -90.0 -44.07 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.79 0.328 . . . . 0.0 110.956 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -163.71 174.91 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.089 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 t -58.38 -37.37 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.834 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 1.0 OUTLIER -67.13 -22.12 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.837 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -80.43 -20.92 42.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.139 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -113.63 54.6 0.61 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 77' ' ' PHE . 29.5 Cg_endo -62.41 -82.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.834 1.689 . . . . 0.0 111.828 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.446 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 2.0 mmt180 -73.41 19.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.336 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' PRO . 59.9 m-85 -103.26 -34.81 8.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.755 0.312 . . . . 0.0 111.108 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -135.33 165.5 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.047 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -112.76 105.01 56.09 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.427 ' HA ' HD13 ' A' ' 100' ' ' LEU . 86.3 Cg_endo -102.57 179.72 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.169 2.579 . . . . 0.0 112.619 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 -173.45 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.11 -82.47 0.44 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.686 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -57.64 -26.71 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.927 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.539 ' HB1' HD23 ' A' ' 182' ' ' LEU . . . -63.41 -48.25 78.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.438 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 9.6 mmt -70.44 -15.81 62.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.686 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mm-40 -66.44 -50.4 63.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.67 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 182' ' ' LEU . 2.7 tm? -61.77 -38.99 90.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.633 ' HB2' HD12 ' A' ' 182' ' ' LEU . 5.1 tpt -64.94 -49.67 69.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.437 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -72.88 -2.59 21.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.368 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.99 -58.88 3.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.295 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.3 74.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.629 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.74 149.22 72.82 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.071 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HB3' HG12 ' A' ' 121' ' ' VAL . 5.2 Cg_exo -78.72 -148.5 0.51 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.18 -1.175 . . . . 0.0 111.952 -1.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.18 8.74 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.979 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.579 ' HB2' HG23 ' A' ' 35' ' ' THR . 3.9 Cg_exo -80.42 43.77 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.221 2.614 . . . . 0.0 112.151 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.491 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 3.6 p90 -112.23 -177.03 3.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -112.89 139.04 48.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.245 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.17 102.77 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.282 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.726 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -101.22 122.9 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 HD21 ' A' ' 182' ' ' LEU . 1.2 mm? -126.91 -179.04 4.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.714 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -74.86 -166.01 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.664 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -119.28 138.19 53.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.182 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 76' ' ' ARG . 4.3 t30 -73.73 -163.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.315 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -39.19 82.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.325 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.563 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -69.46 100.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.688 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.4 pt -80.95 102.87 1.5 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.874 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 60.6 Cg_endo -70.91 138.43 34.16 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.429 2.086 . . . . 0.0 112.248 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.034 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 p -87.43 23.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.874 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 57.7 mt -106.69 -54.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 110.894 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.623 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 6.2 t -87.57 -24.26 24.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.865 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 61' ' ' HIS . . . 69.31 -141.74 36.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.408 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.32 27.6 6.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.437 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 63' ' ' PRO . 1.3 t -123.94 165.58 17.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.327 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -113.16 42.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 116' ' ' ARG . 2.3 mtp180 -136.74 163.63 30.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.52 142.28 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . -92.74 149.59 19.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.454 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.2 mt -144.98 150.26 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.41 124.03 12.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.88 0.371 . . . . 0.0 111.476 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.627 HG12 ' HB3' ' A' ' 93' ' ' PRO . 21.1 t -110.66 83.7 3.61 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.837 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.08 179.5 6.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.589 2.192 . . . . 0.0 112.614 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -93.13 19.65 7.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.108 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.451 ' HB2' ' SG ' ' A' ' 127' ' ' CYS . 66.1 m-20 -82.02 105.57 13.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 128' ' ' ARG . 5.4 pt-20 -57.35 -42.96 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.277 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mm -61.36 -58.13 8.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -58.58 -21.16 52.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.994 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 125' ' ' GLU . 1.8 mtp180 -68.17 -37.54 81.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 34.6 ttt-85 -75.25 -53.23 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.2 mt -59.19 -52.0 65.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.257 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -62.08 -27.86 69.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.599 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -51.27 66.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.997 0.427 . . . . 0.0 110.021 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -91.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.92 144.87 68.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 159.53 49.19 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.185 1.923 . . . . 0.0 111.374 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 137' ' ' THR . 11.7 t -132.67 152.0 35.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.802 0.334 . . . . 0.0 111.244 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.428 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -80.2 153.28 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.4 116.4 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 111.57 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.516 HG21 HD11 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -142.42 140.89 32.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.697 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.433 ' O ' HG12 ' A' ' 55' ' ' VAL . 22.4 p -66.93 139.17 57.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.997 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.393 -179.725 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.401 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 43.1 Cg_exo . . . . . 0 CA--C 1.538 0.709 0 N-CA-C 113.389 0.496 . . . . 0.0 113.389 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 73.9 Cg_endo -75.07 90.41 1.09 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.802 1.668 . . . . 0.0 112.208 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.469 ' HB2' HG12 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -84.78 157.93 60.0 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -96.01 -11.27 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.902 2.401 . . . . 0.0 112.908 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -141.48 141.62 33.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.627 HD21 ' HA ' ' A' ' 166' ' ' LEU . 55.8 mt -60.19 -28.6 68.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.771 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -72.23 -34.45 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.361 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.525 ' HG3' HH21 ' A' ' 157' ' ' ARG . 3.9 tt0 -58.95 -47.07 86.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.804 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.752 HG23 HG21 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.44 -35.43 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -67.33 -20.91 27.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.072 0.463 . . . . 0.0 110.37 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.525 HH21 ' HG3' ' A' ' 154' ' ' GLU . 10.1 ttp180 -73.1 -46.31 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.431 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.17 -41.41 63.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.677 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.504 ' HB3' HG11 ' A' ' 162' ' ' VAL . 2.7 mm? -111.22 68.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.7 t70 -15.93 -63.35 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.094 0.871 . . . . 0.0 112.817 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -157.02 18.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.321 . . . . 0.0 111.251 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.554 HG11 ' N ' ' A' ' 163' ' ' ASP . 7.7 p -80.96 -42.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.909 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 25.5 m-20 -111.21 110.75 21.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.411 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.492 ' HB3' ' OD1' ' A' ' 167' ' ' ASP . 29.7 mt -74.71 61.93 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.746 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.752 HG21 HG23 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -78.84 22.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.732 178.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.627 ' HA ' HD21 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -148.21 34.81 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.492 ' OD1' ' HB3' ' A' ' 164' ' ' LEU . 4.3 m-20 -70.01 -84.09 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.385 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.624 ' HB3' ' HH ' ' A' ' 31' ' ' TYR . . . -86.35 -34.19 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.065 0.46 . . . . 0.0 110.673 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.59 27.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.468 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 32' ' ' PRO . 2.9 m-20 -62.19 -177.55 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 0.0 111.214 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.9 t -140.16 -62.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.55 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.53 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -124.77 -135.61 0.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.7 144.78 26.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.9 ptm -70.32 2.4 3.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.054 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.72 151.29 26.45 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 177' ' ' SER . 64.5 Cg_endo -92.02 -136.64 0.1 OUTLIER 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.946 -1.273 . . . . 0.0 112.46 0.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.427 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -159.33 130.2 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.418 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 96' ' ' TYR . 32.6 m -101.29 139.72 36.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.923 0.392 . . . . 0.0 111.607 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.7 t -129.6 117.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.662 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.31 121.01 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.386 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.745 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -98.25 67.96 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.271 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.633 HD12 ' HB2' ' A' ' 88' ' ' MET . 4.4 tt -69.29 79.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 -78.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.92 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.42 -119.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.381 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 2.1 m-20 -69.57 -52.65 13.95 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.97 109.55 2.6 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.108 1.872 . . . . 0.0 112.767 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.7 Cg_endo -75.97 122.67 6.87 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.444 2.096 . . . . 0.0 111.955 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.745 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 3.3 mmp_? -87.28 61.2 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.88 93.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.569 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -122.05 87.8 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.211 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -89.41 142.81 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.057 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.867 179.764 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 16' ' ' LEU . 23.1 Cg_exo . . . . . 0 C--O 1.23 0.109 0 CA-C-O 120.825 0.26 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.88 -26.53 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.11 -34.54 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.074 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 1.1 mm? -69.65 -47.0 64.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.97 -21.21 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.571 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -74.77 -35.88 62.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.679 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.571 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -67.56 -37.67 82.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.933 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.95 -35.18 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.647 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -33.52 75.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 t -70.1 -32.29 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.0 mmt -61.33 -41.93 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.17 -11.23 60.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.12 -11.82 72.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 37.78 92.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.13 170.22 18.89 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.584 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.609 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -96.3 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.673 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.566 ' N ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.29 135.97 55.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -102.56 152.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.59 0.233 . . . . 0.0 110.586 178.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' HH ' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -160.13 102.5 1.4 Allowed Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.708 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.4 Cg_endo -82.18 136.3 8.94 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 0.0 111.327 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -116.94 -147.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.663 0.268 . . . . 0.0 111.277 -178.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.587 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 8.0 t70 -54.5 -25.41 25.34 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.928 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 174' ' ' MET . 4.3 t -95.43 -120.54 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.586 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.687 HG12 ' H ' ' A' ' 37' ' ' TYR . 9.3 tt -111.77 -171.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.563 0.221 . . . . 0.0 110.876 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.4 m-85 -63.33 129.02 38.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.778 0.323 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -121.14 177.68 16.38 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.146 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 3.6 mp -119.32 141.11 49.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.635 0.255 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.39 114.08 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.587 HG11 ' HB ' ' A' ' 137' ' ' THR . 3.4 p -153.29 161.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.511 0.195 . . . . 0.0 110.867 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.497 ' N ' HG23 ' A' ' 41' ' ' VAL . 5.9 t-20 -55.93 98.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.371 . . . . 0.0 110.346 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.62 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.108 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 9.2 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.086 0.469 . . . . 0.0 111.34 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.91 152.51 26.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.718 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.07 -19.16 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.825 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.47 -25.1 63.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.55 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB2' HG13 ' A' ' 41' ' ' VAL . . . -75.14 -46.2 35.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.29 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 50' ' ' ARG . 32.6 m -65.17 -34.28 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.056 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.424 ' N ' HG22 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -62.72 -40.15 96.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.549 ' HG2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -62.2 -54.5 40.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.146 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.71 -27.29 39.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.293 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.57 -31.57 65.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -40.58 63.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.015 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.5 t -75.12 -35.05 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.397 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.89 0.32 56.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.401 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 -115.37 7.92 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.604 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -100.42 105.12 16.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.871 0.367 . . . . 0.0 110.993 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 63.3 m -151.97 65.12 6.09 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.014 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.7 6.03 5.48 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.598 2.199 . . . . 0.0 112.448 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -122.36 -14.03 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.018 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 5.9 mmtp -88.16 129.19 50.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.18 -175.1 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.549 2.166 . . . . 0.0 111.999 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.55 170.64 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -113.62 134.57 54.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 119' ' ' ILE . 25.9 mm -116.42 159.24 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.387 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 1.6 t -119.15 141.24 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.153 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.824 ' HA ' ' HB2' ' A' ' 131' ' ' ALA . 1.4 p -150.05 173.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.287 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 7.5 t -89.84 -34.15 16.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 110.072 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.9 t -164.26 160.66 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.595 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.615 ' HA ' HD12 ' A' ' 74' ' ' ILE . 21.9 t -57.08 -32.56 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.624 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.35 -26.19 66.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.884 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.655 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -77.1 -22.82 52.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.207 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.783 HG23 HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.61 60.11 0.83 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.655 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 23.5 Cg_exo -64.12 -73.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.158 1.906 . . . . 0.0 112.448 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 15.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.032 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -107.19 -34.93 6.98 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.157 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.419 ' HB2' HD23 ' A' ' 100' ' ' LEU . 93.4 p -135.49 164.2 28.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.0 110.991 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -114.52 103.22 55.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.747 ' HA ' HD11 ' A' ' 100' ' ' LEU . 74.3 Cg_endo -102.15 -169.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.177 2.585 . . . . 0.0 113.063 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.418 ' HB3' ' HB1' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -144.58 -174.85 4.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.06 -86.56 0.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.881 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -29.48 61.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.793 0.33 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -58.44 -49.28 77.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.787 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.542 ' HE2' ' HG ' ' A' ' 182' ' ' LEU . 21.3 mmt -72.17 -17.91 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.956 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.67 -36.22 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.14 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 87' ' ' LEU . 2.8 tm? -64.18 -45.45 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.63 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 31.5 tpp -75.39 -26.56 58.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.376 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -40.76 93.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.399 . . . . 0.0 111.854 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -75.56 -18.46 59.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.4 mt -100.4 -11.29 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.525 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.605 HD11 HG23 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -112.08 151.89 43.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.007 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 174.84 50.58 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.904 -1.29 . . . . 0.0 112.202 0.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.32 -173.61 32.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.568 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.17 28.63 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.661 2.241 . . . . 0.0 112.437 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -101.59 143.36 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -106.96 136.24 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.635 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 182' ' ' LEU . 1.4 p -120.11 111.83 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.406 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.663 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 6.4 t -87.44 127.16 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.922 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.747 HD11 ' HA ' ' A' ' 80' ' ' PRO . 15.1 tp -124.8 178.22 5.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.558 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 1.6 mt-10 -74.4 -170.24 0.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.9 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.543 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.77 138.63 52.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.491 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 176.1 7.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.747 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.57 55.84 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.451 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.499 HD23 ' HD2' ' A' ' 107' ' ' PRO . 1.8 mt -89.85 131.04 35.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 110.768 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.622 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.3 mp -66.84 -51.86 36.16 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.781 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 56.7 Cg_exo -52.21 105.17 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.236 1.957 . . . . 0.0 112.445 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -4.7 53.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 110' ' ' ILE . 14.5 p -71.96 -27.01 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.015 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 109' ' ' VAL . 13.1 mt -93.87 -39.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 p -71.68 -23.21 61.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.6 -157.44 50.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.498 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.85 -21.26 71.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.0 m -108.39 -179.77 3.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.524 ' C ' ' HB2' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -112.98 59.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.029 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 mtm105 -142.72 158.58 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.543 HG23 ' HG2' ' A' ' 102' ' ' ARG . 39.5 t -139.93 117.11 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.61 117.9 4.54 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 66' ' ' ILE . 5.7 mt -130.14 150.43 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.8 0.333 . . . . 0.0 111.037 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.484 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.8 ptp180 -144.48 149.32 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.478 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.605 HG23 HD11 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -110.5 88.72 7.9 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.739 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 21.8 Cg_exo -64.81 -179.52 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.461 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.25 2.11 56.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.188 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 5.1 t0 -71.44 109.11 5.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.27 -40.51 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.243 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mm -69.94 -50.02 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.258 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 20.6 t -61.26 -18.79 60.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.2 OUTLIER -73.69 -46.79 44.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.878 179.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.505 ' O ' ' HB1' ' A' ' 132' ' ' ALA . 0.1 OUTLIER -63.68 -52.54 60.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.562 -179.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 mt -59.45 -55.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.309 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.824 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -62.74 -25.1 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.451 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 129' ' ' ARG . . . -54.92 -57.37 11.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.02 0.438 . . . . 0.0 109.965 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.16 -85.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -77.19 112.32 22.51 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.236 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -65.64 133.33 33.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.279 1.986 . . . . 0.0 111.306 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 66' ' ' ILE . 25.2 m -113.72 166.98 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 120.878 0.371 . . . . 0.0 111.771 -177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.587 ' HB ' HG11 ' A' ' 41' ' ' VAL . 87.7 m -80.97 125.88 30.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -122.58 95.37 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.68 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -126.76 113.87 17.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.859 179.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.559 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -61.84 121.7 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.572 ' HG2' ' HD3' ' A' ' 148' ' ' PRO . 11.1 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.572 ' HD3' ' HG2' ' A' ' 147' ' ' PRO . 67.3 Cg_endo -73.95 73.19 3.74 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.764 1.643 . . . . 0.0 112.653 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.4 110.12 53.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.732 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -95.39 -14.84 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.601 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -130.44 127.02 38.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.45 HD22 ' CG2' ' A' ' 165' ' ' VAL . 45.7 mt -63.12 -37.98 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -17.81 62.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -74.09 -36.95 64.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.015 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.458 ' H ' HG13 ' A' ' 155' ' ' ILE . 2.5 mt -70.96 -45.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 165' ' ' VAL . 4.3 t -54.73 -38.07 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -70.88 -48.83 51.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.579 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -45.98 92.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.461 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.798 ' HB3' ' HB ' ' A' ' 162' ' ' VAL . 1.4 mm? -109.77 81.84 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.084 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.4 -40.79 0.39 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.004 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.75 15.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.318 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.798 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 47.2 t -80.61 -83.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.979 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.609 ' HA ' HG23 ' A' ' 28' ' ' ILE . 4.3 t0 -93.83 85.9 4.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.753 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.56 ' HB3' HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -54.89 123.82 14.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.326 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.58 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.4 p -62.71 177.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.296 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.537 HD13 ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -125.47 137.82 53.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.792 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -9.65 41.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.232 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.486 ' HB3' ' HH ' ' A' ' 31' ' ' TYR . . . -77.44 -35.04 54.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.92 177.86 49.12 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.827 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 16.7 p-10 -71.32 -160.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.39 -64.75 0.44 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.758 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.86 -139.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.04 149.19 24.91 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.533 ' HE3' ' HG3' ' A' ' 175' ' ' GLU . 6.8 ptm -60.99 -10.72 6.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.237 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.533 ' HG3' ' HE3' ' A' ' 174' ' ' MET . 4.2 mt-10 -139.76 158.38 67.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.552 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -92.33 -156.71 0.68 Allowed 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 124.124 -1.198 . . . . 0.0 112.844 1.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.71 120.24 3.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.551 HG23 ' HB3' ' A' ' 191' ' ' ARG . 69.5 m -102.02 138.18 39.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.32 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.52 98.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.061 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.659 HG12 HG12 ' A' ' 189' ' ' VAL . 6.0 mt -108.73 132.96 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.663 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -90.1 71.4 7.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.884 ' HA ' ' HB3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -72.4 82.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.545 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.9 p -83.7 -97.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.181 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.92 -63.2 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.457 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -173.56 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.342 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.57 120.37 8.15 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.927 1.085 . . . . 0.0 110.867 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.884 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 21.2 Cg_endo -62.67 156.69 51.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.811 2.341 . . . . 0.0 112.834 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.92 99.96 10.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.873 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 180' ' ' ILE . 1.4 t -67.75 103.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.78 82.26 1.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . 0.551 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -102.98 159.04 15.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.798 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.735 0.302 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mt -105.35 -66.01 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 4' ' ' ARG . 1.8 tp -74.29 146.92 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.197 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.444 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -74.81 97.66 3.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.2 -179.92 5.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 tt -106.45 153.84 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.833 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.3 p -69.75 -178.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.959 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.06 -65.22 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.989 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -84.71 129.45 34.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -96.26 132.67 26.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.3 129.59 36.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.587 2.192 . . . . 0.0 112.362 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -116.06 99.58 52.75 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.65 179.82 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.577 2.185 . . . . 0.0 112.28 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -37.47 80.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.4 t -71.31 -28.12 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.235 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.87 -48.03 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 20' ' ' ILE . 4.9 pt-20 -72.51 -20.92 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.81 -35.05 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -74.21 -40.18 62.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.457 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 17' ' ' GLU . 2.3 pp -75.65 -18.69 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 111.024 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 1.2 t -68.23 -53.87 21.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 4.9 p -63.78 -33.51 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 17.9 mtt -63.38 -30.32 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.8 -29.2 64.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.07 1.02 89.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.378 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.2 53.42 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.634 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.97 172.72 15.62 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.306 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.691 HG23 ' HD2' ' A' ' 51' ' ' ARG . 1.9 tp -96.38 136.3 27.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.748 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.8 131.63 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER -102.27 162.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.508 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -167.96 104.41 0.56 Allowed Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 93.7 Cg_endo -80.24 145.46 17.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.477 2.118 . . . . 0.0 111.888 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.643 HG23 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -123.05 -150.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.615 0.245 . . . . 0.0 111.224 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.715 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 3.0 m-20 -55.41 -22.43 20.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.603 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 95' ' ' PRO . 12.8 p -99.74 -112.79 0.18 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.945 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.726 HG22 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -161.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.726 0.298 . . . . 0.0 111.051 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -68.7 134.16 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.944 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 178.08 17.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.936 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.1 mt -133.42 139.17 46.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.644 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.83 124.53 2.09 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.989 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.9 p -157.62 165.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.558 0.218 . . . . 0.0 110.814 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.729 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -55.52 100.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 110.646 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -62.28 -42.15 99.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.159 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.5 mm? -77.53 15.6 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.34 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.42 146.23 36.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -24.36 67.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.26 -29.2 69.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.868 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.47 -40.28 70.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.188 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 t -65.35 -35.49 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.984 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -50.3 34.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.691 ' HD2' HG23 ' A' ' 28' ' ' ILE . 3.6 mmt180 -69.7 -13.71 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.503 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -75.25 -49.48 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.359 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -63.93 -25.55 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -66.19 -45.85 79.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 143' ' ' ILE . 41.2 t -72.42 -52.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.347 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -74.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.218 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.73 40.59 98.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.562 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -112.37 -80.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.309 . . . . 0.0 110.925 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.08 129.22 16.93 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.31 22.1 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 112.487 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.89 -8.87 15.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.112 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -88.13 141.33 31.03 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.047 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.05 165.63 25.72 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.518 2.145 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -116.4 156.77 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.062 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 10.6 t -101.0 137.36 39.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.67 173.42 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.5 t -122.21 141.69 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.747 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 p -150.03 177.01 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.555 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -86.07 -46.82 10.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.674 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.25 175.85 9.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.008 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.579 ' HA ' HD12 ' A' ' 74' ' ' ILE . 16.4 t -59.48 -31.78 47.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.429 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 t70 -67.39 -26.03 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.107 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 23.6 mm-40 -80.39 -23.99 40.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.394 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.725 HG23 HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.54 54.81 0.61 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 77' ' ' PHE . 27.6 Cg_endo -61.74 -83.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.864 1.709 . . . . 0.0 111.743 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.49 19.89 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.368 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' H ' ' C ' ' A' ' 75' ' ' PRO . 8.2 m-85 -93.17 -44.13 8.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.801 0.334 . . . . 0.0 111.088 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -128.1 -175.45 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.638 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' HB3' ' CB ' ' A' ' 101' ' ' GLU . 10.1 ttt-85 -112.75 103.54 55.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.589 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -102.33 -178.77 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.223 2.615 . . . . 0.0 112.584 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 85' ' ' MET . 1.5 t -145.98 -176.17 5.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.05 -85.01 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.687 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 5.1 t70 -55.04 -26.31 36.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.754 0.312 . . . . 0.0 110.823 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.16 -51.53 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 81' ' ' SER . 13.7 mmt -69.55 -20.45 63.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.2 mt-10 -71.04 -41.36 70.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.667 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 2.7 tm? -60.08 -44.18 94.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.499 ' HB2' HD21 ' A' ' 182' ' ' LEU . 7.0 tpt -74.6 -35.98 62.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.155 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 92' ' ' LEU . 18.7 mt-10 -64.17 -12.5 40.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.859 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.718 ' HD2' ' HA ' ' A' ' 87' ' ' LEU . 23.8 mtt-85 -75.61 -55.13 5.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.672 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 57.52 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -132.1 154.51 81.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.615 0.245 . . . . 0.0 111.184 178.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.418 ' HB3' HG12 ' A' ' 121' ' ' VAL . 87.3 Cg_endo -78.92 -153.24 0.88 Allowed 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.712 -1.37 . . . . 0.0 112.007 -2.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.46 178.27 28.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.725 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.715 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 99.0 Cg_endo -79.58 32.57 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.673 2.249 . . . . 0.0 112.609 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.458 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -112.67 146.59 38.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.743 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.769 HG21 ' HA ' ' A' ' 179' ' ' VAL . 6.7 t -95.47 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.66 109.31 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.46 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.633 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 8.7 t -98.41 126.29 51.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.56 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.87 -174.9 3.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.714 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -74.6 -177.82 3.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.173 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.99 138.21 52.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.418 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.97 -165.56 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.029 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.65 43.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.602 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.809 HD21 ' HD2' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -80.54 124.72 29.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.518 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 3.4 mp -74.55 -50.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.948 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.809 ' HD2' HD21 ' A' ' 105' ' ' LEU . 86.9 Cg_exo -49.27 103.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.284 1.989 . . . . 0.0 112.554 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 81.2 m-20 -80.94 -4.57 55.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.176 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -70.45 -21.58 23.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.41 -35.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 64.1 p -76.95 -19.97 56.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.07 -167.69 51.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.55 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.72 5.72 73.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.59 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.7 m -122.69 -178.36 3.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.82 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.422 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 43.7 m -105.75 51.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -144.53 149.17 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 118' ' ' GLY . 87.6 t -139.65 142.55 32.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.574 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.538 ' N ' HG12 ' A' ' 117' ' ' VAL . . . -95.8 158.86 22.09 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.54 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.9 mt -142.62 162.62 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -146.63 128.23 15.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 111.321 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 93' ' ' PRO . 4.1 t -110.77 81.18 2.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' ' 33' ' ' THR . 72.1 Cg_endo -76.36 178.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.493 2.129 . . . . 0.0 112.551 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.38 9.74 35.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 9.1 m-20 -70.47 105.09 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.122 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.54 -49.96 74.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.411 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.18 -53.17 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.212 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -60.85 -18.35 55.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 2.6 mtp180 -74.69 -35.88 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.095 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -52.78 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.75 -49.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.747 ' HB3' ' HA ' ' A' ' 68' ' ' VAL . . . -63.29 -27.53 69.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.279 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.467 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . . . -54.67 -56.33 20.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -75.94 -87.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.159 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -77.0 126.75 85.12 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.188 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.08 154.6 66.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.309 2.006 . . . . 0.0 111.637 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.99 161.06 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.344 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.644 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 91.2 m -81.14 128.67 34.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -123.65 101.26 7.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 0.0 111.631 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.491 HG21 HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -124.91 146.4 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.669 178.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.1 m -82.35 120.92 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.149 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.32 84.23 7.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.899 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.407 HD22 HG21 ' A' ' 36' ' ' ILE . 5.4 m-80 -158.13 32.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.227 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.629 ' N ' ' HG2' ' A' ' 147' ' ' PRO . 1.2 pp -75.5 -155.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.015 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.426 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.1 OUTLIER -59.55 147.64 36.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.017 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.402 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 87.63 -138.36 15.18 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.603 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -127.58 66.98 71.47 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.523 0.201 . . . . 0.0 111.044 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.629 ' HG2' ' N ' ' A' ' 143' ' ' ILE . 41.1 Cg_exo -60.75 -48.73 10.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.436 2.091 . . . . 0.0 113.554 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 64.7 Cg_endo -73.25 118.67 5.62 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 121.893 1.729 . . . . 0.0 112.217 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.85 144.49 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -95.96 -13.63 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.927 2.418 . . . . 0.0 112.747 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 126.61 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -63.24 -40.01 96.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.155 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -18.9 62.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.61 -36.78 65.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.117 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.754 HD13 HG23 ' A' ' 165' ' ' VAL . 21.8 mt -68.78 -52.24 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.439 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.55 -27.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.0 -55.91 6.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.613 ' HB3' HD21 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.45 -55.83 13.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.33 -179.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.63 ' HB3' ' H ' ' A' ' 163' ' ' ASP . 2.3 mm? -91.14 73.93 6.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.929 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.13 -42.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.883 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.95 14.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 28' ' ' ILE . 3.0 t -80.67 -78.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.994 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.63 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -100.03 87.81 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.484 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.06 129.77 43.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.326 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.754 HG23 HD13 ' A' ' 155' ' ' ILE . 1.5 p -69.36 -169.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.791 HD21 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -125.91 154.53 42.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.399 . . . . 0.0 110.957 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.46 -21.9 19.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.3 -51.71 6.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.791 ' HA2' HD21 ' A' ' 166' ' ' LEU . . . 97.13 -155.58 20.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.744 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.9 -161.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.763 0.316 . . . . 0.0 111.086 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -146.2 -53.25 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.524 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.92 -128.63 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -85.64 144.56 27.77 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 120.84 0.353 . . . . 0.0 111.603 -178.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.726 ' HG2' HG22 ' A' ' 36' ' ' ILE . 2.5 ttp -65.29 -12.96 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.215 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.39 155.35 23.31 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.87 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.468 ' HB2' ' H ' ' A' ' 177' ' ' SER . 83.1 Cg_endo -91.93 -139.73 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.434 0.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 1.3 p -153.41 140.73 19.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.596 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 23.7 m -101.44 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.0 111.322 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.769 ' HA ' HG21 ' A' ' 97' ' ' THR . 67.5 t -129.25 112.15 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.649 HG12 ' HA ' ' A' ' 189' ' ' VAL . 58.0 mt -116.71 129.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.633 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.25 65.63 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 88' ' ' MET . 39.9 tp -69.9 89.38 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -80.08 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.832 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.45 -127.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.931 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.49 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -59.21 -51.06 84.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.485 ' HD3' HD21 ' A' ' 185' ' ' ASN . 97.8 Cg_endo -79.71 107.15 2.08 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.165 1.91 . . . . 0.0 112.403 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.662 ' HG3' ' HG ' ' A' ' 87' ' ' LEU . 82.1 Cg_endo -77.64 138.31 17.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.482 2.122 . . . . 0.0 111.961 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 181' ' ' ASP . 0.7 OUTLIER -101.08 41.63 1.17 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.374 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.649 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.8 p -56.95 105.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.015 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.1 94.63 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.541 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -83.67 140.1 32.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.756 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -79.54 87.19 5.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -91.44 -170.5 42.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.534 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.09 -169.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.729 0.3 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.55 -175.58 18.78 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.479 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.73 74.95 2.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.571 2.181 . . . . 0.0 112.365 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 40.44 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -59.94 146.05 83.01 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.126 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.58 109.5 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.666 2.244 . . . . 0.0 112.199 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.2 m -74.18 178.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.905 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.1 31.62 5.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 -171.93 1.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -100.26 109.29 21.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -162.54 103.63 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -107.71 -13.08 15.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -85.51 83.45 1.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.658 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.02 -7.62 55.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.988 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.902 179.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.1 mtm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.796 0.332 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.75 178.96 6.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.36 142.9 12.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttp85 -92.06 104.76 17.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 173.57 6.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.968 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 pt -75.07 -141.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.987 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -70.05 -178.82 1.71 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.939 0.399 . . . . 0.0 111.082 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.91 121.4 19.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.94 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.56 -17.86 13.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -98.99 125.41 41.98 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.638 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.75 146.18 86.74 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.481 2.121 . . . . 0.0 112.344 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.1 t -106.04 95.46 11.04 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.846 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.697 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 42.8 Cg_endo -68.28 132.98 27.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.59 2.194 . . . . 0.0 112.537 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -72.2 -35.31 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.797 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 48.8 t -61.35 -35.52 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.75 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.697 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -67.29 -56.51 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.624 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.62 -22.5 61.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.24 -34.91 61.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.006 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -69.46 -34.76 74.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.054 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.67 -39.67 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.721 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 t -72.85 -42.23 63.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 19' ' ' ALA . 8.6 p -68.37 -29.49 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.263 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.539 ' N ' HG11 ' A' ' 22' ' ' VAL . 11.1 mtt -74.24 -25.42 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.859 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -1.99 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.29 5.52 84.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.64 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.31 41.59 99.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.79 178.81 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.572 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.754 HG12 HG11 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -96.46 144.66 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.612 ' N ' HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.88 126.43 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.361 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.512 HG12 ' OD1' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -101.85 164.4 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.513 0.197 . . . . 0.0 110.488 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -165.29 103.76 0.77 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.588 ' HD3' HD13 ' A' ' 166' ' ' LEU . 90.9 Cg_endo -84.1 137.5 7.37 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.704 2.269 . . . . 0.0 111.735 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.501 HG21 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -116.93 -152.15 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.206 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 0.7 OUTLIER -54.73 -22.19 13.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.309 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -100.04 -116.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.49 HD13 ' HG3' ' A' ' 174' ' ' MET . 0.3 OUTLIER -112.2 -175.17 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.753 0.311 . . . . 0.0 111.141 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.449 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.1 m-85 -63.42 134.09 55.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.906 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.33 179.51 16.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.026 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 2.6 mp -122.27 143.57 49.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.971 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.22 117.39 0.96 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.101 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.754 HG11 HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -153.91 166.0 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 111.367 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -56.58 109.73 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.091 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.51 -46.25 84.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.202 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 44' ' ' LEU . 4.6 mm? -84.69 24.92 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.5 148.1 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 -24.66 60.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.83 -27.79 63.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.24 -28.39 59.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.23 -44.56 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.969 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -49.9 72.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.095 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 57.0 mmt-85 -62.29 -42.54 99.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.149 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.01 -25.71 68.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.903 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -30.51 64.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 54' ' ' ARG . 2.9 mmt85 -75.45 -49.9 17.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.309 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.71 -51.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.676 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -79.56 -5.96 56.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.293 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.15 -113.95 6.31 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.36 77.37 1.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 111.002 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -154.89 71.51 5.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 23.28 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.697 2.265 . . . . 0.0 112.531 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -122.5 -8.36 8.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 133.15 50.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.788 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.66 153.51 14.21 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.621 2.214 . . . . 0.0 112.52 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 142.54 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -97.22 148.55 22.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.625 HG13 ' HA ' ' A' ' 119' ' ' ILE . 0.9 OUTLIER -116.06 170.95 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.596 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 3.3 t -122.17 118.59 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.612 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.821 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 1.0 OUTLIER -138.46 177.51 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.799 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.839 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 2.1 t -86.95 -41.37 13.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.453 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.404 ' N ' HG12 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -164.14 170.61 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.991 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.92 -34.03 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 21.9 t70 -67.03 -28.64 68.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.839 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 67.8 mm-40 -74.45 -23.36 58.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.749 HG21 HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.31 61.23 0.79 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.783 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 77' ' ' PHE . 34.8 Cg_endo -65.04 -72.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.063 1.842 . . . . 0.0 112.267 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.86 14.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.63 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' A' ' 75' ' ' PRO . 1.7 t80 -103.64 -54.34 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.406 ' OG ' HD13 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -120.09 172.69 7.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.751 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.52 111.49 41.77 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.933 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.14 175.29 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.948 2.432 . . . . 0.0 112.72 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.56 -177.02 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.896 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.36 -88.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.932 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -26.22 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.999 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.67 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.2 mmt -71.65 -16.22 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.055 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.56 -47.22 61.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.438 . . . . 0.0 110.401 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -57.31 -43.61 83.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.667 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.462 ' HE1' ' HB ' ' A' ' 98' ' ' VAL . 1.8 ttm -66.65 -36.73 83.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -67.96 -10.84 56.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.377 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.64 -51.69 13.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.8 65.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.228 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.627 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 3.1 tt -131.22 139.24 34.86 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 84.4 Cg_endo -79.03 -154.55 1.04 Allowed 'Cis proline' 0 C--N 1.35 0.65 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.548 -1.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 93' ' ' PRO . . . 158.71 160.47 10.36 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.686 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.67 42.37 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 112.271 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.613 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 55.3 p90 -112.18 149.9 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.6 m -96.19 141.78 29.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.156 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 182' ' ' LEU . 1.8 p -127.41 109.99 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.577 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.7 t -92.66 123.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.975 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.595 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 19.6 tp -127.26 172.27 10.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.599 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.595 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 2.8 pm0 -74.58 -176.17 2.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.521 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.784 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.07 139.43 51.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.975 0.417 . . . . 0.0 111.131 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.751 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.52 -157.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.94 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.489 ' H ' HD21 ' A' ' 103' ' ' ASN . 7.0 mm-40 -67.51 -31.85 72.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.505 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.7 tt -69.93 84.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.633 HG12 ' HE ' ' A' ' 102' ' ' ARG . 5.9 mt -80.9 104.48 2.78 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.734 ' HG2' ' HB ' ' A' ' 111' ' ' THR . 59.2 Cg_endo -70.69 154.8 63.85 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.33 2.02 . . . . 0.0 112.201 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.44 -84.04 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.752 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.5 m -81.88 7.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.985 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 6.8 mt -102.53 -35.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.295 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.734 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -83.12 -27.97 29.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.42 -140.55 37.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.383 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.05 -3.78 72.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.433 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -107.04 162.21 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.434 ' HB2' ' NH1' ' A' ' 102' ' ' ARG . 12.2 p -102.98 44.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -136.74 163.33 30.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 102' ' ' ARG . 80.2 t -139.78 133.71 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.652 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.494 ' O ' HD12 ' A' ' 119' ' ' ILE . . . -87.6 157.31 28.69 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.3 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.625 ' HA ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -135.28 167.98 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -154.97 119.46 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.354 . . . . 0.0 111.417 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' HG11 ' A' ' 121' ' ' VAL . 2.8 p -110.59 83.65 3.52 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.516 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.24 -178.86 4.73 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.632 2.221 . . . . 0.0 112.67 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.501 ' H ' HG21 ' A' ' 33' ' ' THR . 0.5 OUTLIER -93.02 -4.88 51.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.4 OUTLIER -62.04 110.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.989 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.06 -46.54 82.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' HB ' ' A' ' 15' ' ' VAL . 38.0 mm -62.03 -54.88 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.969 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.702 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 98.5 m -60.2 -19.78 55.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -75.63 -43.65 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -72.67 -54.45 9.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.654 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 tt -57.44 -45.35 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.504 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.821 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.52 -25.11 62.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.58 -56.5 18.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.024 0.44 . . . . 0.0 110.125 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.91 -83.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.145 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 3.2 t80 -77.11 128.19 81.61 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.409 ' C ' HG22 ' A' ' 136' ' ' VAL . 58.5 Cg_endo -70.3 155.13 64.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.323 2.015 . . . . 0.0 111.603 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 41' ' ' VAL . 2.4 t -135.21 157.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.337 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.599 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.42 138.8 36.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.82 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.02 109.12 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 111.605 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.579 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -131.8 127.29 36.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.789 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.0 t -71.19 119.16 14.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 111.152 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.05 97.59 10.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -163.28 30.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.083 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.1 pp -80.8 -155.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 152.27 16.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.024 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.1 -142.88 17.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.425 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.18 67.89 71.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.503 0.192 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.422 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.7 Cg_exo -60.49 -48.79 10.43 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.372 2.048 . . . . 0.0 113.517 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 65.6 Cg_endo -73.03 118.05 5.39 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.828 1.685 . . . . 0.0 112.378 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 143.77 26.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.817 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -96.0 -12.47 0.68 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.885 2.39 . . . . 0.0 112.863 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.59 122.45 27.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.31 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -30.88 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.841 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -29.18 60.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.124 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -67.43 -28.6 68.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.622 HD13 HG21 ' A' ' 165' ' ' VAL . 46.5 mt -75.04 -50.73 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.485 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.34 -33.82 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.925 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -75.6 -58.4 3.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.756 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.51 -34.05 77.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.821 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.675 ' HB3' HG11 ' A' ' 162' ' ' VAL . 85.0 mt -106.33 68.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.331 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 8.5 t70 -16.34 -63.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.778 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.02 22.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 111.121 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.721 HG11 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.77 -63.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.739 ' HA ' HG21 ' A' ' 28' ' ' ILE . 3.6 t70 -107.56 100.24 9.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.011 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.514 HD12 HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.61 124.7 25.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.601 -177.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.2 p -64.02 -166.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.843 HD21 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -125.62 160.04 30.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.01 -25.02 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.289 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.32 -55.85 3.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.843 ' HA2' HD21 ' A' ' 166' ' ' LEU . . . 101.18 -163.52 18.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.862 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.01 -165.97 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.405 ' HB2' ' C ' ' A' ' 33' ' ' THR . 22.1 m -144.64 -60.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.628 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -124.35 -130.85 0.26 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.1 m-20 -85.91 141.68 29.39 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.801 0.334 . . . . 0.0 111.465 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.49 ' HG3' HD13 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -56.96 -36.78 70.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -142.6 158.79 59.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.73 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 64.4 Cg_endo -91.46 -147.73 0.27 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.734 1.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 p -155.03 156.39 35.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.613 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.5 m -99.56 142.24 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.157 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.0 89.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 189' ' ' VAL . 12.2 mt -104.43 134.17 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -108.28 68.16 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.173 178.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.572 ' HB3' HG22 ' A' ' 98' ' ' VAL . 12.1 tp -69.75 87.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.358 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -77.25 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.66 0.267 . . . . 0.0 110.808 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.56 -126.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.453 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.7 OUTLIER -63.8 -53.42 50.11 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.19 108.22 2.46 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.161 1.907 . . . . 0.0 112.356 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.1 Cg_endo -76.22 139.2 20.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.451 2.1 . . . . 0.0 112.075 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.596 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.2 OUTLIER -99.42 49.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 180' ' ' ILE . 8.9 t -56.87 98.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.45 85.95 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.024 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.68 154.77 23.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.47 48.07 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -83.92 61.93 4.66 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.459 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.14 32.83 0.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.946 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -73.72 -130.24 0.17 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.523 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.8 -54.66 1.44 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.555 2.17 . . . . 0.0 112.259 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.434 HD22 ' HD2' ' A' ' 199' ' ' PRO . 0.3 OUTLIER -153.94 157.89 39.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -51.62 6.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.425 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.434 ' HD2' HD22 ' A' ' 197' ' ' LEU . 50.7 Cg_exo -56.14 159.54 12.33 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.204 1.936 . . . . 0.0 112.254 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.52 147.19 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.09 37.28 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.22 -9.17 58.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.966 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.83 104.77 17.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.892 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -119.28 67.3 0.38 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.407 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -99.99 -40.52 7.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 111.106 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 81.01 -154.34 35.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -86.68 -12.86 47.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.037 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.774 0.321 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.92 178.6 6.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.03 149.6 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 mtp85 -103.06 165.02 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.962 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 157.88 16.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pt -75.1 -27.72 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.036 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -73.89 -166.48 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.16 -163.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -70.04 -71.13 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.033 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -110.02 92.99 13.98 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 9' ' ' LYS . 33.9 Cg_exo -59.97 -64.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.581 2.187 . . . . 0.0 112.282 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 t 55.75 73.3 0.87 Allowed Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.099 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.488 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.0 Cg_exo -57.65 157.46 23.19 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.492 2.128 . . . . 0.0 112.293 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.0 -34.59 73.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 167' ' ' ASP . 18.9 t -59.43 -53.64 45.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 13' ' ' PRO . 3.1 mm? -61.9 -35.98 79.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.407 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 21' ' ' SER . 2.8 mt-10 -57.72 -30.63 65.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.709 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -77.3 -32.89 55.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.286 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -71.15 -46.91 60.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.57 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.84 -17.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 13.0 t -66.12 -53.86 32.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 22' ' ' VAL . 9.7 p -69.78 -27.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.405 ' N ' HG13 ' A' ' 22' ' ' VAL . 6.2 mtt -60.1 -37.15 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.09 -16.68 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.25 9.57 77.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.591 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.27 51.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.49 161.62 22.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.427 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.583 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.3 OUTLIER -96.24 143.21 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -117.04 146.08 21.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.828 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -111.19 165.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 178.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.9 92.0 0.46 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.816 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.9 Cg_endo -81.55 157.3 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.545 2.163 . . . . 0.0 111.127 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.625 ' HA ' ' CB ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.35 -150.88 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.24 -20.81 45.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.521 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.74 -98.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.036 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.571 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.2 OUTLIER -131.47 -166.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.874 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.816 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m-85 -72.68 131.12 41.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.781 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.2 178.59 17.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.136 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.75 HD12 HG23 ' A' ' 139' ' ' THR . 3.5 mt -133.96 144.49 48.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.351 . . . . 0.0 110.831 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.643 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.17 131.48 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.292 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.566 HG12 HG12 ' A' ' 28' ' ' ILE . 1.1 m -156.53 163.35 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.5 m-20 -56.57 106.58 0.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.366 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.95 84.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.877 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 44' ' ' LEU . 4.5 mm? -81.53 18.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.552 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -110.62 146.77 35.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.24 -23.82 57.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.02 -26.77 68.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.21 -36.92 61.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.449 HG22 ' HB ' ' A' ' 109' ' ' VAL . 10.3 t -65.3 -43.64 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -70.05 -42.89 72.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.234 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -68.9 -29.39 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -67.59 -38.39 83.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.891 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -65.35 -37.73 87.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.69 -40.52 95.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.348 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.427 ' HA ' HD12 ' A' ' 143' ' ' ILE . 42.3 t -74.81 -57.92 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.288 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -81.89 -70.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.277 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.32 4.75 24.94 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.614 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.2 18.23 13.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -134.53 66.13 69.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.2 -54.38 5.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.79 2.327 . . . . 0.0 112.454 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -122.39 24.48 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -88.29 149.72 45.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.001 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.13 169.1 14.24 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.506 2.138 . . . . 0.0 112.289 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 110' ' ' ILE . 32.9 m -119.48 162.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.04 138.48 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.522 HG13 HG22 ' A' ' 119' ' ' ILE . 9.4 pt -116.01 165.95 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 41.9 t -122.06 130.45 53.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG21 HG22 ' A' ' 74' ' ' ILE . 1.4 p -138.34 -175.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.394 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.779 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 5.6 t -88.94 -45.85 9.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.49 168.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.831 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 74' ' ' ILE . 10.2 t -55.34 -35.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.631 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.411 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.63 -28.98 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.92 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.779 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 2.9 mp0 -75.23 -15.99 60.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.684 HG22 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.44 58.18 0.7 Allowed Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.934 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' PHE . 20.4 Cg_endo -60.02 -86.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.07 1.847 . . . . 0.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -73.32 22.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 75' ' ' PRO . 27.1 m-85 -96.99 -47.33 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 111.008 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.1 p -129.83 -175.0 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.25 99.84 51.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -102.69 -173.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.284 2.656 . . . . 0.0 112.508 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.648 ' HB2' ' HB1' ' A' ' 84' ' ' ALA . 2.4 m -141.93 176.87 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.61 -87.9 0.2 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.839 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -33.76 64.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.648 ' HB1' ' HB2' ' A' ' 81' ' ' SER . . . -57.34 -46.57 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.78 ' HE1' ' HG ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -75.02 -25.5 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.246 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -46.99 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 0.0 110.924 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 tp -66.41 -43.86 84.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.155 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.451 ' HE3' ' CE1' ' A' ' 96' ' ' TYR . 6.0 tpt -63.44 -57.42 10.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.529 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HA ' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -63.2 -11.81 23.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -67.12 -32.79 74.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.715 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.26 60.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -131.2 149.28 73.23 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.19 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 6.3 Cg_exo -78.54 -158.04 1.61 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.101 -1.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.24 162.08 11.31 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.829 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.401 ' HB2' HG23 ' A' ' 35' ' ' THR . 92.4 Cg_endo -82.25 46.5 2.21 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.847 2.365 . . . . 0.0 112.598 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.451 ' CE1' ' HE3' ' A' ' 88' ' ' MET . 35.8 p90 -112.11 -179.53 3.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.066 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 2.7 m -115.27 145.62 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.685 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.401 HG22 ' HE1' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -129.04 91.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.373 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.686 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 16.7 t -87.28 122.56 39.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.756 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.67 175.91 7.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.591 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.08 158.87 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.218 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.563 ' CZ ' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -119.83 145.47 46.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.208 0.527 . . . . 0.0 111.184 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.84 174.93 8.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -76.66 60.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.22 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.703 HD21 ' HD2' ' A' ' 107' ' ' PRO . 1.6 mt -71.37 154.01 41.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.577 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 mt -76.32 -51.28 2.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.728 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.703 ' HD2' HD21 ' A' ' 105' ' ' LEU . 16.5 Cg_endo -57.04 101.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.234 1.956 . . . . 0.0 112.243 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.427 ' HA ' ' HG1' ' A' ' 111' ' ' THR . 0.3 OUTLIER -82.22 4.56 23.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 49' ' ' VAL . 16.5 m -83.77 -17.63 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.626 HG22 HG21 ' A' ' 64' ' ' VAL . 1.1 pt -113.03 -29.03 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.427 ' HG1' ' HA ' ' A' ' 108' ' ' ASP . 17.3 p -79.07 -35.43 42.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -169.2 46.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -70.47 -14.68 72.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p -117.64 -179.97 3.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.342 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.0 t -107.36 61.86 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mpp_? -141.2 141.5 34.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 102' ' ' ARG . 77.8 t -142.88 139.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.008 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.26 159.45 19.96 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.92 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.674 HG23 ' H ' ' A' ' 120' ' ' ARG . 1.1 mt -141.22 173.47 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.674 ' H ' HG23 ' A' ' 119' ' ' ILE . 7.1 ptp180 -162.64 131.13 4.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.7 t -110.97 86.82 6.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.514 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.4 -177.78 2.93 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.531 2.154 . . . . 0.0 112.423 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.42 8.97 25.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.068 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.5 OUTLIER -76.45 100.91 5.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.717 HD12 ' HB1' ' A' ' 168' ' ' ALA . 85.5 mt -57.84 -50.99 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.549 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -65.99 -18.34 65.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.714 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . 3.8 ttt180 -75.2 -37.66 61.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.999 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -51.21 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.475 ' HB ' HD12 ' A' ' 16' ' ' LEU . 2.0 tt -62.6 -43.69 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -68.06 -28.24 67.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.97 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.01 33.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.084 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -75.76 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.266 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -77.21 128.93 79.5 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.207 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.21 144.03 32.76 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.337 2.025 . . . . 0.0 111.514 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.538 HG11 ' H ' ' A' ' 137' ' ' THR . 3.1 t -125.54 157.02 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 111.462 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.643 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 36.2 m -79.14 143.45 35.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.835 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -139.19 110.1 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.964 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.75 HG23 HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -127.53 150.58 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.281 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.67 116.13 17.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.433 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.17 81.27 7.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.04 33.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -80.85 -154.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.013 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.73 153.52 10.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 89.95 -144.98 17.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.286 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -127.17 66.16 67.1 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.628 0.251 . . . . 0.0 111.23 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.467 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 40.0 Cg_exo -60.46 -49.28 9.32 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.374 2.049 . . . . 0.0 113.228 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 7.4 Cg_exo -73.46 106.23 2.14 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.096 1.864 . . . . 0.0 112.291 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.08 155.95 36.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -95.41 -14.52 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.769 2.312 . . . . 0.0 112.775 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.4 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.7 mmt180 -134.38 128.86 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.935 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.757 HD22 ' HB ' ' A' ' 165' ' ' VAL . 5.7 mt -61.07 -45.46 94.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.066 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -23.52 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.79 -31.19 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.169 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.792 HD12 HG12 ' A' ' 165' ' ' VAL . 1.0 OUTLIER -75.49 -51.21 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.529 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.733 HG11 HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -59.0 -25.5 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.416 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -75.08 -48.99 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.15 -21.77 58.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.578 ' HB3' HG11 ' A' ' 162' ' ' VAL . 81.0 mt -111.23 68.05 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.03 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.5 t70 -16.26 -63.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.176 0.923 . . . . 0.0 112.724 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -159.26 23.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.235 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.658 HG11 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.88 -65.22 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.759 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.658 ' H ' HG11 ' A' ' 162' ' ' VAL . 47.5 t0 -111.37 102.34 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.575 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.49 131.15 40.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.573 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.828 ' HA ' HD11 ' A' ' 30' ' ' ILE . 17.1 m -65.33 -166.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.164 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.492 HD12 ' HA2' ' A' ' 169' ' ' GLY . 0.4 OUTLIER -126.3 167.39 15.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.456 ' HB3' HG13 ' A' ' 15' ' ' VAL . 3.2 t70 -92.47 -39.87 11.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.595 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.717 ' HB1' HD12 ' A' ' 126' ' ' ILE . . . -64.09 -70.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.305 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.492 ' HA2' HD12 ' A' ' 166' ' ' LEU . . . 89.37 51.26 2.98 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.837 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.625 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 3.7 m-20 -71.99 121.2 18.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.75 123.74 4.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.266 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.415 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -137.18 -113.85 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.415 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -85.38 127.53 34.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.571 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.08 -1.64 10.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.122 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.72 157.34 36.08 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.692 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -92.64 -151.66 0.36 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.737 1.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.8 p -156.91 115.1 3.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.1 m -102.31 143.58 31.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 111.499 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.414 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 19.8 t -129.5 105.87 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.54 HG21 HG22 ' A' ' 189' ' ' VAL . 13.7 mt -114.31 131.18 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.725 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.6 m-20 -99.42 73.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.718 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.78 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 0.2 OUTLIER -68.79 81.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.309 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -86.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.321 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.49 -128.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -59.82 -51.03 83.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 72.6 Cg_endo -76.53 108.67 2.71 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.203 1.936 . . . . 0.0 112.504 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 83.8 Cg_endo -83.96 121.92 2.89 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.645 2.23 . . . . 0.0 112.257 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.725 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.6 mtm180 -89.35 54.38 2.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.489 . . . . 0.0 111.149 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.54 HG22 HG21 ' A' ' 180' ' ' ILE . 48.3 t -59.33 106.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.8 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.47 86.86 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -89.75 140.65 29.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -7.58 58.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -95.67 63.45 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.628 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -105.88 -48.67 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -79.33 -141.7 2.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.424 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.42 -176.32 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.688 2.259 . . . . 0.0 112.324 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.543 ' HB3' ' HD2' ' A' ' 199' ' ' PRO . 0.8 OUTLIER -145.1 169.46 18.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 4.1 t0 -73.91 -51.89 4.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.151 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 197' ' ' LEU . 17.6 Cg_exo -66.92 83.83 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.281 1.988 . . . . 0.0 111.993 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.412 HG11 ' H ' ' A' ' 201' ' ' LEU . 1.4 p -71.06 -68.12 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.043 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.412 ' H ' HG11 ' A' ' 200' ' ' VAL . 0.6 OUTLIER -106.9 16.27 24.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.498 . . . . 0.0 110.284 179.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.78 -25.56 65.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.906 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -83.18 126.99 33.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.925 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -125.98 -60.34 0.16 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.55 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -96.18 137.94 34.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.874 0.369 . . . . 0.0 111.13 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -124.34 -34.04 0.74 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.466 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.91 -21.08 13.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.843 0.354 . . . . 0.0 110.887 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.099 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.75 0.31 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.4 mt -88.77 -57.91 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.71 116.17 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.037 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -72.03 169.22 16.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -75.15 154.33 37.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -94.43 142.45 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -175.16 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.024 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.561 ' HD3' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -75.5 175.46 8.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.561 ' H ' ' HD3' ' A' ' 8' ' ' ARG . 27.6 mttt -81.17 132.65 35.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.72 141.37 75.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.13 -164.34 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.51 2.14 . . . . 0.0 112.191 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.73 112.52 9.81 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.006 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HG2' HD22 ' A' ' 16' ' ' LEU . 44.2 Cg_endo -67.6 175.71 5.83 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.484 2.123 . . . . 0.0 112.052 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 m-20 -67.46 -28.12 67.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.87 -58.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.579 HD21 HG22 ' A' ' 126' ' ' ILE . 4.4 mm? -60.27 -42.48 95.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.685 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.27 -31.37 63.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.035 0.445 . . . . 0.0 110.485 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 5.1 mm-40 -76.29 -32.11 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.186 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.524 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -75.64 -41.73 53.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.907 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 16' ' ' LEU . 1.9 pp -71.7 -31.37 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.025 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.482 ' N ' HD12 ' A' ' 20' ' ' ILE . 5.7 p -75.18 -38.0 61.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.836 HG13 HD21 ' A' ' 164' ' ' LEU . 11.6 p -75.66 -29.39 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.083 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.521 ' N ' HG11 ' A' ' 22' ' ' VAL . 1.3 mtt -62.11 -42.7 99.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.634 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -4.97 26.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.813 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.76 78.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 51.69 37.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.812 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.17 165.24 22.57 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.427 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.723 ' HA ' HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -96.5 148.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.592 HG12 HD12 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -116.39 127.42 74.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.733 -179.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -102.71 151.6 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.635 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' HH ' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -157.05 113.35 1.94 Allowed Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.63 134.26 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.721 2.281 . . . . 0.0 111.377 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.564 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -116.49 -149.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 111.191 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 11.7 m-20 -54.58 -22.08 12.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.194 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 36' ' ' ILE . 4.6 t -100.38 -121.82 0.16 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.52 -149.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.761 0.315 . . . . 0.0 111.454 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.524 ' HD2' ' HB2' ' A' ' 141' ' ' ALA . 0.2 OUTLIER -64.96 129.59 40.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.446 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.72 170.68 15.36 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.959 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 139' ' ' THR . 1.6 mp -123.45 141.13 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.929 0.395 . . . . 0.0 111.263 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.34 111.5 0.58 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.696 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 28' ' ' ILE . 2.5 p -151.79 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.645 0.26 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 14.2 m120 -56.42 116.86 3.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 110.493 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.0 -56.02 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.988 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 44' ' ' LEU . 1.4 mm? -82.81 37.11 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.553 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -110.94 156.17 21.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 178.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -31.91 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.441 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.15 -28.15 68.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.518 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -72.25 -35.43 68.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.718 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.0 t -66.17 -48.28 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 50' ' ' ARG . 11.2 mtt180 -63.73 -45.17 91.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.529 ' HG3' HG13 ' A' ' 28' ' ' ILE . 11.0 mmm180 -65.25 -30.67 71.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -66.59 -46.48 75.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.6 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.89 -18.08 63.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.091 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -73.24 -67.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.701 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.28 -41.16 57.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -80.08 -11.32 59.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.626 0.251 . . . . 0.0 111.292 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 -139.0 39.05 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.416 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.2 85.48 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.82 67.45 23.21 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.88 9.31 2.03 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 0.0 112.511 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.404 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -105.21 -26.31 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.28 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.12 128.8 52.31 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.287 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.73 171.63 2.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.446 HG23 HG22 ' A' ' 110' ' ' ILE . 5.0 m -114.85 150.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.322 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -99.91 133.93 43.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.5 pt -113.94 172.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m -122.07 129.37 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.811 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 1.8 p -136.0 179.06 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.691 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 30.3 t -86.18 -42.54 13.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.261 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.5 166.22 20.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.422 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.575 ' HA ' HD12 ' A' ' 74' ' ' ILE . 26.8 t -57.68 -31.33 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.5 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 37.0 t70 -67.44 -27.59 67.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.812 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.691 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 0.6 OUTLIER -76.73 -21.04 55.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.119 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.784 HG21 HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.34 58.79 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 77' ' ' PHE . 34.7 Cg_endo -65.08 -74.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.007 1.804 . . . . 0.0 112.003 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.19 15.18 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.5 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 32.5 m-85 -100.52 -45.95 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 p -135.23 159.49 41.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.679 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.455 ' HG3' ' HB3' ' A' ' 101' ' ' GLU . 7.1 ptm180 -119.14 104.16 46.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.012 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -102.23 -166.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.14 2.56 . . . . 0.0 112.399 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 166.27 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.84 -73.47 0.68 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.586 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.621 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -55.33 -34.44 64.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.797 0.332 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.68 84.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.434 ' SD ' HG22 ' A' ' 71' ' ' VAL . 4.2 mmt -71.36 -17.99 62.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.095 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.621 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.6 mt-10 -71.58 -47.2 56.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.934 0.397 . . . . 0.0 110.573 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.471 HD12 HD11 ' A' ' 182' ' ' LEU . 2.6 tm? -58.23 -40.55 81.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.03 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.682 ' HB2' HD12 ' A' ' 182' ' ' LEU . 4.4 tpt -74.76 -46.12 39.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.507 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.83 -14.64 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.298 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -44.83 63.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.7 pt -108.81 53.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.535 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 6.3 tt -130.97 131.73 23.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 87.6 Cg_endo -78.08 -163.4 3.36 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.478 -0.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.62 167.11 16.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.95 37.22 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.748 2.299 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.17 144.31 41.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.628 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 1.3 m -94.74 148.77 21.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.71 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.544 HG11 ' SD ' ' A' ' 88' ' ' MET . 2.1 t -126.49 102.51 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.24 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.81 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 2.8 t -93.55 120.1 42.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 182' ' ' LEU . 1.1 mp -126.99 -168.5 1.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.576 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.455 ' HB3' ' HG3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -74.83 169.33 18.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.552 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.8 ' HB2' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.17 147.13 44.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.445 ' C ' ' H ' ' A' ' 105' ' ' LEU . 22.1 p-10 -73.72 -152.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.314 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 31.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.47 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.445 ' H ' ' C ' ' A' ' 103' ' ' ASN . 0.3 OUTLIER -69.53 94.85 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.725 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.591 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 6.1 mt -64.91 -50.79 61.0 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.71 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 76.5 Cg_exo -50.38 108.85 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.128 1.885 . . . . 0.0 112.316 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.22 -1.53 41.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.477 HG11 HG13 ' A' ' 110' ' ' ILE . 15.0 p -69.98 -21.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.477 HG13 HG11 ' A' ' 109' ' ' VAL . 5.1 mt -105.03 -52.25 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.037 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -68.2 -14.27 62.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.54 -154.75 40.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -87.62 6.25 83.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.362 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.9 169.93 9.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.769 0.318 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -99.0 39.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -136.92 158.99 43.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.8 HG22 ' HB2' ' A' ' 102' ' ' ARG . 98.7 t -139.95 147.87 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.464 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -98.99 146.89 18.31 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.389 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.464 HG13 ' C ' ' A' ' 118' ' ' GLY . 24.8 mt -148.26 134.98 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -144.58 146.52 32.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.962 0.41 . . . . 0.0 111.438 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.505 HG23 ' HG ' ' A' ' 92' ' ' LEU . 1.7 m -110.22 96.82 27.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.14 -179.28 2.12 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.501 2.134 . . . . 0.0 112.449 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 5.2 47.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.97 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.3 104.54 6.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.35 -49.01 77.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.194 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.579 HG22 HD21 ' A' ' 16' ' ' LEU . 30.6 mm -59.83 -48.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.1 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.515 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 85.8 m -62.53 -20.89 65.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 128' ' ' ARG . 0.3 OUTLIER -75.19 -27.36 59.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.987 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -74.31 -60.4 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.172 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -58.27 -45.5 89.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.811 ' HB3' ' HA ' ' A' ' 68' ' ' VAL . . . -63.73 -28.25 69.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.006 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 129' ' ' ARG . . . -54.76 -53.4 55.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -75.28 -88.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.123 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -77.09 144.96 72.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.41 159.09 47.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.321 2.014 . . . . 0.0 111.603 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.568 HG21 ' HB2' ' A' ' 131' ' ' ALA . 7.5 t -133.65 150.25 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.526 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.607 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 m -80.9 140.47 35.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.824 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.7 107.13 8.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.494 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.12 122.24 22.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.905 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 110.54 5.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 37' ' ' TYR . . . -79.79 104.69 10.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.017 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.84 27.3 0.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.083 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.435 ' HB ' ' H ' ' A' ' 144' ' ' SER . 0.7 OUTLIER -81.37 -156.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.435 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 5.7 p -62.34 174.02 1.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 82.46 -139.26 19.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.445 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.34 72.18 77.09 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.578 0.227 . . . . 0.0 111.04 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.544 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.8 Cg_exo -60.16 -46.9 16.62 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.358 2.039 . . . . 0.0 113.322 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 28.4 Cg_endo -62.1 129.66 27.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.781 1.654 . . . . 0.0 111.976 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.6 p -85.86 121.91 72.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -95.11 -28.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.882 2.388 . . . . 0.0 112.297 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 131.85 18.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.338 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.499 HD22 HG22 ' A' ' 165' ' ' VAL . 25.7 mt -59.95 -36.48 77.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.255 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -19.4 59.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.98 -44.83 79.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.761 HD11 HG21 ' A' ' 165' ' ' VAL . 11.6 mt -68.29 -44.1 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.17 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.96 -41.27 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -75.38 -53.31 8.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.498 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.615 ' HB3' HD22 ' A' ' 159' ' ' LEU . 9.6 t70 -56.6 -39.85 74.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.496 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 155' ' ' ILE . 2.6 mm? -111.37 77.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.934 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.43 -43.2 0.56 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.094 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.26 19.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 48.7 t -80.45 -97.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.658 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -94.72 92.25 6.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.46 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.836 HD21 HG13 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -55.57 135.13 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.026 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 155' ' ' ILE . 0.7 OUTLIER -66.6 172.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.648 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -127.42 127.34 43.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.521 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -7.95 46.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.746 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.521 ' HB1' ' HH ' ' A' ' 31' ' ' TYR . . . -64.08 -38.21 90.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.388 . . . . 0.0 110.655 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.48 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 102.25 166.67 26.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.084 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -152.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.564 ' HB2' ' C ' ' A' ' 33' ' ' THR . 11.4 m -144.28 -63.22 0.37 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.57 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -130.47 -138.68 0.21 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.4 168.43 13.14 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.545 ' O ' HG12 ' A' ' 36' ' ' ILE . 61.9 mtp -71.01 1.39 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.012 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.17 160.17 26.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -97.02 -149.65 0.18 OUTLIER 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.737 1.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.77 120.45 5.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.484 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.452 ' HG1' ' HG3' ' A' ' 191' ' ' ARG . 5.8 m -99.73 137.21 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.398 . . . . 0.0 111.483 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.23 107.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.607 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 189' ' ' VAL . 3.1 mt -119.14 132.95 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.64 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.81 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 9.2 m-20 -97.88 69.24 2.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.163 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 88' ' ' MET . 3.5 tt -69.44 87.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.408 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -81.76 0.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.493 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.5 -126.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.864 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -60.58 -52.63 71.35 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.27 108.39 2.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.237 1.958 . . . . 0.0 112.626 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 1.0 OUTLIER -84.07 132.45 5.39 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.017 2.478 . . . . 0.0 112.071 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.635 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.1 mmm180 -91.88 59.18 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 110.897 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 180' ' ' ILE . 46.7 t -59.16 109.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.53 88.33 2.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.05 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.672 ' HG2' ' H ' ' A' ' 193' ' ' GLY . 5.6 ttt180 -90.94 127.77 36.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.819 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -82.7 3.75 27.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.672 ' H ' ' HG2' ' A' ' 191' ' ' ARG . . . -89.12 167.66 34.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.379 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -175.01 2.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -74.84 -171.8 28.48 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.48 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.68 84.26 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.501 2.134 . . . . 0.0 112.306 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.75 0.92 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.543 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 9.6 m-20 -79.44 -50.19 1.34 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.582 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 198' ' ' ASP . 36.7 Cg_endo -65.13 161.08 38.82 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.101 1.867 . . . . 0.0 112.357 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.613 HG11 ' H ' ' A' ' 201' ' ' LEU . 1.3 t -75.64 170.84 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.119 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.613 ' H ' HG11 ' A' ' 200' ' ' VAL . 0.1 OUTLIER -86.0 77.12 9.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.958 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.8 tp -90.02 -20.57 23.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 203' ' ' ARG . 3.6 mmm180 -91.75 -24.75 19.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.15 117.6 9.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.582 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -97.25 152.18 19.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.3 . . . . 0.0 111.047 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -176.07 -88.04 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.18 -30.17 13.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 110.837 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.116 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.786 0.327 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.86 -172.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.2 -11.82 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -97.05 106.54 18.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -167.34 1.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -99.82 139.56 21.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.994 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 6' ' ' ILE . 82.4 p -73.75 119.9 18.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.971 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -78.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -110.17 129.28 55.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.862 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -109.4 137.64 20.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.2 -175.52 2.01 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.467 2.111 . . . . 0.0 112.367 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.0 77.13 58.8 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.64 148.49 87.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.661 2.241 . . . . 0.0 112.139 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.08 -29.54 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.19 -31.77 25.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.599 HD23 HG23 ' A' ' 126' ' ' ILE . 1.4 mm? -72.92 -41.57 64.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' O ' HD13 ' A' ' 20' ' ' ILE . 1.4 pt-20 -74.87 -19.02 60.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.3 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.0 -36.73 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.82 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -72.77 -40.84 65.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.592 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 17' ' ' GLU . 2.2 pp -75.47 -17.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -71.94 -46.34 57.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.489 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 9.6 p -73.5 -27.78 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.481 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 15.2 mtt -59.76 -49.42 77.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.113 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.67 -12.96 61.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.57 1.03 89.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.503 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.14 44.26 87.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.9 170.43 19.38 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.362 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.654 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -96.45 143.84 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.428 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.63 140.03 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.701 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -105.46 165.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.445 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.2 103.32 0.31 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.779 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.459 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 83.3 Cg_endo -82.69 135.72 8.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.6 2.2 . . . . 0.0 111.744 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.552 HG21 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -120.21 -155.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.804 0.335 . . . . 0.0 111.414 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.8 OUTLIER -54.72 -21.17 10.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -98.42 -117.92 0.14 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.668 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.3 OUTLIER -112.6 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.723 0.297 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.37 131.38 47.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.714 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -123.11 176.47 16.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.482 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.788 HD13 HG21 ' A' ' 139' ' ' THR . 1.4 mt -133.32 142.99 48.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.741 0.305 . . . . 0.0 110.839 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.5 134.69 5.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.059 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.531 HG23 ' NH1' ' A' ' 51' ' ' ARG . 3.9 m -152.69 168.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.776 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -56.61 105.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.259 178.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -58.69 -50.12 75.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.278 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -79.89 22.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.87 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.776 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.25 161.71 15.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 178.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HA ' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -75.01 -25.18 58.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 110.426 178.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 6.5 m-20 -60.59 -28.82 68.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.806 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.09 -27.16 59.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.92 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 46' ' ' GLU . 46.2 t -65.66 -54.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -71.33 -22.19 61.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -68.01 -34.48 76.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.997 0.427 . . . . 0.0 110.754 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.57 HD22 ' HB2' ' A' ' 56' ' ' LYS . 0.8 OUTLIER -74.96 -44.44 48.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.391 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.52 -34.53 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.181 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -66.41 -61.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.439 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.802 HG12 HG12 ' A' ' 143' ' ' ILE . 39.5 t -63.76 -51.12 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.57 ' HB2' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -79.86 -70.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.454 -178.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.93 -11.7 0.62 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.08 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 56' ' ' LYS . 2.6 ptp180 -118.4 40.19 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.784 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 p -141.72 63.75 17.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.44 -66.85 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.652 2.235 . . . . 0.0 112.591 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.714 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 53.3 m80 -108.59 24.44 13.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -88.41 147.48 40.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.16 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.8 161.26 41.99 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.591 2.194 . . . . 0.0 112.269 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 110' ' ' ILE . 3.8 p -114.05 151.53 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.8 t -94.16 134.22 36.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.214 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -116.24 172.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.796 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 20.7 t -119.96 136.88 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -135.86 -179.57 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 1.2 t -76.09 -49.67 16.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.155 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.93 179.86 6.74 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.143 0.497 . . . . 0.0 111.664 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.743 HG23 HD13 ' A' ' 92' ' ' LEU . 60.9 t -52.44 -41.29 35.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.111 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.487 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -69.57 -27.82 65.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.905 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.821 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 1.4 tp10 -80.99 -8.22 59.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -90.86 -38.56 0.39 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.653 ' HG3' ' HG3' ' A' ' 80' ' ' PRO . 99.8 Cg_exo -44.03 -23.3 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.491 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -55.22 -59.33 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -107.51 3.89 25.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -118.05 179.7 4.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.511 ' HG2' HD21 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -131.5 94.44 26.26 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HA ' HD11 ' A' ' 100' ' ' LEU . 68.3 Cg_endo -102.49 -166.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.2 2.6 . . . . 0.0 112.687 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -143.53 177.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.15 -83.28 0.41 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.769 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.93 -33.25 62.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.842 0.353 . . . . 0.0 111.152 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.458 ' O ' HD22 ' A' ' 182' ' ' LEU . . . -60.41 -49.36 77.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.7 mmt -71.94 -14.91 62.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.255 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.0 mm-40 -66.59 -46.68 75.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.4 tm? -61.35 -38.4 86.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.201 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.605 ' HE3' HD12 ' A' ' 91' ' ' ILE . 5.9 tpt -66.29 -43.11 87.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.27 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -69.95 -39.69 75.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.058 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.605 HD12 ' HE3' ' A' ' 88' ' ' MET . 2.3 pt -115.12 51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.275 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -131.36 134.65 25.93 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.28 -162.34 2.95 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.277 -1.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.93 166.78 15.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.562 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.509 ' HB2' HG21 ' A' ' 35' ' ' THR . 86.9 Cg_endo -81.29 41.72 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.742 2.295 . . . . 0.0 112.482 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.419 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 1.2 m-85 -111.31 156.21 21.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.816 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 59.2 m -94.93 135.62 36.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.355 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.486 HG21 ' HE2' ' A' ' 88' ' ' MET . 6.5 t -122.49 98.94 6.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.292 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.775 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 18.9 t -95.48 128.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.623 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.697 HD11 ' HA ' ' A' ' 80' ' ' PRO . 2.3 mm? -126.96 -178.6 4.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -178.73 3.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.325 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.549 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.18 137.7 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.322 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.511 HD21 ' HG2' ' A' ' 79' ' ' ARG . 2.5 t-20 -74.25 -168.19 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.902 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 37.56 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.474 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.868 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 1.6 tp -72.11 132.25 43.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.572 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 19.9 mm -73.33 -50.6 6.22 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.665 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.868 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 72.8 Cg_exo -49.77 109.99 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.241 1.961 . . . . 0.0 112.353 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.09 -17.79 45.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.125 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.558 HG12 HG13 ' A' ' 110' ' ' ILE . 14.8 p -69.18 -22.6 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.247 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.558 HG13 HG12 ' A' ' 109' ' ' VAL . 45.0 mt -93.88 -43.58 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.025 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.629 ' HA ' HG21 ' A' ' 117' ' ' VAL . 22.1 p -81.28 -6.52 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.05 -169.8 50.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.714 ' HA3' ' HB3' ' A' ' 61' ' ' HIS . . . -78.23 -1.5 80.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.365 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.48 -172.75 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 111.017 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.429 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 3.4 p -106.22 39.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -136.77 153.1 50.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.047 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 111' ' ' THR . 93.8 t -139.81 144.53 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.468 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.48 ' N ' HG13 ' A' ' 117' ' ' VAL . . . -91.32 155.55 23.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.385 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 74' ' ' ILE . 3.8 mt -143.94 151.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.566 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.3 ttt180 -144.67 126.79 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.599 HG13 HD12 ' A' ' 92' ' ' LEU . 9.8 t -111.14 78.3 1.71 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 15.2 Cg_exo -69.71 -176.32 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.552 ' H ' HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -91.55 6.48 45.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.83 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 100.2 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -57.47 -45.71 84.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.032 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.599 HG23 HD23 ' A' ' 16' ' ' LEU . 41.9 mt -62.25 -53.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.185 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -24.01 62.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.445 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 1.7 ttm105 -68.95 -36.49 77.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -54.57 12.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.5 mt -60.47 -49.47 84.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 68' ' ' VAL . . . -60.29 -28.91 68.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.821 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.68 -56.7 16.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.35 -89.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -76.69 127.57 83.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.095 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 153.8 72.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.28 1.987 . . . . 0.0 111.628 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 137' ' ' THR . 4.1 t -132.03 155.82 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.119 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.646 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -80.56 139.5 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.031 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -143.24 111.52 6.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.882 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.788 HG21 HD13 ' A' ' 39' ' ' LEU . 2.1 t -140.24 138.15 34.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.545 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 15.0 p -70.6 126.78 30.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.338 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . -88.04 94.21 9.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -154.7 26.64 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.949 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.802 HG12 HG12 ' A' ' 55' ' ' VAL . 1.1 pp -79.12 -155.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.456 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.1 OUTLIER -56.03 162.14 2.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.199 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.416 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 82.62 -144.78 23.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.319 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -127.34 66.45 68.81 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.588 0.233 . . . . 0.0 111.058 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 46.2 Cg_exo -60.42 -46.63 17.01 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.376 2.05 . . . . 0.0 113.474 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 40.6 Cg_endo -67.15 106.49 1.19 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.845 1.697 . . . . 0.0 112.327 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.09 136.5 21.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.511 ' HG2' ' HG2' ' A' ' 151' ' ' ARG . 69.3 Cg_endo -95.71 -12.25 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.865 2.377 . . . . 0.0 112.445 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.511 ' HG2' ' HG2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -128.29 112.34 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.777 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.832 ' HA ' HD12 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -56.49 -32.6 65.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.219 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -24.88 58.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.287 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 2.2 tt0 -72.51 -31.01 65.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.509 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -75.22 -51.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.313 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 157' ' ' ARG . 7.8 p -62.03 -36.32 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.54 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.506 ' N ' HG13 ' A' ' 156' ' ' VAL . 5.4 mmt85 -72.73 -51.15 20.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.338 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.18 -24.57 64.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.433 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.699 HD13 HG22 ' A' ' 155' ' ' ILE . 40.5 mt -111.22 79.46 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.143 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.2 t70 -28.15 -51.2 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.223 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -161.65 26.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.74 -92.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.654 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -89.95 88.51 7.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.489 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -56.26 129.39 40.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.388 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.82 ' HA ' HD12 ' A' ' 30' ' ' ILE . 35.4 m -66.37 -172.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.21 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.74 HD22 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.78 156.25 41.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -92.62 -19.6 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.4 -50.74 7.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.74 ' HA2' HD22 ' A' ' 166' ' ' LEU . . . 94.11 -157.02 22.52 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.909 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.07 -163.26 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.623 0.249 . . . . 0.0 111.105 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 m -150.18 -60.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.519 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -123.57 -130.19 0.26 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.519 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.6 OUTLIER -86.31 144.77 27.21 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.82 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.668 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.6 ttp -68.79 -15.71 63.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -154.51 160.83 30.53 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.582 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 70.2 Cg_endo -89.43 -142.41 0.16 OUTLIER 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.548 0.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.442 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 73.1 m -153.88 131.86 11.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.834 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 75.9 m -102.33 142.13 34.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.816 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 19.2 t -129.08 110.4 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.006 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.485 HG12 HG13 ' A' ' 189' ' ' VAL . 5.4 mt -120.69 125.08 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.182 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.775 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -102.32 66.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.473 ' CD2' ' HB2' ' A' ' 88' ' ' MET . 21.7 tp -69.58 83.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.527 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -80.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.447 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.2 t -120.73 -121.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.166 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -62.66 -52.86 61.7 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.1 109.61 2.73 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.208 1.938 . . . . 0.0 112.445 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 93.9 Cg_endo -80.45 127.83 6.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.615 2.21 . . . . 0.0 112.329 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.549 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -88.39 45.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.485 HG13 HG12 ' A' ' 180' ' ' ILE . 9.1 t -56.87 96.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.791 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.24 84.7 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.149 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.02 140.02 30.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 192' ' ' ARG . 1.2 mtt85 -67.8 91.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.823 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -94.91 72.79 1.01 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -14.34 18.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.714 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -75.87 -67.9 1.63 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.39 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.11 -167.29 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.438 2.092 . . . . 0.0 112.202 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.2 tp -137.48 -73.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -78.89 120.54 81.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.92 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.29 -37.56 7.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.511 2.141 . . . . 0.0 112.336 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.6 m -70.33 160.59 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -114.35 104.6 12.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.56 -177.58 3.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -85.06 -38.66 18.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.21 173.31 50.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.493 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -104.43 -33.19 8.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.735 0.302 . . . . 0.0 111.069 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 175.54 67.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.554 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -108.07 10.48 28.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.719 0.295 . . . . 0.0 110.992 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.999 -179.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.769 0.319 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.78 178.02 4.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 4' ' ' ARG . 7.1 tp -76.84 149.44 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.467 ' N ' HG13 ' A' ' 3' ' ' ILE . 5.9 mtm-85 -107.06 168.59 9.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 169.54 14.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.2 pt -84.9 -28.67 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.6 p -69.63 118.57 12.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.08 -49.64 5.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.11 159.89 24.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.59 124.61 81.91 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.24 175.4 10.99 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.479 2.12 . . . . 0.0 112.41 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.53 99.67 42.2 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.455 ' HB2' HD21 ' A' ' 16' ' ' LEU . 51.4 Cg_exo -55.21 168.68 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.587 2.192 . . . . 0.0 112.329 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -35.74 79.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.147 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.27 -53.21 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.167 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 126' ' ' ILE . 3.3 mm? -60.06 -32.62 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.623 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.98 67.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.788 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -36.6 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.34 -42.8 53.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -66.97 -30.14 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.114 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.8 p -66.5 -44.49 82.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.061 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 18' ' ' GLU . 35.7 t -65.32 -29.45 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.5 mmt -62.7 -44.6 95.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -17.74 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.86 89.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.98 39.78 93.29 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.51 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.84 171.93 15.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.67 ' HA ' HG11 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -96.17 140.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.61 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -116.55 130.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.197 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.623 ' HB ' ' HE1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -101.68 168.89 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.574 0.226 . . . . 0.0 110.756 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.595 ' HH ' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -169.48 102.4 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HG2' ' HA ' ' A' ' 170' ' ' ASP . 89.3 Cg_endo -83.06 143.74 11.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.544 2.163 . . . . 0.0 111.888 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -123.16 -160.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -66.83 -25.35 66.4 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.747 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -88.7 -89.9 0.14 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.257 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.405 HG13 ' HE1' ' A' ' 174' ' ' MET . 1.3 tt -133.68 174.99 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 111.06 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.623 ' HE1' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -68.21 143.16 55.43 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.82 177.13 19.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.745 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.788 ' HB2' HG22 ' A' ' 139' ' ' THR . 3.0 mt -125.55 144.38 50.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.87 0.367 . . . . 0.0 110.553 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.57 125.59 2.35 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.024 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -156.58 178.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 111.105 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.43 122.73 12.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.317 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.84 -60.67 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.05 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.4 mm? -81.07 37.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.1 149.76 30.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -75.14 -18.59 60.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -26.64 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.71 -44.55 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.997 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -35.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -38.87 78.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.671 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.58 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.3 -45.18 70.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.781 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.544 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.3 OUTLIER -60.83 -25.83 66.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.784 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -72.88 -34.82 66.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.27 -49.81 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.358 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.426 HG11 ' N ' ' A' ' 142' ' ' ASN . 70.9 t -65.27 -49.85 76.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.588 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.587 ' HE2' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -79.75 -6.38 57.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 111.18 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.43 -92.05 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.64 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.86 116.05 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.458 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 60.8 p -155.11 57.44 1.65 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.09 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 59' ' ' SER . 50.7 Cg_exo -54.11 -57.18 1.98 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.411 2.074 . . . . 0.0 112.285 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.06 30.32 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HD3' ' HE2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.54 135.77 33.86 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.826 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.92 160.79 45.34 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 112.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 m -118.75 162.51 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 t -110.6 141.15 44.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.97 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.483 HG13 HG12 ' A' ' 119' ' ' ILE . 5.9 pt -116.49 167.34 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.01 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -119.78 135.7 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.714 ' HA ' ' HB2' ' A' ' 131' ' ' ALA . 1.3 p -141.53 -178.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.634 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.616 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 21.6 t -89.71 -41.86 11.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.564 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.18 170.69 16.02 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG13 ' SD ' ' A' ' 85' ' ' MET . 8.2 t -57.52 -37.63 59.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -67.41 -21.89 65.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.159 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -77.15 -26.27 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.527 HG22 HG21 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -113.48 58.81 0.74 Allowed Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 77' ' ' PHE . 21.5 Cg_endo -60.49 -84.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.066 1.844 . . . . 0.0 111.965 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.57 23.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.389 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' PRO . 26.0 m-85 -98.9 -31.78 11.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.673 0.273 . . . . 0.0 111.228 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.438 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -135.08 178.31 7.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.083 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -113.23 90.21 16.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 78' ' ' SER . 69.2 Cg_endo -102.23 176.39 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.049 2.499 . . . . 0.0 112.645 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -177.31 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.046 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.03 -75.23 0.74 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.516 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -59.19 -29.95 67.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.821 0.343 . . . . 0.0 110.856 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.74 -47.34 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.473 ' SD ' HG13 ' A' ' 71' ' ' VAL . 9.5 mmt -74.21 -18.63 60.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.161 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.4 mm-40 -63.01 -45.18 93.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.524 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.586 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.583 ' HG2' HG22 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.92 -58.24 8.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.306 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -4.0 16.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.321 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -56.33 4.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.048 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.45 71.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.583 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.587 ' H ' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.35 151.76 79.36 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.997 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.712 ' HB3' HG21 ' A' ' 121' ' ' VAL . 5.5 Cg_exo -78.36 -148.45 0.5 Allowed 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.175 -0.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.67 163.6 12.55 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.723 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.747 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 92.8 Cg_endo -81.6 35.2 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.756 2.304 . . . . 0.0 112.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.721 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 44.9 p90 -112.26 162.86 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.8 m -115.23 124.86 52.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 182' ' ' LEU . 2.4 p -108.31 109.01 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.131 0.491 . . . . 0.0 110.982 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.601 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 44.7 t -103.72 128.61 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.147 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.628 HD12 HD12 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -126.59 -165.87 1.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.308 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.69 -176.05 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.683 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.7 143.33 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.994 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -74.73 -170.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -76.49 55.2 0.99 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.207 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.784 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 24.1 tp -88.79 129.63 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.619 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 11.4 mm -72.02 -52.47 7.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.784 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 75.6 Cg_exo -50.88 100.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.304 2.003 . . . . 0.0 112.536 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.454 ' HA ' ' HG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -82.04 1.08 37.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.442 HG13 HG12 ' A' ' 110' ' ' ILE . 10.4 p -70.8 -26.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.097 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -107.48 -29.51 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.454 ' HG1' ' HA ' ' A' ' 108' ' ' ASP . 19.8 p -78.76 -18.08 54.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.937 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.13 -169.21 54.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.375 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.08 -8.39 83.08 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.401 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.2 p -114.68 -175.46 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.513 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 74.8 m -111.63 62.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -143.22 138.21 29.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 102' ' ' ARG . 97.8 t -139.94 140.28 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.356 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.35 157.08 19.95 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.643 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.628 HD12 HD12 ' A' ' 100' ' ' LEU . 27.8 mt -146.23 151.74 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -146.39 137.71 24.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.459 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.712 HG21 ' HB3' ' A' ' 93' ' ' PRO . 2.7 p -110.6 87.72 6.88 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.489 ' HB2' HG22 ' A' ' 33' ' ' THR . 55.2 Cg_endo -70.39 -179.74 3.42 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.411 2.074 . . . . 0.0 112.628 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.29 -4.49 57.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.975 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 7.1 m-20 -62.33 103.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -45.98 83.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.546 HG22 HD13 ' A' ' 16' ' ' LEU . 41.5 mm -59.48 -50.8 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -63.56 -20.93 66.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.653 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -74.98 -27.21 60.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.492 ' O ' ' HB1' ' A' ' 132' ' ' ALA . 0.1 OUTLIER -75.05 -60.6 2.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.9 mt -57.79 -48.15 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.178 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -62.09 -29.87 70.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.358 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.617 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.6 -54.92 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 110.028 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -75.92 -89.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.26 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -77.04 141.07 67.03 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.09 153.77 46.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.303 2.002 . . . . 0.0 111.577 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.98 156.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.677 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.7 m -80.38 129.97 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.027 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.53 102.9 6.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.846 0.355 . . . . 0.0 111.856 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.788 HG22 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -130.28 141.76 50.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 p -61.72 125.52 24.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.692 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . -70.61 123.97 23.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 111.373 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.426 ' N ' HG11 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -153.06 58.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.658 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.445 ' O ' ' HG3' ' A' ' 147' ' ' PRO . 1.6 mm -70.67 168.94 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.898 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.57 143.84 52.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.661 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.31 -119.4 5.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -125.83 91.04 49.2 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.675 0.274 . . . . 0.0 111.145 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.456 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.4 Cg_exo -60.52 -48.53 11.07 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.435 2.09 . . . . 0.0 113.246 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 21.6 Cg_exo -65.24 100.22 0.37 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.008 1.805 . . . . 0.0 112.112 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.21 149.25 40.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.994 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -95.37 -18.03 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.858 2.372 . . . . 0.0 112.433 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -136.94 130.34 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.524 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.774 ' HA ' HD13 ' A' ' 155' ' ' ILE . 9.2 tp -56.78 -41.92 78.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.139 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.43 -38.01 88.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -58.66 -49.21 78.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -61.16 -39.32 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.493 ' HA ' HD11 ' A' ' 159' ' ' LEU . 57.7 t -52.46 -37.66 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.728 0.299 . . . . 0.0 111.399 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.39 86.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.495 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.85 -22.69 55.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.158 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.691 HD22 ' HB ' ' A' ' 155' ' ' ILE . 2.0 pp -108.65 43.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -16.8 -58.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.342 0.657 . . . . 0.0 112.535 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.38 10.06 0.43 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.52 HG11 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -80.87 -82.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.247 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.599 ' HA ' HG22 ' A' ' 28' ' ' ILE . 2.0 p-10 -100.51 92.7 5.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.796 0.331 . . . . 0.0 110.783 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 159' ' ' LEU . 0.6 OUTLIER -65.42 130.7 44.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.736 -178.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.597 HG12 HD12 ' A' ' 155' ' ' ILE . 27.0 m -59.98 -171.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.26 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.579 ' O ' HD21 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -126.76 156.05 41.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.51 -7.81 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.595 ' HB3' ' HH ' ' A' ' 31' ' ' TYR . . . -84.58 -40.12 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.892 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.88 -178.82 43.95 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.484 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.424 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 14.7 p-10 -70.73 -159.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.501 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 39.6 m -136.78 -59.66 0.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.262 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.71 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -135.85 -116.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.387 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 58.4 m-20 -86.13 150.63 24.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.405 ' HE1' HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.66 -15.07 62.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 178.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 6.2 pt-20 -153.07 160.6 30.75 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.668 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.519 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 66.0 Cg_endo -95.27 -139.56 0.13 OUTLIER 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.249 -1.146 . . . . 0.0 112.648 0.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.434 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 7.6 t -154.01 146.54 24.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.721 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 69.5 m -101.19 142.96 31.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.122 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.11 97.1 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.699 HG12 ' HA ' ' A' ' 189' ' ' VAL . 25.3 mt -109.94 131.58 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.211 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.6 ' HB3' ' HE ' ' A' ' 188' ' ' ARG . 0.2 OUTLIER -108.43 65.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.004 0.43 . . . . 0.0 110.571 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.669 ' HB3' HG23 ' A' ' 98' ' ' VAL . 19.0 tp -69.29 89.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -78.41 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 0.0 110.858 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -128.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.476 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 2.1 t-20 -59.68 -52.23 75.43 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.0 Cg_exo -76.92 108.9 2.74 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.497 2.131 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 94.1 Cg_endo -80.72 134.23 9.64 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.519 2.146 . . . . 0.0 112.037 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.6 ' HE ' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -96.31 45.91 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.274 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.699 ' HA ' HG12 ' A' ' 180' ' ' ILE . 20.2 t -56.63 103.81 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.21 93.26 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.452 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -85.07 149.54 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.769 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.03 47.51 1.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.038 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.19 162.47 46.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.426 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -98.06 -77.73 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.752 0.31 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -89.97 -162.02 37.97 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.485 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.418 ' HG2' HD23 ' A' ' 197' ' ' LEU . 49.7 Cg_endo -68.59 -43.3 4.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.583 2.189 . . . . 0.0 112.346 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.418 HD23 ' HG2' ' A' ' 196' ' ' PRO . 0.9 OUTLIER -151.24 171.22 17.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -64.51 130.64 94.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.929 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.63 106.24 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.513 2.142 . . . . 0.0 112.202 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.5 t -57.75 115.88 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.065 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.72 53.87 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.9 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -33.63 75.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.886 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.42 -11.66 34.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.78 18.46 20.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -80.91 -179.05 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.062 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 127.06 124.75 2.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.594 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -109.63 17.12 21.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.744 0.307 . . . . 0.0 110.866 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.098 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mmt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.834 0.35 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.21 -177.09 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.989 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mt -102.39 141.07 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.082 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.1 -170.76 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -87.48 156.19 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.897 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 tt -98.3 143.47 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.11 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -72.87 -177.25 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.969 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -73.06 149.28 43.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.055 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 -67.84 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.637 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 15.1 m120 -81.96 -51.08 0.82 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.454 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 10' ' ' ASN . 46.0 Cg_exo -56.52 125.02 17.67 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.192 1.928 . . . . 0.0 112.174 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.1 p -155.83 148.84 18.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.968 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.96 166.66 2.86 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.558 2.172 . . . . 0.0 112.215 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -69.81 -42.45 73.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.028 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -67.75 -25.22 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD22 HG22 ' A' ' 126' ' ' ILE . 2.0 mm? -70.98 -52.21 21.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.086 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -69.19 -14.53 63.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.25 -34.72 59.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.566 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.12 -42.98 55.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.776 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -75.55 -20.22 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.734 0.302 . . . . 0.0 111.274 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.422 ' N ' HD13 ' A' ' 20' ' ' ILE . 46.0 t -70.35 -48.5 56.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.52 -28.16 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.128 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 21.9 mtt -62.47 -38.57 90.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.064 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -70.29 -20.54 63.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.82 5.05 62.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.29 38.92 94.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.91 168.51 15.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.504 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.799 ' HA ' HG23 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -96.45 148.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.434 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.438 ' N ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -119.1 146.94 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER -114.78 164.85 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.272 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -172.91 103.42 0.32 Allowed Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD3' HD13 ' A' ' 166' ' ' LEU . 3.5 Cg_exo -79.79 137.03 12.38 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.769 2.312 . . . . 0.0 111.408 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.82 -151.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.738 0.304 . . . . 0.0 111.161 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -54.87 -20.95 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.606 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -100.1 -114.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.126 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.611 HG22 ' HG2' ' A' ' 174' ' ' MET . 0.0 OUTLIER -112.55 -163.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.353 . . . . 0.0 110.995 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.86 131.38 47.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.586 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.88 174.68 15.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.067 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.576 HD13 HG21 ' A' ' 139' ' ' THR . 2.5 mt -133.25 138.52 46.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.821 0.343 . . . . 0.0 111.132 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.1 121.16 1.48 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.836 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.799 HG23 ' HA ' ' A' ' 28' ' ' ILE . 5.3 p -159.76 163.97 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.712 0.292 . . . . 0.0 111.221 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.721 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -55.25 102.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.01 0.434 . . . . 0.0 110.944 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -68.12 -41.74 81.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.938 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' N ' HD21 ' A' ' 44' ' ' LEU . 4.3 mm? -76.26 12.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.306 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.721 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.46 150.46 28.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -19.53 60.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.77 -30.0 70.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.1 -22.89 57.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.22 -54.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -63.88 -40.25 96.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 8.2 mmt180 -64.18 -38.86 92.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -68.16 -18.4 64.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.798 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -36.76 62.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.2 -40.69 90.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 144' ' ' SER . 37.7 t -73.89 -52.96 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -79.38 -76.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.902 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 17.27 32.9 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.697 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -68.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.349 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.51 ' HB3' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -136.78 76.26 47.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.852 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.11 27.21 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 0.0 112.597 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.51 ' NE2' ' HB3' ' A' ' 59' ' ' SER . 23.7 p80 -105.28 -21.91 13.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.958 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.33 154.3 90.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.973 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HB3' ' O ' ' A' ' 116' ' ' ARG . 75.6 Cg_exo -50.62 154.88 5.96 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.597 2.198 . . . . 0.0 112.46 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 m -114.54 151.31 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -96.48 136.61 36.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.689 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.647 HD13 HD12 ' A' ' 74' ' ' ILE . 14.4 pt -116.27 172.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.27 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.676 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 12.5 t -117.87 135.57 54.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.974 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.24 174.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.604 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.47 -47.63 15.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.992 0.425 . . . . 0.0 110.462 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.17 176.3 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.449 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.573 HG12 ' HG3' ' A' ' 85' ' ' MET . 2.8 t -59.13 -33.74 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.764 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -67.54 -27.65 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.156 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.633 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 1.2 mp0 -80.43 -17.21 52.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.217 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.671 HG12 ' HB2' ' A' ' 78' ' ' SER . 21.5 tt -114.65 50.71 0.59 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.633 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 37.4 Cg_exo -59.07 -84.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.046 1.83 . . . . 0.0 113.182 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.42 12.27 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -177.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.654 ' HB3' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -107.77 -17.03 14.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.969 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.671 ' HB2' HG12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.5 177.22 7.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.889 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.472 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 12.4 mtp180 -129.81 85.43 58.05 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -101.96 -175.29 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.059 2.506 . . . . 0.0 112.853 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 85' ' ' MET . 1.3 m -140.4 179.9 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.878 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.25 -74.0 0.92 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.39 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.047 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.573 ' HG3' HG12 ' A' ' 71' ' ' VAL . 9.6 mmt -70.64 -16.32 62.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.169 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 41.3 mm-40 -64.89 -50.47 66.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.595 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.94 -35.98 80.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.6 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 36.3 mmm -65.6 -45.43 83.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.279 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.94 -16.89 62.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 111.117 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -39.1 63.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.38 40.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.798 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.692 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 4.8 tt -129.54 137.91 31.97 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.692 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 96.8 Cg_endo -78.45 -161.66 2.76 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.351 -0.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.98 167.06 16.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.928 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HB2' HG22 ' A' ' 35' ' ' THR . 92.2 Cg_endo -79.85 44.35 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.919 2.412 . . . . 0.0 112.359 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.432 ' OH ' HD11 ' A' ' 92' ' ' LEU . 10.6 p90 -112.19 141.24 46.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 m -102.55 112.51 25.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 180' ' ' ILE . 3.5 p -108.39 123.98 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.0 111.672 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.544 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 21.3 t -102.45 129.42 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.941 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.647 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 0.8 OUTLIER -126.88 177.17 6.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.802 -178.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.647 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 10.0 mt-10 -74.09 172.94 10.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.68 ' HB3' HG22 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -119.71 143.56 47.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.409 . . . . 0.0 111.477 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.472 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.13 -164.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.481 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.39 56.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.405 HD21 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -74.15 136.2 42.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.605 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.6 mt -80.16 -51.39 1.09 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.457 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 40.4 Cg_exo -57.75 103.35 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.328 2.019 . . . . 0.0 112.418 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.78 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.2 m -76.21 -17.39 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.2 -32.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.104 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.7 p -74.41 -26.79 60.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.5 -163.56 54.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.61 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.15 -3.06 80.87 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.483 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.9 m -114.68 171.32 7.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.426 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 33.5 p -103.87 59.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.585 ' HG2' ' HA ' ' A' ' 101' ' ' GLU . 9.6 mtm105 -152.31 149.1 28.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.022 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.68 HG22 ' HB3' ' A' ' 102' ' ' ARG . 77.7 t -139.8 131.81 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.589 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -78.68 167.6 53.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -147.04 162.48 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttt85 -149.14 125.62 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 111.463 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.03 77.79 1.52 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.706 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.641 ' HB2' HG23 ' A' ' 33' ' ' THR . 73.2 Cg_endo -75.34 -178.65 4.39 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.478 2.118 . . . . 0.0 112.605 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.28 -4.02 58.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 0.3 OUTLIER -62.8 99.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 45.3 mt-10 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.673 HG22 HD22 ' A' ' 16' ' ' LEU . 37.4 mt -60.08 -50.16 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.955 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -61.22 -24.57 66.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.819 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 132' ' ' ALA . 15.9 mtm180 -70.12 -32.56 70.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.148 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -59.61 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 mt -58.92 -49.25 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.567 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 127' ' ' CYS . . . -61.61 -29.32 69.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.406 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 128' ' ' ARG . . . -54.64 -56.64 16.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 109.909 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.4 ' HB2' ' H ' ' A' ' 134' ' ' PHE . 2.5 mmt85 -76.44 -88.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.166 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.4 ' H ' ' HB2' ' A' ' 133' ' ' ARG . 27.1 m-85 -76.64 117.56 65.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.45 152.03 83.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.321 2.014 . . . . 0.0 111.319 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -134.46 169.55 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 111.472 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.659 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.2 m -80.85 138.8 36.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.492 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . . . -136.99 96.54 3.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.277 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.576 HG21 HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -125.72 145.33 50.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.32 117.07 22.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.186 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.53 115.3 24.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -166.77 -37.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.915 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.411 HD12 HG11 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.45 -110.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -177.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -61.85 162.69 8.52 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.92 0.391 . . . . 0.0 111.51 -178.087 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.477 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 73.28 -156.35 51.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.39 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.482 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -127.26 60.91 45.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.555 0.217 . . . . 0.0 111.007 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 146' ' ' LYS . 36.0 Cg_exo -60.89 -49.12 8.97 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.442 2.095 . . . . 0.0 113.404 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.1 Cg_exo -65.65 87.75 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.03 1.82 . . . . 0.0 112.175 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.451 ' HG ' HG21 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -96.62 142.97 25.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.911 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -95.74 -16.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.557 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -132.37 121.25 23.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.693 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.839 ' HA ' HD11 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -58.04 -38.7 76.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.195 -179.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.719 ' HA ' HG23 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -67.24 -41.48 85.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.29 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.0 -38.38 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.839 HD11 ' HA ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -71.94 -33.23 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 153' ' ' GLU . 21.6 t -53.42 -47.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.476 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -69.37 -32.45 71.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.861 0.363 . . . . 0.0 110.77 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -21.69 56.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.244 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.669 HD13 ' HA ' ' A' ' 164' ' ' LEU . 2.6 pp -98.76 43.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 159' ' ' LEU . 13.8 t0 -17.53 -54.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.709 0.63 . . . . 0.0 112.254 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -160.75 11.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.569 HG11 ' H ' ' A' ' 163' ' ' ASP . 1.4 p -81.84 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.859 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.657 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -108.24 96.19 6.19 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.743 0.306 . . . . 0.0 111.396 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.669 ' HA ' HD13 ' A' ' 159' ' ' LEU . 1.4 mm? -64.16 139.77 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.676 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.73 ' HB ' HD21 ' A' ' 152' ' ' LEU . 3.4 m -61.03 -174.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.508 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.698 HD23 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.32 145.6 50.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.739 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.85 -22.49 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.72 -52.79 5.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.138 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.698 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 96.64 -160.34 21.82 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.48 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.07 -163.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.415 ' HB3' ' N ' ' A' ' 34' ' ' ASP . 49.1 t -145.34 -57.4 0.33 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.612 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -126.16 -130.07 0.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.536 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.3 OUTLIER -86.16 147.63 26.05 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -177.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.611 ' HG2' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.21 -23.3 66.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 158.84 33.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.684 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 177' ' ' SER . 64.9 Cg_endo -90.95 -149.86 0.35 Allowed 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.024 -1.24 . . . . 0.0 112.663 1.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 89.1 p -154.67 153.74 31.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 191' ' ' ARG . 0.3 OUTLIER -99.91 141.58 32.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.0 t -129.05 78.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.754 HG12 ' HA ' ' A' ' 189' ' ' VAL . 23.2 mt -101.67 131.32 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.209 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 188' ' ' ARG . 6.9 t70 -108.78 61.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.3 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.492 ' HB3' HG22 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -70.14 100.15 1.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.333 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 -73.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.813 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.56 -109.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.028 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.488 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -74.63 -52.76 3.56 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.466 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 4.8 Cg_exo -77.68 108.0 2.48 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.496 2.131 . . . . 0.0 112.237 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 98.7 Cg_endo -79.46 131.15 9.34 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 3.8 mmt85 -86.65 53.12 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.973 0.416 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.754 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.93 107.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.12 82.73 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.795 ' HB3' HG21 ' A' ' 178' ' ' THR . 5.3 ptm180 -89.57 142.07 28.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.98 110.1 18.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.023 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -96.2 127.63 9.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.206 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -90.69 -35.77 14.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.746 0.308 . . . . 0.0 111.102 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -79.66 132.22 11.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.611 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.76 -21.44 18.88 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.589 2.193 . . . . 0.0 112.299 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -137.58 -174.77 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.87 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.417 ' O ' HD13 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -62.02 149.02 87.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.56 152.68 15.72 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.536 2.158 . . . . 0.0 112.247 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.26 148.17 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.218 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.54 114.3 27.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.56 -26.52 20.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -77.27 -10.83 59.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.078 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -153.63 123.48 1.42 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.62 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -96.17 153.57 17.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.84 0.353 . . . . 0.0 111.017 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -86.9 53.26 4.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.414 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.89 -44.49 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.032 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.082 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.837 0.351 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.543 ' N ' HD22 ' A' ' 2' ' ' LEU . 4.0 mm? -76.19 -174.27 2.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.928 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.19 131.48 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -89.2 146.47 24.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 175.15 10.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -93.41 143.59 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.007 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -69.79 125.89 28.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -69.8 -22.21 63.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -90.75 100.93 13.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.809 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -110.15 89.15 7.93 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 9' ' ' LYS . 34.4 Cg_exo -59.93 103.66 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.545 2.164 . . . . 0.0 112.201 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.75 66.97 74.3 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.756 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.525 ' HD2' HD22 ' A' ' 16' ' ' LEU . 73.2 Cg_endo -74.22 177.37 8.35 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.545 2.163 . . . . 0.0 112.352 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.05 -28.25 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.665 HG22 ' HB3' ' A' ' 167' ' ' ASP . 82.7 t -57.5 -62.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.18 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.767 HD13 HG12 ' A' ' 126' ' ' ILE . 2.9 mp -60.53 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.366 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.06 -29.61 67.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.482 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.97 -31.9 59.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.329 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.64 56.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.326 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 16' ' ' LEU . 2.2 pp -75.21 -22.05 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 0.0 111.224 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -69.08 -53.15 21.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG11 HD23 ' A' ' 164' ' ' LEU . 7.6 p -64.4 -28.62 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.4 mtt -57.09 -51.15 70.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.64 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.37 9.15 74.72 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.707 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 39.42 92.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.723 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.56 168.58 13.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.192 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.763 HD12 HG13 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -96.29 141.28 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.619 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -116.19 110.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.078 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER -100.49 151.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 111.247 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -154.33 114.12 2.48 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.171 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.552 ' HD3' HD12 ' A' ' 166' ' ' LEU . 68.4 Cg_endo -84.9 139.25 7.31 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.81 2.34 . . . . 0.0 111.391 176.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -119.2 -149.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.708 0.289 . . . . 0.0 111.457 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -54.82 -23.75 19.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.561 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.412 ' OG1' HG13 ' A' ' 36' ' ' ILE . 2.1 t -100.48 -114.94 0.17 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.011 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.71 -166.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.892 0.377 . . . . 0.0 111.592 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.59 138.57 55.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -130.98 168.71 21.86 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.116 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 139' ' ' THR . 8.3 mp -113.91 143.71 44.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.741 0.305 . . . . 0.0 110.863 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.13 112.97 0.68 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.763 HG13 HD12 ' A' ' 28' ' ' ILE . 18.6 m -151.52 172.41 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.748 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.87 95.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.233 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.54 84.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.998 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HG ' HD13 ' A' ' 110' ' ' ILE . 2.5 mp -67.38 -29.77 69.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 111.417 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -86.51 154.24 21.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.026 -177.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -60.58 -12.4 9.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.062 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -60.75 -34.03 73.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 110.262 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 41' ' ' VAL . . . -76.28 -49.32 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.493 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 46' ' ' GLU . 8.1 p -59.66 -20.9 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.195 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.07 -57.84 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 179.312 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -63.17 -25.43 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.721 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.879 HD23 HG21 ' A' ' 64' ' ' VAL . 1.7 mp -63.64 -54.43 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.768 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -54.57 -28.91 49.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.082 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -67.48 -57.26 6.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.605 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.9 t -75.55 -56.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.5 5.86 11.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.47 -121.85 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.353 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.04 109.24 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.0 111.015 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.609 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -148.25 66.8 9.53 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.82 -7.51 20.86 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.53 2.153 . . . . 0.0 112.306 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 21.7 m-70 -103.79 -19.14 14.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -85.96 132.51 43.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.8 166.22 27.01 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.433 2.089 . . . . 0.0 112.057 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.879 HG21 HD23 ' A' ' 52' ' ' LEU . 12.1 p -112.97 141.91 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.153 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.74 138.39 32.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.762 HD13 HG23 ' A' ' 119' ' ' ILE . 1.5 pp -115.99 174.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.534 ' SG ' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -122.23 132.68 54.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.538 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.769 HG21 HG22 ' A' ' 74' ' ' ILE . 1.2 p -138.47 179.83 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.731 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.819 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 3.0 t -90.09 -41.8 11.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.63 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.72 170.67 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.513 ' HA ' HD12 ' A' ' 74' ' ' ILE . 5.2 t -57.52 -38.54 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.13 -24.45 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.985 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.819 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 56.2 mm-40 -76.04 -20.89 57.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.775 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.769 HG22 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.55 61.84 0.9 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.729 178.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 28.9 Cg_exo -61.94 -79.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.086 1.858 . . . . 0.0 112.226 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -73.25 22.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 75' ' ' PRO . 1.1 t80 -100.56 -48.9 4.38 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.954 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.605 ' HG ' HD11 ' A' ' 74' ' ' ILE . 80.7 p -131.38 -179.98 5.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -129.14 101.61 19.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 88.2 Cg_endo -102.4 -172.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.143 2.562 . . . . 0.0 112.634 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.19 -171.86 3.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.14 -82.08 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.629 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 1.1 m-20 -56.43 -26.11 52.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.67 71.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.509 ' SD ' HG21 ' A' ' 71' ' ' VAL . 27.0 mmt -74.27 -12.89 60.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.75 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 1.8 mt-10 -70.68 -50.28 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.487 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.7 tp -63.96 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.833 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.629 ' HB2' HD12 ' A' ' 182' ' ' LEU . 7.9 tpt -75.01 -42.41 57.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.383 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.542 ' HA ' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -61.55 -23.7 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.715 -178.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.1 ptm180 -75.84 -36.21 59.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.472 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 pt -103.61 14.94 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.064 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' HG3' ' A' ' 88' ' ' MET . 0.3 OUTLIER -130.97 152.77 81.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.823 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.17 -174.38 14.66 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.563 -1.432 . . . . 0.0 112.67 0.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.61 -174.63 32.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.473 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 96.0 Cg_endo -79.87 39.29 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.597 2.198 . . . . 0.0 112.29 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.13 160.92 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.815 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 27.2 m -107.54 131.05 54.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.512 HG11 ' SD ' ' A' ' 88' ' ' MET . 3.8 t -114.29 107.34 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.828 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 5.5 t -102.89 131.02 52.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 182' ' ' LEU . 3.1 mm? -126.75 177.95 6.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.469 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 177.03 6.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.745 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -119.65 141.09 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.189 0.518 . . . . 0.0 111.429 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.553 ' H ' HD21 ' A' ' 103' ' ' ASN . 0.7 OUTLIER -74.8 -167.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.426 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -76.91 37.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.506 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.27 116.47 9.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.909 0.385 . . . . 0.0 110.786 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 25.5 mm -63.55 -48.55 80.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.159 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.5 Cg_exo -49.63 108.9 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.092 1.862 . . . . 0.0 112.483 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -2.62 48.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.858 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 110' ' ' ILE . 10.5 p -71.78 -27.03 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.73 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.62 HG13 HG13 ' A' ' 109' ' ' VAL . 4.4 mt -101.2 -35.6 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.686 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.549 HG23 ' HG2' ' A' ' 102' ' ' ARG . 2.0 m -73.88 -30.69 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.81 -143.01 27.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.357 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -89.98 -18.29 51.1 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.1 m -106.61 -172.08 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.704 0.288 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.2 m -113.12 42.44 1.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 116' ' ' ARG . 5.7 mtm-85 -136.63 156.36 48.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 102' ' ' ARG . 62.0 t -140.15 145.52 26.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -99.2 159.18 20.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.227 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.762 HG23 HD13 ' A' ' 66' ' ' ILE . 9.3 mt -142.57 159.89 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.621 ' H ' HG21 ' A' ' 119' ' ' ILE . 7.0 ttp85 -151.12 124.7 9.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 111.151 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.48 87.96 7.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.71 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HB2' HG22 ' A' ' 33' ' ' THR . 60.2 Cg_endo -72.25 -179.97 4.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.409 2.072 . . . . 0.0 112.47 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.506 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -93.0 17.92 9.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.182 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 109.77 15.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.01 -47.01 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.106 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.767 HG12 HD13 ' A' ' 16' ' ' LEU . 2.2 mp -64.39 -52.08 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.482 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 95.8 m -59.32 -16.15 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 69' ' ' SER . 31.7 ttt180 -74.94 -46.98 31.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -66.89 -48.88 67.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.388 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.616 HD13 HG21 ' A' ' 126' ' ' ILE . 37.9 mt -61.23 -55.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.192 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 127' ' ' CYS . . . -61.53 -26.42 67.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.228 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 128' ' ' ARG . . . -54.7 -57.1 12.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -76.0 -87.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.072 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.9 124.7 87.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.401 ' C ' HG21 ' A' ' 136' ' ' VAL . 59.6 Cg_endo -71.44 151.63 59.57 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.341 2.027 . . . . 0.0 111.879 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.534 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.6 t -131.42 157.71 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.046 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.689 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.4 OUTLIER -80.75 136.64 36.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.071 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -129.27 98.39 4.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 111.349 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -128.21 105.13 8.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.623 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.829 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 78.5 p -61.71 128.56 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . -79.35 132.92 36.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.842 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -162.17 -43.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.362 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.87 -117.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.388 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 m -62.26 172.63 1.4 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.011 0.434 . . . . 0.0 111.397 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.471 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 82.96 -155.06 32.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.532 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.38 67.55 47.31 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.697 0.284 . . . . 0.0 110.852 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 37.7 Cg_exo -60.82 -47.69 12.56 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.557 2.171 . . . . 0.0 113.484 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 57.1 Cg_endo -69.94 97.68 0.66 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.804 1.669 . . . . 0.0 112.198 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m -89.75 135.19 30.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -95.2 -43.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.752 2.301 . . . . 0.0 112.718 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.697 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 4.2 ttt180 -131.69 137.47 48.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.695 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.521 HD21 HG12 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -61.01 -40.67 94.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.427 ' HA ' HG13 ' A' ' 156' ' ' VAL . 0.2 OUTLIER -72.97 -19.93 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.697 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 3.7 tm-20 -67.29 -40.98 86.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.723 HD12 HG21 ' A' ' 165' ' ' VAL . 5.4 mt -70.06 -48.46 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.346 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 153' ' ' GLU . 4.5 p -61.76 -31.02 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.318 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ttt180 -75.36 -52.95 9.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.113 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.732 ' HB3' HD23 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -60.07 -38.62 83.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.179 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.732 HD23 ' HB3' ' A' ' 158' ' ' ASP . 2.7 mm? -109.29 73.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -37.19 -39.83 0.29 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.25 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.84 11.88 0.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.606 0.241 . . . . 0.0 111.597 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 5.3 t -80.67 -81.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.755 ' HA ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -104.34 99.39 9.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.469 HD23 HG11 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -73.68 127.87 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -178.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.825 HG22 ' H ' ' A' ' 166' ' ' LEU . 3.5 p -65.19 -163.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.825 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.68 143.55 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.976 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.665 ' HB3' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -92.31 -14.96 28.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.24 -41.73 16.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.425 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.53 -167.67 28.8 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.163 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.428 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 3.0 p30 -73.1 -165.11 0.21 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.75 0.31 . . . . 0.0 111.022 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -61.4 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.724 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -126.33 -132.57 0.25 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -86.88 165.16 16.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.87 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.468 ' O ' HG12 ' A' ' 36' ' ' ILE . 1.8 ttp -70.33 -8.96 54.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.839 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.14 162.17 36.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -97.5 -148.97 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.71 1.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.27 110.31 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.423 HG23 HD11 ' A' ' 180' ' ' ILE . 95.6 m -101.46 138.72 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.198 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.815 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.0 t -129.24 109.24 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.69 HG12 HG13 ' A' ' 189' ' ' VAL . 4.5 mt -117.84 137.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.828 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.2 m-20 -108.0 67.44 0.68 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.629 HD12 ' HB2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -69.5 83.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.354 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.25 -83.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.523 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.96 -100.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.282 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.451 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -83.9 -51.82 0.6 Allowed Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -73.84 110.4 3.07 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.125 1.883 . . . . 0.0 112.259 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.5 Cg_endo -82.15 118.1 2.94 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.673 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -86.94 49.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.69 HG13 HG12 ' A' ' 180' ' ' ILE . 6.6 t -56.6 104.01 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.012 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.03 77.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.017 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -83.81 131.66 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -83.09 -47.61 11.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -98.11 133.48 11.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.322 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -90.36 171.5 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.426 . . . . 0.0 110.98 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -87.05 -70.0 1.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.25 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.39 -166.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.67 2.247 . . . . 0.0 112.105 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.66 145.52 27.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.073 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.401 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 2.1 m-20 -68.7 -49.88 26.84 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.487 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 198' ' ' ASP . 77.5 Cg_exo -51.35 132.66 40.4 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.325 2.017 . . . . 0.0 112.532 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.13 134.28 30.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.018 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.09 61.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.0 tp -67.2 -37.01 82.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.79 170.22 9.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.47 -138.65 5.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.533 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.47 99.28 10.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.757 0.313 . . . . 0.0 111.052 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -144.48 12.79 2.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.442 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.6 14.07 16.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 0.0 110.972 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.098 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.846 0.355 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -171.31 1.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 mm -102.25 132.54 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -81.49 139.73 34.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' HG3' ' H ' ' A' ' 8' ' ' ARG . 2.5 ptpt -73.07 177.85 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 pt -83.24 -29.72 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.7 -67.2 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.054 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.51 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -101.02 89.52 3.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -71.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -110.08 111.29 58.32 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.811 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' HG2' ' H ' ' A' ' 12' ' ' SER . 41.1 Cg_endo -68.11 -70.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.469 2.113 . . . . 0.0 112.386 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.608 ' HG ' ' HG2' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -157.52 146.88 15.02 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.843 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.11 160.59 7.95 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.545 2.163 . . . . 0.0 112.275 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -40.26 84.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 12.3 t -66.9 -34.01 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.014 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.724 HD23 HG21 ' A' ' 126' ' ' ILE . 1.2 mm? -68.95 -46.63 67.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.608 ' HG2' ' HG ' ' A' ' 12' ' ' SER . 11.5 mm-40 -61.5 -21.55 64.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.161 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -75.18 -36.68 61.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.632 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.21 80.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.78 -32.26 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -59.99 -38.73 83.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 t -67.82 -34.68 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.566 ' HE2' ' HA ' ' A' ' 41' ' ' VAL . 15.0 mmt -56.06 -40.87 74.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.96 -23.14 58.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.21 -2.35 74.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.507 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.67 57.91 10.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.99 163.18 22.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.491 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.641 ' HA ' HG21 ' A' ' 41' ' ' VAL . 1.2 tp -96.21 143.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.772 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.44 120.32 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.543 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -101.58 149.96 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 0.0 110.981 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -153.18 100.08 2.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.005 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 2.5 Cg_endo -78.53 134.0 12.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.824 2.349 . . . . 0.0 110.791 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.531 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 93.9 m -138.35 -85.44 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.664 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 3.0 m-20 -74.46 -72.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.561 -177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 ' SD ' ' A' ' 174' ' ' MET . 1.0 OUTLIER -77.72 -86.89 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.047 -177.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.566 HG13 ' H ' ' A' ' 37' ' ' TYR . 3.9 tp -133.33 -155.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.672 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.566 ' H ' HG13 ' A' ' 36' ' ' ILE . 8.9 m-85 -63.27 131.5 48.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.37 172.85 14.42 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.177 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -118.2 135.85 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.96 0.41 . . . . 0.0 111.113 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.76 114.44 0.72 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.769 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 28' ' ' ILE . 1.5 p -158.12 175.88 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.638 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -56.35 118.55 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.592 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HA ' ' HG1' ' A' ' 137' ' ' THR . . . -59.85 -56.24 24.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.03 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 44' ' ' LEU . 2.6 mm? -82.29 37.52 0.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.926 0.393 . . . . 0.0 111.45 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.638 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.14 153.98 24.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.861 178.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -71.5 -29.16 64.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.833 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.04 -33.35 75.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.02 -35.99 74.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.78 -44.03 89.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.036 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -66.12 -43.11 88.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HA ' HH11 ' A' ' 51' ' ' ARG . 7.2 mmt-85 -70.96 -24.71 62.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.633 HD13 HG23 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -71.83 -44.99 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.985 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -20.47 62.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.41 -49.77 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.787 ' HA ' HD13 ' A' ' 143' ' ' ILE . 48.0 t -75.55 -40.36 41.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.439 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.95 -12.23 59.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.94 -108.0 2.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.533 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -118.19 90.6 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.049 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 m -153.79 70.7 6.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.12 14.98 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.566 2.177 . . . . 0.0 112.594 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -121.06 -19.02 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.951 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 131.68 49.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.01 175.34 1.01 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.555 2.17 . . . . 0.0 112.247 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.633 HG23 HD13 ' A' ' 52' ' ' LEU . 10.0 p -112.98 152.07 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 4.8 t -93.93 129.0 40.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 9.5 mm -107.98 161.51 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 51.4 t -122.23 127.44 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.71 HG21 ' HB2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -140.84 177.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.575 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.71 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -87.18 -41.76 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 110.462 179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.42 170.57 15.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.799 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.774 HG13 ' HE1' ' A' ' 85' ' ' MET . 5.1 t -59.03 -33.07 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -24.91 66.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.668 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.71 ' HB2' HG21 ' A' ' 68' ' ' VAL . 73.5 mm-40 -78.06 -21.04 51.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -113.66 56.52 0.69 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.625 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -58.68 -85.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.033 1.822 . . . . 0.0 112.11 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.458 ' H ' ' HB2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -73.17 18.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.59 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 25.2 m-85 -92.34 -34.42 14.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.76 0.315 . . . . 0.0 110.958 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.673 ' HB2' HD21 ' A' ' 100' ' ' LEU . 57.1 p -135.37 -178.14 4.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.837 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.807 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 6.5 mmt180 -114.1 83.76 8.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.667 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 76.4 Cg_endo -102.46 178.46 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.111 2.541 . . . . 0.0 113.036 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -129.93 179.43 5.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.932 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.19 -78.63 0.63 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.762 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -55.08 -31.39 61.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 184' ' ' VAL . . . -60.73 -41.14 94.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.774 ' HE1' HG13 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -69.97 -25.95 63.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.279 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.3 mm-40 -57.99 -56.09 26.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.418 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.513 HD22 HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -55.04 -39.23 68.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.896 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.647 ' HB2' HD13 ' A' ' 182' ' ' LEU . 3.9 tpt -66.69 -41.34 88.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.343 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.23 -7.72 44.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.265 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.95 -37.92 61.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 pt -115.06 48.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.532 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 4.1 tp -131.21 138.52 33.04 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 97.0 Cg_endo -78.51 -162.95 3.14 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.481 -0.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.52 164.68 13.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.376 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.14 30.76 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.603 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -100.99 132.99 46.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.905 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.61 120.54 40.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.427 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.717 HG11 ' HB ' ' A' ' 180' ' ' ILE . 2.4 m -110.36 135.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 0.0 111.681 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -101.76 130.19 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.283 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -126.78 -179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.744 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 2.1 tt0 -74.27 175.71 7.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.508 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.53 ' HD3' ' HG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -119.24 144.77 46.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.417 . . . . 0.0 111.325 -179.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 105' ' ' LEU . 5.7 p-10 -74.34 -159.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.936 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 27.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.563 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -69.45 113.47 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.2 mt -68.58 -49.45 29.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.89 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 7.5 Cg_endo -49.93 110.08 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.444 2.096 . . . . 0.0 112.459 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.515 ' HA ' HG21 ' A' ' 111' ' ' THR . 3.9 m-20 -76.15 -5.06 44.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.872 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.442 HG12 HG12 ' A' ' 110' ' ' ILE . 7.7 p -69.77 -24.68 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.686 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 109' ' ' VAL . 26.0 mm -95.18 -51.71 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.168 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.53 ' HG1' ' HD3' ' A' ' 102' ' ' ARG . 11.7 t -77.93 -0.64 28.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.51 -160.17 51.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.588 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.37 83.89 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.473 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 m -113.82 -171.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.486 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 55.2 m -105.26 47.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -137.05 155.74 49.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.0 0.428 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.1 t -139.72 138.8 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.458 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.66 152.25 21.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.841 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 120' ' ' ARG . 42.9 mt -147.68 142.85 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' N ' HG21 ' A' ' 119' ' ' ILE . 0.0 OUTLIER -148.76 137.94 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.943 0.401 . . . . 0.0 111.21 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 t -110.21 98.09 33.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.025 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.19 -179.1 4.92 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.459 2.106 . . . . 0.0 112.568 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.23 14.01 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 1.5 t0 -76.14 106.09 7.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -52.71 64.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.235 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.724 HG21 HD23 ' A' ' 16' ' ' LEU . 31.6 mt -59.2 -49.07 84.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -62.53 -23.66 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.891 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -67.04 -35.11 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.786 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -53.74 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 mt -60.58 -54.75 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.307 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 67' ' ' CYS . . . -58.32 -28.73 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.376 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.8 -55.27 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 109.904 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -75.48 -89.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.02 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.97 134.35 68.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.784 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.97 152.59 76.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.379 2.053 . . . . 0.0 111.811 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.3 153.61 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.204 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.621 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 6.8 m -80.68 137.55 36.32 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -133.91 108.47 8.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.707 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.91 136.04 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -79.43 113.88 17.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.97 88.12 7.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -154.15 25.54 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.787 HD13 ' HA ' ' A' ' 55' ' ' VAL . 2.9 pt -77.96 -157.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.06 160.22 2.14 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.065 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.417 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 85.65 -144.67 20.6 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.285 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.412 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 33.2 tttt -127.46 63.47 59.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.487 0.184 . . . . 0.0 111.279 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 41.9 Cg_exo -60.49 -47.79 13.09 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.336 2.024 . . . . 0.0 113.352 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 74.0 Cg_endo -74.81 115.81 4.41 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 112.358 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.4 152.69 38.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -95.86 -14.51 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.83 2.353 . . . . 0.0 113.004 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -135.88 136.88 40.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.856 0.36 . . . . 0.0 111.109 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.693 HD23 ' HB ' ' A' ' 165' ' ' VAL . 8.3 mt -65.3 -45.16 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.907 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -27.0 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.145 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -37.42 86.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.146 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.601 HD11 HG12 ' A' ' 165' ' ' VAL . 1.1 mt -72.7 -34.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.154 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 152' ' ' LEU . 16.0 t -64.17 -30.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.813 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -75.5 -53.02 9.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.444 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.41 -45.85 68.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.748 HD13 ' HB ' ' A' ' 162' ' ' VAL . 0.8 OUTLIER -90.83 64.22 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -37.05 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.186 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -171.51 16.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.748 ' HB ' HD13 ' A' ' 159' ' ' LEU . 47.1 t -80.78 -91.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.603 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -98.41 95.85 7.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.403 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.46 138.65 57.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.79 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.693 ' HB ' HD23 ' A' ' 152' ' ' LEU . 26.9 m -65.04 -169.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 166' ' ' LEU . 1.0 OUTLIER -125.84 135.76 52.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.211 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -2.16 54.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.01 -33.61 24.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.349 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.24 130.18 6.92 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.505 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 4.8 p-10 -73.41 -175.97 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.674 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.7 OUTLIER -136.72 -171.49 2.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.643 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -143.86 38.65 1.34 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.664 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 1.4 m-20 -85.08 56.89 4.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.111 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.443 ' SD ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -54.43 173.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.377 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.84 ' H ' ' HA ' ' A' ' 176' ' ' PRO . 2.1 tp10 -160.12 -47.77 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.84 ' HA ' ' H ' ' A' ' 175' ' ' GLU . 89.6 Cg_endo -83.45 -52.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.358 1.048 0 C-N-CA 124.653 -0.978 . . . . 0.0 113.495 3.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.96 144.82 22.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.664 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 96' ' ' TYR . 53.0 m -102.41 150.39 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.464 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.505 ' N ' HG23 ' A' ' 178' ' ' THR . 11.9 t -125.6 86.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.343 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.717 ' HB ' HG11 ' A' ' 98' ' ' VAL . 10.3 mt -100.71 131.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.65 ' HB3' ' HG3' ' A' ' 188' ' ' ARG . 7.3 t0 -98.84 64.53 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.953 0.406 . . . . 0.0 110.685 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.647 HD13 ' HB2' ' A' ' 88' ' ' MET . 1.3 tt -70.2 75.68 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.419 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.56 -79.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.444 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.498 ' CG1' ' H ' ' A' ' 185' ' ' ASN . 1.7 p -120.42 -95.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.546 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.511 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 2.2 t-20 -90.47 -51.31 0.33 Allowed Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 18.3 Cg_exo -67.52 107.26 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.571 2.18 . . . . 0.0 112.314 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 87.7 Cg_endo -84.55 116.51 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.683 2.255 . . . . 0.0 112.477 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.65 ' HG3' ' HB3' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -91.96 67.9 5.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.06 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 180' ' ' ILE . 2.5 t -63.71 112.77 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.3 94.08 2.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.585 ' HG2' HG22 ' A' ' 178' ' ' THR . 2.0 mtt180 -83.99 147.18 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -85.07 53.92 2.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -97.01 125.19 8.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.59 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.96 -10.68 17.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -76.01 -167.78 24.56 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.473 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.1 -176.85 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.596 2.197 . . . . 0.0 112.171 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.4 9.5 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.976 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -78.96 138.3 57.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 202' ' ' LEU . 53.0 Cg_endo -69.45 -141.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.471 2.114 . . . . 0.0 112.227 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.498 ' H ' ' HB2' ' A' ' 199' ' ' PRO . 4.6 t -63.76 -97.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.173 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.411 ' H ' ' HB ' ' A' ' 200' ' ' VAL . 0.2 OUTLIER -115.38 67.06 0.7 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.805 0.336 . . . . 0.0 111.154 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 199' ' ' PRO . 18.0 tp -95.14 149.79 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.918 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.08 111.15 19.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -179.16 79.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.512 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -100.88 -177.14 3.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 111.078 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 169.18 -28.09 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.433 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -102.91 -26.02 13.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.011 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.805 0.336 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 2' ' ' LEU . 4.6 mm? -71.99 -172.24 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.978 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.43 ' HB ' ' H ' ' A' ' 4' ' ' ARG . 1.7 mt -89.73 -101.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.978 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.43 ' H ' ' HB ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -75.25 128.61 35.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.0 -175.56 1.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -92.38 144.45 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.018 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.455 ' N ' HG13 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -70.13 121.53 17.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.72 140.81 48.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.68 -74.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.01 101.3 44.11 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.933 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.56 56.69 6.18 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.523 2.149 . . . . 0.0 112.434 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.15 71.3 4.56 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.794 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 26.1 Cg_exo -63.3 140.94 79.83 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.662 2.241 . . . . 0.0 112.374 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -54.52 6.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.414 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.8 t -64.39 -45.95 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.607 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.794 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.7 mm? -58.94 -50.77 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.124 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -55.07 -27.57 45.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.839 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 1.8 mt-10 -75.82 -43.75 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.59 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.13 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.9 mm -67.41 -22.35 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 3.6 t -65.16 -58.9 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 23' ' ' MET . 14.6 p -62.41 -29.65 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.464 ' N ' HG11 ' A' ' 22' ' ' VAL . 3.7 mtt -64.57 -28.52 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.35 13.89 62.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.522 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.05 58.92 9.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.84 162.35 19.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.753 ' HA ' HG21 ' A' ' 41' ' ' VAL . 1.4 tp -95.05 140.0 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.721 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.39 131.99 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.571 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER -102.28 163.2 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.679 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -168.33 102.44 0.54 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.761 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.695 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 92.6 Cg_endo -84.27 155.47 12.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.745 2.297 . . . . 0.0 112.121 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.437 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 40.8 p -131.51 -155.28 0.68 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.553 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -55.34 -19.03 7.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.715 0.293 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -97.61 -118.64 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.795 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.652 HG13 ' HE3' ' A' ' 174' ' ' MET . 1.1 tt -111.94 -174.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 110.827 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.695 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -63.24 134.64 56.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.94 178.9 17.76 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.119 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 4.4 mt -133.25 138.01 46.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.174 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.46 122.61 1.73 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.609 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.753 HG21 ' HA ' ' A' ' 28' ' ' ILE . 1.7 p -159.77 177.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.723 0.296 . . . . 0.0 111.281 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.632 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 1.9 m120 -56.13 106.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.976 0.417 . . . . 0.0 110.669 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.14 -49.73 76.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.091 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.29 27.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.944 0.402 . . . . 0.0 111.748 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.632 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 147.77 34.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.815 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -73.32 -24.78 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 110.593 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -58.37 -30.14 66.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.809 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -65.88 -30.37 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 t -71.15 -46.07 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -65.15 -41.13 95.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.656 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mpt_? -67.01 -53.87 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.077 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -54.56 -25.76 27.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -73.76 -52.98 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -55.49 -35.88 66.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.713 HG11 ' H ' ' A' ' 142' ' ' ASN . 54.5 t -70.68 -58.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -72.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.41 17.0 30.71 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.31 -16.16 9.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 110.93 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.544 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -140.05 67.65 33.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 -4.59 15.41 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.551 2.167 . . . . 0.0 112.213 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.91 -4.46 17.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 0.0 OUTLIER -86.43 145.36 39.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.993 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.442 ' HD2' ' HD2' ' A' ' 62' ' ' LYS . 24.2 Cg_endo -60.82 156.98 40.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.673 2.249 . . . . 0.0 112.147 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.9 p -112.59 147.26 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -94.18 145.03 25.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.2 161.83 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.819 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.486 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 10.8 t -111.73 131.55 55.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.723 HG23 ' HB2' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -137.74 170.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.798 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 4.1 t -86.47 -39.4 16.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.489 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.7 t -164.08 174.09 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG12 ' HG3' ' A' ' 85' ' ' MET . 37.9 t -59.93 -38.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.541 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m-20 -67.22 -23.4 65.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.798 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 24.5 mm-40 -80.62 -23.17 39.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.231 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.459 HG13 ' CB ' ' A' ' 77' ' ' PHE . 18.9 tt -114.22 50.66 0.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.029 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 20.8 Cg_endo -61.97 -78.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.099 1.866 . . . . 0.0 113.176 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 9.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.522 ' CE2' ' HG2' ' A' ' 135' ' ' PRO . 1.8 m-85 -108.21 -13.63 14.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.219 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.769 ' HB2' HD22 ' A' ' 100' ' ' LEU . 60.3 p -135.74 178.11 7.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.622 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.484 ' N ' ' HD3' ' A' ' 80' ' ' PRO . 3.8 mtp-105 -133.5 62.14 57.89 Favored Pre-proline 0 N--CA 1.464 0.232 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.485 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.514 ' HB3' HD23 ' A' ' 100' ' ' LEU . 65.6 Cg_endo -102.38 173.15 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.784 2.323 . . . . 0.0 113.203 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.5 -177.71 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.53 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.09 4.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.783 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -55.59 -41.28 73.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 0.0 111.211 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.557 ' HB3' ' HE3' ' A' ' 85' ' ' MET . . . -66.16 -51.6 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.643 ' HG3' HG12 ' A' ' 71' ' ' VAL . 24.0 mmt -71.74 -7.81 50.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -72.28 -54.58 9.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.342 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -37.49 74.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.695 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.499 ' HE1' HG21 ' A' ' 98' ' ' VAL . 3.4 tpt -73.76 -41.36 62.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.633 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 85' ' ' MET . 0.5 OUTLIER -63.42 -13.82 43.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.05 -31.17 61.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.27 45.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.472 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 147.09 64.82 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.843 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.37 -172.08 10.76 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.953 -1.269 . . . . 0.0 112.14 -0.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.25 179.93 29.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.582 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 36.8 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.782 2.321 . . . . 0.0 112.279 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.403 ' HB2' ' HE2' ' A' ' 88' ' ' MET . 13.9 m-85 -106.86 114.42 28.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 26.0 m -96.99 117.29 30.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -108.83 108.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG12 ' HA2' ' A' ' 118' ' ' GLY . 7.1 t -84.93 124.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.769 HD22 ' HB2' ' A' ' 78' ' ' SER . 0.2 OUTLIER -128.13 162.3 27.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.394 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.584 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 3.6 mt-10 -59.08 174.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.724 ' HE ' ' HB3' ' A' ' 105' ' ' LEU . 18.8 ttt85 -118.57 159.06 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.151 0.501 . . . . 0.0 111.835 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.407 ' H ' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.13 -162.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.343 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 16.53 0.37 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.836 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.724 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 1.7 tm? -69.83 153.75 42.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.583 0.23 . . . . 0.0 110.459 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.65 HG13 ' H ' ' A' ' 108' ' ' ASP . 1.8 tp -59.54 106.41 0.73 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 74.3 Cg_endo -72.25 16.79 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.003 2.469 . . . . 0.0 113.431 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.65 ' H ' HG13 ' A' ' 106' ' ' ILE . 22.4 t0 -61.32 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.76 6.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.615 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.402 HG22 ' CZ ' ' A' ' 102' ' ' ARG . 10.1 mm -95.95 -59.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.297 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 p -87.5 -31.11 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.014 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 -89.8 0.29 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.19 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.93 -84.01 0.17 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.114 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -103.95 -167.71 1.4 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.558 0.218 . . . . 0.0 110.896 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.7 60.4 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 111.188 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 116' ' ' ARG . 9.5 mtt85 -136.44 143.6 43.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 102' ' ' ARG . 90.3 t -140.0 138.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.71 151.82 36.33 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.793 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 118' ' ' GLY . 26.0 mt -149.61 135.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.642 0.258 . . . . 0.0 110.453 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.596 ' HD2' ' HD3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -156.46 149.99 24.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 111.454 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.87 89.08 8.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.404 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.596 ' HD3' ' HD2' ' A' ' 120' ' ' ARG . 22.7 Cg_endo -61.75 -178.77 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.499 2.133 . . . . 0.0 112.721 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.428 ' H ' HG21 ' A' ' 33' ' ' THR . 3.5 t0 -85.72 7.46 23.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.3 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 127' ' ' CYS . 7.3 m-20 -80.2 94.86 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.868 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.26 -33.41 67.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.0 mt -69.67 -52.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.725 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -61.34 -13.93 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.754 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -75.15 -48.06 25.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.89 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.496 ' O ' ' HB1' ' A' ' 132' ' ' ALA . 7.2 mtp180 -59.65 -54.25 48.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mt -59.03 -49.05 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.064 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.4 -27.68 69.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 129' ' ' ARG . . . -54.42 -56.71 15.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -89.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.747 176.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -77.08 124.88 87.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.818 177.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.522 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 25.9 Cg_exo -64.78 157.72 54.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.283 1.989 . . . . 0.0 111.69 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 41' ' ' VAL . 12.3 t -128.94 155.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.646 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 8.0 m -80.51 132.51 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.927 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.23 104.29 7.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 111.548 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.4 HG22 HD11 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -133.22 163.32 29.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 t -81.31 131.22 35.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.483 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . -76.78 119.02 19.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.044 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.713 ' H ' HG11 ' A' ' 55' ' ' VAL . 1.2 m120 -163.6 63.06 0.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -76.7 179.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.975 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.9 t -62.3 145.23 54.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.53 -125.58 7.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.622 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.81 88.86 50.35 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.595 0.236 . . . . 0.0 110.957 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.458 ' HG2' ' HA ' ' A' ' 142' ' ' ASN . 45.5 Cg_exo -59.99 -47.6 14.84 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.588 2.192 . . . . 0.0 113.228 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 26.1 Cg_exo -62.0 91.24 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.899 1.733 . . . . 0.0 111.931 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.94 148.52 78.96 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -95.48 -15.53 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.994 2.462 . . . . 0.0 112.368 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -136.53 125.89 24.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.425 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.599 ' HA ' HD11 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -58.29 -40.8 82.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -70.22 -20.04 63.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 151' ' ' ARG . 15.2 tt0 -75.12 -28.68 60.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.777 HD13 HG12 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -74.95 -46.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 -179.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -60.09 -31.22 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.29 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -74.96 -47.02 31.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.071 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.14 -23.75 60.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.252 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.52 ' HB3' HG12 ' A' ' 162' ' ' VAL . 97.2 mt -111.34 67.13 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -16.19 -63.15 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.077 0.86 . . . . 0.0 112.776 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.18 22.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.005 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -81.13 -70.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.983 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.685 ' H ' HG12 ' A' ' 162' ' ' VAL . 38.6 t0 -107.98 96.7 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.578 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -67.51 135.77 53.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.777 HG12 HD13 ' A' ' 155' ' ' ILE . 18.8 m -67.4 -164.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.255 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.852 HD22 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.27 161.38 27.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.869 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -92.41 -25.08 18.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.59 -57.56 3.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.128 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.852 ' HA2' HD22 ' A' ' 166' ' ' LEU . . . 102.05 -161.87 17.33 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.934 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.65 -162.73 0.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.676 0.274 . . . . 0.0 110.915 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.437 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.73 -56.11 0.16 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.705 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.499 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -133.46 -133.15 0.17 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.499 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -85.89 142.6 28.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.873 0.368 . . . . 0.0 111.963 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.652 ' HE3' HG13 ' A' ' 36' ' ' ILE . 69.2 mmm -62.4 -25.36 67.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.319 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.4 159.17 42.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.741 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 177' ' ' SER . 75.3 Cg_endo -86.79 -149.59 0.44 Allowed 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.694 0.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.4 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.2 OUTLIER -153.98 157.12 38.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.75 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.45 132.23 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.87 90.33 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.946 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.71 HG12 ' HA ' ' A' ' 189' ' ' VAL . 22.6 mt -108.42 137.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 0.5 OUTLIER -106.49 67.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.042 178.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 98' ' ' VAL . 31.8 tp -70.28 90.04 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.682 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -79.25 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.447 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 3.5 t -120.23 -123.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.059 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.492 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -62.51 -52.02 68.6 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -77.92 108.42 2.53 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.138 1.892 . . . . 0.0 112.645 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.521 ' HB3' HD12 ' A' ' 182' ' ' LEU . 84.6 Cg_endo -83.25 129.65 5.24 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.2 mmt85 -88.68 60.9 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.038 0.447 . . . . 0.0 111.001 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.71 ' HA ' HG12 ' A' ' 180' ' ' ILE . 32.6 t -62.38 92.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.949 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.55 87.04 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -83.56 145.93 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -73.17 97.48 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.722 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -93.78 125.47 8.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.646 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.27 -28.5 12.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.999 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -86.66 114.36 4.06 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.499 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 -12.91 37.07 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.513 2.142 . . . . 0.0 112.363 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.92 171.63 19.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.008 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 19.8 m-20 -76.54 137.1 67.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 24.3 Cg_exo -63.9 -178.16 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.652 2.235 . . . . 0.0 112.235 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.12 123.28 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.983 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.94 37.41 2.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 172.19 9.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.899 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -72.05 112.89 8.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -117.18 48.09 0.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.494 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -88.12 34.64 0.74 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.173 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 137.07 127.98 2.65 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.389 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -101.64 -1.07 33.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.841 0.353 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.147 -179.786 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.658 ' HB2' ' HB2' ' A' ' 4' ' ' ARG . 13.6 ptt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.829 0.347 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -107.78 -77.48 0.6 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.28 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.498 ' N ' ' HG ' ' A' ' 2' ' ' LEU . 9.0 tp -84.41 -7.33 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.999 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 1.0 OUTLIER -84.63 137.12 33.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 177.68 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.437 ' HB ' ' HE1' ' A' ' 1' ' ' MET . 7.5 tt -95.01 137.27 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.049 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -78.85 125.72 29.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.07 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 169.51 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.016 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.04 99.98 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.79 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -99.05 107.26 43.11 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.85 106.14 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.568 2.179 . . . . 0.0 112.323 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.495 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 4.0 m -101.05 -51.09 0.18 Allowed Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.355 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 12' ' ' SER . 52.8 Cg_exo -56.22 151.41 43.76 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.213 1.942 . . . . 0.0 112.287 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.672 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -75.07 -27.72 60.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.48 -49.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.725 HD23 HG21 ' A' ' 126' ' ' ILE . 4.1 mm? -66.22 -32.15 73.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.152 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.672 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -71.77 -31.3 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.575 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -75.54 -38.21 59.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.264 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.68 -45.44 58.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.8 -30.35 37.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.72 -40.81 88.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 164' ' ' LEU . 3.3 t -62.82 -31.03 50.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.0 mmt -61.5 -43.88 98.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.38 -23.21 58.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.809 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -19.0 63.8 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.44 36.34 88.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.687 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.74 170.57 14.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.142 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.654 HD12 HD23 ' A' ' 39' ' ' LEU . 1.5 tp -90.52 136.06 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.453 HG11 ' O ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER -116.7 133.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.665 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.516 HG12 ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -101.87 163.01 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.55 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.21 101.15 0.79 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.79 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.6 Cg_endo -82.61 144.64 12.67 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.592 2.195 . . . . 0.0 111.601 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.558 HG22 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -121.55 -152.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.717 0.294 . . . . 0.0 111.291 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -55.05 -21.99 14.29 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.457 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 1.8 t -100.02 -115.0 0.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.657 HG22 ' HG2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -112.34 -172.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.852 0.358 . . . . 0.0 111.173 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.646 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.8 m-85 -63.69 137.9 58.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.926 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.02 -176.66 14.77 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.014 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.654 HD23 HD12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -127.08 140.98 51.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.644 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.33 120.83 1.35 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.708 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 28' ' ' ILE . 1.5 p -165.98 177.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.775 0.321 . . . . 0.0 111.65 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.77 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t-20 -56.73 107.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -62.7 -52.09 64.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 33.1 0.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.6 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.77 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 159.69 17.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.833 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.13 -36.7 61.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.791 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 25.0 t70 -58.49 -26.54 63.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.109 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.83 -33.28 62.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.52 -52.69 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -65.01 -45.85 83.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.92 -31.95 63.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -27.9 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -42.91 53.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' HA ' HD12 ' A' ' 143' ' ' ILE . 48.1 t -74.72 -43.37 47.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.245 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.63 -17.9 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.012 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.93 -95.33 0.19 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -118.06 83.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.63 69.55 15.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.9 11.96 2.6 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.609 2.206 . . . . 0.0 112.526 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.17 -14.93 8.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -88.46 127.01 58.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.156 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.16 -166.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.692 2.261 . . . . 0.0 112.084 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 110' ' ' ILE . 12.6 p -118.68 135.64 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.138 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 8.6 t -96.24 131.69 42.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 32.3 pt -116.89 169.93 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -114.75 137.1 52.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.353 . . . . 0.0 110.603 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.612 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.2 p -145.84 173.91 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -80.17 -42.52 23.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.958 0.408 . . . . 0.0 110.371 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.41 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -163.45 168.51 20.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 74' ' ' ILE . 15.8 t -57.17 -29.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.943 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.46 -32.68 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.225 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.99 -13.24 59.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.489 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 74' ' ' ILE . 6.3 tt -114.16 44.52 0.32 Allowed Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 72.9 Cg_endo -76.39 -46.76 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.726 1.618 . . . . 0.0 112.634 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -72.42 -1.03 14.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.886 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.78 -56.07 2.28 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.652 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 p -114.55 171.03 7.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.347 . . . . 0.0 111.144 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -121.94 108.18 34.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.625 ' HA ' HD13 ' A' ' 100' ' ' LEU . 57.5 Cg_endo -102.45 -168.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.221 2.614 . . . . 0.0 113.007 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 85' ' ' MET . 3.2 t -138.82 -178.24 5.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.88 -83.72 0.37 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.843 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.783 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.96 -27.78 46.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.111 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.433 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -61.66 -46.43 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 81' ' ' SER . 19.5 mmt -74.92 -11.98 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.783 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -71.17 -48.28 52.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.992 0.425 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 5.0 tp -65.21 -35.99 82.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.79 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.752 ' HE2' HD23 ' A' ' 182' ' ' LEU . 7.7 tpp -68.41 -44.61 74.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.63 -13.82 61.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 5.7 tpt180 -73.43 -42.11 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.651 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 pt -110.55 43.79 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.041 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.766 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -131.2 143.5 49.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.766 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.4 Cg_exo -78.13 -165.14 4.37 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.174 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.81 173.33 23.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.588 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.537 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 93.0 Cg_endo -79.82 39.23 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.563 2.175 . . . . 0.0 112.358 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.62 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.3 m-85 -111.98 143.87 42.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.525 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 29.1 m -94.82 135.95 35.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.9 t -120.29 109.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.429 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.784 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 19.1 t -99.66 135.97 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.276 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HB2' HD13 ' A' ' 119' ' ' ILE . 2.4 mm? -126.45 -172.69 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.043 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.04 -165.84 0.43 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.733 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.485 ' HG2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.13 132.44 56.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.97 0.414 . . . . 0.0 111.106 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -74.87 -173.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.15 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 9.27 2.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.483 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.683 HD21 ' H ' ' A' ' 106' ' ' ILE . 1.3 mt -69.39 -174.39 0.67 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.711 0.291 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.683 ' H ' HD21 ' A' ' 105' ' ' LEU . 2.8 mt -79.53 107.47 6.55 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.283 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 65.4 Cg_endo -71.65 23.56 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.675 2.25 . . . . 0.0 112.941 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 106' ' ' ILE . 3.7 m-20 -61.55 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.683 0.278 . . . . 0.0 111.2 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 m -90.21 5.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.703 0.287 . . . . 0.0 111.202 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 ' HA ' HG11 ' A' ' 64' ' ' VAL . 4.1 mt -96.4 -35.01 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.4 OUTLIER -87.13 -37.27 17.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.622 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.78 -101.35 0.64 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.347 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.26 -60.42 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.631 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.78 -179.32 3.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.728 0.299 . . . . 0.0 110.906 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.532 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -92.78 70.1 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.995 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -136.75 163.69 30.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.322 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.485 HG21 ' HG2' ' A' ' 102' ' ' ARG . 95.3 t -139.54 125.07 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.377 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.53 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -78.92 152.71 37.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.899 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' HB2' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -144.87 156.06 14.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.653 0.263 . . . . 0.0 110.553 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -148.49 124.82 10.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.261 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.641 HG22 HD21 ' A' ' 92' ' ' LEU . 5.2 t -110.42 86.99 5.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.56 179.77 5.25 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.518 2.146 . . . . 0.0 112.65 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.558 ' H ' HG22 ' A' ' 33' ' ' THR . 0.3 OUTLIER -93.28 5.17 52.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.03 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.87 106.99 7.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.155 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -57.34 -39.44 75.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.771 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.725 HG21 HD23 ' A' ' 16' ' ' LEU . 45.2 mm -63.1 -54.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.873 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -61.87 -18.53 60.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -72.27 -36.46 69.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.404 ' O ' ' HB1' ' A' ' 132' ' ' ALA . 13.0 mtp180 -75.02 -52.53 10.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.239 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.0 mt -60.0 -53.72 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.84 -26.93 67.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.277 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 129' ' ' ARG . . . -54.63 -56.77 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.018 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -86.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.326 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.78 115.29 46.84 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.68 137.75 46.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.558 2.172 . . . . 0.0 111.602 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 m -114.74 170.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 120.943 0.402 . . . . 0.0 111.737 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.644 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 46.2 m -80.76 139.94 35.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.012 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.66 103.71 4.92 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.287 0.367 . . . . 0.0 111.37 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -130.28 126.31 36.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.7 p -70.93 110.86 5.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.1 96.59 7.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -154.25 25.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.041 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 55' ' ' VAL . 10.9 pt -81.16 -154.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.251 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.1 p -59.83 170.39 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.921 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.425 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 75.98 -139.64 24.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.293 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.432 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -127.55 62.91 57.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.449 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 39.5 Cg_exo -60.53 -50.19 7.36 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.24 1.96 . . . . 0.0 113.178 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 91.0 Cg_endo -78.99 103.05 1.59 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.898 1.732 . . . . 0.0 112.148 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.413 ' OG ' HG22 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -82.91 145.97 51.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -95.53 -11.22 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.916 2.411 . . . . 0.0 111.929 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.93 128.88 14.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.04 -27.36 66.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.578 ' O ' HG13 ' A' ' 156' ' ' VAL . 3.7 tt0 -71.07 -37.89 72.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.171 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -55.73 31.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.323 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.6 OUTLIER -63.47 -42.98 98.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -53.08 -30.1 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -39.21 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -26.79 57.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.257 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 155' ' ' ILE . 2.0 pp -94.98 46.8 1.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t70 -16.03 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.728 0.643 . . . . 0.0 112.551 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -157.32 10.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.761 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -81.39 -75.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.381 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.761 ' H ' HG13 ' A' ' 162' ' ' VAL . 4.2 t70 -95.79 109.07 21.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.791 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.567 ' HB2' HG13 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -73.85 120.65 19.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.99 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 155' ' ' ILE . 4.3 p -61.72 -179.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.779 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.632 HD13 ' HD2' ' A' ' 32' ' ' PRO . 1.3 pt? -125.28 149.28 48.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.828 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.19 -19.61 22.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.289 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.53 -48.0 61.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.945 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.56 -168.51 31.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.777 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -163.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.074 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.423 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 44.2 m -140.95 -56.94 0.5 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.48 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -129.43 -130.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.518 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -86.36 146.29 26.53 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.487 -178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.657 ' HG2' HG22 ' A' ' 36' ' ' ILE . 3.7 ttp -69.35 0.17 5.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.179 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.81 156.75 30.99 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.631 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.487 ' HB2' ' H ' ' A' ' 177' ' ' SER . 70.7 Cg_endo -88.71 -140.27 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.921 -1.283 . . . . 0.0 112.576 0.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.487 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -153.63 124.77 7.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.623 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.62 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 34.8 m -101.99 131.69 48.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.45 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.525 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -129.48 109.15 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.707 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.714 HG12 ' HA ' ' A' ' 189' ' ' VAL . 15.1 mt -120.9 137.14 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.474 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.784 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 6.0 t70 -107.99 66.91 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.589 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.752 HD23 ' HE2' ' A' ' 88' ' ' MET . 21.9 tp -69.77 88.26 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -79.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.437 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.64 -121.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.484 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.9 t-20 -63.48 -50.59 72.53 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 79.7 Cg_endo -77.87 108.75 2.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.24 1.96 . . . . 0.0 112.566 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.1 Cg_endo -82.44 128.6 5.52 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.558 2.172 . . . . 0.0 112.248 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 17.8 mtp180 -87.58 56.1 3.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.714 ' HA ' HG12 ' A' ' 180' ' ' ILE . 17.9 t -59.97 104.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.75 74.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -89.73 139.58 30.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.81 89.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -87.2 168.46 38.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.61 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.24 -174.61 2.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.331 . . . . 0.0 110.802 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.91 -66.8 2.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.49 159.85 30.19 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.692 2.262 . . . . 0.0 112.209 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.7 174.21 10.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.35 149.68 97.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.56 143.45 97.01 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.518 2.145 . . . . 0.0 112.271 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.2 m -71.32 -179.94 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.248 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.88 26.03 7.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.984 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.99 172.3 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.58 -56.34 4.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.007 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.29 -127.11 9.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.464 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.49 149.44 45.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.769 0.319 . . . . 0.0 111.063 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -124.76 20.33 6.84 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.559 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.51 18.76 19.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.046 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' H1 ' ' HG2' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.824 0.345 . . . . 0.0 111.111 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.13 -178.56 6.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.024 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 mm -78.9 131.5 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.941 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -83.97 157.93 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.011 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -75.0 -166.36 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.462 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -110.38 -68.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.027 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 p -106.24 -79.15 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.173 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -102.23 175.82 5.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.38 -67.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.014 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -94.12 131.17 32.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.017 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.61 -66.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.583 2.189 . . . . 0.0 112.075 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m 55.18 83.89 0.22 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.683 ' HG2' HD13 ' A' ' 16' ' ' LEU . 45.1 Cg_exo -56.59 149.52 57.72 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.466 2.111 . . . . 0.0 112.233 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.38 -28.74 68.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.066 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.6 t -65.31 -57.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.683 HD13 ' HG2' ' A' ' 13' ' ' PRO . 13.7 mt -62.01 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -64.15 -23.75 67.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.712 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.5 -32.69 58.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.165 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.27 -44.33 62.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.761 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -75.55 -18.37 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.182 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 t -75.52 -47.95 24.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.352 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -74.52 -26.93 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.656 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.612 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 15.7 ptp -73.97 -31.51 63.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 0.0 111.112 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -25.09 65.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.84 31.18 6.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.435 ' HA2' ' CG ' ' A' ' 47' ' ' ASP . . . 67.0 47.53 64.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 23' ' ' MET . . . -130.12 147.47 18.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.735 HD13 HD21 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -96.28 143.0 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.505 ' H ' HG13 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -117.94 145.26 24.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.766 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.844 HG22 HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -111.96 167.27 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.255 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.669 ' HH ' ' HB1' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -171.72 94.52 0.41 Allowed Pre-proline 0 C--N 1.332 -0.152 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.832 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.2 Cg_endo -84.14 142.71 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.872 2.381 . . . . 0.0 110.549 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.673 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 85.7 m -138.09 -97.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.047 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.12 -59.13 2.88 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.564 ' OG1' HG13 ' A' ' 36' ' ' ILE . 1.2 t -79.87 -104.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.564 HG13 ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -114.68 -146.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.62 0.248 . . . . 0.0 111.048 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.832 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.1 m-85 -81.84 134.39 35.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 111.038 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.4 -178.34 18.09 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.086 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.844 HD23 HG22 ' A' ' 30' ' ' ILE . 4.5 mt -133.65 142.68 48.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.638 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.39 132.2 4.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.881 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.564 HG13 HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -158.97 171.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.148 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.725 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 4.1 t-20 -56.58 122.2 11.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.131 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.49 -67.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -176.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.616 ' N ' HD21 ' A' ' 44' ' ' LEU . 4.3 mm? -80.5 37.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -110.41 146.67 35.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.681 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -73.99 -25.82 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.707 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.435 ' CG ' ' HA2' ' A' ' 26' ' ' GLY . 3.3 m-20 -61.63 -29.75 70.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.625 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HB2' HG21 ' A' ' 41' ' ' VAL . . . -75.39 -36.11 60.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.09 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 46' ' ' GLU . 18.7 t -61.62 -46.77 95.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -48.69 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.126 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.504 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 1.9 mmp_? -63.79 -21.55 66.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -71.41 -40.92 70.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.79 -19.45 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.562 ' HB3' HD11 ' A' ' 143' ' ' ILE . 4.2 mmt180 -71.86 -56.4 5.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.357 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.571 HG13 ' H ' ' A' ' 142' ' ' ASN . 45.6 t -75.36 -43.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.742 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.71 -3.17 46.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.303 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -113.75 5.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.19 90.12 3.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 t -144.8 71.37 15.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.66 7.37 4.58 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.763 2.309 . . . . 0.0 112.721 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -114.35 -14.41 12.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.14 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 122.03 70.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.24 171.47 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.594 2.196 . . . . 0.0 112.315 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 110' ' ' ILE . 10.5 p -112.8 145.02 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.008 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -93.6 146.49 23.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 136' ' ' VAL . 6.7 mm -116.39 154.31 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.8 t -105.02 122.93 46.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.761 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 1.8 p -147.51 177.68 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.765 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.536 ' HB2' ' HB1' ' A' ' 132' ' ' ALA . 2.5 t -86.74 -36.32 18.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.109 0.481 . . . . 0.0 110.23 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.486 ' O ' HG11 ' A' ' 68' ' ' VAL . 3.5 t -162.89 161.16 25.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.325 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.563 HG11 ' HB3' ' A' ' 80' ' ' PRO . 17.8 t -55.58 -32.69 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.379 . . . . 0.0 111.099 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 2.0 m-20 -67.35 -29.36 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.001 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HB2' HG22 ' A' ' 68' ' ' VAL . 78.5 mm-40 -80.58 -15.27 57.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.371 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 119' ' ' ILE . 3.0 tt -114.34 47.9 0.44 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 98.8 Cg_endo -79.08 -32.67 1.74 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.778 1.652 . . . . 0.0 112.298 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -11.8 60.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.672 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.59 -49.44 3.24 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.483 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.9 p -114.83 178.23 4.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -117.22 116.63 37.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.023 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.563 ' HB3' HG11 ' A' ' 71' ' ' VAL . 68.2 Cg_endo -102.22 178.09 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.162 2.575 . . . . 0.0 112.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.76 177.35 8.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.89 -99.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.966 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.04 -25.49 30.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.158 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.16 87.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -27.93 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.003 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -57.88 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.578 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 11.8 tp -57.82 -26.2 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.884 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.544 ' SD ' HG12 ' A' ' 98' ' ' VAL . 6.9 tpt -72.39 -46.79 53.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.427 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.35 -4.03 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.273 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.59 -38.52 87.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.066 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.05 58.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -123.97 141.23 36.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.7 Cg_exo -78.66 -161.57 2.74 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.246 -1.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.45 163.1 11.65 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.748 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.17 38.55 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.2 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.426 ' OH ' ' HB2' ' A' ' 92' ' ' LEU . 30.6 p90 -99.96 158.03 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.08 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -110.51 137.67 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.545 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.544 HG12 ' SD ' ' A' ' 88' ' ' MET . 15.7 t -117.93 109.2 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.853 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 50.4 t -104.33 126.57 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.282 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.469 HD11 HG12 ' A' ' 71' ' ' VAL . 1.2 mt -126.33 -167.02 1.65 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.559 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.58 -167.94 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.687 178.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.547 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.45 137.44 53.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.252 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -74.43 -173.19 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.084 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -75.54 5.14 6.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.295 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.7 163.38 25.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.911 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -65.8 108.99 2.56 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 30.48 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.956 2.437 . . . . 0.0 113.051 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.429 ' HB2' HG12 ' A' ' 106' ' ' ILE . 37.8 t70 -61.46 -97.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.578 0.227 . . . . 0.0 111.559 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 109' ' ' VAL . 6.3 p -89.74 5.6 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.798 0.332 . . . . 0.0 111.618 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.415 ' HA ' HG12 ' A' ' 64' ' ' VAL . 1.4 mt -97.87 -36.27 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.313 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -87.11 -39.62 15.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.102 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.09 -96.53 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.44 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.45 -64.47 1.22 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.891 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.652 ' HB2' ' HE ' ' A' ' 116' ' ' ARG . 0.7 OUTLIER -104.56 176.27 5.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.681 0.277 . . . . 0.0 111.111 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.503 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -92.47 71.89 5.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.652 ' HE ' ' HB2' ' A' ' 114' ' ' SER . 64.2 mtm180 -136.32 160.36 38.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.547 HG23 ' HG2' ' A' ' 102' ' ' ARG . 21.6 t -139.26 125.92 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.411 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -85.61 161.55 35.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.514 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.539 HG12 HD12 ' A' ' 74' ' ' ILE . 30.5 mt -144.74 152.34 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.632 0.253 . . . . 0.0 110.452 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.61 120.23 9.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 92' ' ' LEU . 10.6 t -110.83 86.58 5.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.736 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.95 -178.02 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.516 2.144 . . . . 0.0 112.513 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 33' ' ' THR . 0.2 OUTLIER -83.54 -0.58 50.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.982 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.7 t0 -72.88 96.09 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -43.12 83.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.599 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.5 mt -67.48 -48.64 76.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.004 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 15.1 t -57.81 -29.02 64.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.546 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.8 mtp180 -67.35 -33.95 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.484 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -64.43 -58.77 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.973 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 tt -63.83 -35.08 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.376 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.761 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.43 -30.05 64.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.151 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 69' ' ' SER . . . -55.35 -55.36 32.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.178 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.441 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 12.9 ttm180 -75.9 -83.86 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.296 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.441 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 1.1 t80 -75.67 110.11 9.79 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 133' ' ' ARG . 17.1 Cg_exo -66.23 147.26 83.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.429 2.086 . . . . 0.0 111.768 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 41' ' ' VAL . 3.9 t -125.89 159.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.638 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 5.2 m -80.13 141.75 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.14 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.63 109.85 6.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 111.756 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.591 HG22 HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.75 157.06 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.508 178.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 p -78.52 126.51 30.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.055 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.62 117.92 17.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.07 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.571 ' H ' HG13 ' A' ' 55' ' ' VAL . 6.9 t30 -161.47 47.46 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -74.63 173.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.3 p -58.9 148.97 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.92 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.23 -126.95 8.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.475 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.46 90.85 50.35 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.596 0.236 . . . . 0.0 110.924 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -60.48 -49.48 8.9 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.477 2.118 . . . . 0.0 113.459 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.89 110.4 3.03 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.861 1.707 . . . . 0.0 112.279 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.37 151.94 38.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -95.88 -12.03 0.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.948 2.432 . . . . 0.0 112.934 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -131.48 137.39 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.208 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.442 HD22 ' CG2' ' A' ' 165' ' ' VAL . 64.2 mt -68.8 -33.39 73.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.717 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.1 -19.27 60.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.913 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -36.79 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.73 HD13 HG22 ' A' ' 165' ' ' VAL . 69.4 mt -67.62 -55.56 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.142 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.424 HG12 HG13 ' A' ' 165' ' ' VAL . 2.2 m -54.87 -33.85 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -59.46 2.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.626 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.45 -43.01 83.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.429 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.718 ' HG ' ' HB3' ' A' ' 163' ' ' ASP . 2.3 mm? -101.3 66.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 159' ' ' LEU . 33.8 t70 -16.87 -61.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.033 0.833 . . . . 0.0 112.706 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -152.15 11.56 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.241 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.447 ' H ' HG11 ' A' ' 162' ' ' VAL . 1.5 p -81.01 -63.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.837 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.718 ' HB3' ' HG ' ' A' ' 159' ' ' LEU . 40.4 t0 -109.34 91.33 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.477 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.67 139.81 53.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.473 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.73 HG22 HD13 ' A' ' 155' ' ' ILE . 1.4 p -74.62 -175.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.047 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.473 ' H ' HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.55 134.21 50.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -4.22 53.67 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB1' ' HH ' ' A' ' 31' ' ' TYR . . . -63.48 -43.14 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.755 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.436 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 86.71 28.82 25.55 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.995 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.673 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 25.7 m-20 -73.28 119.89 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.842 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.7 125.62 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.591 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -136.7 -138.64 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.216 -179.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.542 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -86.26 137.22 32.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.88 0.371 . . . . 0.0 111.598 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.6 ttt -68.83 -5.78 22.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.813 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -149.99 156.54 38.0 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.693 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 72.7 Cg_endo -90.63 -152.92 0.55 Allowed 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.864 -1.307 . . . . 0.0 112.633 0.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -155.52 122.25 5.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.521 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.681 HG22 HD11 ' A' ' 180' ' ' ILE . 0.2 OUTLIER -101.79 137.15 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.471 -179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.91 91.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.531 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.681 HD11 HG22 ' A' ' 178' ' ' THR . 2.2 mp -106.55 128.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.752 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.853 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -103.01 64.13 0.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.116 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.55 94.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.427 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -77.09 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.578 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.22 -123.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.589 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -63.39 -52.2 62.36 Favored Pre-proline 0 CA--C 1.532 0.253 0 O-C-N 122.423 -0.173 . . . . 0.0 111.256 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.4 Cg_exo -75.07 109.22 2.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.554 2.169 . . . . 0.0 112.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 93.2 Cg_endo -84.19 131.58 5.04 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.61 2.206 . . . . 0.0 112.405 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.585 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 23.8 mmm-85 -89.44 51.08 2.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.989 0.424 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.519 ' HA ' HG21 ' A' ' 180' ' ' ILE . 14.7 t -58.26 98.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.781 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.5 91.42 3.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.133 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 178.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 98.58 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.35 19.47 35.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -97.03 -60.27 1.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.029 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.43 114.18 5.28 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.414 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.0 161.47 35.77 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.569 2.179 . . . . 0.0 112.366 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.91 8.59 3.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.95 -49.99 55.02 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.487 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.34 154.3 19.5 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.189 1.926 . . . . 0.0 112.318 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.08 145.07 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.052 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.76 27.31 3.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.31 -42.29 13.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.984 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -173.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -149.55 113.67 0.62 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.589 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -90.95 14.87 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 0.0 111.084 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -150.59 58.92 0.43 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.444 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.87 -10.63 41.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.8 0.333 . . . . 0.0 111.041 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.4 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.102 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.799 0.333 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.88 -168.84 0.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.75 134.37 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.205 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -109.86 90.04 3.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.52 173.15 12.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 8' ' ' ARG . 6.9 tt -110.03 143.81 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -59.86 2.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.076 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.45 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -97.65 -173.15 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -50.23 8.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.765 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.469 ' ND2' ' HG2' ' A' ' 17' ' ' GLU . 22.8 m120 -84.4 133.71 44.19 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.81 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 48.0 Cg_exo -55.64 -79.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.482 2.122 . . . . 0.0 112.181 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.471 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -173.5 -52.12 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.49 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.784 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 73.9 Cg_endo -76.4 151.72 33.68 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.225 1.95 . . . . 0.0 112.663 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.5 -32.51 68.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.77 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.71 HG22 ' HB3' ' A' ' 167' ' ' ASP . 58.8 t -60.43 -35.93 66.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.738 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.784 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -74.03 -39.13 63.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HG2' ' ND2' ' A' ' 10' ' ' ASN . 36.1 mt-10 -71.58 -21.34 61.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.981 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -35.68 58.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.777 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.77 75.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.285 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.506 ' H ' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -75.66 -21.35 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -66.9 -50.43 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.58 ' HB ' HD23 ' A' ' 164' ' ' LEU . 8.0 p -65.15 -32.99 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.447 ' N ' HG13 ' A' ' 22' ' ' VAL . 2.4 mtt -61.48 -29.22 69.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.76 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.83 -30.54 62.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.01 5.11 77.88 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.577 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.16 36.6 93.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.692 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.9 169.65 13.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.19 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.733 HG21 ' HA ' ' A' ' 163' ' ' ASP . 0.3 OUTLIER -96.43 146.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -119.51 131.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.606 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -102.35 162.81 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' HA ' HD21 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -167.81 99.63 0.59 Allowed Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.638 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 79.1 Cg_endo -84.1 166.62 12.75 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.545 2.164 . . . . 0.0 110.922 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.723 ' HA ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.72 -157.61 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.937 178.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 10.4 p-10 -63.61 -13.19 39.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.819 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.755 ' HB ' ' HB3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -100.37 -94.49 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.996 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.475 ' HA ' ' HE2' ' A' ' 174' ' ' MET . 0.2 OUTLIER -133.13 173.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.661 0.267 . . . . 0.0 111.177 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.638 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m-85 -63.88 144.28 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.827 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.09 -174.83 13.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.334 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 mp -126.68 146.54 50.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.55 121.53 1.46 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.183 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.719 HG11 HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -157.75 171.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.744 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -56.76 123.43 14.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.055 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB2' HD23 ' A' ' 44' ' ' LEU . . . -57.24 -65.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.264 -177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 44' ' ' LEU . 4.1 mm? -82.95 40.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.762 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.744 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.38 149.41 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HA ' HG22 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -75.47 -28.76 59.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -65.23 -27.17 68.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.292 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.5 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.071 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.555 HG11 ' HB ' ' A' ' 109' ' ' VAL . 20.5 m -65.53 -28.83 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.219 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 4.8 mtp180 -72.39 -46.98 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.824 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -70.42 -27.09 64.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.733 HD11 HG21 ' A' ' 139' ' ' THR . 2.0 mp -67.12 -34.57 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -69.62 -39.74 77.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.953 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -65.19 -48.58 72.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.95 -40.04 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 5.6 mptt -83.0 -2.16 54.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.961 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.29 -102.78 0.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.326 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 71.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.036 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.02 70.25 70.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.11 -1.58 11.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.503 2.135 . . . . 0.0 112.425 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -121.12 -1.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -82.98 124.63 76.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.999 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.05 160.9 9.49 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.575 2.184 . . . . 0.0 112.431 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.28 148.67 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 t -95.38 149.86 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 111.074 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.0 mt -116.02 157.65 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.846 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.691 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 6.9 t -116.25 119.75 36.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -136.03 171.09 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.993 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -84.59 -38.83 19.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.103 0.477 . . . . 0.0 110.447 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.06 169.52 17.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.398 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.499 HG11 ' HG3' ' A' ' 85' ' ' MET . 22.2 t -59.2 -32.7 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.07 -26.62 66.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.755 ' HB2' HG22 ' A' ' 68' ' ' VAL . 17.8 mm-40 -81.12 -19.9 42.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.296 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.585 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 15.4 tt -114.74 47.49 0.45 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.637 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 21.7 Cg_exo -66.93 -65.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.832 1.688 . . . . 0.0 113.208 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -72.29 4.21 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' HB3' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -108.0 -24.03 11.77 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.571 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -129.31 159.27 36.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.37 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.539 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.57 87.12 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.69 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.35 -163.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.062 2.508 . . . . 0.0 112.83 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.76 -177.67 5.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.5 -77.2 0.73 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.645 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.761 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -56.2 -31.31 63.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.816 0.341 . . . . 0.0 111.066 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 184' ' ' VAL . . . -60.53 -46.07 91.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.119 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.499 ' HG3' HG11 ' A' ' 71' ' ' VAL . 20.2 mmt -71.41 -17.61 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.761 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -63.75 -50.35 69.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.263 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 2.5 tm? -60.58 -37.77 82.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.304 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.9 tpt -66.78 -33.31 75.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.016 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.14 -15.04 61.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.116 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 87' ' ' LEU . 1.2 mtp85 -67.0 -61.98 1.66 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 pt -98.68 57.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.051 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.725 HD12 HG22 ' A' ' 121' ' ' VAL . 3.9 tt -131.03 129.19 22.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.912 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.42 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 6.0 Cg_exo -78.14 -159.97 2.19 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.28 -0.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 156.83 163.04 11.97 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.626 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.755 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 4.6 Cg_exo -78.1 39.49 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.051 2.501 . . . . 0.0 112.371 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -112.3 130.97 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.337 -179.344 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.17 114.9 26.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.3 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.721 HG12 ' HB ' ' A' ' 180' ' ' ILE . 2.0 m -108.87 118.81 57.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.92 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.428 HG13 ' HD3' ' A' ' 116' ' ' ARG . 22.0 t -91.64 131.07 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.218 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 182' ' ' LEU . 0.3 OUTLIER -127.18 178.93 5.71 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.426 0.453 . . . . 0.0 111.121 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.75 176.08 7.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.679 ' HB3' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.05 137.14 53.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.979 0.419 . . . . 0.0 111.36 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.539 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 1.5 t-20 -74.59 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.024 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -75.55 15.8 0.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.477 HD11 ' H ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -69.51 153.98 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.679 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.477 ' H ' HD11 ' A' ' 105' ' ' LEU . 4.7 pt -59.67 109.61 2.1 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.24 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.599 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 59.2 Cg_endo -70.81 1.93 4.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.692 2.261 . . . . 0.0 112.785 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.13 -93.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.762 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.555 ' HB ' HG11 ' A' ' 49' ' ' VAL . 22.6 m -81.78 7.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.428 HG13 HD12 ' A' ' 105' ' ' LEU . 41.3 mm -103.2 -64.93 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 111.317 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.4 p -87.42 -26.97 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.39 -116.67 4.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.727 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.35 -20.2 42.58 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.019 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -104.83 179.8 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.575 0.226 . . . . 0.0 110.845 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -113.45 42.37 1.97 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.428 ' HD3' HG13 ' A' ' 99' ' ' VAL . 0.3 OUTLIER -136.64 156.19 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.352 -179.352 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' A' ' 102' ' ' ARG . 58.8 t -139.51 144.6 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -84.04 160.08 36.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.96 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.511 ' O ' HG21 ' A' ' 98' ' ' VAL . 34.0 mt -149.15 141.14 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -148.91 134.11 18.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.946 0.403 . . . . 0.0 111.566 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.725 HG22 HD12 ' A' ' 92' ' ' LEU . 34.2 t -111.02 81.96 2.92 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.768 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.536 ' HG2' ' OD1' ' A' ' 124' ' ' ASP . 34.9 Cg_endo -64.38 -178.86 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.566 2.177 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.91 -0.98 55.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.72 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.536 ' OD1' ' HG2' ' A' ' 122' ' ' PRO . 0.8 OUTLIER -64.75 105.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 111.034 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.35 -42.88 82.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.437 HG21 HD22 ' A' ' 16' ' ' LEU . 38.5 mm -61.44 -58.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.218 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.65 -19.85 42.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 42.6 ttt-85 -70.11 -35.88 74.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.37 -51.89 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.05 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.38 -51.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -61.17 -29.41 69.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -55.08 -55.27 32.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.422 . . . . 0.0 110.039 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -75.78 -90.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.114 177.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 1.9 m-85 -77.17 127.34 83.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.935 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 23.1 Cg_exo -65.54 154.15 75.03 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 111.555 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 137' ' ' THR . 3.0 t -130.55 156.28 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.637 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 2.1 m -80.41 136.7 36.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.777 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . . . -133.02 108.05 8.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.868 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.733 HG21 HD11 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -127.76 118.54 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.582 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.43 112.17 2.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.982 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.41 81.48 7.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.21 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -156.34 25.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.27 -145.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.09 162.52 2.51 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.866 0.365 . . . . 0.0 111.146 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.441 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 76.04 -144.96 31.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.362 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 7.8 tttt -127.47 63.09 57.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.633 0.254 . . . . 0.0 111.23 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 42.3 Cg_exo -60.65 -48.69 10.38 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.323 2.015 . . . . 0.0 113.336 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.23 132.21 12.39 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.868 1.712 . . . . 0.0 112.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.413 ' CB ' HG21 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -97.16 156.56 36.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.897 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -95.06 -16.59 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.718 2.279 . . . . 0.0 112.382 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.686 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 12.5 ttm180 -141.7 129.13 21.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.319 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -58.07 -31.12 66.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.273 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.594 ' O ' HG13 ' A' ' 156' ' ' VAL . 2.1 tt0 -74.42 -34.74 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.396 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.686 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.6 -42.9 97.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.46 -178.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -74.17 -38.81 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.606 -178.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -53.37 -32.84 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.269 -177.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -75.92 -41.71 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.994 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -22.9 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.652 HD11 ' HA ' ' A' ' 164' ' ' LEU . 3.3 pp -93.22 37.41 1.04 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.101 -0.24 . . . . 0.0 111.643 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 159' ' ' LEU . 27.6 t70 -18.38 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.753 0.658 . . . . 0.0 112.517 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -154.64 7.95 0.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.417 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.442 ' CG1' ' H ' ' A' ' 163' ' ' ASP . 1.3 p -81.37 -80.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.618 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.733 ' HA ' HG21 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -104.64 89.44 3.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.652 ' HA ' HD11 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -57.22 121.18 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.679 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 152' ' ' LEU . 2.3 p -60.24 -170.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.391 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.571 HD12 ' HD2' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -125.95 156.97 38.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.942 -179.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.71 ' HB3' HG22 ' A' ' 15' ' ' VAL . 2.3 t70 -91.77 -26.98 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.8 -59.21 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.797 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.523 ' H ' HD13 ' A' ' 166' ' ' LEU . . . 81.62 49.21 5.53 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.13 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.723 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -70.63 105.73 3.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.337 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -157.54 122.12 4.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.329 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -137.43 -104.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.4 m-20 -85.37 111.71 20.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.475 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 83.9 mmm -65.89 -16.8 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.175 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.97 154.64 39.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -91.67 -149.7 0.33 Allowed 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.681 0.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.0 p -158.27 146.35 18.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.494 HG22 HG13 ' A' ' 180' ' ' ILE . 40.5 m -101.87 145.19 29.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.899 0.38 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.98 96.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.721 ' HB ' HG12 ' A' ' 98' ' ' VAL . 12.5 mt -110.64 135.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.395 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.92 65.43 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.068 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.469 ' O ' HD13 ' A' ' 100' ' ' LEU . 18.6 tp -70.14 82.63 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.397 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.34 -75.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.336 . . . . 0.0 110.433 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.454 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 5.0 t -120.58 -120.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.562 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.1 m-80 -67.4 -52.83 26.4 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.0 109.05 2.26 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.38 2.053 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.3 Cg_endo -82.91 123.83 3.73 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.529 2.152 . . . . 0.0 112.162 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -88.01 54.4 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.598 ' HA ' HG23 ' A' ' 180' ' ' ILE . 11.6 t -57.56 104.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.904 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.39 89.9 2.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.074 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -86.95 141.01 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 192' ' ' ARG . 0.8 OUTLIER -79.0 -21.19 47.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -92.07 -153.4 29.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.532 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.3 128.69 55.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.822 0.344 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -74.63 164.64 54.65 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.512 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.729 ' HG2' HD23 ' A' ' 197' ' ' LEU . 59.7 Cg_endo -72.78 -6.31 18.79 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.569 2.179 . . . . 0.0 112.36 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.729 HD23 ' HG2' ' A' ' 196' ' ' PRO . 0.6 OUTLIER -149.22 29.06 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.511 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -77.64 -50.9 1.93 Allowed Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.415 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 198' ' ' ASP . 50.6 Cg_endo -68.27 -46.45 2.13 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.213 1.942 . . . . 0.0 112.503 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 202' ' ' LEU . 14.7 p -69.18 142.25 16.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.076 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.18 35.57 4.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 200' ' ' VAL . 0.1 OUTLIER -78.06 -71.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.055 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -82.3 178.77 8.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.081 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -164.15 150.85 19.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.527 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -80.95 112.31 18.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.7 0.286 . . . . 0.0 111.107 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 154.12 85.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.468 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.27 26.39 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 0.0 110.951 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.086 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.805 0.336 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.544 HD13 ' HE ' ' A' ' 4' ' ' ARG . 1.1 mt -104.65 -175.58 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 tp -79.75 -6.78 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.544 ' HE ' HD13 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -75.07 161.76 29.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.859 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 153.74 37.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.923 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 pt -84.56 -30.03 7.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.222 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -71.99 173.46 8.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.015 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.43 150.84 28.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.003 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -77.59 149.24 34.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.606 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -110.0 94.83 18.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.215 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 -45.05 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.386 2.057 . . . . 0.0 112.06 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 53.27 70.78 1.64 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.176 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.649 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 19.0 Cg_exo -65.6 142.48 71.19 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.559 2.173 . . . . 0.0 112.008 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 4.4 m-20 -74.24 -38.68 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -69.66 -26.5 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 mm? -70.87 -52.27 21.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -64.82 -20.06 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -67.65 -47.46 69.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.18 82.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.222 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 16' ' ' LEU . 28.2 mm -67.92 -33.26 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.81 -30.71 70.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.974 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.78 HG22 ' HG ' ' A' ' 164' ' ' LEU . 11.7 t -72.68 -33.38 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.5 mmt -64.03 -50.15 69.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.025 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.02 -17.57 64.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.252 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 0.91 84.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.2 35.02 90.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.59 165.06 12.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.663 ' HA ' HG21 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -96.19 146.59 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.511 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.15 129.87 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.701 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -102.42 163.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.677 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.432 ' HH ' ' HB2' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -163.68 88.42 1.19 Allowed Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.574 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 94.5 Cg_endo -78.22 119.94 4.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.498 2.132 . . . . 0.0 110.749 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.847 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 0.6 OUTLIER -116.46 -139.17 0.37 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.04 0.448 . . . . 0.0 111.961 -176.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB3' ' HG3' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -53.62 -47.77 69.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.52 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -79.0 -119.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.741 HG12 ' H ' ' A' ' 37' ' ' TYR . 8.3 tt -112.36 -168.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.282 -0.261 . . . . 0.0 110.846 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.741 ' H ' HG12 ' A' ' 36' ' ' ILE . 4.1 m-85 -63.43 127.89 33.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 110.353 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.43 170.58 13.34 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.368 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -120.12 139.58 52.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.657 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.36 117.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.869 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 28' ' ' ILE . 2.0 p -158.36 174.63 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.708 0.29 . . . . 0.0 111.331 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.799 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.22 114.36 1.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.653 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.48 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -66.17 -49.75 66.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.038 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 44' ' ' LEU . 1.2 mm? -80.97 28.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 111.564 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.799 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -111.02 152.23 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.71 178.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -75.36 -29.0 59.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.835 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -28.79 68.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.039 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.59 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.779 ' HA ' HD22 ' A' ' 52' ' ' LEU . 56.5 t -70.12 -48.67 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.135 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.32 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.245 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.98 -55.78 8.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.276 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.779 HD22 ' HA ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -60.13 -17.51 40.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.335 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -51.96 13.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.025 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -59.19 -38.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.218 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -70.71 -58.2 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -83.54 -76.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.18 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.03 27.68 51.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.55 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -108.48 -47.26 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 16.7 m -135.42 82.43 40.29 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.21 -3.39 10.7 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.812 2.342 . . . . 0.0 112.662 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -109.01 -19.94 13.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.246 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -68.0 147.39 98.44 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.487 ' HG3' ' HG ' ' A' ' 114' ' ' SER . 50.1 Cg_exo -53.47 158.64 7.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.52 2.147 . . . . 0.0 112.324 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 110' ' ' ILE . 9.0 p -112.8 153.54 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 136.0 34.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 12.0 mm -113.92 148.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.259 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.4 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -108.4 127.64 54.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.767 HG23 HG21 ' A' ' 74' ' ' ILE . 1.5 p -141.96 179.99 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.589 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.891 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 12.5 t -86.32 -41.35 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 0.0 110.529 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.4 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -164.14 169.22 18.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.88 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' HA ' ' CD1' ' A' ' 74' ' ' ILE . 16.2 t -57.17 -34.61 45.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.29 -26.87 66.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.067 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.891 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 80.9 mm-40 -77.46 -20.02 55.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.767 HG21 HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.31 61.42 0.8 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.812 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 77' ' ' PHE . 37.1 Cg_endo -65.81 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.149 1.899 . . . . 0.0 112.421 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -73.02 16.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.976 -179.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CE1' HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -105.3 -49.53 3.43 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.135 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -126.4 165.38 19.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -113.0 96.97 40.58 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -102.29 -179.12 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.112 2.542 . . . . 0.0 112.567 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.443 ' HB3' ' CB ' ' A' ' 84' ' ' ALA . 47.4 t -133.59 169.96 16.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.45 -77.29 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.839 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.559 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -57.51 -29.62 64.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 81' ' ' SER . . . -61.44 -45.84 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.427 ' HE2' HD23 ' A' ' 100' ' ' LEU . 17.7 mmt -74.41 -11.65 60.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.334 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.559 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 4.4 mt-10 -72.43 -49.92 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.872 0.368 . . . . 0.0 110.603 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 8.3 tp -63.18 -36.37 83.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.949 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.828 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 3.7 tpt -70.67 -51.21 29.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.92 -14.98 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.465 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.98 -34.14 77.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 pt -115.04 52.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.46 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -131.03 140.56 39.05 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.75 -163.96 3.72 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.625 -1.406 . . . . 0.0 112.37 -1.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.85 166.39 15.2 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.625 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.495 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 5.7 Cg_exo -78.23 35.34 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.057 2.504 . . . . 0.0 112.043 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.531 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 25.0 p90 -99.0 164.86 12.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.969 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.707 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 36.8 m -115.29 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.698 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.828 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 1.7 p -123.6 104.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.444 . . . . 0.0 110.955 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 15.4 t -101.47 129.92 51.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.86 -175.11 3.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.595 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -178.79 3.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.747 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.76 141.27 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.969 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -74.28 -174.17 1.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 104' ' ' GLU . 2.5 pt-20 -76.56 43.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.491 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.406 HD21 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -73.97 146.16 44.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.804 0.335 . . . . 0.0 110.973 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.559 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.2 mp -80.02 -50.28 1.2 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 77.7 Cg_exo -51.07 100.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.186 1.924 . . . . 0.0 112.461 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.661 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.3 OUTLIER -82.38 1.98 34.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.407 HG21 HG23 ' A' ' 49' ' ' VAL . 9.0 p -80.92 -23.88 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.065 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.504 ' O ' HG12 ' A' ' 64' ' ' VAL . 15.0 pt -96.87 -39.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.151 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 108' ' ' ASP . 12.9 t -76.8 -15.51 59.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.953 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.24 -171.5 42.94 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.635 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -71.02 -6.67 60.83 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.487 ' HG ' ' HG3' ' A' ' 63' ' ' PRO . 4.2 p -106.24 -176.57 3.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.3 m -111.57 40.31 2.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -139.02 150.43 45.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 102' ' ' ARG . 93.0 t -139.7 144.56 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.497 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.569 ' HA2' HG11 ' A' ' 99' ' ' VAL . . . -91.77 158.3 25.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 120' ' ' ARG . 43.7 mt -145.82 151.16 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 97' ' ' THR . 13.3 mtp180 -147.67 134.06 19.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.617 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.8 87.26 6.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.551 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.55 -176.33 2.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.555 2.17 . . . . 0.0 112.586 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 11.55 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 13.4 t0 -76.83 97.89 4.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -47.92 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.09 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.2 mm -61.06 -50.98 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.027 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 6.9 t -61.35 -23.74 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 69' ' ' SER . 9.2 ttm180 -67.04 -31.85 72.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.591 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtt85 -75.09 -56.19 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.1 -50.9 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.371 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 127' ' ' CYS . . . -63.22 -26.96 69.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.391 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.58 -56.51 18.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 109.989 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -75.86 -86.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.998 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -76.59 125.56 87.21 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.717 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.45 147.19 82.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.283 1.988 . . . . 0.0 111.949 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 41' ' ' VAL . 3.1 t -120.52 155.1 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.209 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.657 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 11.3 m -80.22 133.84 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.228 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.71 104.97 7.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -134.15 161.18 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.3 m -76.87 123.33 26.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.789 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.87 136.0 53.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -163.37 51.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.823 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.455 ' O ' ' HG3' ' A' ' 147' ' ' PRO . 13.6 mm -60.96 154.14 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 m -54.04 142.67 24.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.993 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.06 -109.28 3.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.462 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.45 94.92 41.93 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.25 . . . . 0.0 110.948 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 45.0 Cg_exo -60.26 -48.7 11.08 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.58 2.187 . . . . 0.0 113.281 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 24.0 Cg_exo -64.27 113.07 2.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.932 1.755 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -97.1 137.9 21.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 64.6 Cg_endo -96.09 -12.35 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.885 2.39 . . . . 0.0 112.983 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -133.05 134.85 44.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.551 HD23 HG22 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -67.0 -43.13 83.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.817 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.04 -18.0 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 158' ' ' ASP . 4.4 tt0 -73.44 -37.03 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 165' ' ' VAL . 6.1 mt -70.59 -46.4 70.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.593 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.58 -36.66 78.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.956 0.407 . . . . 0.0 111.403 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -75.61 -49.03 19.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.095 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -72.64 -41.96 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.302 . . . . 0.0 111.694 -177.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.611 HD22 HG22 ' A' ' 155' ' ' ILE . 2.9 mm? -93.77 72.28 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' A' ' 159' ' ' LEU . 11.3 t70 -15.97 -66.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.057 0.848 . . . . 0.0 112.925 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.14 25.94 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.281 . . . . 0.0 111.43 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.661 HG11 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.83 -67.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.661 ' H ' HG11 ' A' ' 162' ' ' VAL . 1.5 p-10 -111.12 94.19 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.413 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.78 ' HG ' HG22 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -60.01 127.76 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.608 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.72 HG21 ' H ' ' A' ' 166' ' ' LEU . 3.4 p -60.79 176.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.039 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.72 ' H ' HG21 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.79 125.54 41.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.135 0.493 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -4.34 52.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.67 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.432 ' HB2' ' HH ' ' A' ' 31' ' ' TYR . . . -63.39 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 84.71 65.62 1.49 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.996 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.847 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 5.6 m-20 -72.88 -116.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.73 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -149.89 -171.67 3.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.635 0.255 . . . . 0.0 111.112 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 9.11 1.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.4 94.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.42 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.73 -15.44 0.72 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 150.69 64.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.538 0.209 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.42 -160.87 2.41 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.663 0.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.0 t -160.9 112.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 3.4 m -102.16 136.18 42.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.707 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -128.93 98.9 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.795 HG22 HG22 ' A' ' 189' ' ' VAL . 36.9 mt -116.49 132.51 65.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.511 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.711 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -108.3 64.41 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 178.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 18.2 tp -69.91 100.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.533 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.42 -85.63 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.352 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.75 -94.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.213 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.522 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 23.0 t-20 -82.78 -53.15 0.63 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 85.5 Cg_endo -77.75 107.08 2.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.244 1.963 . . . . 0.0 112.231 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 86.9 Cg_endo -82.16 130.71 6.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.508 2.139 . . . . 0.0 112.367 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -90.42 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.982 0.42 . . . . 0.0 110.547 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.795 HG22 HG22 ' A' ' 180' ' ' ILE . 94.3 t -56.44 101.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.12 86.62 2.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.008 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -83.92 143.93 29.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.994 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -160.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.964 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.56 135.88 16.13 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.53 -52.64 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 0.0 110.852 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.04 121.16 8.29 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.433 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.57 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.438 2.092 . . . . 0.0 112.407 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.88 -50.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.973 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.55 124.33 82.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.04 -35.38 14.89 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.438 2.092 . . . . 0.0 112.316 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.3 t -66.31 117.93 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.91 27.93 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.03 -64.49 1.04 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.949 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -79.08 146.18 33.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -126.34 104.1 0.71 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.48 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -106.94 137.03 45.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 111.172 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -132.92 -46.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.421 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -89.02 -53.39 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.795 0.331 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.128 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.789 0.328 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.2 mt -73.38 -82.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.02 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 mm -96.61 145.37 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.194 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.22 127.64 43.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -86.99 -169.48 2.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 tt -88.26 140.31 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.028 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -69.95 115.99 9.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.38 125.76 51.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.15 109.27 5.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.023 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -108.01 117.13 55.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.421 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 52.6 Cg_exo -55.63 152.68 32.98 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.561 2.174 . . . . 0.0 112.188 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -86.33 110.42 31.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.02 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 11' ' ' PRO . 50.3 Cg_exo -53.81 153.69 18.91 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.49 2.127 . . . . 0.0 112.291 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.27 -48.47 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.14 -33.75 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -63.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.193 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.79 -20.01 60.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.276 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.02 -46.5 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.06 94.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.282 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' MET . 2.0 mp -72.26 -29.12 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -54.56 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.253 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.649 HG23 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.93 -26.79 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.571 ' HE2' ' HA ' ' A' ' 41' ' ' VAL . 10.8 mmt -56.56 -44.59 81.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -19.66 61.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.9 -0.43 64.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.694 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.52 27.23 71.52 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.36 170.75 13.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.676 HD12 ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -96.36 153.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.531 ' N ' HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.32 151.13 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 111.447 -178.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -108.3 154.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.22 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.79 106.93 0.45 Allowed Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.651 ' HD3' HD13 ' A' ' 166' ' ' LEU . 1.4 Cg_endo -84.55 162.59 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.292 2.661 . . . . 0.0 112.136 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -137.33 -150.34 0.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.637 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.765 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 5.9 m-20 -60.16 -20.36 58.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.725 0.297 . . . . 0.0 111.148 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 95' ' ' PRO . 7.9 p -100.18 -112.31 0.18 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.806 HG13 ' HE1' ' A' ' 174' ' ' MET . 1.3 tt -111.82 -179.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.665 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -84.2 128.89 34.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.197 0.522 . . . . 0.0 110.686 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -118.75 -167.98 14.03 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.676 ' HB3' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.799 0.333 . . . . 0.0 110.5 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -144.26 136.1 6.57 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.987 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.571 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 1.4 p -172.28 -169.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.792 -0.204 . . . . 0.0 110.743 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.8 t-20 -56.33 103.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.003 0.43 . . . . 0.0 110.327 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.84 -39.23 91.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.017 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.99 24.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.441 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.85 155.16 22.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.775 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -75.23 -21.74 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -72.89 -23.23 60.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.629 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.34 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 46' ' ' GLU . 11.5 p -72.27 -30.25 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.816 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -41.76 61.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -64.44 -44.38 91.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.52 -40.69 95.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.13 -28.54 69.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.005 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -64.26 -45.72 86.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.247 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 t -72.51 -51.25 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.03 -78.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.86 7.41 16.14 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.851 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -118.35 11.8 13.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.721 0.296 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.61 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 1.6 m -147.11 65.35 9.56 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.104 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 59' ' ' SER . 8.9 Cg_exo -72.8 -2.63 12.21 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.728 2.286 . . . . 0.0 112.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -112.61 -24.33 9.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.2 OUTLIER -68.47 148.67 98.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 177.35 3.12 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.515 2.144 . . . . 0.0 112.344 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.599 HG13 HD13 ' A' ' 66' ' ' ILE . 14.6 p -112.92 149.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.798 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 134.27 35.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.599 HD13 HG13 ' A' ' 64' ' ' VAL . 4.1 mm -116.12 160.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.056 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 9.9 t -122.62 137.63 54.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.726 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.717 HG13 HG12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -139.35 -176.2 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.484 ' N ' HG11 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -73.3 -50.03 24.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.709 179.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.469 ' N ' HG11 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -164.71 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.265 0.555 . . . . 0.0 111.797 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.58 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 16.8 t -52.83 -22.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.85 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 2.2 t70 -67.92 -52.78 32.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.76 13.77 3.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.658 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.717 HG12 HG13 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.17 -42.88 0.41 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 72' ' ' ASP . 76.9 Cg_exo -51.62 -17.42 4.75 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.244 1.963 . . . . 0.0 112.935 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -72.2 -39.01 68.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.433 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 23.7 m-85 -97.44 -35.71 10.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.516 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 88.8 p -116.24 -173.81 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.957 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.39 100.7 28.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HA ' HD23 ' A' ' 100' ' ' LEU . 92.3 Cg_endo -102.74 -170.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.211 2.608 . . . . 0.0 112.677 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.5 ' H ' ' HE2' ' A' ' 85' ' ' MET . 0.3 OUTLIER -126.98 177.09 6.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.22 -88.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.857 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -55.72 -27.48 50.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.128 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.43 -44.12 97.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.918 0.39 . . . . 0.0 110.932 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.5 ' HE2' ' H ' ' A' ' 81' ' ' SER . 6.6 mmt -73.94 -16.13 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.307 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 mt-10 -67.44 -51.27 53.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.591 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.6 tp -62.61 -32.4 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.666 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.584 ' HG3' HD12 ' A' ' 92' ' ' LEU . 6.0 tpt -70.15 -48.12 58.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -65.42 -11.42 42.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.7 tpt180 -72.95 -31.08 64.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.09 32.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.474 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.584 HD12 ' HG3' ' A' ' 88' ' ' MET . 4.4 mt -131.11 152.93 81.5 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.815 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.94 -172.65 11.55 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.555 -1.435 . . . . 0.0 112.512 0.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.55 -177.81 31.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.687 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.765 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 87.8 Cg_endo -81.03 43.45 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.751 2.301 . . . . 0.0 112.239 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.52 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 5.6 m-85 -111.43 136.28 50.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 m -94.92 120.93 35.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.344 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.465 HG11 ' HG2' ' A' ' 88' ' ' MET . 3.2 t -108.86 116.52 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.675 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 3.5 t -104.1 127.47 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 80' ' ' PRO . 1.6 mt -126.87 -169.37 2.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.969 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -172.63 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.648 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.685 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.9 142.53 47.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 1.3 t-20 -74.38 -172.37 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.207 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -75.82 12.83 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.48 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 106' ' ' ILE . 1.0 OUTLIER -69.73 -172.93 0.55 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.807 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.655 ' H ' HD22 ' A' ' 105' ' ' LEU . 1.2 mt -80.25 105.12 3.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.128 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 65.9 Cg_endo -71.43 2.8 4.11 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.585 2.19 . . . . 0.0 112.611 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.82 -88.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.075 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 p -84.77 -0.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.0 mt -96.8 -63.59 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.648 0.261 . . . . 0.0 111.379 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.446 HG21 ' HA ' ' A' ' 107' ' ' PRO . 4.4 p -87.18 -23.75 24.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.59 -130.14 20.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.553 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.41 11.68 60.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.698 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -119.1 169.45 9.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.707 0.289 . . . . 0.0 111.035 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 39.8 m -113.44 31.95 6.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -136.6 166.58 23.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.685 HG23 ' HB2' ' A' ' 102' ' ' ARG . 77.2 t -139.93 142.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.479 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.65 155.75 41.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.366 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.593 HG22 HG13 ' A' ' 74' ' ' ILE . 8.4 mt -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.604 0.24 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.518 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER -146.1 127.34 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.387 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.37 80.13 2.47 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.597 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.595 ' HB3' HG23 ' A' ' 33' ' ' THR . 20.2 Cg_exo -66.6 179.08 2.28 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.505 2.137 . . . . 0.0 112.713 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.69 -0.9 55.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.2 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 83.5 m-20 -61.98 109.1 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.155 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.43 -56.59 19.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.438 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 126' ' ' ILE . 36.6 mm -58.66 -50.79 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.7 OUTLIER -63.06 -17.24 62.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -75.14 -38.48 60.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -45.01 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.05 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.8 mm -62.91 -46.15 97.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 127' ' ' CYS . . . -64.38 -28.4 69.67 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.898 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 69' ' ' SER . . . -54.79 -55.0 34.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.041 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -75.48 -88.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.174 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -77.2 138.55 64.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.88 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.56 146.94 62.99 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.36 2.04 . . . . 0.0 111.849 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.31 133.32 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.47 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.703 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.2 m -67.35 141.47 57.1 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 67' ' ' CYS . . . -140.06 104.53 4.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.856 0.36 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.61 125.47 15.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.702 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.587 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -61.18 135.85 57.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.872 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.95 137.19 37.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.859 0.361 . . . . 0.0 111.171 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -159.41 49.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.67 HG13 ' H ' ' A' ' 144' ' ' SER . 5.3 tp -68.22 166.84 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.99 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.67 ' H ' HG13 ' A' ' 143' ' ' ILE . 2.3 m -55.01 155.64 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.971 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.25 -124.38 7.44 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.407 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.04 90.3 50.85 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.638 0.256 . . . . 0.0 110.932 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.52 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 48.0 Cg_exo -60.23 -43.65 33.78 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.653 2.235 . . . . 0.0 113.866 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.46 94.98 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.847 1.698 . . . . 0.0 112.419 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.6 128.49 69.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.748 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -95.95 -8.24 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.886 2.39 . . . . 0.0 112.951 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -129.19 120.12 25.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.493 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.697 ' HG ' HG22 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -60.05 -36.31 77.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.518 178.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 156' ' ' VAL . 0.0 OUTLIER -71.47 -23.83 61.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.647 179.084 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -36.87 84.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.974 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.703 HD12 HG23 ' A' ' 165' ' ' VAL . 55.0 mt -68.77 -55.15 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.591 HG13 HG13 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -60.38 -32.51 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.46 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -75.67 -54.99 6.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.39 -24.08 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.585 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.53 ' HG ' ' OD2' ' A' ' 163' ' ' ASP . 3.2 mm? -111.25 70.69 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.818 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 16.4 t0 -15.94 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 124.049 0.843 . . . . 0.0 112.823 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -156.85 25.5 0.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.7 0.285 . . . . 0.0 111.469 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.61 -69.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.573 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.707 ' HB2' HD12 ' A' ' 30' ' ' ILE . 2.0 p-10 -111.29 102.65 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.488 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.649 ' HB2' HG23 ' A' ' 22' ' ' VAL . 3.2 mm? -71.45 131.52 43.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.703 HG23 HD12 ' A' ' 155' ' ' ILE . 2.0 p -62.98 -163.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.879 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.8 HD23 ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.1 160.81 29.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 111.124 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.87 -25.8 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.68 -56.29 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.472 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.8 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 102.24 -163.28 16.86 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.792 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.63 ' HA ' ' HB2' ' A' ' 32' ' ' PRO . 7.2 p-10 -70.89 -164.72 0.1 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.829 0.347 . . . . 0.0 111.124 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.51 -57.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.563 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.505 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -124.17 -134.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.505 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.15 146.4 26.6 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.794 0.331 . . . . 0.0 111.841 -177.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.806 ' HE1' HG13 ' A' ' 36' ' ' ILE . 71.0 mmm -62.98 -27.47 69.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.71 154.28 47.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.655 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -91.39 -149.36 0.33 Allowed 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.867 -1.305 . . . . 0.0 112.67 1.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.553 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.82 158.29 39.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.52 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.2 m -102.27 139.0 38.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.1 t -129.1 88.8 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.048 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 189' ' ' VAL . 13.0 mt -108.87 129.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.373 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.675 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.55 66.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.414 178.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 187' ' ' PRO . 53.4 tp -69.71 93.67 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.318 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.51 -81.7 0.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.409 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 12.2 t -120.84 -115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.046 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.5 m-20 -66.41 -52.69 35.11 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 185' ' ' ASN . 3.5 Cg_exo -77.22 108.04 2.54 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.497 2.131 . . . . 0.0 112.093 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.4 Cg_endo -81.49 133.38 8.36 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.451 2.101 . . . . 0.0 112.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 188' ' ' ARG . 5.8 mtt180 -91.92 51.12 1.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.545 ' HA ' HG12 ' A' ' 180' ' ' ILE . 6.3 t -58.64 100.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 tp -126.54 86.64 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.426 ' NH1' HG12 ' A' ' 189' ' ' VAL . 8.5 ptt-85 -87.06 161.62 18.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.824 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' A' ' 193' ' ' GLY . 0.2 OUTLIER -64.69 169.52 4.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.869 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 192' ' ' ARG . . . -85.2 80.63 1.8 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.592 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.458 ' HB3' ' H ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -109.82 -87.8 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.724 0.297 . . . . 0.0 110.789 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.458 ' H ' ' HB3' ' A' ' 194' ' ' LYS . . . -90.09 134.71 12.51 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.305 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 197' ' ' LEU . 24.3 Cg_exo -63.01 -82.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.539 2.159 . . . . 0.0 112.133 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.413 ' H ' ' HB2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -157.21 -85.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.808 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 145.0 59.37 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.924 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.22 131.05 40.88 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.541 2.161 . . . . 0.0 112.083 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.58 137.83 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.043 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.6 mt -105.82 43.0 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.015 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.93 -172.62 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.7 8.86 29.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.94 49.57 2.25 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.546 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -104.72 -51.65 3.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 111.091 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -135.11 85.72 0.26 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.422 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.46 -69.81 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.984 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.091 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.423 ' H3 ' ' HG2' ' A' ' 1' ' ' MET . 1.7 ptm . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.12 176.3 5.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.436 ' HB ' ' HD3' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -71.39 121.85 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.013 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.08 35.9 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.982 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -98.72 159.59 14.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.021 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 tt -82.84 134.45 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -70.45 -82.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.075 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.72 151.57 26.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.89 103.09 3.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.821 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.13 -51.49 0.78 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.444 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.12 -71.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.149 1.9 . . . . 0.0 112.177 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m 56.43 79.15 0.34 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 38.1 Cg_exo -57.42 158.3 19.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.662 2.242 . . . . 0.0 112.287 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.71 -39.88 66.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.28 -22.78 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.074 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.31 -43.62 66.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -75.23 -28.54 59.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.626 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.07 -38.9 69.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 111.018 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.626 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -74.08 -36.32 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.75 -30.0 48.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -68.84 -48.33 63.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.808 HG21 ' HG ' ' A' ' 164' ' ' LEU . 7.5 p -72.3 -21.8 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.412 ' N ' HG13 ' A' ' 22' ' ' VAL . 0.8 OUTLIER -60.85 -48.4 81.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.809 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.37 -13.52 62.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.098 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.53 -2.87 76.57 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.453 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.29 53.84 33.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.552 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.37 161.6 23.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.516 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 163' ' ' ASP . 1.4 tp -90.89 136.05 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 110.568 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.74 140.96 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.958 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -101.99 150.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.053 178.763 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' HA ' ' HG ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -165.99 107.04 0.72 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 96.7 Cg_endo -84.26 159.29 13.13 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.763 2.309 . . . . 0.0 111.837 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -135.32 -149.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -54.81 -20.6 8.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.28 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 t -100.17 -117.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.651 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -157.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.117 0 O-C-N 122.198 -0.314 . . . . 0.0 111.202 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.608 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 3.9 m-85 -68.62 132.11 46.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.26 -176.76 15.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.265 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.673 HD12 HD12 ' A' ' 30' ' ' ILE . 1.7 mp -131.93 142.94 49.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.88 0.372 . . . . 0.0 111.172 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.89 115.46 0.82 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.595 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 42' ' ' ASN . 2.4 p -153.96 150.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.802 0.334 . . . . 0.0 111.067 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.571 ' N ' HG23 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -55.87 104.65 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.397 . . . . 0.0 110.574 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -65.4 -34.53 78.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.942 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 44' ' ' LEU . 4.4 mm? -76.7 13.92 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.946 0.403 . . . . 0.0 111.151 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -110.48 156.25 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.893 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -69.72 -25.22 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 31.1 t70 -66.5 -21.18 66.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.09 -38.14 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 50' ' ' ARG . 14.6 p -74.25 -35.86 41.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.778 0.323 . . . . 0.0 110.829 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.465 ' N ' HG12 ' A' ' 49' ' ' VAL . 1.1 ttp85 -69.89 -44.21 70.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.487 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.613 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.54 -37.43 84.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.453 179.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.613 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -60.05 -30.85 69.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.898 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.2 -32.01 66.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.762 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmt-85 -68.8 -48.71 62.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.547 HG13 HG13 ' A' ' 143' ' ' ILE . 29.7 t -75.05 -51.01 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.4 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.56 -67.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.296 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.06 33.03 82.48 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.446 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -100.4 -81.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 110.959 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 m -149.25 146.14 20.65 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.91 2.13 7.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.584 2.189 . . . . 0.0 112.489 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -1.55 26.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.099 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.77 145.29 50.04 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 158.28 54.6 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.517 2.145 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 m -117.04 163.21 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.6 136.6 46.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.623 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.27 168.32 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 8.3 t -122.57 133.35 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.949 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 74' ' ' ILE . 1.1 p -143.39 179.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.577 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -89.3 -42.99 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.931 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.3 t -164.21 170.21 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.089 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.537 ' HA ' HD11 ' A' ' 74' ' ' ILE . 6.8 t -56.94 -34.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.662 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -67.28 -29.84 69.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.936 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.601 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 58.8 mm-40 -73.53 -19.84 60.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 71' ' ' VAL . 0.4 OUTLIER -113.39 60.82 0.8 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.034 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.601 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 44.1 Cg_exo -56.08 -92.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.972 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.434 ' H ' ' HB2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -73.64 22.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.234 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 3.3 m-85 -92.89 -51.95 4.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -128.19 170.51 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.793 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.05 109.21 24.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HA ' HD22 ' A' ' 100' ' ' LEU . 81.1 Cg_endo -102.22 -169.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.108 2.539 . . . . 0.0 112.475 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.618 ' O ' ' HB3' ' A' ' 85' ' ' MET . 0.5 OUTLIER -127.61 170.26 12.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.009 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.85 -111.23 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.933 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -25.53 35.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 0.0 110.985 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 185' ' ' ASN . . . -59.97 -53.63 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.712 ' HE3' HG22 ' A' ' 98' ' ' VAL . 1.6 tpp -73.76 -24.16 59.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.098 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -55.55 -40.37 71.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -67.6 -40.54 84.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 178.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.83 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 12.0 tpt -61.69 -50.07 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.441 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' O ' HD21 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.83 -6.26 46.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.529 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.574 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.2 ttm180 -67.29 -24.88 65.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 pt -111.07 49.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.407 HD21 ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -128.05 150.37 73.54 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.18 179.06 32.11 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.392 0.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.15 174.34 26.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.72 39.91 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.671 2.248 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.446 ' HD2' HG22 ' A' ' 178' ' ' THR . 55.4 m-85 -98.74 138.43 35.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 7.7 m -97.92 141.45 30.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.654 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.83 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 2.5 p -126.18 99.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.18 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 65.3 t -96.7 117.13 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.63 HD21 HD13 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -126.12 -166.3 1.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.63 178.32 5.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.621 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.704 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -120.1 143.6 48.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.659 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -71.94 -170.56 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.19 -178.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.28 35.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.646 HD23 ' HD2' ' A' ' 107' ' ' PRO . 1.9 mt -69.86 146.3 51.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.852 0.358 . . . . 0.0 110.816 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 36.8 mm -80.1 -49.15 1.27 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.9 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.646 ' HD2' HD23 ' A' ' 105' ' ' LEU . 72.7 Cg_exo -50.22 94.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.482 2.121 . . . . 0.0 112.857 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.687 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.5 OUTLIER -82.45 -3.47 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.7 179.227 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 t -74.2 -24.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.292 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pt -98.27 -42.23 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.687 HG23 ' HA ' ' A' ' 108' ' ' ASP . 14.5 t -75.8 -14.54 60.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.814 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.8 -151.72 37.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.657 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.33 -26.4 57.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 m -106.29 175.54 5.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 111.001 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.49 67.65 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -142.12 131.49 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.704 HG23 ' HB2' ' A' ' 102' ' ' ARG . 59.8 t -139.85 140.89 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.786 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -98.95 162.4 20.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.384 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.444 ' HB ' HG12 ' A' ' 98' ' ' VAL . 10.3 mt -141.8 164.31 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.8 127.15 11.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 t -110.4 88.55 7.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.528 ' HB2' HG21 ' A' ' 33' ' ' THR . 78.6 Cg_endo -76.97 -179.35 5.34 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.59 2.193 . . . . 0.0 112.533 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.43 5.45 51.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -72.4 108.29 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -57.29 -43.05 82.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 130' ' ' ILE . 31.2 mm -64.16 -53.62 41.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -62.88 -17.68 61.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.883 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.535 ' HG2' ' HG ' ' A' ' 69' ' ' SER . 7.6 ttt180 -75.49 -44.68 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -54.61 11.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.531 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.0 tt -57.31 -43.08 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.552 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 127' ' ' CYS . . . -71.36 -25.8 62.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.418 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.55 -58.05 8.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.013 0.435 . . . . 0.0 109.88 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -83.28 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.243 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.62 114.48 39.08 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.62 144.39 72.15 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.368 2.045 . . . . 0.0 111.565 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 41' ' ' VAL . 1.6 t -127.65 161.99 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.845 0.355 . . . . 0.0 111.267 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.47 139.26 36.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.063 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -131.07 107.48 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.381 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -132.75 141.41 48.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.54 ' HB2' HD22 ' A' ' 142' ' ' ASN . 10.9 p -80.72 115.74 20.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.86 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -83.51 90.21 7.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.54 HD22 ' HB2' ' A' ' 140' ' ' SER . 0.8 OUTLIER -162.07 33.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.942 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.557 ' N ' ' HG2' ' A' ' 147' ' ' PRO . 0.4 OUTLIER -81.13 -154.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.07 155.6 6.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.741 0.305 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 82.1 -142.1 22.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.244 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.14 67.46 70.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.547 0.213 . . . . 0.0 111.114 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.557 ' HG2' ' N ' ' A' ' 143' ' ' ILE . 38.9 Cg_exo -60.29 -48.42 11.8 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.265 1.977 . . . . 0.0 113.172 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.6 Cg_exo -64.74 104.19 0.53 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.932 1.754 . . . . 0.0 111.862 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.7 t -77.08 149.54 79.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.211 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -95.21 -18.73 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.81 2.34 . . . . 0.0 112.403 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.64 141.41 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.494 HD21 ' O ' ' A' ' 166' ' ' LEU . 49.7 mt -64.47 -43.95 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.72 -17.18 63.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -75.06 -39.97 60.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.12 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.3 -56.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.201 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.409 HG12 ' HB ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -55.84 -40.86 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.32 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -65.41 -50.48 65.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.666 ' HB3' HD21 ' A' ' 159' ' ' LEU . 8.0 t0 -63.68 -35.17 79.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.823 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -110.88 75.32 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t0 -15.95 -64.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.117 0.886 . . . . 0.0 112.85 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -150.97 11.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.685 0.279 . . . . 0.0 111.35 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.823 HG13 ' HB3' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -81.15 -62.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.831 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.597 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 1.4 t0 -103.03 97.13 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.808 ' HG ' HG21 ' A' ' 22' ' ' VAL . 2.8 mm? -74.49 129.13 37.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.557 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.486 HG23 HD23 ' A' ' 152' ' ' LEU . 2.4 p -66.31 -179.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.306 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.509 ' C ' HD21 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.31 147.33 49.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.484 179.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.9 -26.8 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.951 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.64 -54.08 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.88 0.372 . . . . 0.0 111.343 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 98.24 -165.64 21.76 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.945 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -71.94 -165.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.415 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -141.68 -51.74 0.42 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.322 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -132.33 -135.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 175' ' ' GLU . 4.4 t0 -86.57 154.81 20.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.778 0.323 . . . . 0.0 111.667 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.509 ' O ' HG12 ' A' ' 36' ' ' ILE . 19.3 ptm -70.9 17.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.434 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 173' ' ' ASP . 1.5 mt-10 -155.35 157.86 31.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.563 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -95.67 -151.89 0.28 Allowed 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.185 -1.173 . . . . 0.0 112.662 1.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.55 96.74 1.93 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 191' ' ' ARG . 97.0 m -100.97 135.51 42.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.231 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.517 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 21.0 t -127.64 104.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.804 HG23 HG21 ' A' ' 189' ' ' VAL . 36.9 mt -109.11 127.71 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.462 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.2 m-20 -89.35 74.71 7.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.303 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.693 ' HG ' ' HE2' ' A' ' 85' ' ' MET . 0.8 OUTLIER -68.51 79.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -84.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.507 ' HA ' ' HG ' ' A' ' 81' ' ' SER . 3.1 t -121.0 -128.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.66 177.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.484 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 57.7 t30 -60.24 -51.74 78.09 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 68.3 Cg_endo -74.32 109.02 2.81 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.19 1.927 . . . . 0.0 112.637 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 84.7 Cg_endo -82.8 120.83 3.15 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.611 2.207 . . . . 0.0 112.157 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 1.2 mpp_? -87.87 53.17 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.131 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.804 HG21 HG23 ' A' ' 180' ' ' ILE . 21.5 t -56.73 97.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.71 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.96 89.41 3.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.269 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -91.17 131.9 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -83.63 -20.62 33.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -82.98 84.09 1.57 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.59 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -93.46 83.05 4.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.311 . . . . 0.0 110.969 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -80.69 162.37 45.11 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.542 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.05 166.99 27.98 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.586 2.19 . . . . 0.0 112.264 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.02 106.63 4.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.855 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.7 -51.36 21.53 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.403 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.19 90.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.14 1.893 . . . . 0.0 112.263 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.417 ' H ' HG21 ' A' ' 200' ' ' VAL . 3.2 m -73.52 153.96 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.012 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.479 ' C ' HD22 ' A' ' 201' ' ' LEU . 0.0 OUTLIER -107.01 37.51 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -46.23 62.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.001 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.85 3.23 33.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -135.17 73.8 0.44 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.531 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -102.31 -24.65 13.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.299 . . . . 0.0 111.054 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 131.29 -78.55 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.593 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.86 89.48 3.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.071 -179.902 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtm . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.87 -71.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 mm -81.51 107.01 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -109.77 172.46 6.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.737 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.25 -176.94 2.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.965 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 tt -76.63 140.25 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.004 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 t -70.22 -176.41 1.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.83 172.27 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.945 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -82.91 112.76 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.548 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 1.9 m-20 -90.76 -52.12 0.31 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.403 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 10' ' ' ASN . 34.7 Cg_exo -60.04 139.28 86.88 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.14 1.894 . . . . 0.0 112.101 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -161.52 107.18 1.2 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.058 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 52.2 Cg_endo -69.15 171.36 13.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.534 2.156 . . . . 0.0 112.259 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.53 -32.98 73.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.402 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 15.6 t -68.14 -36.67 76.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.085 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.596 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.13 -39.77 71.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.15 -24.79 65.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.791 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -74.65 -33.93 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -67.67 -37.3 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.835 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 16' ' ' LEU . 7.8 mm -75.11 -18.71 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -73.41 -44.98 57.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.053 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 19' ' ' ALA . 14.1 p -68.46 -31.19 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 53.0 mtt -66.99 -31.24 71.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.861 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.12 -35.26 64.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.053 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.16 10.32 69.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.661 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.01 58.88 9.47 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.529 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.27 160.52 22.03 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.621 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -96.26 146.9 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.434 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.94 133.03 64.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.474 ' H ' HG13 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -102.58 154.14 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.62 0.248 . . . . 0.0 110.946 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.659 ' HH ' ' HB2' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -158.47 100.13 1.71 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.762 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 4.7 Cg_exo -78.01 142.29 19.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.975 2.45 . . . . 0.0 111.299 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 88.4 m -138.62 -82.4 0.3 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 112.304 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.541 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 6.0 m-20 -75.36 -78.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.722 ' HA ' ' HG3' ' A' ' 174' ' ' MET . 0.8 OUTLIER -79.4 -88.59 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.366 -177.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.626 HG21 ' HB3' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -118.59 -150.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 -178.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.529 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 7.4 m-85 -69.81 141.2 53.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.05 -177.22 17.77 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.911 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.592 ' HG ' HD11 ' A' ' 28' ' ' ILE . 1.5 mp -122.7 140.21 53.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -147.22 110.35 0.51 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.719 HG13 ' HB ' ' A' ' 137' ' ' THR . 2.6 p -153.48 156.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 111.099 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.537 ' N ' HG23 ' A' ' 41' ' ' VAL . 3.0 m120 -55.05 101.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.025 0.44 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.68 76.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.938 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.4 18.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.048 0.452 . . . . 0.0 111.238 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.84 156.97 20.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.565 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER -75.27 -30.32 60.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.973 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.486 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 6.9 m-20 -62.48 -32.32 73.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.093 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.65 -34.1 71.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG12 HG22 ' A' ' 109' ' ' VAL . 4.1 t -68.42 -44.79 83.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -66.88 -44.52 80.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.772 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.412 ' NH2' HG21 ' A' ' 162' ' ' VAL . 51.9 mmt-85 -67.01 -23.7 65.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.15 -53.58 19.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -65.86 -14.89 62.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -66.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.313 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -75.56 -38.48 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.408 ' N ' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -81.76 -1.54 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.385 -178.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.23 -148.57 50.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -98.61 117.6 33.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 3.2 p -153.35 69.65 6.72 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.822 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.25 1.36 5.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.772 2.314 . . . . 0.0 112.619 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.636 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.8 m80 -114.21 -21.68 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.206 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 8.7 mtpt -88.11 126.43 60.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.28 174.5 7.04 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.451 2.101 . . . . 0.0 112.069 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 110' ' ' ILE . 2.5 m -113.06 153.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.028 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 t -111.3 132.39 54.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.732 HD13 HG12 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -111.67 172.74 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.678 ' HB3' ' HB1' ' A' ' 138' ' ' ALA . 3.0 p -119.56 135.31 54.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.849 HG23 ' HB2' ' A' ' 73' ' ' GLU . 1.3 p -143.69 173.18 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.663 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -83.0 -39.94 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.996 0.427 . . . . 0.0 110.426 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.1 165.75 21.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 74' ' ' ILE . 18.5 t -55.41 -33.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.769 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.29 -31.36 71.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.116 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.849 ' HB2' HG23 ' A' ' 68' ' ' VAL . 9.2 mm-40 -71.07 -21.41 62.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.152 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.797 HG22 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.27 63.73 0.92 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.791 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.626 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 27.9 Cg_exo -62.29 -76.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.211 1.941 . . . . 0.0 112.38 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.21 23.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.143 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -102.5 -53.04 2.97 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.262 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.455 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 22.5 p -123.01 177.24 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 9.2 mtt-85 -113.64 88.76 14.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 78' ' ' SER . 94.2 Cg_endo -102.74 -169.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.241 2.627 . . . . 0.0 112.786 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.749 ' HB3' ' HB1' ' A' ' 84' ' ' ALA . 2.2 t -145.96 179.21 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.853 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.33 -86.46 0.3 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.046 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.595 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -54.96 -32.71 61.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.346 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.749 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -60.29 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.0 110.871 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.597 ' HE1' ' HG ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -72.5 -17.91 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.595 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 2.5 mm-40 -59.14 -51.63 69.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.279 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.5 OUTLIER -64.37 -32.81 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.273 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.708 ' HE1' ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -65.51 -49.39 69.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.463 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.476 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -70.22 -8.76 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.265 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -75.02 -20.21 59.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.407 HD13 ' CE1' ' A' ' 96' ' ' TYR . 1.7 mt -108.35 13.18 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.695 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 4.2 pp -131.2 166.07 30.52 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.544 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.695 ' HA ' ' HB2' ' A' ' 92' ' ' LEU . 97.2 Cg_endo -78.87 162.69 87.1 Favored 'Cis proline' 0 C--N 1.354 0.819 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.91 -0.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 96' ' ' TYR . . . 153.88 -151.04 22.81 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.982 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.407 ' HG3' ' HD2' ' A' ' 176' ' ' PRO . 85.6 Cg_endo -78.08 35.12 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.411 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.623 ' HE2' ' HG3' ' A' ' 88' ' ' MET . 16.9 t80 -92.62 135.35 34.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.592 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.703 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 13.2 m -114.02 120.23 39.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.708 ' HB ' ' HE1' ' A' ' 88' ' ' MET . 0.2 OUTLIER -115.92 108.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.224 0.535 . . . . 0.0 111.551 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.88 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -105.66 128.73 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.435 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.59 -172.44 2.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 1.7 tt0 -74.42 -176.65 2.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.296 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.795 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.71 141.36 49.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 111.279 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 7.7 t30 -74.54 -177.02 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.943 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.43 52.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.816 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 4.5 tp -79.97 134.84 36.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.588 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 27.4 mt -72.27 -50.58 8.51 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.428 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.816 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 71.0 Cg_exo -51.9 109.1 0.29 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.304 2.003 . . . . 0.0 112.327 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -81.98 -19.82 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.182 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.437 HG23 HG13 ' A' ' 110' ' ' ILE . 24.3 m -69.25 -15.38 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.197 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.519 HG23 HG21 ' A' ' 64' ' ' VAL . 48.1 mt -98.15 -43.08 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.3 t -77.0 -12.78 59.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.44 -155.73 49.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.455 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -82.44 -13.65 78.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.397 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.86 -175.06 2.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.782 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.409 ' CA ' ' HD2' ' A' ' 102' ' ' ARG . 3.0 m -112.91 44.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -137.22 159.91 40.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.063 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.795 HG23 ' HB2' ' A' ' 102' ' ' ARG . 84.1 t -139.79 143.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.459 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -99.33 152.49 19.56 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.328 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.732 HG12 HD13 ' A' ' 66' ' ' ILE . 19.4 mt -145.92 149.61 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.3 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 119' ' ' ILE . 3.5 ttm-85 -148.56 137.07 21.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.215 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.26 88.03 6.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.757 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.547 ' HD2' ' NH2' ' A' ' 128' ' ' ARG . 30.6 Cg_endo -63.95 -177.68 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.591 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.83 8.11 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.21 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.55 115.06 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.984 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -57.46 -56.37 22.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.663 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.457 HG23 HD23 ' A' ' 16' ' ' LEU . 66.7 mt -60.61 -48.47 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.444 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 7.2 t -57.49 -16.95 11.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.663 ' HE ' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -75.4 -55.04 6.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.149 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -51.09 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.652 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 tt -59.62 -40.22 81.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.597 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 127' ' ' CYS . . . -72.75 -26.49 61.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.13 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.45 -54.76 36.58 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -75.98 -88.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.2 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -77.85 119.18 76.38 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.456 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.64 156.41 63.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.405 2.07 . . . . 0.0 111.605 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.511 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.2 t -134.9 159.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.208 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.719 ' HB ' HG13 ' A' ' 41' ' ' VAL . 29.0 m -80.85 139.24 36.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.1 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 67' ' ' CYS . . . -133.42 106.38 7.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.801 0.334 . . . . 0.0 111.62 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -136.75 122.05 19.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.976 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.1 111.36 3.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.55 103.71 11.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.206 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -160.23 29.14 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.09 -157.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.047 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.8 p -57.41 163.34 2.37 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.931 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.35 -144.18 22.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.344 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.21 69.38 74.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.681 0.277 . . . . 0.0 110.914 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.7 -47.48 13.36 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.562 2.175 . . . . 0.0 113.69 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.626 ' HB3' HG21 ' A' ' 36' ' ' ILE . 72.7 Cg_endo -76.36 121.23 5.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.906 1.737 . . . . 0.0 112.601 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -97.32 147.77 33.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.798 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -95.99 -13.72 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.913 2.408 . . . . 0.0 113.204 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -134.58 140.06 45.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.01 72.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.583 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.68 -17.43 63.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -75.27 -37.56 60.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.468 HG22 HD23 ' A' ' 159' ' ' LEU . 49.1 mt -67.48 -45.15 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.355 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.43 -28.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -75.7 -54.22 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.436 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.04 -43.96 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.722 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.58 ' HB3' HG11 ' A' ' 162' ' ' VAL . 2.7 mm? -90.5 66.59 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 159' ' ' LEU . 5.0 t70 -16.68 -64.35 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.062 0.851 . . . . 0.0 112.761 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.35 25.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.67 HG11 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.77 -68.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.722 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.67 ' H ' HG11 ' A' ' 162' ' ' VAL . 1.7 p-10 -111.1 96.55 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.676 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.68 130.42 46.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.199 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.67 HG23 ' H ' ' A' ' 166' ' ' LEU . 3.6 p -67.34 175.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.88 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.67 ' H ' HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.62 124.92 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 111.172 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 -7.54 45.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.274 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.659 ' HB2' ' HH ' ' A' ' 31' ' ' TYR . . . -63.83 -31.94 73.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.38 123.2 5.21 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 9.5 p-10 -73.25 -166.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.895 0.379 . . . . 0.0 111.259 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 5.1 m -136.49 -168.5 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.554 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.412 ' H ' ' HB3' ' A' ' 171' ' ' CYS . 0.0 OUTLIER -143.53 39.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.541 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -83.37 46.36 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.858 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.722 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 9.1 ttm -59.15 -17.97 31.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.467 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -139.92 136.05 16.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.407 ' HD2' ' HG3' ' A' ' 95' ' ' PRO . 84.1 Cg_endo -83.68 -151.93 0.73 Allowed 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.452 0.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.69 92.59 1.58 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.685 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -102.27 129.92 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.703 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 98.3 t -128.02 100.82 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.378 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.821 HG12 ' HA ' ' A' ' 189' ' ' VAL . 73.8 mt -116.29 139.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.827 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.88 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.8 m-20 -107.48 58.69 0.62 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 187' ' ' PRO . 9.7 tp -69.96 105.78 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.391 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.29 -88.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.242 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.7 t -120.96 -83.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.646 0.26 . . . . 0.0 111.371 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.522 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.0 OUTLIER -89.01 -52.14 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.67 -179.053 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.36 106.75 1.37 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.248 1.965 . . . . 0.0 112.491 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.647 ' HB3' HD11 ' A' ' 182' ' ' LEU . 98.2 Cg_endo -84.27 129.57 4.48 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.752 2.301 . . . . 0.0 112.499 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.599 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.2 mtt180 -90.48 50.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 180' ' ' ILE . 47.8 t -56.47 105.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.28 83.57 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.132 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 191' ' ' ARG . 8.1 ptt180 -85.95 174.1 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.26 109.66 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.737 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.03 81.41 1.6 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.607 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.85 110.42 22.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.73 0.3 . . . . 0.0 110.822 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -83.56 -108.12 0.53 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.68 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.17 118.27 5.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.519 2.146 . . . . 0.0 112.555 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.24 171.26 16.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.789 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.56 133.4 77.08 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.031 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.647 ' HA ' HD13 ' A' ' 202' ' ' LEU . 85.3 Cg_endo -82.22 45.25 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.65 2.233 . . . . 0.0 112.368 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -74.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.308 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.85 48.31 1.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.992 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.647 HD13 ' HA ' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -67.18 -60.97 2.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -72.95 143.1 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -170.5 176.89 43.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.544 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -106.91 150.43 26.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.721 0.296 . . . . 0.0 111.002 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 151.56 -0.99 0.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -105.77 -22.73 12.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.754 0.311 . . . . 0.0 110.916 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.073 179.89 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.82 0.343 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.71 -175.74 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tp -85.83 150.54 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -104.69 172.63 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.006 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 161.28 20.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tt -102.99 141.31 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.05 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -71.09 120.62 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.003 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.65 167.96 11.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.976 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.22 53.78 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.929 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.516 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -76.24 -50.97 2.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.49 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 10' ' ' ASN . 43.6 Cg_endo -67.91 -52.18 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.091 1.86 . . . . 0.0 112.439 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.7 122.05 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.91 128.55 17.99 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.523 2.148 . . . . 0.0 112.32 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.86 -33.97 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.798 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.651 HG12 HG13 ' A' ' 126' ' ' ILE . 26.2 t -61.51 -40.14 85.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.489 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -68.43 -34.77 76.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.723 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.09 -26.58 63.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.554 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.65 -37.22 68.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.654 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.554 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -66.08 -37.25 85.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.814 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 16' ' ' LEU . 22.8 mm -75.3 -23.95 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 t -68.18 -47.75 67.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.53 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 7.3 p -69.72 -31.02 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 1.7 mtt -71.23 -27.91 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.075 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.84 -33.82 76.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.81 73.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.519 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.35 65.48 2.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.36 175.84 16.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.413 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 163' ' ' ASP . 2.2 tp -96.04 142.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.552 HG23 HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -116.69 121.15 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.678 HG21 ' HB3' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -102.06 165.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.733 ' HH ' ' HB1' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -169.91 86.28 0.57 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.601 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 73.0 Cg_endo -75.09 118.97 5.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.265 1.977 . . . . 0.0 111.009 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.83 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 1.0 OUTLIER -116.31 -137.29 0.36 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.034 0.445 . . . . 0.0 111.68 -176.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -54.24 -46.56 72.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.202 -179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.538 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.8 -122.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.485 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.798 HG22 ' HG3' ' A' ' 174' ' ' MET . 0.0 OUTLIER -112.51 -158.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 110.9 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.455 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . 1.8 m-85 -69.99 115.46 9.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.468 ' HA3' HH22 ' A' ' 120' ' ' ARG . . . -116.16 126.48 7.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.525 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.678 ' HB3' HG21 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -111.17 138.77 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 111.199 -178.126 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 41' ' ' VAL . . . -145.18 160.52 28.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.987 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -158.95 -169.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.047 -178.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.722 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t30 -56.14 124.0 16.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.197 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.09 -67.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.226 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 44' ' ' LEU . 2.1 mm? -80.84 42.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 111.625 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.722 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.33 152.82 25.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.849 178.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.28 -30.28 60.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.89 -25.5 68.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.88 -38.88 76.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 t -72.34 -37.63 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -67.66 -37.73 82.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.093 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -75.19 -20.29 59.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.036 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -44.92 66.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.956 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -75.26 -27.94 59.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -68.58 -56.52 7.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.72 -49.42 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.429 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -72.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.285 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.64 78.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.656 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.86 -69.31 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.91 98.7 11.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.73 14.72 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.567 2.178 . . . . 0.0 112.448 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -104.88 -7.35 19.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.6 148.5 44.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.978 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.56 165.13 1.78 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.662 2.241 . . . . 0.0 112.319 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.675 HG22 HG21 ' A' ' 110' ' ' ILE . 13.0 m -113.3 159.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.27 138.49 43.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.565 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 118' ' ' GLY . 22.6 pt -114.76 169.08 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.502 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 118.22 27.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 73' ' ' GLU . 1.5 p -135.86 -179.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.472 ' OG ' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -87.65 -40.1 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.042 0.449 . . . . 0.0 110.582 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 166.73 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.562 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -59.17 -29.38 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.752 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.31 -27.51 67.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.777 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.823 ' HB2' HG23 ' A' ' 68' ' ' VAL . 12.8 mm-40 -79.31 -22.87 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.74 56.67 0.71 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 42.8 Cg_endo -68.35 -62.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.857 1.705 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.404 ' H ' ' HG2' ' A' ' 75' ' ' PRO . 15.8 mtt180 -72.89 4.09 4.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.559 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -92.2 -64.54 1.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.736 0.303 . . . . 0.0 110.837 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.06 -178.03 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -116.59 116.62 38.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.956 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -102.07 -176.71 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.203 2.602 . . . . 0.0 112.558 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 85' ' ' MET . 29.5 t -143.4 173.08 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.99 -103.25 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.129 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 86' ' ' GLU . 1.5 m-20 -55.17 -26.54 39.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -60.61 -51.95 67.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.989 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.737 ' HE2' ' HG ' ' A' ' 182' ' ' LEU . 0.2 OUTLIER -74.26 -21.01 59.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -63.61 -44.83 92.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -44.65 95.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.621 ' HE3' ' HB ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -66.4 -29.98 70.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.555 ' HA ' HD22 ' A' ' 92' ' ' LEU . 3.7 mt-10 -72.39 -17.3 61.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.082 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -75.22 -13.82 60.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.179 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 41.95 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' A' ' 89' ' ' GLU . 1.8 pp -127.27 146.65 58.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.994 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.59 -171.95 10.59 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.37 -1.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.35 163.42 12.29 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.856 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.538 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.0 Cg_endo -81.06 48.78 3.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.413 ' HD2' ' HE1' ' A' ' 88' ' ' MET . 27.1 p90 -107.5 159.68 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.57 138.84 44.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.632 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.502 HG12 ' HG2' ' A' ' 88' ' ' MET . 0.4 OUTLIER -120.07 106.58 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.285 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.739 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 14.0 t -103.85 122.48 56.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 182' ' ' LEU . 1.2 mp -126.36 -167.66 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.442 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -177.53 3.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.314 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -119.8 147.87 44.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.091 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 8.7 t30 -74.28 -173.21 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.39 38.38 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.826 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 10.8 tp -76.63 127.77 33.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.79 0.329 . . . . 0.0 110.799 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.566 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.5 mt -75.68 -50.34 3.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.692 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.826 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 76.4 Cg_exo -50.58 108.32 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.267 1.978 . . . . 0.0 112.443 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.629 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.8 OUTLIER -80.82 1.37 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.73 -15.02 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.72 HD13 HD22 ' A' ' 105' ' ' LEU . 4.3 mt -109.5 -44.33 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 108' ' ' ASP . 8.8 t -77.26 -9.63 58.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.834 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.35 -150.25 38.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.7 -10.52 67.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.549 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.3 p -117.02 -171.35 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.757 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.558 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.4 p -109.67 64.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.702 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -140.42 152.59 45.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.012 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 102' ' ' ARG . 92.9 t -139.86 135.07 38.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.411 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 66' ' ' ILE . . . -99.21 155.99 19.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.563 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.505 HG23 HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -135.06 173.23 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.468 HH22 ' HA3' ' A' ' 38' ' ' GLY . 3.2 ttp180 -157.29 117.5 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 111.392 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.87 79.38 1.85 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.846 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.57 -170.47 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.594 2.196 . . . . 0.0 112.548 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.11 23.01 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.104 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.1 t0 -82.2 96.06 7.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.57 -44.99 85.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.651 HG13 HG12 ' A' ' 15' ' ' VAL . 30.6 mm -64.91 -53.42 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.947 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 14.5 t -63.11 -12.78 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 6.4 ttt85 -75.47 -42.85 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -73.25 -54.46 8.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.518 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.18 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.299 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.605 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.13 -26.6 63.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.36 -53.79 49.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -89.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.824 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 90.1 m-85 -77.74 123.16 86.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 20.7 Cg_exo -65.51 163.53 29.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 41' ' ' VAL . 21.0 t -134.06 146.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 111.517 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -74.47 151.24 39.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.29 114.87 8.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.952 0.406 . . . . 0.0 111.939 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.52 148.51 50.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.54 124.9 29.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . . . -69.75 119.59 14.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.199 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.432 ' HA ' ' HG2' ' A' ' 147' ' ' PRO . 2.4 t30 -162.61 31.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.7 tt -68.37 171.17 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.872 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.3 p -54.04 149.18 9.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.014 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.75 -136.74 13.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.557 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -116.72 90.26 31.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.554 0.216 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.9 Cg_exo -60.55 -50.57 6.56 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.423 2.082 . . . . 0.0 113.136 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 86.3 Cg_endo -82.26 125.62 4.63 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.924 1.749 . . . . 0.0 112.571 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.08 154.63 38.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -95.85 -10.67 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.72 2.28 . . . . 0.0 112.972 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.35 139.54 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.389 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -65.53 -45.25 84.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.853 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.24 -18.5 65.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.611 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -40.92 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.748 HG22 HD23 ' A' ' 159' ' ' LEU . 24.0 mt -69.29 -37.87 76.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.217 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.11 -44.17 95.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.42 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -75.45 -46.9 29.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.753 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.655 ' HB3' HD21 ' A' ' 159' ' ' LEU . 6.3 t70 -70.18 -43.45 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.574 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.748 HD23 HG22 ' A' ' 155' ' ' ILE . 2.8 mm? -100.23 67.11 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -16.59 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.048 0.843 . . . . 0.0 112.848 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.44 25.09 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.649 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.55 -69.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.553 179.031 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.706 ' H ' HG12 ' A' ' 162' ' ' VAL . 1.2 p-10 -108.29 99.51 8.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.498 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.53 ' HG ' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.97 130.2 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.735 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.544 HG23 HD13 ' A' ' 155' ' ' ILE . 1.9 p -64.33 -170.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.948 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.612 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.53 119.95 28.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.155 0.502 . . . . 0.0 111.426 -178.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.4 -0.69 57.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.076 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.733 ' HB1' ' HH ' ' A' ' 31' ' ' TYR . . . -75.75 -38.71 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.82 64.85 1.7 Allowed Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.767 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.83 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 7.3 m-20 -73.14 -124.0 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.859 -0.2 . . . . 0.0 110.744 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.809 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -141.72 -170.1 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.232 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.86 10.1 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -64.63 91.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.149 0.5 . . . . 0.0 111.364 -176.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.798 ' HG3' HG22 ' A' ' 36' ' ' ILE . 10.0 ttt -55.04 -15.79 2.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.857 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -139.68 150.58 63.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.055 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.417 ' HB2' ' H ' ' A' ' 177' ' ' SER . 94.8 Cg_endo -85.95 -151.92 0.66 Allowed 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 123.497 -1.46 . . . . 0.0 112.533 0.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.417 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 25.0 m -153.91 115.21 4.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.444 HG21 ' HB3' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -101.44 124.18 46.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.333 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.4 t -129.24 105.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.564 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.621 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 3.7 mp -121.2 132.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.739 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -95.3 71.86 3.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.737 ' HG ' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -68.37 84.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.299 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -88.0 0.08 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.414 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 2.4 t -120.72 -128.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.842 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.547 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.6 OUTLIER -59.33 -51.17 83.32 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.36 106.27 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.238 1.958 . . . . 0.0 112.371 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 96.1 Cg_endo -84.29 140.56 8.67 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.601 2.2 . . . . 0.0 112.401 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.2 mmm-85 -97.18 59.31 1.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.473 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 43.2 t -58.24 107.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.117 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.01 80.36 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.444 ' HB3' HG21 ' A' ' 178' ' ' THR . 0.0 OUTLIER -99.2 143.45 29.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -84.51 81.62 8.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -89.14 114.48 4.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.6 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 21.74 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -81.03 -99.48 0.36 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.448 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.97 76.22 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.787 2.325 . . . . 0.0 112.179 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -7.92 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.981 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.59 123.48 88.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.876 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.16 -57.91 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.604 2.203 . . . . 0.0 112.287 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 202' ' ' LEU . 12.7 t -73.79 112.95 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.06 30.92 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.621 ' HB2' HG11 ' A' ' 200' ' ' VAL . 0.2 OUTLIER -66.12 -26.94 67.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.02 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.69 -72.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 144.46 163.48 10.02 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -94.23 -34.21 12.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.712 0.292 . . . . 0.0 111.102 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -134.77 105.81 0.57 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.46 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -93.86 -23.71 18.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.979 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.143 -179.915 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.789 0.328 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.1 171.56 9.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.901 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 mm -92.24 125.71 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -82.71 -171.1 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.007 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -171.41 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.504 HG13 ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -105.65 143.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.156 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.504 ' N ' HG13 ' A' ' 6' ' ' ILE . 13.2 t -75.93 -178.63 4.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 8' ' ' ARG . 6.6 mtm180 -73.12 167.41 21.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.797 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -92.98 -76.73 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.888 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -110.1 132.31 21.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.77 -157.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.576 2.184 . . . . 0.0 112.162 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.35 111.35 16.48 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.7 172.52 5.63 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.63 2.22 . . . . 0.0 112.134 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -33.75 76.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.469 HG11 ' OE2' ' A' ' 18' ' ' GLU . 95.3 t -65.93 -35.67 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.135 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -47.08 70.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.87 -21.18 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.03 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.469 ' OE2' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.22 -34.21 61.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.661 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.68 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.058 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.6 mm -69.71 -31.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m -64.04 -47.54 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.47 -25.5 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.42 -47.24 86.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -23.71 61.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.983 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.35 -5.3 79.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.519 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.0 57.13 12.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.81 174.72 16.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.719 HD12 HD13 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -96.44 148.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.756 0.313 . . . . 0.0 110.67 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG13 HD11 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -117.8 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.614 ' HB ' HG12 ' A' ' 165' ' ' VAL . 2.5 mt -102.38 174.23 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.624 ' HH ' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -171.31 106.44 0.39 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' A' ' 170' ' ' ASP . 87.2 Cg_endo -84.28 125.39 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.602 2.201 . . . . 0.0 111.506 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.62 -154.84 0.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 6.8 m-20 -54.7 -30.1 54.89 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.255 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.579 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -93.54 -118.23 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.512 ' H ' ' HB ' ' A' ' 35' ' ' THR . 0.1 OUTLIER -112.18 -165.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.165 -179.593 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.468 ' HE2' HG13 ' A' ' 165' ' ' VAL . 33.6 m-85 -71.87 126.02 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.537 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.2 121.19 2.79 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.719 HD13 HD12 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -112.16 149.32 32.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 0.0 112.062 -176.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' HG11 ' A' ' 41' ' ' VAL . . . -144.93 169.04 26.8 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.946 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.583 HG11 HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -159.27 -170.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.909 0.385 . . . . 0.0 111.118 -179.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.674 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.5 t30 -56.75 119.74 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 45' ' ' ASP . . . -58.56 -63.23 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.37 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 44' ' ' LEU . 1.2 mm? -78.33 33.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 111.863 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 1.1 m-20 -111.28 147.68 34.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.973 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -75.57 -29.63 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.305 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.71 -25.68 63.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -72.33 -31.48 65.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.145 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.13 -45.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.489 ' NH2' ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -67.75 -34.92 77.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 24.2 mmt180 -73.64 -35.1 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -67.23 -24.65 65.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.846 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -46.68 32.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.384 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -54.46 -48.21 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.391 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 140' ' ' SER . 10.7 t -75.21 -49.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.36 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.71 ' HE3' ' HB2' ' A' ' 58' ' ' ARG . 14.7 tptt -93.69 -71.25 0.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.411 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.85 15.33 34.32 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.697 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.71 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 76.7 mtp85 -118.23 22.91 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.521 ' HG ' ' HG2' ' A' ' 56' ' ' LYS . 2.4 p -149.7 66.21 8.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.93 -54.94 4.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.575 2.184 . . . . 0.0 112.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' HA3' ' A' ' 112' ' ' GLY . 32.2 p-80 -123.84 24.09 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.137 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HE3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -88.55 146.55 37.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.6 ' HD2' ' HE3' ' A' ' 62' ' ' LYS . 76.9 Cg_exo -51.74 148.32 22.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.662 2.241 . . . . 0.0 112.559 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.9 166.13 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.573 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 0.4 OUTLIER -106.92 140.22 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 118' ' ' GLY . 1.8 pt -116.21 171.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.6 t -122.8 125.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.504 179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 131' ' ' ALA . 0.8 OUTLIER -135.97 -179.11 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.878 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 1.5 t -90.0 -44.07 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.79 0.328 . . . . 0.0 110.956 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -163.71 174.91 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.089 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 t -58.38 -37.37 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.834 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 1.0 OUTLIER -67.13 -22.12 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.837 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -80.43 -20.92 42.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.139 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -113.63 54.6 0.61 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 77' ' ' PHE . 29.5 Cg_endo -62.41 -82.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.834 1.689 . . . . 0.0 111.828 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.446 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 2.0 mmt180 -73.41 19.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.336 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' PRO . 59.9 m-85 -103.26 -34.81 8.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.755 0.312 . . . . 0.0 111.108 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -135.33 165.5 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.047 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -112.76 105.01 56.09 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.427 ' HA ' HD13 ' A' ' 100' ' ' LEU . 86.3 Cg_endo -102.57 179.72 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.169 2.579 . . . . 0.0 112.619 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 -173.45 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.11 -82.47 0.44 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.686 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -57.64 -26.71 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.927 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.539 ' HB1' HD23 ' A' ' 182' ' ' LEU . . . -63.41 -48.25 78.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.438 ' HE1' ' HA ' ' A' ' 85' ' ' MET . 9.6 mmt -70.44 -15.81 62.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.686 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mm-40 -66.44 -50.4 63.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.67 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 182' ' ' LEU . 2.7 tm? -61.77 -38.99 90.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.633 ' HB2' HD12 ' A' ' 182' ' ' LEU . 5.1 tpt -64.94 -49.67 69.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.437 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -72.88 -2.59 21.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.368 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.99 -58.88 3.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.295 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.3 74.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.629 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.74 149.22 72.82 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.071 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HB3' HG12 ' A' ' 121' ' ' VAL . 5.2 Cg_exo -78.72 -148.5 0.51 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.18 -1.175 . . . . 0.0 111.952 -1.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.18 8.74 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.979 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.579 ' HB2' HG23 ' A' ' 35' ' ' THR . 3.9 Cg_exo -80.42 43.77 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.221 2.614 . . . . 0.0 112.151 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.491 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 3.6 p90 -112.23 -177.03 3.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -112.89 139.04 48.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.245 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.17 102.77 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.282 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.726 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -101.22 122.9 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 HD21 ' A' ' 182' ' ' LEU . 1.2 mm? -126.91 -179.04 4.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.714 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -74.86 -166.01 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.664 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -119.28 138.19 53.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.182 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 76' ' ' ARG . 4.3 t30 -73.73 -163.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.315 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -39.19 82.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.325 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.563 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -69.46 100.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.688 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.4 pt -80.95 102.87 1.5 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.874 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 60.6 Cg_endo -70.91 138.43 34.16 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.429 2.086 . . . . 0.0 112.248 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.034 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 p -87.43 23.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.874 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 57.7 mt -106.69 -54.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 110.894 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.623 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 6.2 t -87.57 -24.26 24.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.865 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 61' ' ' HIS . . . 69.31 -141.74 36.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.408 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.32 27.6 6.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.437 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 63' ' ' PRO . 1.3 t -123.94 165.58 17.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.327 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -113.16 42.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 116' ' ' ARG . 2.3 mtp180 -136.74 163.63 30.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.52 142.28 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . -92.74 149.59 19.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.454 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 72.2 mt -144.98 150.26 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.41 124.03 12.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.88 0.371 . . . . 0.0 111.476 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.627 HG12 ' HB3' ' A' ' 93' ' ' PRO . 21.1 t -110.66 83.7 3.61 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.837 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.08 179.5 6.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.589 2.192 . . . . 0.0 112.614 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -93.13 19.65 7.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.108 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.451 ' HB2' ' SG ' ' A' ' 127' ' ' CYS . 66.1 m-20 -82.02 105.57 13.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 128' ' ' ARG . 5.4 pt-20 -57.35 -42.96 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.277 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mm -61.36 -58.13 8.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -58.58 -21.16 52.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.994 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 125' ' ' GLU . 1.8 mtp180 -68.17 -37.54 81.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 34.6 ttt-85 -75.25 -53.23 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.425 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.2 mt -59.19 -52.0 65.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.257 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -62.08 -27.86 69.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.599 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -51.27 66.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.997 0.427 . . . . 0.0 110.021 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -91.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.92 144.87 68.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 159.53 49.19 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.185 1.923 . . . . 0.0 111.374 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 137' ' ' THR . 11.7 t -132.67 152.0 35.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.802 0.334 . . . . 0.0 111.244 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.428 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -80.2 153.28 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.4 116.4 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 111.57 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.516 HG21 HD11 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -142.42 140.89 32.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.697 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.433 ' O ' HG12 ' A' ' 55' ' ' VAL . 22.4 p -66.93 139.17 57.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.997 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.06 145.09 46.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.393 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.433 ' CB ' HG13 ' A' ' 55' ' ' VAL . 1.6 t-20 -165.96 46.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.803 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.473 ' O ' ' HG3' ' A' ' 147' ' ' PRO . 7.2 mm -61.06 160.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.8 m -59.4 142.35 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.727 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.07 -109.81 3.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 148' ' ' PRO . 0.4 OUTLIER -127.19 94.31 39.2 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.593 0.235 . . . . 0.0 111.029 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.473 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 43.1 Cg_exo -60.34 -48.12 12.55 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.498 2.132 . . . . 0.0 113.389 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.487 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 73.9 Cg_endo -75.07 90.41 1.09 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.802 1.668 . . . . 0.0 112.208 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.469 ' HB2' HG12 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -84.78 157.93 60.0 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -96.01 -11.27 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.902 2.401 . . . . 0.0 112.908 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -141.48 141.62 33.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.627 HD21 ' HA ' ' A' ' 166' ' ' LEU . 55.8 mt -60.19 -28.6 68.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.771 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -72.23 -34.45 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.361 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.525 ' HG3' HH21 ' A' ' 157' ' ' ARG . 3.9 tt0 -58.95 -47.07 86.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.804 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.752 HG23 HG21 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.44 -35.43 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -67.33 -20.91 27.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.072 0.463 . . . . 0.0 110.37 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.525 HH21 ' HG3' ' A' ' 154' ' ' GLU . 10.1 ttp180 -73.1 -46.31 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.431 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.17 -41.41 63.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.677 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.504 ' HB3' HG11 ' A' ' 162' ' ' VAL . 2.7 mm? -111.22 68.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.7 t70 -15.93 -63.35 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.094 0.871 . . . . 0.0 112.817 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -157.02 18.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.321 . . . . 0.0 111.251 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.554 HG11 ' N ' ' A' ' 163' ' ' ASP . 7.7 p -80.96 -42.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.909 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 25.5 m-20 -111.21 110.75 21.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.411 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.492 ' HB3' ' OD1' ' A' ' 167' ' ' ASP . 29.7 mt -74.71 61.93 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.746 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.752 HG21 HG23 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -78.84 22.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.732 178.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.627 ' HA ' HD21 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -148.21 34.81 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.492 ' OD1' ' HB3' ' A' ' 164' ' ' LEU . 4.3 m-20 -70.01 -84.09 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.385 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.624 ' HB3' ' HH ' ' A' ' 31' ' ' TYR . . . -86.35 -34.19 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.065 0.46 . . . . 0.0 110.673 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.59 27.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.468 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 32' ' ' PRO . 2.9 m-20 -62.19 -177.55 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 0.0 111.214 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.9 t -140.16 -62.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.55 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.53 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -124.77 -135.61 0.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.7 144.78 26.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.9 ptm -70.32 2.4 3.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.054 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.72 151.29 26.45 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 177' ' ' SER . 64.5 Cg_endo -92.02 -136.64 0.1 OUTLIER 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.946 -1.273 . . . . 0.0 112.46 0.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.427 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -159.33 130.2 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.418 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 96' ' ' TYR . 32.6 m -101.29 139.72 36.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.923 0.392 . . . . 0.0 111.607 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.7 t -129.6 117.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.662 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.31 121.01 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.386 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.745 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -98.25 67.96 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.271 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.633 HD12 ' HB2' ' A' ' 88' ' ' MET . 4.4 tt -69.29 79.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 -78.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.92 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.42 -119.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.381 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 2.1 m-20 -69.57 -52.65 13.95 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.97 109.55 2.6 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.108 1.872 . . . . 0.0 112.767 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.7 Cg_endo -75.97 122.67 6.87 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.444 2.096 . . . . 0.0 111.955 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.745 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 3.3 mmp_? -87.28 61.2 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.88 93.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.569 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -122.05 87.8 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.211 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -89.41 142.81 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.057 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -84.59 2.94 39.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.867 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -95.92 -166.53 34.49 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.627 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -95.62 93.36 7.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -88.11 162.3 32.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.403 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.55 124.32 10.21 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.536 2.157 . . . . 0.0 112.334 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.46 -38.12 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.55 134.27 66.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.77 169.31 19.23 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.478 2.119 . . . . 0.0 112.301 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.9 t -72.04 97.64 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.631 HD23 ' HA3' ' A' ' 204' ' ' GLY . 0.2 OUTLIER -85.18 85.68 7.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.8 tp -88.31 -51.68 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.25 1.11 38.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.012 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.631 ' HA3' HD23 ' A' ' 201' ' ' LEU . . . -100.64 -97.09 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.493 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -109.4 -75.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 111.034 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 63.49 -157.2 41.45 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.455 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.75 -14.63 14.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.042 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.76 0.314 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.7 179.81 4.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mt -99.44 100.02 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.021 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -91.52 138.47 31.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.53 -167.96 2.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.01 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 tt -99.0 134.91 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.015 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 p -82.64 -178.78 7.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 98.45 9.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.691 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -109.08 8.64 26.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.049 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -98.28 104.85 25.34 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.56 124.25 12.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.526 2.15 . . . . 0.0 112.084 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.28 82.44 11.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.99 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 16' ' ' LEU . 23.1 Cg_exo -64.65 171.76 7.86 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.663 2.242 . . . . 0.0 112.104 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.88 -26.53 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.11 -34.54 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.074 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 1.1 mm? -69.65 -47.0 64.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.97 -21.21 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.571 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -74.77 -35.88 62.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.679 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.571 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -67.56 -37.67 82.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.933 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.95 -35.18 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.647 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -33.52 75.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 t -70.1 -32.29 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.0 mmt -61.33 -41.93 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.17 -11.23 60.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.12 -11.82 72.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 37.78 92.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.13 170.22 18.89 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.584 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.609 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -96.3 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.673 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.566 ' N ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.29 135.97 55.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -102.56 152.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.59 0.233 . . . . 0.0 110.586 178.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' HH ' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -160.13 102.5 1.4 Allowed Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.708 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.4 Cg_endo -82.18 136.3 8.94 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 0.0 111.327 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -116.94 -147.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.663 0.268 . . . . 0.0 111.277 -178.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.587 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 8.0 t70 -54.5 -25.41 25.34 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.928 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 174' ' ' MET . 4.3 t -95.43 -120.54 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.586 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.687 HG12 ' H ' ' A' ' 37' ' ' TYR . 9.3 tt -111.77 -171.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.563 0.221 . . . . 0.0 110.876 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.4 m-85 -63.33 129.02 38.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.778 0.323 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -121.14 177.68 16.38 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.146 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 3.6 mp -119.32 141.11 49.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.635 0.255 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.39 114.08 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.587 HG11 ' HB ' ' A' ' 137' ' ' THR . 3.4 p -153.29 161.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.511 0.195 . . . . 0.0 110.867 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.497 ' N ' HG23 ' A' ' 41' ' ' VAL . 5.9 t-20 -55.93 98.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.371 . . . . 0.0 110.346 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.62 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.108 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 9.2 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.086 0.469 . . . . 0.0 111.34 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.91 152.51 26.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.718 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.07 -19.16 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.825 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.47 -25.1 63.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.55 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' HB2' HG13 ' A' ' 41' ' ' VAL . . . -75.14 -46.2 35.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.29 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 50' ' ' ARG . 32.6 m -65.17 -34.28 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.056 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.424 ' N ' HG22 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -62.72 -40.15 96.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.549 ' HG2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -62.2 -54.5 40.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.146 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.71 -27.29 39.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.293 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.57 -31.57 65.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.516 HH21 ' HA2' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -73.52 -40.58 63.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.015 -179.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG13 HD12 ' A' ' 143' ' ' ILE . 78.5 t -75.12 -35.05 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.397 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.89 0.32 56.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.401 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 -115.37 7.92 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.604 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -100.42 105.12 16.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.871 0.367 . . . . 0.0 110.993 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 63.3 m -151.97 65.12 6.09 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.014 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.7 6.03 5.48 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.598 2.199 . . . . 0.0 112.448 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -122.36 -14.03 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.018 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 5.9 mmtp -88.16 129.19 50.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.18 -175.1 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.549 2.166 . . . . 0.0 111.999 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.55 170.64 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -113.62 134.57 54.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 119' ' ' ILE . 25.9 mm -116.42 159.24 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.387 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HB2' ' HB1' ' A' ' 138' ' ' ALA . 1.6 t -119.15 141.24 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.153 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.824 ' HA ' ' HB2' ' A' ' 131' ' ' ALA . 1.4 p -150.05 173.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.287 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 7.5 t -89.84 -34.15 16.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 110.072 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.9 t -164.26 160.66 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.595 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.615 ' HA ' HD12 ' A' ' 74' ' ' ILE . 21.9 t -57.08 -32.56 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.624 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.35 -26.19 66.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.884 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.655 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -77.1 -22.82 52.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.207 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.783 HG23 HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.61 60.11 0.83 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.655 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 23.5 Cg_exo -64.12 -73.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.158 1.906 . . . . 0.0 112.448 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 15.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.032 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -107.19 -34.93 6.98 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.157 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.419 ' HB2' HD23 ' A' ' 100' ' ' LEU . 93.4 p -135.49 164.2 28.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.0 110.991 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -114.52 103.22 55.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.747 ' HA ' HD11 ' A' ' 100' ' ' LEU . 74.3 Cg_endo -102.15 -169.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.177 2.585 . . . . 0.0 113.063 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.418 ' HB3' ' HB1' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -144.58 -174.85 4.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.06 -86.56 0.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.881 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -29.48 61.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.793 0.33 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 81' ' ' SER . . . -58.44 -49.28 77.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.787 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.542 ' HE2' ' HG ' ' A' ' 182' ' ' LEU . 21.3 mmt -72.17 -17.91 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.956 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.67 -36.22 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.14 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 87' ' ' LEU . 2.8 tm? -64.18 -45.45 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.63 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 31.5 tpp -75.39 -26.56 58.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.376 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -40.76 93.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.399 . . . . 0.0 111.854 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -75.56 -18.46 59.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.4 mt -100.4 -11.29 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.525 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.605 HD11 HG23 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -112.08 151.89 43.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.007 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 174.84 50.58 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.904 -1.29 . . . . 0.0 112.202 0.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.32 -173.61 32.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.568 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.17 28.63 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.661 2.241 . . . . 0.0 112.437 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -101.59 143.36 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -106.96 136.24 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.635 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 182' ' ' LEU . 1.4 p -120.11 111.83 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.406 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.663 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 6.4 t -87.44 127.16 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.922 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.747 HD11 ' HA ' ' A' ' 80' ' ' PRO . 15.1 tp -124.8 178.22 5.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.558 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 1.6 mt-10 -74.4 -170.24 0.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.9 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.543 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.77 138.63 52.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.491 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 176.1 7.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.747 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.57 55.84 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.451 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.499 HD23 ' HD2' ' A' ' 107' ' ' PRO . 1.8 mt -89.85 131.04 35.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 110.768 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.622 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.3 mp -66.84 -51.86 36.16 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.781 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 56.7 Cg_exo -52.21 105.17 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.236 1.957 . . . . 0.0 112.445 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -4.7 53.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 110' ' ' ILE . 14.5 p -71.96 -27.01 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.015 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 109' ' ' VAL . 13.1 mt -93.87 -39.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 p -71.68 -23.21 61.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.6 -157.44 50.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.498 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.85 -21.26 71.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.0 m -108.39 -179.77 3.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.524 ' C ' ' HB2' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -112.98 59.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.029 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 mtm105 -142.72 158.58 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.543 HG23 ' HG2' ' A' ' 102' ' ' ARG . 39.5 t -139.93 117.11 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.61 117.9 4.54 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 66' ' ' ILE . 5.7 mt -130.14 150.43 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.8 0.333 . . . . 0.0 111.037 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.484 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.8 ptp180 -144.48 149.32 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.478 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.605 HG23 HD11 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -110.5 88.72 7.9 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.739 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 21.8 Cg_exo -64.81 -179.52 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.461 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.25 2.11 56.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.188 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 5.1 t0 -71.44 109.11 5.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.27 -40.51 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.243 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mm -69.94 -50.02 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.258 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 20.6 t -61.26 -18.79 60.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.2 OUTLIER -73.69 -46.79 44.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.878 179.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.505 ' O ' ' HB1' ' A' ' 132' ' ' ALA . 0.1 OUTLIER -63.68 -52.54 60.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.562 -179.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 mt -59.45 -55.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.309 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.824 ' HB2' ' HA ' ' A' ' 68' ' ' VAL . . . -62.74 -25.1 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.451 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 129' ' ' ARG . . . -54.92 -57.37 11.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.02 0.438 . . . . 0.0 109.965 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.16 -85.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -77.19 112.32 22.51 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.236 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -65.64 133.33 33.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.279 1.986 . . . . 0.0 111.306 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 66' ' ' ILE . 25.2 m -113.72 166.98 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 120.878 0.371 . . . . 0.0 111.771 -177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.587 ' HB ' HG11 ' A' ' 41' ' ' VAL . 87.7 m -80.97 125.88 30.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -122.58 95.37 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.68 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -126.76 113.87 17.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.859 179.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.559 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -61.84 121.7 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . -79.08 129.98 35.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -160.11 -43.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.435 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.489 ' HB ' ' H ' ' A' ' 144' ' ' SER . 1.1 mp -80.31 -106.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.489 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.3 OUTLIER -62.41 178.42 0.41 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.967 0.413 . . . . 0.0 111.469 -179.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.516 ' HA2' HH21 ' A' ' 54' ' ' ARG . . . 73.6 -152.24 45.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.379 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.34 62.94 56.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 0.0 110.886 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.572 ' HG2' ' HD3' ' A' ' 148' ' ' PRO . 11.1 Cg_endo -60.77 -38.23 72.43 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.445 2.097 . . . . 0.0 114.377 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.572 ' HD3' ' HG2' ' A' ' 147' ' ' PRO . 67.3 Cg_endo -73.95 73.19 3.74 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.764 1.643 . . . . 0.0 112.653 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.4 110.12 53.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.732 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -95.39 -14.84 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.601 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -130.44 127.02 38.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.45 HD22 ' CG2' ' A' ' 165' ' ' VAL . 45.7 mt -63.12 -37.98 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -17.81 62.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -74.09 -36.95 64.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.015 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.458 ' H ' HG13 ' A' ' 155' ' ' ILE . 2.5 mt -70.96 -45.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 165' ' ' VAL . 4.3 t -54.73 -38.07 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -70.88 -48.83 51.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.579 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -45.98 92.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.461 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.798 ' HB3' ' HB ' ' A' ' 162' ' ' VAL . 1.4 mm? -109.77 81.84 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.084 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.4 -40.79 0.39 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.004 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.75 15.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.318 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.798 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 47.2 t -80.61 -83.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.979 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.609 ' HA ' HG23 ' A' ' 28' ' ' ILE . 4.3 t0 -93.83 85.9 4.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.753 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.56 ' HB3' HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -54.89 123.82 14.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.326 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.58 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.4 p -62.71 177.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.296 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.537 HD13 ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -125.47 137.82 53.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.792 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -9.65 41.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.232 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.486 ' HB3' ' HH ' ' A' ' 31' ' ' TYR . . . -77.44 -35.04 54.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.92 177.86 49.12 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.827 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 16.7 p-10 -71.32 -160.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.39 -64.75 0.44 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.758 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.86 -139.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.04 149.19 24.91 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.533 ' HE3' ' HG3' ' A' ' 175' ' ' GLU . 6.8 ptm -60.99 -10.72 6.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.237 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.533 ' HG3' ' HE3' ' A' ' 174' ' ' MET . 4.2 mt-10 -139.76 158.38 67.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.552 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -92.33 -156.71 0.68 Allowed 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 124.124 -1.198 . . . . 0.0 112.844 1.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.71 120.24 3.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.551 HG23 ' HB3' ' A' ' 191' ' ' ARG . 69.5 m -102.02 138.18 39.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.32 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.52 98.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.061 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.659 HG12 HG12 ' A' ' 189' ' ' VAL . 6.0 mt -108.73 132.96 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.663 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -90.1 71.4 7.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.884 ' HA ' ' HB3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -72.4 82.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.545 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.9 p -83.7 -97.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.181 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.92 -63.2 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.457 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -173.56 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.342 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.57 120.37 8.15 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.927 1.085 . . . . 0.0 110.867 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.884 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 21.2 Cg_endo -62.67 156.69 51.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.811 2.341 . . . . 0.0 112.834 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.92 99.96 10.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.873 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 180' ' ' ILE . 1.4 t -67.75 103.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.78 82.26 1.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . 0.551 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -102.98 159.04 15.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.798 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 144.13 40.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -86.46 132.76 11.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.498 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.78 -34.32 9.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.922 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -86.0 163.26 36.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.522 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.51 -56.73 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 112.328 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.22 144.15 19.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.61 116.64 51.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.92 139.62 88.95 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.55 2.167 . . . . 0.0 112.261 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.0 m -62.02 169.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.211 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.03 40.93 0.94 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.14 178.74 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.939 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.35 141.87 31.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.028 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.29 -159.85 22.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.447 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -79.2 148.21 32.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 0.0 111.113 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.16 -168.57 35.43 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.565 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -87.15 -3.88 59.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.774 0.321 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.0 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.224 -0.894 . . . . 0.0 111.101 -179.981 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.932 0.305 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -37.47 80.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.4 t -71.31 -28.12 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.235 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.425 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.1 mm? -68.87 -48.03 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 21' ' ' SER . 4.9 pt-20 -72.51 -20.92 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.81 -35.05 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -74.21 -40.18 62.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.457 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 20' ' ' ILE . 2.3 pp -75.65 -18.69 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 111.024 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 1.2 t -68.23 -53.87 21.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.744 HG21 ' HB2' ' A' ' 164' ' ' LEU . 4.9 p -63.78 -33.51 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 17.9 mtt -63.38 -30.32 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.8 -29.2 64.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.07 1.02 89.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.378 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.2 53.42 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.634 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.97 172.72 15.62 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.306 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.685 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.9 tp -96.38 136.3 27.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.748 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.552 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.8 131.63 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -102.27 162.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.508 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -167.96 104.41 0.56 Allowed Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 93.7 Cg_endo -80.24 145.46 17.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.477 2.118 . . . . 0.0 111.888 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -123.05 -150.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.615 0.245 . . . . 0.0 111.224 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.736 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 3.0 m-20 -55.41 -22.43 20.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.603 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 95' ' ' PRO . 12.8 p -99.74 -112.79 0.18 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.945 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.84 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -161.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.726 0.298 . . . . 0.0 111.051 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -68.7 134.16 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.944 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -116.45 178.08 17.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.936 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.666 ' HB2' HG23 ' A' ' 139' ' ' THR . 1.1 mt -133.42 139.17 46.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.83 124.53 2.09 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.989 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 136' ' ' VAL . 8.9 p -157.62 165.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.558 0.218 . . . . 0.0 110.814 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.738 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -55.52 100.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 110.646 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.15 99.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.159 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.5 mm? -77.53 15.6 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.34 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.42 146.23 36.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -24.36 67.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.26 -29.2 69.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.868 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.47 -40.28 70.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.188 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 t -65.35 -35.49 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.984 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -50.3 34.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -69.7 -13.71 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -75.25 -49.48 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.359 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' N ' HD13 ' A' ' 52' ' ' LEU . 5.5 t80 -63.93 -25.55 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 54' ' ' ARG . 1.1 mmm180 -66.19 -45.85 79.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.42 -52.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.347 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -74.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.218 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.73 40.59 98.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.562 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -112.37 -80.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.309 . . . . 0.0 110.925 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.08 129.22 16.93 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.31 22.1 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 112.487 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.89 -8.87 15.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.112 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -88.13 141.33 31.03 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.047 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.05 165.63 25.72 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.518 2.145 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 110' ' ' ILE . 2.6 m -116.4 156.77 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.062 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 10.6 t -101.0 137.36 39.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.67 173.42 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.792 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 16.5 t -122.21 141.69 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.883 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -150.03 177.01 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.615 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -86.07 -46.82 10.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.674 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.25 175.85 9.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.008 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.48 -31.78 47.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 t70 -67.39 -26.03 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.107 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.563 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 23.6 mm-40 -80.39 -23.99 40.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.394 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.883 HG23 HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.54 54.81 0.61 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 77' ' ' PHE . 27.6 Cg_endo -61.74 -83.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.864 1.709 . . . . 0.0 111.743 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.49 19.89 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.368 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' PRO . 8.2 m-85 -93.17 -44.13 8.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.801 0.334 . . . . 0.0 111.088 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -128.1 -175.45 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.638 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HB3' ' CB ' ' A' ' 101' ' ' GLU . 10.1 ttt-85 -112.75 103.54 55.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.589 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -102.33 -178.77 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.223 2.615 . . . . 0.0 112.584 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 1.5 t -145.98 -176.17 5.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.05 -85.01 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.687 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.442 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 5.1 t70 -55.04 -26.31 36.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.754 0.312 . . . . 0.0 110.823 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.16 -51.53 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 81' ' ' SER . 13.7 mmt -69.55 -20.45 63.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.2 mt-10 -71.04 -41.36 70.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.667 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.741 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 2.7 tm? -60.08 -44.18 94.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.587 ' HB2' HD22 ' A' ' 182' ' ' LEU . 7.0 tpt -74.6 -35.98 62.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.155 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -64.17 -12.5 40.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.741 ' HD2' ' HA ' ' A' ' 87' ' ' LEU . 23.8 mtt-85 -75.61 -55.13 5.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.672 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 57.52 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.701 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -132.1 154.51 81.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.615 0.245 . . . . 0.0 111.184 178.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.92 -153.24 0.88 Allowed 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.712 -1.37 . . . . 0.0 112.007 -2.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.46 178.27 28.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.725 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.736 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 99.0 Cg_endo -79.58 32.57 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.673 2.249 . . . . 0.0 112.609 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -112.67 146.59 38.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.743 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.834 HG22 ' HA ' ' A' ' 179' ' ' VAL . 6.7 t -95.47 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.585 HG11 ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -115.66 109.31 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.46 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 8.7 t -98.41 126.29 51.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.56 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.87 -174.9 3.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.714 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.416 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -74.6 -177.82 3.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.173 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.525 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.99 138.21 52.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.97 -165.56 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.029 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.65 43.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.602 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -80.54 124.72 29.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.532 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 3.4 mp -74.55 -50.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.948 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.57 ' HD2' HD23 ' A' ' 105' ' ' LEU . 86.9 Cg_exo -49.27 103.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.284 1.989 . . . . 0.0 112.554 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 81.2 m-20 -80.94 -4.57 55.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.176 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -70.45 -21.58 23.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.592 HG22 HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -111.41 -35.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 64.1 p -76.95 -19.97 56.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.07 -167.69 51.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.55 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.72 5.72 73.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.59 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.7 m -122.69 -178.36 3.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.82 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 43.7 m -105.75 51.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -144.53 149.17 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.453 HG23 ' CB ' ' A' ' 102' ' ' ARG . 87.6 t -139.65 142.55 32.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.574 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -95.8 158.86 22.09 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.54 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 120' ' ' ARG . 18.9 mt -142.62 162.62 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 119' ' ' ILE . 12.5 ttt85 -146.63 128.23 15.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 111.321 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.77 81.18 2.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HB2' HG21 ' A' ' 33' ' ' THR . 72.1 Cg_endo -76.36 178.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.493 2.129 . . . . 0.0 112.551 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.38 9.74 35.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 9.1 m-20 -70.47 105.09 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.122 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.54 -49.96 74.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.411 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.18 -53.17 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.212 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -60.85 -18.35 55.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -74.69 -35.88 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -52.78 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 16' ' ' LEU . 43.7 mm -60.75 -49.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.29 -27.53 69.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.279 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.477 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . . . -54.67 -56.33 20.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -75.94 -87.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.159 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -77.0 126.75 85.12 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.188 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.08 154.6 66.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.309 2.006 . . . . 0.0 111.637 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -133.99 161.06 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.344 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 91.2 m -81.14 128.67 34.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -123.65 101.26 7.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 0.0 111.631 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -124.91 146.4 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.669 178.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.1 m -82.35 120.92 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.149 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.899 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.43 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.1 Cg_exo . . . . . 0 CA--C 1.537 0.648 0 N-CA-C 113.554 0.559 . . . . 0.0 113.554 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 64.7 Cg_endo -73.25 118.67 5.62 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 121.893 1.729 . . . . 0.0 112.217 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -85.85 144.49 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 68.4 Cg_endo -95.96 -13.63 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.927 2.418 . . . . 0.0 112.747 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 126.61 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.715 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -63.24 -40.01 96.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.155 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -18.9 62.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.61 -36.78 65.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.117 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.83 HD12 HG23 ' A' ' 165' ' ' VAL . 21.8 mt -68.78 -52.24 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.439 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.55 -27.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.0 -55.91 6.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.71 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.45 -55.83 13.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.33 -179.1 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.3 mm? -91.14 73.93 6.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.929 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.13 -42.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.883 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.95 14.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.422 ' HB ' HD12 ' A' ' 159' ' ' LEU . 3.0 t -80.67 -78.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.994 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.685 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -100.03 87.81 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.484 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.744 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.06 129.77 43.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.326 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.83 HG23 HD12 ' A' ' 155' ' ' ILE . 1.5 p -69.36 -169.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.744 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.91 154.53 42.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.399 . . . . 0.0 110.957 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.46 -21.9 19.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.3 -51.71 6.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.459 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 97.13 -155.58 20.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.744 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.9 -161.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.763 0.316 . . . . 0.0 111.086 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -146.2 -53.25 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.524 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.92 -128.63 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.526 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -85.64 144.56 27.77 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 120.84 0.353 . . . . 0.0 111.603 -178.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.84 ' HG2' HG23 ' A' ' 36' ' ' ILE . 2.5 ttp -65.29 -12.96 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.215 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.39 155.35 23.31 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.87 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.93 -139.73 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.434 0.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 192' ' ' ARG . 1.3 p -153.41 140.73 19.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.596 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 191' ' ' ARG . 23.7 m -101.44 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.0 111.322 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.834 ' HA ' HG22 ' A' ' 97' ' ' THR . 67.5 t -129.25 112.15 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.661 HG12 ' HA ' ' A' ' 189' ' ' VAL . 58.0 mt -116.71 129.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.65 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.25 65.63 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 88' ' ' MET . 39.9 tp -69.9 89.38 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -80.08 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.832 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.45 -127.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.931 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -59.21 -51.06 84.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.71 107.15 2.08 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.165 1.91 . . . . 0.0 112.403 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.667 ' HG3' ' HG ' ' A' ' 87' ' ' LEU . 82.1 Cg_endo -77.64 138.31 17.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.482 2.122 . . . . 0.0 111.961 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 181' ' ' ASP . 0.7 OUTLIER -101.08 41.63 1.17 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.374 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.661 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.8 p -56.95 105.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.015 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.1 94.63 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.541 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 178' ' ' THR . 23.3 ptt85 -83.67 140.1 32.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.756 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 177' ' ' SER . 1.6 mtt85 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.698 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 42.8 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.932 0.305 . . . . 0.0 112.537 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 29.4 m-20 -72.2 -35.31 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.797 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 48.8 t -61.35 -35.52 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.75 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.714 HD11 ' HB ' ' A' ' 130' ' ' ILE . 0.7 OUTLIER -67.29 -56.51 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.624 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.62 -22.5 61.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.24 -34.91 61.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.006 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -69.46 -34.76 74.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.054 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.67 -39.67 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.721 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 t -72.85 -42.23 63.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.833 HG22 HD13 ' A' ' 164' ' ' LEU . 8.6 p -68.37 -29.49 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.263 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 mtt -74.24 -25.42 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -1.99 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.29 5.52 84.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.64 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.31 41.59 99.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.79 178.81 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.572 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.687 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.46 144.66 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.687 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.88 126.43 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.361 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.624 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -101.85 164.4 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.513 0.197 . . . . 0.0 110.488 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -165.29 103.76 0.77 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 90.9 Cg_endo -84.1 137.5 7.37 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.704 2.269 . . . . 0.0 111.735 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.816 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.93 -152.15 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.206 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 0.7 OUTLIER -54.73 -22.19 13.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.309 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.688 HG23 ' HB2' ' A' ' 95' ' ' PRO . 2.5 p -100.04 -116.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -112.2 -175.17 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.753 0.311 . . . . 0.0 111.141 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.452 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.1 m-85 -63.42 134.09 55.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.906 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -120.33 179.51 16.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.026 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 2.6 mp -122.27 143.57 49.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.971 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.22 117.39 0.96 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.101 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG11 HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -153.91 166.0 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 111.367 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 54.9 m-20 -56.58 109.73 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.091 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.51 -46.25 84.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.202 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.69 24.92 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.5 148.1 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 -24.66 60.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.83 -27.79 63.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.24 -28.39 59.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 109' ' ' VAL . 26.0 t -67.23 -44.56 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -49.9 72.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.095 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 57.0 mmt-85 -62.29 -42.54 99.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.149 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.01 -25.71 68.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.903 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -30.51 64.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 54' ' ' ARG . 2.9 mmt85 -75.45 -49.9 17.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.309 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.71 -51.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.676 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -79.56 -5.96 56.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.293 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.15 -113.95 6.31 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.36 77.37 1.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 111.002 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -154.89 71.51 5.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 23.28 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.697 2.265 . . . . 0.0 112.531 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -122.5 -8.36 8.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 133.15 50.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.788 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.66 153.51 14.21 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.621 2.214 . . . . 0.0 112.52 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 142.54 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -97.22 148.55 22.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.653 HG13 ' HA ' ' A' ' 119' ' ' ILE . 0.9 OUTLIER -116.06 170.95 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 3.3 t -122.17 118.59 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.612 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -138.46 177.51 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.799 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.83 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 2.1 t -86.95 -41.37 13.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.453 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.405 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -164.14 170.61 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.991 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.92 -34.03 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 21.9 t70 -67.03 -28.64 68.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 67.8 mm-40 -74.45 -23.36 58.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.767 HG23 HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.31 61.23 0.79 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.783 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 34.8 Cg_endo -65.04 -72.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.063 1.842 . . . . 0.0 112.267 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.86 14.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.63 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 74' ' ' ILE . 1.7 t80 -103.64 -54.34 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.493 ' CB ' HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -120.09 172.69 7.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.768 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.52 111.49 41.77 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.933 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.14 175.29 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.948 2.432 . . . . 0.0 112.72 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.56 -177.02 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.896 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.36 -88.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.932 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -26.22 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.999 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.67 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.2 mmt -71.65 -16.22 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.055 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.56 -47.22 61.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.438 . . . . 0.0 110.401 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -57.31 -43.61 83.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.667 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.456 ' HE1' ' HE2' ' A' ' 96' ' ' TYR . 1.8 ttm -66.65 -36.73 83.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -67.96 -10.84 56.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.377 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.64 -51.69 13.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.8 65.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.228 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 3.1 tt -131.22 139.24 34.86 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.598 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 84.4 Cg_endo -79.03 -154.55 1.04 Allowed 'Cis proline' 0 C--N 1.35 0.65 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.548 -1.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.71 160.47 10.36 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.686 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 35' ' ' THR . 91.4 Cg_endo -78.67 42.37 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 112.271 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.609 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 55.3 p90 -112.18 149.9 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.6 m -96.19 141.78 29.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.156 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 182' ' ' LEU . 1.8 p -127.41 109.99 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.577 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.7 t -92.66 123.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.975 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 19.6 tp -127.26 172.27 10.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.599 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.583 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 2.8 pm0 -74.58 -176.17 2.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.521 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.659 ' HE ' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -119.07 139.43 51.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.975 0.417 . . . . 0.0 111.131 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.768 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -74.52 -157.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.94 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 106' ' ' ILE . 7.0 mm-40 -67.51 -31.85 72.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.525 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.7 tt -69.93 84.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.659 HG12 ' HE ' ' A' ' 102' ' ' ARG . 5.9 mt -80.9 104.48 2.78 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.758 ' HG2' ' HB ' ' A' ' 111' ' ' THR . 59.2 Cg_endo -70.69 154.8 63.85 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.33 2.02 . . . . 0.0 112.201 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.44 -84.04 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.752 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.79 HG21 HG22 ' A' ' 49' ' ' VAL . 27.5 m -81.88 7.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.985 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.693 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 6.8 mt -102.53 -35.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.295 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.758 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -83.12 -27.97 29.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.42 -140.55 37.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.383 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.05 -3.78 72.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.433 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -107.04 162.21 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.448 ' HB2' ' NH1' ' A' ' 102' ' ' ARG . 12.2 p -102.98 44.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -136.74 163.33 30.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 102' ' ' ARG . 80.2 t -139.78 133.71 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.652 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 119' ' ' ILE . . . -87.6 157.31 28.69 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.3 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.653 ' HA ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -135.28 167.98 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' H ' HG22 ' A' ' 119' ' ' ILE . 4.9 ttp180 -154.97 119.46 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.354 . . . . 0.0 111.417 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 121' ' ' VAL . 2.8 p -110.59 83.65 3.52 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.516 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.816 ' HB2' HG21 ' A' ' 33' ' ' THR . 72.8 Cg_endo -76.24 -178.86 4.73 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.632 2.221 . . . . 0.0 112.67 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.02 -4.88 51.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.714 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.4 OUTLIER -62.04 110.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.989 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.06 -46.54 82.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.672 HG23 HD22 ' A' ' 16' ' ' LEU . 38.0 mm -62.03 -54.88 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.969 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.714 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 98.5 m -60.2 -19.78 55.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -75.63 -43.65 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -72.67 -54.45 9.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.654 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.714 ' HB ' HD11 ' A' ' 16' ' ' LEU . 1.5 tt -57.44 -45.35 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.504 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.52 -25.11 62.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.58 -56.5 18.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.024 0.44 . . . . 0.0 110.125 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -75.91 -83.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.145 177.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 3.2 t80 -77.11 128.19 81.61 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.3 155.13 64.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.323 2.015 . . . . 0.0 111.603 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.21 157.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.337 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.604 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.42 138.8 36.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.82 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.02 109.12 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 111.605 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -131.8 127.29 36.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.789 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.0 t -71.19 119.16 14.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 111.152 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.7 Cg_exo . . . . . 0 CA--C 1.537 0.637 0 N-CA-C 113.517 0.545 . . . . 0.0 113.517 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 65.6 Cg_endo -73.03 118.05 5.39 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.828 1.685 . . . . 0.0 112.378 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 143.77 26.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.817 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -96.0 -12.47 0.68 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.885 2.39 . . . . 0.0 112.863 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.59 122.45 27.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.31 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -59.97 -30.88 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.841 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -29.18 60.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.124 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -67.43 -28.6 68.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 159' ' ' LEU . 46.5 mt -75.04 -50.73 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.485 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.34 -33.82 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.925 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -75.6 -58.4 3.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.756 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.51 -34.05 77.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.821 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.939 HD13 ' HB3' ' A' ' 163' ' ' ASP . 85.0 mt -106.33 68.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.331 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 8.5 t70 -16.34 -63.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.778 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.02 22.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 111.121 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.65 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.77 -63.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.939 ' HB3' HD13 ' A' ' 159' ' ' LEU . 3.6 t70 -107.56 100.24 9.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.011 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.833 HD13 HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.61 124.7 25.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.601 -177.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.805 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.2 p -64.02 -166.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.805 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.62 160.04 30.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.01 -25.02 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.289 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.32 -55.85 3.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.456 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 101.18 -163.52 18.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.862 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.01 -165.97 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.413 ' HB2' ' C ' ' A' ' 33' ' ' THR . 22.1 m -144.64 -60.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.628 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -124.35 -130.85 0.26 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.91 141.68 29.39 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.801 0.334 . . . . 0.0 111.465 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.96 -36.78 70.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -142.6 158.79 59.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.73 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 64.4 Cg_endo -91.46 -147.73 0.27 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.734 1.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 1.4 p -155.03 156.39 35.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.609 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.5 m -99.56 142.24 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.157 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.408 HG21 ' NH1' ' A' ' 192' ' ' ARG . 0.7 OUTLIER -129.0 89.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.771 HG23 ' HA ' ' A' ' 189' ' ' VAL . 12.2 mt -104.43 134.17 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -108.28 68.16 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.173 178.145 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.637 ' HB3' HG23 ' A' ' 98' ' ' VAL . 12.1 tp -69.75 87.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.358 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -77.25 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.66 0.267 . . . . 0.0 110.808 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.56 -126.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.467 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.7 OUTLIER -63.8 -53.42 50.11 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.19 108.22 2.46 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.161 1.907 . . . . 0.0 112.356 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.1 Cg_endo -76.22 139.2 20.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.451 2.1 . . . . 0.0 112.075 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.2 OUTLIER -99.42 49.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 180' ' ' ILE . 8.9 t -56.87 98.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.45 85.95 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.024 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.568 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -83.68 154.77 23.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.408 ' NH1' HG21 ' A' ' 179' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.0 Cg_exo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.855 0.273 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.0 -34.59 73.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.796 HG11 HD13 ' A' ' 126' ' ' ILE . 18.9 t -59.43 -53.64 45.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 20' ' ' ILE . 3.1 mm? -61.9 -35.98 79.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.407 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' ' 20' ' ' ILE . 2.8 mt-10 -57.72 -30.63 65.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.709 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -77.3 -32.89 55.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.286 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -71.15 -46.91 60.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.57 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -75.84 -17.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 13.0 t -66.12 -53.86 32.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 164' ' ' LEU . 9.7 p -69.78 -27.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 mtt -60.1 -37.15 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.09 -16.68 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.25 9.57 77.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.591 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.27 51.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.49 161.62 22.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.427 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.663 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.24 143.21 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.663 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.04 146.08 21.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.511 ' H ' HG13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -111.19 165.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 178.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -170.9 92.0 0.46 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.815 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.9 Cg_endo -81.55 157.3 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.545 2.163 . . . . 0.0 111.127 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.63 ' HA ' ' CB ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.35 -150.88 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.24 -20.81 45.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.74 -98.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.036 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.2 OUTLIER -131.47 -166.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.874 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.815 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m-85 -72.68 131.12 41.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.781 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -117.2 178.59 17.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.136 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.731 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.5 mt -133.96 144.49 48.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.351 . . . . 0.0 110.831 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.17 131.48 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.292 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.564 HG11 HG12 ' A' ' 28' ' ' ILE . 1.1 m -156.53 163.35 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.5 m-20 -56.57 106.58 0.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.366 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.95 84.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.877 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.53 18.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -110.62 146.77 35.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.24 -23.82 57.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.02 -26.77 68.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.21 -36.92 61.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -65.3 -43.64 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -70.05 -42.89 72.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.234 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -68.9 -29.39 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -67.59 -38.39 83.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.891 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -65.35 -37.73 87.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.69 -40.52 95.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.348 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.81 -57.92 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.288 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -81.89 -70.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.277 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.32 4.75 24.94 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.614 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.2 18.23 13.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -134.53 66.13 69.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.2 -54.38 5.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.79 2.327 . . . . 0.0 112.454 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -122.39 24.48 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -88.29 149.72 45.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.001 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.13 169.1 14.24 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.506 2.138 . . . . 0.0 112.289 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG21 HG22 ' A' ' 110' ' ' ILE . 32.9 m -119.48 162.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.04 138.48 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.563 HG13 HG23 ' A' ' 119' ' ' ILE . 9.4 pt -116.01 165.95 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 41.9 t -122.06 130.45 53.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.941 HG21 HG23 ' A' ' 74' ' ' ILE . 1.4 p -138.34 -175.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.394 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.782 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 5.6 t -88.94 -45.85 9.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -164.49 168.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.831 179.416 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.608 HG11 ' HG3' ' A' ' 85' ' ' MET . 10.2 t -55.34 -35.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.631 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.63 -28.98 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.92 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 2.9 mp0 -75.23 -15.99 60.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.44 58.18 0.7 Allowed Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.934 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 77' ' ' PHE . 20.4 Cg_endo -60.02 -86.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.07 1.847 . . . . 0.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -73.32 22.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 75' ' ' PRO . 27.1 m-85 -96.99 -47.33 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 111.008 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.1 p -129.83 -175.0 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.25 99.84 51.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -102.69 -173.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.284 2.656 . . . . 0.0 112.508 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.768 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.4 m -141.93 176.87 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.61 -87.9 0.2 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.839 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -33.76 64.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -57.34 -46.57 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.608 ' HG3' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -75.02 -25.5 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.246 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -46.99 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 0.0 110.924 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.9 tp -66.41 -43.86 84.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.155 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.605 ' SD ' HD23 ' A' ' 182' ' ' LEU . 6.0 tpt -63.44 -57.42 10.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.529 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -63.2 -11.81 23.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 1.8 mtt180 -67.12 -32.79 74.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.26 60.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -131.2 149.28 73.23 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.19 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 6.3 Cg_exo -78.54 -158.04 1.61 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.101 -1.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.24 162.08 11.31 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.829 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.25 46.5 2.21 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.847 2.365 . . . . 0.0 112.598 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -112.11 -179.53 3.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.066 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 m -115.27 145.62 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.685 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.04 91.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.373 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 16.7 t -87.28 122.56 39.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.756 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.446 HD12 HD12 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -126.67 175.91 7.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.591 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.08 158.87 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.218 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.564 ' CZ ' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -119.83 145.47 46.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.208 0.527 . . . . 0.0 111.184 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.84 174.93 8.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -76.66 60.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.22 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.467 HD12 ' NH1' ' A' ' 102' ' ' ARG . 1.6 mt -71.37 154.01 41.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.579 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 mt -76.32 -51.28 2.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.728 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 16.5 Cg_endo -57.04 101.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.234 1.956 . . . . 0.0 112.243 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.22 4.56 23.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -83.77 -17.63 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.706 HG22 HG21 ' A' ' 64' ' ' VAL . 1.1 pt -113.03 -29.03 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 107' ' ' PRO . 17.3 p -79.07 -35.43 42.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -169.2 46.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -70.47 -14.68 72.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p -117.64 -179.97 3.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.342 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.0 t -107.36 61.86 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mpp_? -141.2 141.5 34.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.564 HG21 ' CZ ' ' A' ' 102' ' ' ARG . 77.8 t -142.88 139.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.008 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.26 159.45 19.96 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.92 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.704 HD13 HD13 ' A' ' 74' ' ' ILE . 1.1 mt -141.22 173.47 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.602 ' H ' HG22 ' A' ' 119' ' ' ILE . 7.1 ptp180 -162.64 131.13 4.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.7 t -110.97 86.82 6.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.514 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.4 -177.78 2.93 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.531 2.154 . . . . 0.0 112.423 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.42 8.97 25.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.068 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.5 OUTLIER -76.45 100.91 5.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.796 HD13 HG11 ' A' ' 15' ' ' VAL . 85.5 mt -57.84 -50.99 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -65.99 -18.34 65.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.714 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 69' ' ' SER . 3.8 ttt180 -75.2 -37.66 61.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.999 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -51.21 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 131' ' ' ALA . 2.0 tt -62.6 -43.69 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.775 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -68.06 -28.24 67.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.97 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.01 33.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.084 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -75.76 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.266 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -77.21 128.93 79.5 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.207 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.21 144.03 32.76 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.337 2.025 . . . . 0.0 111.514 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.54 157.02 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 111.462 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.651 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 36.2 m -79.14 143.45 35.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.835 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -139.19 110.1 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.964 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.731 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -127.53 150.58 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.281 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.67 116.13 17.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.433 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.6 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 40.0 Cg_exo . . . . . 0 CA--C 1.538 0.719 0 N-CA-C 113.228 0.434 . . . . 0.0 113.228 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 7.4 Cg_exo -73.46 106.23 2.14 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.096 1.864 . . . . 0.0 112.291 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.08 155.95 36.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -95.41 -14.52 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.769 2.312 . . . . 0.0 112.775 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.7 mmt180 -134.38 128.86 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.935 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.592 ' O ' HG11 ' A' ' 165' ' ' VAL . 5.7 mt -61.07 -45.46 94.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.066 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -23.52 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.79 -31.19 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.169 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -75.49 -51.21 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.529 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.815 HG13 HG13 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -59.0 -25.5 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.416 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -75.08 -48.99 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.15 -21.77 58.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 163' ' ' ASP . 81.0 mt -111.23 68.05 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.03 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.5 t70 -16.26 -63.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.176 0.923 . . . . 0.0 112.724 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -159.26 23.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.235 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.643 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.88 -65.22 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.759 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 159' ' ' LEU . 47.5 t0 -111.37 102.34 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.575 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -74.49 131.15 40.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.573 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.815 HG13 HG13 ' A' ' 156' ' ' VAL . 17.1 m -65.33 -166.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.164 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.775 HD12 ' H ' ' A' ' 169' ' ' GLY . 0.4 OUTLIER -126.3 167.39 15.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.669 ' HB3' HG13 ' A' ' 15' ' ' VAL . 3.2 t70 -92.47 -39.87 11.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.595 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 126' ' ' ILE . . . -64.09 -70.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.305 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.775 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 89.37 51.26 2.98 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.837 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.63 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 3.7 m-20 -71.99 121.2 18.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.75 123.74 4.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.266 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -137.18 -113.85 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.448 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -85.38 127.53 34.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.506 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.08 -1.64 10.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.122 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.72 157.34 36.08 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.692 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -92.64 -151.66 0.36 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.737 1.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.8 p -156.91 115.1 3.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.1 m -102.31 143.58 31.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 111.499 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.5 105.87 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.727 HG23 ' HA ' ' A' ' 189' ' ' VAL . 13.7 mt -114.31 131.18 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.72 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.6 m-20 -99.42 73.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.718 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.605 HD23 ' SD ' ' A' ' 88' ' ' MET . 0.2 OUTLIER -68.79 81.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.309 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -86.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.321 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.49 -128.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -59.82 -51.03 83.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 72.6 Cg_endo -76.53 108.67 2.71 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.203 1.936 . . . . 0.0 112.504 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 83.8 Cg_endo -83.96 121.92 2.89 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.645 2.23 . . . . 0.0 112.257 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.72 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.6 mtm180 -89.35 54.38 2.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.489 . . . . 0.0 111.149 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.727 ' HA ' HG23 ' A' ' 180' ' ' ILE . 48.3 t -59.33 106.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.8 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.47 86.86 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -89.75 140.65 29.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.605 ' HG2' HD23 ' A' ' 16' ' ' LEU . 44.2 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.599 0.166 . . . . 0.0 112.052 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.714 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 m-20 -67.46 -28.12 67.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.87 -58.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.605 HD23 ' HG2' ' A' ' 13' ' ' PRO . 4.4 mm? -60.27 -42.48 95.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.27 -31.37 63.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.035 0.445 . . . . 0.0 110.485 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 5.1 mm-40 -76.29 -32.11 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.186 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -75.64 -41.73 53.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.907 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 21' ' ' SER . 1.9 pp -71.7 -31.37 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.025 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.532 ' N ' HD12 ' A' ' 20' ' ' ILE . 5.7 p -75.18 -38.0 61.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.787 HG11 HD13 ' A' ' 164' ' ' LEU . 11.6 p -75.66 -29.39 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.083 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mtt -62.11 -42.7 99.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.634 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -4.97 26.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.813 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.76 78.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 51.69 37.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.812 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.17 165.24 22.57 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.427 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.5 148.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.703 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -116.39 127.42 74.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.733 -179.383 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.504 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -102.71 151.6 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.635 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.519 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -157.05 113.35 1.94 Allowed Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.63 134.26 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.721 2.281 . . . . 0.0 111.377 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.574 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -116.49 -149.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 111.191 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 11.7 m-20 -54.58 -22.08 12.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.194 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 36' ' ' ILE . 4.6 t -100.38 -121.82 0.16 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.75 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.52 -149.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.761 0.315 . . . . 0.0 111.454 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.476 ' OH ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -64.96 129.59 40.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.446 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.72 170.68 15.36 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.959 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 139' ' ' THR . 1.6 mp -123.45 141.13 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.929 0.395 . . . . 0.0 111.263 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.34 111.5 0.58 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.696 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 42' ' ' ASN . 2.5 p -151.79 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.645 0.26 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.601 ' H ' HG22 ' A' ' 41' ' ' VAL . 14.2 m120 -56.42 116.86 3.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 110.493 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.0 -56.02 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.988 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 44' ' ' LEU . 1.4 mm? -82.81 37.11 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.553 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -110.94 156.17 21.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 178.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -31.91 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.441 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.15 -28.15 68.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.518 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -72.25 -35.43 68.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.718 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.0 t -66.17 -48.28 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 50' ' ' ARG . 11.2 mtt180 -63.73 -45.17 91.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.546 ' HG3' HG13 ' A' ' 28' ' ' ILE . 11.0 mmm180 -65.25 -30.67 71.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -66.59 -46.48 75.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.6 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.89 -18.08 63.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.091 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -73.24 -67.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.701 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.28 -41.16 57.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -80.08 -11.32 59.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.626 0.251 . . . . 0.0 111.292 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 -139.0 39.05 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.416 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.2 85.48 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.82 67.45 23.21 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.88 9.31 2.03 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 0.0 112.511 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -105.21 -26.31 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.28 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -88.12 128.8 52.31 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.287 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 35.7 Cg_exo -59.73 171.63 2.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 110' ' ' ILE . 5.0 m -114.85 150.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.322 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -99.91 133.93 43.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.449 HD11 HG12 ' A' ' 119' ' ' ILE . 10.5 pt -113.94 172.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.505 ' SG ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m -122.07 129.37 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG21 HG23 ' A' ' 74' ' ' ILE . 1.8 p -136.0 179.06 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.707 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 30.3 t -86.18 -42.54 13.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.261 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.5 166.22 20.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.422 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG21 ' SD ' ' A' ' 85' ' ' MET . 26.8 t -57.68 -31.33 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.5 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 37.0 t70 -67.44 -27.59 67.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.812 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 0.6 OUTLIER -76.73 -21.04 55.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.119 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.809 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.34 58.79 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 34.7 Cg_endo -65.08 -74.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.007 1.804 . . . . 0.0 112.003 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.19 15.18 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.5 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 32.5 m-85 -100.52 -45.95 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 p -135.23 159.49 41.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.679 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.496 ' HG3' ' HB3' ' A' ' 101' ' ' GLU . 7.1 ptm180 -119.14 104.16 46.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.012 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HB3' HD22 ' A' ' 100' ' ' LEU . 85.5 Cg_endo -102.23 -166.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.14 2.56 . . . . 0.0 112.399 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 166.27 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.84 -73.47 0.68 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.586 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.636 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -55.33 -34.44 64.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.797 0.332 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.47 ' HB1' HD21 ' A' ' 182' ' ' LEU . . . -64.01 -36.68 84.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.678 ' SD ' HG21 ' A' ' 71' ' ' VAL . 4.2 mmt -71.36 -17.99 62.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.095 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.636 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.6 mt-10 -71.58 -47.2 56.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.934 0.397 . . . . 0.0 110.573 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.23 -40.55 81.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.533 ' HG2' HG11 ' A' ' 98' ' ' VAL . 4.4 tpt -74.76 -46.12 39.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.507 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.83 -14.64 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.298 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -44.83 63.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.4 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 3.7 pt -108.81 53.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 6.3 tt -130.97 131.73 23.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 87.6 Cg_endo -78.08 -163.4 3.36 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.478 -0.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.62 167.11 16.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.95 37.22 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.748 2.299 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.4 ' CE2' ' HB ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -112.17 144.31 41.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.647 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 1.3 m -94.74 148.77 21.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.71 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.533 HG11 ' HG2' ' A' ' 88' ' ' MET . 2.1 t -126.49 102.51 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.24 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.834 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 2.8 t -93.55 120.1 42.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 80' ' ' PRO . 1.1 mp -126.99 -168.5 1.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.576 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -74.83 169.33 18.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.552 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.563 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.17 147.13 44.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 105' ' ' LEU . 22.1 p-10 -73.72 -152.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.314 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 31.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.47 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.738 HD13 ' HD2' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -69.53 94.85 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.725 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.603 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 6.1 mt -64.91 -50.79 61.0 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.71 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.738 ' HD2' HD13 ' A' ' 105' ' ' LEU . 76.5 Cg_exo -50.38 108.85 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.128 1.885 . . . . 0.0 112.316 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.22 -1.53 41.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.788 HG13 HG13 ' A' ' 110' ' ' ILE . 15.0 p -69.98 -21.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.788 HG13 HG13 ' A' ' 109' ' ' VAL . 5.1 mt -105.03 -52.25 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.037 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -68.2 -14.27 62.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.54 -154.75 40.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -87.62 6.25 83.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.362 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.9 169.93 9.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.769 0.318 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -99.0 39.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -136.92 158.99 43.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 102' ' ' ARG . 98.7 t -139.95 147.87 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.478 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -98.99 146.89 18.31 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.389 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.759 HD13 HD13 ' A' ' 74' ' ' ILE . 24.8 mt -148.26 134.98 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -144.58 146.52 32.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.962 0.41 . . . . 0.0 111.438 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 68' ' ' VAL . 1.7 m -110.22 96.82 27.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HB2' HG21 ' A' ' 33' ' ' THR . 50.6 Cg_endo -68.14 -179.28 2.12 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.501 2.134 . . . . 0.0 112.449 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 5.2 47.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.97 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.3 104.54 6.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.35 -49.01 77.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.194 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.493 HG23 HD21 ' A' ' 16' ' ' LEU . 30.6 mm -59.83 -48.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.1 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -20.89 65.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 128' ' ' ARG . 0.3 OUTLIER -75.19 -27.36 59.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.987 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -74.31 -60.4 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.172 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -58.27 -45.5 89.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.73 -28.25 69.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.006 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 129' ' ' ARG . . . -54.76 -53.4 55.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -75.28 -88.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.123 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -77.09 144.96 72.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.41 159.09 47.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.321 2.014 . . . . 0.0 111.603 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 t -133.65 150.25 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.526 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.614 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 m -80.9 140.47 35.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.824 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.7 107.13 8.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.494 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.12 122.24 22.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.905 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 110.54 5.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.017 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.552 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.8 Cg_exo . . . . . 0 CA--C 1.536 0.583 0 N-CA-C 113.322 0.47 . . . . 0.0 113.322 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 28.4 Cg_endo -62.1 129.66 27.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.781 1.654 . . . . 0.0 111.976 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.468 ' HB3' HD11 ' A' ' 155' ' ' ILE . 8.6 p -85.86 121.91 72.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -95.11 -28.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.882 2.388 . . . . 0.0 112.297 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 131.85 18.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.338 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 152' ' ' LEU . 25.7 mt -59.95 -36.48 77.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.255 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -19.4 59.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.98 -44.83 79.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.851 HD12 HG23 ' A' ' 165' ' ' VAL . 11.6 mt -68.29 -44.1 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.17 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.96 -41.27 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.418 ' HD2' HH11 ' A' ' 157' ' ' ARG . 0.1 OUTLIER -75.38 -53.31 8.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.498 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.644 ' HB3' HD22 ' A' ' 159' ' ' LEU . 9.6 t70 -56.6 -39.85 74.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.496 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.644 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.6 mm? -111.37 77.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.934 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.43 -43.2 0.56 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.094 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.26 19.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 48.7 t -80.45 -97.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.529 ' OD1' ' HG ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -94.72 92.25 6.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.46 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.787 HD13 HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -55.57 135.13 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.026 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.851 HG23 HD12 ' A' ' 155' ' ' ILE . 0.7 OUTLIER -66.6 172.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.648 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.55 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -127.42 127.34 43.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.521 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -7.95 46.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.746 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -64.08 -38.21 90.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.388 . . . . 0.0 110.655 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.498 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 102.25 166.67 26.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.084 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -152.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.574 ' HB2' ' C ' ' A' ' 33' ' ' THR . 11.4 m -144.28 -63.22 0.37 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -130.47 -138.68 0.21 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.4 168.43 13.14 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.75 ' HG2' HG23 ' A' ' 36' ' ' ILE . 61.9 mtp -71.01 1.39 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.012 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.17 160.17 26.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 177' ' ' SER . 68.8 Cg_endo -97.02 -149.65 0.18 OUTLIER 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.737 1.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.436 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -153.77 120.45 5.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.484 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.8 m -99.73 137.21 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.398 . . . . 0.0 111.483 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.23 107.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.607 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.576 HG23 ' HA ' ' A' ' 189' ' ' VAL . 3.1 mt -119.14 132.95 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.64 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.834 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 9.2 m-20 -97.88 69.24 2.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.163 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 88' ' ' MET . 3.5 tt -69.44 87.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.408 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -81.76 0.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.493 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.5 -126.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.864 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.41 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -60.58 -52.63 71.35 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -77.27 108.39 2.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.237 1.958 . . . . 0.0 112.626 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 1.0 OUTLIER -84.07 132.45 5.39 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.017 2.478 . . . . 0.0 112.071 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.655 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.1 mmm180 -91.88 59.18 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 110.897 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 180' ' ' ILE . 46.7 t -59.16 109.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.53 88.33 2.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.05 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -90.94 127.77 36.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.819 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.654 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.819 0.258 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.08 -29.54 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.19 -31.77 25.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.92 -41.57 64.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 21' ' ' SER . 1.4 pt-20 -74.87 -19.02 60.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.3 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.0 -36.73 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.82 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -72.77 -40.84 65.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.592 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.47 -17.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -71.94 -46.34 57.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 164' ' ' LEU . 9.6 p -73.5 -27.78 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 15.2 mtt -59.76 -49.42 77.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.113 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.67 -12.96 61.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.57 1.03 89.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.503 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.14 44.26 87.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.9 170.43 19.38 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.362 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.45 143.84 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.428 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.681 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.63 140.03 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.701 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.578 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -105.46 165.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.445 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.2 103.32 0.31 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.779 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 83.3 Cg_endo -82.69 135.72 8.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.6 2.2 . . . . 0.0 111.744 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -120.21 -155.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.804 0.335 . . . . 0.0 111.414 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.8 OUTLIER -54.72 -21.17 10.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -98.42 -117.92 0.14 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.848 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.3 OUTLIER -112.6 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.723 0.297 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.37 131.38 47.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.714 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -123.11 176.47 16.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.482 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.4 mt -133.32 142.99 48.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.741 0.305 . . . . 0.0 110.839 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.665 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.5 134.69 5.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.059 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.664 HG22 ' NH1' ' A' ' 51' ' ' ARG . 3.9 m -152.69 168.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.773 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 6.2 t-20 -56.61 105.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.259 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.12 75.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.278 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -79.89 22.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.87 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.773 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.25 161.71 15.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 178.449 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -25.18 58.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 110.426 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 6.5 m-20 -60.59 -28.82 68.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.806 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.09 -27.16 59.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.92 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.686 HG13 HG21 ' A' ' 109' ' ' VAL . 46.2 t -65.66 -54.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -71.33 -22.19 61.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.688 ' NH2' HG22 ' A' ' 139' ' ' THR . 0.0 OUTLIER -68.01 -34.48 76.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.997 0.427 . . . . 0.0 110.754 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.571 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.8 OUTLIER -74.96 -44.44 48.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.391 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.52 -34.53 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.181 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -66.41 -61.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.439 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.76 -51.12 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -79.86 -70.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.454 -178.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.93 -11.7 0.62 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.08 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 56' ' ' LYS . 2.6 ptp180 -118.4 40.19 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.784 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 p -141.72 63.75 17.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.44 -66.85 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.652 2.235 . . . . 0.0 112.591 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.719 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 53.3 m80 -108.59 24.44 13.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 2.1 mttt -88.41 147.48 40.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.16 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HD2' ' HG2' ' A' ' 62' ' ' LYS . 62.0 Cg_endo -73.8 161.26 41.99 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.591 2.194 . . . . 0.0 112.269 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 110' ' ' ILE . 3.8 p -114.05 151.53 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.8 t -94.16 134.22 36.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.214 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -116.24 172.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.796 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 20.7 t -119.96 136.88 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.768 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -135.86 -179.57 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.639 ' H ' HG22 ' A' ' 68' ' ' VAL . 1.2 t -76.09 -49.67 16.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.155 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.579 ' SG ' HD21 ' A' ' 92' ' ' LEU . 1.2 m -163.93 179.86 6.74 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.143 0.497 . . . . 0.0 111.664 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.712 ' HA ' HD11 ' A' ' 74' ' ' ILE . 60.9 t -52.44 -41.29 35.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.111 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -69.57 -27.82 65.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.905 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.85 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 1.4 tp10 -80.99 -8.22 59.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.712 HD11 ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -90.86 -38.56 0.39 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.668 ' HG3' ' HG3' ' A' ' 80' ' ' PRO . 99.8 Cg_exo -44.03 -23.3 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.491 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -55.22 -59.33 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -107.51 3.89 25.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -118.05 179.7 4.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.5 94.44 26.26 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.668 ' HG3' ' HG3' ' A' ' 75' ' ' PRO . 68.3 Cg_endo -102.49 -166.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.2 2.6 . . . . 0.0 112.687 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 177.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.15 -83.28 0.41 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.769 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.93 -33.25 62.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.842 0.353 . . . . 0.0 111.152 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -60.41 -49.36 77.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.44 ' CE ' HD11 ' A' ' 100' ' ' LEU . 17.7 mmt -71.94 -14.91 62.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.255 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.0 mm-40 -66.59 -46.68 75.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.4 tm? -61.35 -38.4 86.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.201 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.476 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 5.9 tpt -66.29 -43.11 87.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.27 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -69.95 -39.69 75.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.058 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.12 51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.648 HD13 HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -131.36 134.65 25.93 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.28 -162.34 2.95 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.277 -1.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.93 166.78 15.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.562 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.9 Cg_endo -81.29 41.72 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.742 2.295 . . . . 0.0 112.482 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.2 m-85 -111.31 156.21 21.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.819 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 59.2 m -94.93 135.62 36.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.355 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.434 ' O ' ' HB ' ' A' ' 119' ' ' ILE . 6.5 t -122.49 98.94 6.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.292 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.797 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 18.9 t -95.48 128.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.623 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.44 HD11 ' CE ' ' A' ' 85' ' ' MET . 2.3 mm? -126.96 -178.6 4.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -178.73 3.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.325 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.546 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.18 137.7 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.322 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 6.8 t30 -74.25 -168.19 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.902 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 37.56 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.474 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.877 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 1.6 tp -72.11 132.25 43.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.58 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 19.9 mm -73.33 -50.6 6.22 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.665 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.877 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 72.8 Cg_exo -49.77 109.99 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.241 1.961 . . . . 0.0 112.353 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.09 -17.79 45.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.125 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.686 HG21 HG13 ' A' ' 49' ' ' VAL . 14.8 p -69.18 -22.6 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.247 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.524 ' O ' HG12 ' A' ' 64' ' ' VAL . 45.0 mt -93.88 -43.58 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.025 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.691 ' HA ' HG22 ' A' ' 117' ' ' VAL . 22.1 p -81.28 -6.52 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.05 -169.8 50.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 61' ' ' HIS . . . -78.23 -1.5 80.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.365 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.48 -172.75 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 111.017 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 3.4 p -106.22 39.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -136.77 153.1 50.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.047 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 111' ' ' THR . 93.8 t -139.81 144.53 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.468 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.491 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -91.32 155.55 23.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.385 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 118' ' ' GLY . 3.8 mt -143.94 151.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.592 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.3 ttt180 -144.67 126.79 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.41 HG11 HD11 ' A' ' 92' ' ' LEU . 9.8 t -111.14 78.3 1.71 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 15.2 Cg_exo -69.71 -176.32 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.55 6.48 45.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.83 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 100.2 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -57.47 -45.71 84.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.032 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.9 mt -62.25 -53.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.185 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -24.01 62.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 1.7 ttm105 -68.95 -36.49 77.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -54.57 12.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.5 mt -60.47 -49.47 84.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.768 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.29 -28.91 68.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.85 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.68 -56.7 16.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.35 -89.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -76.69 127.57 83.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.095 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 153.8 72.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.28 1.987 . . . . 0.0 111.628 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.03 155.82 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.119 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.665 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -80.56 139.5 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.031 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -143.24 111.52 6.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.882 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.688 HG22 ' NH2' ' A' ' 51' ' ' ARG . 2.1 t -140.24 138.15 34.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.545 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 15.0 p -70.6 126.78 30.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.338 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.523 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 46.2 Cg_exo . . . . . 0 CA--C 1.537 0.667 0 N-CA-C 113.474 0.529 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 40.6 Cg_endo -67.15 106.49 1.19 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.845 1.697 . . . . 0.0 112.327 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.09 136.5 21.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.517 ' HG2' ' HG2' ' A' ' 151' ' ' ARG . 69.3 Cg_endo -95.71 -12.25 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.865 2.377 . . . . 0.0 112.445 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -128.29 112.34 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.777 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -56.49 -32.6 65.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.219 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -24.88 58.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.287 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 2.2 tt0 -72.51 -31.01 65.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.509 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.707 HG22 HD12 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -75.22 -51.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.313 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.03 -36.32 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.54 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 157' ' ' ARG . 5.4 mmt85 -72.73 -51.15 20.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.338 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.18 -24.57 64.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.433 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.707 HD12 HG22 ' A' ' 155' ' ' ILE . 40.5 mt -111.22 79.46 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.143 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.2 t70 -28.15 -51.2 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.223 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -161.65 26.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.74 -92.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.535 ' OD1' HD13 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -89.95 88.51 7.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.795 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -56.26 129.39 40.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.388 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.552 HG12 HD12 ' A' ' 155' ' ' ILE . 35.4 m -66.37 -172.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.21 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.676 HD22 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.78 156.25 41.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -92.62 -19.6 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.4 -50.74 7.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 94.11 -157.02 22.52 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.909 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.07 -163.26 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.623 0.249 . . . . 0.0 111.105 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 m -150.18 -60.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -123.57 -130.19 0.26 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.6 OUTLIER -86.31 144.77 27.21 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.82 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.848 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.6 ttp -68.79 -15.71 63.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -154.51 160.83 30.53 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 70.2 Cg_endo -89.43 -142.41 0.16 OUTLIER 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.548 0.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 73.1 m -153.88 131.86 11.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.834 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.691 HG23 ' HB3' ' A' ' 191' ' ' ARG . 75.9 m -102.33 142.13 34.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.819 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 19.2 t -129.08 110.4 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.006 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.738 HG23 ' HA ' ' A' ' 189' ' ' VAL . 5.4 mt -120.69 125.08 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.182 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.797 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -102.32 66.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 84' ' ' ALA . 21.7 tp -69.58 83.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.527 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -80.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.447 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 185' ' ' ASN . 4.2 t -120.73 -121.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.166 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.454 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -62.66 -52.86 61.7 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.1 109.61 2.73 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.208 1.938 . . . . 0.0 112.445 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 189' ' ' VAL . 93.9 Cg_endo -80.45 127.83 6.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.615 2.21 . . . . 0.0 112.329 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -88.39 45.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 180' ' ' ILE . 9.1 t -56.87 96.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.791 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.24 84.7 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.149 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.691 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -86.02 140.02 30.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 192' ' ' ARG . 1.2 mtt85 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.823 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' CG ' HD23 ' A' ' 16' ' ' LEU . 51.4 Cg_exo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.888 0.287 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -35.74 79.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.147 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.27 -53.21 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.167 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.3 mm? -60.06 -32.62 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.623 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.98 67.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.788 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -36.6 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.55 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.34 -42.8 53.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -66.97 -30.14 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.114 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.8 p -66.5 -44.49 82.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.061 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 18' ' ' GLU . 35.7 t -65.32 -29.45 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.5 mmt -62.7 -44.6 95.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -17.74 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.86 89.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.98 39.78 93.29 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.51 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.84 171.93 15.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.7 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -96.17 140.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.61 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.646 ' H ' HG13 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -116.55 130.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.197 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -101.68 168.89 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.574 0.226 . . . . 0.0 110.756 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -169.48 102.4 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.413 ' HG2' ' HA ' ' A' ' 170' ' ' ASP . 89.3 Cg_endo -83.06 143.74 11.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.544 2.163 . . . . 0.0 111.888 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.43 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -123.16 -160.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.732 ' HB3' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -66.83 -25.35 66.4 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -88.7 -89.9 0.14 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.257 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' H ' HG23 ' A' ' 35' ' ' THR . 1.3 tt -133.68 174.99 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 111.06 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -68.21 143.16 55.43 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -134.82 177.13 19.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.745 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.769 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.0 mt -125.55 144.38 50.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.87 0.367 . . . . 0.0 110.553 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.57 125.59 2.35 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.024 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.646 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -156.58 178.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 111.105 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.43 122.73 12.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.317 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.84 -60.67 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.05 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.4 mm? -81.07 37.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.1 149.76 30.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -75.14 -18.59 60.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -26.64 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.667 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -74.71 -44.55 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.997 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -35.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -38.87 78.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.671 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.584 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.3 -45.18 70.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.781 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.639 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.3 OUTLIER -60.83 -25.83 66.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.784 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -72.88 -34.82 66.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.27 -49.81 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.358 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 140' ' ' SER . 70.9 t -65.27 -49.85 76.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.588 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.602 ' HE2' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -79.75 -6.38 57.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 111.18 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.43 -92.05 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.64 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HG3' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -102.86 116.05 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.466 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 60.8 p -155.11 57.44 1.65 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.09 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 59' ' ' SER . 50.7 Cg_exo -54.11 -57.18 1.98 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.411 2.074 . . . . 0.0 112.285 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.06 30.32 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HD3' ' HE2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.54 135.77 33.86 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.826 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.92 160.79 45.34 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 112.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 110' ' ' ILE . 9.3 m -118.75 162.51 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 t -110.6 141.15 44.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.97 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.503 HG13 HG12 ' A' ' 119' ' ' ILE . 5.9 pt -116.49 167.34 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.01 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.701 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -119.78 135.7 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.874 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -141.53 -178.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.634 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 68' ' ' VAL . 21.6 t -89.71 -41.86 11.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.564 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.18 170.69 16.02 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.52 -37.63 59.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -67.41 -21.89 65.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.159 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -77.15 -26.27 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.874 HG23 HG21 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -113.48 58.81 0.74 Allowed Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 21.5 Cg_endo -60.49 -84.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.066 1.844 . . . . 0.0 111.965 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.57 23.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.389 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 26.0 m-85 -98.9 -31.78 11.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.673 0.273 . . . . 0.0 111.228 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -135.08 178.31 7.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.083 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -113.23 90.21 16.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 78' ' ' SER . 69.2 Cg_endo -102.23 176.39 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.049 2.499 . . . . 0.0 112.645 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -177.31 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.046 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.03 -75.23 0.74 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.516 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.461 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -59.19 -29.95 67.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.821 0.343 . . . . 0.0 110.856 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -61.74 -47.34 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 9.5 mmt -74.21 -18.63 60.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.161 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.4 mm-40 -63.01 -45.18 93.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.524 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.586 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.611 ' HG2' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.92 -58.24 8.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.306 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -4.0 16.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.321 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -56.33 4.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.048 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.45 71.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.583 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.606 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.35 151.76 79.36 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.997 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.648 ' HB3' HG22 ' A' ' 121' ' ' VAL . 5.5 Cg_exo -78.36 -148.45 0.5 Allowed 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.175 -0.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.67 163.6 12.55 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.723 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.78 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 92.8 Cg_endo -81.6 35.2 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.756 2.304 . . . . 0.0 112.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.742 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 44.9 p90 -112.26 162.86 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.411 HG23 ' HB3' ' A' ' 120' ' ' ARG . 7.8 m -115.23 124.86 52.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 182' ' ' LEU . 2.4 p -108.31 109.01 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.131 0.491 . . . . 0.0 110.982 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 44.7 t -103.72 128.61 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.147 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -126.59 -165.87 1.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.308 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.69 -176.05 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.736 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.7 143.33 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.994 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -74.73 -170.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -76.49 55.2 0.99 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.207 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.778 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 24.1 tp -88.79 129.63 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.632 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 11.4 mm -72.02 -52.47 7.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.778 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 75.6 Cg_exo -50.88 100.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.304 2.003 . . . . 0.0 112.536 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.445 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -82.04 1.08 37.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.8 -26.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.097 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.704 HG22 HG21 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -107.48 -29.51 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 19.8 p -78.76 -18.08 54.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.937 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.13 -169.21 54.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.375 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.08 -8.39 83.08 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.401 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.2 p -114.68 -175.46 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.524 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 74.8 m -111.63 62.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -143.22 138.21 29.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' ' 102' ' ' ARG . 97.8 t -139.94 140.28 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.356 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.35 157.08 19.95 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.643 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.508 HD13 HD13 ' A' ' 74' ' ' ILE . 27.8 mt -146.23 151.74 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HB3' HG23 ' A' ' 97' ' ' THR . 0.4 OUTLIER -146.39 137.71 24.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.459 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 93' ' ' PRO . 2.7 p -110.6 87.72 6.88 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.39 -179.74 3.42 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.411 2.074 . . . . 0.0 112.628 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.29 -4.49 57.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.975 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 7.1 m-20 -62.33 103.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -45.98 83.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.48 -50.8 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -63.56 -20.93 66.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.653 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 128' ' ' ARG . 1.7 ttp180 -74.98 -27.21 60.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -60.6 2.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.9 mt -57.79 -48.15 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.178 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.826 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.09 -29.87 70.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.358 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.6 -54.92 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 110.028 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -75.92 -89.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.26 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -77.04 141.07 67.03 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.09 153.77 46.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.303 2.002 . . . . 0.0 111.577 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.98 156.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.691 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.7 m -80.38 129.97 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.027 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.701 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . . . -128.53 102.9 6.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.846 0.355 . . . . 0.0 111.856 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.769 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -130.28 141.76 50.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' HG11 ' A' ' 55' ' ' VAL . 1.4 p -61.72 125.52 24.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 111.373 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.417 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.4 Cg_exo . . . . . 0 CA--C 1.537 0.663 0 N-CA-C 113.246 0.441 . . . . 0.0 113.246 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 21.6 Cg_exo -65.24 100.22 0.37 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.008 1.805 . . . . 0.0 112.112 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.21 149.25 40.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.994 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -95.37 -18.03 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.858 2.372 . . . . 0.0 112.433 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -136.94 130.34 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.524 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.652 ' O ' HG23 ' A' ' 156' ' ' VAL . 9.2 tp -56.78 -41.92 78.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.139 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.43 -38.01 88.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -58.66 -49.21 78.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -61.16 -39.32 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 152' ' ' LEU . 57.7 t -52.46 -37.66 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.728 0.299 . . . . 0.0 111.399 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.39 86.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.495 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.85 -22.69 55.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.158 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 163' ' ' ASP . 2.0 pp -108.65 43.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -16.8 -58.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.342 0.657 . . . . 0.0 112.535 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.38 10.06 0.43 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.757 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -80.87 -82.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.247 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.757 ' H ' HG13 ' A' ' 162' ' ' VAL . 2.0 p-10 -100.51 92.7 5.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.796 0.331 . . . . 0.0 110.783 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.532 ' HA ' HD13 ' A' ' 159' ' ' LEU . 0.6 OUTLIER -65.42 130.7 44.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.736 -178.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.617 HG12 HD12 ' A' ' 155' ' ' ILE . 27.0 m -59.98 -171.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.26 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.92 HD23 ' H ' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.76 156.05 41.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.51 -7.81 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.609 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.58 -40.12 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.892 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.92 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 89.88 -178.82 43.95 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.484 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 14.7 p-10 -70.73 -159.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.515 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 39.6 m -136.78 -59.66 0.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.262 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.732 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -135.85 -116.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.387 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.474 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 58.4 m-20 -86.13 150.63 24.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -15.07 62.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 6.2 pt-20 -153.07 160.6 30.75 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.668 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 177' ' ' SER . 66.0 Cg_endo -95.27 -139.56 0.13 OUTLIER 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.249 -1.146 . . . . 0.0 112.648 0.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 7.6 t -154.01 146.54 24.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.742 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 69.5 m -101.19 142.96 31.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.122 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.11 97.1 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.714 HG12 ' HA ' ' A' ' 189' ' ' VAL . 25.3 mt -109.94 131.58 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.211 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.637 ' HB3' ' HE ' ' A' ' 188' ' ' ARG . 0.2 OUTLIER -108.43 65.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.004 0.43 . . . . 0.0 110.571 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.76 ' HB3' HG23 ' A' ' 98' ' ' VAL . 19.0 tp -69.29 89.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -78.41 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 0.0 110.858 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -128.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 2.1 t-20 -59.68 -52.23 75.43 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.0 Cg_exo -76.92 108.9 2.74 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.497 2.131 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 94.1 Cg_endo -80.72 134.23 9.64 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.519 2.146 . . . . 0.0 112.037 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.637 ' HE ' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -96.31 45.91 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.274 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.714 ' HA ' HG12 ' A' ' 180' ' ' ILE . 20.2 t -56.63 103.81 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.21 93.26 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.452 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -85.07 149.54 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.769 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.038 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HG2' HD23 ' A' ' 16' ' ' LEU . 53.0 Cg_exo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.823 0.259 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -69.81 -42.45 73.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.028 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -67.75 -25.22 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -70.98 -52.21 21.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.086 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.637 ' HA ' HD12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -69.19 -14.53 63.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.564 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.25 -34.72 59.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.564 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.12 -42.98 55.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.776 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -75.55 -20.22 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.734 0.302 . . . . 0.0 111.274 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.423 ' N ' HD13 ' A' ' 20' ' ' ILE . 46.0 t -70.35 -48.5 56.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 164' ' ' LEU . 11.3 p -69.52 -28.16 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.128 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 21.9 mtt -62.47 -38.57 90.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.064 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -70.29 -20.54 63.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.82 5.05 62.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.29 38.92 94.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.91 168.51 15.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.504 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.718 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.45 148.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.434 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.718 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -119.1 146.94 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -114.78 164.85 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.272 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.518 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -172.91 103.42 0.32 Allowed Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.79 137.03 12.38 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.769 2.312 . . . . 0.0 111.408 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.82 -151.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.738 0.304 . . . . 0.0 111.161 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -54.87 -20.95 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.606 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.82 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -100.1 -114.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.126 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.85 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.0 OUTLIER -112.55 -163.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.353 . . . . 0.0 110.995 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.86 131.38 47.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.586 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.88 174.68 15.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.067 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HB2' HG23 ' A' ' 139' ' ' THR . 2.5 mt -133.25 138.52 46.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.821 0.343 . . . . 0.0 111.132 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.1 121.16 1.48 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.836 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 136' ' ' VAL . 5.3 p -159.76 163.97 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.712 0.292 . . . . 0.0 111.221 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.718 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -55.25 102.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.01 0.434 . . . . 0.0 110.944 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.74 81.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.938 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.561 HD21 ' HZ ' ' A' ' 77' ' ' PHE . 4.3 mm? -76.26 12.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.306 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.46 150.46 28.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -19.53 60.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.77 -30.0 70.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.1 -22.89 57.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.22 -54.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -63.88 -40.25 96.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 8.2 mmt180 -64.18 -38.86 92.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -68.16 -18.4 64.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.798 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -36.76 62.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.2 -40.69 90.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.7 t -73.89 -52.96 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -79.38 -76.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.902 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 17.27 32.9 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.697 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -68.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.349 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB3' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -136.78 76.26 47.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.852 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.11 27.21 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 0.0 112.597 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' ' 59' ' ' SER . 23.7 p80 -105.28 -21.91 13.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.958 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -73.33 154.3 90.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.973 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 116' ' ' ARG . 75.6 Cg_exo -50.62 154.88 5.96 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.597 2.198 . . . . 0.0 112.46 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.635 HG21 HG22 ' A' ' 110' ' ' ILE . 4.3 m -114.54 151.31 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -96.48 136.61 36.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.689 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 14.4 pt -116.27 172.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.27 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 12.5 t -117.87 135.57 54.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.974 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.754 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.1 p -146.24 174.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.604 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.593 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.47 -47.63 15.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.992 0.425 . . . . 0.0 110.462 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.17 176.3 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.449 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.586 HG11 ' HG3' ' A' ' 85' ' ' MET . 2.8 t -59.13 -33.74 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.764 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -67.54 -27.65 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.156 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.664 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 1.2 mp0 -80.43 -17.21 52.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.217 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.685 HG13 ' HB3' ' A' ' 77' ' ' PHE . 21.5 tt -114.65 50.71 0.59 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.664 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 37.4 Cg_exo -59.07 -84.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.046 1.83 . . . . 0.0 113.182 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.42 12.27 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -177.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.685 ' HB3' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -107.77 -17.03 14.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.969 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.656 ' HB2' HG12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.5 177.22 7.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.889 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 12.4 mtp180 -129.81 85.43 58.05 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -101.96 -175.29 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.059 2.506 . . . . 0.0 112.853 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 85' ' ' MET . 1.3 m -140.4 179.9 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.878 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.25 -74.0 0.92 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.39 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.047 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.586 ' HG3' HG11 ' A' ' 71' ' ' VAL . 9.6 mmt -70.64 -16.32 62.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.169 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 41.3 mm-40 -64.89 -50.47 66.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.595 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.94 -35.98 80.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.6 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 182' ' ' LEU . 36.3 mmm -65.6 -45.43 83.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.279 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.94 -16.89 62.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 111.117 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -39.1 63.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.38 40.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.798 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 4.8 tt -129.54 137.91 31.97 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.67 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 96.8 Cg_endo -78.45 -161.66 2.76 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.351 -0.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.98 167.06 16.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.928 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.82 ' HB2' HG23 ' A' ' 35' ' ' THR . 92.2 Cg_endo -79.85 44.35 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.919 2.412 . . . . 0.0 112.359 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 10.6 p90 -112.19 141.24 46.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 m -102.55 112.51 25.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 180' ' ' ILE . 3.5 p -108.39 123.98 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.0 111.672 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 21.3 t -102.45 129.42 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.941 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.64 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 0.8 OUTLIER -126.88 177.17 6.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.802 -178.365 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.64 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 10.0 mt-10 -74.09 172.94 10.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.672 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -119.71 143.56 47.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.409 . . . . 0.0 111.477 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.475 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 1.5 t-20 -74.13 -164.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.481 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.39 56.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.518 HD22 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -74.15 136.2 42.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.61 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.6 mt -80.16 -51.39 1.09 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.457 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 40.4 Cg_exo -57.75 103.35 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.328 2.019 . . . . 0.0 112.418 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.78 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 109' ' ' VAL . 2.2 m -76.21 -17.39 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.635 HG22 HG21 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -113.2 -32.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.104 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 107' ' ' PRO . 5.7 p -74.41 -26.79 60.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.5 -163.56 54.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.61 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.15 -3.06 80.87 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.483 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.9 m -114.68 171.32 7.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.449 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 33.5 p -103.87 59.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.61 ' HG2' ' HA ' ' A' ' 101' ' ' GLU . 9.6 mtm105 -152.31 149.1 28.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.022 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 102' ' ' ARG . 77.7 t -139.8 131.81 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.589 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -78.68 167.6 53.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -147.04 162.48 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttt85 -149.14 125.62 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 111.463 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.03 77.79 1.52 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.706 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.75 ' HB2' HG21 ' A' ' 33' ' ' THR . 73.2 Cg_endo -75.34 -178.65 4.39 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.478 2.118 . . . . 0.0 112.605 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.28 -4.02 58.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 0.3 OUTLIER -62.8 99.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 45.3 mt-10 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.08 -50.16 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.955 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -61.22 -24.57 66.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.819 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 15.9 mtm180 -70.12 -32.56 70.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.148 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -59.61 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 mt -58.92 -49.25 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.567 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.754 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.61 -29.32 69.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.406 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.64 -56.64 16.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 109.909 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HB2' ' H ' ' A' ' 134' ' ' PHE . 2.5 mmt85 -76.44 -88.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.166 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.45 ' H ' ' HB2' ' A' ' 133' ' ' ARG . 27.1 m-85 -76.64 117.56 65.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 21.2 Cg_exo -65.45 152.03 83.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.321 2.014 . . . . 0.0 111.319 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -134.46 169.55 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 111.472 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.668 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.2 m -80.85 138.8 36.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.492 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -136.99 96.54 3.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.277 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -125.72 145.33 50.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.32 117.07 22.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.186 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.559 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 36.0 Cg_exo . . . . . 0 CA--C 1.537 0.653 0 N-CA-C 113.404 0.502 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.441 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.1 Cg_exo -65.65 87.75 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.03 1.82 . . . . 0.0 112.175 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -96.62 142.97 25.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.911 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 67.6 Cg_endo -95.74 -16.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.557 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -132.37 121.25 23.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.693 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.582 ' HA ' HD11 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -58.04 -38.7 76.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.195 -179.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -41.48 85.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.0 -38.38 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.839 HD12 HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -71.94 -33.23 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 152' ' ' LEU . 21.6 t -53.42 -47.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.476 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -69.37 -32.45 71.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.861 0.363 . . . . 0.0 110.77 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -21.69 56.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.244 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.833 HD21 HG13 ' A' ' 165' ' ' VAL . 2.6 pp -98.76 43.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 159' ' ' LEU . 13.8 t0 -17.53 -54.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.709 0.63 . . . . 0.0 112.254 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -160.75 11.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.4 p -81.84 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.859 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 162' ' ' VAL . 0.3 OUTLIER -108.24 96.19 6.19 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.743 0.306 . . . . 0.0 111.396 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.717 ' HA ' HD13 ' A' ' 159' ' ' LEU . 1.4 mm? -64.16 139.77 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.676 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.839 HG12 HD12 ' A' ' 155' ' ' ILE . 3.4 m -61.03 -174.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.508 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.72 HD22 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.32 145.6 50.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.739 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.85 -22.49 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.72 -52.79 5.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.138 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.621 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 96.64 -160.34 21.82 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.48 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.07 -163.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.427 ' HB3' ' N ' ' A' ' 34' ' ' ASP . 49.1 t -145.34 -57.4 0.33 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.612 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -126.16 -130.07 0.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.3 OUTLIER -86.16 147.63 26.05 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -177.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.85 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.21 -23.3 66.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 158.84 33.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.684 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.55 ' O ' HG22 ' A' ' 35' ' ' THR . 64.9 Cg_endo -90.95 -149.86 0.35 Allowed 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.024 -1.24 . . . . 0.0 112.663 1.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.1 p -154.67 153.74 31.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.793 HG23 ' HB3' ' A' ' 191' ' ' ARG . 0.3 OUTLIER -99.91 141.58 32.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.0 t -129.05 78.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 189' ' ' VAL . 23.2 mt -101.67 131.32 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.209 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 188' ' ' ARG . 6.9 t70 -108.78 61.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.3 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -70.14 100.15 1.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.333 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 -73.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.813 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 185' ' ' ASN . 23.1 t -120.56 -109.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.028 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -74.63 -52.76 3.56 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.486 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 4.8 Cg_exo -77.68 108.0 2.48 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.496 2.131 . . . . 0.0 112.237 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 98.7 Cg_endo -79.46 131.15 9.34 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 3.8 mmt85 -86.65 53.12 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.973 0.416 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.769 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.93 107.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.12 82.73 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.793 ' HB3' HG23 ' A' ' 178' ' ' THR . 5.3 ptm180 -89.57 142.07 28.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.023 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' HD22 ' A' ' 16' ' ' LEU . 73.2 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.85 0.271 . . . . 0.0 112.352 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.05 -28.25 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.625 HG22 ' HB3' ' A' ' 167' ' ' ASP . 82.7 t -57.5 -62.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.18 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.842 HD11 HG12 ' A' ' 126' ' ' ILE . 2.9 mp -60.53 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.366 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.06 -29.61 67.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.482 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.97 -31.9 59.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.329 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.64 56.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.326 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 16' ' ' LEU . 2.2 pp -75.21 -22.05 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 0.0 111.224 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -69.08 -53.15 21.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.4 -28.62 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.4 mtt -57.09 -51.15 70.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.64 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.37 9.15 74.72 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.707 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 39.42 92.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.723 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.56 168.58 13.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.192 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.733 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -96.29 141.28 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.619 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -116.19 110.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.078 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.615 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -100.49 151.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 111.247 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.489 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 1.9 m-85 -154.33 114.12 2.48 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.171 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 68.4 Cg_endo -84.9 139.25 7.31 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.81 2.34 . . . . 0.0 111.391 176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.775 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -119.2 -149.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.708 0.289 . . . . 0.0 111.457 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -54.82 -23.75 19.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.561 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 36' ' ' ILE . 2.1 t -100.48 -114.94 0.17 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.011 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.763 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.71 -166.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.892 0.377 . . . . 0.0 111.592 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.59 138.57 55.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -130.98 168.71 21.86 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.116 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.707 ' HB2' HG23 ' A' ' 139' ' ' THR . 8.3 mp -113.91 143.71 44.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.741 0.305 . . . . 0.0 110.863 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.7 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.13 112.97 0.68 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.679 HG13 HD12 ' A' ' 28' ' ' ILE . 18.6 m -151.52 172.41 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.772 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.87 95.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.233 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HA ' ' CB ' ' A' ' 48' ' ' ALA . . . -57.85 -42.54 84.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.998 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HG ' HD11 ' A' ' 110' ' ' ILE . 2.5 mp -67.38 -29.77 69.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 111.417 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.772 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -86.51 154.24 21.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.026 -177.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -60.58 -12.4 9.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.062 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -60.75 -34.03 73.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 110.262 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -76.28 -49.32 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.493 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 46' ' ' GLU . 8.1 p -59.66 -20.9 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.195 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.07 -57.84 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 179.312 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -63.17 -25.43 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.721 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 64' ' ' VAL . 1.7 mp -63.64 -54.43 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.768 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -54.57 -28.91 49.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.082 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -67.48 -57.26 6.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.605 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.9 t -75.55 -56.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.5 5.86 11.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.47 -121.85 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.353 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.04 109.24 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.0 111.015 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.619 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -148.25 66.8 9.53 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.82 -7.51 20.86 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.53 2.153 . . . . 0.0 112.306 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 21.7 m-70 -103.79 -19.14 14.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -85.96 132.51 43.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.8 166.22 27.01 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.433 2.089 . . . . 0.0 112.057 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 110' ' ' ILE . 12.1 p -112.97 141.91 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.153 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.74 138.39 32.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 66' ' ' ILE . 1.5 pp -115.99 174.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.545 ' SG ' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -122.23 132.68 54.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.538 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG21 HG23 ' A' ' 74' ' ' ILE . 1.2 p -138.47 179.83 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.731 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.824 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 3.0 t -90.09 -41.8 11.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.63 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.72 170.67 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 74' ' ' ILE . 5.2 t -57.52 -38.54 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.13 -24.45 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.985 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 56.2 mm-40 -76.04 -20.89 57.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.775 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.802 HG23 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.55 61.84 0.9 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.729 178.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.66 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 28.9 Cg_exo -61.94 -79.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.086 1.858 . . . . 0.0 112.226 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -73.25 22.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' A' ' 117' ' ' VAL . 1.1 t80 -100.56 -48.9 4.38 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.954 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 80.7 p -131.38 -179.98 5.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -129.14 101.61 19.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 88.2 Cg_endo -102.4 -172.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.143 2.562 . . . . 0.0 112.634 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.19 -171.86 3.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.14 -82.08 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.629 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 1.1 m-20 -56.43 -26.11 52.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.67 71.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.463 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 27.0 mmt -74.27 -12.89 60.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.75 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 1.8 mt-10 -70.68 -50.28 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.7 tp -63.96 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.833 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.668 ' HB2' HD13 ' A' ' 182' ' ' LEU . 7.9 tpt -75.01 -42.41 57.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.383 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -23.7 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.715 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.1 ptm180 -75.84 -36.21 59.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.472 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.419 HG13 ' HE3' ' A' ' 88' ' ' MET . 3.6 pt -103.61 14.94 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.064 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.486 HD23 ' C ' ' A' ' 88' ' ' MET . 0.3 OUTLIER -130.97 152.77 81.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.823 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.426 ' N ' HD12 ' A' ' 92' ' ' LEU . 71.6 Cg_endo -78.17 -174.38 14.66 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.563 -1.432 . . . . 0.0 112.67 0.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.61 -174.63 32.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.491 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 96.0 Cg_endo -79.87 39.29 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.597 2.198 . . . . 0.0 112.29 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.13 160.92 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.784 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 27.2 m -107.54 131.05 54.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.29 107.34 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.852 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 5.5 t -102.89 131.02 52.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD11 ' HE3' ' A' ' 85' ' ' MET . 3.1 mm? -126.75 177.95 6.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.469 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 177.03 6.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.847 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -119.65 141.09 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.189 0.518 . . . . 0.0 111.429 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -74.8 -167.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.426 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -76.91 37.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.506 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -69.27 116.47 9.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.909 0.385 . . . . 0.0 110.786 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.521 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 25.5 mm -63.55 -48.55 80.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.159 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.5 Cg_exo -49.63 108.9 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.092 1.862 . . . . 0.0 112.483 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -2.62 48.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.858 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.728 HG13 HG13 ' A' ' 110' ' ' ILE . 10.5 p -71.78 -27.03 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.73 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.728 HG13 HG13 ' A' ' 109' ' ' VAL . 4.4 mt -101.2 -35.6 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.686 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.653 HG23 ' HG2' ' A' ' 102' ' ' ARG . 2.0 m -73.88 -30.69 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.81 -143.01 27.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.357 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -89.98 -18.29 51.1 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.529 ' O ' HG22 ' A' ' 111' ' ' THR . 22.1 m -106.61 -172.08 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.704 0.288 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.2 m -113.12 42.44 1.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 116' ' ' ARG . 5.7 mtm-85 -136.63 156.36 48.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 102' ' ' ARG . 62.0 t -140.15 145.52 26.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.558 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -99.2 159.18 20.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.227 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.61 HD13 HD13 ' A' ' 74' ' ' ILE . 9.3 mt -142.57 159.89 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.406 ' N ' HG22 ' A' ' 119' ' ' ILE . 7.0 ttp85 -151.12 124.7 9.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 111.151 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.48 87.96 7.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.71 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.775 ' HB2' HG21 ' A' ' 33' ' ' THR . 60.2 Cg_endo -72.25 -179.97 4.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.409 2.072 . . . . 0.0 112.47 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.52 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -93.0 17.92 9.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.182 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 109.77 15.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.01 -47.01 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.106 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.842 HG12 HD11 ' A' ' 16' ' ' LEU . 2.2 mp -64.39 -52.08 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 95.8 m -59.32 -16.15 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 69' ' ' SER . 31.7 ttt180 -74.94 -46.98 31.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.409 HH21 HG12 ' A' ' 130' ' ' ILE . 5.7 ttp180 -66.89 -48.88 67.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.388 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.409 HG12 HH21 ' A' ' 129' ' ' ARG . 37.9 mt -61.23 -55.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.192 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.53 -26.42 67.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.228 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.7 -57.1 12.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -76.0 -87.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.072 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.9 124.7 87.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 151.63 59.57 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.341 2.027 . . . . 0.0 111.879 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.545 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.6 t -131.42 157.71 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.046 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.7 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.4 OUTLIER -80.75 136.64 36.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.071 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.505 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . . . -129.27 98.39 4.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 111.349 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -128.21 105.13 8.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.623 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.853 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 78.5 p -61.71 128.56 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.842 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.487 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 37.7 Cg_exo . . . . . 0 CA--C 1.537 0.669 0 N-CA-C 113.484 0.532 . . . . 0.0 113.484 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 57.1 Cg_endo -69.94 97.68 0.66 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.804 1.669 . . . . 0.0 112.198 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.432 ' HB3' HD11 ' A' ' 155' ' ' ILE . 1.4 m -89.75 135.19 30.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 94.1 Cg_endo -95.2 -43.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.752 2.301 . . . . 0.0 112.718 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.688 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 4.2 ttt180 -131.69 137.47 48.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.695 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.686 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -61.01 -40.67 94.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -19.93 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.688 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 3.7 tm-20 -67.29 -40.98 86.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.657 HD12 HG23 ' A' ' 165' ' ' VAL . 5.4 mt -70.06 -48.46 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.346 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.76 -31.02 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.318 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ttt180 -75.36 -52.95 9.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.113 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.741 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -60.07 -38.62 83.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.179 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.7 mm? -109.29 73.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -37.19 -39.83 0.29 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.25 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.84 11.88 0.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.606 0.241 . . . . 0.0 111.597 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 5.3 t -80.67 -81.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.733 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -104.34 99.39 9.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.353 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.502 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -73.68 127.87 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -178.37 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.841 HG22 ' H ' ' A' ' 166' ' ' LEU . 3.5 p -65.19 -163.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.841 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.68 143.55 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.976 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.625 ' HB3' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -92.31 -14.96 28.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.489 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.24 -41.73 16.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.425 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.56 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 93.53 -167.67 28.8 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.163 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 3.0 p30 -73.1 -165.11 0.21 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.75 0.31 . . . . 0.0 111.022 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -61.4 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.724 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.69 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -126.33 -132.57 0.25 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.511 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 3.8 t70 -86.88 165.16 16.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.87 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.763 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.8 ttp -70.33 -8.96 54.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.839 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.14 162.17 36.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' A' ' 177' ' ' SER . 66.4 Cg_endo -97.5 -148.97 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.71 1.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -155.27 110.31 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 191' ' ' ARG . 95.6 m -101.46 138.72 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.198 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.784 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.0 t -129.24 109.24 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.746 HG23 ' HA ' ' A' ' 189' ' ' VAL . 4.5 mt -117.84 137.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.852 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.2 m-20 -108.0 67.44 0.68 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -69.5 83.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.354 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.25 -83.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.523 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.96 -100.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.282 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -83.9 -51.82 0.6 Allowed Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -73.84 110.4 3.07 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.125 1.883 . . . . 0.0 112.259 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.5 Cg_endo -82.15 118.1 2.94 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.707 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -86.94 49.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.746 ' HA ' HG23 ' A' ' 180' ' ' ILE . 6.6 t -56.6 104.01 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.012 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.03 77.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.017 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.518 ' HB3' HG23 ' A' ' 178' ' ' THR . 3.0 ptp180 -83.81 131.66 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.493 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.709 0.212 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -40.26 84.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 12.3 t -66.9 -34.01 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.014 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.95 -46.63 67.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -61.5 -21.55 64.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.161 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -75.18 -36.68 61.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.632 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.21 80.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.78 -32.26 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -59.99 -38.73 83.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.78 HG21 HD22 ' A' ' 164' ' ' LEU . 7.4 t -67.82 -34.68 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.0 mmt -56.06 -40.87 74.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.96 -23.14 58.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.21 -2.35 74.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.507 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.67 57.91 10.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.99 163.18 22.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.491 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.718 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.2 tp -96.21 143.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.772 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.541 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.44 120.32 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.543 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.6 OUTLIER -101.58 149.96 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 0.0 110.981 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 1.5 m-85 -153.18 100.08 2.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.005 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.509 ' HG3' ' CD2' ' A' ' 37' ' ' TYR . 2.5 Cg_endo -78.53 134.0 12.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.824 2.349 . . . . 0.0 110.791 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 93.9 m -138.35 -85.44 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 3.0 m-20 -74.46 -72.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.561 -177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.509 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -77.72 -86.89 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.047 -177.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.682 HG23 ' N ' ' A' ' 37' ' ' TYR . 3.9 tp -133.33 -155.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.672 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.682 ' N ' HG23 ' A' ' 36' ' ' ILE . 8.9 m-85 -63.27 131.5 48.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.37 172.85 14.42 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.177 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -118.2 135.85 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.96 0.41 . . . . 0.0 111.113 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.76 114.44 0.72 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.769 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.5 p -158.12 175.88 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -56.35 118.55 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.592 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.433 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.85 -56.24 24.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.03 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.6 mm? -82.29 37.52 0.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.926 0.393 . . . . 0.0 111.45 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.651 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.14 153.98 24.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.861 178.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -71.5 -29.16 64.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.833 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.04 -33.35 75.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.02 -35.99 74.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.78 -44.03 89.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.036 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -66.12 -43.11 88.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HA ' HH11 ' A' ' 51' ' ' ARG . 7.2 mmt-85 -70.96 -24.71 62.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.61 HD11 HG23 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -71.83 -44.99 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.985 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -20.47 62.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.41 -49.77 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 48.0 t -75.55 -40.36 41.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.439 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.95 -12.23 59.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.94 -108.0 2.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.533 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -118.19 90.6 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.049 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 m -153.79 70.7 6.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.12 14.98 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.566 2.177 . . . . 0.0 112.594 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -121.06 -19.02 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.951 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -84.26 131.68 49.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 32.1 Cg_exo -60.01 175.34 1.01 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.555 2.17 . . . . 0.0 112.247 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.61 HG23 HD11 ' A' ' 52' ' ' LEU . 10.0 p -112.98 152.07 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 4.8 t -93.93 129.0 40.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 67' ' ' CYS . 9.5 mm -107.98 161.51 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.861 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 51.4 t -122.23 127.44 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.865 HG21 HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -140.84 177.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.575 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.703 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -87.18 -41.76 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 110.462 179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.42 170.57 15.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.799 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.826 HG11 ' HG3' ' A' ' 85' ' ' MET . 5.1 t -59.03 -33.07 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -24.91 66.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.668 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.703 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 73.5 mm-40 -78.06 -21.04 51.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.66 56.52 0.69 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.652 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -58.68 -85.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.033 1.822 . . . . 0.0 112.11 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 18.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.59 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.472 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 25.2 m-85 -92.34 -34.42 14.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.76 0.315 . . . . 0.0 110.958 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 57.1 p -135.37 -178.14 4.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.837 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.835 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 6.5 mmt180 -114.1 83.76 8.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.667 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 76.4 Cg_endo -102.46 178.46 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.111 2.541 . . . . 0.0 113.036 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 3.0 m -129.93 179.43 5.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.19 -78.63 0.63 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.762 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -55.08 -31.39 61.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -60.73 -41.14 94.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.826 ' HG3' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -69.97 -25.95 63.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.279 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.3 mm-40 -57.99 -56.09 26.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.418 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -55.04 -39.23 68.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.896 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.557 ' SD ' HG21 ' A' ' 98' ' ' VAL . 3.9 tpt -66.69 -41.34 88.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.343 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.23 -7.72 44.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.265 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.95 -37.92 61.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 pt -115.06 48.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 121' ' ' VAL . 4.1 tp -131.21 138.52 33.04 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.513 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 97.0 Cg_endo -78.51 -162.95 3.14 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.481 -0.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.52 164.68 13.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.376 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.14 30.76 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.586 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -100.99 132.99 46.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.905 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -101.61 120.54 40.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.427 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' A' ' 180' ' ' ILE . 2.4 m -110.36 135.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 0.0 111.681 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -101.76 130.19 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.283 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -126.78 -179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.744 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.835 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 2.1 tt0 -74.27 175.71 7.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.508 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.628 HH11 HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -119.24 144.77 46.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.417 . . . . 0.0 111.325 -179.306 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 105' ' ' LEU . 5.8 p30 -74.34 -159.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.936 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 27.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.563 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.436 ' HG ' ' HG2' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -69.45 113.47 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.2 mt -68.58 -49.45 29.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.89 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 7.5 Cg_endo -49.93 110.08 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.444 2.096 . . . . 0.0 112.459 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.414 ' HA ' HG22 ' A' ' 111' ' ' THR . 3.9 m-20 -76.15 -5.06 44.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.872 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.77 -24.68 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.686 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.605 ' O ' HG12 ' A' ' 64' ' ' VAL . 26.0 mm -95.18 -51.71 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.168 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.628 HG21 HH11 ' A' ' 102' ' ' ARG . 11.7 t -77.93 -0.64 28.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.51 -160.17 51.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.588 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.37 83.89 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.473 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 m -113.82 -171.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.496 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 55.2 m -105.26 47.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -137.05 155.74 49.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.0 0.428 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 102' ' ' ARG . 67.1 t -139.72 138.8 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.458 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -90.66 152.25 21.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.841 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.593 HD13 HD13 ' A' ' 74' ' ' ILE . 42.9 mt -147.68 142.85 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.582 ' HB3' HG23 ' A' ' 97' ' ' THR . 0.0 OUTLIER -148.76 137.94 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.943 0.401 . . . . 0.0 111.21 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 92' ' ' LEU . 6.8 t -110.21 98.09 33.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.025 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.19 -179.1 4.92 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.459 2.106 . . . . 0.0 112.568 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.23 14.01 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 1.5 t0 -76.14 106.09 7.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -52.71 64.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.235 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.2 -49.07 84.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -62.53 -23.66 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.891 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -67.04 -35.11 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.786 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -53.74 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 mt -60.58 -54.75 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.307 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.745 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -58.32 -28.73 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.376 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.8 -55.27 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 109.904 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 133' ' ' ARG . 1.6 mtm180 -75.48 -89.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.02 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.97 134.35 68.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.784 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.97 152.59 76.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.379 2.053 . . . . 0.0 111.811 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.3 153.61 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.204 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.63 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 6.8 m -80.68 137.55 36.32 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.861 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -133.91 108.47 8.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.707 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.91 136.04 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -79.43 113.88 17.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.422 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.9 Cg_exo . . . . . 0 CA--C 1.537 0.643 0 N-CA-C 113.352 0.482 . . . . 0.0 113.352 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 74.0 Cg_endo -74.81 115.81 4.41 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 112.358 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.4 152.69 38.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -95.86 -14.51 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.83 2.353 . . . . 0.0 113.004 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.1 mmt180 -135.88 136.88 40.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.856 0.36 . . . . 0.0 111.109 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' HG11 ' A' ' 165' ' ' VAL . 8.3 mt -65.3 -45.16 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.907 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -27.0 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.145 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -37.42 86.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.146 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.464 ' HB ' ' CG1' ' A' ' 165' ' ' VAL . 1.1 mt -72.7 -34.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.154 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 152' ' ' LEU . 16.0 t -64.17 -30.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.813 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -75.5 -53.02 9.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.444 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.41 -45.85 68.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.814 HD12 ' HB ' ' A' ' 162' ' ' VAL . 0.8 OUTLIER -90.83 64.22 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -37.05 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.186 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -171.51 16.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.814 ' HB ' HD12 ' A' ' 159' ' ' LEU . 47.1 t -80.78 -91.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.718 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -98.41 95.85 7.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.403 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.78 HD22 HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -60.46 138.65 57.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.79 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 152' ' ' LEU . 26.9 m -65.04 -169.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 169' ' ' GLY . 1.0 OUTLIER -125.84 135.76 52.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.211 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -2.16 54.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.01 -33.61 24.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.349 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.439 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 102.24 130.18 6.92 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.505 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 4.8 p-10 -73.41 -175.97 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.674 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.7 OUTLIER -136.72 -171.49 2.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.643 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.86 38.65 1.34 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 1.4 m-20 -85.08 56.89 4.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.111 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -54.43 173.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.377 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.921 ' H ' ' HA ' ' A' ' 176' ' ' PRO . 2.1 tp10 -160.12 -47.77 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.921 ' HA ' ' H ' ' A' ' 175' ' ' GLU . 89.6 Cg_endo -83.45 -52.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.358 1.048 0 C-N-CA 124.653 -0.978 . . . . 0.0 113.495 3.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.96 144.82 22.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.664 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 96' ' ' TYR . 53.0 m -102.41 150.39 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.464 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.6 86.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.343 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.722 ' HB ' HG12 ' A' ' 98' ' ' VAL . 10.3 mt -100.71 131.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.654 ' HB3' ' HG3' ' A' ' 188' ' ' ARG . 7.3 t0 -98.84 64.53 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.953 0.406 . . . . 0.0 110.685 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.3 tt -70.2 75.68 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.419 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.56 -79.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.444 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.779 HG13 ' H ' ' A' ' 185' ' ' ASN . 1.7 p -120.42 -95.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.546 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.779 ' H ' HG13 ' A' ' 184' ' ' VAL . 2.2 t-20 -90.47 -51.31 0.33 Allowed Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 18.3 Cg_exo -67.52 107.26 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.571 2.18 . . . . 0.0 112.314 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 87.7 Cg_endo -84.55 116.51 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.683 2.255 . . . . 0.0 112.477 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.654 ' HG3' ' HB3' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -91.96 67.9 5.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.06 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.56 HG13 HG12 ' A' ' 180' ' ' ILE . 2.5 t -63.71 112.77 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.3 94.08 2.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -83.99 147.18 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.827 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 26.1 Cg_exo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.724 0.218 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -54.52 6.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.414 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.6 HG11 HD13 ' A' ' 126' ' ' ILE . 41.8 t -64.39 -45.95 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.607 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.7 mm? -58.94 -50.77 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.124 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -55.07 -27.57 45.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.839 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 1.8 mt-10 -75.82 -43.75 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.59 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.13 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.9 mm -67.41 -22.35 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 3.6 t -65.16 -58.9 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 164' ' ' LEU . 14.6 p -62.41 -29.65 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 mtt -64.57 -28.52 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.35 13.89 62.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.522 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.05 58.92 9.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.84 162.35 19.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.697 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.4 tp -95.05 140.0 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.721 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.61 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.39 131.99 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.571 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.551 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -102.28 163.2 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.679 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -168.33 102.44 0.54 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.761 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.686 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 92.6 Cg_endo -84.27 155.47 12.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.745 2.297 . . . . 0.0 112.121 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.458 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 40.8 p -131.51 -155.28 0.68 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.553 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -55.34 -19.03 7.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.715 0.293 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -97.61 -118.64 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.795 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.514 ' H ' ' HB ' ' A' ' 35' ' ' THR . 1.1 tt -111.94 -174.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 110.827 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.686 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -63.24 134.64 56.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.94 178.9 17.76 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.119 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 4.4 mt -133.25 138.01 46.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.174 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.46 122.61 1.73 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.609 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.7 p -159.77 177.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.723 0.296 . . . . 0.0 111.281 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.655 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 1.9 m120 -56.13 106.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.976 0.417 . . . . 0.0 110.669 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.14 -49.73 76.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.091 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -80.29 27.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.944 0.402 . . . . 0.0 111.748 -178.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 147.77 34.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.815 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -73.32 -24.78 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 110.593 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -58.37 -30.14 66.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.809 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -65.88 -30.37 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 t -71.15 -46.07 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 50' ' ' ARG . 9.9 mtm180 -65.15 -41.13 95.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.682 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mpt_? -67.01 -53.87 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.077 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -54.56 -25.76 27.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -73.76 -52.98 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 54' ' ' ARG . 6.6 mmp_? -55.49 -35.88 66.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.68 -58.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -72.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.41 17.0 30.71 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.31 -16.16 9.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 110.93 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -140.05 67.65 33.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 -4.59 15.41 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.551 2.167 . . . . 0.0 112.213 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.91 -4.46 17.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 0.0 OUTLIER -86.43 145.36 39.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.993 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HD2' ' HD2' ' A' ' 62' ' ' LYS . 24.2 Cg_endo -60.82 156.98 40.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.673 2.249 . . . . 0.0 112.147 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 110' ' ' ILE . 11.9 p -112.59 147.26 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -94.18 145.03 25.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.2 161.83 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.819 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 10.8 t -111.73 131.55 55.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 0.8 OUTLIER -137.74 170.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.803 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 4.1 t -86.47 -39.4 16.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.489 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.7 t -164.08 174.09 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.56 HG11 ' HG3' ' A' ' 85' ' ' MET . 37.9 t -59.93 -38.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m-20 -67.22 -23.4 65.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.803 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 24.5 mm-40 -80.62 -23.17 39.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.231 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.718 ' HB ' HG21 ' A' ' 68' ' ' VAL . 18.9 tt -114.22 50.66 0.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.029 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 20.8 Cg_endo -61.97 -78.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.099 1.866 . . . . 0.0 113.176 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 9.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CE2' ' HG2' ' A' ' 135' ' ' PRO . 1.8 m-85 -108.21 -13.63 14.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.219 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.657 ' HB2' HD23 ' A' ' 100' ' ' LEU . 60.3 p -135.74 178.11 7.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.622 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.656 ' O ' HD11 ' A' ' 100' ' ' LEU . 3.8 mtp-105 -133.5 62.14 57.89 Favored Pre-proline 0 N--CA 1.464 0.232 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.485 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.626 ' HB3' HD22 ' A' ' 100' ' ' LEU . 65.6 Cg_endo -102.38 173.15 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.784 2.323 . . . . 0.0 113.203 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.5 -177.71 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.53 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.09 4.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.783 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -55.59 -41.28 73.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 0.0 111.211 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.16 -51.6 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.56 ' HG3' HG11 ' A' ' 71' ' ' VAL . 24.0 mmt -71.74 -7.81 50.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -72.28 -54.58 9.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.342 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -37.49 74.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.695 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.491 ' HG2' HG11 ' A' ' 98' ' ' VAL . 3.4 tpt -73.76 -41.36 62.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.633 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -63.42 -13.82 43.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.05 -31.17 61.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.27 45.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.472 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -131.27 147.09 64.82 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.843 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.37 -172.08 10.76 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.953 -1.269 . . . . 0.0 112.14 -0.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.25 179.93 29.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.582 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 36.8 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.782 2.321 . . . . 0.0 112.279 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.405 ' HD2' HG21 ' A' ' 178' ' ' THR . 13.9 m-85 -106.86 114.42 28.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.474 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 26.0 m -96.99 117.29 30.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -108.83 108.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.517 HG13 ' HA2' ' A' ' 118' ' ' GLY . 7.1 t -84.93 124.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 78' ' ' SER . 0.2 OUTLIER -128.13 162.3 27.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.394 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.606 ' H ' HD12 ' A' ' 100' ' ' LEU . 3.6 mt-10 -59.08 174.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.756 ' HE ' ' HB3' ' A' ' 105' ' ' LEU . 18.8 ttt85 -118.57 159.06 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.151 0.501 . . . . 0.0 111.835 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.417 ' H ' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.13 -162.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.343 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 16.53 0.37 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.836 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.756 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 1.7 tm? -69.83 153.75 42.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.583 0.23 . . . . 0.0 110.459 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.714 HG13 ' H ' ' A' ' 108' ' ' ASP . 1.8 tp -59.54 106.41 0.73 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.629 ' HA ' HG23 ' A' ' 111' ' ' THR . 74.3 Cg_endo -72.25 16.79 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.003 2.469 . . . . 0.0 113.431 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.714 ' H ' HG13 ' A' ' 106' ' ' ILE . 22.4 t0 -61.32 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.76 6.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.615 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.588 ' O ' HG12 ' A' ' 64' ' ' VAL . 10.1 mm -95.95 -59.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.297 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 107' ' ' PRO . 5.9 p -87.5 -31.11 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.014 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 -89.8 0.29 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.19 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.93 -84.01 0.17 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.114 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -103.95 -167.71 1.4 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.558 0.218 . . . . 0.0 110.896 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.7 60.4 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 111.188 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 116' ' ' ARG . 9.5 mtt85 -136.44 143.6 43.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.692 HG21 HH11 ' A' ' 102' ' ' ARG . 90.3 t -140.0 138.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.71 151.82 36.33 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.793 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 118' ' ' GLY . 26.0 mt -149.61 135.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.642 0.258 . . . . 0.0 110.453 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.575 ' HD2' ' HD3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -156.46 149.99 24.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 111.454 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 92' ' ' LEU . 2.3 t -110.87 89.08 8.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.404 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.575 ' HD3' ' HD2' ' A' ' 120' ' ' ARG . 22.7 Cg_endo -61.75 -178.77 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.499 2.133 . . . . 0.0 112.721 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.72 7.46 23.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.3 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 127' ' ' CYS . 7.3 m-20 -80.2 94.86 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.868 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.26 -33.41 67.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.6 HD13 HG11 ' A' ' 15' ' ' VAL . 2.0 mt -69.67 -52.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.725 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -61.34 -13.93 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.754 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.65 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -75.15 -48.06 25.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.89 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -59.65 -54.25 48.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mt -59.03 -49.05 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.064 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.4 -27.68 69.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.42 -56.71 15.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -89.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.747 176.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -77.08 124.88 87.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.818 177.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.528 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 25.9 Cg_exo -64.78 157.72 54.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.283 1.989 . . . . 0.0 111.69 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.3 t -128.94 155.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.651 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 8.0 m -80.51 132.51 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.927 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.23 104.29 7.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 111.548 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -133.22 163.32 29.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 t -81.31 131.22 35.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.044 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.4 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 45.5 Cg_exo . . . . . 0 CA--C 1.536 0.622 0 N-CA-C 113.228 0.434 . . . . 0.0 113.228 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 26.1 Cg_exo -62.0 91.24 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.899 1.733 . . . . 0.0 111.931 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.94 148.52 78.96 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -95.48 -15.53 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.994 2.462 . . . . 0.0 112.368 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.48 ' HG2' ' HB2' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -136.53 125.89 24.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.425 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.507 HD21 HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -58.29 -40.8 82.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -20.04 63.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.48 ' HB2' ' HG2' ' A' ' 151' ' ' ARG . 15.2 tt0 -75.12 -28.68 60.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.61 HG22 HD12 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -74.95 -46.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 -179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -60.09 -31.22 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.29 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -74.96 -47.02 31.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.071 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.14 -23.75 60.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.252 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.864 HD13 ' HB3' ' A' ' 163' ' ' ASP . 97.2 mt -111.34 67.13 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -16.19 -63.15 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.077 0.86 . . . . 0.0 112.776 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.18 22.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.005 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.7 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -81.13 -70.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.983 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.864 ' HB3' HD13 ' A' ' 159' ' ' LEU . 38.6 t0 -107.98 96.7 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.578 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.49 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -67.51 135.77 53.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 156' ' ' VAL . 18.8 m -67.4 -164.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.255 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.701 HD22 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.27 161.38 27.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.869 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.439 ' HB3' HG13 ' A' ' 15' ' ' VAL . 15.3 t70 -92.41 -25.08 18.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.59 -57.56 3.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.128 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.419 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 102.05 -161.87 17.33 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.934 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.65 -162.73 0.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.676 0.274 . . . . 0.0 110.915 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.458 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.73 -56.11 0.16 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.705 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -133.46 -133.15 0.17 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -85.89 142.6 28.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.873 0.368 . . . . 0.0 111.963 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 35' ' ' THR . 69.2 mmm -62.4 -25.36 67.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.319 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.4 159.17 42.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.741 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.54 ' O ' HG22 ' A' ' 35' ' ' THR . 75.3 Cg_endo -86.79 -149.59 0.44 Allowed 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.694 0.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.98 157.12 38.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -99.45 132.23 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.87 90.33 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.946 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.719 HG12 ' HA ' ' A' ' 189' ' ' VAL . 22.6 mt -108.42 137.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.499 ' H ' ' HB2' ' A' ' 188' ' ' ARG . 0.5 OUTLIER -106.49 67.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.042 178.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 187' ' ' PRO . 31.8 tp -70.28 90.04 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.682 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -79.25 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.447 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.23 -123.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.059 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -62.51 -52.02 68.6 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 80.9 Cg_endo -77.92 108.42 2.53 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.138 1.892 . . . . 0.0 112.645 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.58 ' HB3' HD13 ' A' ' 182' ' ' LEU . 84.6 Cg_endo -83.25 129.65 5.24 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.499 ' HB2' ' H ' ' A' ' 181' ' ' ASP . 9.2 mmt85 -88.68 60.9 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.038 0.447 . . . . 0.0 111.001 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.719 ' HA ' HG12 ' A' ' 180' ' ' ILE . 32.6 t -62.38 92.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.949 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.55 87.04 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -83.56 145.93 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.722 179.687 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.863 0.276 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.693 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -75.07 -27.72 60.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.48 -49.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 4.1 mm? -66.22 -32.15 73.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.152 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -71.77 -31.3 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -75.54 -38.21 59.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.264 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.566 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.68 -45.44 58.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.8 -30.35 37.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.72 -40.81 88.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.726 HG22 ' HG ' ' A' ' 164' ' ' LEU . 3.3 t -62.82 -31.03 50.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.0 mmt -61.5 -43.88 98.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.38 -23.21 58.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.809 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -19.0 63.8 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.44 36.34 88.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.687 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.74 170.57 14.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.142 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 163' ' ' ASP . 1.5 tp -90.52 136.06 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.597 HG22 HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -116.7 133.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.665 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.517 HG12 ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -101.87 163.01 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.55 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -165.21 101.15 0.79 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.79 -178.616 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.63 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.6 Cg_endo -82.61 144.64 12.67 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.592 2.195 . . . . 0.0 111.601 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.507 HG21 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -121.55 -152.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.717 0.294 . . . . 0.0 111.291 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.593 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -55.05 -21.99 14.29 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.457 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 1.8 t -100.02 -115.0 0.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.78 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -112.34 -172.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.852 0.358 . . . . 0.0 111.173 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.63 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.8 m-85 -63.69 137.9 58.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.926 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -124.02 -176.66 14.77 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.014 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -127.08 140.98 51.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.33 120.83 1.35 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.708 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.634 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.5 p -165.98 177.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.775 0.321 . . . . 0.0 111.65 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.763 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t-20 -56.73 107.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -62.7 -52.09 64.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 33.1 0.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.6 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.763 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 159.69 17.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.833 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.13 -36.7 61.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.791 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 25.0 t70 -58.49 -26.54 63.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.109 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.83 -33.28 62.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.52 -52.69 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -65.01 -45.85 83.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.92 -31.95 63.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -27.9 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -42.91 53.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.72 -43.37 47.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.245 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.63 -17.9 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.012 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.93 -95.33 0.19 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -118.06 83.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.63 69.55 15.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.9 11.96 2.6 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.609 2.206 . . . . 0.0 112.526 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.17 -14.93 8.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 1.8 ttmt -88.46 127.01 58.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.156 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 23.4 Cg_exo -65.16 -166.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.692 2.261 . . . . 0.0 112.084 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 p -118.68 135.64 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.138 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 8.6 t -96.24 131.69 42.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.592 HD11 HD11 ' A' ' 74' ' ' ILE . 32.3 pt -116.89 169.93 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.524 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -114.75 137.1 52.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.353 . . . . 0.0 110.603 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.662 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.2 p -145.84 173.91 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.591 ' H ' HG22 ' A' ' 68' ' ' VAL . 21.4 t -80.17 -42.52 23.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.958 0.408 . . . . 0.0 110.371 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.51 20.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 74' ' ' ILE . 15.8 t -57.17 -29.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.943 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.46 -32.68 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.225 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.99 -13.24 59.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.489 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.592 HD11 HD11 ' A' ' 66' ' ' ILE . 6.3 tt -114.16 44.52 0.32 Allowed Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 72.9 Cg_endo -76.39 -46.76 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.726 1.618 . . . . 0.0 112.634 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -72.42 -1.03 14.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.886 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -107.78 -56.07 2.28 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.652 -179.27 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 p -114.55 171.03 7.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.347 . . . . 0.0 111.144 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -121.94 108.18 34.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -102.45 -168.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.221 2.614 . . . . 0.0 113.007 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 3.2 t -138.82 -178.24 5.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.88 -83.72 0.37 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.843 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.797 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.96 -27.78 46.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.111 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.66 -46.43 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 81' ' ' SER . 19.5 mmt -74.92 -11.98 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.797 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -71.17 -48.28 52.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.992 0.425 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 5.0 tp -65.21 -35.99 82.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.79 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.444 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 7.7 tpp -68.41 -44.61 74.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.63 -13.82 61.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 5.7 tpt180 -73.43 -42.11 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.651 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 pt -110.55 43.79 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.041 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.907 HD21 HG21 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -131.2 143.5 49.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.804 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.4 Cg_exo -78.13 -165.14 4.37 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.174 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.81 173.33 23.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.588 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 93.0 Cg_endo -79.82 39.23 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.563 2.175 . . . . 0.0 112.358 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.647 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.3 m-85 -111.98 143.87 42.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.518 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 29.1 m -94.82 135.95 35.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.435 HG11 ' HG2' ' A' ' 88' ' ' MET . 4.9 t -120.29 109.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.429 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.802 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 19.1 t -99.66 135.97 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.276 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.572 ' HB2' HD11 ' A' ' 119' ' ' ILE . 2.4 mm? -126.45 -172.69 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.043 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.04 -165.84 0.43 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.733 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.821 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.13 132.44 56.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.97 0.414 . . . . 0.0 111.106 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 5.9 t30 -74.87 -173.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.15 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 9.27 2.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.483 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HB2' HH12 ' A' ' 102' ' ' ARG . 1.3 mt -69.39 -174.39 0.67 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.711 0.291 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 108' ' ' ASP . 2.8 mt -79.53 107.47 6.55 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.283 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 65.4 Cg_endo -71.65 23.56 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.675 2.25 . . . . 0.0 112.941 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 106' ' ' ILE . 3.7 m-20 -61.55 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.683 0.278 . . . . 0.0 111.2 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 m -90.21 5.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.703 0.287 . . . . 0.0 111.202 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.439 HG21 HH21 ' A' ' 102' ' ' ARG . 4.1 mt -96.4 -35.01 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.4 OUTLIER -87.13 -37.27 17.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.622 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.78 -101.35 0.64 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.347 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.26 -60.42 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.631 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.78 -179.32 3.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.728 0.299 . . . . 0.0 110.906 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.543 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -92.78 70.1 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.995 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -136.75 163.69 30.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.322 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.821 HG23 ' HG2' ' A' ' 102' ' ' ARG . 95.3 t -139.54 125.07 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.377 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.553 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -78.92 152.71 37.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.899 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -144.87 156.06 14.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.653 0.263 . . . . 0.0 110.553 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -148.49 124.82 10.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.261 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.907 HG21 HD21 ' A' ' 92' ' ' LEU . 5.2 t -110.42 86.99 5.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.56 179.77 5.25 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.518 2.146 . . . . 0.0 112.65 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.507 ' H ' HG21 ' A' ' 33' ' ' THR . 0.3 OUTLIER -93.28 5.17 52.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.03 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.87 106.99 7.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.155 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -57.34 -39.44 75.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.771 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 16' ' ' LEU . 45.2 mm -63.1 -54.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.873 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -18.53 60.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -72.27 -36.46 69.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -75.02 -52.53 10.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.239 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' ' 130' ' ' ILE . 17.0 mt -60.0 -53.72 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.662 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.84 -26.93 67.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.277 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -54.63 -56.77 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.018 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -86.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.326 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.78 115.29 46.84 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.68 137.75 46.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.558 2.172 . . . . 0.0 111.602 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 67' ' ' CYS . 27.2 m -114.74 170.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 120.943 0.402 . . . . 0.0 111.737 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.654 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 46.2 m -80.76 139.94 35.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.012 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.66 103.71 4.92 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.287 0.367 . . . . 0.0 111.37 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -130.28 126.31 36.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.7 p -70.93 110.86 5.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 39.5 Cg_exo . . . . . 0 CA--C 1.537 0.636 0 N-CA-C 113.178 0.415 . . . . 0.0 113.178 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 91.0 Cg_endo -78.99 103.05 1.59 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.898 1.732 . . . . 0.0 112.148 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -82.91 145.97 51.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 72.2 Cg_endo -95.53 -11.22 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.916 2.411 . . . . 0.0 111.929 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.93 128.88 14.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.04 -27.36 66.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 156' ' ' VAL . 3.7 tt0 -71.07 -37.89 72.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.171 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -55.73 31.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.323 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 165' ' ' VAL . 0.6 OUTLIER -63.47 -42.98 98.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -53.08 -30.1 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -39.21 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -26.79 57.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.257 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 155' ' ' ILE . 2.0 pp -94.98 46.8 1.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t70 -16.03 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.728 0.643 . . . . 0.0 112.551 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -157.32 10.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.77 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -81.39 -75.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.381 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.77 ' H ' HG13 ' A' ' 162' ' ' VAL . 4.2 t70 -95.79 109.07 21.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.791 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.726 ' HG ' HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -73.85 120.65 19.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.99 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.76 HG22 ' H ' ' A' ' 166' ' ' LEU . 4.3 p -61.72 -179.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.779 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.76 ' H ' HG22 ' A' ' 165' ' ' VAL . 1.3 pt? -125.28 149.28 48.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.828 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.19 -19.61 22.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.289 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.53 -48.0 61.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.945 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 91.56 -168.51 31.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.777 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -163.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.074 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.44 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 44.2 m -140.95 -56.94 0.5 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.48 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -129.43 -130.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.518 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.514 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 33.9 m-20 -86.36 146.29 26.53 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.487 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.78 ' HG2' HG23 ' A' ' 36' ' ' ILE . 3.7 ttp -69.35 0.17 5.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.179 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.81 156.75 30.99 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.631 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 177' ' ' SER . 70.7 Cg_endo -88.71 -140.27 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.921 -1.283 . . . . 0.0 112.576 0.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -153.63 124.77 7.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.623 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 191' ' ' ARG . 34.8 m -101.99 131.69 48.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.45 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.518 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -129.48 109.15 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.707 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.72 HG12 ' HA ' ' A' ' 189' ' ' VAL . 15.1 mt -120.9 137.14 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.474 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.802 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 6.0 t70 -107.99 66.91 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.589 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.444 ' CD2' ' HB2' ' A' ' 88' ' ' MET . 21.9 tp -69.77 88.26 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -79.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.437 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 185' ' ' ASN . 4.8 t -120.64 -121.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.9 t-20 -63.48 -50.59 72.53 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 79.7 Cg_endo -77.87 108.75 2.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.24 1.96 . . . . 0.0 112.566 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.1 Cg_endo -82.44 128.6 5.52 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.558 2.172 . . . . 0.0 112.248 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 17.8 mtp180 -87.58 56.1 3.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.72 ' HA ' HG12 ' A' ' 180' ' ' ILE . 17.9 t -59.97 104.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.423 ' O ' HG23 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -127.75 74.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.682 ' HB3' HG23 ' A' ' 178' ' ' THR . 1.5 ptp85 -89.73 139.58 30.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.941 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HD2' HD12 ' A' ' 16' ' ' LEU . 45.1 Cg_exo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.808 0.253 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.38 -28.74 68.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.066 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.6 t -65.31 -57.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.013 HD11 HG22 ' A' ' 126' ' ' ILE . 13.7 mt -62.01 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 20' ' ' ILE . 3.4 mt-10 -64.15 -23.75 67.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.712 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.5 -32.69 58.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.165 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.27 -44.33 62.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.761 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.608 ' HA ' ' HG2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -75.55 -18.37 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.182 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 t -75.52 -47.95 24.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.352 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.545 HG21 HD23 ' A' ' 164' ' ' LEU . 12.7 p -74.52 -26.93 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.656 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 15.7 ptp -73.97 -31.51 63.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 0.0 111.112 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -25.09 65.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.84 31.18 6.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 47' ' ' ASP . . . 67.0 47.53 64.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' MET . . . -130.12 147.47 18.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.28 143.0 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.638 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -117.94 145.26 24.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.766 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.658 HD11 HG21 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.96 167.27 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.255 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -171.72 94.52 0.41 Allowed Pre-proline 0 C--N 1.332 -0.152 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.2 Cg_endo -84.14 142.71 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.872 2.381 . . . . 0.0 110.549 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.696 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 85.7 m -138.09 -97.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.047 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.675 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.12 -59.13 2.88 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.58 ' OG1' HG13 ' A' ' 36' ' ' ILE . 1.2 t -79.87 -104.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.58 HG13 ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -114.68 -146.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.62 0.248 . . . . 0.0 111.048 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.818 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.1 m-85 -81.84 134.39 35.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 111.038 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -116.4 -178.34 18.09 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.086 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.689 ' HB2' HG23 ' A' ' 139' ' ' THR . 4.5 mt -133.65 142.68 48.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.39 132.2 4.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.881 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -158.97 171.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.148 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.729 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 4.1 t-20 -56.58 122.2 11.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.131 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.49 -67.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -176.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.5 37.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -110.41 146.67 35.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.681 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.99 -25.82 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.707 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.448 ' CG ' ' HA2' ' A' ' 26' ' ' GLY . 3.3 m-20 -61.63 -29.75 70.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.625 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -36.11 60.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.09 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.838 HG13 HG21 ' A' ' 109' ' ' VAL . 18.7 t -61.62 -46.77 95.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -48.69 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.126 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.523 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 1.9 mmp_? -63.79 -21.55 66.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -71.41 -40.92 70.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.79 -19.45 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 51' ' ' ARG . 4.2 mmt180 -71.86 -56.4 5.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.357 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -75.36 -43.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.742 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.71 -3.17 46.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.303 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -113.75 5.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.19 90.12 3.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 t -144.8 71.37 15.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.66 7.37 4.58 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.763 2.309 . . . . 0.0 112.721 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -114.35 -14.41 12.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.14 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 122.03 70.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.24 171.47 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.594 2.196 . . . . 0.0 112.315 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 110' ' ' ILE . 10.5 p -112.8 145.02 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.008 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -93.6 146.49 23.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -116.39 154.31 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 52.8 t -105.02 122.93 46.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.633 HG22 ' H ' ' A' ' 69' ' ' SER . 1.8 p -147.51 177.68 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.765 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.633 ' H ' HG22 ' A' ' 68' ' ' VAL . 2.5 t -86.74 -36.32 18.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.109 0.481 . . . . 0.0 110.23 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.442 ' N ' HG13 ' A' ' 68' ' ' VAL . 3.5 t -162.89 161.16 25.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.325 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.767 HG21 ' HE2' ' A' ' 85' ' ' MET . 17.8 t -55.58 -32.69 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.379 . . . . 0.0 111.099 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 2.0 m-20 -67.35 -29.36 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.001 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -80.58 -15.27 57.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.371 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.506 ' O ' HG12 ' A' ' 74' ' ' ILE . 3.0 tt -114.34 47.9 0.44 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 98.8 Cg_endo -79.08 -32.67 1.74 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.778 1.652 . . . . 0.0 112.298 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.49 -11.8 60.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.672 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.59 -49.44 3.24 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.483 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.9 p -114.83 178.23 4.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.602 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -117.22 116.63 37.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.023 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 71' ' ' VAL . 68.2 Cg_endo -102.22 178.09 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.162 2.575 . . . . 0.0 112.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -140.76 177.35 8.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.89 -99.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.966 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.04 -25.49 30.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.158 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -60.25 -47.16 87.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.767 ' HE2' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -67.97 -27.93 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.003 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -57.88 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.578 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 11.8 tp -57.82 -26.2 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.884 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.546 ' SD ' HD13 ' A' ' 182' ' ' LEU . 6.9 tpt -72.39 -46.79 53.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.427 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.35 -4.03 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.273 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.59 -38.52 87.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.066 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.05 58.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -123.97 141.23 36.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.7 Cg_exo -78.66 -161.57 2.74 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.246 -1.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.45 163.1 11.65 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.748 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.17 38.55 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.2 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 92' ' ' LEU . 30.6 p90 -99.96 158.03 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.08 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -110.51 137.67 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.545 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 15.7 t -117.93 109.2 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.881 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 50.4 t -104.33 126.57 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.282 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.479 HD11 ' HE1' ' A' ' 85' ' ' MET . 1.2 mt -126.33 -167.02 1.65 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.559 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.58 -167.94 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.687 178.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.52 ' HG2' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.45 137.44 53.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.252 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -74.43 -173.19 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.084 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -75.54 5.14 6.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.295 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.419 ' HB2' HH21 ' A' ' 102' ' ' ARG . 1.5 mt -69.7 163.38 25.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.911 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.462 HG12 ' HB2' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -65.8 108.99 2.56 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 30.48 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.956 2.437 . . . . 0.0 113.051 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.462 ' HB2' HG12 ' A' ' 106' ' ' ILE . 37.8 t70 -61.46 -97.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.578 0.227 . . . . 0.0 111.559 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 49' ' ' VAL . 6.3 p -89.74 5.6 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.798 0.332 . . . . 0.0 111.618 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 64' ' ' VAL . 1.4 mt -97.87 -36.27 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.313 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.513 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -87.11 -39.62 15.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.102 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.09 -96.53 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.44 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.45 -64.47 1.22 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.891 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.679 ' HB2' ' HE ' ' A' ' 116' ' ' ARG . 0.7 OUTLIER -104.56 176.27 5.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.681 0.277 . . . . 0.0 111.111 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.513 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -92.47 71.89 5.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.679 ' HE ' ' HB2' ' A' ' 114' ' ' SER . 64.2 mtm180 -136.32 160.36 38.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 102' ' ' ARG . 21.6 t -139.26 125.92 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -85.61 161.55 35.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.514 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 98' ' ' VAL . 30.5 mt -144.74 152.34 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.632 0.253 . . . . 0.0 110.452 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.61 120.23 9.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.83 86.58 5.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.736 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.95 -178.02 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.516 2.144 . . . . 0.0 112.513 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -0.58 50.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.982 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.843 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.7 t0 -72.88 96.09 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -43.12 83.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.599 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 1.013 HG22 HD11 ' A' ' 16' ' ' LEU . 9.5 mt -67.48 -48.64 76.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.004 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.843 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 15.1 t -57.81 -29.02 64.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.546 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.8 mtp180 -67.35 -33.95 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.484 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -64.43 -58.77 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.973 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 tt -63.83 -35.08 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.376 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.43 -30.05 64.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.151 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -55.35 -55.36 32.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.178 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -75.9 -83.86 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.296 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.67 110.11 9.79 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.23 147.26 83.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.429 2.086 . . . . 0.0 111.768 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.89 159.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 5.2 m -80.13 141.75 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.14 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.63 109.85 6.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 111.756 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.689 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.75 157.06 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.508 178.674 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 p -78.52 126.51 30.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.055 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.509 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.07 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo . . . . . 0 CA--C 1.537 0.627 0 N-CA-C 113.459 0.523 . . . . 0.0 113.459 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.89 110.4 3.03 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.861 1.707 . . . . 0.0 112.279 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.37 151.94 38.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -95.88 -12.03 0.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.948 2.432 . . . . 0.0 112.934 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -131.48 137.39 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.208 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.8 -33.39 73.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.717 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.1 -19.27 60.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.913 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -36.79 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.702 HD12 HG23 ' A' ' 165' ' ' VAL . 69.4 mt -67.62 -55.56 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.142 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.2 m -54.87 -33.85 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -59.46 2.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.626 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.608 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -57.45 -43.01 83.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.429 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.753 ' HG ' ' HB3' ' A' ' 163' ' ' ASP . 2.3 mm? -101.3 66.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 159' ' ' LEU . 33.8 t70 -16.87 -61.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.033 0.833 . . . . 0.0 112.706 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -152.15 11.56 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.241 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.651 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.5 p -81.01 -63.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.837 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HB3' ' HG ' ' A' ' 159' ' ' LEU . 40.4 t0 -109.34 91.33 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.477 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.545 HD23 HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -69.67 139.81 53.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.473 -178.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.702 HG23 HD12 ' A' ' 155' ' ' ILE . 1.4 p -74.62 -175.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.047 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.695 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.55 134.21 50.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -4.22 53.67 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.14 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.755 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.484 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 86.71 28.82 25.55 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.995 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.696 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 25.7 m-20 -73.28 119.89 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.842 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.7 125.62 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.591 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -136.7 -138.64 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.216 -179.522 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -86.26 137.22 32.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.88 0.371 . . . . 0.0 111.598 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.6 ttt -68.83 -5.78 22.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.813 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -149.99 156.54 38.0 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.693 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.63 -152.92 0.55 Allowed 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.864 -1.307 . . . . 0.0 112.633 0.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -155.52 122.25 5.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.521 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.79 137.15 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.471 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.91 91.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.531 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.601 HG23 ' HA ' ' A' ' 189' ' ' VAL . 2.2 mp -106.55 128.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.752 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.881 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -103.01 64.13 0.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.116 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.546 HD13 ' SD ' ' A' ' 88' ' ' MET . 5.1 tt -69.55 94.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.427 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -77.09 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.578 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.22 -123.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.589 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 3.0 t-20 -63.39 -52.2 62.36 Favored Pre-proline 0 CA--C 1.532 0.253 0 O-C-N 122.423 -0.173 . . . . 0.0 111.256 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.4 Cg_exo -75.07 109.22 2.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.554 2.169 . . . . 0.0 112.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 93.2 Cg_endo -84.19 131.58 5.04 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.61 2.206 . . . . 0.0 112.405 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 23.8 mmm-85 -89.44 51.08 2.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.989 0.424 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.601 ' HA ' HG23 ' A' ' 180' ' ' ILE . 14.7 t -58.26 98.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.781 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.5 91.42 3.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.133 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 178.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.783 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 73.9 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 CA-C-O 120.966 0.319 . . . . 0.0 112.663 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.5 -32.51 68.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.77 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 167' ' ' ASP . 58.8 t -60.43 -35.93 66.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.738 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.783 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -74.03 -39.13 63.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.58 -21.34 61.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.981 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -76.42 -35.68 58.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.777 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.77 75.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.285 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' H ' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -75.66 -21.35 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -66.9 -50.43 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.774 ' HB ' HD22 ' A' ' 164' ' ' LEU . 8.0 p -65.15 -32.99 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 mtt -61.48 -29.22 69.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.83 -30.54 62.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.01 5.11 77.88 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.577 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.16 36.6 93.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.692 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.9 169.65 13.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.19 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.43 146.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.7 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -119.51 131.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.632 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -102.35 162.81 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.565 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -167.81 99.63 0.59 Allowed Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.404 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.633 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 79.1 Cg_endo -84.1 166.62 12.75 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.545 2.164 . . . . 0.0 110.922 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.748 ' HA ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.72 -157.61 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.937 178.522 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.573 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 10.4 p-10 -63.61 -13.19 39.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.819 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -100.37 -94.49 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.996 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.481 ' H ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -133.13 173.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.661 0.267 . . . . 0.0 111.177 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m-85 -63.88 144.28 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.827 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -135.09 -174.83 13.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.334 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 mp -126.68 146.54 50.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.55 121.53 1.46 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.183 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.595 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.75 171.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 179.406 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.748 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -56.76 123.43 14.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.055 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.24 -65.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.264 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.95 40.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.762 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.38 149.41 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.47 -28.76 59.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -65.23 -27.17 68.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.292 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -75.5 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.071 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 46' ' ' GLU . 20.5 m -65.53 -28.83 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.219 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 4.8 mtp180 -72.39 -46.98 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.824 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -70.42 -27.09 64.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 48' ' ' ALA . 2.0 mp -67.12 -34.57 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -69.62 -39.74 77.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.953 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -65.19 -48.58 72.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.95 -40.04 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 5.6 mptt -83.0 -2.16 54.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.961 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.29 -102.78 0.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.326 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 71.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.036 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.02 70.25 70.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.11 -1.58 11.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.503 2.135 . . . . 0.0 112.425 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -121.12 -1.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -82.98 124.63 76.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.999 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.05 160.9 9.49 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.575 2.184 . . . . 0.0 112.431 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 110' ' ' ILE . 7.3 p -117.28 148.67 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 t -95.38 149.86 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 111.074 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 117' ' ' VAL . 25.0 mt -116.02 157.65 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.846 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 6.9 t -116.25 119.75 36.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.767 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 1.0 OUTLIER -136.03 171.09 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.993 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.464 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -84.59 -38.83 19.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.103 0.477 . . . . 0.0 110.447 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.06 169.52 17.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.398 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' A' ' 85' ' ' MET . 22.2 t -59.2 -32.7 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.07 -26.62 66.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.663 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 17.8 mm-40 -81.12 -19.9 42.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.296 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.596 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 15.4 tt -114.74 47.49 0.45 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 21.7 Cg_exo -66.93 -65.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.832 1.688 . . . . 0.0 113.208 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -72.29 4.21 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HB3' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -108.0 -24.03 11.77 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.571 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -129.31 159.27 36.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.37 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.565 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.57 87.12 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.69 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.35 -163.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.062 2.508 . . . . 0.0 112.83 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.76 -177.67 5.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.5 -77.2 0.73 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.645 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.778 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -56.2 -31.31 63.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.816 0.341 . . . . 0.0 111.066 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.07 91.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.119 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.515 ' HG3' HG11 ' A' ' 71' ' ' VAL . 20.2 mmt -71.41 -17.61 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.778 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -63.75 -50.35 69.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.263 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 2.5 tm? -60.58 -37.77 82.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.304 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.532 ' SD ' HG21 ' A' ' 98' ' ' VAL . 5.9 tpt -66.78 -33.31 75.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.016 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.14 -15.04 61.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.116 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 87' ' ' LEU . 1.2 mtp85 -67.0 -61.98 1.66 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 pt -98.68 57.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.051 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 121' ' ' VAL . 3.9 tt -131.03 129.19 22.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.912 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HB3' HG12 ' A' ' 121' ' ' VAL . 6.0 Cg_exo -78.14 -159.97 2.19 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.28 -0.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.433 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 156.83 163.04 11.97 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.626 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.756 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 4.6 Cg_exo -78.1 39.49 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.051 2.501 . . . . 0.0 112.371 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.433 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -112.3 130.97 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.337 -179.344 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.17 114.9 26.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.3 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.532 HG21 ' SD ' ' A' ' 88' ' ' MET . 2.0 m -108.87 118.81 57.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.92 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 22.0 t -91.64 131.07 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.218 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 183' ' ' THR . 0.3 OUTLIER -127.18 178.93 5.71 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.426 0.453 . . . . 0.0 111.121 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.75 176.08 7.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.681 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.05 137.14 53.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.979 0.419 . . . . 0.0 111.36 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.565 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 1.5 t-20 -74.59 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.024 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -75.55 15.8 0.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.648 HD13 ' H ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -69.51 153.98 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.679 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 105' ' ' LEU . 4.7 pt -59.67 109.61 2.1 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.24 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 59.2 Cg_endo -70.81 1.93 4.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.692 2.261 . . . . 0.0 112.785 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.13 -93.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.762 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.78 7.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 64' ' ' VAL . 41.3 mm -103.2 -64.93 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 111.317 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 107' ' ' PRO . 8.4 p -87.42 -26.97 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.39 -116.67 4.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.727 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.35 -20.2 42.58 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.019 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -104.83 179.8 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.575 0.226 . . . . 0.0 110.845 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -113.45 42.37 1.97 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -136.64 156.19 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.352 -179.352 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.681 HG23 ' HB3' ' A' ' 102' ' ' ARG . 58.8 t -139.51 144.6 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.521 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -84.04 160.08 36.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.96 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 118' ' ' GLY . 34.0 mt -149.15 141.14 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -148.91 134.11 18.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.946 0.403 . . . . 0.0 111.566 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 92' ' ' LEU . 34.2 t -111.02 81.96 2.92 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.768 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.549 ' HG2' ' OD1' ' A' ' 124' ' ' ASP . 34.9 Cg_endo -64.38 -178.86 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.566 2.177 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.91 -0.98 55.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.72 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.549 ' OD1' ' HG2' ' A' ' 122' ' ' PRO . 0.8 OUTLIER -64.75 105.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 111.034 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.35 -42.88 82.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.44 -58.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.218 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.65 -19.85 42.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . 42.6 ttt-85 -70.11 -35.88 74.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.37 -51.89 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.05 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.38 -51.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.767 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.17 -29.41 69.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -55.08 -55.27 32.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.422 . . . . 0.0 110.039 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -90.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.114 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 1.9 m-85 -77.17 127.34 83.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.935 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 23.1 Cg_exo -65.54 154.15 75.03 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 111.555 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.55 156.28 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.64 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 2.1 m -80.41 136.7 36.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.777 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -133.02 108.05 8.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.868 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -127.76 118.54 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.582 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -62.43 112.17 2.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.982 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.21 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo . . . . . 0 CA--C 1.538 0.692 0 N-CA-C 113.336 0.476 . . . . 0.0 113.336 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.23 132.21 12.39 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.868 1.712 . . . . 0.0 112.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.16 156.56 36.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.897 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -95.06 -16.59 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.718 2.279 . . . . 0.0 112.382 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.691 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 12.5 ttm180 -141.7 129.13 21.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.319 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.512 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -58.07 -31.12 66.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.273 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.614 ' O ' HG12 ' A' ' 156' ' ' VAL . 2.1 tt0 -74.42 -34.74 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.396 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.691 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.6 -42.9 97.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.46 -178.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.762 HD12 HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.17 -38.81 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.606 -178.749 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -53.37 -32.84 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.269 -177.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HD2' HH11 ' A' ' 157' ' ' ARG . 2.1 mtm180 -75.92 -41.71 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.994 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -22.9 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 164' ' ' LEU . 3.3 pp -93.22 37.41 1.04 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.101 -0.24 . . . . 0.0 111.643 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 159' ' ' LEU . 27.6 t70 -18.38 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.753 0.658 . . . . 0.0 112.517 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -154.64 7.95 0.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.417 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -81.37 -80.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.618 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -104.64 89.44 3.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.774 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -57.22 121.18 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.679 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.823 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.3 p -60.24 -170.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.391 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.885 HD12 ' H ' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -125.95 156.97 38.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.942 -179.061 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.478 ' HB3' HG22 ' A' ' 15' ' ' VAL . 2.3 t70 -91.77 -26.98 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.8 -59.21 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.797 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.885 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 81.62 49.21 5.53 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.13 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.748 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -70.63 105.73 3.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.337 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -157.54 122.12 4.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.329 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -137.43 -104.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.4 m-20 -85.37 111.71 20.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 35' ' ' THR . 83.9 mmm -65.89 -16.8 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.175 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.97 154.64 39.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 177' ' ' SER . 67.7 Cg_endo -91.67 -149.7 0.33 Allowed 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.681 0.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 23.0 p -158.27 146.35 18.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.473 HG22 HG13 ' A' ' 180' ' ' ILE . 40.5 m -101.87 145.19 29.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.899 0.38 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.98 96.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.59 HG23 ' HA ' ' A' ' 189' ' ' VAL . 12.5 mt -110.64 135.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.395 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.92 65.43 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.068 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 100' ' ' LEU . 18.6 tp -70.14 82.63 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.397 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.34 -75.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.336 . . . . 0.0 110.433 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.58 -120.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.562 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.1 m-80 -67.4 -52.83 26.4 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.0 109.05 2.26 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.38 2.053 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.3 Cg_endo -82.91 123.83 3.73 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.529 2.152 . . . . 0.0 112.162 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -88.01 54.4 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.59 ' HA ' HG23 ' A' ' 180' ' ' ILE . 11.6 t -57.56 104.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.904 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.39 89.9 2.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.074 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -86.95 141.01 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 192' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.656 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 19.0 Cg_exo . . . . . 0 C--O 1.232 0.2 0 CA-C-O 120.709 0.212 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 4.4 m-20 -74.24 -38.68 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -69.66 -26.5 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 mm? -70.87 -52.27 21.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -64.82 -20.06 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.5 mm-40 -67.65 -47.46 69.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.18 82.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.222 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 16' ' ' LEU . 28.2 mm -67.92 -33.26 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.81 -30.71 70.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.974 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG22 ' HG ' ' A' ' 164' ' ' LEU . 11.7 t -72.68 -33.38 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.5 mmt -64.03 -50.15 69.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.025 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.02 -17.57 64.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.252 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 0.91 84.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.2 35.02 90.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.59 165.06 12.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.19 146.59 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.511 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.695 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.15 129.87 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.701 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -102.42 163.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.677 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -163.68 88.42 1.19 Allowed Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.599 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 94.5 Cg_endo -78.22 119.94 4.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.498 2.132 . . . . 0.0 110.749 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.858 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 0.6 OUTLIER -116.46 -139.17 0.37 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.04 0.448 . . . . 0.0 111.961 -176.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -53.62 -47.77 69.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.52 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 36' ' ' ILE . 3.3 t -79.0 -119.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.735 HG12 ' H ' ' A' ' 37' ' ' TYR . 8.3 tt -112.36 -168.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.282 -0.261 . . . . 0.0 110.846 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.735 ' H ' HG12 ' A' ' 36' ' ' ILE . 4.1 m-85 -63.43 127.89 33.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 110.353 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.43 170.58 13.34 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.368 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -120.12 139.58 52.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.36 117.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.869 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 42' ' ' ASN . 2.0 p -158.36 174.63 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.708 0.29 . . . . 0.0 111.331 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.809 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.22 114.36 1.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.653 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.481 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -66.17 -49.75 66.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.038 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' A' ' 44' ' ' LEU . 1.2 mm? -80.97 28.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 111.564 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.809 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -111.02 152.23 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.71 178.629 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -75.36 -29.0 59.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.835 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -28.79 68.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.039 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.49 ' O ' HD23 ' A' ' 52' ' ' LEU . . . -68.18 -32.59 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.534 ' HA ' HD23 ' A' ' 52' ' ' LEU . 56.5 t -70.12 -48.67 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.135 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.32 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.245 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.98 -55.78 8.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.276 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -60.13 -17.51 40.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.335 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -51.96 13.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.025 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -59.19 -38.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.218 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -70.71 -58.2 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -83.54 -76.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.18 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.03 27.68 51.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.55 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -108.48 -47.26 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 16.7 m -135.42 82.43 40.29 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.21 -3.39 10.7 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.812 2.342 . . . . 0.0 112.662 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -109.01 -19.94 13.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.246 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -68.0 147.39 98.44 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.44 ' HG3' ' OG ' ' A' ' 114' ' ' SER . 50.1 Cg_exo -53.47 158.64 7.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.52 2.147 . . . . 0.0 112.324 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 110' ' ' ILE . 9.0 p -112.8 153.54 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 136.0 34.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 77' ' ' PHE . 12.0 mm -113.92 148.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.259 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.4 127.64 54.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.759 HG21 HG23 ' A' ' 74' ' ' ILE . 1.5 p -141.96 179.99 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.589 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.882 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 12.5 t -86.32 -41.35 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 0.0 110.529 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.14 169.22 18.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.88 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.686 ' HA ' HD11 ' A' ' 74' ' ' ILE . 16.2 t -57.17 -34.61 45.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.29 -26.87 66.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.067 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.882 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 80.9 mm-40 -77.46 -20.02 55.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.773 HD13 HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -113.31 61.42 0.8 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.812 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.149 1.899 . . . . 0.0 112.421 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.02 16.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.976 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE1' HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -105.3 -49.53 3.43 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.135 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -126.4 165.38 19.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.464 HH11 ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -113.0 96.97 40.58 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -102.29 -179.12 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.112 2.542 . . . . 0.0 112.567 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 47.4 t -133.59 169.96 16.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.45 -77.29 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.839 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.564 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -57.51 -29.62 64.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.44 -45.84 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 81' ' ' SER . 17.7 mmt -74.41 -11.65 60.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.334 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 4.4 mt-10 -72.43 -49.92 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.872 0.368 . . . . 0.0 110.603 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 8.3 tp -63.18 -36.37 83.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.949 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.53 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 3.7 tpt -70.67 -51.21 29.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.92 -14.98 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.465 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.98 -34.14 77.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 pt -115.04 52.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.463 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -131.03 140.56 39.05 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.75 -163.96 3.72 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.625 -1.406 . . . . 0.0 112.37 -1.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.85 166.39 15.2 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.625 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.522 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 5.7 Cg_exo -78.23 35.34 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.057 2.504 . . . . 0.0 112.043 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.555 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 25.0 p90 -99.0 164.86 12.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.969 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.689 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 36.8 m -115.29 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.698 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.53 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 1.7 p -123.6 104.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.444 . . . . 0.0 110.955 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.733 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 15.4 t -101.47 129.92 51.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.86 -175.11 3.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.595 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -178.79 3.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -119.76 141.27 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.969 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -74.28 -174.17 1.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 104' ' ' GLU . 2.5 pt-20 -76.56 43.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.491 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.647 HD22 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -73.97 146.16 44.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.804 0.335 . . . . 0.0 110.973 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.567 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.2 mp -80.02 -50.28 1.2 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.647 ' HD2' HD22 ' A' ' 105' ' ' LEU . 77.7 Cg_exo -51.07 100.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.186 1.924 . . . . 0.0 112.461 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -82.38 1.98 34.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.92 -23.88 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.065 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.52 ' O ' HG12 ' A' ' 64' ' ' VAL . 15.0 pt -96.87 -39.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.151 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 108' ' ' ASP . 12.9 t -76.8 -15.51 59.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.953 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.24 -171.5 42.94 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.635 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -71.02 -6.67 60.83 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.44 ' OG ' ' HG3' ' A' ' 63' ' ' PRO . 4.2 p -106.24 -176.57 3.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.503 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.3 m -111.57 40.31 2.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -139.02 150.43 45.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 111' ' ' THR . 93.0 t -139.7 144.56 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.497 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.583 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -91.77 158.3 25.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.773 HD13 HD13 ' A' ' 74' ' ' ILE . 43.7 mt -145.82 151.16 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HG2' ' HA ' ' A' ' 97' ' ' THR . 13.3 mtp180 -147.67 134.06 19.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.617 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.8 87.26 6.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.551 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.55 -176.33 2.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.555 2.17 . . . . 0.0 112.586 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 11.55 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 13.4 t0 -76.83 97.89 4.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -47.92 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.09 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.411 HG23 HD22 ' A' ' 16' ' ' LEU . 32.2 mm -61.06 -50.98 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 6.9 t -61.35 -23.74 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 69' ' ' SER . 9.2 ttm180 -67.04 -31.85 72.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.591 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtt85 -75.09 -56.19 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.1 -50.9 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.371 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.678 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.22 -26.96 69.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.391 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 128' ' ' ARG . . . -54.58 -56.51 18.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 109.989 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -75.86 -86.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.998 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 61.4 m-85 -76.59 125.56 87.21 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.717 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.45 147.19 82.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.283 1.988 . . . . 0.0 111.949 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -120.52 155.1 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.209 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.661 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 11.3 m -80.22 133.84 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.228 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.71 104.97 7.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -134.15 161.18 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.3 m -76.87 123.33 26.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.789 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 45.0 Cg_exo . . . . . 0 CA--C 1.538 0.682 0 N-CA-C 113.281 0.454 . . . . 0.0 113.281 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 24.0 Cg_exo -64.27 113.07 2.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.932 1.755 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -97.1 137.9 21.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 64.6 Cg_endo -96.09 -12.35 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.885 2.39 . . . . 0.0 112.983 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -133.05 134.85 44.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -43.13 83.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.817 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.04 -18.0 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 158' ' ' ASP . 4.4 tt0 -73.44 -37.03 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.816 HD12 HG23 ' A' ' 165' ' ' VAL . 6.1 mt -70.59 -46.4 70.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.593 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.58 -36.66 78.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.956 0.407 . . . . 0.0 111.403 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -75.61 -49.03 19.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.095 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -72.64 -41.96 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.302 . . . . 0.0 111.694 -177.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.558 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -93.77 72.28 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' A' ' 159' ' ' LEU . 11.3 t70 -15.97 -66.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.057 0.848 . . . . 0.0 112.925 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.14 25.94 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.281 . . . . 0.0 111.43 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.673 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.83 -67.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.673 ' H ' HG13 ' A' ' 162' ' ' VAL . 1.5 p-10 -111.12 94.19 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.413 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.521 ' HG ' HG22 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -60.01 127.76 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.608 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.816 HG23 HD12 ' A' ' 155' ' ' ILE . 3.4 p -60.79 176.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.039 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.684 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.79 125.54 41.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.135 0.493 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -4.34 52.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.67 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.42 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 84.71 65.62 1.49 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.996 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.858 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 5.6 m-20 -72.88 -116.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.77 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -149.89 -171.67 3.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.635 0.255 . . . . 0.0 111.112 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 9.11 1.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.4 94.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.42 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.73 -15.44 0.72 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 150.69 64.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.538 0.209 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.42 -160.87 2.41 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.663 0.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.0 t -160.9 112.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 3.4 m -102.16 136.18 42.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.689 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -128.93 98.9 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.268 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 189' ' ' VAL . 36.9 mt -116.49 132.51 65.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.511 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.733 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -108.3 64.41 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 178.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 18.2 tp -69.91 100.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.533 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.431 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -82.42 -85.63 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.352 178.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.75 -94.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.213 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 23.0 t-20 -82.78 -53.15 0.63 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 85.5 Cg_endo -77.75 107.08 2.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.244 1.963 . . . . 0.0 112.231 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.569 ' HB2' HG23 ' A' ' 189' ' ' VAL . 86.9 Cg_endo -82.16 130.71 6.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.508 2.139 . . . . 0.0 112.367 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -90.42 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.982 0.42 . . . . 0.0 110.547 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.778 ' HA ' HG12 ' A' ' 180' ' ' ILE . 94.3 t -56.44 101.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.12 86.62 2.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.008 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -83.92 143.93 29.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.994 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.741 0.225 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.27 -48.47 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.14 -33.75 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -63.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.193 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.79 -20.01 60.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.276 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.02 -46.5 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.06 94.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.282 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' MET . 2.0 mp -72.26 -29.12 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -54.56 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.253 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.93 -26.79 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 10.8 mmt -56.56 -44.59 81.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -19.66 61.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.9 -0.43 64.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.694 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.52 27.23 71.52 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.36 170.75 13.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.36 153.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.74 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.32 151.13 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 111.447 -178.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -108.3 154.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.22 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.79 106.93 0.45 Allowed Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HB2' ' HA ' ' A' ' 170' ' ' ASP . 1.4 Cg_endo -84.55 162.59 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.292 2.661 . . . . 0.0 112.136 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -137.33 -150.34 0.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.637 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.781 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 5.9 m-20 -60.16 -20.36 58.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.725 0.297 . . . . 0.0 111.148 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 95' ' ' PRO . 7.9 p -100.18 -112.31 0.18 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tt -111.82 -179.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.665 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -84.2 128.89 34.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.197 0.522 . . . . 0.0 110.686 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -118.75 -167.98 14.03 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.753 HD12 HG23 ' A' ' 139' ' ' THR . 0.2 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.799 0.333 . . . . 0.0 110.5 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.727 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -144.26 136.1 6.57 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.987 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.697 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.4 p -172.28 -169.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.792 -0.204 . . . . 0.0 110.743 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.697 ' H ' HG22 ' A' ' 41' ' ' VAL . 2.8 t-20 -56.33 103.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.003 0.43 . . . . 0.0 110.327 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.84 -39.23 91.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.017 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.99 24.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.441 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.85 155.16 22.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.775 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -21.74 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -72.89 -23.23 60.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.629 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.34 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.755 HG21 HG22 ' A' ' 109' ' ' VAL . 11.5 p -72.27 -30.25 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.816 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -41.76 61.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -64.44 -44.38 91.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -61.52 -40.69 95.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.13 -28.54 69.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.005 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -64.26 -45.72 86.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.247 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 t -72.51 -51.25 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.03 -78.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.86 7.41 16.14 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.851 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -118.35 11.8 13.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.721 0.296 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 1.6 m -147.11 65.35 9.56 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.104 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 59' ' ' SER . 8.9 Cg_exo -72.8 -2.63 12.21 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.728 2.286 . . . . 0.0 112.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -112.61 -24.33 9.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.2 OUTLIER -68.47 148.67 98.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 177.35 3.12 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.515 2.144 . . . . 0.0 112.344 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 66' ' ' ILE . 14.6 p -112.92 149.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.798 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 134.27 35.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.502 HD11 HG13 ' A' ' 64' ' ' VAL . 4.1 mm -116.12 160.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.056 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 9.9 t -122.62 137.63 54.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.726 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.806 HG11 HG12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -139.35 -176.2 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.663 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -73.3 -50.03 24.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.709 179.017 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.484 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -164.71 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.265 0.555 . . . . 0.0 111.797 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.606 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 16.8 t -52.83 -22.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.85 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 2.2 t70 -67.92 -52.78 32.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.76 13.77 3.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.658 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.806 HG12 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.17 -42.88 0.41 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 72' ' ' ASP . 76.9 Cg_exo -51.62 -17.42 4.75 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.244 1.963 . . . . 0.0 112.935 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -72.2 -39.01 68.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.433 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 23.7 m-85 -97.44 -35.71 10.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.516 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 74' ' ' ILE . 88.8 p -116.24 -173.81 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.957 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.39 100.7 28.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.719 ' HA ' HD22 ' A' ' 100' ' ' LEU . 92.3 Cg_endo -102.74 -170.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.211 2.608 . . . . 0.0 112.677 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.538 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -126.98 177.09 6.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.22 -88.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.857 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -55.72 -27.48 50.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.128 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.43 -44.12 97.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.918 0.39 . . . . 0.0 110.932 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.526 ' CE ' HD21 ' A' ' 100' ' ' LEU . 6.6 mmt -73.94 -16.13 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.307 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 mt-10 -67.44 -51.27 53.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.591 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.6 tp -62.61 -32.4 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.666 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.435 ' O ' HD12 ' A' ' 92' ' ' LEU . 6.0 tpt -70.15 -48.12 58.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -65.42 -11.42 42.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.7 tpt180 -72.95 -31.08 64.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.09 32.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.474 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 93' ' ' PRO . 4.4 mt -131.11 152.93 81.5 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.815 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 92' ' ' LEU . 83.3 Cg_endo -77.94 -172.65 11.55 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.555 -1.435 . . . . 0.0 112.512 0.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.55 -177.81 31.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.687 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.781 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 87.8 Cg_endo -81.03 43.45 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.751 2.301 . . . . 0.0 112.239 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.515 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 5.6 m-85 -111.43 136.28 50.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 m -94.92 120.93 35.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.344 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.435 HG11 ' HG2' ' A' ' 88' ' ' MET . 3.2 t -108.86 116.52 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.695 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 3.5 t -104.1 127.47 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.719 HD22 ' HA ' ' A' ' 80' ' ' PRO . 1.6 mt -126.87 -169.37 2.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.969 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -172.63 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.648 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.684 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.9 142.53 47.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 1.3 t-20 -74.38 -172.37 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.207 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -75.82 12.83 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.48 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.533 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -69.73 -172.93 0.55 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.807 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.25 105.12 3.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.128 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.599 ' HA ' HG23 ' A' ' 111' ' ' THR . 65.9 Cg_endo -71.43 2.8 4.11 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.585 2.19 . . . . 0.0 112.611 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.82 -88.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.075 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.755 HG22 HG21 ' A' ' 49' ' ' VAL . 3.2 p -84.77 -0.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.0 mt -96.8 -63.59 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.648 0.261 . . . . 0.0 111.379 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.602 HG21 ' HG3' ' A' ' 102' ' ' ARG . 4.4 p -87.18 -23.75 24.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.59 -130.14 20.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.553 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.41 11.68 60.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.698 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -119.1 169.45 9.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.707 0.289 . . . . 0.0 111.035 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 39.8 m -113.44 31.95 6.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -136.6 166.58 23.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.684 HG23 ' HB2' ' A' ' 102' ' ' ARG . 77.2 t -139.93 142.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.65 155.75 41.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.366 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 100' ' ' LEU . 8.4 mt -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.604 0.24 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.541 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER -146.1 127.34 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.387 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.37 80.13 2.47 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.597 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 20.2 Cg_exo -66.6 179.08 2.28 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.505 2.137 . . . . 0.0 112.713 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.69 -0.9 55.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.2 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 83.5 m-20 -61.98 109.1 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.155 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.43 -56.59 19.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.438 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.6 mm -58.66 -50.79 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -17.24 62.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -75.14 -38.48 60.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -45.01 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.05 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.8 mm -62.91 -46.15 97.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -64.38 -28.4 69.67 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.898 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 69' ' ' SER . . . -54.79 -55.0 34.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.041 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -75.48 -88.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.174 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -77.2 138.55 64.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.88 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.56 146.94 62.99 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.36 2.04 . . . . 0.0 111.849 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 131' ' ' ALA . 13.4 t -125.31 133.32 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.47 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.727 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.2 m -67.35 141.47 57.1 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -140.06 104.53 4.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.856 0.36 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.753 HG23 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.61 125.47 15.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.702 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.62 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -61.18 135.85 57.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.872 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 120.859 0.361 . . . . 0.0 111.171 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 CA--C 1.536 0.597 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.46 94.98 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.847 1.698 . . . . 0.0 112.419 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.6 128.49 69.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.748 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -95.95 -8.24 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.886 2.39 . . . . 0.0 112.951 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -129.19 120.12 25.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.493 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -60.05 -36.31 77.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.518 178.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -23.83 61.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.647 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -36.87 84.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.974 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 165' ' ' VAL . 55.0 mt -68.77 -55.15 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -32.51 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.46 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -75.67 -54.99 6.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.39 -24.08 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.585 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.558 ' HB3' HG13 ' A' ' 162' ' ' VAL . 3.2 mm? -111.25 70.69 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.818 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 16.4 t0 -15.94 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 124.049 0.843 . . . . 0.0 112.823 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -156.85 25.5 0.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.7 0.285 . . . . 0.0 111.469 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.686 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.61 -69.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.573 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.799 ' HB2' HD11 ' A' ' 30' ' ' ILE . 2.0 p-10 -111.29 102.65 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.488 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.621 ' HB2' HG21 ' A' ' 22' ' ' VAL . 3.2 mm? -71.45 131.52 43.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.743 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.0 p -62.98 -163.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.879 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.743 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.1 160.81 29.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 111.124 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.87 -25.8 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.68 -56.29 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.472 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.24 -163.28 16.86 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.792 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.623 ' HA ' ' HB2' ' A' ' 32' ' ' PRO . 7.2 p-10 -70.89 -164.72 0.1 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.829 0.347 . . . . 0.0 111.124 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.51 -57.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.563 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -124.17 -134.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.15 146.4 26.6 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.794 0.331 . . . . 0.0 111.841 -177.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' THR . 71.0 mmm -62.98 -27.47 69.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.71 154.28 47.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.655 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 177' ' ' SER . 65.7 Cg_endo -91.39 -149.36 0.33 Allowed 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.867 -1.305 . . . . 0.0 112.67 1.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.505 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.82 158.29 39.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.515 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.2 m -102.27 139.0 38.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.1 t -129.1 88.8 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.048 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.654 HG23 ' HA ' ' A' ' 189' ' ' VAL . 13.0 mt -108.87 129.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.373 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.695 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.55 66.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.414 178.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 187' ' ' PRO . 53.4 tp -69.71 93.67 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.318 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.42 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -79.51 -81.7 0.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.409 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 185' ' ' ASN . 12.2 t -120.84 -115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.046 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.5 m-20 -66.41 -52.69 35.11 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 185' ' ' ASN . 3.5 Cg_exo -77.22 108.04 2.54 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.497 2.131 . . . . 0.0 112.093 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.4 Cg_endo -81.49 133.38 8.36 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.451 2.101 . . . . 0.0 112.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 188' ' ' ARG . 5.8 mtt180 -91.92 51.12 1.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.654 ' HA ' HG23 ' A' ' 180' ' ' ILE . 6.3 t -58.64 100.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 tp -126.54 86.64 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.43 ' HB3' HG23 ' A' ' 178' ' ' THR . 8.5 ptt-85 -87.06 161.62 18.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.824 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 192' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.869 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 38.1 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.872 0.28 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.71 -39.88 66.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.28 -22.78 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.074 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.31 -43.62 66.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -75.23 -28.54 59.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.622 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.07 -38.9 69.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 111.018 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.622 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -74.08 -36.32 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.75 -30.0 48.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -68.84 -48.33 63.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.847 HG21 ' HG ' ' A' ' 164' ' ' LEU . 7.5 p -72.3 -21.8 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -48.4 81.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.809 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.37 -13.52 62.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.098 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.53 -2.87 76.57 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.453 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.29 53.84 33.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.552 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.37 161.6 23.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.516 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.673 HD11 ' HG ' ' A' ' 39' ' ' LEU . 1.4 tp -90.89 136.05 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 110.568 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.634 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.74 140.96 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.958 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.421 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -101.99 150.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.053 178.763 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.661 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -165.99 107.04 0.72 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.113 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 96.7 Cg_endo -84.26 159.29 13.13 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.763 2.309 . . . . 0.0 111.837 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.892 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -135.32 -149.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -54.81 -20.6 8.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.28 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 36' ' ' ILE . 2.7 t -100.17 -117.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.651 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.694 HG23 ' HB2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -157.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.117 0 O-C-N 122.198 -0.314 . . . . 0.0 111.202 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.595 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 3.9 m-85 -68.62 132.11 46.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.26 -176.76 15.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.265 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.673 ' HG ' HD11 ' A' ' 28' ' ' ILE . 1.7 mp -131.93 142.94 49.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.88 0.372 . . . . 0.0 111.172 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.89 115.46 0.82 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.595 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 136' ' ' VAL . 2.4 p -153.96 150.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.802 0.334 . . . . 0.0 111.067 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -55.87 104.65 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.397 . . . . 0.0 110.574 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.53 78.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.942 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.4 mm? -76.7 13.92 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.946 0.403 . . . . 0.0 111.151 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -110.48 156.25 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.893 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.589 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -69.72 -25.22 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 31.1 t70 -66.5 -21.18 66.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.09 -38.14 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 46' ' ' GLU . 14.6 p -74.25 -35.86 41.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.778 0.323 . . . . 0.0 110.829 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -69.89 -44.21 70.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.487 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.607 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.54 -37.43 84.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.453 179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.607 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -60.05 -30.85 69.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.898 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.2 -32.01 66.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.762 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmt-85 -68.8 -48.71 62.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.559 ' HB ' HH21 ' A' ' 51' ' ' ARG . 29.7 t -75.05 -51.01 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.4 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.56 -67.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.296 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.06 33.03 82.48 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.446 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -100.4 -81.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 110.959 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 m -149.25 146.14 20.65 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.91 2.13 7.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.584 2.189 . . . . 0.0 112.489 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -1.55 26.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.099 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.77 145.29 50.04 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 158.28 54.6 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.517 2.145 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 m -117.04 163.21 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.6 136.6 46.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.623 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.27 168.32 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.817 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 8.3 t -122.57 133.35 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.949 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.91 HG21 HG23 ' A' ' 74' ' ' ILE . 1.1 p -143.39 179.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.627 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -89.3 -42.99 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.931 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.3 t -164.21 170.21 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.089 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HA ' HD11 ' A' ' 74' ' ' ILE . 6.8 t -56.94 -34.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.662 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -67.28 -29.84 69.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.936 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 58.8 mm-40 -73.53 -19.84 60.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.39 60.82 0.8 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.034 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.625 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 44.1 Cg_exo -56.08 -92.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.972 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.442 ' H ' ' HB2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -73.64 22.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.234 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 3.3 m-85 -92.89 -51.95 4.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -128.19 170.51 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.793 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.05 109.21 24.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -102.22 -169.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.108 2.539 . . . . 0.0 112.475 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.947 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -127.61 170.26 12.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.009 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.85 -111.23 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.933 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -25.53 35.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 0.0 110.985 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.947 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -59.97 -53.63 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.629 ' HB3' ' O ' ' A' ' 81' ' ' SER . 1.6 tpp -73.76 -24.16 59.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.098 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -55.55 -40.37 71.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.581 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -67.6 -40.54 84.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 178.326 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.492 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 12.0 tpt -61.69 -50.07 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.441 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.551 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.83 -6.26 46.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.529 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.581 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.2 ttm180 -67.29 -24.88 65.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 pt -111.07 49.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -128.05 150.37 73.54 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.18 179.06 32.11 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.392 0.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.15 174.34 26.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.72 39.91 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.671 2.248 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -98.74 138.43 35.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 7.7 m -97.92 141.45 30.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.654 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.556 HG13 ' HB ' ' A' ' 119' ' ' ILE . 2.5 p -126.18 99.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.18 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.732 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 65.3 t -96.7 117.13 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -126.12 -166.3 1.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.63 178.32 5.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.621 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.665 HH22 HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -120.1 143.6 48.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.659 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.94 -170.56 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.19 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.28 35.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.499 HD22 ' HD2' ' A' ' 107' ' ' PRO . 1.9 mt -69.86 146.3 51.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.852 0.358 . . . . 0.0 110.816 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.561 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 36.8 mm -80.1 -49.15 1.27 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.9 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.7 Cg_exo -50.22 94.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.482 2.121 . . . . 0.0 112.857 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.747 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.5 OUTLIER -82.45 -3.47 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.7 179.227 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 t -74.2 -24.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.292 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.665 HD12 HH22 ' A' ' 102' ' ' ARG . 1.3 pt -98.27 -42.23 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.747 HG22 ' HA ' ' A' ' 108' ' ' ASP . 14.5 t -75.8 -14.54 60.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.814 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.8 -151.72 37.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.657 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.33 -26.4 57.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 m -106.29 175.54 5.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 111.001 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.49 67.65 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -142.12 131.49 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.656 HG21 HH21 ' A' ' 102' ' ' ARG . 59.8 t -139.85 140.89 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.786 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -98.95 162.4 20.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.384 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.556 ' HB ' HG13 ' A' ' 98' ' ' VAL . 10.3 mt -141.8 164.31 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -149.8 127.15 11.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 t -110.4 88.55 7.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.892 ' HB2' HG21 ' A' ' 33' ' ' THR . 78.6 Cg_endo -76.97 -179.35 5.34 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.59 2.193 . . . . 0.0 112.533 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.43 5.45 51.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -72.4 108.29 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -57.29 -43.05 82.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 130' ' ' ILE . 31.2 mm -64.16 -53.62 41.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.88 -17.68 61.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 7.6 ttt180 -75.49 -44.68 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -54.61 11.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.531 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.0 tt -57.31 -43.08 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.552 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.36 -25.8 62.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.418 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -54.55 -58.05 8.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.013 0.435 . . . . 0.0 109.88 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -76.74 -83.28 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.243 177.199 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.415 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -76.62 114.48 39.08 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.62 144.39 72.15 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.368 2.045 . . . . 0.0 111.565 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 41' ' ' VAL . 1.6 t -127.65 161.99 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.845 0.355 . . . . 0.0 111.267 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.606 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.47 139.26 36.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.063 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -131.07 107.48 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.381 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -132.75 141.41 48.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.9 p -80.72 115.74 20.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.86 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.433 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 38.9 Cg_exo . . . . . 0 CA--C 1.537 0.649 0 N-CA-C 113.172 0.412 . . . . 0.0 113.172 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.6 Cg_exo -64.74 104.19 0.53 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.932 1.754 . . . . 0.0 111.862 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.7 t -77.08 149.54 79.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.211 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -95.21 -18.73 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.81 2.34 . . . . 0.0 112.403 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.64 141.41 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.54 HD22 HG22 ' A' ' 165' ' ' VAL . 49.7 mt -64.47 -43.95 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.72 -17.18 63.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -75.06 -39.97 60.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.12 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 1.029 HD12 HG23 ' A' ' 165' ' ' VAL . 7.9 mt -65.3 -56.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.201 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -55.84 -40.86 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.32 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -65.41 -50.48 65.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.666 ' HB3' HD22 ' A' ' 159' ' ' LEU . 8.0 t0 -63.68 -35.17 79.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.771 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -110.88 75.32 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t0 -15.95 -64.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.117 0.886 . . . . 0.0 112.85 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -150.97 11.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.685 0.279 . . . . 0.0 111.35 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -81.15 -62.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.831 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.665 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 1.4 t0 -103.03 97.13 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.847 ' HG ' HG21 ' A' ' 22' ' ' VAL . 2.8 mm? -74.49 129.13 37.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.557 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 1.029 HG23 HD12 ' A' ' 155' ' ' ILE . 2.4 p -66.31 -179.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.306 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.805 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.31 147.33 49.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.484 179.224 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.9 -26.8 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.951 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.661 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -64.64 -54.08 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.88 0.372 . . . . 0.0 111.343 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.804 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 98.24 -165.64 21.76 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.945 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -71.94 -165.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.431 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -141.68 -51.74 0.42 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.322 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -132.33 -135.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 175' ' ' GLU . 4.4 t0 -86.57 154.81 20.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.778 0.323 . . . . 0.0 111.667 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.694 ' HB2' HG23 ' A' ' 36' ' ' ILE . 19.3 ptm -70.9 17.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.434 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 173' ' ' ASP . 1.5 mt-10 -155.35 157.86 31.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.563 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -95.67 -151.89 0.28 Allowed 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.185 -1.173 . . . . 0.0 112.662 1.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.55 96.74 1.93 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 191' ' ' ARG . 97.0 m -100.97 135.51 42.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.231 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 21.0 t -127.64 104.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.66 HG12 ' HA ' ' A' ' 189' ' ' VAL . 36.9 mt -109.11 127.71 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.462 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.2 m-20 -89.35 74.71 7.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.303 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.645 HD12 HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -68.51 79.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -84.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 3.1 t -121.0 -128.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.66 177.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 57.7 t30 -60.24 -51.74 78.09 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 68.3 Cg_endo -74.32 109.02 2.81 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.19 1.927 . . . . 0.0 112.637 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 84.7 Cg_endo -82.8 120.83 3.15 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.611 2.207 . . . . 0.0 112.157 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 1.2 mpp_? -87.87 53.17 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.131 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.73 97.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.71 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.96 89.41 3.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.269 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.578 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -91.17 131.9 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 -179.867 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 52.2 Cg_endo . . . . . 0 C--O 1.231 0.139 0 CA-C-O 120.854 0.272 . . . . 0.0 112.259 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.53 -32.98 73.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -68.14 -36.67 76.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.085 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.598 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.13 -39.77 71.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.15 -24.79 65.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.791 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -33.93 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -67.67 -37.3 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.835 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 16' ' ' LEU . 7.8 mm -75.11 -18.71 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -73.41 -44.98 57.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.053 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.634 ' HB ' HD13 ' A' ' 164' ' ' LEU . 14.1 p -68.46 -31.19 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 53.0 mtt -66.99 -31.24 71.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.861 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.12 -35.26 64.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.053 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.16 10.32 69.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.661 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.01 58.88 9.47 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.529 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.27 160.52 22.03 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.26 146.9 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.434 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.699 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.94 133.03 64.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -102.58 154.14 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.62 0.248 . . . . 0.0 110.946 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.8 OUTLIER -158.47 100.13 1.71 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.762 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 4.7 Cg_exo -78.01 142.29 19.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.975 2.45 . . . . 0.0 111.299 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.5 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 88.4 m -138.62 -82.4 0.3 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 112.304 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 6.0 m-20 -75.36 -78.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.738 ' HA ' ' HG3' ' A' ' 174' ' ' MET . 0.8 OUTLIER -79.4 -88.59 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.366 -177.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.59 -150.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 7.4 m-85 -69.81 141.2 53.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.05 -177.22 17.77 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.911 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.5 mp -122.7 140.21 53.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -147.22 110.35 0.51 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 42' ' ' ASN . 2.6 p -153.48 156.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 111.099 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 41' ' ' VAL . 3.0 m120 -55.05 101.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.025 0.44 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.68 76.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.938 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.4 18.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.048 0.452 . . . . 0.0 111.238 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.84 156.97 20.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.565 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER -75.27 -30.32 60.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.973 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.485 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 6.9 m-20 -62.48 -32.32 73.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.093 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.65 -34.1 71.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.42 -44.79 83.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -66.88 -44.52 80.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.772 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.49 ' NH2' HG23 ' A' ' 162' ' ' VAL . 51.9 mmt-85 -67.01 -23.7 65.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.15 -53.58 19.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -65.86 -14.89 62.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -66.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.313 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -38.48 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -1.54 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.385 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.23 -148.57 50.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -98.61 117.6 33.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 3.2 p -153.35 69.65 6.72 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.822 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.25 1.36 5.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.772 2.314 . . . . 0.0 112.619 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.643 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.8 m80 -114.21 -21.68 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.206 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 8.7 mtpt -88.11 126.43 60.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.28 174.5 7.04 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.451 2.101 . . . . 0.0 112.069 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 110' ' ' ILE . 2.5 m -113.06 153.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.028 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 t -111.3 132.39 54.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.463 HD11 HG12 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -111.67 172.74 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.778 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 3.0 p -119.56 135.31 54.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.725 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -143.69 173.18 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.704 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -83.0 -39.94 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.996 0.427 . . . . 0.0 110.426 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.1 165.75 21.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.637 ' HA ' HD11 ' A' ' 74' ' ' ILE . 18.5 t -55.41 -33.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.769 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.29 -31.36 71.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.116 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.656 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 9.2 mm-40 -71.07 -21.41 62.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.152 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.725 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.27 63.73 0.92 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.791 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.648 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 27.9 Cg_exo -62.29 -76.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.211 1.941 . . . . 0.0 112.38 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.21 23.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.143 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -102.5 -53.04 2.97 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.262 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 22.5 p -123.01 177.24 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 9.2 mtt-85 -113.64 88.76 14.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 78' ' ' SER . 94.2 Cg_endo -102.74 -169.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.241 2.627 . . . . 0.0 112.786 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 2.2 t -145.96 179.21 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.853 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.33 -86.46 0.3 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.046 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -54.96 -32.71 61.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.346 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.595 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -60.29 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.0 110.871 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.564 ' HE1' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.5 -17.91 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.617 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 2.5 mm-40 -59.14 -51.63 69.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.279 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.5 OUTLIER -64.37 -32.81 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.273 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.633 ' HG3' ' HE2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -65.51 -49.39 69.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.463 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -70.22 -8.76 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.265 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -75.02 -20.21 59.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 ' CE1' ' A' ' 96' ' ' TYR . 1.7 mt -108.35 13.18 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.728 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 4.2 pp -131.2 166.07 30.52 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.544 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.728 ' HA ' ' HB2' ' A' ' 92' ' ' LEU . 97.2 Cg_endo -78.87 162.69 87.1 Favored 'Cis proline' 0 C--N 1.354 0.819 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.91 -0.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.88 -151.04 22.81 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.442 ' HG3' ' HD2' ' A' ' 176' ' ' PRO . 85.6 Cg_endo -78.08 35.12 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.411 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.633 ' HE2' ' HG3' ' A' ' 88' ' ' MET . 16.9 t80 -92.62 135.35 34.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.592 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 13.2 m -114.02 120.23 39.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.529 ' HB ' ' HE2' ' A' ' 88' ' ' MET . 0.2 OUTLIER -115.92 108.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.224 0.535 . . . . 0.0 111.551 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.906 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -105.66 128.73 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.435 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.564 HD21 ' HE1' ' A' ' 85' ' ' MET . 1.1 mt -126.59 -172.44 2.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 1.7 tt0 -74.42 -176.65 2.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.296 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.812 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.71 141.36 49.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 111.279 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 7.7 t30 -74.54 -177.02 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.943 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.43 52.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.838 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 4.5 tp -79.97 134.84 36.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 27.4 mt -72.27 -50.58 8.51 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.428 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.838 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 71.0 Cg_exo -51.9 109.1 0.29 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.304 2.003 . . . . 0.0 112.327 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.631 ' HA ' HG22 ' A' ' 111' ' ' THR . 4.4 p-10 -81.98 -19.82 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.182 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.25 -15.38 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.197 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 107' ' ' PRO . 48.1 mt -98.15 -43.08 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.631 HG22 ' HA ' ' A' ' 108' ' ' ASP . 10.3 t -77.0 -12.78 59.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.44 -155.73 49.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.455 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -82.44 -13.65 78.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.397 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.86 -175.06 2.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.782 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.411 ' CA ' ' HD2' ' A' ' 102' ' ' ARG . 3.0 m -112.91 44.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -137.22 159.91 40.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.063 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 102' ' ' ARG . 84.1 t -139.79 143.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.596 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -99.33 152.49 19.56 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.328 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.637 HD13 HD13 ' A' ' 74' ' ' ILE . 19.4 mt -145.92 149.61 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.3 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -148.56 137.07 21.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.215 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.26 88.03 6.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.757 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.532 ' HD2' ' NH2' ' A' ' 128' ' ' ARG . 30.6 Cg_endo -63.95 -177.68 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.591 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -92.83 8.11 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.21 -179.414 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.55 115.06 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.984 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -57.46 -56.37 22.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.663 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.488 ' CG2' HD21 ' A' ' 16' ' ' LEU . 66.7 mt -60.61 -48.47 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.444 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.2 t -57.49 -16.95 11.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.704 ' HE ' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -75.4 -55.04 6.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.149 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -51.09 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.652 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 tt -59.62 -40.22 81.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.597 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.75 -26.49 61.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.13 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.45 -54.76 36.58 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -75.98 -88.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.2 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 19.0 m-85 -77.85 119.18 76.38 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.456 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 21.6 Cg_exo -65.64 156.41 63.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.405 2.07 . . . . 0.0 111.605 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.521 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.2 t -134.9 159.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.208 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 29.0 m -80.85 139.24 36.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.1 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.778 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . . . -133.42 106.38 7.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.801 0.334 . . . . 0.0 111.62 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -136.75 122.05 19.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.976 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.1 111.36 3.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.206 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.409 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 42.5 Cg_exo . . . . . 0 CA--C 1.537 0.662 0 N-CA-C 113.69 0.612 . . . . 0.0 113.69 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 72.7 Cg_endo -76.36 121.23 5.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.906 1.737 . . . . 0.0 112.601 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -97.32 147.77 33.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.798 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -95.99 -13.72 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.913 2.408 . . . . 0.0 113.204 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -134.58 140.06 45.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.01 72.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.583 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.68 -17.43 63.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -75.27 -37.56 60.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.876 HD12 HG23 ' A' ' 165' ' ' VAL . 49.1 mt -67.48 -45.15 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.355 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.43 -28.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -75.7 -54.22 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.436 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.04 -43.96 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.722 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.564 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.7 mm? -90.5 66.59 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 159' ' ' LEU . 5.0 t70 -16.68 -64.35 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.062 0.851 . . . . 0.0 112.761 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.35 25.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.652 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.77 -68.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.722 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.652 ' H ' HG13 ' A' ' 162' ' ' VAL . 1.7 p-10 -111.1 96.55 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.676 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -59.68 130.42 46.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.199 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.876 HG23 HD12 ' A' ' 155' ' ' ILE . 3.6 p -67.34 175.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.88 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.682 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.62 124.92 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 111.172 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 -7.54 45.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.274 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.94 73.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.38 123.2 5.21 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 9.5 p-10 -73.25 -166.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.895 0.379 . . . . 0.0 111.259 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 5.1 m -136.49 -168.5 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.554 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 39.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -83.37 46.36 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.858 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.738 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 9.1 ttm -59.15 -17.97 31.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.467 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -139.92 136.05 16.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 95' ' ' PRO . 84.1 Cg_endo -83.68 -151.93 0.73 Allowed 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.452 0.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.419 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -153.69 92.59 1.58 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.685 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -102.27 129.92 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 98.3 t -128.02 100.82 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.378 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.826 HG12 ' HA ' ' A' ' 189' ' ' VAL . 73.8 mt -116.29 139.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.827 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.906 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.8 m-20 -107.48 58.69 0.62 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 187' ' ' PRO . 9.7 tp -69.96 105.78 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.391 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.478 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -83.29 -88.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.242 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.7 t -120.96 -83.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.646 0.26 . . . . 0.0 111.371 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.527 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.0 OUTLIER -89.01 -52.14 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.67 -179.053 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.36 106.75 1.37 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.248 1.965 . . . . 0.0 112.491 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.658 ' HB3' HD13 ' A' ' 182' ' ' LEU . 98.2 Cg_endo -84.27 129.57 4.48 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.752 2.301 . . . . 0.0 112.499 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.611 ' HD3' ' HB2' ' A' ' 181' ' ' ASP . 9.2 mtt180 -90.48 50.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.826 ' HA ' HG12 ' A' ' 180' ' ' ILE . 47.8 t -56.47 105.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.28 83.57 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.132 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 191' ' ' ARG . 8.1 ptt180 -85.95 174.1 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.737 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.803 0.251 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.86 -33.97 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.798 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG11 HG13 ' A' ' 126' ' ' ILE . 26.2 t -61.51 -40.14 85.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.602 HD22 HG23 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -68.43 -34.77 76.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.723 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.09 -26.58 63.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.65 -37.22 68.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.654 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -66.08 -37.25 85.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.814 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 16' ' ' LEU . 22.8 mm -75.3 -23.95 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 t -68.18 -47.75 67.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.57 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.3 p -69.72 -31.02 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 1.7 mtt -71.23 -27.91 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.075 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.84 -33.82 76.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.81 73.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.519 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.35 65.48 2.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.36 175.84 16.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.413 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' ' 39' ' ' LEU . 2.2 tp -96.04 142.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.661 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.69 121.15 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -102.06 165.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -169.91 86.28 0.57 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 73.0 Cg_endo -75.09 118.97 5.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.265 1.977 . . . . 0.0 111.009 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.855 ' HA ' ' H ' ' A' ' 171' ' ' CYS . 1.0 OUTLIER -116.31 -137.29 0.36 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.034 0.445 . . . . 0.0 111.68 -176.575 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -54.24 -46.56 72.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.202 -179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.8 -122.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.485 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.471 ' H ' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -112.51 -158.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 110.9 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -69.99 115.46 9.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA3' HH22 ' A' ' 120' ' ' ARG . . . -116.16 126.48 7.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.525 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.68 ' HB2' HD11 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -111.17 138.77 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 111.199 -178.126 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.18 160.52 28.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.987 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.494 ' CG1' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -158.95 -169.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.047 -178.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.725 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -56.14 124.0 16.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.197 178.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.09 -67.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.226 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.1 mm? -80.84 42.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 111.625 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.33 152.82 25.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.849 178.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.28 -30.28 60.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.89 -25.5 68.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -69.88 -38.88 76.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 t -72.34 -37.63 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -67.66 -37.73 82.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.093 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -75.19 -20.29 59.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.036 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -44.92 66.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.956 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -75.26 -27.94 59.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -68.58 -56.52 7.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.72 -49.42 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.429 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -72.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.285 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.64 78.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.656 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.86 -69.31 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.91 98.7 11.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.73 14.72 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.567 2.178 . . . . 0.0 112.448 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -104.88 -7.35 19.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.6 148.5 44.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.978 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.56 165.13 1.78 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.662 2.241 . . . . 0.0 112.319 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.3 159.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.27 138.49 43.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.565 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 118' ' ' GLY . 22.6 pt -114.76 169.08 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.502 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 118.22 27.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.854 HG11 HG12 ' A' ' 74' ' ' ILE . 1.5 p -135.86 -179.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.634 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.65 -40.1 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.042 0.449 . . . . 0.0 110.582 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 166.73 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.562 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.671 HG21 ' SD ' ' A' ' 85' ' ' MET . 3.3 t -59.17 -29.38 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.31 -27.51 67.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.777 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HG3' ' OG ' ' A' ' 69' ' ' SER . 12.8 mm-40 -79.31 -22.87 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.854 HG12 HG11 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.74 56.67 0.71 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 42.8 Cg_endo -68.35 -62.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.857 1.705 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -72.89 4.09 4.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.559 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 66' ' ' ILE . 1.8 t80 -92.2 -64.54 1.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.736 0.303 . . . . 0.0 110.837 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.06 -178.03 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -116.59 116.62 38.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.956 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 71' ' ' VAL . 69.1 Cg_endo -102.07 -176.71 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.203 2.602 . . . . 0.0 112.558 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.923 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 29.5 t -143.4 173.08 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.99 -103.25 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.129 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 86' ' ' GLU . 1.5 m-20 -55.17 -26.54 39.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -60.61 -51.95 67.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.989 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.671 ' SD ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -74.26 -21.01 59.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -63.61 -44.83 92.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -44.65 95.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.578 ' HE1' HD13 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -66.4 -29.98 70.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.696 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.7 mt-10 -72.39 -17.3 61.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.082 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -75.22 -13.82 60.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.179 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 41.95 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 89' ' ' GLU . 1.8 pp -127.27 146.65 58.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.994 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.59 -171.95 10.59 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.37 -1.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.35 163.42 12.29 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.856 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.0 Cg_endo -81.06 48.78 3.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -107.5 159.68 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.57 138.84 44.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.632 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.07 106.58 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.285 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.763 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 14.0 t -103.85 122.48 56.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.427 HD21 ' HE3' ' A' ' 85' ' ' MET . 1.2 mp -126.36 -167.66 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.442 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -177.53 3.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.314 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.769 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.8 147.87 44.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.091 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.527 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 8.7 t30 -74.28 -173.21 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.39 38.38 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.826 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 10.8 tp -76.63 127.77 33.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.79 0.329 . . . . 0.0 110.799 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.57 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.5 mt -75.68 -50.34 3.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.692 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.826 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 76.4 Cg_exo -50.58 108.32 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.267 1.978 . . . . 0.0 112.443 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.592 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.8 OUTLIER -80.82 1.37 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.73 -15.02 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 107' ' ' PRO . 4.3 mt -109.5 -44.33 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 108' ' ' ASP . 8.8 t -77.26 -9.63 58.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.834 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.35 -150.25 38.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.7 -10.52 67.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.549 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.3 p -117.02 -171.35 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.757 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.573 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.4 p -109.67 64.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.702 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -140.42 152.59 45.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.012 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 102' ' ' ARG . 92.9 t -139.86 135.07 38.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.411 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.557 ' O ' HG12 ' A' ' 66' ' ' ILE . . . -99.21 155.99 19.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.563 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.638 HD12 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.06 173.23 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' H ' HG22 ' A' ' 119' ' ' ILE . 3.2 ttp180 -157.29 117.5 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 111.392 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.87 79.38 1.85 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.846 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.57 -170.47 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.594 2.196 . . . . 0.0 112.548 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.11 23.01 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.104 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.69 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.1 t0 -82.2 96.06 7.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.57 -44.99 85.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.602 HG23 HD22 ' A' ' 16' ' ' LEU . 30.6 mm -64.91 -53.42 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.947 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 14.5 t -63.11 -12.78 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.507 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 6.4 ttt85 -75.47 -42.85 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -73.25 -54.46 8.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.518 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.18 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.299 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.13 -26.6 63.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.36 -53.79 49.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -89.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.824 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 90.1 m-85 -77.74 123.16 86.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 20.7 Cg_exo -65.51 163.53 29.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.06 146.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 111.517 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.418 HG21 ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -74.47 151.24 39.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.746 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.29 114.87 8.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.952 0.406 . . . . 0.0 111.939 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.52 148.51 50.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.54 124.9 29.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.199 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.471 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.9 Cg_exo . . . . . 0 CA--C 1.537 0.674 0 N-CA-C 113.136 0.399 . . . . 0.0 113.136 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 86.3 Cg_endo -82.26 125.62 4.63 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.924 1.749 . . . . 0.0 112.571 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.08 154.63 38.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -95.85 -10.67 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.72 2.28 . . . . 0.0 112.972 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.35 139.54 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.389 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -65.53 -45.25 84.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.853 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.24 -18.5 65.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.611 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -40.92 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.77 HD12 HG23 ' A' ' 165' ' ' VAL . 24.0 mt -69.29 -37.87 76.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.217 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.11 -44.17 95.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.42 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -75.45 -46.9 29.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.753 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.676 ' HB3' HD22 ' A' ' 159' ' ' LEU . 6.3 t70 -70.18 -43.45 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.574 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.8 mm? -100.23 67.11 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -16.59 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.048 0.843 . . . . 0.0 112.848 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.44 25.09 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.649 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.55 -69.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.553 179.031 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.677 ' HA ' HG23 ' A' ' 28' ' ' ILE . 1.2 p-10 -108.29 99.51 8.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.498 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.57 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.97 130.2 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.735 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.77 HG23 HD12 ' A' ' 155' ' ' ILE . 1.9 p -64.33 -170.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.948 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.768 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.53 119.95 28.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.155 0.502 . . . . 0.0 111.426 -178.733 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.4 -0.69 57.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.076 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.591 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -75.75 -38.71 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.82 64.85 1.7 Allowed Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.767 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.844 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 7.3 m-20 -73.14 -124.0 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.859 -0.2 . . . . 0.0 110.744 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.855 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -141.72 -170.1 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.232 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.86 10.1 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -64.63 91.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.149 0.5 . . . . 0.0 111.364 -176.177 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.404 ' HG3' HG23 ' A' ' 36' ' ' ILE . 10.0 ttt -55.04 -15.79 2.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.857 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -139.68 150.58 63.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.055 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.95 -151.92 0.66 Allowed 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 123.497 -1.46 . . . . 0.0 112.533 0.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -153.91 115.21 4.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.18 46.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.333 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.4 t -129.24 105.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.564 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 189' ' ' VAL . 3.7 mp -121.2 132.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.763 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -95.3 71.86 3.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.553 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 0.0 OUTLIER -68.37 84.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.299 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -88.0 0.08 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.414 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.72 -128.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.6 OUTLIER -59.33 -51.17 83.32 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.36 106.27 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.238 1.958 . . . . 0.0 112.371 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 96.1 Cg_endo -84.29 140.56 8.67 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.601 2.2 . . . . 0.0 112.401 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.67 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.2 mmm-85 -97.18 59.31 1.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.473 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.699 ' HA ' HG23 ' A' ' 180' ' ' ILE . 43.2 t -58.24 107.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.117 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.01 80.36 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -99.2 143.45 29.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.712 0.213 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -33.75 76.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.437 HG13 ' OE2' ' A' ' 18' ' ' GLU . 95.3 t -65.93 -35.67 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.135 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -47.08 70.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.87 -21.18 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.03 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' OE2' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.22 -34.21 61.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.661 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -70.42 -36.68 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.058 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.6 mm -69.71 -31.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m -64.04 -47.54 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 19' ' ' ALA . 4.4 p -64.47 -25.5 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.031 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.42 -47.24 86.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -23.71 61.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.983 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.35 -5.3 79.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.519 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.0 57.13 12.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.81 174.72 16.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -96.44 148.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.756 0.313 . . . . 0.0 110.67 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.553 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.8 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.744 HG22 ' H ' ' A' ' 31' ' ' TYR . 2.5 mt -102.38 174.23 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.744 ' H ' HG22 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -171.31 106.44 0.39 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.457 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' N ' ' A' ' 170' ' ' ASP . 87.2 Cg_endo -84.28 125.39 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.602 2.201 . . . . 0.0 111.506 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.62 -154.84 0.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 6.8 m-20 -54.7 -30.1 54.89 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.255 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 176' ' ' PRO . 0.2 OUTLIER -93.54 -118.23 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.18 -165.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.165 -179.593 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -71.87 126.02 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.537 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.2 121.19 2.79 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -112.16 149.32 32.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 0.0 112.062 -176.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 41' ' ' VAL . . . -144.93 169.04 26.8 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.946 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -159.27 -170.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.909 0.385 . . . . 0.0 111.118 -179.04 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.5 t30 -56.75 119.74 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.56 -63.23 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.37 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 44' ' ' LEU . 1.2 mm? -78.33 33.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 111.863 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 1.1 m-20 -111.28 147.68 34.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.973 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -75.57 -29.63 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.305 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.71 -25.68 63.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -72.33 -31.48 65.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.145 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.13 -45.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.496 ' NH2' ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -67.75 -34.92 77.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 24.2 mmt180 -73.64 -35.1 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.1 OUTLIER -67.23 -24.65 65.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.846 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -46.68 32.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.384 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -54.46 -48.21 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.391 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 140' ' ' SER . 10.7 t -75.21 -49.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.36 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.737 ' HE3' ' HB2' ' A' ' 58' ' ' ARG . 14.7 tptt -93.69 -71.25 0.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.411 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.85 15.33 34.32 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.697 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.737 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 76.7 mtp85 -118.23 22.91 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -149.7 66.21 8.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.93 -54.94 4.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.575 2.184 . . . . 0.0 112.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.424 ' O ' ' HA3' ' A' ' 112' ' ' GLY . 32.2 p-80 -123.84 24.09 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.137 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.619 ' HE3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -88.55 146.55 37.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.619 ' HD2' ' HE3' ' A' ' 62' ' ' LYS . 76.9 Cg_exo -51.74 148.32 22.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.662 2.241 . . . . 0.0 112.559 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.9 166.13 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.58 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 0.4 OUTLIER -106.92 140.22 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 118' ' ' GLY . 1.8 pt -116.21 171.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.6 t -122.8 125.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.504 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.876 HG21 HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -135.97 -179.11 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.878 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.608 ' H ' HG22 ' A' ' 68' ' ' VAL . 1.5 t -90.0 -44.07 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.79 0.328 . . . . 0.0 110.956 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -163.71 174.91 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.089 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HA ' HD11 ' A' ' 74' ' ' ILE . 5.8 t -58.38 -37.37 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.834 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 1.0 OUTLIER -67.13 -22.12 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.837 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.63 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -80.43 -20.92 42.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.139 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.876 HG23 HG21 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -113.63 54.6 0.61 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 29.5 Cg_endo -62.41 -82.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.834 1.689 . . . . 0.0 111.828 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.41 19.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.336 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' PRO . 59.9 m-85 -103.26 -34.81 8.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.755 0.312 . . . . 0.0 111.108 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.456 ' OG ' HD11 ' A' ' 119' ' ' ILE . 2.2 m -135.33 165.5 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -112.76 105.01 56.09 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.415 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 86.3 Cg_endo -102.57 179.72 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.169 2.579 . . . . 0.0 112.619 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 -173.45 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.11 -82.47 0.44 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.713 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -57.64 -26.71 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.927 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.471 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -63.41 -48.25 78.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 9.6 mmt -70.44 -15.81 62.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.713 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mm-40 -66.44 -50.4 63.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.67 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 182' ' ' LEU . 2.7 tm? -61.77 -38.99 90.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.449 ' SD ' HD13 ' A' ' 182' ' ' LEU . 5.1 tpt -64.94 -49.67 69.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.437 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -72.88 -2.59 21.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.368 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.99 -58.88 3.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.295 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.3 74.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.629 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.74 149.22 72.82 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.071 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.72 -148.5 0.51 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.18 -1.175 . . . . 0.0 111.952 -1.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.18 8.74 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.979 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.42 ' HB2' HG23 ' A' ' 35' ' ' THR . 3.9 Cg_exo -80.42 43.77 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.221 2.614 . . . . 0.0 112.151 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.497 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 3.6 p90 -112.23 -177.03 3.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -112.89 139.04 48.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.245 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.17 102.77 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.282 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.745 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -101.22 122.9 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -126.91 -179.04 4.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.714 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -74.86 -166.01 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.664 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -119.28 138.19 53.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.182 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.73 -163.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.315 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -39.19 82.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.325 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.576 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -69.46 100.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.688 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.4 pt -80.95 102.87 1.5 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.922 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 60.6 Cg_endo -70.91 138.43 34.16 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.429 2.086 . . . . 0.0 112.248 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.034 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 109' ' ' VAL . 7.0 p -87.43 23.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.922 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 57.7 mt -106.69 -54.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 110.894 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.677 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 6.2 t -87.57 -24.26 24.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.865 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 61' ' ' HIS . . . 69.31 -141.74 36.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.408 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.32 27.6 6.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.437 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' A' ' 63' ' ' PRO . 1.3 t -123.94 165.58 17.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.327 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -113.16 42.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 116' ' ' ARG . 2.3 mtp180 -136.74 163.63 30.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.52 142.28 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . -92.74 149.59 19.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.454 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.503 HD13 HD13 ' A' ' 74' ' ' ILE . 72.2 mt -144.98 150.26 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.41 124.03 12.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.88 0.371 . . . . 0.0 111.476 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.1 t -110.66 83.7 3.61 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.837 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.08 179.5 6.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.589 2.192 . . . . 0.0 112.614 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -93.13 19.65 7.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.108 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.471 ' HB2' ' SG ' ' A' ' 127' ' ' CYS . 66.1 m-20 -82.02 105.57 13.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' ARG . 5.4 pt-20 -57.35 -42.96 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.277 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mm -61.36 -58.13 8.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -58.58 -21.16 52.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.994 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 125' ' ' GLU . 1.8 mtp180 -68.17 -37.54 81.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 34.6 ttt-85 -75.25 -53.23 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.2 mt -59.19 -52.0 65.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.257 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.798 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.08 -27.86 69.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.63 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -51.27 66.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.997 0.427 . . . . 0.0 110.021 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.521 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -75.19 -91.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 177.573 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.521 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -77.92 144.87 68.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 178.136 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 159.53 49.19 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.185 1.923 . . . . 0.0 111.374 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 t -132.67 152.0 35.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.802 0.334 . . . . 0.0 111.244 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.466 HG21 ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -80.2 153.28 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.122 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.4 116.4 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 111.57 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.651 HG23 HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -142.42 140.89 32.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.697 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.439 ' O ' HG11 ' A' ' 55' ' ' VAL . 22.4 p -66.93 139.17 57.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.997 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.393 -179.725 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.416 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 43.1 Cg_exo . . . . . 0 CA--C 1.538 0.709 0 N-CA-C 113.389 0.496 . . . . 0.0 113.389 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 73.9 Cg_endo -75.07 90.41 1.09 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.802 1.668 . . . . 0.0 112.208 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.489 ' HB2' HG12 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -84.78 157.93 60.0 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -96.01 -11.27 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.902 2.401 . . . . 0.0 112.908 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -141.48 141.62 33.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.87 HD22 ' HA ' ' A' ' 166' ' ' LEU . 55.8 mt -60.19 -28.6 68.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.771 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -72.23 -34.45 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.361 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.54 ' HG3' HH21 ' A' ' 157' ' ' ARG . 3.9 tt0 -58.95 -47.07 86.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.804 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.542 ' H ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -74.44 -35.43 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -67.33 -20.91 27.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.072 0.463 . . . . 0.0 110.37 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.54 HH21 ' HG3' ' A' ' 154' ' ' GLU . 10.1 ttp180 -73.1 -46.31 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.431 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.17 -41.41 63.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.677 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 160' ' ' ASP . 2.7 mm? -111.22 68.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.7 t70 -15.93 -63.35 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.094 0.871 . . . . 0.0 112.817 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -157.02 18.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.321 . . . . 0.0 111.251 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.96 -42.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.909 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 25.5 m-20 -111.21 110.75 21.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.411 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.529 HD12 HG13 ' A' ' 29' ' ' VAL . 29.7 mt -74.71 61.93 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.746 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.646 HG13 ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -78.84 22.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.732 178.159 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.87 ' HA ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -148.21 34.81 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.499 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.501 ' OD1' ' HB3' ' A' ' 164' ' ' LEU . 4.3 m-20 -70.01 -84.09 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.385 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.638 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -86.35 -34.19 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.065 0.46 . . . . 0.0 110.673 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.59 27.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.468 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' HG2' ' A' ' 32' ' ' PRO . 2.9 m-20 -62.19 -177.55 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 0.0 111.214 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.9 t -140.16 -62.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.55 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -124.77 -135.61 0.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.495 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.7 144.78 26.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.9 ptm -70.32 2.4 3.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.054 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.72 151.29 26.45 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.626 ' O ' HG22 ' A' ' 35' ' ' THR . 64.5 Cg_endo -92.02 -136.64 0.1 OUTLIER 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.946 -1.273 . . . . 0.0 112.46 0.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.411 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -159.33 130.2 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.418 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 191' ' ' ARG . 32.6 m -101.29 139.72 36.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.923 0.392 . . . . 0.0 111.607 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.7 t -129.6 117.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.662 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.31 121.01 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.386 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -98.25 67.96 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.271 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 87' ' ' LEU . 4.4 tt -69.29 79.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 -78.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.92 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 185' ' ' ASN . 5.7 t -120.42 -119.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.381 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 2.1 m-20 -69.57 -52.65 13.95 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.97 109.55 2.6 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.108 1.872 . . . . 0.0 112.767 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.7 Cg_endo -75.97 122.67 6.87 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.444 2.096 . . . . 0.0 111.955 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.776 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 3.3 mmp_? -87.28 61.2 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.88 93.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.569 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -122.05 87.8 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.211 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.614 ' HB3' HG23 ' A' ' 178' ' ' THR . 1.5 ptm180 -89.41 142.81 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.057 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.867 179.764 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 16' ' ' LEU . 23.1 Cg_exo . . . . . 0 C--O 1.23 0.109 0 CA-C-O 120.825 0.26 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.88 -26.53 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.488 HG13 ' OD2' ' A' ' 167' ' ' ASP . 44.9 t -75.11 -34.54 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.074 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 1.1 mm? -69.65 -47.0 64.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.97 -21.21 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.57 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -74.77 -35.88 62.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.679 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.57 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -67.56 -37.67 82.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.933 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.95 -35.18 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.647 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -33.52 75.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 18' ' ' GLU . 16.8 t -70.1 -32.29 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.0 mmt -61.33 -41.93 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.17 -11.23 60.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.12 -11.82 72.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 37.78 92.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.13 170.22 18.89 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.584 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.675 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -96.3 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.673 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.675 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.29 135.97 55.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -102.56 152.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.59 0.233 . . . . 0.0 110.586 178.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -160.13 102.5 1.4 Allowed Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.093 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.689 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.4 Cg_endo -82.18 136.3 8.94 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 0.0 111.327 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 -147.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.663 0.268 . . . . 0.0 111.277 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.601 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 8.0 t70 -54.5 -25.41 25.34 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.928 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 174' ' ' MET . 4.3 t -95.43 -120.54 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.586 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.7 HG12 ' H ' ' A' ' 37' ' ' TYR . 9.3 tt -111.77 -171.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.563 0.221 . . . . 0.0 110.876 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.7 ' H ' HG12 ' A' ' 36' ' ' ILE . 1.4 m-85 -63.33 129.02 38.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.778 0.323 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -121.14 177.68 16.38 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.146 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.654 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.6 mp -119.32 141.11 49.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.635 0.255 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.39 114.08 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 42' ' ' ASN . 3.4 p -153.29 161.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.511 0.195 . . . . 0.0 110.867 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.492 ' N ' HG22 ' A' ' 41' ' ' VAL . 5.9 t-20 -55.93 98.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.371 . . . . 0.0 110.346 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.62 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.108 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 9.2 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.086 0.469 . . . . 0.0 111.34 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.91 152.51 26.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.718 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.7 mt-10 -74.07 -19.16 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.825 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.47 -25.1 63.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.55 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.2 35.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.29 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 46' ' ' GLU . 32.6 m -65.17 -34.28 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.056 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -40.15 96.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.557 ' HG2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -62.2 -54.5 40.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.146 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.71 -27.29 39.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.293 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.57 -31.57 65.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -40.58 63.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.015 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.5 t -75.12 -35.05 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.397 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.89 0.32 56.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.401 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 -115.37 7.92 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.604 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -100.42 105.12 16.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.871 0.367 . . . . 0.0 110.993 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 63.3 m -151.97 65.12 6.09 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.014 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.7 6.03 5.48 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.598 2.199 . . . . 0.0 112.448 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -122.36 -14.03 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.018 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 5.9 mmtp -88.16 129.19 50.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 35.0 Cg_exo -61.18 -175.1 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.549 2.166 . . . . 0.0 111.999 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.55 170.64 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -113.62 134.57 54.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 25.9 mm -116.42 159.24 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.387 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.888 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 1.6 t -119.15 141.24 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.153 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 74' ' ' ILE . 1.4 p -150.05 173.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.287 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.572 ' H ' HG22 ' A' ' 68' ' ' VAL . 7.5 t -89.84 -34.15 16.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 110.072 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.9 t -164.26 160.66 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.595 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.53 ' HA ' HD11 ' A' ' 74' ' ' ILE . 21.9 t -57.08 -32.56 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.624 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.35 -26.19 66.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.884 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.677 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -77.1 -22.82 52.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.207 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.646 HG12 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.61 60.11 0.83 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.677 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 23.5 Cg_exo -64.12 -73.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.158 1.906 . . . . 0.0 112.448 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 15.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.032 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 -34.93 6.98 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.157 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.569 ' HB2' HD23 ' A' ' 100' ' ' LEU . 93.4 p -135.49 164.2 28.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.0 110.991 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -114.52 103.22 55.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.756 ' HA ' HD11 ' A' ' 100' ' ' LEU . 74.3 Cg_endo -102.15 -169.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.177 2.585 . . . . 0.0 113.063 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -144.58 -174.85 4.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.06 -86.56 0.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.881 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -29.48 61.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.793 0.33 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 184' ' ' VAL . . . -58.44 -49.28 77.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.787 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.516 ' SD ' HG21 ' A' ' 71' ' ' VAL . 21.3 mmt -72.17 -17.91 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.956 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.67 -36.22 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.14 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 182' ' ' LEU . 2.8 tm? -64.18 -45.45 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.852 ' HB2' HD23 ' A' ' 182' ' ' LEU . 31.5 tpp -75.39 -26.56 58.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.376 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HA ' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -60.72 -40.76 93.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.399 . . . . 0.0 111.854 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -75.56 -18.46 59.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.4 mt -100.4 -11.29 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.525 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -112.08 151.89 43.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.007 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 174.84 50.58 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.904 -1.29 . . . . 0.0 112.202 0.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.32 -173.61 32.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.568 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.17 28.63 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.661 2.241 . . . . 0.0 112.437 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -101.59 143.36 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -106.96 136.24 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.635 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 182' ' ' LEU . 1.4 p -120.11 111.83 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.406 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.678 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 6.4 t -87.44 127.16 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.922 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' HA ' ' A' ' 80' ' ' PRO . 15.1 tp -124.8 178.22 5.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.562 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 1.6 mt-10 -74.4 -170.24 0.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.9 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.64 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.77 138.63 52.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.491 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 176.1 7.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.747 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.57 55.84 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.451 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 107' ' ' PRO . 1.8 mt -89.85 131.04 35.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 110.768 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.631 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.3 mp -66.84 -51.86 36.16 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.781 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.734 ' HD2' HD22 ' A' ' 105' ' ' LEU . 56.7 Cg_exo -52.21 105.17 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.236 1.957 . . . . 0.0 112.445 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -4.7 53.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 110' ' ' ILE . 14.5 p -71.96 -27.01 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.015 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.62 HG13 HG13 ' A' ' 109' ' ' VAL . 13.1 mt -93.87 -39.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.426 HG22 ' NE ' ' A' ' 102' ' ' ARG . 2.5 p -71.68 -23.21 61.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.6 -157.44 50.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.498 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.85 -21.26 71.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.0 m -108.39 -179.77 3.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.533 ' C ' ' HB2' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -112.98 59.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.029 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 mtm105 -142.72 158.58 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.64 HG23 ' HG2' ' A' ' 102' ' ' ARG . 39.5 t -139.93 117.11 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.61 117.9 4.54 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 74' ' ' ILE . 5.7 mt -130.14 150.43 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.8 0.333 . . . . 0.0 111.037 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.8 ptp180 -144.48 149.32 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.478 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -110.5 88.72 7.9 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.739 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 21.8 Cg_exo -64.81 -179.52 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.461 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.25 2.11 56.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.188 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 5.1 t0 -71.44 109.11 5.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.27 -40.51 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.243 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mm -69.94 -50.02 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.258 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 20.6 t -61.26 -18.79 60.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.2 OUTLIER -73.69 -46.79 44.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.878 179.688 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -52.54 60.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.562 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.5 mt -59.45 -55.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.309 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.74 -25.1 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.451 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB1' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -57.37 11.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.02 0.438 . . . . 0.0 109.965 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.458 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -76.16 -85.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 177.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.458 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 28.7 m-85 -77.19 112.32 22.51 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.236 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -65.64 133.33 33.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.279 1.986 . . . . 0.0 111.306 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.72 166.98 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 120.878 0.371 . . . . 0.0 111.771 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.578 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 87.7 m -80.97 125.88 30.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -122.58 95.37 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.68 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.654 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -126.76 113.87 17.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.859 179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.579 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -61.84 121.7 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.58 ' HG2' ' HD3' ' A' ' 148' ' ' PRO . 11.1 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.58 ' HD3' ' HG2' ' A' ' 147' ' ' PRO . 67.3 Cg_endo -73.95 73.19 3.74 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.764 1.643 . . . . 0.0 112.653 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.4 110.12 53.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.732 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -95.39 -14.84 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.601 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -130.44 127.02 38.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.602 HD22 HG22 ' A' ' 165' ' ' VAL . 45.7 mt -63.12 -37.98 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -17.81 62.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -74.09 -36.95 64.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.015 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.947 HD12 HG23 ' A' ' 165' ' ' VAL . 2.5 mt -70.96 -45.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 152' ' ' LEU . 4.3 t -54.73 -38.07 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -70.88 -48.83 51.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.579 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -45.98 92.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.461 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.807 ' HB3' ' HB ' ' A' ' 162' ' ' VAL . 1.4 mm? -109.77 81.84 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.084 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.4 -40.79 0.39 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.004 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.75 15.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.318 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.807 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 47.2 t -80.61 -83.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.979 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 4.3 t0 -93.83 85.9 4.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.753 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.587 ' HB3' HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -54.89 123.82 14.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.326 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.947 HG23 HD12 ' A' ' 155' ' ' ILE . 1.4 p -62.71 177.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.296 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.629 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -125.47 137.82 53.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.792 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.488 ' OD2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -92.26 -9.65 41.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.232 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.582 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -77.44 -35.04 54.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.571 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 86.92 177.86 49.12 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.827 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 16.7 p-10 -71.32 -160.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.39 -64.75 0.44 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.758 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.601 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.86 -139.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.466 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -87.04 149.19 24.91 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.252 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.8 ptm -60.99 -10.72 6.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.237 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.76 158.38 67.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.552 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -92.33 -156.71 0.68 Allowed 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 124.124 -1.198 . . . . 0.0 112.844 1.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.71 120.24 3.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.815 HG23 ' HB3' ' A' ' 191' ' ' ARG . 69.5 m -102.02 138.18 39.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.32 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.52 98.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.061 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.668 HG12 ' HA ' ' A' ' 189' ' ' VAL . 6.0 mt -108.73 132.96 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.678 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -90.1 71.4 7.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.893 ' HA ' ' HB3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -72.4 82.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.545 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.9 p -83.7 -97.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.181 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 6.2 t -121.92 -63.2 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.457 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -173.56 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.342 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HA ' ' HD2' ' A' ' 187' ' ' PRO . 51.8 Cg_exo -59.57 120.37 8.15 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.927 1.085 . . . . 0.0 110.867 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.893 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 21.2 Cg_endo -62.67 156.69 51.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.811 2.341 . . . . 0.0 112.834 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.417 ' HD3' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -101.92 99.96 10.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.873 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.668 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.4 t -67.75 103.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.78 82.26 1.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ARG . . . . . 0.815 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -102.98 159.04 15.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.798 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.735 0.302 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mt -105.35 -66.01 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 4' ' ' ARG . 1.8 tp -74.29 146.92 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.197 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -74.81 97.66 3.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.2 -179.92 5.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 tt -106.45 153.84 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.833 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.3 p -69.75 -178.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.959 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.06 -65.22 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.989 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -84.71 129.45 34.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -96.26 132.67 26.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.3 129.59 36.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.587 2.192 . . . . 0.0 112.362 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -116.06 99.58 52.75 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.65 179.82 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.577 2.185 . . . . 0.0 112.28 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -37.47 80.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.4 t -71.31 -28.12 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.235 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.425 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.1 mm? -68.87 -48.03 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 21' ' ' SER . 4.9 pt-20 -72.51 -20.92 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.81 -35.05 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -74.21 -40.18 62.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.457 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 20' ' ' ILE . 2.3 pp -75.65 -18.69 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 111.024 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 1.2 t -68.23 -53.87 21.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.744 HG21 ' HB2' ' A' ' 164' ' ' LEU . 4.9 p -63.78 -33.51 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 17.9 mtt -63.38 -30.32 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.8 -29.2 64.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.07 1.02 89.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.378 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.2 53.42 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.634 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.97 172.72 15.62 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.306 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.685 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.9 tp -96.38 136.3 27.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.748 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.552 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.8 131.63 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -102.27 162.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.508 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -167.96 104.41 0.56 Allowed Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 93.7 Cg_endo -80.24 145.46 17.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.477 2.118 . . . . 0.0 111.888 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -123.05 -150.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.615 0.245 . . . . 0.0 111.224 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.736 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 3.0 m-20 -55.41 -22.43 20.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.603 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 95' ' ' PRO . 12.8 p -99.74 -112.79 0.18 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.945 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.84 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -161.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.726 0.298 . . . . 0.0 111.051 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -68.7 134.16 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.944 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -116.45 178.08 17.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.936 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.666 ' HB2' HG23 ' A' ' 139' ' ' THR . 1.1 mt -133.42 139.17 46.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.83 124.53 2.09 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.989 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 136' ' ' VAL . 8.9 p -157.62 165.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.558 0.218 . . . . 0.0 110.814 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.738 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -55.52 100.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 110.646 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.15 99.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.159 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.5 mm? -77.53 15.6 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.34 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.42 146.23 36.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -24.36 67.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.26 -29.2 69.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.868 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.47 -40.28 70.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.188 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 t -65.35 -35.49 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.984 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -50.3 34.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -69.7 -13.71 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -75.25 -49.48 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.359 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' N ' HD13 ' A' ' 52' ' ' LEU . 5.5 t80 -63.93 -25.55 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 54' ' ' ARG . 1.1 mmm180 -66.19 -45.85 79.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.638 HG13 HG12 ' A' ' 143' ' ' ILE . 41.2 t -72.42 -52.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.347 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -74.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.218 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.73 40.59 98.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.562 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -112.37 -80.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.309 . . . . 0.0 110.925 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.08 129.22 16.93 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.31 22.1 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 112.487 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.89 -8.87 15.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.112 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -88.13 141.33 31.03 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.047 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.05 165.63 25.72 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.518 2.145 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 110' ' ' ILE . 2.6 m -116.4 156.77 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.062 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 10.6 t -101.0 137.36 39.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.67 173.42 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.792 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 16.5 t -122.21 141.69 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.883 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -150.03 177.01 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.615 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -86.07 -46.82 10.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.674 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.25 175.85 9.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.008 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.48 -31.78 47.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 t70 -67.39 -26.03 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.107 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.563 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 23.6 mm-40 -80.39 -23.99 40.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.394 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.883 HG23 HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.54 54.81 0.61 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 77' ' ' PHE . 27.6 Cg_endo -61.74 -83.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.864 1.709 . . . . 0.0 111.743 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.49 19.89 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.368 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' PRO . 8.2 m-85 -93.17 -44.13 8.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.801 0.334 . . . . 0.0 111.088 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -128.1 -175.45 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.638 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HB3' ' CB ' ' A' ' 101' ' ' GLU . 10.1 ttt-85 -112.75 103.54 55.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.589 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -102.33 -178.77 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.223 2.615 . . . . 0.0 112.584 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 1.5 t -145.98 -176.17 5.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.05 -85.01 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.687 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.442 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 5.1 t70 -55.04 -26.31 36.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.754 0.312 . . . . 0.0 110.823 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.16 -51.53 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 81' ' ' SER . 13.7 mmt -69.55 -20.45 63.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.2 mt-10 -71.04 -41.36 70.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.667 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.741 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 2.7 tm? -60.08 -44.18 94.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.587 ' HB2' HD22 ' A' ' 182' ' ' LEU . 7.0 tpt -74.6 -35.98 62.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.155 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -64.17 -12.5 40.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.741 ' HD2' ' HA ' ' A' ' 87' ' ' LEU . 23.8 mtt-85 -75.61 -55.13 5.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.672 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 57.52 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.701 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -132.1 154.51 81.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.615 0.245 . . . . 0.0 111.184 178.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.92 -153.24 0.88 Allowed 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.712 -1.37 . . . . 0.0 112.007 -2.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.46 178.27 28.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.725 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.736 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 99.0 Cg_endo -79.58 32.57 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.673 2.249 . . . . 0.0 112.609 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -112.67 146.59 38.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.743 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.834 HG22 ' HA ' ' A' ' 179' ' ' VAL . 6.7 t -95.47 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.585 HG11 ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -115.66 109.31 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.46 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 8.7 t -98.41 126.29 51.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.56 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.87 -174.9 3.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.714 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.416 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -74.6 -177.82 3.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.173 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.525 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.99 138.21 52.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.97 -165.56 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.029 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.65 43.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.602 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -80.54 124.72 29.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.532 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 3.4 mp -74.55 -50.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.948 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.57 ' HD2' HD23 ' A' ' 105' ' ' LEU . 86.9 Cg_exo -49.27 103.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.284 1.989 . . . . 0.0 112.554 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 81.2 m-20 -80.94 -4.57 55.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.176 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -70.45 -21.58 23.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.592 HG22 HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -111.41 -35.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 64.1 p -76.95 -19.97 56.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.07 -167.69 51.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.55 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.72 5.72 73.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.59 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.7 m -122.69 -178.36 3.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.82 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 43.7 m -105.75 51.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -144.53 149.17 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.453 HG23 ' CB ' ' A' ' 102' ' ' ARG . 87.6 t -139.65 142.55 32.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.574 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -95.8 158.86 22.09 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.54 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 120' ' ' ARG . 18.9 mt -142.62 162.62 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 119' ' ' ILE . 12.5 ttt85 -146.63 128.23 15.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 111.321 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.77 81.18 2.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HB2' HG21 ' A' ' 33' ' ' THR . 72.1 Cg_endo -76.36 178.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.493 2.129 . . . . 0.0 112.551 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.38 9.74 35.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 9.1 m-20 -70.47 105.09 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.122 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.54 -49.96 74.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.411 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.18 -53.17 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.212 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -60.85 -18.35 55.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -74.69 -35.88 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -52.78 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 16' ' ' LEU . 43.7 mm -60.75 -49.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.29 -27.53 69.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.279 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.477 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . . . -54.67 -56.33 20.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -75.94 -87.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.159 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -77.0 126.75 85.12 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.188 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.08 154.6 66.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.309 2.006 . . . . 0.0 111.637 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -133.99 161.06 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.344 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 91.2 m -81.14 128.67 34.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -123.65 101.26 7.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 0.0 111.631 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -124.91 146.4 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.669 178.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.1 m -82.35 120.92 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.149 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . -86.32 84.23 7.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.899 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -158.13 32.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.227 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.649 ' N ' ' HG2' ' A' ' 147' ' ' PRO . 1.2 pp -75.5 -155.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.015 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 147.64 36.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.425 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 87.63 -138.36 15.18 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.603 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -127.58 66.98 71.47 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.523 0.201 . . . . 0.0 111.044 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.649 ' HG2' ' N ' ' A' ' 143' ' ' ILE . 41.1 Cg_exo -60.75 -48.73 10.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.436 2.091 . . . . 0.0 113.554 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 64.7 Cg_endo -73.25 118.67 5.62 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 121.893 1.729 . . . . 0.0 112.217 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -85.85 144.49 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 68.4 Cg_endo -95.96 -13.63 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.927 2.418 . . . . 0.0 112.747 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 126.61 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.715 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -63.24 -40.01 96.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.155 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -18.9 62.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.61 -36.78 65.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.117 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.83 HD12 HG23 ' A' ' 165' ' ' VAL . 21.8 mt -68.78 -52.24 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.439 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.55 -27.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.0 -55.91 6.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.71 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.45 -55.83 13.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.33 -179.1 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.3 mm? -91.14 73.93 6.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.929 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.13 -42.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.883 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.95 14.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.422 ' HB ' HD12 ' A' ' 159' ' ' LEU . 3.0 t -80.67 -78.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.994 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.685 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -100.03 87.81 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.484 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.744 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.06 129.77 43.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.326 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.83 HG23 HD12 ' A' ' 155' ' ' ILE . 1.5 p -69.36 -169.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.744 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.91 154.53 42.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.399 . . . . 0.0 110.957 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.46 -21.9 19.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.3 -51.71 6.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.459 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 97.13 -155.58 20.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.744 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.9 -161.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.763 0.316 . . . . 0.0 111.086 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -146.2 -53.25 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.524 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.92 -128.63 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.526 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -85.64 144.56 27.77 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 120.84 0.353 . . . . 0.0 111.603 -178.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.84 ' HG2' HG23 ' A' ' 36' ' ' ILE . 2.5 ttp -65.29 -12.96 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.215 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.39 155.35 23.31 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.87 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.93 -139.73 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.434 0.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 192' ' ' ARG . 1.3 p -153.41 140.73 19.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.596 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 191' ' ' ARG . 23.7 m -101.44 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.0 111.322 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.834 ' HA ' HG22 ' A' ' 97' ' ' THR . 67.5 t -129.25 112.15 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.661 HG12 ' HA ' ' A' ' 189' ' ' VAL . 58.0 mt -116.71 129.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.65 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.25 65.63 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 88' ' ' MET . 39.9 tp -69.9 89.38 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -80.08 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.832 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.45 -127.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.931 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -59.21 -51.06 84.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.71 107.15 2.08 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.165 1.91 . . . . 0.0 112.403 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.667 ' HG3' ' HG ' ' A' ' 87' ' ' LEU . 82.1 Cg_endo -77.64 138.31 17.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.482 2.122 . . . . 0.0 111.961 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 181' ' ' ASP . 0.7 OUTLIER -101.08 41.63 1.17 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.374 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.661 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.8 p -56.95 105.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.015 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.1 94.63 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.541 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 178' ' ' THR . 23.3 ptt85 -83.67 140.1 32.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.756 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 177' ' ' SER . 1.6 mtt85 -79.54 87.19 5.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -91.44 -170.5 42.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.534 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.09 -169.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.729 0.3 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.55 -175.58 18.78 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.479 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.73 74.95 2.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.571 2.181 . . . . 0.0 112.365 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 40.44 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -59.94 146.05 83.01 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.126 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.58 109.5 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.666 2.244 . . . . 0.0 112.199 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.2 m -74.18 178.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.905 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.1 31.62 5.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 -171.93 1.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 109.29 21.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -162.54 103.63 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -107.71 -13.08 15.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -85.51 83.45 1.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.658 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.02 -7.62 55.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.988 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.902 179.893 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.1 mtm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.796 0.332 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.75 178.96 6.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.36 142.9 12.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttp85 -92.06 104.76 17.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 173.57 6.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.968 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 pt -75.07 -141.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.987 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -70.05 -178.82 1.71 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.939 0.399 . . . . 0.0 111.082 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.91 121.4 19.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.94 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.56 -17.86 13.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 3.8 p-10 -98.99 125.41 41.98 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 10' ' ' ASN . 37.4 Cg_exo -57.75 146.18 86.74 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.481 2.121 . . . . 0.0 112.344 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.1 t -106.04 95.46 11.04 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.846 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.698 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 42.8 Cg_endo -68.28 132.98 27.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.59 2.194 . . . . 0.0 112.537 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 29.4 m-20 -72.2 -35.31 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.797 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 48.8 t -61.35 -35.52 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.75 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.714 HD11 ' HB ' ' A' ' 130' ' ' ILE . 0.7 OUTLIER -67.29 -56.51 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.624 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.62 -22.5 61.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.24 -34.91 61.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.006 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -69.46 -34.76 74.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.054 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.67 -39.67 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.721 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 t -72.85 -42.23 63.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.833 HG22 HD13 ' A' ' 164' ' ' LEU . 8.6 p -68.37 -29.49 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.263 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 mtt -74.24 -25.42 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -1.99 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.29 5.52 84.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.64 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.31 41.59 99.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.79 178.81 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.572 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.687 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.46 144.66 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.687 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.88 126.43 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.361 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.624 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -101.85 164.4 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.513 0.197 . . . . 0.0 110.488 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -165.29 103.76 0.77 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 90.9 Cg_endo -84.1 137.5 7.37 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.704 2.269 . . . . 0.0 111.735 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.816 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.93 -152.15 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.206 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 0.7 OUTLIER -54.73 -22.19 13.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.309 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.688 HG23 ' HB2' ' A' ' 95' ' ' PRO . 2.5 p -100.04 -116.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -112.2 -175.17 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.753 0.311 . . . . 0.0 111.141 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.452 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.1 m-85 -63.42 134.09 55.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.906 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -120.33 179.51 16.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.026 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 2.6 mp -122.27 143.57 49.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.971 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.22 117.39 0.96 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.101 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG11 HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -153.91 166.0 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 111.367 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 54.9 m-20 -56.58 109.73 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.091 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.51 -46.25 84.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.202 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.69 24.92 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.5 148.1 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 -24.66 60.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.83 -27.79 63.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.24 -28.39 59.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 109' ' ' VAL . 26.0 t -67.23 -44.56 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -49.9 72.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.095 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 57.0 mmt-85 -62.29 -42.54 99.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.149 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.01 -25.71 68.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.903 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -30.51 64.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 54' ' ' ARG . 2.9 mmt85 -75.45 -49.9 17.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.309 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.71 -51.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.676 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -79.56 -5.96 56.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.293 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.15 -113.95 6.31 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.36 77.37 1.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 111.002 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -154.89 71.51 5.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 23.28 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.697 2.265 . . . . 0.0 112.531 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -122.5 -8.36 8.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 133.15 50.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.788 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.66 153.51 14.21 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.621 2.214 . . . . 0.0 112.52 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 142.54 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -97.22 148.55 22.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.653 HG13 ' HA ' ' A' ' 119' ' ' ILE . 0.9 OUTLIER -116.06 170.95 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 3.3 t -122.17 118.59 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.612 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -138.46 177.51 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.799 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.83 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 2.1 t -86.95 -41.37 13.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.453 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.405 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -164.14 170.61 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.991 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.92 -34.03 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 21.9 t70 -67.03 -28.64 68.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 67.8 mm-40 -74.45 -23.36 58.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.767 HG23 HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.31 61.23 0.79 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.783 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 34.8 Cg_endo -65.04 -72.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.063 1.842 . . . . 0.0 112.267 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.86 14.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.63 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 74' ' ' ILE . 1.7 t80 -103.64 -54.34 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.493 ' CB ' HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -120.09 172.69 7.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.768 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.52 111.49 41.77 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.933 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.14 175.29 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.948 2.432 . . . . 0.0 112.72 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.56 -177.02 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.896 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.36 -88.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.932 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -26.22 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.999 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.67 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.2 mmt -71.65 -16.22 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.055 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.56 -47.22 61.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.438 . . . . 0.0 110.401 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -57.31 -43.61 83.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.667 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.456 ' HE1' ' HE2' ' A' ' 96' ' ' TYR . 1.8 ttm -66.65 -36.73 83.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -67.96 -10.84 56.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.377 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.64 -51.69 13.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.8 65.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.228 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 3.1 tt -131.22 139.24 34.86 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.598 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 84.4 Cg_endo -79.03 -154.55 1.04 Allowed 'Cis proline' 0 C--N 1.35 0.65 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.548 -1.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.71 160.47 10.36 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.686 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 35' ' ' THR . 91.4 Cg_endo -78.67 42.37 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 112.271 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.609 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 55.3 p90 -112.18 149.9 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.6 m -96.19 141.78 29.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.156 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 182' ' ' LEU . 1.8 p -127.41 109.99 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.577 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.7 t -92.66 123.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.975 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 19.6 tp -127.26 172.27 10.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.599 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.583 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 2.8 pm0 -74.58 -176.17 2.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.521 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.659 ' HE ' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -119.07 139.43 51.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.975 0.417 . . . . 0.0 111.131 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.768 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -74.52 -157.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.94 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 106' ' ' ILE . 7.0 mm-40 -67.51 -31.85 72.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.525 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.7 tt -69.93 84.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.659 HG12 ' HE ' ' A' ' 102' ' ' ARG . 5.9 mt -80.9 104.48 2.78 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.758 ' HG2' ' HB ' ' A' ' 111' ' ' THR . 59.2 Cg_endo -70.69 154.8 63.85 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.33 2.02 . . . . 0.0 112.201 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.44 -84.04 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.752 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.79 HG21 HG22 ' A' ' 49' ' ' VAL . 27.5 m -81.88 7.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.985 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.693 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 6.8 mt -102.53 -35.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.295 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.758 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -83.12 -27.97 29.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.42 -140.55 37.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.383 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.05 -3.78 72.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.433 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -107.04 162.21 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.448 ' HB2' ' NH1' ' A' ' 102' ' ' ARG . 12.2 p -102.98 44.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -136.74 163.33 30.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 102' ' ' ARG . 80.2 t -139.78 133.71 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.652 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 119' ' ' ILE . . . -87.6 157.31 28.69 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.3 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.653 ' HA ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -135.28 167.98 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' H ' HG22 ' A' ' 119' ' ' ILE . 4.9 ttp180 -154.97 119.46 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.354 . . . . 0.0 111.417 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 121' ' ' VAL . 2.8 p -110.59 83.65 3.52 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.516 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.816 ' HB2' HG21 ' A' ' 33' ' ' THR . 72.8 Cg_endo -76.24 -178.86 4.73 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.632 2.221 . . . . 0.0 112.67 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.02 -4.88 51.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.714 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.4 OUTLIER -62.04 110.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.989 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.06 -46.54 82.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.672 HG23 HD22 ' A' ' 16' ' ' LEU . 38.0 mm -62.03 -54.88 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.969 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.714 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 98.5 m -60.2 -19.78 55.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -75.63 -43.65 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -72.67 -54.45 9.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.654 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.714 ' HB ' HD11 ' A' ' 16' ' ' LEU . 1.5 tt -57.44 -45.35 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.504 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.52 -25.11 62.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.58 -56.5 18.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.024 0.44 . . . . 0.0 110.125 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -75.91 -83.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.145 177.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 3.2 t80 -77.11 128.19 81.61 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.3 155.13 64.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.323 2.015 . . . . 0.0 111.603 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.21 157.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.337 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.604 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.42 138.8 36.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.82 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.02 109.12 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 111.605 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -131.8 127.29 36.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.789 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.0 t -71.19 119.16 14.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 111.152 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -87.05 97.59 10.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -163.28 30.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.083 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 144' ' ' SER . 1.1 pp -80.8 -155.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.001 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.404 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.5 OUTLIER -57.84 152.27 16.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.024 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 89.1 -142.88 17.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.425 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.18 67.89 71.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.503 0.192 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.7 Cg_exo -60.49 -48.79 10.43 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.372 2.048 . . . . 0.0 113.517 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 65.6 Cg_endo -73.03 118.05 5.39 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.828 1.685 . . . . 0.0 112.378 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 143.77 26.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.817 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -96.0 -12.47 0.68 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.885 2.39 . . . . 0.0 112.863 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.59 122.45 27.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.31 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -59.97 -30.88 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.841 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -29.18 60.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.124 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -67.43 -28.6 68.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 159' ' ' LEU . 46.5 mt -75.04 -50.73 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.485 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.34 -33.82 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.925 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -75.6 -58.4 3.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.756 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.51 -34.05 77.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.821 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.939 HD13 ' HB3' ' A' ' 163' ' ' ASP . 85.0 mt -106.33 68.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.331 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 8.5 t70 -16.34 -63.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.778 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.02 22.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 111.121 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.65 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.77 -63.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.939 ' HB3' HD13 ' A' ' 159' ' ' LEU . 3.6 t70 -107.56 100.24 9.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.011 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.833 HD13 HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.61 124.7 25.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.601 -177.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.805 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.2 p -64.02 -166.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.805 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.62 160.04 30.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.01 -25.02 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.289 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.32 -55.85 3.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.456 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 101.18 -163.52 18.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.862 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.01 -165.97 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.413 ' HB2' ' C ' ' A' ' 33' ' ' THR . 22.1 m -144.64 -60.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.628 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -124.35 -130.85 0.26 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.91 141.68 29.39 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.801 0.334 . . . . 0.0 111.465 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.96 -36.78 70.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -142.6 158.79 59.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.73 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 64.4 Cg_endo -91.46 -147.73 0.27 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.734 1.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 1.4 p -155.03 156.39 35.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.609 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.5 m -99.56 142.24 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.157 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.408 HG21 ' NH1' ' A' ' 192' ' ' ARG . 0.7 OUTLIER -129.0 89.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.771 HG23 ' HA ' ' A' ' 189' ' ' VAL . 12.2 mt -104.43 134.17 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -108.28 68.16 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.173 178.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.637 ' HB3' HG23 ' A' ' 98' ' ' VAL . 12.1 tp -69.75 87.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.358 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -77.25 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.66 0.267 . . . . 0.0 110.808 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.56 -126.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.467 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.7 OUTLIER -63.8 -53.42 50.11 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.19 108.22 2.46 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.161 1.907 . . . . 0.0 112.356 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.1 Cg_endo -76.22 139.2 20.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.451 2.1 . . . . 0.0 112.075 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.2 OUTLIER -99.42 49.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 180' ' ' ILE . 8.9 t -56.87 98.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.45 85.95 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.024 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.568 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -83.68 154.77 23.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.408 ' NH1' HG21 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -84.47 48.07 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -83.92 61.93 4.66 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.459 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.14 32.83 0.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.946 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -73.72 -130.24 0.17 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.523 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.8 -54.66 1.44 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.555 2.17 . . . . 0.0 112.259 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.675 HD23 ' HD2' ' A' ' 199' ' ' PRO . 0.3 OUTLIER -153.94 157.89 39.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -51.62 6.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.425 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.675 ' HD2' HD23 ' A' ' 197' ' ' LEU . 50.7 Cg_exo -56.14 159.54 12.33 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.204 1.936 . . . . 0.0 112.254 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.52 147.19 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.09 37.28 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.22 -9.17 58.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.966 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.83 104.77 17.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.892 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -119.28 67.3 0.38 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.407 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -99.99 -40.52 7.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 111.106 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 81.01 -154.34 35.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -86.68 -12.86 47.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.037 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.774 0.321 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.92 178.6 6.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.03 149.6 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 mtp85 -103.06 165.02 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.962 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 157.88 16.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pt -75.1 -27.72 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.036 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -73.89 -166.48 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.16 -163.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -70.04 -71.13 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.033 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -110.02 92.99 13.98 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 9' ' ' LYS . 33.9 Cg_exo -59.97 -64.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.581 2.187 . . . . 0.0 112.282 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 t 55.75 73.3 0.87 Allowed Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.099 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.0 Cg_exo -57.65 157.46 23.19 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.492 2.128 . . . . 0.0 112.293 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.0 -34.59 73.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.796 HG11 HD13 ' A' ' 126' ' ' ILE . 18.9 t -59.43 -53.64 45.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 20' ' ' ILE . 3.1 mm? -61.9 -35.98 79.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.407 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' ' 20' ' ' ILE . 2.8 mt-10 -57.72 -30.63 65.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.709 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -77.3 -32.89 55.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.286 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -71.15 -46.91 60.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.57 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -75.84 -17.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 13.0 t -66.12 -53.86 32.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 164' ' ' LEU . 9.7 p -69.78 -27.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 mtt -60.1 -37.15 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.09 -16.68 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.25 9.57 77.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.591 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.27 51.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.49 161.62 22.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.427 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.663 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.24 143.21 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.663 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.04 146.08 21.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.511 ' H ' HG13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -111.19 165.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 178.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -170.9 92.0 0.46 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.815 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.9 Cg_endo -81.55 157.3 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.545 2.163 . . . . 0.0 111.127 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.63 ' HA ' ' CB ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.35 -150.88 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.24 -20.81 45.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.74 -98.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.036 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.2 OUTLIER -131.47 -166.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.874 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.815 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m-85 -72.68 131.12 41.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.781 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -117.2 178.59 17.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.136 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.731 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.5 mt -133.96 144.49 48.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.351 . . . . 0.0 110.831 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.17 131.48 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.292 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.564 HG11 HG12 ' A' ' 28' ' ' ILE . 1.1 m -156.53 163.35 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.5 m-20 -56.57 106.58 0.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.366 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.95 84.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.877 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.53 18.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -110.62 146.77 35.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.24 -23.82 57.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.02 -26.77 68.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.21 -36.92 61.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -65.3 -43.64 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -70.05 -42.89 72.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.234 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -68.9 -29.39 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -67.59 -38.39 83.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.891 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -65.35 -37.73 87.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.69 -40.52 95.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.348 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.75 HG13 HG12 ' A' ' 143' ' ' ILE . 42.3 t -74.81 -57.92 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.288 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -81.89 -70.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.277 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.32 4.75 24.94 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.614 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.2 18.23 13.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -134.53 66.13 69.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.2 -54.38 5.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.79 2.327 . . . . 0.0 112.454 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -122.39 24.48 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -88.29 149.72 45.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.001 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.13 169.1 14.24 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.506 2.138 . . . . 0.0 112.289 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG21 HG22 ' A' ' 110' ' ' ILE . 32.9 m -119.48 162.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.04 138.48 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.563 HG13 HG23 ' A' ' 119' ' ' ILE . 9.4 pt -116.01 165.95 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 41.9 t -122.06 130.45 53.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.941 HG21 HG23 ' A' ' 74' ' ' ILE . 1.4 p -138.34 -175.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.394 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.782 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 5.6 t -88.94 -45.85 9.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -164.49 168.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.831 179.416 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.608 HG11 ' HG3' ' A' ' 85' ' ' MET . 10.2 t -55.34 -35.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.631 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.63 -28.98 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.92 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 2.9 mp0 -75.23 -15.99 60.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.44 58.18 0.7 Allowed Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.934 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 77' ' ' PHE . 20.4 Cg_endo -60.02 -86.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.07 1.847 . . . . 0.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -73.32 22.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 75' ' ' PRO . 27.1 m-85 -96.99 -47.33 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 111.008 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.1 p -129.83 -175.0 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.25 99.84 51.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -102.69 -173.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.284 2.656 . . . . 0.0 112.508 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.768 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.4 m -141.93 176.87 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.61 -87.9 0.2 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.839 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -33.76 64.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -57.34 -46.57 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.608 ' HG3' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -75.02 -25.5 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.246 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -46.99 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 0.0 110.924 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.9 tp -66.41 -43.86 84.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.155 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.605 ' SD ' HD23 ' A' ' 182' ' ' LEU . 6.0 tpt -63.44 -57.42 10.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.529 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -63.2 -11.81 23.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 1.8 mtt180 -67.12 -32.79 74.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.26 60.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -131.2 149.28 73.23 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.19 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 6.3 Cg_exo -78.54 -158.04 1.61 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.101 -1.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.24 162.08 11.31 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.829 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.25 46.5 2.21 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.847 2.365 . . . . 0.0 112.598 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -112.11 -179.53 3.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.066 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 m -115.27 145.62 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.685 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.04 91.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.373 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 16.7 t -87.28 122.56 39.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.756 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.446 HD12 HD12 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -126.67 175.91 7.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.591 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.08 158.87 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.218 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.564 ' CZ ' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -119.83 145.47 46.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.208 0.527 . . . . 0.0 111.184 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.84 174.93 8.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -76.66 60.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.22 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.467 HD12 ' NH1' ' A' ' 102' ' ' ARG . 1.6 mt -71.37 154.01 41.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.579 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 mt -76.32 -51.28 2.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.728 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 16.5 Cg_endo -57.04 101.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.234 1.956 . . . . 0.0 112.243 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.22 4.56 23.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -83.77 -17.63 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.706 HG22 HG21 ' A' ' 64' ' ' VAL . 1.1 pt -113.03 -29.03 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 107' ' ' PRO . 17.3 p -79.07 -35.43 42.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -169.2 46.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -70.47 -14.68 72.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p -117.64 -179.97 3.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.342 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.0 t -107.36 61.86 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mpp_? -141.2 141.5 34.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.564 HG21 ' CZ ' ' A' ' 102' ' ' ARG . 77.8 t -142.88 139.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.008 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.26 159.45 19.96 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.92 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.704 HD13 HD13 ' A' ' 74' ' ' ILE . 1.1 mt -141.22 173.47 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.602 ' H ' HG22 ' A' ' 119' ' ' ILE . 7.1 ptp180 -162.64 131.13 4.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.7 t -110.97 86.82 6.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.514 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.4 -177.78 2.93 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.531 2.154 . . . . 0.0 112.423 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.42 8.97 25.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.068 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.5 OUTLIER -76.45 100.91 5.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.796 HD13 HG11 ' A' ' 15' ' ' VAL . 85.5 mt -57.84 -50.99 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -65.99 -18.34 65.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.714 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 69' ' ' SER . 3.8 ttt180 -75.2 -37.66 61.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.999 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -51.21 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 131' ' ' ALA . 2.0 tt -62.6 -43.69 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.775 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -68.06 -28.24 67.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.97 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.01 33.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.084 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -75.76 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.266 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -77.21 128.93 79.5 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.207 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.21 144.03 32.76 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.337 2.025 . . . . 0.0 111.514 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.54 157.02 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 111.462 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.651 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 36.2 m -79.14 143.45 35.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.835 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -139.19 110.1 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.964 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.731 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -127.53 150.58 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.281 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.67 116.13 17.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.433 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.6 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . . . -88.17 81.27 7.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.04 33.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.75 HG12 HG13 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -80.85 -154.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.013 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.442 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.4 OUTLIER -56.73 153.52 10.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.837 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.43 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 89.95 -144.98 17.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.286 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -127.17 66.16 67.1 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.628 0.251 . . . . 0.0 111.23 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 40.0 Cg_exo -60.46 -49.28 9.32 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.374 2.049 . . . . 0.0 113.228 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 7.4 Cg_exo -73.46 106.23 2.14 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.096 1.864 . . . . 0.0 112.291 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.08 155.95 36.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -95.41 -14.52 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.769 2.312 . . . . 0.0 112.775 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.7 mmt180 -134.38 128.86 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.935 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.592 ' O ' HG11 ' A' ' 165' ' ' VAL . 5.7 mt -61.07 -45.46 94.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.066 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -23.52 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.79 -31.19 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.169 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -75.49 -51.21 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.529 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.815 HG13 HG13 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -59.0 -25.5 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.416 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -75.08 -48.99 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.15 -21.77 58.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 163' ' ' ASP . 81.0 mt -111.23 68.05 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.03 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.5 t70 -16.26 -63.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.176 0.923 . . . . 0.0 112.724 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -159.26 23.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.235 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.643 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.88 -65.22 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.759 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 159' ' ' LEU . 47.5 t0 -111.37 102.34 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.575 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -74.49 131.15 40.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.573 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.815 HG13 HG13 ' A' ' 156' ' ' VAL . 17.1 m -65.33 -166.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.164 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.775 HD12 ' H ' ' A' ' 169' ' ' GLY . 0.4 OUTLIER -126.3 167.39 15.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.669 ' HB3' HG13 ' A' ' 15' ' ' VAL . 3.2 t70 -92.47 -39.87 11.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.595 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 126' ' ' ILE . . . -64.09 -70.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.305 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.775 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 89.37 51.26 2.98 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.837 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.63 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 3.7 m-20 -71.99 121.2 18.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.75 123.74 4.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.266 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -137.18 -113.85 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.448 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -85.38 127.53 34.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.506 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.08 -1.64 10.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.122 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.72 157.34 36.08 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.692 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -92.64 -151.66 0.36 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.737 1.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.8 p -156.91 115.1 3.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.1 m -102.31 143.58 31.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 111.499 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.5 105.87 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.727 HG23 ' HA ' ' A' ' 189' ' ' VAL . 13.7 mt -114.31 131.18 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.72 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.6 m-20 -99.42 73.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.718 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.605 HD23 ' SD ' ' A' ' 88' ' ' MET . 0.2 OUTLIER -68.79 81.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.309 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -86.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.321 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.49 -128.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -59.82 -51.03 83.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 72.6 Cg_endo -76.53 108.67 2.71 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.203 1.936 . . . . 0.0 112.504 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 83.8 Cg_endo -83.96 121.92 2.89 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.645 2.23 . . . . 0.0 112.257 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.72 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.6 mtm180 -89.35 54.38 2.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.489 . . . . 0.0 111.149 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.727 ' HA ' HG23 ' A' ' 180' ' ' ILE . 48.3 t -59.33 106.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.8 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.47 86.86 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -89.75 140.65 29.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -7.58 58.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -95.67 63.45 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.628 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -105.88 -48.67 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -79.33 -141.7 2.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.424 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.42 -176.32 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.688 2.259 . . . . 0.0 112.324 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.572 ' HB3' ' HD2' ' A' ' 199' ' ' PRO . 0.8 OUTLIER -145.1 169.46 18.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.444 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 4.1 t0 -73.91 -51.89 4.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.151 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 197' ' ' LEU . 17.6 Cg_exo -66.92 83.83 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.281 1.988 . . . . 0.0 111.993 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.736 HG13 HD23 ' A' ' 201' ' ' LEU . 1.4 p -71.06 -68.12 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.043 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.736 HD23 HG13 ' A' ' 200' ' ' VAL . 0.6 OUTLIER -106.9 16.27 24.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.498 . . . . 0.0 110.284 179.136 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.78 -25.56 65.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.906 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -83.18 126.99 33.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.925 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -125.98 -60.34 0.16 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.55 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -96.18 137.94 34.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.874 0.369 . . . . 0.0 111.13 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -124.34 -34.04 0.74 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.466 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.91 -21.08 13.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.843 0.354 . . . . 0.0 110.887 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.099 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.75 0.31 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.4 mt -88.77 -57.91 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.71 116.17 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.037 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -72.03 169.22 16.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -75.15 154.33 37.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -94.43 142.45 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -175.16 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.024 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.595 ' HD3' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -75.5 175.46 8.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.595 ' H ' ' HD3' ' A' ' 8' ' ' ARG . 27.6 mttt -81.17 132.65 35.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.72 141.37 75.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.13 -164.34 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.51 2.14 . . . . 0.0 112.191 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.73 112.52 9.81 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.006 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.605 ' HG2' HD23 ' A' ' 16' ' ' LEU . 44.2 Cg_endo -67.6 175.71 5.83 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.484 2.123 . . . . 0.0 112.052 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.714 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 m-20 -67.46 -28.12 67.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.87 -58.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.605 HD23 ' HG2' ' A' ' 13' ' ' PRO . 4.4 mm? -60.27 -42.48 95.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.27 -31.37 63.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.035 0.445 . . . . 0.0 110.485 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 5.1 mm-40 -76.29 -32.11 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.186 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -75.64 -41.73 53.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.907 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 21' ' ' SER . 1.9 pp -71.7 -31.37 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.025 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.532 ' N ' HD12 ' A' ' 20' ' ' ILE . 5.7 p -75.18 -38.0 61.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.787 HG11 HD13 ' A' ' 164' ' ' LEU . 11.6 p -75.66 -29.39 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.083 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mtt -62.11 -42.7 99.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.634 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -4.97 26.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.813 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.76 78.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 51.69 37.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.812 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.17 165.24 22.57 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.427 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.5 148.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.703 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -116.39 127.42 74.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.733 -179.383 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.504 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -102.71 151.6 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.635 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.519 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -157.05 113.35 1.94 Allowed Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.63 134.26 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.721 2.281 . . . . 0.0 111.377 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.574 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -116.49 -149.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 111.191 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 11.7 m-20 -54.58 -22.08 12.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.194 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 36' ' ' ILE . 4.6 t -100.38 -121.82 0.16 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.75 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.52 -149.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.761 0.315 . . . . 0.0 111.454 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.476 ' OH ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -64.96 129.59 40.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.446 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.72 170.68 15.36 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.959 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 139' ' ' THR . 1.6 mp -123.45 141.13 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.929 0.395 . . . . 0.0 111.263 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.34 111.5 0.58 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.696 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 42' ' ' ASN . 2.5 p -151.79 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.645 0.26 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.601 ' H ' HG22 ' A' ' 41' ' ' VAL . 14.2 m120 -56.42 116.86 3.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 110.493 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.0 -56.02 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.988 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 44' ' ' LEU . 1.4 mm? -82.81 37.11 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.553 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -110.94 156.17 21.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 178.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -31.91 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.441 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.15 -28.15 68.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.518 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -72.25 -35.43 68.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.718 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.0 t -66.17 -48.28 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 50' ' ' ARG . 11.2 mtt180 -63.73 -45.17 91.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.546 ' HG3' HG13 ' A' ' 28' ' ' ILE . 11.0 mmm180 -65.25 -30.67 71.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -66.59 -46.48 75.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.6 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.89 -18.08 63.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.091 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -73.24 -67.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.701 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG13 HG23 ' A' ' 143' ' ' ILE . 56.2 t -73.28 -41.16 57.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -80.08 -11.32 59.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.626 0.251 . . . . 0.0 111.292 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 -139.0 39.05 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.416 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.2 85.48 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.82 67.45 23.21 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.88 9.31 2.03 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 0.0 112.511 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -105.21 -26.31 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.28 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -88.12 128.8 52.31 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.287 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 35.7 Cg_exo -59.73 171.63 2.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 110' ' ' ILE . 5.0 m -114.85 150.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.322 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -99.91 133.93 43.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.449 HD11 HG12 ' A' ' 119' ' ' ILE . 10.5 pt -113.94 172.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.505 ' SG ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m -122.07 129.37 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG21 HG23 ' A' ' 74' ' ' ILE . 1.8 p -136.0 179.06 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.707 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 30.3 t -86.18 -42.54 13.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.261 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.5 166.22 20.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.422 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG21 ' SD ' ' A' ' 85' ' ' MET . 26.8 t -57.68 -31.33 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.5 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 37.0 t70 -67.44 -27.59 67.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.812 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 0.6 OUTLIER -76.73 -21.04 55.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.119 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.809 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.34 58.79 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 34.7 Cg_endo -65.08 -74.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.007 1.804 . . . . 0.0 112.003 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.19 15.18 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.5 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 32.5 m-85 -100.52 -45.95 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 p -135.23 159.49 41.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.679 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.496 ' HG3' ' HB3' ' A' ' 101' ' ' GLU . 7.1 ptm180 -119.14 104.16 46.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.012 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HB3' HD22 ' A' ' 100' ' ' LEU . 85.5 Cg_endo -102.23 -166.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.14 2.56 . . . . 0.0 112.399 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 166.27 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.84 -73.47 0.68 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.586 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.636 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -55.33 -34.44 64.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.797 0.332 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.47 ' HB1' HD21 ' A' ' 182' ' ' LEU . . . -64.01 -36.68 84.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.678 ' SD ' HG21 ' A' ' 71' ' ' VAL . 4.2 mmt -71.36 -17.99 62.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.095 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.636 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.6 mt-10 -71.58 -47.2 56.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.934 0.397 . . . . 0.0 110.573 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.23 -40.55 81.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.533 ' HG2' HG11 ' A' ' 98' ' ' VAL . 4.4 tpt -74.76 -46.12 39.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.507 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.83 -14.64 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.298 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -44.83 63.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.4 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 3.7 pt -108.81 53.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 6.3 tt -130.97 131.73 23.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 87.6 Cg_endo -78.08 -163.4 3.36 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.478 -0.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.62 167.11 16.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.95 37.22 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.748 2.299 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.4 ' CE2' ' HB ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -112.17 144.31 41.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.647 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 1.3 m -94.74 148.77 21.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.71 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.533 HG11 ' HG2' ' A' ' 88' ' ' MET . 2.1 t -126.49 102.51 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.24 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.834 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 2.8 t -93.55 120.1 42.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 80' ' ' PRO . 1.1 mp -126.99 -168.5 1.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.576 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -74.83 169.33 18.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.552 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.563 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.17 147.13 44.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 105' ' ' LEU . 22.1 p-10 -73.72 -152.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.314 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 31.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.47 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.738 HD13 ' HD2' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -69.53 94.85 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.725 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.603 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 6.1 mt -64.91 -50.79 61.0 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.71 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.738 ' HD2' HD13 ' A' ' 105' ' ' LEU . 76.5 Cg_exo -50.38 108.85 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.128 1.885 . . . . 0.0 112.316 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.22 -1.53 41.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.788 HG13 HG13 ' A' ' 110' ' ' ILE . 15.0 p -69.98 -21.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.788 HG13 HG13 ' A' ' 109' ' ' VAL . 5.1 mt -105.03 -52.25 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.037 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -68.2 -14.27 62.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.54 -154.75 40.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -87.62 6.25 83.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.362 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.9 169.93 9.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.769 0.318 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -99.0 39.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -136.92 158.99 43.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 102' ' ' ARG . 98.7 t -139.95 147.87 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.478 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -98.99 146.89 18.31 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.389 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.759 HD13 HD13 ' A' ' 74' ' ' ILE . 24.8 mt -148.26 134.98 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -144.58 146.52 32.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.962 0.41 . . . . 0.0 111.438 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 68' ' ' VAL . 1.7 m -110.22 96.82 27.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HB2' HG21 ' A' ' 33' ' ' THR . 50.6 Cg_endo -68.14 -179.28 2.12 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.501 2.134 . . . . 0.0 112.449 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 5.2 47.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.97 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.3 104.54 6.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.35 -49.01 77.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.194 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.493 HG23 HD21 ' A' ' 16' ' ' LEU . 30.6 mm -59.83 -48.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.1 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -20.89 65.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 128' ' ' ARG . 0.3 OUTLIER -75.19 -27.36 59.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.987 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -74.31 -60.4 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.172 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -58.27 -45.5 89.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.73 -28.25 69.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.006 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 129' ' ' ARG . . . -54.76 -53.4 55.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -75.28 -88.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.123 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -77.09 144.96 72.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.41 159.09 47.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.321 2.014 . . . . 0.0 111.603 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 t -133.65 150.25 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.526 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.614 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 m -80.9 140.47 35.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.824 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.7 107.13 8.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.494 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.12 122.24 22.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.905 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 110.54 5.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -79.79 104.69 10.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.017 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -150.84 27.3 0.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.083 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -81.37 -156.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.406 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 5.7 p -62.34 174.02 1.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 82.46 -139.26 19.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.445 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.34 72.18 77.09 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.578 0.227 . . . . 0.0 111.04 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.552 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.8 Cg_exo -60.16 -46.9 16.62 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.358 2.039 . . . . 0.0 113.322 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 28.4 Cg_endo -62.1 129.66 27.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.781 1.654 . . . . 0.0 111.976 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.468 ' HB3' HD11 ' A' ' 155' ' ' ILE . 8.6 p -85.86 121.91 72.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -95.11 -28.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.882 2.388 . . . . 0.0 112.297 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 131.85 18.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.338 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 152' ' ' LEU . 25.7 mt -59.95 -36.48 77.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.255 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -19.4 59.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.98 -44.83 79.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.851 HD12 HG23 ' A' ' 165' ' ' VAL . 11.6 mt -68.29 -44.1 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.17 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.96 -41.27 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.418 ' HD2' HH11 ' A' ' 157' ' ' ARG . 0.1 OUTLIER -75.38 -53.31 8.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.498 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.644 ' HB3' HD22 ' A' ' 159' ' ' LEU . 9.6 t70 -56.6 -39.85 74.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.496 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.644 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.6 mm? -111.37 77.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.934 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.43 -43.2 0.56 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.094 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.26 19.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 48.7 t -80.45 -97.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.529 ' OD1' ' HG ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -94.72 92.25 6.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.46 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.787 HD13 HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -55.57 135.13 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.026 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.851 HG23 HD12 ' A' ' 155' ' ' ILE . 0.7 OUTLIER -66.6 172.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.648 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.55 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -127.42 127.34 43.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.521 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -7.95 46.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.746 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -64.08 -38.21 90.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.388 . . . . 0.0 110.655 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.498 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 102.25 166.67 26.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.084 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -152.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.574 ' HB2' ' C ' ' A' ' 33' ' ' THR . 11.4 m -144.28 -63.22 0.37 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -130.47 -138.68 0.21 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.4 168.43 13.14 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.75 ' HG2' HG23 ' A' ' 36' ' ' ILE . 61.9 mtp -71.01 1.39 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.012 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.17 160.17 26.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 177' ' ' SER . 68.8 Cg_endo -97.02 -149.65 0.18 OUTLIER 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.737 1.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.436 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -153.77 120.45 5.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.484 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.8 m -99.73 137.21 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.398 . . . . 0.0 111.483 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.23 107.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.607 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.576 HG23 ' HA ' ' A' ' 189' ' ' VAL . 3.1 mt -119.14 132.95 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.64 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.834 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 9.2 m-20 -97.88 69.24 2.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.163 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 88' ' ' MET . 3.5 tt -69.44 87.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.408 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -81.76 0.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.493 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.5 -126.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.864 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.41 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -60.58 -52.63 71.35 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -77.27 108.39 2.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.237 1.958 . . . . 0.0 112.626 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 1.0 OUTLIER -84.07 132.45 5.39 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.017 2.478 . . . . 0.0 112.071 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.655 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.1 mmm180 -91.88 59.18 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 110.897 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 180' ' ' ILE . 46.7 t -59.16 109.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.53 88.33 2.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.05 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.754 ' HG2' ' H ' ' A' ' 193' ' ' GLY . 5.6 ttt180 -90.94 127.77 36.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.819 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -82.7 3.75 27.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.754 ' H ' ' HG2' ' A' ' 191' ' ' ARG . . . -89.12 167.66 34.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.379 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -175.01 2.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -74.84 -171.8 28.48 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.48 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.68 84.26 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.501 2.134 . . . . 0.0 112.306 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.75 0.92 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.558 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 9.6 m-20 -79.44 -50.19 1.34 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.582 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 198' ' ' ASP . 36.7 Cg_endo -65.13 161.08 38.82 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.101 1.867 . . . . 0.0 112.357 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 201' ' ' LEU . 1.3 t -75.64 170.84 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.119 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.512 ' H ' HG12 ' A' ' 200' ' ' VAL . 0.1 OUTLIER -86.0 77.12 9.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.958 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.8 tp -90.02 -20.57 23.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 203' ' ' ARG . 3.6 mmm180 -91.75 -24.75 19.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.15 117.6 9.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.582 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -97.25 152.18 19.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.3 . . . . 0.0 111.047 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -176.07 -88.04 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.18 -30.17 13.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 110.837 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.116 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.786 0.327 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.86 -172.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.2 -11.82 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -97.05 106.54 18.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -167.34 1.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -99.82 139.56 21.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.994 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.43 ' N ' HG13 ' A' ' 6' ' ' ILE . 82.4 p -73.75 119.9 18.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.971 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -78.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 129.28 55.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.862 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -109.4 137.64 20.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.2 -175.52 2.01 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.467 2.111 . . . . 0.0 112.367 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.0 77.13 58.8 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.64 148.49 87.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.661 2.241 . . . . 0.0 112.139 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.08 -29.54 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.19 -31.77 25.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.92 -41.57 64.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 21' ' ' SER . 1.4 pt-20 -74.87 -19.02 60.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.3 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.0 -36.73 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.82 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -72.77 -40.84 65.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.592 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.47 -17.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -71.94 -46.34 57.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 164' ' ' LEU . 9.6 p -73.5 -27.78 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 15.2 mtt -59.76 -49.42 77.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.113 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.67 -12.96 61.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.57 1.03 89.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.503 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.14 44.26 87.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.9 170.43 19.38 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.362 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.45 143.84 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.428 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.681 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.63 140.03 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.701 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.578 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -105.46 165.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.445 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.2 103.32 0.31 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.779 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 83.3 Cg_endo -82.69 135.72 8.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.6 2.2 . . . . 0.0 111.744 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -120.21 -155.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.804 0.335 . . . . 0.0 111.414 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.8 OUTLIER -54.72 -21.17 10.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -98.42 -117.92 0.14 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.848 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.3 OUTLIER -112.6 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.723 0.297 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.37 131.38 47.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.714 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -123.11 176.47 16.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.482 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.4 mt -133.32 142.99 48.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.741 0.305 . . . . 0.0 110.839 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.665 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.5 134.69 5.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.059 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.664 HG22 ' NH1' ' A' ' 51' ' ' ARG . 3.9 m -152.69 168.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.773 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 6.2 t-20 -56.61 105.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.259 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.12 75.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.278 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -79.89 22.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.87 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.773 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.25 161.71 15.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 178.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -25.18 58.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 110.426 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 6.5 m-20 -60.59 -28.82 68.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.806 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.09 -27.16 59.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.92 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.686 HG13 HG21 ' A' ' 109' ' ' VAL . 46.2 t -65.66 -54.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -71.33 -22.19 61.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.688 ' NH2' HG22 ' A' ' 139' ' ' THR . 0.0 OUTLIER -68.01 -34.48 76.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.997 0.427 . . . . 0.0 110.754 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.571 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.8 OUTLIER -74.96 -44.44 48.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.391 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.52 -34.53 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.181 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -66.41 -61.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.439 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.888 HG13 HG12 ' A' ' 143' ' ' ILE . 39.5 t -63.76 -51.12 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -79.86 -70.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.454 -178.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.93 -11.7 0.62 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.08 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 56' ' ' LYS . 2.6 ptp180 -118.4 40.19 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.784 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 p -141.72 63.75 17.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.44 -66.85 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.652 2.235 . . . . 0.0 112.591 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.719 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 53.3 m80 -108.59 24.44 13.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 2.1 mttt -88.41 147.48 40.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.16 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HD2' ' HG2' ' A' ' 62' ' ' LYS . 62.0 Cg_endo -73.8 161.26 41.99 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.591 2.194 . . . . 0.0 112.269 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 110' ' ' ILE . 3.8 p -114.05 151.53 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.8 t -94.16 134.22 36.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.214 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -116.24 172.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.796 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 20.7 t -119.96 136.88 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.768 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -135.86 -179.57 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.639 ' H ' HG22 ' A' ' 68' ' ' VAL . 1.2 t -76.09 -49.67 16.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.155 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.579 ' SG ' HD21 ' A' ' 92' ' ' LEU . 1.2 m -163.93 179.86 6.74 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.143 0.497 . . . . 0.0 111.664 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.712 ' HA ' HD11 ' A' ' 74' ' ' ILE . 60.9 t -52.44 -41.29 35.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.111 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -69.57 -27.82 65.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.905 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.85 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 1.4 tp10 -80.99 -8.22 59.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.712 HD11 ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -90.86 -38.56 0.39 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.668 ' HG3' ' HG3' ' A' ' 80' ' ' PRO . 99.8 Cg_exo -44.03 -23.3 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.491 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -55.22 -59.33 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -107.51 3.89 25.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -118.05 179.7 4.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.5 94.44 26.26 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.668 ' HG3' ' HG3' ' A' ' 75' ' ' PRO . 68.3 Cg_endo -102.49 -166.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.2 2.6 . . . . 0.0 112.687 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 177.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.15 -83.28 0.41 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.769 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.93 -33.25 62.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.842 0.353 . . . . 0.0 111.152 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -60.41 -49.36 77.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.44 ' CE ' HD11 ' A' ' 100' ' ' LEU . 17.7 mmt -71.94 -14.91 62.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.255 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.0 mm-40 -66.59 -46.68 75.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.4 tm? -61.35 -38.4 86.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.201 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.476 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 5.9 tpt -66.29 -43.11 87.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.27 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -69.95 -39.69 75.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.058 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.12 51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.648 HD13 HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -131.36 134.65 25.93 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.28 -162.34 2.95 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.277 -1.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.93 166.78 15.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.562 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.9 Cg_endo -81.29 41.72 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.742 2.295 . . . . 0.0 112.482 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.2 m-85 -111.31 156.21 21.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.819 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 59.2 m -94.93 135.62 36.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.355 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.434 ' O ' ' HB ' ' A' ' 119' ' ' ILE . 6.5 t -122.49 98.94 6.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.292 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.797 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 18.9 t -95.48 128.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.623 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.44 HD11 ' CE ' ' A' ' 85' ' ' MET . 2.3 mm? -126.96 -178.6 4.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -178.73 3.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.325 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.546 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.18 137.7 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.322 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 6.8 t30 -74.25 -168.19 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.902 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 37.56 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.474 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.877 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 1.6 tp -72.11 132.25 43.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.58 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 19.9 mm -73.33 -50.6 6.22 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.665 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.877 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 72.8 Cg_exo -49.77 109.99 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.241 1.961 . . . . 0.0 112.353 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.09 -17.79 45.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.125 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.686 HG21 HG13 ' A' ' 49' ' ' VAL . 14.8 p -69.18 -22.6 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.247 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.524 ' O ' HG12 ' A' ' 64' ' ' VAL . 45.0 mt -93.88 -43.58 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.025 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.691 ' HA ' HG22 ' A' ' 117' ' ' VAL . 22.1 p -81.28 -6.52 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.05 -169.8 50.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 61' ' ' HIS . . . -78.23 -1.5 80.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.365 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.48 -172.75 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 111.017 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 3.4 p -106.22 39.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -136.77 153.1 50.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.047 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 111' ' ' THR . 93.8 t -139.81 144.53 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.468 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.491 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -91.32 155.55 23.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.385 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 118' ' ' GLY . 3.8 mt -143.94 151.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.592 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.3 ttt180 -144.67 126.79 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.41 HG11 HD11 ' A' ' 92' ' ' LEU . 9.8 t -111.14 78.3 1.71 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 15.2 Cg_exo -69.71 -176.32 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.55 6.48 45.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.83 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 100.2 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -57.47 -45.71 84.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.032 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.9 mt -62.25 -53.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.185 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -24.01 62.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 1.7 ttm105 -68.95 -36.49 77.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -54.57 12.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.5 mt -60.47 -49.47 84.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.768 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.29 -28.91 68.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.85 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.68 -56.7 16.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.35 -89.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -76.69 127.57 83.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.095 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 153.8 72.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.28 1.987 . . . . 0.0 111.628 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.03 155.82 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.119 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.665 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -80.56 139.5 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.031 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -143.24 111.52 6.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.882 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.688 HG22 ' NH2' ' A' ' 51' ' ' ARG . 2.1 t -140.24 138.15 34.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.545 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 15.0 p -70.6 126.78 30.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.338 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . -88.04 94.21 9.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -154.7 26.64 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.949 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.888 HG12 HG13 ' A' ' 55' ' ' VAL . 1.1 pp -79.12 -155.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.03 162.14 2.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.199 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.438 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 82.62 -144.78 23.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.319 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -127.34 66.45 68.81 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.588 0.233 . . . . 0.0 111.058 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.523 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 46.2 Cg_exo -60.42 -46.63 17.01 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.376 2.05 . . . . 0.0 113.474 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 40.6 Cg_endo -67.15 106.49 1.19 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.845 1.697 . . . . 0.0 112.327 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.09 136.5 21.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.517 ' HG2' ' HG2' ' A' ' 151' ' ' ARG . 69.3 Cg_endo -95.71 -12.25 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.865 2.377 . . . . 0.0 112.445 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -128.29 112.34 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.777 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -56.49 -32.6 65.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.219 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -24.88 58.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.287 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 2.2 tt0 -72.51 -31.01 65.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.509 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.707 HG22 HD12 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -75.22 -51.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.313 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.03 -36.32 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.54 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 157' ' ' ARG . 5.4 mmt85 -72.73 -51.15 20.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.338 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.18 -24.57 64.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.433 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.707 HD12 HG22 ' A' ' 155' ' ' ILE . 40.5 mt -111.22 79.46 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.143 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.2 t70 -28.15 -51.2 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.223 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -161.65 26.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.74 -92.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.535 ' OD1' HD13 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -89.95 88.51 7.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.795 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -56.26 129.39 40.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.388 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.552 HG12 HD12 ' A' ' 155' ' ' ILE . 35.4 m -66.37 -172.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.21 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.676 HD22 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.78 156.25 41.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -92.62 -19.6 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.4 -50.74 7.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 94.11 -157.02 22.52 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.909 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.07 -163.26 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.623 0.249 . . . . 0.0 111.105 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 m -150.18 -60.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -123.57 -130.19 0.26 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.6 OUTLIER -86.31 144.77 27.21 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.82 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.848 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.6 ttp -68.79 -15.71 63.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -154.51 160.83 30.53 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 70.2 Cg_endo -89.43 -142.41 0.16 OUTLIER 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.548 0.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 73.1 m -153.88 131.86 11.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.834 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.691 HG23 ' HB3' ' A' ' 191' ' ' ARG . 75.9 m -102.33 142.13 34.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.819 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 19.2 t -129.08 110.4 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.006 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.738 HG23 ' HA ' ' A' ' 189' ' ' VAL . 5.4 mt -120.69 125.08 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.182 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.797 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -102.32 66.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 84' ' ' ALA . 21.7 tp -69.58 83.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.527 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -80.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.447 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 185' ' ' ASN . 4.2 t -120.73 -121.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.166 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.454 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -62.66 -52.86 61.7 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.1 109.61 2.73 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.208 1.938 . . . . 0.0 112.445 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 189' ' ' VAL . 93.9 Cg_endo -80.45 127.83 6.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.615 2.21 . . . . 0.0 112.329 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -88.39 45.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 180' ' ' ILE . 9.1 t -56.87 96.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.791 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.24 84.7 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.149 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.691 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -86.02 140.02 30.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 192' ' ' ARG . 1.2 mtt85 -67.8 91.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.823 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -94.91 72.79 1.01 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -14.34 18.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.714 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -75.87 -67.9 1.63 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.39 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.11 -167.29 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.438 2.092 . . . . 0.0 112.202 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.2 tp -137.48 -73.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -78.89 120.54 81.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.92 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.29 -37.56 7.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.511 2.141 . . . . 0.0 112.336 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.6 m -70.33 160.59 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -114.35 104.6 12.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.56 -177.58 3.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -85.06 -38.66 18.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.21 173.31 50.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.493 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -104.43 -33.19 8.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.735 0.302 . . . . 0.0 111.069 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 175.54 67.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.554 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -108.07 10.48 28.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.719 0.295 . . . . 0.0 110.992 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.999 -179.939 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.769 0.319 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.78 178.02 4.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 4' ' ' ARG . 7.1 tp -76.84 149.44 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.463 ' N ' HG13 ' A' ' 3' ' ' ILE . 5.9 mtm-85 -107.06 168.59 9.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 169.54 14.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.2 pt -84.9 -28.67 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.6 p -69.63 118.57 12.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.08 -49.64 5.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.11 159.89 24.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.59 124.61 81.91 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.24 175.4 10.99 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.479 2.12 . . . . 0.0 112.41 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.53 99.67 42.2 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' CG ' HD23 ' A' ' 16' ' ' LEU . 51.4 Cg_exo -55.21 168.68 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.587 2.192 . . . . 0.0 112.329 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -35.74 79.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.147 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.27 -53.21 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.167 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.3 mm? -60.06 -32.62 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.623 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.98 67.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.788 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -36.6 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.34 -42.8 53.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -66.97 -30.14 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.114 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.8 p -66.5 -44.49 82.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.061 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 18' ' ' GLU . 35.7 t -65.32 -29.45 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.5 mmt -62.7 -44.6 95.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -17.74 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.86 89.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.98 39.78 93.29 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.51 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.84 171.93 15.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.7 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -96.17 140.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.61 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.646 ' H ' HG13 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -116.55 130.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.197 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -101.68 168.89 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.574 0.226 . . . . 0.0 110.756 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -169.48 102.4 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.413 ' HG2' ' HA ' ' A' ' 170' ' ' ASP . 89.3 Cg_endo -83.06 143.74 11.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.544 2.163 . . . . 0.0 111.888 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.43 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -123.16 -160.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.732 ' HB3' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -66.83 -25.35 66.4 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -88.7 -89.9 0.14 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.257 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' H ' HG23 ' A' ' 35' ' ' THR . 1.3 tt -133.68 174.99 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 111.06 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -68.21 143.16 55.43 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -134.82 177.13 19.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.745 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.769 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.0 mt -125.55 144.38 50.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.87 0.367 . . . . 0.0 110.553 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.57 125.59 2.35 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.024 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.646 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -156.58 178.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 111.105 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.43 122.73 12.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.317 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.84 -60.67 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.05 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.4 mm? -81.07 37.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.1 149.76 30.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -75.14 -18.59 60.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -26.64 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.667 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -74.71 -44.55 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.997 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -35.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -38.87 78.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.671 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.584 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.3 -45.18 70.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.781 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.639 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.3 OUTLIER -60.83 -25.83 66.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.784 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -72.88 -34.82 66.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.27 -49.81 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.358 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 140' ' ' SER . 70.9 t -65.27 -49.85 76.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.588 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.602 ' HE2' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -79.75 -6.38 57.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 111.18 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.43 -92.05 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.64 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HG3' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -102.86 116.05 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.466 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 60.8 p -155.11 57.44 1.65 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.09 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 59' ' ' SER . 50.7 Cg_exo -54.11 -57.18 1.98 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.411 2.074 . . . . 0.0 112.285 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.06 30.32 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HD3' ' HE2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.54 135.77 33.86 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.826 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.92 160.79 45.34 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 112.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 110' ' ' ILE . 9.3 m -118.75 162.51 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 t -110.6 141.15 44.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.97 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.503 HG13 HG12 ' A' ' 119' ' ' ILE . 5.9 pt -116.49 167.34 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.01 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.701 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -119.78 135.7 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.874 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -141.53 -178.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.634 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 68' ' ' VAL . 21.6 t -89.71 -41.86 11.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.564 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.18 170.69 16.02 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.52 -37.63 59.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -67.41 -21.89 65.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.159 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -77.15 -26.27 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.874 HG23 HG21 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -113.48 58.81 0.74 Allowed Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 21.5 Cg_endo -60.49 -84.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.066 1.844 . . . . 0.0 111.965 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.57 23.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.389 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 26.0 m-85 -98.9 -31.78 11.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.673 0.273 . . . . 0.0 111.228 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -135.08 178.31 7.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.083 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -113.23 90.21 16.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 78' ' ' SER . 69.2 Cg_endo -102.23 176.39 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.049 2.499 . . . . 0.0 112.645 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -177.31 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.046 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.03 -75.23 0.74 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.516 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.461 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -59.19 -29.95 67.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.821 0.343 . . . . 0.0 110.856 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -61.74 -47.34 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 9.5 mmt -74.21 -18.63 60.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.161 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.4 mm-40 -63.01 -45.18 93.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.524 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.586 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.611 ' HG2' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.92 -58.24 8.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.306 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -4.0 16.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.321 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -56.33 4.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.048 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.45 71.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.583 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.606 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.35 151.76 79.36 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.997 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.648 ' HB3' HG22 ' A' ' 121' ' ' VAL . 5.5 Cg_exo -78.36 -148.45 0.5 Allowed 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.175 -0.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.67 163.6 12.55 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.723 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.78 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 92.8 Cg_endo -81.6 35.2 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.756 2.304 . . . . 0.0 112.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.742 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 44.9 p90 -112.26 162.86 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.411 HG23 ' HB3' ' A' ' 120' ' ' ARG . 7.8 m -115.23 124.86 52.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 182' ' ' LEU . 2.4 p -108.31 109.01 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.131 0.491 . . . . 0.0 110.982 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 44.7 t -103.72 128.61 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.147 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -126.59 -165.87 1.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.308 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.69 -176.05 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.736 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.7 143.33 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.994 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -74.73 -170.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -76.49 55.2 0.99 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.207 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.778 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 24.1 tp -88.79 129.63 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.632 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 11.4 mm -72.02 -52.47 7.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.778 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 75.6 Cg_exo -50.88 100.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.304 2.003 . . . . 0.0 112.536 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.445 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -82.04 1.08 37.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.8 -26.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.097 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.704 HG22 HG21 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -107.48 -29.51 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 19.8 p -78.76 -18.08 54.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.937 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.13 -169.21 54.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.375 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.08 -8.39 83.08 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.401 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.2 p -114.68 -175.46 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.524 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 74.8 m -111.63 62.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -143.22 138.21 29.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' ' 102' ' ' ARG . 97.8 t -139.94 140.28 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.356 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.35 157.08 19.95 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.643 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.508 HD13 HD13 ' A' ' 74' ' ' ILE . 27.8 mt -146.23 151.74 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HB3' HG23 ' A' ' 97' ' ' THR . 0.4 OUTLIER -146.39 137.71 24.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.459 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 93' ' ' PRO . 2.7 p -110.6 87.72 6.88 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.39 -179.74 3.42 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.411 2.074 . . . . 0.0 112.628 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.29 -4.49 57.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.975 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 7.1 m-20 -62.33 103.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -45.98 83.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.48 -50.8 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -63.56 -20.93 66.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.653 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 128' ' ' ARG . 1.7 ttp180 -74.98 -27.21 60.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -60.6 2.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.9 mt -57.79 -48.15 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.178 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.826 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.09 -29.87 70.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.358 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.6 -54.92 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 110.028 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -75.92 -89.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.26 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -77.04 141.07 67.03 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.09 153.77 46.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.303 2.002 . . . . 0.0 111.577 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.98 156.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.691 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.7 m -80.38 129.97 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.027 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.701 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . . . -128.53 102.9 6.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.846 0.355 . . . . 0.0 111.856 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.769 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -130.28 141.76 50.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' HG11 ' A' ' 55' ' ' VAL . 1.4 p -61.72 125.52 24.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . -70.61 123.97 23.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 111.373 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 147' ' ' PRO . 0.7 OUTLIER -153.06 58.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.658 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.485 HD13 HG22 ' A' ' 55' ' ' VAL . 1.6 mm -70.67 168.94 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.898 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.465 ' H ' HG22 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -60.57 143.84 52.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.661 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.31 -119.4 5.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -125.83 91.04 49.2 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.675 0.274 . . . . 0.0 111.145 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 33.4 Cg_exo -60.52 -48.53 11.07 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.435 2.09 . . . . 0.0 113.246 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 21.6 Cg_exo -65.24 100.22 0.37 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.008 1.805 . . . . 0.0 112.112 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.21 149.25 40.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.994 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -95.37 -18.03 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.858 2.372 . . . . 0.0 112.433 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -136.94 130.34 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.524 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.652 ' O ' HG23 ' A' ' 156' ' ' VAL . 9.2 tp -56.78 -41.92 78.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.139 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.43 -38.01 88.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -58.66 -49.21 78.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -61.16 -39.32 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 152' ' ' LEU . 57.7 t -52.46 -37.66 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.728 0.299 . . . . 0.0 111.399 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.39 86.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.495 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.85 -22.69 55.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.158 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 163' ' ' ASP . 2.0 pp -108.65 43.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -16.8 -58.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.342 0.657 . . . . 0.0 112.535 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.38 10.06 0.43 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.757 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -80.87 -82.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.247 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.757 ' H ' HG13 ' A' ' 162' ' ' VAL . 2.0 p-10 -100.51 92.7 5.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.796 0.331 . . . . 0.0 110.783 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.532 ' HA ' HD13 ' A' ' 159' ' ' LEU . 0.6 OUTLIER -65.42 130.7 44.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.736 -178.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.617 HG12 HD12 ' A' ' 155' ' ' ILE . 27.0 m -59.98 -171.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.26 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.92 HD23 ' H ' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.76 156.05 41.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.51 -7.81 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.609 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.58 -40.12 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.892 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.92 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 89.88 -178.82 43.95 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.484 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 14.7 p-10 -70.73 -159.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.515 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 39.6 m -136.78 -59.66 0.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.262 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.732 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -135.85 -116.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.387 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.474 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 58.4 m-20 -86.13 150.63 24.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -15.07 62.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 6.2 pt-20 -153.07 160.6 30.75 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.668 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 177' ' ' SER . 66.0 Cg_endo -95.27 -139.56 0.13 OUTLIER 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.249 -1.146 . . . . 0.0 112.648 0.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 7.6 t -154.01 146.54 24.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.742 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 69.5 m -101.19 142.96 31.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.122 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.11 97.1 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.714 HG12 ' HA ' ' A' ' 189' ' ' VAL . 25.3 mt -109.94 131.58 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.211 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.637 ' HB3' ' HE ' ' A' ' 188' ' ' ARG . 0.2 OUTLIER -108.43 65.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.004 0.43 . . . . 0.0 110.571 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.76 ' HB3' HG23 ' A' ' 98' ' ' VAL . 19.0 tp -69.29 89.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -78.41 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 0.0 110.858 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -128.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 2.1 t-20 -59.68 -52.23 75.43 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.0 Cg_exo -76.92 108.9 2.74 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.497 2.131 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 94.1 Cg_endo -80.72 134.23 9.64 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.519 2.146 . . . . 0.0 112.037 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.637 ' HE ' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -96.31 45.91 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.274 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.714 ' HA ' HG12 ' A' ' 180' ' ' ILE . 20.2 t -56.63 103.81 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.21 93.26 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.452 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -85.07 149.54 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.769 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.03 47.51 1.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.038 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.19 162.47 46.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.426 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -98.06 -77.73 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.752 0.31 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -89.97 -162.02 37.97 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.485 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.458 ' HG2' HD23 ' A' ' 197' ' ' LEU . 49.7 Cg_endo -68.59 -43.3 4.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.583 2.189 . . . . 0.0 112.346 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.458 HD23 ' HG2' ' A' ' 196' ' ' PRO . 0.9 OUTLIER -151.24 171.22 17.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 7.4 p-10 -64.51 130.64 94.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.929 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 51.6 Cg_exo -54.63 106.24 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.513 2.142 . . . . 0.0 112.202 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.5 t -57.75 115.88 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.065 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.72 53.87 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.9 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -33.63 75.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.886 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.42 -11.66 34.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.78 18.46 20.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -80.91 -179.05 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.062 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 127.06 124.75 2.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.594 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -109.63 17.12 21.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.744 0.307 . . . . 0.0 110.866 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.098 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mmt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.834 0.35 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.21 -177.09 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.989 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mt -102.39 141.07 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.082 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.1 -170.76 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -87.48 156.19 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.897 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 tt -98.3 143.47 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.11 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -72.87 -177.25 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.969 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.539 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -73.06 149.28 43.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.055 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 -67.84 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.642 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 15.1 m120 -81.96 -51.08 0.82 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.454 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 10' ' ' ASN . 46.0 Cg_exo -56.52 125.02 17.67 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.192 1.928 . . . . 0.0 112.174 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.1 p -155.83 148.84 18.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.968 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HG2' HD23 ' A' ' 16' ' ' LEU . 53.0 Cg_exo -55.96 166.66 2.86 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.558 2.172 . . . . 0.0 112.215 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -69.81 -42.45 73.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.028 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -67.75 -25.22 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -70.98 -52.21 21.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.086 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.637 ' HA ' HD12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -69.19 -14.53 63.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.564 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.25 -34.72 59.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.564 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.12 -42.98 55.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.776 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -75.55 -20.22 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.734 0.302 . . . . 0.0 111.274 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.423 ' N ' HD13 ' A' ' 20' ' ' ILE . 46.0 t -70.35 -48.5 56.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 164' ' ' LEU . 11.3 p -69.52 -28.16 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.128 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 21.9 mtt -62.47 -38.57 90.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.064 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -70.29 -20.54 63.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.82 5.05 62.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.29 38.92 94.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.91 168.51 15.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.504 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.718 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.45 148.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.434 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.718 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -119.1 146.94 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -114.78 164.85 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.272 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.518 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -172.91 103.42 0.32 Allowed Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.79 137.03 12.38 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.769 2.312 . . . . 0.0 111.408 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.82 -151.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.738 0.304 . . . . 0.0 111.161 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -54.87 -20.95 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.606 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.82 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -100.1 -114.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.126 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.85 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.0 OUTLIER -112.55 -163.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.353 . . . . 0.0 110.995 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.86 131.38 47.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.586 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.88 174.68 15.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.067 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HB2' HG23 ' A' ' 139' ' ' THR . 2.5 mt -133.25 138.52 46.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.821 0.343 . . . . 0.0 111.132 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.1 121.16 1.48 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.836 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 136' ' ' VAL . 5.3 p -159.76 163.97 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.712 0.292 . . . . 0.0 111.221 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.718 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -55.25 102.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.01 0.434 . . . . 0.0 110.944 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.74 81.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.938 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.561 HD21 ' HZ ' ' A' ' 77' ' ' PHE . 4.3 mm? -76.26 12.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.306 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.46 150.46 28.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -19.53 60.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.77 -30.0 70.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.1 -22.89 57.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.22 -54.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -63.88 -40.25 96.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 8.2 mmt180 -64.18 -38.86 92.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -68.16 -18.4 64.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.798 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -36.76 62.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.2 -40.69 90.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 144' ' ' SER . 37.7 t -73.89 -52.96 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -79.38 -76.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.902 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 17.27 32.9 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.697 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -68.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.349 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB3' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -136.78 76.26 47.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.852 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.11 27.21 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 0.0 112.597 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' ' 59' ' ' SER . 23.7 p80 -105.28 -21.91 13.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.958 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -73.33 154.3 90.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.973 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 116' ' ' ARG . 75.6 Cg_exo -50.62 154.88 5.96 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.597 2.198 . . . . 0.0 112.46 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.635 HG21 HG22 ' A' ' 110' ' ' ILE . 4.3 m -114.54 151.31 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -96.48 136.61 36.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.689 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 14.4 pt -116.27 172.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.27 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 12.5 t -117.87 135.57 54.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.974 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.754 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.1 p -146.24 174.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.604 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.593 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.47 -47.63 15.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.992 0.425 . . . . 0.0 110.462 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.17 176.3 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.449 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.586 HG11 ' HG3' ' A' ' 85' ' ' MET . 2.8 t -59.13 -33.74 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.764 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -67.54 -27.65 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.156 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.664 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 1.2 mp0 -80.43 -17.21 52.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.217 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.685 HG13 ' HB3' ' A' ' 77' ' ' PHE . 21.5 tt -114.65 50.71 0.59 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.664 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 37.4 Cg_exo -59.07 -84.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.046 1.83 . . . . 0.0 113.182 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.42 12.27 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -177.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.685 ' HB3' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -107.77 -17.03 14.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.969 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.656 ' HB2' HG12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.5 177.22 7.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.889 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 12.4 mtp180 -129.81 85.43 58.05 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -101.96 -175.29 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.059 2.506 . . . . 0.0 112.853 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 85' ' ' MET . 1.3 m -140.4 179.9 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.878 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.25 -74.0 0.92 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.39 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.047 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.586 ' HG3' HG11 ' A' ' 71' ' ' VAL . 9.6 mmt -70.64 -16.32 62.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.169 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 41.3 mm-40 -64.89 -50.47 66.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.595 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.94 -35.98 80.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.6 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 182' ' ' LEU . 36.3 mmm -65.6 -45.43 83.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.279 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.94 -16.89 62.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 111.117 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -39.1 63.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.38 40.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.798 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 4.8 tt -129.54 137.91 31.97 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.67 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 96.8 Cg_endo -78.45 -161.66 2.76 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.351 -0.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.98 167.06 16.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.928 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.82 ' HB2' HG23 ' A' ' 35' ' ' THR . 92.2 Cg_endo -79.85 44.35 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.919 2.412 . . . . 0.0 112.359 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 10.6 p90 -112.19 141.24 46.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 m -102.55 112.51 25.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 180' ' ' ILE . 3.5 p -108.39 123.98 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.0 111.672 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 21.3 t -102.45 129.42 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.941 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.64 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 0.8 OUTLIER -126.88 177.17 6.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.802 -178.365 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.64 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 10.0 mt-10 -74.09 172.94 10.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.672 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -119.71 143.56 47.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.409 . . . . 0.0 111.477 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.475 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 1.5 t-20 -74.13 -164.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.481 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.39 56.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.518 HD22 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -74.15 136.2 42.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.61 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.6 mt -80.16 -51.39 1.09 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.457 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 40.4 Cg_exo -57.75 103.35 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.328 2.019 . . . . 0.0 112.418 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.78 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 109' ' ' VAL . 2.2 m -76.21 -17.39 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.635 HG22 HG21 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -113.2 -32.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.104 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 107' ' ' PRO . 5.7 p -74.41 -26.79 60.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.5 -163.56 54.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.61 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.15 -3.06 80.87 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.483 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.9 m -114.68 171.32 7.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.449 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 33.5 p -103.87 59.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.61 ' HG2' ' HA ' ' A' ' 101' ' ' GLU . 9.6 mtm105 -152.31 149.1 28.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.022 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 102' ' ' ARG . 77.7 t -139.8 131.81 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.589 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -78.68 167.6 53.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -147.04 162.48 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttt85 -149.14 125.62 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 111.463 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.03 77.79 1.52 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.706 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.75 ' HB2' HG21 ' A' ' 33' ' ' THR . 73.2 Cg_endo -75.34 -178.65 4.39 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.478 2.118 . . . . 0.0 112.605 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.28 -4.02 58.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 0.3 OUTLIER -62.8 99.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 45.3 mt-10 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.08 -50.16 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.955 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -61.22 -24.57 66.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.819 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 15.9 mtm180 -70.12 -32.56 70.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.148 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -59.61 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 mt -58.92 -49.25 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.567 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.754 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.61 -29.32 69.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.406 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.64 -56.64 16.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 109.909 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HB2' ' H ' ' A' ' 134' ' ' PHE . 2.5 mmt85 -76.44 -88.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.166 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.45 ' H ' ' HB2' ' A' ' 133' ' ' ARG . 27.1 m-85 -76.64 117.56 65.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 21.2 Cg_exo -65.45 152.03 83.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.321 2.014 . . . . 0.0 111.319 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -134.46 169.55 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 111.472 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.668 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.2 m -80.85 138.8 36.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.492 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -136.99 96.54 3.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.277 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -125.72 145.33 50.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.32 117.07 22.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.186 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . -87.53 115.3 24.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -166.77 -37.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.915 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.45 -110.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -177.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -61.85 162.69 8.52 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.92 0.391 . . . . 0.0 111.51 -178.087 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.496 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 73.28 -156.35 51.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.39 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -127.26 60.91 45.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.555 0.217 . . . . 0.0 111.007 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.559 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 36.0 Cg_exo -60.89 -49.12 8.97 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.442 2.095 . . . . 0.0 113.404 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.441 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.1 Cg_exo -65.65 87.75 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.03 1.82 . . . . 0.0 112.175 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -96.62 142.97 25.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.911 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 67.6 Cg_endo -95.74 -16.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.557 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -132.37 121.25 23.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.693 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.582 ' HA ' HD11 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -58.04 -38.7 76.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.195 -179.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -41.48 85.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.0 -38.38 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.839 HD12 HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -71.94 -33.23 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 152' ' ' LEU . 21.6 t -53.42 -47.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.476 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -69.37 -32.45 71.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.861 0.363 . . . . 0.0 110.77 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -21.69 56.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.244 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.833 HD21 HG13 ' A' ' 165' ' ' VAL . 2.6 pp -98.76 43.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 159' ' ' LEU . 13.8 t0 -17.53 -54.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.709 0.63 . . . . 0.0 112.254 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -160.75 11.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.4 p -81.84 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.859 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 162' ' ' VAL . 0.3 OUTLIER -108.24 96.19 6.19 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.743 0.306 . . . . 0.0 111.396 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.717 ' HA ' HD13 ' A' ' 159' ' ' LEU . 1.4 mm? -64.16 139.77 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.676 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.839 HG12 HD12 ' A' ' 155' ' ' ILE . 3.4 m -61.03 -174.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.508 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.72 HD22 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.32 145.6 50.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.739 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.85 -22.49 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.72 -52.79 5.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.138 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.621 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 96.64 -160.34 21.82 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.48 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.07 -163.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.427 ' HB3' ' N ' ' A' ' 34' ' ' ASP . 49.1 t -145.34 -57.4 0.33 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.612 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -126.16 -130.07 0.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.3 OUTLIER -86.16 147.63 26.05 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -177.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.85 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.21 -23.3 66.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 158.84 33.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.684 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.55 ' O ' HG22 ' A' ' 35' ' ' THR . 64.9 Cg_endo -90.95 -149.86 0.35 Allowed 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.024 -1.24 . . . . 0.0 112.663 1.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.1 p -154.67 153.74 31.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.793 HG23 ' HB3' ' A' ' 191' ' ' ARG . 0.3 OUTLIER -99.91 141.58 32.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.0 t -129.05 78.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 189' ' ' VAL . 23.2 mt -101.67 131.32 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.209 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 188' ' ' ARG . 6.9 t70 -108.78 61.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.3 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -70.14 100.15 1.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.333 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 -73.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.813 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 185' ' ' ASN . 23.1 t -120.56 -109.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.028 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -74.63 -52.76 3.56 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.486 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 4.8 Cg_exo -77.68 108.0 2.48 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.496 2.131 . . . . 0.0 112.237 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 98.7 Cg_endo -79.46 131.15 9.34 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 3.8 mmt85 -86.65 53.12 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.973 0.416 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.769 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.93 107.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.12 82.73 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.793 ' HB3' HG23 ' A' ' 178' ' ' THR . 5.3 ptm180 -89.57 142.07 28.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.98 110.1 18.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.023 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -96.2 127.63 9.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.206 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -90.69 -35.77 14.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.746 0.308 . . . . 0.0 111.102 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -79.66 132.22 11.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.611 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.76 -21.44 18.88 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.589 2.193 . . . . 0.0 112.299 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -137.58 -174.77 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.87 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.404 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -62.02 149.02 87.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.56 152.68 15.72 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.536 2.158 . . . . 0.0 112.247 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.26 148.17 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.218 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.54 114.3 27.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.56 -26.52 20.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -77.27 -10.83 59.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.078 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -153.63 123.48 1.42 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.62 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -96.17 153.57 17.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.84 0.353 . . . . 0.0 111.017 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -86.9 53.26 4.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.414 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.89 -44.49 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.032 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.082 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.837 0.351 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 2' ' ' LEU . 4.0 mm? -76.19 -174.27 2.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.928 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.19 131.48 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -89.2 146.47 24.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 175.15 10.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -93.41 143.59 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.007 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.405 ' N ' HG13 ' A' ' 6' ' ' ILE . 30.1 p -69.79 125.89 28.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -69.8 -22.21 63.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -90.75 100.93 13.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.809 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -110.15 89.15 7.93 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 9' ' ' LYS . 34.4 Cg_exo -59.93 103.66 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.545 2.164 . . . . 0.0 112.201 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.75 66.97 74.3 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.756 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' HD22 ' A' ' 16' ' ' LEU . 73.2 Cg_endo -74.22 177.37 8.35 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.545 2.163 . . . . 0.0 112.352 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.05 -28.25 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.625 HG22 ' HB3' ' A' ' 167' ' ' ASP . 82.7 t -57.5 -62.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.18 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.842 HD11 HG12 ' A' ' 126' ' ' ILE . 2.9 mp -60.53 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.366 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.06 -29.61 67.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.482 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.97 -31.9 59.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.329 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.64 56.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.326 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 16' ' ' LEU . 2.2 pp -75.21 -22.05 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 0.0 111.224 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -69.08 -53.15 21.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.4 -28.62 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.4 mtt -57.09 -51.15 70.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.64 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.37 9.15 74.72 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.707 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 39.42 92.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.723 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.56 168.58 13.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.192 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.733 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -96.29 141.28 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.619 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -116.19 110.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.078 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.615 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -100.49 151.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 111.247 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.489 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 1.9 m-85 -154.33 114.12 2.48 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.171 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 68.4 Cg_endo -84.9 139.25 7.31 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.81 2.34 . . . . 0.0 111.391 176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.775 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -119.2 -149.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.708 0.289 . . . . 0.0 111.457 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -54.82 -23.75 19.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.561 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 36' ' ' ILE . 2.1 t -100.48 -114.94 0.17 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.011 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.763 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.71 -166.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.892 0.377 . . . . 0.0 111.592 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.59 138.57 55.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -130.98 168.71 21.86 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.116 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.707 ' HB2' HG23 ' A' ' 139' ' ' THR . 8.3 mp -113.91 143.71 44.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.741 0.305 . . . . 0.0 110.863 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.7 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.13 112.97 0.68 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.679 HG13 HD12 ' A' ' 28' ' ' ILE . 18.6 m -151.52 172.41 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.772 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.87 95.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.233 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HA ' ' CB ' ' A' ' 48' ' ' ALA . . . -57.85 -42.54 84.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.998 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HG ' HD11 ' A' ' 110' ' ' ILE . 2.5 mp -67.38 -29.77 69.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 111.417 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.772 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -86.51 154.24 21.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.026 -177.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -60.58 -12.4 9.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.062 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -60.75 -34.03 73.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 110.262 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -76.28 -49.32 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.493 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 46' ' ' GLU . 8.1 p -59.66 -20.9 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.195 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.07 -57.84 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 179.312 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -63.17 -25.43 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.721 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 64' ' ' VAL . 1.7 mp -63.64 -54.43 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.768 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -54.57 -28.91 49.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.082 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -67.48 -57.26 6.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.605 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 143' ' ' ILE . 69.9 t -75.55 -56.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.5 5.86 11.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.47 -121.85 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.353 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.04 109.24 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.0 111.015 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.619 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -148.25 66.8 9.53 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.82 -7.51 20.86 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.53 2.153 . . . . 0.0 112.306 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 21.7 m-70 -103.79 -19.14 14.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -85.96 132.51 43.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.8 166.22 27.01 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.433 2.089 . . . . 0.0 112.057 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 110' ' ' ILE . 12.1 p -112.97 141.91 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.153 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.74 138.39 32.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 66' ' ' ILE . 1.5 pp -115.99 174.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.545 ' SG ' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -122.23 132.68 54.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.538 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG21 HG23 ' A' ' 74' ' ' ILE . 1.2 p -138.47 179.83 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.731 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.824 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 3.0 t -90.09 -41.8 11.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.63 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.72 170.67 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 74' ' ' ILE . 5.2 t -57.52 -38.54 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.13 -24.45 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.985 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 56.2 mm-40 -76.04 -20.89 57.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.775 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.802 HG23 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.55 61.84 0.9 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.729 178.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.66 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 28.9 Cg_exo -61.94 -79.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.086 1.858 . . . . 0.0 112.226 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -73.25 22.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' A' ' 117' ' ' VAL . 1.1 t80 -100.56 -48.9 4.38 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.954 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 80.7 p -131.38 -179.98 5.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -129.14 101.61 19.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 88.2 Cg_endo -102.4 -172.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.143 2.562 . . . . 0.0 112.634 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.19 -171.86 3.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.14 -82.08 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.629 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 1.1 m-20 -56.43 -26.11 52.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.67 71.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.463 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 27.0 mmt -74.27 -12.89 60.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.75 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 1.8 mt-10 -70.68 -50.28 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.7 tp -63.96 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.833 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.668 ' HB2' HD13 ' A' ' 182' ' ' LEU . 7.9 tpt -75.01 -42.41 57.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.383 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -23.7 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.715 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.1 ptm180 -75.84 -36.21 59.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.472 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.419 HG13 ' HE3' ' A' ' 88' ' ' MET . 3.6 pt -103.61 14.94 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.064 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.486 HD23 ' C ' ' A' ' 88' ' ' MET . 0.3 OUTLIER -130.97 152.77 81.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.823 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.426 ' N ' HD12 ' A' ' 92' ' ' LEU . 71.6 Cg_endo -78.17 -174.38 14.66 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.563 -1.432 . . . . 0.0 112.67 0.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.61 -174.63 32.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.491 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 96.0 Cg_endo -79.87 39.29 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.597 2.198 . . . . 0.0 112.29 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.13 160.92 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.784 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 27.2 m -107.54 131.05 54.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.29 107.34 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.852 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 5.5 t -102.89 131.02 52.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD11 ' HE3' ' A' ' 85' ' ' MET . 3.1 mm? -126.75 177.95 6.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.469 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 177.03 6.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.847 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -119.65 141.09 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.189 0.518 . . . . 0.0 111.429 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -74.8 -167.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.426 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -76.91 37.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.506 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -69.27 116.47 9.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.909 0.385 . . . . 0.0 110.786 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.521 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 25.5 mm -63.55 -48.55 80.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.159 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.5 Cg_exo -49.63 108.9 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.092 1.862 . . . . 0.0 112.483 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -2.62 48.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.858 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.728 HG13 HG13 ' A' ' 110' ' ' ILE . 10.5 p -71.78 -27.03 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.73 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.728 HG13 HG13 ' A' ' 109' ' ' VAL . 4.4 mt -101.2 -35.6 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.686 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.653 HG23 ' HG2' ' A' ' 102' ' ' ARG . 2.0 m -73.88 -30.69 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.81 -143.01 27.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.357 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -89.98 -18.29 51.1 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.529 ' O ' HG22 ' A' ' 111' ' ' THR . 22.1 m -106.61 -172.08 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.704 0.288 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.2 m -113.12 42.44 1.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 116' ' ' ARG . 5.7 mtm-85 -136.63 156.36 48.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 102' ' ' ARG . 62.0 t -140.15 145.52 26.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.558 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -99.2 159.18 20.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.227 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.61 HD13 HD13 ' A' ' 74' ' ' ILE . 9.3 mt -142.57 159.89 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.406 ' N ' HG22 ' A' ' 119' ' ' ILE . 7.0 ttp85 -151.12 124.7 9.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 111.151 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.48 87.96 7.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.71 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.775 ' HB2' HG21 ' A' ' 33' ' ' THR . 60.2 Cg_endo -72.25 -179.97 4.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.409 2.072 . . . . 0.0 112.47 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.52 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -93.0 17.92 9.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.182 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 109.77 15.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.01 -47.01 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.106 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.842 HG12 HD11 ' A' ' 16' ' ' LEU . 2.2 mp -64.39 -52.08 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 95.8 m -59.32 -16.15 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 69' ' ' SER . 31.7 ttt180 -74.94 -46.98 31.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.409 HH21 HG12 ' A' ' 130' ' ' ILE . 5.7 ttp180 -66.89 -48.88 67.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.388 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.409 HG12 HH21 ' A' ' 129' ' ' ARG . 37.9 mt -61.23 -55.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.192 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.53 -26.42 67.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.228 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.7 -57.1 12.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -76.0 -87.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.072 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.9 124.7 87.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 151.63 59.57 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.341 2.027 . . . . 0.0 111.879 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.545 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.6 t -131.42 157.71 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.046 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.7 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.4 OUTLIER -80.75 136.64 36.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.071 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.505 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . . . -129.27 98.39 4.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 111.349 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -128.21 105.13 8.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.623 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.853 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 78.5 p -61.71 128.56 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -79.35 132.92 36.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.842 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -162.17 -43.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.362 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.599 HD12 HG12 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -72.87 -117.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.388 -178.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 m -62.26 172.63 1.4 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.011 0.434 . . . . 0.0 111.397 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.491 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 82.96 -155.06 32.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.532 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.38 67.55 47.31 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.697 0.284 . . . . 0.0 110.852 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 37.7 Cg_exo -60.82 -47.69 12.56 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.557 2.171 . . . . 0.0 113.484 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 57.1 Cg_endo -69.94 97.68 0.66 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.804 1.669 . . . . 0.0 112.198 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.432 ' HB3' HD11 ' A' ' 155' ' ' ILE . 1.4 m -89.75 135.19 30.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 94.1 Cg_endo -95.2 -43.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.752 2.301 . . . . 0.0 112.718 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.688 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 4.2 ttt180 -131.69 137.47 48.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.695 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.686 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -61.01 -40.67 94.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -19.93 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.688 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 3.7 tm-20 -67.29 -40.98 86.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.657 HD12 HG23 ' A' ' 165' ' ' VAL . 5.4 mt -70.06 -48.46 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.346 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.76 -31.02 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.318 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ttt180 -75.36 -52.95 9.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.113 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.741 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -60.07 -38.62 83.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.179 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.7 mm? -109.29 73.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -37.19 -39.83 0.29 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.25 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.84 11.88 0.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.606 0.241 . . . . 0.0 111.597 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 5.3 t -80.67 -81.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.733 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -104.34 99.39 9.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.353 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.502 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -73.68 127.87 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -178.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.841 HG22 ' H ' ' A' ' 166' ' ' LEU . 3.5 p -65.19 -163.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.841 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.68 143.55 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.976 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.625 ' HB3' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -92.31 -14.96 28.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.489 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.24 -41.73 16.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.425 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.56 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 93.53 -167.67 28.8 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.163 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 3.0 p30 -73.1 -165.11 0.21 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.75 0.31 . . . . 0.0 111.022 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -61.4 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.724 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.69 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -126.33 -132.57 0.25 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.511 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 3.8 t70 -86.88 165.16 16.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.87 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.763 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.8 ttp -70.33 -8.96 54.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.839 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.14 162.17 36.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' A' ' 177' ' ' SER . 66.4 Cg_endo -97.5 -148.97 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.71 1.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -155.27 110.31 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 191' ' ' ARG . 95.6 m -101.46 138.72 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.198 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.784 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.0 t -129.24 109.24 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.746 HG23 ' HA ' ' A' ' 189' ' ' VAL . 4.5 mt -117.84 137.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.852 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.2 m-20 -108.0 67.44 0.68 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -69.5 83.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.354 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.25 -83.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.523 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.96 -100.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.282 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -83.9 -51.82 0.6 Allowed Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -73.84 110.4 3.07 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.125 1.883 . . . . 0.0 112.259 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.5 Cg_endo -82.15 118.1 2.94 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.707 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -86.94 49.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.746 ' HA ' HG23 ' A' ' 180' ' ' ILE . 6.6 t -56.6 104.01 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.012 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.03 77.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.017 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.518 ' HB3' HG23 ' A' ' 178' ' ' THR . 3.0 ptp180 -83.81 131.66 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -83.09 -47.61 11.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -98.11 133.48 11.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.322 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -90.36 171.5 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.426 . . . . 0.0 110.98 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -87.05 -70.0 1.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.25 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.39 -166.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.67 2.247 . . . . 0.0 112.105 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.66 145.52 27.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.073 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.401 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 2.1 m-20 -68.7 -49.88 26.84 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.487 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 198' ' ' ASP . 77.5 Cg_exo -51.35 132.66 40.4 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.325 2.017 . . . . 0.0 112.532 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.13 134.28 30.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.018 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.09 61.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.0 tp -67.2 -37.01 82.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.79 170.22 9.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.47 -138.65 5.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.533 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.47 99.28 10.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.757 0.313 . . . . 0.0 111.052 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -144.48 12.79 2.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.442 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.6 14.07 16.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 0.0 110.972 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.098 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.846 0.355 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.643 ' H ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -110.06 -171.31 1.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 mm -102.25 132.54 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 4' ' ' ARG . 3.1 mtp180 -81.49 139.73 34.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.56 ' HG3' ' H ' ' A' ' 8' ' ' ARG . 2.5 ptpt -73.07 177.85 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 pt -83.24 -29.72 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.7 -67.2 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.054 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.56 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -101.02 89.52 3.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -71.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -110.08 111.29 58.32 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.811 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HG2' ' H ' ' A' ' 12' ' ' SER . 41.1 Cg_endo -68.11 -70.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.469 2.113 . . . . 0.0 112.386 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -157.52 146.88 15.02 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.843 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.11 160.59 7.95 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.545 2.163 . . . . 0.0 112.275 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -40.26 84.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 12.3 t -66.9 -34.01 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.014 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.95 -46.63 67.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -61.5 -21.55 64.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.161 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -75.18 -36.68 61.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.632 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.21 80.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.78 -32.26 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -59.99 -38.73 83.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.78 HG21 HD22 ' A' ' 164' ' ' LEU . 7.4 t -67.82 -34.68 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.0 mmt -56.06 -40.87 74.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.96 -23.14 58.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.21 -2.35 74.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.507 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.67 57.91 10.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.99 163.18 22.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.491 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.718 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.2 tp -96.21 143.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.772 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.541 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.44 120.32 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.543 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.6 OUTLIER -101.58 149.96 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 0.0 110.981 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 1.5 m-85 -153.18 100.08 2.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.005 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.509 ' HG3' ' CD2' ' A' ' 37' ' ' TYR . 2.5 Cg_endo -78.53 134.0 12.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.824 2.349 . . . . 0.0 110.791 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 93.9 m -138.35 -85.44 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 3.0 m-20 -74.46 -72.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.561 -177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.509 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -77.72 -86.89 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.047 -177.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.682 HG23 ' N ' ' A' ' 37' ' ' TYR . 3.9 tp -133.33 -155.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.672 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.682 ' N ' HG23 ' A' ' 36' ' ' ILE . 8.9 m-85 -63.27 131.5 48.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.37 172.85 14.42 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.177 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -118.2 135.85 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.96 0.41 . . . . 0.0 111.113 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.76 114.44 0.72 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.769 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.5 p -158.12 175.88 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -56.35 118.55 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.592 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.433 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.85 -56.24 24.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.03 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.6 mm? -82.29 37.52 0.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.926 0.393 . . . . 0.0 111.45 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.651 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.14 153.98 24.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.861 178.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -71.5 -29.16 64.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.833 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.04 -33.35 75.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.02 -35.99 74.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.78 -44.03 89.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.036 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -66.12 -43.11 88.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HA ' HH11 ' A' ' 51' ' ' ARG . 7.2 mmt-85 -70.96 -24.71 62.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.61 HD11 HG23 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -71.83 -44.99 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.985 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -20.47 62.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.41 -49.77 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.621 ' HA ' HD13 ' A' ' 143' ' ' ILE . 48.0 t -75.55 -40.36 41.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.439 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.95 -12.23 59.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.94 -108.0 2.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.533 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -118.19 90.6 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.049 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 m -153.79 70.7 6.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.12 14.98 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.566 2.177 . . . . 0.0 112.594 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -121.06 -19.02 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.951 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -84.26 131.68 49.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 32.1 Cg_exo -60.01 175.34 1.01 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.555 2.17 . . . . 0.0 112.247 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.61 HG23 HD11 ' A' ' 52' ' ' LEU . 10.0 p -112.98 152.07 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 4.8 t -93.93 129.0 40.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 67' ' ' CYS . 9.5 mm -107.98 161.51 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.861 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 51.4 t -122.23 127.44 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.865 HG21 HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -140.84 177.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.575 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.703 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -87.18 -41.76 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 110.462 179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.42 170.57 15.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.799 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.826 HG11 ' HG3' ' A' ' 85' ' ' MET . 5.1 t -59.03 -33.07 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -24.91 66.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.668 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.703 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 73.5 mm-40 -78.06 -21.04 51.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.66 56.52 0.69 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.652 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -58.68 -85.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.033 1.822 . . . . 0.0 112.11 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 18.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.59 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.472 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 25.2 m-85 -92.34 -34.42 14.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.76 0.315 . . . . 0.0 110.958 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 57.1 p -135.37 -178.14 4.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.837 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.835 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 6.5 mmt180 -114.1 83.76 8.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.667 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 76.4 Cg_endo -102.46 178.46 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.111 2.541 . . . . 0.0 113.036 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 3.0 m -129.93 179.43 5.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.19 -78.63 0.63 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.762 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -55.08 -31.39 61.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -60.73 -41.14 94.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.826 ' HG3' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -69.97 -25.95 63.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.279 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.3 mm-40 -57.99 -56.09 26.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.418 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -55.04 -39.23 68.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.896 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.557 ' SD ' HG21 ' A' ' 98' ' ' VAL . 3.9 tpt -66.69 -41.34 88.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.343 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.23 -7.72 44.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.265 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.95 -37.92 61.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 pt -115.06 48.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 121' ' ' VAL . 4.1 tp -131.21 138.52 33.04 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.513 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 97.0 Cg_endo -78.51 -162.95 3.14 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.481 -0.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.52 164.68 13.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.376 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.14 30.76 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.586 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -100.99 132.99 46.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.905 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -101.61 120.54 40.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.427 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' A' ' 180' ' ' ILE . 2.4 m -110.36 135.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 0.0 111.681 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -101.76 130.19 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.283 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -126.78 -179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.744 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.835 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 2.1 tt0 -74.27 175.71 7.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.508 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.628 HH11 HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -119.24 144.77 46.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.417 . . . . 0.0 111.325 -179.306 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 105' ' ' LEU . 5.8 p30 -74.34 -159.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.936 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 27.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.563 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.436 ' HG ' ' HG2' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -69.45 113.47 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.2 mt -68.58 -49.45 29.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.89 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 7.5 Cg_endo -49.93 110.08 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.444 2.096 . . . . 0.0 112.459 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.414 ' HA ' HG22 ' A' ' 111' ' ' THR . 3.9 m-20 -76.15 -5.06 44.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.872 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.77 -24.68 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.686 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.605 ' O ' HG12 ' A' ' 64' ' ' VAL . 26.0 mm -95.18 -51.71 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.168 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.628 HG21 HH11 ' A' ' 102' ' ' ARG . 11.7 t -77.93 -0.64 28.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.51 -160.17 51.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.588 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.37 83.89 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.473 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 m -113.82 -171.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.496 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 55.2 m -105.26 47.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -137.05 155.74 49.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.0 0.428 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 102' ' ' ARG . 67.1 t -139.72 138.8 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.458 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -90.66 152.25 21.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.841 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.593 HD13 HD13 ' A' ' 74' ' ' ILE . 42.9 mt -147.68 142.85 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.582 ' HB3' HG23 ' A' ' 97' ' ' THR . 0.0 OUTLIER -148.76 137.94 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.943 0.401 . . . . 0.0 111.21 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 92' ' ' LEU . 6.8 t -110.21 98.09 33.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.025 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.19 -179.1 4.92 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.459 2.106 . . . . 0.0 112.568 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.23 14.01 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 1.5 t0 -76.14 106.09 7.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -52.71 64.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.235 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.2 -49.07 84.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -62.53 -23.66 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.891 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -67.04 -35.11 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.786 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -53.74 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 mt -60.58 -54.75 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.307 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.745 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -58.32 -28.73 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.376 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.8 -55.27 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 109.904 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 133' ' ' ARG . 1.6 mtm180 -75.48 -89.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.02 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.97 134.35 68.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.784 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.97 152.59 76.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.379 2.053 . . . . 0.0 111.811 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.3 153.61 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.204 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.63 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 6.8 m -80.68 137.55 36.32 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.861 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -133.91 108.47 8.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.707 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.91 136.04 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -79.43 113.88 17.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -85.97 88.12 7.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.589 ' HB3' HG21 ' A' ' 36' ' ' ILE . 4.8 p-10 -154.15 25.54 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' A' ' 55' ' ' VAL . 2.9 pt -77.96 -157.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.434 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.9 OUTLIER -55.06 160.22 2.14 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.065 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.442 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 85.65 -144.67 20.6 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.285 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 33.2 tttt -127.46 63.47 59.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.487 0.184 . . . . 0.0 111.279 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 41.9 Cg_exo -60.49 -47.79 13.09 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.336 2.024 . . . . 0.0 113.352 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 74.0 Cg_endo -74.81 115.81 4.41 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 112.358 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.4 152.69 38.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -95.86 -14.51 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.83 2.353 . . . . 0.0 113.004 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.1 mmt180 -135.88 136.88 40.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.856 0.36 . . . . 0.0 111.109 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' HG11 ' A' ' 165' ' ' VAL . 8.3 mt -65.3 -45.16 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.907 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -27.0 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.145 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -37.42 86.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.146 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.464 ' HB ' ' CG1' ' A' ' 165' ' ' VAL . 1.1 mt -72.7 -34.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.154 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 152' ' ' LEU . 16.0 t -64.17 -30.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.813 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -75.5 -53.02 9.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.444 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.41 -45.85 68.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.814 HD12 ' HB ' ' A' ' 162' ' ' VAL . 0.8 OUTLIER -90.83 64.22 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -37.05 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.186 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -171.51 16.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.814 ' HB ' HD12 ' A' ' 159' ' ' LEU . 47.1 t -80.78 -91.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.718 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -98.41 95.85 7.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.403 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.78 HD22 HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -60.46 138.65 57.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.79 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 152' ' ' LEU . 26.9 m -65.04 -169.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 169' ' ' GLY . 1.0 OUTLIER -125.84 135.76 52.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.211 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -2.16 54.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.01 -33.61 24.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.349 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.439 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 102.24 130.18 6.92 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.505 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 4.8 p-10 -73.41 -175.97 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.674 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.7 OUTLIER -136.72 -171.49 2.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.643 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.86 38.65 1.34 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 1.4 m-20 -85.08 56.89 4.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.111 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -54.43 173.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.377 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.921 ' H ' ' HA ' ' A' ' 176' ' ' PRO . 2.1 tp10 -160.12 -47.77 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.921 ' HA ' ' H ' ' A' ' 175' ' ' GLU . 89.6 Cg_endo -83.45 -52.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.358 1.048 0 C-N-CA 124.653 -0.978 . . . . 0.0 113.495 3.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.96 144.82 22.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.664 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 96' ' ' TYR . 53.0 m -102.41 150.39 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.464 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.6 86.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.343 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.722 ' HB ' HG12 ' A' ' 98' ' ' VAL . 10.3 mt -100.71 131.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.654 ' HB3' ' HG3' ' A' ' 188' ' ' ARG . 7.3 t0 -98.84 64.53 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.953 0.406 . . . . 0.0 110.685 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.3 tt -70.2 75.68 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.419 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.56 -79.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.444 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.779 HG13 ' H ' ' A' ' 185' ' ' ASN . 1.7 p -120.42 -95.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.546 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.779 ' H ' HG13 ' A' ' 184' ' ' VAL . 2.2 t-20 -90.47 -51.31 0.33 Allowed Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 18.3 Cg_exo -67.52 107.26 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.571 2.18 . . . . 0.0 112.314 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 87.7 Cg_endo -84.55 116.51 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.683 2.255 . . . . 0.0 112.477 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.654 ' HG3' ' HB3' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -91.96 67.9 5.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.06 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.56 HG13 HG12 ' A' ' 180' ' ' ILE . 2.5 t -63.71 112.77 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.3 94.08 2.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -83.99 147.18 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -85.07 53.92 2.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -97.01 125.19 8.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.59 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.96 -10.68 17.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -76.01 -167.78 24.56 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.473 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.1 -176.85 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.596 2.197 . . . . 0.0 112.171 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.4 9.5 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.976 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -78.96 138.3 57.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 202' ' ' LEU . 53.0 Cg_endo -69.45 -141.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.471 2.114 . . . . 0.0 112.227 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.429 ' H ' ' HB2' ' A' ' 199' ' ' PRO . 4.6 t -63.76 -97.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.173 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.38 67.06 0.7 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.805 0.336 . . . . 0.0 111.154 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.645 ' HB2' ' HG2' ' A' ' 199' ' ' PRO . 18.0 tp -95.14 149.79 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.918 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.08 111.15 19.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -179.16 79.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.512 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -100.88 -177.14 3.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 111.078 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 169.18 -28.09 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.433 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -102.91 -26.02 13.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.011 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.805 0.336 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.99 -172.24 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mt -89.73 -101.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.978 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -75.25 128.61 35.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.0 -175.56 1.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -92.38 144.45 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.018 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -70.13 121.53 17.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.72 140.81 48.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.68 -74.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.01 101.3 44.11 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.933 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.56 56.69 6.18 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.523 2.149 . . . . 0.0 112.434 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.15 71.3 4.56 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.827 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 26.1 Cg_exo -63.3 140.94 79.83 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.662 2.241 . . . . 0.0 112.374 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -54.52 6.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.414 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.6 HG11 HD13 ' A' ' 126' ' ' ILE . 41.8 t -64.39 -45.95 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.607 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.7 mm? -58.94 -50.77 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.124 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -55.07 -27.57 45.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.839 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 1.8 mt-10 -75.82 -43.75 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.59 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.13 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.9 mm -67.41 -22.35 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 3.6 t -65.16 -58.9 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 164' ' ' LEU . 14.6 p -62.41 -29.65 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 mtt -64.57 -28.52 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.35 13.89 62.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.522 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.05 58.92 9.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.84 162.35 19.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.697 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.4 tp -95.05 140.0 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.721 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.61 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.39 131.99 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.571 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.551 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -102.28 163.2 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.679 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -168.33 102.44 0.54 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.761 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.686 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 92.6 Cg_endo -84.27 155.47 12.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.745 2.297 . . . . 0.0 112.121 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.458 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 40.8 p -131.51 -155.28 0.68 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.553 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -55.34 -19.03 7.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.715 0.293 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -97.61 -118.64 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.795 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' H ' ' HB ' ' A' ' 35' ' ' THR . 1.1 tt -111.94 -174.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 110.827 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.686 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -63.24 134.64 56.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.94 178.9 17.76 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.119 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 4.4 mt -133.25 138.01 46.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.174 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.46 122.61 1.73 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.609 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.7 p -159.77 177.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.723 0.296 . . . . 0.0 111.281 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.655 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 1.9 m120 -56.13 106.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.976 0.417 . . . . 0.0 110.669 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.14 -49.73 76.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.091 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -80.29 27.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.944 0.402 . . . . 0.0 111.748 -178.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 147.77 34.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.815 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -73.32 -24.78 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 110.593 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -58.37 -30.14 66.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.809 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -65.88 -30.37 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 t -71.15 -46.07 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 50' ' ' ARG . 9.9 mtm180 -65.15 -41.13 95.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.682 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mpt_? -67.01 -53.87 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.077 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -54.56 -25.76 27.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -73.76 -52.98 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 54' ' ' ARG . 6.6 mmp_? -55.49 -35.88 66.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 HG23 ' A' ' 143' ' ' ILE . 54.5 t -70.68 -58.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -72.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.41 17.0 30.71 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.31 -16.16 9.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 110.93 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -140.05 67.65 33.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 -4.59 15.41 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.551 2.167 . . . . 0.0 112.213 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.91 -4.46 17.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 0.0 OUTLIER -86.43 145.36 39.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.993 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HD2' ' HD2' ' A' ' 62' ' ' LYS . 24.2 Cg_endo -60.82 156.98 40.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.673 2.249 . . . . 0.0 112.147 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 110' ' ' ILE . 11.9 p -112.59 147.26 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -94.18 145.03 25.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.2 161.83 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.819 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 10.8 t -111.73 131.55 55.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 0.8 OUTLIER -137.74 170.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.803 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 4.1 t -86.47 -39.4 16.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.489 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.7 t -164.08 174.09 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.56 HG11 ' HG3' ' A' ' 85' ' ' MET . 37.9 t -59.93 -38.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m-20 -67.22 -23.4 65.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.803 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 24.5 mm-40 -80.62 -23.17 39.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.231 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.718 ' HB ' HG21 ' A' ' 68' ' ' VAL . 18.9 tt -114.22 50.66 0.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.029 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 20.8 Cg_endo -61.97 -78.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.099 1.866 . . . . 0.0 113.176 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 9.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CE2' ' HG2' ' A' ' 135' ' ' PRO . 1.8 m-85 -108.21 -13.63 14.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.219 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.657 ' HB2' HD23 ' A' ' 100' ' ' LEU . 60.3 p -135.74 178.11 7.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.622 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.656 ' O ' HD11 ' A' ' 100' ' ' LEU . 3.8 mtp-105 -133.5 62.14 57.89 Favored Pre-proline 0 N--CA 1.464 0.232 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.485 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.626 ' HB3' HD22 ' A' ' 100' ' ' LEU . 65.6 Cg_endo -102.38 173.15 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.784 2.323 . . . . 0.0 113.203 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.5 -177.71 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.53 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.09 4.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.783 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -55.59 -41.28 73.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 0.0 111.211 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.16 -51.6 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.56 ' HG3' HG11 ' A' ' 71' ' ' VAL . 24.0 mmt -71.74 -7.81 50.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -72.28 -54.58 9.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.342 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -37.49 74.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.695 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.491 ' HG2' HG11 ' A' ' 98' ' ' VAL . 3.4 tpt -73.76 -41.36 62.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.633 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -63.42 -13.82 43.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.05 -31.17 61.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.27 45.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.472 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -131.27 147.09 64.82 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.843 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.37 -172.08 10.76 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.953 -1.269 . . . . 0.0 112.14 -0.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.25 179.93 29.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.582 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 36.8 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.782 2.321 . . . . 0.0 112.279 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.405 ' HD2' HG21 ' A' ' 178' ' ' THR . 13.9 m-85 -106.86 114.42 28.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.474 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 26.0 m -96.99 117.29 30.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -108.83 108.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.517 HG13 ' HA2' ' A' ' 118' ' ' GLY . 7.1 t -84.93 124.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 78' ' ' SER . 0.2 OUTLIER -128.13 162.3 27.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.394 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.606 ' H ' HD12 ' A' ' 100' ' ' LEU . 3.6 mt-10 -59.08 174.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.756 ' HE ' ' HB3' ' A' ' 105' ' ' LEU . 18.8 ttt85 -118.57 159.06 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.151 0.501 . . . . 0.0 111.835 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.417 ' H ' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.13 -162.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.343 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 16.53 0.37 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.836 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.756 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 1.7 tm? -69.83 153.75 42.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.583 0.23 . . . . 0.0 110.459 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.714 HG13 ' H ' ' A' ' 108' ' ' ASP . 1.8 tp -59.54 106.41 0.73 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.629 ' HA ' HG23 ' A' ' 111' ' ' THR . 74.3 Cg_endo -72.25 16.79 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.003 2.469 . . . . 0.0 113.431 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.714 ' H ' HG13 ' A' ' 106' ' ' ILE . 22.4 t0 -61.32 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.76 6.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.615 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.588 ' O ' HG12 ' A' ' 64' ' ' VAL . 10.1 mm -95.95 -59.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.297 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 107' ' ' PRO . 5.9 p -87.5 -31.11 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.014 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 -89.8 0.29 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.19 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.93 -84.01 0.17 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.114 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -103.95 -167.71 1.4 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.558 0.218 . . . . 0.0 110.896 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.7 60.4 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 111.188 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 116' ' ' ARG . 9.5 mtt85 -136.44 143.6 43.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.692 HG21 HH11 ' A' ' 102' ' ' ARG . 90.3 t -140.0 138.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.71 151.82 36.33 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.793 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 118' ' ' GLY . 26.0 mt -149.61 135.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.642 0.258 . . . . 0.0 110.453 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.575 ' HD2' ' HD3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -156.46 149.99 24.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 111.454 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 92' ' ' LEU . 2.3 t -110.87 89.08 8.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.404 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.575 ' HD3' ' HD2' ' A' ' 120' ' ' ARG . 22.7 Cg_endo -61.75 -178.77 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.499 2.133 . . . . 0.0 112.721 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.72 7.46 23.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.3 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 127' ' ' CYS . 7.3 m-20 -80.2 94.86 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.868 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.26 -33.41 67.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.6 HD13 HG11 ' A' ' 15' ' ' VAL . 2.0 mt -69.67 -52.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.725 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -61.34 -13.93 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.754 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.65 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -75.15 -48.06 25.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.89 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -59.65 -54.25 48.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mt -59.03 -49.05 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.064 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.4 -27.68 69.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.42 -56.71 15.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -89.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.747 176.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -77.08 124.88 87.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.818 177.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.528 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 25.9 Cg_exo -64.78 157.72 54.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.283 1.989 . . . . 0.0 111.69 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.3 t -128.94 155.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.651 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 8.0 m -80.51 132.51 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.927 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.23 104.29 7.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 111.548 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -133.22 163.32 29.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 t -81.31 131.22 35.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . -76.78 119.02 19.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.044 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.507 ' H ' HG13 ' A' ' 55' ' ' VAL . 1.2 m120 -163.6 63.06 0.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.656 HG23 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -76.7 179.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.975 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.9 t -62.3 145.23 54.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.53 -125.58 7.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.622 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.81 88.86 50.35 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.595 0.236 . . . . 0.0 110.957 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 142' ' ' ASN . 45.5 Cg_exo -59.99 -47.6 14.84 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.588 2.192 . . . . 0.0 113.228 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 26.1 Cg_exo -62.0 91.24 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.899 1.733 . . . . 0.0 111.931 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.94 148.52 78.96 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -95.48 -15.53 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.994 2.462 . . . . 0.0 112.368 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.48 ' HG2' ' HB2' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -136.53 125.89 24.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.425 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.507 HD21 HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -58.29 -40.8 82.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -20.04 63.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.48 ' HB2' ' HG2' ' A' ' 151' ' ' ARG . 15.2 tt0 -75.12 -28.68 60.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.61 HG22 HD12 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -74.95 -46.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 -179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -60.09 -31.22 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.29 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -74.96 -47.02 31.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.071 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.14 -23.75 60.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.252 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.864 HD13 ' HB3' ' A' ' 163' ' ' ASP . 97.2 mt -111.34 67.13 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -16.19 -63.15 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.077 0.86 . . . . 0.0 112.776 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.18 22.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.005 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.7 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -81.13 -70.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.983 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.864 ' HB3' HD13 ' A' ' 159' ' ' LEU . 38.6 t0 -107.98 96.7 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.578 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.49 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -67.51 135.77 53.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 156' ' ' VAL . 18.8 m -67.4 -164.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.255 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.701 HD22 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.27 161.38 27.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.869 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.439 ' HB3' HG13 ' A' ' 15' ' ' VAL . 15.3 t70 -92.41 -25.08 18.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.59 -57.56 3.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.128 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.419 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 102.05 -161.87 17.33 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.934 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.65 -162.73 0.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.676 0.274 . . . . 0.0 110.915 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.458 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.73 -56.11 0.16 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.705 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -133.46 -133.15 0.17 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -85.89 142.6 28.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.873 0.368 . . . . 0.0 111.963 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 35' ' ' THR . 69.2 mmm -62.4 -25.36 67.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.319 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.4 159.17 42.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.741 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' O ' HG22 ' A' ' 35' ' ' THR . 75.3 Cg_endo -86.79 -149.59 0.44 Allowed 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.694 0.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.98 157.12 38.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -99.45 132.23 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.87 90.33 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.946 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.719 HG12 ' HA ' ' A' ' 189' ' ' VAL . 22.6 mt -108.42 137.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.499 ' H ' ' HB2' ' A' ' 188' ' ' ARG . 0.5 OUTLIER -106.49 67.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.042 178.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 187' ' ' PRO . 31.8 tp -70.28 90.04 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.682 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -79.25 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.447 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.23 -123.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.059 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -62.51 -52.02 68.6 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 80.9 Cg_endo -77.92 108.42 2.53 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.138 1.892 . . . . 0.0 112.645 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.58 ' HB3' HD13 ' A' ' 182' ' ' LEU . 84.6 Cg_endo -83.25 129.65 5.24 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.499 ' HB2' ' H ' ' A' ' 181' ' ' ASP . 9.2 mmt85 -88.68 60.9 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.038 0.447 . . . . 0.0 111.001 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.719 ' HA ' HG12 ' A' ' 180' ' ' ILE . 32.6 t -62.38 92.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.949 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.55 87.04 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -83.56 145.93 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -73.17 97.48 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.722 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -93.78 125.47 8.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.646 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.27 -28.5 12.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.999 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -86.66 114.36 4.06 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.499 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.4 ' HG2' HD23 ' A' ' 197' ' ' LEU . 42.7 Cg_endo -67.72 -12.91 37.07 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.513 2.142 . . . . 0.0 112.363 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 196' ' ' PRO . 0.7 OUTLIER -155.92 171.63 19.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.008 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 19.8 m-20 -76.54 137.1 67.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 24.3 Cg_exo -63.9 -178.16 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.652 2.235 . . . . 0.0 112.235 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 202' ' ' LEU . 46.6 t -68.12 123.28 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.983 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.94 37.41 2.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.531 ' H ' HG12 ' A' ' 200' ' ' VAL . 0.1 OUTLIER -70.72 172.19 9.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -72.05 112.89 8.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -117.18 48.09 0.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.494 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -88.12 34.64 0.74 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.173 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 137.07 127.98 2.65 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.389 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -101.64 -1.07 33.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.841 0.353 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.147 -179.786 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.689 ' HB2' ' HB2' ' A' ' 4' ' ' ARG . 13.6 ptt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.829 0.347 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -107.78 -77.48 0.6 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.28 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.501 ' N ' ' HG ' ' A' ' 2' ' ' LEU . 9.0 tp -84.41 -7.33 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.999 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.689 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 1.0 OUTLIER -84.63 137.12 33.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 177.68 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 tt -95.01 137.27 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -78.85 125.72 29.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.07 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 169.51 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.016 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.04 99.98 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.79 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -99.05 107.26 43.11 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.85 106.14 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.568 2.179 . . . . 0.0 112.323 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.516 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 4.0 m -101.05 -51.09 0.18 Allowed Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.355 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 12' ' ' SER . 52.8 Cg_exo -56.22 151.41 43.76 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.213 1.942 . . . . 0.0 112.287 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.693 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -75.07 -27.72 60.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.48 -49.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 4.1 mm? -66.22 -32.15 73.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.152 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -71.77 -31.3 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -75.54 -38.21 59.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.264 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.566 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.68 -45.44 58.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.8 -30.35 37.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.72 -40.81 88.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.726 HG22 ' HG ' ' A' ' 164' ' ' LEU . 3.3 t -62.82 -31.03 50.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.0 mmt -61.5 -43.88 98.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.38 -23.21 58.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.809 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -19.0 63.8 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.44 36.34 88.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.687 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.74 170.57 14.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.142 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 163' ' ' ASP . 1.5 tp -90.52 136.06 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.597 HG22 HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -116.7 133.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.665 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.517 HG12 ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -101.87 163.01 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.55 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -165.21 101.15 0.79 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.79 -178.616 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.63 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.6 Cg_endo -82.61 144.64 12.67 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.592 2.195 . . . . 0.0 111.601 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.507 HG21 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -121.55 -152.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.717 0.294 . . . . 0.0 111.291 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.593 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -55.05 -21.99 14.29 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.457 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 1.8 t -100.02 -115.0 0.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.78 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -112.34 -172.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.852 0.358 . . . . 0.0 111.173 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.63 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.8 m-85 -63.69 137.9 58.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.926 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -124.02 -176.66 14.77 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.014 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -127.08 140.98 51.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.33 120.83 1.35 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.708 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.634 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.5 p -165.98 177.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.775 0.321 . . . . 0.0 111.65 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.763 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t-20 -56.73 107.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -62.7 -52.09 64.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 33.1 0.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.6 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.763 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 159.69 17.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.833 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.13 -36.7 61.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.791 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 25.0 t70 -58.49 -26.54 63.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.109 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.83 -33.28 62.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.52 -52.69 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -65.01 -45.85 83.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.92 -31.95 63.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -27.9 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -42.91 53.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.529 ' HA ' HD13 ' A' ' 143' ' ' ILE . 48.1 t -74.72 -43.37 47.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.245 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.63 -17.9 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.012 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.93 -95.33 0.19 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -118.06 83.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.63 69.55 15.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.9 11.96 2.6 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.609 2.206 . . . . 0.0 112.526 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.17 -14.93 8.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 1.8 ttmt -88.46 127.01 58.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.156 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 23.4 Cg_exo -65.16 -166.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.692 2.261 . . . . 0.0 112.084 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 p -118.68 135.64 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.138 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 8.6 t -96.24 131.69 42.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.592 HD11 HD11 ' A' ' 74' ' ' ILE . 32.3 pt -116.89 169.93 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.524 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -114.75 137.1 52.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.353 . . . . 0.0 110.603 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.662 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.2 p -145.84 173.91 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.591 ' H ' HG22 ' A' ' 68' ' ' VAL . 21.4 t -80.17 -42.52 23.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.958 0.408 . . . . 0.0 110.371 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.51 20.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 74' ' ' ILE . 15.8 t -57.17 -29.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.943 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.46 -32.68 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.225 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.99 -13.24 59.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.489 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.592 HD11 HD11 ' A' ' 66' ' ' ILE . 6.3 tt -114.16 44.52 0.32 Allowed Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 72.9 Cg_endo -76.39 -46.76 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.726 1.618 . . . . 0.0 112.634 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -72.42 -1.03 14.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.886 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -107.78 -56.07 2.28 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.652 -179.27 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 p -114.55 171.03 7.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.347 . . . . 0.0 111.144 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -121.94 108.18 34.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -102.45 -168.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.221 2.614 . . . . 0.0 113.007 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 3.2 t -138.82 -178.24 5.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.88 -83.72 0.37 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.843 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.797 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.96 -27.78 46.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.111 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.66 -46.43 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 81' ' ' SER . 19.5 mmt -74.92 -11.98 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.797 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -71.17 -48.28 52.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.992 0.425 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 5.0 tp -65.21 -35.99 82.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.79 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.444 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 7.7 tpp -68.41 -44.61 74.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.63 -13.82 61.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 5.7 tpt180 -73.43 -42.11 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.651 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 pt -110.55 43.79 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.041 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.907 HD21 HG21 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -131.2 143.5 49.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.804 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.4 Cg_exo -78.13 -165.14 4.37 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.174 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.81 173.33 23.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.588 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 93.0 Cg_endo -79.82 39.23 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.563 2.175 . . . . 0.0 112.358 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.647 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.3 m-85 -111.98 143.87 42.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.518 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 29.1 m -94.82 135.95 35.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.435 HG11 ' HG2' ' A' ' 88' ' ' MET . 4.9 t -120.29 109.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.429 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.802 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 19.1 t -99.66 135.97 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.276 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.572 ' HB2' HD11 ' A' ' 119' ' ' ILE . 2.4 mm? -126.45 -172.69 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.043 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.04 -165.84 0.43 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.733 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.821 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.13 132.44 56.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.97 0.414 . . . . 0.0 111.106 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 5.9 t30 -74.87 -173.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.15 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 9.27 2.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.483 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HB2' HH12 ' A' ' 102' ' ' ARG . 1.3 mt -69.39 -174.39 0.67 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.711 0.291 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 108' ' ' ASP . 2.8 mt -79.53 107.47 6.55 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.283 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 65.4 Cg_endo -71.65 23.56 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.675 2.25 . . . . 0.0 112.941 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 106' ' ' ILE . 3.7 m-20 -61.55 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.683 0.278 . . . . 0.0 111.2 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 m -90.21 5.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.703 0.287 . . . . 0.0 111.202 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.439 HG21 HH21 ' A' ' 102' ' ' ARG . 4.1 mt -96.4 -35.01 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.4 OUTLIER -87.13 -37.27 17.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.622 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.78 -101.35 0.64 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.347 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.26 -60.42 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.631 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.78 -179.32 3.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.728 0.299 . . . . 0.0 110.906 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.543 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -92.78 70.1 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.995 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -136.75 163.69 30.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.322 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.821 HG23 ' HG2' ' A' ' 102' ' ' ARG . 95.3 t -139.54 125.07 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.377 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.553 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -78.92 152.71 37.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.899 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -144.87 156.06 14.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.653 0.263 . . . . 0.0 110.553 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -148.49 124.82 10.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.261 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.907 HG21 HD21 ' A' ' 92' ' ' LEU . 5.2 t -110.42 86.99 5.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.56 179.77 5.25 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.518 2.146 . . . . 0.0 112.65 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.507 ' H ' HG21 ' A' ' 33' ' ' THR . 0.3 OUTLIER -93.28 5.17 52.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.03 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.87 106.99 7.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.155 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -57.34 -39.44 75.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.771 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 16' ' ' LEU . 45.2 mm -63.1 -54.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.873 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -18.53 60.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -72.27 -36.46 69.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -75.02 -52.53 10.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.239 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' ' 130' ' ' ILE . 17.0 mt -60.0 -53.72 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.662 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.84 -26.93 67.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.277 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -54.63 -56.77 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.018 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -86.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.326 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.78 115.29 46.84 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.68 137.75 46.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.558 2.172 . . . . 0.0 111.602 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 67' ' ' CYS . 27.2 m -114.74 170.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 120.943 0.402 . . . . 0.0 111.737 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.654 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 46.2 m -80.76 139.94 35.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.012 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.66 103.71 4.92 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.287 0.367 . . . . 0.0 111.37 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -130.28 126.31 36.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.7 p -70.93 110.86 5.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -82.1 96.59 7.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -154.25 25.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.041 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 55' ' ' VAL . 10.9 pt -81.16 -154.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.251 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.1 p -59.83 170.39 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.921 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.449 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 75.98 -139.64 24.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.293 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -127.55 62.91 57.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 39.5 Cg_exo -60.53 -50.19 7.36 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.24 1.96 . . . . 0.0 113.178 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 91.0 Cg_endo -78.99 103.05 1.59 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.898 1.732 . . . . 0.0 112.148 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -82.91 145.97 51.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 72.2 Cg_endo -95.53 -11.22 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.916 2.411 . . . . 0.0 111.929 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.93 128.88 14.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.04 -27.36 66.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 156' ' ' VAL . 3.7 tt0 -71.07 -37.89 72.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.171 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -55.73 31.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.323 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 165' ' ' VAL . 0.6 OUTLIER -63.47 -42.98 98.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -53.08 -30.1 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -39.21 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -26.79 57.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.257 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 155' ' ' ILE . 2.0 pp -94.98 46.8 1.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t70 -16.03 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.728 0.643 . . . . 0.0 112.551 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -157.32 10.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.77 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -81.39 -75.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.381 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.77 ' H ' HG13 ' A' ' 162' ' ' VAL . 4.2 t70 -95.79 109.07 21.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.791 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.726 ' HG ' HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -73.85 120.65 19.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.99 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.76 HG22 ' H ' ' A' ' 166' ' ' LEU . 4.3 p -61.72 -179.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.779 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.76 ' H ' HG22 ' A' ' 165' ' ' VAL . 1.3 pt? -125.28 149.28 48.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.828 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.19 -19.61 22.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.289 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.53 -48.0 61.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.945 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 91.56 -168.51 31.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.777 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -163.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.074 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.44 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 44.2 m -140.95 -56.94 0.5 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.48 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -129.43 -130.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.518 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.514 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 33.9 m-20 -86.36 146.29 26.53 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.487 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.78 ' HG2' HG23 ' A' ' 36' ' ' ILE . 3.7 ttp -69.35 0.17 5.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.179 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.81 156.75 30.99 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.631 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 177' ' ' SER . 70.7 Cg_endo -88.71 -140.27 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.921 -1.283 . . . . 0.0 112.576 0.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -153.63 124.77 7.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.623 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 191' ' ' ARG . 34.8 m -101.99 131.69 48.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.45 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.518 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -129.48 109.15 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.707 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.72 HG12 ' HA ' ' A' ' 189' ' ' VAL . 15.1 mt -120.9 137.14 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.474 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.802 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 6.0 t70 -107.99 66.91 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.589 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.444 ' CD2' ' HB2' ' A' ' 88' ' ' MET . 21.9 tp -69.77 88.26 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -79.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.437 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 185' ' ' ASN . 4.8 t -120.64 -121.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.9 t-20 -63.48 -50.59 72.53 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 79.7 Cg_endo -77.87 108.75 2.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.24 1.96 . . . . 0.0 112.566 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.1 Cg_endo -82.44 128.6 5.52 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.558 2.172 . . . . 0.0 112.248 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 17.8 mtp180 -87.58 56.1 3.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.72 ' HA ' HG12 ' A' ' 180' ' ' ILE . 17.9 t -59.97 104.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.423 ' O ' HG23 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -127.75 74.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.682 ' HB3' HG23 ' A' ' 178' ' ' THR . 1.5 ptp85 -89.73 139.58 30.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.941 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.81 89.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -87.2 168.46 38.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.61 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.24 -174.61 2.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.331 . . . . 0.0 110.802 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.91 -66.8 2.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.49 159.85 30.19 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.692 2.262 . . . . 0.0 112.209 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.7 174.21 10.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.35 149.68 97.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.56 143.45 97.01 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.518 2.145 . . . . 0.0 112.271 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.2 m -71.32 -179.94 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.248 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.88 26.03 7.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.984 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.99 172.3 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.58 -56.34 4.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.007 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.29 -127.11 9.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.464 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.49 149.44 45.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.769 0.319 . . . . 0.0 111.063 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -124.76 20.33 6.84 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.559 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.51 18.76 19.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.046 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.824 0.345 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.13 -178.56 6.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.024 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 mm -78.9 131.5 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.941 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -83.97 157.93 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.011 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -75.0 -166.36 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -110.38 -68.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.027 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 p -106.24 -79.15 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.173 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -102.23 175.82 5.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.38 -67.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.014 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 11.9 m120 -94.12 131.17 32.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.017 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 10' ' ' ASN . 33.2 Cg_exo -59.61 -66.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.583 2.189 . . . . 0.0 112.075 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m 55.18 83.89 0.22 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HD2' HD12 ' A' ' 16' ' ' LEU . 45.1 Cg_exo -56.59 149.52 57.72 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.466 2.111 . . . . 0.0 112.233 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.38 -28.74 68.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.066 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.6 t -65.31 -57.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.013 HD11 HG22 ' A' ' 126' ' ' ILE . 13.7 mt -62.01 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 20' ' ' ILE . 3.4 mt-10 -64.15 -23.75 67.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.712 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.5 -32.69 58.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.165 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.27 -44.33 62.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.761 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.608 ' HA ' ' HG2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -75.55 -18.37 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.182 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 t -75.52 -47.95 24.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.352 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.545 HG21 HD23 ' A' ' 164' ' ' LEU . 12.7 p -74.52 -26.93 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.656 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 15.7 ptp -73.97 -31.51 63.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 0.0 111.112 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -25.09 65.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.84 31.18 6.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 47' ' ' ASP . . . 67.0 47.53 64.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' MET . . . -130.12 147.47 18.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.28 143.0 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.638 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -117.94 145.26 24.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.766 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.658 HD11 HG21 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.96 167.27 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.255 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -171.72 94.52 0.41 Allowed Pre-proline 0 C--N 1.332 -0.152 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.2 Cg_endo -84.14 142.71 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.872 2.381 . . . . 0.0 110.549 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.696 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 85.7 m -138.09 -97.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.047 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.675 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.12 -59.13 2.88 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.58 ' OG1' HG13 ' A' ' 36' ' ' ILE . 1.2 t -79.87 -104.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.58 HG13 ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -114.68 -146.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.62 0.248 . . . . 0.0 111.048 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.818 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.1 m-85 -81.84 134.39 35.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 111.038 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -116.4 -178.34 18.09 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.086 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.689 ' HB2' HG23 ' A' ' 139' ' ' THR . 4.5 mt -133.65 142.68 48.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.39 132.2 4.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.881 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -158.97 171.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.148 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.729 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 4.1 t-20 -56.58 122.2 11.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.131 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.49 -67.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -176.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.5 37.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -110.41 146.67 35.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.681 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.99 -25.82 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.707 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.448 ' CG ' ' HA2' ' A' ' 26' ' ' GLY . 3.3 m-20 -61.63 -29.75 70.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.625 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -36.11 60.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.09 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.838 HG13 HG21 ' A' ' 109' ' ' VAL . 18.7 t -61.62 -46.77 95.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -48.69 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.126 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.523 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 1.9 mmp_? -63.79 -21.55 66.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -71.41 -40.92 70.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.79 -19.45 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 51' ' ' ARG . 4.2 mmt180 -71.86 -56.4 5.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.357 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -75.36 -43.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.742 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.71 -3.17 46.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.303 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -113.75 5.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.19 90.12 3.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 t -144.8 71.37 15.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.66 7.37 4.58 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.763 2.309 . . . . 0.0 112.721 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -114.35 -14.41 12.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.14 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 122.03 70.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.24 171.47 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.594 2.196 . . . . 0.0 112.315 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 110' ' ' ILE . 10.5 p -112.8 145.02 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.008 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -93.6 146.49 23.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -116.39 154.31 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 52.8 t -105.02 122.93 46.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.633 HG22 ' H ' ' A' ' 69' ' ' SER . 1.8 p -147.51 177.68 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.765 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.633 ' H ' HG22 ' A' ' 68' ' ' VAL . 2.5 t -86.74 -36.32 18.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.109 0.481 . . . . 0.0 110.23 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.442 ' N ' HG13 ' A' ' 68' ' ' VAL . 3.5 t -162.89 161.16 25.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.325 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.767 HG21 ' HE2' ' A' ' 85' ' ' MET . 17.8 t -55.58 -32.69 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.379 . . . . 0.0 111.099 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 2.0 m-20 -67.35 -29.36 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.001 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -80.58 -15.27 57.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.371 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.506 ' O ' HG12 ' A' ' 74' ' ' ILE . 3.0 tt -114.34 47.9 0.44 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 98.8 Cg_endo -79.08 -32.67 1.74 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.778 1.652 . . . . 0.0 112.298 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.49 -11.8 60.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.672 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.59 -49.44 3.24 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.483 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.9 p -114.83 178.23 4.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.602 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -117.22 116.63 37.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.023 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 71' ' ' VAL . 68.2 Cg_endo -102.22 178.09 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.162 2.575 . . . . 0.0 112.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -140.76 177.35 8.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.89 -99.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.966 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.04 -25.49 30.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.158 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -60.25 -47.16 87.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.767 ' HE2' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -67.97 -27.93 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.003 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -57.88 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.578 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 11.8 tp -57.82 -26.2 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.884 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.546 ' SD ' HD13 ' A' ' 182' ' ' LEU . 6.9 tpt -72.39 -46.79 53.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.427 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.35 -4.03 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.273 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.59 -38.52 87.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.066 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.05 58.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -123.97 141.23 36.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.7 Cg_exo -78.66 -161.57 2.74 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.246 -1.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.45 163.1 11.65 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.748 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.17 38.55 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.2 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 92' ' ' LEU . 30.6 p90 -99.96 158.03 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.08 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -110.51 137.67 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.545 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 15.7 t -117.93 109.2 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.881 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 50.4 t -104.33 126.57 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.282 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.479 HD11 ' HE1' ' A' ' 85' ' ' MET . 1.2 mt -126.33 -167.02 1.65 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.559 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.58 -167.94 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.687 178.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.52 ' HG2' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.45 137.44 53.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.252 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -74.43 -173.19 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.084 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -75.54 5.14 6.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.295 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.419 ' HB2' HH21 ' A' ' 102' ' ' ARG . 1.5 mt -69.7 163.38 25.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.911 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.462 HG12 ' HB2' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -65.8 108.99 2.56 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 30.48 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.956 2.437 . . . . 0.0 113.051 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.462 ' HB2' HG12 ' A' ' 106' ' ' ILE . 37.8 t70 -61.46 -97.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.578 0.227 . . . . 0.0 111.559 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 49' ' ' VAL . 6.3 p -89.74 5.6 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.798 0.332 . . . . 0.0 111.618 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 64' ' ' VAL . 1.4 mt -97.87 -36.27 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.313 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.513 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -87.11 -39.62 15.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.102 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.09 -96.53 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.44 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.45 -64.47 1.22 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.891 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.679 ' HB2' ' HE ' ' A' ' 116' ' ' ARG . 0.7 OUTLIER -104.56 176.27 5.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.681 0.277 . . . . 0.0 111.111 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.513 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -92.47 71.89 5.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.679 ' HE ' ' HB2' ' A' ' 114' ' ' SER . 64.2 mtm180 -136.32 160.36 38.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 102' ' ' ARG . 21.6 t -139.26 125.92 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -85.61 161.55 35.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.514 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 98' ' ' VAL . 30.5 mt -144.74 152.34 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.632 0.253 . . . . 0.0 110.452 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.61 120.23 9.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.83 86.58 5.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.736 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.95 -178.02 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.516 2.144 . . . . 0.0 112.513 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -0.58 50.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.982 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.843 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.7 t0 -72.88 96.09 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -43.12 83.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.599 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 1.013 HG22 HD11 ' A' ' 16' ' ' LEU . 9.5 mt -67.48 -48.64 76.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.004 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.843 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 15.1 t -57.81 -29.02 64.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.546 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.8 mtp180 -67.35 -33.95 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.484 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -64.43 -58.77 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.973 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 tt -63.83 -35.08 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.376 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.43 -30.05 64.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.151 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -55.35 -55.36 32.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.178 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -75.9 -83.86 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.296 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.67 110.11 9.79 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.23 147.26 83.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.429 2.086 . . . . 0.0 111.768 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.89 159.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 5.2 m -80.13 141.75 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.14 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.63 109.85 6.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 111.756 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.689 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.75 157.06 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.508 178.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 p -78.52 126.51 30.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.055 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.509 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . -74.62 117.92 17.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.07 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 147' ' ' PRO . 6.9 t30 -161.47 47.46 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.63 173.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.3 p -58.9 148.97 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.92 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.23 -126.95 8.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.475 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.46 90.85 50.35 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.596 0.236 . . . . 0.0 110.924 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.403 ' HG2' ' HA ' ' A' ' 142' ' ' ASN . 36.7 Cg_exo -60.48 -49.48 8.9 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.477 2.118 . . . . 0.0 113.459 -178.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.89 110.4 3.03 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.861 1.707 . . . . 0.0 112.279 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.37 151.94 38.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -95.88 -12.03 0.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.948 2.432 . . . . 0.0 112.934 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -131.48 137.39 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.208 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.8 -33.39 73.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.717 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.1 -19.27 60.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.913 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -36.79 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.702 HD12 HG23 ' A' ' 165' ' ' VAL . 69.4 mt -67.62 -55.56 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.142 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.2 m -54.87 -33.85 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -59.46 2.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.626 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.608 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -57.45 -43.01 83.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.429 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.753 ' HG ' ' HB3' ' A' ' 163' ' ' ASP . 2.3 mm? -101.3 66.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 159' ' ' LEU . 33.8 t70 -16.87 -61.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.033 0.833 . . . . 0.0 112.706 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -152.15 11.56 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.241 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.651 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.5 p -81.01 -63.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.837 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HB3' ' HG ' ' A' ' 159' ' ' LEU . 40.4 t0 -109.34 91.33 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.477 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.545 HD23 HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -69.67 139.81 53.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.473 -178.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.702 HG23 HD12 ' A' ' 155' ' ' ILE . 1.4 p -74.62 -175.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.047 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.695 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.55 134.21 50.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -4.22 53.67 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.14 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.755 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.484 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 86.71 28.82 25.55 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.995 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.696 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 25.7 m-20 -73.28 119.89 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.842 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.7 125.62 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.591 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -136.7 -138.64 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.216 -179.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -86.26 137.22 32.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.88 0.371 . . . . 0.0 111.598 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.6 ttt -68.83 -5.78 22.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.813 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -149.99 156.54 38.0 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.693 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.63 -152.92 0.55 Allowed 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.864 -1.307 . . . . 0.0 112.633 0.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -155.52 122.25 5.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.521 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.79 137.15 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.471 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.91 91.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.531 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.601 HG23 ' HA ' ' A' ' 189' ' ' VAL . 2.2 mp -106.55 128.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.752 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.881 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -103.01 64.13 0.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.116 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.546 HD13 ' SD ' ' A' ' 88' ' ' MET . 5.1 tt -69.55 94.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.427 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -77.09 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.578 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.22 -123.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.589 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 3.0 t-20 -63.39 -52.2 62.36 Favored Pre-proline 0 CA--C 1.532 0.253 0 O-C-N 122.423 -0.173 . . . . 0.0 111.256 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.4 Cg_exo -75.07 109.22 2.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.554 2.169 . . . . 0.0 112.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 93.2 Cg_endo -84.19 131.58 5.04 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.61 2.206 . . . . 0.0 112.405 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 23.8 mmm-85 -89.44 51.08 2.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.989 0.424 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.601 ' HA ' HG23 ' A' ' 180' ' ' ILE . 14.7 t -58.26 98.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.781 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.5 91.42 3.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.133 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 178.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 98.58 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.35 19.47 35.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -97.03 -60.27 1.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.029 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.43 114.18 5.28 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.414 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.0 161.47 35.77 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.569 2.179 . . . . 0.0 112.366 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.91 8.59 3.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.95 -49.99 55.02 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.487 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.34 154.3 19.5 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.189 1.926 . . . . 0.0 112.318 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.08 145.07 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.052 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.76 27.31 3.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.31 -42.29 13.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.984 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -173.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -149.55 113.67 0.62 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.589 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -90.95 14.87 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 0.0 111.084 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -150.59 58.92 0.43 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.444 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.87 -10.63 41.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.8 0.333 . . . . 0.0 111.041 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.4 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.102 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.799 0.333 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.88 -168.84 0.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.75 134.37 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.205 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -109.86 90.04 3.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.52 173.15 12.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 8' ' ' ARG . 6.9 tt -110.03 143.81 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -59.86 2.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.076 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.451 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -97.65 -173.15 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -50.23 8.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.765 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 73.1 m-20 -84.4 133.71 44.19 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.81 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.546 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 48.0 Cg_exo -55.64 -79.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.482 2.122 . . . . 0.0 112.181 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.513 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -173.5 -52.12 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.49 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.783 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 73.9 Cg_endo -76.4 151.72 33.68 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.225 1.95 . . . . 0.0 112.663 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.5 -32.51 68.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.77 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 167' ' ' ASP . 58.8 t -60.43 -35.93 66.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.738 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.783 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -74.03 -39.13 63.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.58 -21.34 61.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.981 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -76.42 -35.68 58.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.777 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.77 75.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.285 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' H ' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -75.66 -21.35 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -66.9 -50.43 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.774 ' HB ' HD22 ' A' ' 164' ' ' LEU . 8.0 p -65.15 -32.99 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 mtt -61.48 -29.22 69.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.83 -30.54 62.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.01 5.11 77.88 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.577 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.16 36.6 93.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.692 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.9 169.65 13.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.19 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.43 146.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.7 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -119.51 131.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.632 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -102.35 162.81 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.565 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -167.81 99.63 0.59 Allowed Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.404 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.633 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 79.1 Cg_endo -84.1 166.62 12.75 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.545 2.164 . . . . 0.0 110.922 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.748 ' HA ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.72 -157.61 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.937 178.522 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.573 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 10.4 p-10 -63.61 -13.19 39.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.819 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -100.37 -94.49 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.996 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.481 ' H ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -133.13 173.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.661 0.267 . . . . 0.0 111.177 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m-85 -63.88 144.28 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.827 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -135.09 -174.83 13.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.334 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 mp -126.68 146.54 50.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.55 121.53 1.46 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.183 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.595 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.75 171.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 179.406 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.748 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -56.76 123.43 14.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.055 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.24 -65.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.264 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.95 40.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.762 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.38 149.41 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.47 -28.76 59.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -65.23 -27.17 68.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.292 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -75.5 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.071 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 46' ' ' GLU . 20.5 m -65.53 -28.83 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.219 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 4.8 mtp180 -72.39 -46.98 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.824 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -70.42 -27.09 64.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 48' ' ' ALA . 2.0 mp -67.12 -34.57 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -69.62 -39.74 77.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.953 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -65.19 -48.58 72.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.95 -40.04 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 5.6 mptt -83.0 -2.16 54.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.961 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.29 -102.78 0.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.326 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 71.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.036 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.02 70.25 70.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.11 -1.58 11.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.503 2.135 . . . . 0.0 112.425 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -121.12 -1.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -82.98 124.63 76.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.999 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.05 160.9 9.49 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.575 2.184 . . . . 0.0 112.431 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 110' ' ' ILE . 7.3 p -117.28 148.67 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 t -95.38 149.86 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 111.074 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 117' ' ' VAL . 25.0 mt -116.02 157.65 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.846 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 6.9 t -116.25 119.75 36.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.767 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 1.0 OUTLIER -136.03 171.09 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.993 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.464 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -84.59 -38.83 19.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.103 0.477 . . . . 0.0 110.447 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.06 169.52 17.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.398 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' A' ' 85' ' ' MET . 22.2 t -59.2 -32.7 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.07 -26.62 66.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.663 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 17.8 mm-40 -81.12 -19.9 42.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.296 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.596 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 15.4 tt -114.74 47.49 0.45 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 21.7 Cg_exo -66.93 -65.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.832 1.688 . . . . 0.0 113.208 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -72.29 4.21 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HB3' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -108.0 -24.03 11.77 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.571 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -129.31 159.27 36.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.37 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.565 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.57 87.12 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.69 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.35 -163.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.062 2.508 . . . . 0.0 112.83 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.76 -177.67 5.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.5 -77.2 0.73 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.645 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.778 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -56.2 -31.31 63.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.816 0.341 . . . . 0.0 111.066 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.07 91.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.119 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.515 ' HG3' HG11 ' A' ' 71' ' ' VAL . 20.2 mmt -71.41 -17.61 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.778 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -63.75 -50.35 69.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.263 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 2.5 tm? -60.58 -37.77 82.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.304 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.532 ' SD ' HG21 ' A' ' 98' ' ' VAL . 5.9 tpt -66.78 -33.31 75.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.016 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.14 -15.04 61.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.116 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 87' ' ' LEU . 1.2 mtp85 -67.0 -61.98 1.66 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 pt -98.68 57.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.051 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 121' ' ' VAL . 3.9 tt -131.03 129.19 22.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.912 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HB3' HG12 ' A' ' 121' ' ' VAL . 6.0 Cg_exo -78.14 -159.97 2.19 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.28 -0.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.433 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 156.83 163.04 11.97 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.626 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.756 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 4.6 Cg_exo -78.1 39.49 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.051 2.501 . . . . 0.0 112.371 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.433 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -112.3 130.97 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.337 -179.344 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.17 114.9 26.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.3 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.532 HG21 ' SD ' ' A' ' 88' ' ' MET . 2.0 m -108.87 118.81 57.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.92 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 22.0 t -91.64 131.07 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.218 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 183' ' ' THR . 0.3 OUTLIER -127.18 178.93 5.71 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.426 0.453 . . . . 0.0 111.121 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.75 176.08 7.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.681 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.05 137.14 53.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.979 0.419 . . . . 0.0 111.36 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.565 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 1.5 t-20 -74.59 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.024 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -75.55 15.8 0.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.648 HD13 ' H ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -69.51 153.98 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.679 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 105' ' ' LEU . 4.7 pt -59.67 109.61 2.1 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.24 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 59.2 Cg_endo -70.81 1.93 4.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.692 2.261 . . . . 0.0 112.785 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.13 -93.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.762 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.78 7.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 64' ' ' VAL . 41.3 mm -103.2 -64.93 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 111.317 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 107' ' ' PRO . 8.4 p -87.42 -26.97 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.39 -116.67 4.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.727 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.35 -20.2 42.58 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.019 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -104.83 179.8 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.575 0.226 . . . . 0.0 110.845 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -113.45 42.37 1.97 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -136.64 156.19 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.352 -179.352 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.681 HG23 ' HB3' ' A' ' 102' ' ' ARG . 58.8 t -139.51 144.6 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.521 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -84.04 160.08 36.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.96 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 118' ' ' GLY . 34.0 mt -149.15 141.14 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -148.91 134.11 18.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.946 0.403 . . . . 0.0 111.566 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 92' ' ' LEU . 34.2 t -111.02 81.96 2.92 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.768 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.549 ' HG2' ' OD1' ' A' ' 124' ' ' ASP . 34.9 Cg_endo -64.38 -178.86 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.566 2.177 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.91 -0.98 55.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.72 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.549 ' OD1' ' HG2' ' A' ' 122' ' ' PRO . 0.8 OUTLIER -64.75 105.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 111.034 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.35 -42.88 82.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.44 -58.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.218 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.65 -19.85 42.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . 42.6 ttt-85 -70.11 -35.88 74.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.37 -51.89 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.05 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.38 -51.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.767 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.17 -29.41 69.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -55.08 -55.27 32.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.422 . . . . 0.0 110.039 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -90.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.114 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 1.9 m-85 -77.17 127.34 83.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.935 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 23.1 Cg_exo -65.54 154.15 75.03 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 111.555 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.55 156.28 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.64 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 2.1 m -80.41 136.7 36.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.777 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -133.02 108.05 8.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.868 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -127.76 118.54 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.582 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -62.43 112.17 2.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.982 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -88.41 81.48 7.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.21 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 3.5 p-10 -156.34 25.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 143' ' ' ILE . 0.9 OUTLIER -81.27 -145.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.09 162.52 2.51 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.866 0.365 . . . . 0.0 111.146 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.464 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 76.04 -144.96 31.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.362 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 7.8 tttt -127.47 63.09 57.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.633 0.254 . . . . 0.0 111.23 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 42.3 Cg_exo -60.65 -48.69 10.38 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.323 2.015 . . . . 0.0 113.336 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 142' ' ' ASN . 73.7 Cg_endo -77.23 132.21 12.39 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.868 1.712 . . . . 0.0 112.427 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.16 156.56 36.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.897 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -95.06 -16.59 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.718 2.279 . . . . 0.0 112.382 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.691 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 12.5 ttm180 -141.7 129.13 21.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.319 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.512 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -58.07 -31.12 66.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.273 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.614 ' O ' HG12 ' A' ' 156' ' ' VAL . 2.1 tt0 -74.42 -34.74 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.396 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.691 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.6 -42.9 97.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.46 -178.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.762 HD12 HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.17 -38.81 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.606 -178.749 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -53.37 -32.84 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.269 -177.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HD2' HH11 ' A' ' 157' ' ' ARG . 2.1 mtm180 -75.92 -41.71 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.994 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -22.9 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 164' ' ' LEU . 3.3 pp -93.22 37.41 1.04 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.101 -0.24 . . . . 0.0 111.643 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 159' ' ' LEU . 27.6 t70 -18.38 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.753 0.658 . . . . 0.0 112.517 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -154.64 7.95 0.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.417 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -81.37 -80.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.618 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -104.64 89.44 3.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.774 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -57.22 121.18 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.679 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.823 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.3 p -60.24 -170.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.391 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.885 HD12 ' H ' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -125.95 156.97 38.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.942 -179.061 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.478 ' HB3' HG22 ' A' ' 15' ' ' VAL . 2.3 t70 -91.77 -26.98 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.8 -59.21 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.797 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.885 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 81.62 49.21 5.53 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.13 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.748 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -70.63 105.73 3.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.337 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -157.54 122.12 4.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.329 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -137.43 -104.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.4 m-20 -85.37 111.71 20.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 35' ' ' THR . 83.9 mmm -65.89 -16.8 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.175 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.97 154.64 39.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 177' ' ' SER . 67.7 Cg_endo -91.67 -149.7 0.33 Allowed 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.681 0.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 23.0 p -158.27 146.35 18.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.473 HG22 HG13 ' A' ' 180' ' ' ILE . 40.5 m -101.87 145.19 29.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.899 0.38 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.98 96.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.59 HG23 ' HA ' ' A' ' 189' ' ' VAL . 12.5 mt -110.64 135.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.395 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.92 65.43 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.068 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 100' ' ' LEU . 18.6 tp -70.14 82.63 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.397 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.34 -75.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.336 . . . . 0.0 110.433 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.58 -120.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.562 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.1 m-80 -67.4 -52.83 26.4 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.0 109.05 2.26 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.38 2.053 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.3 Cg_endo -82.91 123.83 3.73 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.529 2.152 . . . . 0.0 112.162 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -88.01 54.4 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.59 ' HA ' HG23 ' A' ' 180' ' ' ILE . 11.6 t -57.56 104.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.904 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.39 89.9 2.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.074 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -86.95 141.01 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 192' ' ' ARG . 0.8 OUTLIER -79.0 -21.19 47.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -92.07 -153.4 29.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.532 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.3 128.69 55.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.822 0.344 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -74.63 164.64 54.65 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.512 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.712 ' HG2' HD23 ' A' ' 197' ' ' LEU . 59.7 Cg_endo -72.78 -6.31 18.79 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.569 2.179 . . . . 0.0 112.36 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.712 HD23 ' HG2' ' A' ' 196' ' ' PRO . 0.6 OUTLIER -149.22 29.06 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.523 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -77.64 -50.9 1.93 Allowed Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.415 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 198' ' ' ASP . 50.6 Cg_endo -68.27 -46.45 2.13 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.213 1.942 . . . . 0.0 112.503 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.543 HG22 ' H ' ' A' ' 202' ' ' LEU . 14.7 p -69.18 142.25 16.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.076 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.18 35.57 4.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.543 ' H ' HG22 ' A' ' 200' ' ' VAL . 0.1 OUTLIER -78.06 -71.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.055 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -82.3 178.77 8.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.081 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -164.15 150.85 19.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.527 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -80.95 112.31 18.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.7 0.286 . . . . 0.0 111.107 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 154.12 85.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.468 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.27 26.39 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 0.0 110.951 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.086 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.805 0.336 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.438 HD12 ' HE ' ' A' ' 4' ' ' ARG . 1.1 mt -104.65 -175.58 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 tp -79.75 -6.78 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HE ' HD12 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -75.07 161.76 29.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.859 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 153.74 37.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.923 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 pt -84.56 -30.03 7.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.222 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -71.99 173.46 8.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.015 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.43 150.84 28.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.003 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -77.59 149.24 34.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.606 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -110.0 94.83 18.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.215 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 -45.05 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.386 2.057 . . . . 0.0 112.06 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 53.27 70.78 1.64 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.176 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.656 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 19.0 Cg_exo -65.6 142.48 71.19 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.559 2.173 . . . . 0.0 112.008 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 4.4 m-20 -74.24 -38.68 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -69.66 -26.5 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 mm? -70.87 -52.27 21.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -64.82 -20.06 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.5 mm-40 -67.65 -47.46 69.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.18 82.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.222 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 16' ' ' LEU . 28.2 mm -67.92 -33.26 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.81 -30.71 70.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.974 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.521 HG22 ' HG ' ' A' ' 164' ' ' LEU . 11.7 t -72.68 -33.38 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.5 mmt -64.03 -50.15 69.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.025 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.02 -17.57 64.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.252 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 0.91 84.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.2 35.02 90.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.59 165.06 12.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.19 146.59 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.511 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.695 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.15 129.87 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.701 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -102.42 163.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.677 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -163.68 88.42 1.19 Allowed Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.599 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 94.5 Cg_endo -78.22 119.94 4.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.498 2.132 . . . . 0.0 110.749 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.858 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 0.6 OUTLIER -116.46 -139.17 0.37 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.04 0.448 . . . . 0.0 111.961 -176.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -53.62 -47.77 69.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.52 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 36' ' ' ILE . 3.3 t -79.0 -119.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.735 HG12 ' H ' ' A' ' 37' ' ' TYR . 8.3 tt -112.36 -168.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.282 -0.261 . . . . 0.0 110.846 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.735 ' H ' HG12 ' A' ' 36' ' ' ILE . 4.1 m-85 -63.43 127.89 33.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 110.353 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.43 170.58 13.34 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.368 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -120.12 139.58 52.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.36 117.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.869 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 42' ' ' ASN . 2.0 p -158.36 174.63 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.708 0.29 . . . . 0.0 111.331 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.809 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.22 114.36 1.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.653 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.481 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -66.17 -49.75 66.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.038 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' A' ' 44' ' ' LEU . 1.2 mm? -80.97 28.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 111.564 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.809 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -111.02 152.23 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.71 178.629 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -75.36 -29.0 59.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.835 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -28.79 68.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.039 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.49 ' O ' HD23 ' A' ' 52' ' ' LEU . . . -68.18 -32.59 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.534 ' HA ' HD23 ' A' ' 52' ' ' LEU . 56.5 t -70.12 -48.67 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.135 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.32 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.245 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.98 -55.78 8.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.276 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -60.13 -17.51 40.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.335 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -51.96 13.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.025 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -59.19 -38.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.218 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG22 HD13 ' A' ' 143' ' ' ILE . 44.8 t -70.71 -58.2 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -83.54 -76.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.18 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.03 27.68 51.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.55 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -108.48 -47.26 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 16.7 m -135.42 82.43 40.29 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.21 -3.39 10.7 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.812 2.342 . . . . 0.0 112.662 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -109.01 -19.94 13.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.246 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -68.0 147.39 98.44 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.44 ' HG3' ' OG ' ' A' ' 114' ' ' SER . 50.1 Cg_exo -53.47 158.64 7.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.52 2.147 . . . . 0.0 112.324 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 110' ' ' ILE . 9.0 p -112.8 153.54 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 136.0 34.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 77' ' ' PHE . 12.0 mm -113.92 148.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.259 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.4 127.64 54.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.759 HG21 HG23 ' A' ' 74' ' ' ILE . 1.5 p -141.96 179.99 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.589 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.882 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 12.5 t -86.32 -41.35 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 0.0 110.529 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.14 169.22 18.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.88 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.686 ' HA ' HD11 ' A' ' 74' ' ' ILE . 16.2 t -57.17 -34.61 45.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.29 -26.87 66.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.067 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.882 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 80.9 mm-40 -77.46 -20.02 55.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.773 HD13 HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -113.31 61.42 0.8 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.812 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.149 1.899 . . . . 0.0 112.421 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.02 16.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.976 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE1' HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -105.3 -49.53 3.43 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.135 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -126.4 165.38 19.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.464 HH11 ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -113.0 96.97 40.58 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -102.29 -179.12 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.112 2.542 . . . . 0.0 112.567 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 47.4 t -133.59 169.96 16.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.45 -77.29 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.839 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.564 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -57.51 -29.62 64.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.44 -45.84 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 81' ' ' SER . 17.7 mmt -74.41 -11.65 60.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.334 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 4.4 mt-10 -72.43 -49.92 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.872 0.368 . . . . 0.0 110.603 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 8.3 tp -63.18 -36.37 83.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.949 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.53 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 3.7 tpt -70.67 -51.21 29.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.92 -14.98 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.465 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.98 -34.14 77.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 pt -115.04 52.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.463 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -131.03 140.56 39.05 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.75 -163.96 3.72 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.625 -1.406 . . . . 0.0 112.37 -1.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.85 166.39 15.2 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.625 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 5.7 Cg_exo -78.23 35.34 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.057 2.504 . . . . 0.0 112.043 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.555 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 25.0 p90 -99.0 164.86 12.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.969 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.689 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 36.8 m -115.29 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.698 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.53 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 1.7 p -123.6 104.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.444 . . . . 0.0 110.955 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.733 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 15.4 t -101.47 129.92 51.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.86 -175.11 3.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.595 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -178.79 3.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -119.76 141.27 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.969 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -74.28 -174.17 1.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 104' ' ' GLU . 2.5 pt-20 -76.56 43.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.491 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.647 HD22 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -73.97 146.16 44.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.804 0.335 . . . . 0.0 110.973 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.567 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.2 mp -80.02 -50.28 1.2 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.647 ' HD2' HD22 ' A' ' 105' ' ' LEU . 77.7 Cg_exo -51.07 100.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.186 1.924 . . . . 0.0 112.461 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -82.38 1.98 34.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.92 -23.88 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.065 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.52 ' O ' HG12 ' A' ' 64' ' ' VAL . 15.0 pt -96.87 -39.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.151 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 108' ' ' ASP . 12.9 t -76.8 -15.51 59.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.953 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.24 -171.5 42.94 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.635 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -71.02 -6.67 60.83 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.44 ' OG ' ' HG3' ' A' ' 63' ' ' PRO . 4.2 p -106.24 -176.57 3.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.503 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.3 m -111.57 40.31 2.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -139.02 150.43 45.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 111' ' ' THR . 93.0 t -139.7 144.56 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.497 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.583 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -91.77 158.3 25.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.773 HD13 HD13 ' A' ' 74' ' ' ILE . 43.7 mt -145.82 151.16 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HG2' ' HA ' ' A' ' 97' ' ' THR . 13.3 mtp180 -147.67 134.06 19.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.617 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.8 87.26 6.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.551 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.55 -176.33 2.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.555 2.17 . . . . 0.0 112.586 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 11.55 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 13.4 t0 -76.83 97.89 4.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -47.92 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.09 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.411 HG23 HD22 ' A' ' 16' ' ' LEU . 32.2 mm -61.06 -50.98 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 6.9 t -61.35 -23.74 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 69' ' ' SER . 9.2 ttm180 -67.04 -31.85 72.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.591 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtt85 -75.09 -56.19 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.1 -50.9 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.371 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.678 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.22 -26.96 69.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.391 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 128' ' ' ARG . . . -54.58 -56.51 18.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 109.989 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -75.86 -86.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.998 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 61.4 m-85 -76.59 125.56 87.21 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.717 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.45 147.19 82.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.283 1.988 . . . . 0.0 111.949 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -120.52 155.1 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.209 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.661 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 11.3 m -80.22 133.84 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.228 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.71 104.97 7.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -134.15 161.18 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.3 m -76.87 123.33 26.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.789 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . -67.87 136.0 53.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -163.37 51.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.823 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.491 HD13 HG22 ' A' ' 55' ' ' VAL . 13.6 mm -60.96 154.14 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 m -54.04 142.67 24.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.993 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.06 -109.28 3.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.462 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.45 94.92 41.93 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.25 . . . . 0.0 110.948 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.453 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 45.0 Cg_exo -60.26 -48.7 11.08 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.58 2.187 . . . . 0.0 113.281 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 24.0 Cg_exo -64.27 113.07 2.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.932 1.755 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -97.1 137.9 21.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 64.6 Cg_endo -96.09 -12.35 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.885 2.39 . . . . 0.0 112.983 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -133.05 134.85 44.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -43.13 83.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.817 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.04 -18.0 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 158' ' ' ASP . 4.4 tt0 -73.44 -37.03 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.816 HD12 HG23 ' A' ' 165' ' ' VAL . 6.1 mt -70.59 -46.4 70.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.593 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.58 -36.66 78.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.956 0.407 . . . . 0.0 111.403 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -75.61 -49.03 19.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.095 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -72.64 -41.96 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.302 . . . . 0.0 111.694 -177.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.558 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -93.77 72.28 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' A' ' 159' ' ' LEU . 11.3 t70 -15.97 -66.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.057 0.848 . . . . 0.0 112.925 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.14 25.94 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.281 . . . . 0.0 111.43 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.673 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.83 -67.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.673 ' H ' HG13 ' A' ' 162' ' ' VAL . 1.5 p-10 -111.12 94.19 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.413 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.521 ' HG ' HG22 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -60.01 127.76 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.608 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.816 HG23 HD12 ' A' ' 155' ' ' ILE . 3.4 p -60.79 176.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.039 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.684 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.79 125.54 41.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.135 0.493 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -4.34 52.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.67 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.42 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 84.71 65.62 1.49 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.996 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.858 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 5.6 m-20 -72.88 -116.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.77 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -149.89 -171.67 3.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.635 0.255 . . . . 0.0 111.112 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 9.11 1.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.4 94.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.42 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.73 -15.44 0.72 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 150.69 64.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.538 0.209 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.42 -160.87 2.41 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.663 0.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.0 t -160.9 112.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 3.4 m -102.16 136.18 42.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.689 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -128.93 98.9 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.268 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 189' ' ' VAL . 36.9 mt -116.49 132.51 65.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.511 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.733 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -108.3 64.41 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 178.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 18.2 tp -69.91 100.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.533 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.431 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -82.42 -85.63 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.352 178.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.75 -94.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.213 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 23.0 t-20 -82.78 -53.15 0.63 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 85.5 Cg_endo -77.75 107.08 2.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.244 1.963 . . . . 0.0 112.231 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.569 ' HB2' HG23 ' A' ' 189' ' ' VAL . 86.9 Cg_endo -82.16 130.71 6.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.508 2.139 . . . . 0.0 112.367 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -90.42 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.982 0.42 . . . . 0.0 110.547 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.778 ' HA ' HG12 ' A' ' 180' ' ' ILE . 94.3 t -56.44 101.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.12 86.62 2.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.008 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -83.92 143.93 29.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.994 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -160.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.964 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.56 135.88 16.13 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.53 -52.64 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 0.0 110.852 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.04 121.16 8.29 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.433 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.57 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.438 2.092 . . . . 0.0 112.407 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.88 -50.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.973 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.55 124.33 82.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.04 -35.38 14.89 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.438 2.092 . . . . 0.0 112.316 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.3 t -66.31 117.93 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.91 27.93 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.03 -64.49 1.04 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.949 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -79.08 146.18 33.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -126.34 104.1 0.71 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.48 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -106.94 137.03 45.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 111.172 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -132.92 -46.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.421 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -89.02 -53.39 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.795 0.331 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.128 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.789 0.328 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.2 mt -73.38 -82.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.02 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 mm -96.61 145.37 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.194 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.22 127.64 43.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -86.99 -169.48 2.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 tt -88.26 140.31 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.028 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -69.95 115.99 9.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.38 125.76 51.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.15 109.27 5.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.023 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -108.01 117.13 55.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 52.6 Cg_exo -55.63 152.68 32.98 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.561 2.174 . . . . 0.0 112.188 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -86.33 110.42 31.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.02 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 11' ' ' PRO . 50.3 Cg_exo -53.81 153.69 18.91 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.49 2.127 . . . . 0.0 112.291 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.27 -48.47 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.14 -33.75 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -63.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.193 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.79 -20.01 60.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.276 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.02 -46.5 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.06 94.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.282 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' MET . 2.0 mp -72.26 -29.12 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -54.56 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.253 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.93 -26.79 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 10.8 mmt -56.56 -44.59 81.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -19.66 61.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.9 -0.43 64.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.694 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.52 27.23 71.52 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.36 170.75 13.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.36 153.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.74 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.32 151.13 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 111.447 -178.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -108.3 154.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.22 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.79 106.93 0.45 Allowed Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HB2' ' HA ' ' A' ' 170' ' ' ASP . 1.4 Cg_endo -84.55 162.59 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.292 2.661 . . . . 0.0 112.136 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -137.33 -150.34 0.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.637 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.781 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 5.9 m-20 -60.16 -20.36 58.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.725 0.297 . . . . 0.0 111.148 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 95' ' ' PRO . 7.9 p -100.18 -112.31 0.18 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tt -111.82 -179.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.665 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -84.2 128.89 34.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.197 0.522 . . . . 0.0 110.686 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -118.75 -167.98 14.03 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.753 HD12 HG23 ' A' ' 139' ' ' THR . 0.2 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.799 0.333 . . . . 0.0 110.5 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.727 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -144.26 136.1 6.57 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.987 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.697 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.4 p -172.28 -169.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.792 -0.204 . . . . 0.0 110.743 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.697 ' H ' HG22 ' A' ' 41' ' ' VAL . 2.8 t-20 -56.33 103.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.003 0.43 . . . . 0.0 110.327 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.84 -39.23 91.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.017 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.99 24.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.441 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.85 155.16 22.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.775 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -21.74 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -72.89 -23.23 60.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.629 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.34 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.755 HG21 HG22 ' A' ' 109' ' ' VAL . 11.5 p -72.27 -30.25 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.816 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -41.76 61.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -64.44 -44.38 91.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -61.52 -40.69 95.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.13 -28.54 69.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.005 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -64.26 -45.72 86.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.247 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 t -72.51 -51.25 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.03 -78.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.86 7.41 16.14 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.851 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -118.35 11.8 13.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.721 0.296 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 1.6 m -147.11 65.35 9.56 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.104 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 59' ' ' SER . 8.9 Cg_exo -72.8 -2.63 12.21 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.728 2.286 . . . . 0.0 112.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -112.61 -24.33 9.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.2 OUTLIER -68.47 148.67 98.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 177.35 3.12 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.515 2.144 . . . . 0.0 112.344 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 66' ' ' ILE . 14.6 p -112.92 149.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.798 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 134.27 35.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.502 HD11 HG13 ' A' ' 64' ' ' VAL . 4.1 mm -116.12 160.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.056 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 9.9 t -122.62 137.63 54.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.726 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.806 HG11 HG12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -139.35 -176.2 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.663 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -73.3 -50.03 24.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.709 179.017 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.484 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -164.71 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.265 0.555 . . . . 0.0 111.797 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.606 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 16.8 t -52.83 -22.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.85 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 2.2 t70 -67.92 -52.78 32.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.76 13.77 3.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.658 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.806 HG12 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.17 -42.88 0.41 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 72' ' ' ASP . 76.9 Cg_exo -51.62 -17.42 4.75 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.244 1.963 . . . . 0.0 112.935 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -72.2 -39.01 68.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.433 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 23.7 m-85 -97.44 -35.71 10.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.516 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 74' ' ' ILE . 88.8 p -116.24 -173.81 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.957 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.39 100.7 28.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.719 ' HA ' HD22 ' A' ' 100' ' ' LEU . 92.3 Cg_endo -102.74 -170.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.211 2.608 . . . . 0.0 112.677 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.538 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -126.98 177.09 6.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.22 -88.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.857 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -55.72 -27.48 50.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.128 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.43 -44.12 97.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.918 0.39 . . . . 0.0 110.932 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.526 ' CE ' HD21 ' A' ' 100' ' ' LEU . 6.6 mmt -73.94 -16.13 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.307 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 mt-10 -67.44 -51.27 53.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.591 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.6 tp -62.61 -32.4 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.666 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.435 ' O ' HD12 ' A' ' 92' ' ' LEU . 6.0 tpt -70.15 -48.12 58.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -65.42 -11.42 42.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.7 tpt180 -72.95 -31.08 64.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.09 32.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.474 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 93' ' ' PRO . 4.4 mt -131.11 152.93 81.5 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.815 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 92' ' ' LEU . 83.3 Cg_endo -77.94 -172.65 11.55 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.555 -1.435 . . . . 0.0 112.512 0.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.55 -177.81 31.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.687 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.781 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 87.8 Cg_endo -81.03 43.45 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.751 2.301 . . . . 0.0 112.239 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.515 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 5.6 m-85 -111.43 136.28 50.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 m -94.92 120.93 35.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.344 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.435 HG11 ' HG2' ' A' ' 88' ' ' MET . 3.2 t -108.86 116.52 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.695 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 3.5 t -104.1 127.47 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.719 HD22 ' HA ' ' A' ' 80' ' ' PRO . 1.6 mt -126.87 -169.37 2.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.969 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -172.63 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.648 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.684 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.9 142.53 47.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 1.3 t-20 -74.38 -172.37 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.207 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -75.82 12.83 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.48 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.533 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -69.73 -172.93 0.55 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.807 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.25 105.12 3.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.128 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.599 ' HA ' HG23 ' A' ' 111' ' ' THR . 65.9 Cg_endo -71.43 2.8 4.11 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.585 2.19 . . . . 0.0 112.611 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.82 -88.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.075 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.755 HG22 HG21 ' A' ' 49' ' ' VAL . 3.2 p -84.77 -0.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.0 mt -96.8 -63.59 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.648 0.261 . . . . 0.0 111.379 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.602 HG21 ' HG3' ' A' ' 102' ' ' ARG . 4.4 p -87.18 -23.75 24.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.59 -130.14 20.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.553 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.41 11.68 60.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.698 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -119.1 169.45 9.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.707 0.289 . . . . 0.0 111.035 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 39.8 m -113.44 31.95 6.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -136.6 166.58 23.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.684 HG23 ' HB2' ' A' ' 102' ' ' ARG . 77.2 t -139.93 142.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.65 155.75 41.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.366 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 100' ' ' LEU . 8.4 mt -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.604 0.24 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.541 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER -146.1 127.34 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.387 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.37 80.13 2.47 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.597 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 20.2 Cg_exo -66.6 179.08 2.28 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.505 2.137 . . . . 0.0 112.713 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.69 -0.9 55.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.2 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 83.5 m-20 -61.98 109.1 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.155 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.43 -56.59 19.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.438 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.6 mm -58.66 -50.79 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -17.24 62.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -75.14 -38.48 60.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -45.01 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.05 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.8 mm -62.91 -46.15 97.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -64.38 -28.4 69.67 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.898 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 69' ' ' SER . . . -54.79 -55.0 34.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.041 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -75.48 -88.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.174 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -77.2 138.55 64.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.88 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.56 146.94 62.99 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.36 2.04 . . . . 0.0 111.849 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 131' ' ' ALA . 13.4 t -125.31 133.32 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.47 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.727 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.2 m -67.35 141.47 57.1 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -140.06 104.53 4.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.856 0.36 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.753 HG23 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.61 125.47 15.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.702 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.62 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -61.18 135.85 57.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.872 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -78.95 137.19 37.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.859 0.361 . . . . 0.0 111.171 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -159.41 49.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.648 HG13 ' H ' ' A' ' 144' ' ' SER . 5.3 tp -68.22 166.84 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.99 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.648 ' H ' HG13 ' A' ' 143' ' ' ILE . 2.3 m -55.01 155.64 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.971 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.25 -124.38 7.44 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.407 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.04 90.3 50.85 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.638 0.256 . . . . 0.0 110.932 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.535 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 48.0 Cg_exo -60.23 -43.65 33.78 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.653 2.235 . . . . 0.0 113.866 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.46 94.98 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.847 1.698 . . . . 0.0 112.419 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.6 128.49 69.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.748 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -95.95 -8.24 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.886 2.39 . . . . 0.0 112.951 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -129.19 120.12 25.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.493 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -60.05 -36.31 77.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.518 178.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -23.83 61.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.647 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -36.87 84.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.974 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 165' ' ' VAL . 55.0 mt -68.77 -55.15 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -32.51 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.46 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -75.67 -54.99 6.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.39 -24.08 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.585 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.558 ' HB3' HG13 ' A' ' 162' ' ' VAL . 3.2 mm? -111.25 70.69 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.818 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 16.4 t0 -15.94 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 124.049 0.843 . . . . 0.0 112.823 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -156.85 25.5 0.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.7 0.285 . . . . 0.0 111.469 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.686 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.61 -69.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.573 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.799 ' HB2' HD11 ' A' ' 30' ' ' ILE . 2.0 p-10 -111.29 102.65 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.488 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.621 ' HB2' HG21 ' A' ' 22' ' ' VAL . 3.2 mm? -71.45 131.52 43.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.743 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.0 p -62.98 -163.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.879 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.743 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.1 160.81 29.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 111.124 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.87 -25.8 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.68 -56.29 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.472 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.24 -163.28 16.86 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.792 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.623 ' HA ' ' HB2' ' A' ' 32' ' ' PRO . 7.2 p-10 -70.89 -164.72 0.1 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.829 0.347 . . . . 0.0 111.124 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.51 -57.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.563 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -124.17 -134.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.15 146.4 26.6 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.794 0.331 . . . . 0.0 111.841 -177.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' THR . 71.0 mmm -62.98 -27.47 69.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.71 154.28 47.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.655 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 177' ' ' SER . 65.7 Cg_endo -91.39 -149.36 0.33 Allowed 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.867 -1.305 . . . . 0.0 112.67 1.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.505 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.82 158.29 39.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.515 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.2 m -102.27 139.0 38.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.1 t -129.1 88.8 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.048 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.654 HG23 ' HA ' ' A' ' 189' ' ' VAL . 13.0 mt -108.87 129.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.373 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.695 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.55 66.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.414 178.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 187' ' ' PRO . 53.4 tp -69.71 93.67 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.318 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.42 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -79.51 -81.7 0.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.409 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 185' ' ' ASN . 12.2 t -120.84 -115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.046 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.5 m-20 -66.41 -52.69 35.11 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 185' ' ' ASN . 3.5 Cg_exo -77.22 108.04 2.54 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.497 2.131 . . . . 0.0 112.093 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.4 Cg_endo -81.49 133.38 8.36 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.451 2.101 . . . . 0.0 112.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 188' ' ' ARG . 5.8 mtt180 -91.92 51.12 1.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.654 ' HA ' HG23 ' A' ' 180' ' ' ILE . 6.3 t -58.64 100.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 tp -126.54 86.64 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.43 ' HB3' HG23 ' A' ' 178' ' ' THR . 8.5 ptt-85 -87.06 161.62 18.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.824 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' A' ' 193' ' ' GLY . 0.2 OUTLIER -64.69 169.52 4.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.869 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 192' ' ' ARG . . . -85.2 80.63 1.8 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.592 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -109.82 -87.8 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.724 0.297 . . . . 0.0 110.789 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 194' ' ' LYS . . . -90.09 134.71 12.51 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.305 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 197' ' ' LEU . 24.3 Cg_exo -63.01 -82.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.539 2.159 . . . . 0.0 112.133 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.451 ' H ' ' HB2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -157.21 -85.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.808 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 145.0 59.37 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.924 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.22 131.05 40.88 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.541 2.161 . . . . 0.0 112.083 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.58 137.83 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.043 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.6 mt -105.82 43.0 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.015 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.461 HD23 ' HB3' ' A' ' 205' ' ' ALA . 0.7 OUTLIER -75.93 -172.62 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.7 8.86 29.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.94 49.57 2.25 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.546 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 202' ' ' LEU . . . -104.72 -51.65 3.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 111.091 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -135.11 85.72 0.26 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.422 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.46 -69.81 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.984 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.091 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.12 176.3 5.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.428 ' HB ' ' HD3' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -71.39 121.85 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.013 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.08 35.9 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.982 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -98.72 159.59 14.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.021 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 tt -82.84 134.45 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -70.45 -82.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.075 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.72 151.57 26.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.89 103.09 3.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.821 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.13 -51.49 0.78 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.444 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.12 -71.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.149 1.9 . . . . 0.0 112.177 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m 56.43 79.15 0.34 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 38.1 Cg_exo -57.42 158.3 19.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.662 2.242 . . . . 0.0 112.287 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.71 -39.88 66.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.28 -22.78 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.074 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.31 -43.62 66.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -75.23 -28.54 59.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.622 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.07 -38.9 69.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 111.018 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.622 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -74.08 -36.32 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.75 -30.0 48.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -68.84 -48.33 63.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.847 HG21 ' HG ' ' A' ' 164' ' ' LEU . 7.5 p -72.3 -21.8 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -48.4 81.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.809 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.37 -13.52 62.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.098 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.53 -2.87 76.57 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.453 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.29 53.84 33.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.552 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.37 161.6 23.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.516 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.673 HD11 ' HG ' ' A' ' 39' ' ' LEU . 1.4 tp -90.89 136.05 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 110.568 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.634 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.74 140.96 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.958 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.421 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -101.99 150.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.053 178.763 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.661 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -165.99 107.04 0.72 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.113 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 96.7 Cg_endo -84.26 159.29 13.13 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.763 2.309 . . . . 0.0 111.837 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.892 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -135.32 -149.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -54.81 -20.6 8.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.28 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 36' ' ' ILE . 2.7 t -100.17 -117.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.651 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.694 HG23 ' HB2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -157.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.117 0 O-C-N 122.198 -0.314 . . . . 0.0 111.202 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.595 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 3.9 m-85 -68.62 132.11 46.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.26 -176.76 15.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.265 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.673 ' HG ' HD11 ' A' ' 28' ' ' ILE . 1.7 mp -131.93 142.94 49.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.88 0.372 . . . . 0.0 111.172 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.89 115.46 0.82 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.595 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 136' ' ' VAL . 2.4 p -153.96 150.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.802 0.334 . . . . 0.0 111.067 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -55.87 104.65 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.397 . . . . 0.0 110.574 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.53 78.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.942 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.4 mm? -76.7 13.92 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.946 0.403 . . . . 0.0 111.151 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -110.48 156.25 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.893 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.589 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -69.72 -25.22 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 31.1 t70 -66.5 -21.18 66.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.09 -38.14 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 46' ' ' GLU . 14.6 p -74.25 -35.86 41.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.778 0.323 . . . . 0.0 110.829 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -69.89 -44.21 70.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.487 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.607 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.54 -37.43 84.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.453 179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.607 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -60.05 -30.85 69.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.898 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.2 -32.01 66.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.762 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmt-85 -68.8 -48.71 62.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.559 ' HB ' HH21 ' A' ' 51' ' ' ARG . 29.7 t -75.05 -51.01 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.4 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.56 -67.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.296 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.06 33.03 82.48 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.446 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -100.4 -81.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 110.959 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 m -149.25 146.14 20.65 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.91 2.13 7.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.584 2.189 . . . . 0.0 112.489 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -1.55 26.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.099 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.77 145.29 50.04 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 158.28 54.6 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.517 2.145 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 m -117.04 163.21 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.6 136.6 46.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.623 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.27 168.32 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.817 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 8.3 t -122.57 133.35 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.949 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.91 HG21 HG23 ' A' ' 74' ' ' ILE . 1.1 p -143.39 179.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.627 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -89.3 -42.99 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.931 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.3 t -164.21 170.21 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.089 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HA ' HD11 ' A' ' 74' ' ' ILE . 6.8 t -56.94 -34.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.662 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -67.28 -29.84 69.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.936 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 58.8 mm-40 -73.53 -19.84 60.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.39 60.82 0.8 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.034 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.625 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 44.1 Cg_exo -56.08 -92.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.972 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.442 ' H ' ' HB2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -73.64 22.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.234 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 3.3 m-85 -92.89 -51.95 4.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -128.19 170.51 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.793 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.05 109.21 24.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -102.22 -169.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.108 2.539 . . . . 0.0 112.475 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.947 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -127.61 170.26 12.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.009 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.85 -111.23 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.933 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -25.53 35.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 0.0 110.985 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.947 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -59.97 -53.63 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.629 ' HB3' ' O ' ' A' ' 81' ' ' SER . 1.6 tpp -73.76 -24.16 59.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.098 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -55.55 -40.37 71.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.581 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -67.6 -40.54 84.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 178.326 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.492 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 12.0 tpt -61.69 -50.07 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.441 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.551 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.83 -6.26 46.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.529 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.581 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.2 ttm180 -67.29 -24.88 65.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 pt -111.07 49.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -128.05 150.37 73.54 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.18 179.06 32.11 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.392 0.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.15 174.34 26.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.72 39.91 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.671 2.248 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -98.74 138.43 35.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 7.7 m -97.92 141.45 30.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.654 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.556 HG13 ' HB ' ' A' ' 119' ' ' ILE . 2.5 p -126.18 99.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.18 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.732 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 65.3 t -96.7 117.13 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -126.12 -166.3 1.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.63 178.32 5.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.621 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.665 HH22 HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -120.1 143.6 48.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.659 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.94 -170.56 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.19 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.28 35.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.499 HD22 ' HD2' ' A' ' 107' ' ' PRO . 1.9 mt -69.86 146.3 51.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.852 0.358 . . . . 0.0 110.816 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.561 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 36.8 mm -80.1 -49.15 1.27 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.9 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.7 Cg_exo -50.22 94.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.482 2.121 . . . . 0.0 112.857 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.747 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.5 OUTLIER -82.45 -3.47 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.7 179.227 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 t -74.2 -24.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.292 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.665 HD12 HH22 ' A' ' 102' ' ' ARG . 1.3 pt -98.27 -42.23 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.747 HG22 ' HA ' ' A' ' 108' ' ' ASP . 14.5 t -75.8 -14.54 60.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.814 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.8 -151.72 37.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.657 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.33 -26.4 57.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 m -106.29 175.54 5.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 111.001 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.49 67.65 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -142.12 131.49 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.656 HG21 HH21 ' A' ' 102' ' ' ARG . 59.8 t -139.85 140.89 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.786 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -98.95 162.4 20.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.384 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.556 ' HB ' HG13 ' A' ' 98' ' ' VAL . 10.3 mt -141.8 164.31 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -149.8 127.15 11.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 t -110.4 88.55 7.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.892 ' HB2' HG21 ' A' ' 33' ' ' THR . 78.6 Cg_endo -76.97 -179.35 5.34 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.59 2.193 . . . . 0.0 112.533 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.43 5.45 51.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -72.4 108.29 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -57.29 -43.05 82.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 130' ' ' ILE . 31.2 mm -64.16 -53.62 41.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.88 -17.68 61.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 7.6 ttt180 -75.49 -44.68 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -54.61 11.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.531 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.0 tt -57.31 -43.08 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.552 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.36 -25.8 62.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.418 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -54.55 -58.05 8.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.013 0.435 . . . . 0.0 109.88 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -76.74 -83.28 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.243 177.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.415 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -76.62 114.48 39.08 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.62 144.39 72.15 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.368 2.045 . . . . 0.0 111.565 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 41' ' ' VAL . 1.6 t -127.65 161.99 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.845 0.355 . . . . 0.0 111.267 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.606 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.47 139.26 36.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.063 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -131.07 107.48 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.381 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -132.75 141.41 48.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.9 p -80.72 115.74 20.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.86 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -83.51 90.21 7.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.07 33.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.942 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.58 ' N ' ' HG2' ' A' ' 147' ' ' PRO . 0.4 OUTLIER -81.13 -154.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.421 ' H ' HG22 ' A' ' 143' ' ' ILE . 0.6 OUTLIER -56.07 155.6 6.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.741 0.305 . . . . 0.0 110.887 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 82.1 -142.1 22.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.244 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.14 67.46 70.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.547 0.213 . . . . 0.0 111.114 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.58 ' HG2' ' N ' ' A' ' 143' ' ' ILE . 38.9 Cg_exo -60.29 -48.42 11.8 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.265 1.977 . . . . 0.0 113.172 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.6 Cg_exo -64.74 104.19 0.53 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.932 1.754 . . . . 0.0 111.862 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.7 t -77.08 149.54 79.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.211 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -95.21 -18.73 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.81 2.34 . . . . 0.0 112.403 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.64 141.41 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.54 HD22 HG22 ' A' ' 165' ' ' VAL . 49.7 mt -64.47 -43.95 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.72 -17.18 63.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -75.06 -39.97 60.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.12 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 1.029 HD12 HG23 ' A' ' 165' ' ' VAL . 7.9 mt -65.3 -56.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.201 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -55.84 -40.86 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.32 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -65.41 -50.48 65.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.666 ' HB3' HD22 ' A' ' 159' ' ' LEU . 8.0 t0 -63.68 -35.17 79.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.771 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -110.88 75.32 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t0 -15.95 -64.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.117 0.886 . . . . 0.0 112.85 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -150.97 11.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.685 0.279 . . . . 0.0 111.35 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -81.15 -62.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.831 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.665 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 1.4 t0 -103.03 97.13 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.847 ' HG ' HG21 ' A' ' 22' ' ' VAL . 2.8 mm? -74.49 129.13 37.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.557 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 1.029 HG23 HD12 ' A' ' 155' ' ' ILE . 2.4 p -66.31 -179.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.306 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.805 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.31 147.33 49.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.484 179.224 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.9 -26.8 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.951 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.661 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -64.64 -54.08 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.88 0.372 . . . . 0.0 111.343 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.804 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 98.24 -165.64 21.76 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.945 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -71.94 -165.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.431 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -141.68 -51.74 0.42 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.322 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -132.33 -135.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 175' ' ' GLU . 4.4 t0 -86.57 154.81 20.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.778 0.323 . . . . 0.0 111.667 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.694 ' HB2' HG23 ' A' ' 36' ' ' ILE . 19.3 ptm -70.9 17.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.434 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 173' ' ' ASP . 1.5 mt-10 -155.35 157.86 31.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.563 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -95.67 -151.89 0.28 Allowed 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.185 -1.173 . . . . 0.0 112.662 1.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.55 96.74 1.93 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 191' ' ' ARG . 97.0 m -100.97 135.51 42.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.231 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 21.0 t -127.64 104.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.66 HG12 ' HA ' ' A' ' 189' ' ' VAL . 36.9 mt -109.11 127.71 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.462 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.2 m-20 -89.35 74.71 7.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.303 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.645 HD12 HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -68.51 79.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -84.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 3.1 t -121.0 -128.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.66 177.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 57.7 t30 -60.24 -51.74 78.09 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 68.3 Cg_endo -74.32 109.02 2.81 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.19 1.927 . . . . 0.0 112.637 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 84.7 Cg_endo -82.8 120.83 3.15 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.611 2.207 . . . . 0.0 112.157 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 1.2 mpp_? -87.87 53.17 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.131 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.73 97.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.71 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.96 89.41 3.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.269 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.578 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -91.17 131.9 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -83.63 -20.62 33.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -82.98 84.09 1.57 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.59 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -93.46 83.05 4.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.311 . . . . 0.0 110.969 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -80.69 162.37 45.11 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.542 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.05 166.99 27.98 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.586 2.19 . . . . 0.0 112.264 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.02 106.63 4.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.855 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.7 -51.36 21.53 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.403 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.19 90.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.14 1.893 . . . . 0.0 112.263 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 200' ' ' VAL . 3.2 m -73.52 153.96 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.012 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -107.01 37.51 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -46.23 62.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.001 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.85 3.23 33.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -135.17 73.8 0.44 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.531 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -102.31 -24.65 13.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.299 . . . . 0.0 111.054 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 131.29 -78.55 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.593 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.86 89.48 3.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.071 -179.902 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtm . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.87 -71.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 mm -81.51 107.01 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -109.77 172.46 6.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.737 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.25 -176.94 2.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.965 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 tt -76.63 140.25 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.004 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 t -70.22 -176.41 1.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.83 172.27 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.945 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -82.91 112.76 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.526 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 1.9 m-20 -90.76 -52.12 0.31 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.403 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 10' ' ' ASN . 34.7 Cg_exo -60.04 139.28 86.88 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.14 1.894 . . . . 0.0 112.101 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -161.52 107.18 1.2 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.058 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 52.2 Cg_endo -69.15 171.36 13.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.534 2.156 . . . . 0.0 112.259 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.53 -32.98 73.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -68.14 -36.67 76.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.085 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.598 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.13 -39.77 71.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.15 -24.79 65.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.791 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -33.93 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -67.67 -37.3 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.835 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 16' ' ' LEU . 7.8 mm -75.11 -18.71 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -73.41 -44.98 57.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.053 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.634 ' HB ' HD13 ' A' ' 164' ' ' LEU . 14.1 p -68.46 -31.19 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 53.0 mtt -66.99 -31.24 71.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.861 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.12 -35.26 64.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.053 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.16 10.32 69.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.661 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.01 58.88 9.47 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.529 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.27 160.52 22.03 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.26 146.9 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.434 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.699 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.94 133.03 64.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -102.58 154.14 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.62 0.248 . . . . 0.0 110.946 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.8 OUTLIER -158.47 100.13 1.71 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.762 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 4.7 Cg_exo -78.01 142.29 19.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.975 2.45 . . . . 0.0 111.299 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.5 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 88.4 m -138.62 -82.4 0.3 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 112.304 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 6.0 m-20 -75.36 -78.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.738 ' HA ' ' HG3' ' A' ' 174' ' ' MET . 0.8 OUTLIER -79.4 -88.59 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.366 -177.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.59 -150.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 7.4 m-85 -69.81 141.2 53.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.05 -177.22 17.77 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.911 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.5 mp -122.7 140.21 53.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -147.22 110.35 0.51 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 42' ' ' ASN . 2.6 p -153.48 156.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 111.099 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 41' ' ' VAL . 3.0 m120 -55.05 101.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.025 0.44 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.68 76.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.938 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.4 18.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.048 0.452 . . . . 0.0 111.238 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.84 156.97 20.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.565 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER -75.27 -30.32 60.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.973 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.485 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 6.9 m-20 -62.48 -32.32 73.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.093 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.65 -34.1 71.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.42 -44.79 83.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -66.88 -44.52 80.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.772 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.49 ' NH2' HG23 ' A' ' 162' ' ' VAL . 51.9 mmt-85 -67.01 -23.7 65.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.15 -53.58 19.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -65.86 -14.89 62.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -66.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.313 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.68 HG22 HG12 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -75.56 -38.48 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -1.54 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.385 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.23 -148.57 50.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -98.61 117.6 33.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 3.2 p -153.35 69.65 6.72 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.822 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.25 1.36 5.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.772 2.314 . . . . 0.0 112.619 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.643 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.8 m80 -114.21 -21.68 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.206 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 8.7 mtpt -88.11 126.43 60.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.28 174.5 7.04 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.451 2.101 . . . . 0.0 112.069 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 110' ' ' ILE . 2.5 m -113.06 153.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.028 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 t -111.3 132.39 54.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.463 HD11 HG12 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -111.67 172.74 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.778 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 3.0 p -119.56 135.31 54.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.725 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -143.69 173.18 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.704 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -83.0 -39.94 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.996 0.427 . . . . 0.0 110.426 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.1 165.75 21.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.637 ' HA ' HD11 ' A' ' 74' ' ' ILE . 18.5 t -55.41 -33.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.769 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.29 -31.36 71.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.116 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.656 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 9.2 mm-40 -71.07 -21.41 62.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.152 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.725 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.27 63.73 0.92 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.791 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.648 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 27.9 Cg_exo -62.29 -76.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.211 1.941 . . . . 0.0 112.38 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.21 23.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.143 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -102.5 -53.04 2.97 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.262 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 22.5 p -123.01 177.24 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 9.2 mtt-85 -113.64 88.76 14.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 78' ' ' SER . 94.2 Cg_endo -102.74 -169.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.241 2.627 . . . . 0.0 112.786 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 2.2 t -145.96 179.21 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.853 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.33 -86.46 0.3 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.046 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -54.96 -32.71 61.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.346 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.595 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -60.29 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.0 110.871 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.564 ' HE1' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.5 -17.91 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.617 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 2.5 mm-40 -59.14 -51.63 69.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.279 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.5 OUTLIER -64.37 -32.81 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.273 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.633 ' HG3' ' HE2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -65.51 -49.39 69.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.463 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -70.22 -8.76 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.265 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -75.02 -20.21 59.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 ' CE1' ' A' ' 96' ' ' TYR . 1.7 mt -108.35 13.18 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.728 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 4.2 pp -131.2 166.07 30.52 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.544 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.728 ' HA ' ' HB2' ' A' ' 92' ' ' LEU . 97.2 Cg_endo -78.87 162.69 87.1 Favored 'Cis proline' 0 C--N 1.354 0.819 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.91 -0.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.88 -151.04 22.81 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.442 ' HG3' ' HD2' ' A' ' 176' ' ' PRO . 85.6 Cg_endo -78.08 35.12 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.411 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.633 ' HE2' ' HG3' ' A' ' 88' ' ' MET . 16.9 t80 -92.62 135.35 34.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.592 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 13.2 m -114.02 120.23 39.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.529 ' HB ' ' HE2' ' A' ' 88' ' ' MET . 0.2 OUTLIER -115.92 108.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.224 0.535 . . . . 0.0 111.551 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.906 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -105.66 128.73 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.435 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.564 HD21 ' HE1' ' A' ' 85' ' ' MET . 1.1 mt -126.59 -172.44 2.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 1.7 tt0 -74.42 -176.65 2.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.296 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.812 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.71 141.36 49.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 111.279 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 7.7 t30 -74.54 -177.02 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.943 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.43 52.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.838 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 4.5 tp -79.97 134.84 36.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 27.4 mt -72.27 -50.58 8.51 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.428 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.838 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 71.0 Cg_exo -51.9 109.1 0.29 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.304 2.003 . . . . 0.0 112.327 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.631 ' HA ' HG22 ' A' ' 111' ' ' THR . 4.4 p-10 -81.98 -19.82 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.182 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.25 -15.38 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.197 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 107' ' ' PRO . 48.1 mt -98.15 -43.08 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.631 HG22 ' HA ' ' A' ' 108' ' ' ASP . 10.3 t -77.0 -12.78 59.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.44 -155.73 49.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.455 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -82.44 -13.65 78.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.397 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.86 -175.06 2.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.782 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.411 ' CA ' ' HD2' ' A' ' 102' ' ' ARG . 3.0 m -112.91 44.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -137.22 159.91 40.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.063 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 102' ' ' ARG . 84.1 t -139.79 143.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.596 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -99.33 152.49 19.56 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.328 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.637 HD13 HD13 ' A' ' 74' ' ' ILE . 19.4 mt -145.92 149.61 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.3 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -148.56 137.07 21.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.215 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.26 88.03 6.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.757 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.532 ' HD2' ' NH2' ' A' ' 128' ' ' ARG . 30.6 Cg_endo -63.95 -177.68 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.591 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -92.83 8.11 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.21 -179.414 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.55 115.06 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.984 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -57.46 -56.37 22.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.663 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.488 ' CG2' HD21 ' A' ' 16' ' ' LEU . 66.7 mt -60.61 -48.47 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.444 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.2 t -57.49 -16.95 11.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.704 ' HE ' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -75.4 -55.04 6.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.149 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -51.09 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.652 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 tt -59.62 -40.22 81.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.597 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.75 -26.49 61.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.13 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.45 -54.76 36.58 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -75.98 -88.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.2 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 19.0 m-85 -77.85 119.18 76.38 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.456 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 21.6 Cg_exo -65.64 156.41 63.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.405 2.07 . . . . 0.0 111.605 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.521 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.2 t -134.9 159.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.208 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 29.0 m -80.85 139.24 36.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.1 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.778 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . . . -133.42 106.38 7.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.801 0.334 . . . . 0.0 111.62 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -136.75 122.05 19.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.976 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.1 111.36 3.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -81.55 103.71 11.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -160.23 29.14 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.68 HG12 HG22 ' A' ' 55' ' ' VAL . 1.1 pt -79.09 -157.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.047 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.8 p -57.41 163.34 2.37 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.931 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.416 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 83.35 -144.18 22.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.344 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.21 69.38 74.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.681 0.277 . . . . 0.0 110.914 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 42.5 Cg_exo -60.7 -47.48 13.36 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.562 2.175 . . . . 0.0 113.69 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 72.7 Cg_endo -76.36 121.23 5.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.906 1.737 . . . . 0.0 112.601 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -97.32 147.77 33.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.798 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -95.99 -13.72 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.913 2.408 . . . . 0.0 113.204 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -134.58 140.06 45.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.01 72.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.583 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.68 -17.43 63.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -75.27 -37.56 60.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.876 HD12 HG23 ' A' ' 165' ' ' VAL . 49.1 mt -67.48 -45.15 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.355 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.43 -28.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -75.7 -54.22 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.436 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.04 -43.96 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.722 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.564 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.7 mm? -90.5 66.59 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 159' ' ' LEU . 5.0 t70 -16.68 -64.35 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.062 0.851 . . . . 0.0 112.761 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.35 25.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.652 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.77 -68.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.722 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.652 ' H ' HG13 ' A' ' 162' ' ' VAL . 1.7 p-10 -111.1 96.55 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.676 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -59.68 130.42 46.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.199 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.876 HG23 HD12 ' A' ' 155' ' ' ILE . 3.6 p -67.34 175.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.88 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.682 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.62 124.92 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 111.172 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 -7.54 45.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.274 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.94 73.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.38 123.2 5.21 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 9.5 p-10 -73.25 -166.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.895 0.379 . . . . 0.0 111.259 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 5.1 m -136.49 -168.5 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.554 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 39.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -83.37 46.36 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.858 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.738 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 9.1 ttm -59.15 -17.97 31.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.467 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -139.92 136.05 16.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 95' ' ' PRO . 84.1 Cg_endo -83.68 -151.93 0.73 Allowed 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.452 0.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.419 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -153.69 92.59 1.58 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.685 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -102.27 129.92 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 98.3 t -128.02 100.82 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.378 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.826 HG12 ' HA ' ' A' ' 189' ' ' VAL . 73.8 mt -116.29 139.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.827 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.906 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.8 m-20 -107.48 58.69 0.62 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 187' ' ' PRO . 9.7 tp -69.96 105.78 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.391 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.478 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -83.29 -88.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.242 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.7 t -120.96 -83.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.646 0.26 . . . . 0.0 111.371 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.527 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.0 OUTLIER -89.01 -52.14 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.67 -179.053 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.36 106.75 1.37 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.248 1.965 . . . . 0.0 112.491 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.658 ' HB3' HD13 ' A' ' 182' ' ' LEU . 98.2 Cg_endo -84.27 129.57 4.48 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.752 2.301 . . . . 0.0 112.499 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.611 ' HD3' ' HB2' ' A' ' 181' ' ' ASP . 9.2 mtt180 -90.48 50.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.826 ' HA ' HG12 ' A' ' 180' ' ' ILE . 47.8 t -56.47 105.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.28 83.57 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.132 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 191' ' ' ARG . 8.1 ptt180 -85.95 174.1 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.26 109.66 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.737 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.03 81.41 1.6 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.607 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.85 110.42 22.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.73 0.3 . . . . 0.0 110.822 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.518 ' O ' HD23 ' A' ' 197' ' ' LEU . . . -83.56 -108.12 0.53 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.68 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.17 118.27 5.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.519 2.146 . . . . 0.0 112.555 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -149.24 171.26 16.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.789 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.403 ' OD2' HG13 ' A' ' 200' ' ' VAL . 6.0 t70 -74.56 133.4 77.08 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.031 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.415 ' HA ' HD13 ' A' ' 202' ' ' LEU . 85.3 Cg_endo -82.22 45.25 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.65 2.233 . . . . 0.0 112.368 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.566 HG23 ' H ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -55.31 -74.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.308 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.566 ' H ' HG23 ' A' ' 200' ' ' VAL . 0.3 OUTLIER -114.85 48.31 1.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.992 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -67.18 -60.97 2.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' A' ' 203' ' ' ARG . 8.6 ptp180 -72.95 143.1 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -170.5 176.89 43.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.544 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -106.91 150.43 26.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.721 0.296 . . . . 0.0 111.002 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 151.56 -0.99 0.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -105.77 -22.73 12.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.754 0.311 . . . . 0.0 110.916 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.073 179.89 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.82 0.343 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.71 -175.74 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tp -85.83 150.54 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.408 ' H ' ' HG2' ' A' ' 4' ' ' ARG . 1.6 ptt180 -104.69 172.63 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.006 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 161.28 20.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tt -102.99 141.31 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.05 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -71.09 120.62 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.003 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.65 167.96 11.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.976 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -98.22 53.78 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.929 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.53 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -76.24 -50.97 2.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.49 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 10' ' ' ASN . 43.6 Cg_endo -67.91 -52.18 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.091 1.86 . . . . 0.0 112.439 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.7 122.05 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.91 128.55 17.99 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.523 2.148 . . . . 0.0 112.32 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.86 -33.97 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.798 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG11 HG13 ' A' ' 126' ' ' ILE . 26.2 t -61.51 -40.14 85.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.602 HD22 HG23 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -68.43 -34.77 76.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.723 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.09 -26.58 63.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.65 -37.22 68.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.654 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -66.08 -37.25 85.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.814 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 16' ' ' LEU . 22.8 mm -75.3 -23.95 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 t -68.18 -47.75 67.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.57 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.3 p -69.72 -31.02 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 1.7 mtt -71.23 -27.91 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.075 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.84 -33.82 76.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.81 73.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.519 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.35 65.48 2.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.36 175.84 16.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.413 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' ' 39' ' ' LEU . 2.2 tp -96.04 142.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.661 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.69 121.15 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -102.06 165.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -169.91 86.28 0.57 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 73.0 Cg_endo -75.09 118.97 5.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.265 1.977 . . . . 0.0 111.009 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.855 ' HA ' ' H ' ' A' ' 171' ' ' CYS . 1.0 OUTLIER -116.31 -137.29 0.36 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.034 0.445 . . . . 0.0 111.68 -176.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -54.24 -46.56 72.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.202 -179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.8 -122.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.485 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.471 ' H ' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -112.51 -158.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 110.9 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -69.99 115.46 9.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA3' HH22 ' A' ' 120' ' ' ARG . . . -116.16 126.48 7.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.525 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.68 ' HB2' HD11 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -111.17 138.77 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 111.199 -178.126 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.18 160.52 28.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.987 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.494 ' CG1' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -158.95 -169.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.047 -178.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.725 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -56.14 124.0 16.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.197 178.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.09 -67.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.226 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.1 mm? -80.84 42.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 111.625 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.33 152.82 25.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.849 178.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.28 -30.28 60.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.89 -25.5 68.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -69.88 -38.88 76.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 t -72.34 -37.63 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -67.66 -37.73 82.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.093 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -75.19 -20.29 59.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.036 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -44.92 66.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.956 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -75.26 -27.94 59.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -68.58 -56.52 7.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 143' ' ' ILE . 17.4 t -66.72 -49.42 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.429 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -72.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.285 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.64 78.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.656 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.86 -69.31 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.91 98.7 11.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.73 14.72 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.567 2.178 . . . . 0.0 112.448 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -104.88 -7.35 19.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.6 148.5 44.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.978 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.56 165.13 1.78 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.662 2.241 . . . . 0.0 112.319 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.3 159.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.27 138.49 43.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.565 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 118' ' ' GLY . 22.6 pt -114.76 169.08 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.502 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 118.22 27.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.854 HG11 HG12 ' A' ' 74' ' ' ILE . 1.5 p -135.86 -179.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.634 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.65 -40.1 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.042 0.449 . . . . 0.0 110.582 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 166.73 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.562 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.671 HG21 ' SD ' ' A' ' 85' ' ' MET . 3.3 t -59.17 -29.38 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.31 -27.51 67.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.777 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HG3' ' OG ' ' A' ' 69' ' ' SER . 12.8 mm-40 -79.31 -22.87 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.854 HG12 HG11 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.74 56.67 0.71 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 42.8 Cg_endo -68.35 -62.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.857 1.705 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -72.89 4.09 4.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.559 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 66' ' ' ILE . 1.8 t80 -92.2 -64.54 1.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.736 0.303 . . . . 0.0 110.837 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.06 -178.03 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -116.59 116.62 38.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.956 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 71' ' ' VAL . 69.1 Cg_endo -102.07 -176.71 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.203 2.602 . . . . 0.0 112.558 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.923 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 29.5 t -143.4 173.08 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.99 -103.25 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.129 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 86' ' ' GLU . 1.5 m-20 -55.17 -26.54 39.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -60.61 -51.95 67.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.989 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.671 ' SD ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -74.26 -21.01 59.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -63.61 -44.83 92.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -44.65 95.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.578 ' HE1' HD13 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -66.4 -29.98 70.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.696 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.7 mt-10 -72.39 -17.3 61.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.082 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -75.22 -13.82 60.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.179 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 41.95 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 89' ' ' GLU . 1.8 pp -127.27 146.65 58.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.994 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.59 -171.95 10.59 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.37 -1.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.35 163.42 12.29 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.856 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.0 Cg_endo -81.06 48.78 3.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -107.5 159.68 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.57 138.84 44.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.632 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.07 106.58 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.285 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.763 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 14.0 t -103.85 122.48 56.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.427 HD21 ' HE3' ' A' ' 85' ' ' MET . 1.2 mp -126.36 -167.66 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.442 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -177.53 3.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.314 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.769 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.8 147.87 44.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.091 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 8.7 t30 -74.28 -173.21 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.39 38.38 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.826 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 10.8 tp -76.63 127.77 33.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.79 0.329 . . . . 0.0 110.799 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.57 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.5 mt -75.68 -50.34 3.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.692 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.826 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 76.4 Cg_exo -50.58 108.32 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.267 1.978 . . . . 0.0 112.443 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.592 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.8 OUTLIER -80.82 1.37 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.73 -15.02 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 107' ' ' PRO . 4.3 mt -109.5 -44.33 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 108' ' ' ASP . 8.8 t -77.26 -9.63 58.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.834 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.35 -150.25 38.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.7 -10.52 67.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.549 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.3 p -117.02 -171.35 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.757 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.573 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.4 p -109.67 64.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.702 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -140.42 152.59 45.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.012 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 102' ' ' ARG . 92.9 t -139.86 135.07 38.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.411 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.557 ' O ' HG12 ' A' ' 66' ' ' ILE . . . -99.21 155.99 19.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.563 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.638 HD12 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.06 173.23 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' H ' HG22 ' A' ' 119' ' ' ILE . 3.2 ttp180 -157.29 117.5 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 111.392 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.87 79.38 1.85 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.846 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.57 -170.47 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.594 2.196 . . . . 0.0 112.548 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.11 23.01 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.104 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.69 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.1 t0 -82.2 96.06 7.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.57 -44.99 85.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.602 HG23 HD22 ' A' ' 16' ' ' LEU . 30.6 mm -64.91 -53.42 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.947 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 14.5 t -63.11 -12.78 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.507 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 6.4 ttt85 -75.47 -42.85 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -73.25 -54.46 8.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.518 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.18 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.299 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.13 -26.6 63.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.36 -53.79 49.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -89.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.824 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 90.1 m-85 -77.74 123.16 86.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 20.7 Cg_exo -65.51 163.53 29.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.06 146.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 111.517 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.418 HG21 ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -74.47 151.24 39.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.746 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.29 114.87 8.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.952 0.406 . . . . 0.0 111.939 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.52 148.51 50.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.54 124.9 29.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . -69.75 119.59 14.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.199 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.463 ' HA ' ' HG2' ' A' ' 147' ' ' PRO . 2.4 t30 -162.61 31.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 55' ' ' VAL . 4.7 tt -68.37 171.17 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.3 p -54.04 149.18 9.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.014 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.75 -136.74 13.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.557 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -116.72 90.26 31.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.554 0.216 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.471 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.9 Cg_exo -60.55 -50.57 6.56 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.423 2.082 . . . . 0.0 113.136 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 86.3 Cg_endo -82.26 125.62 4.63 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.924 1.749 . . . . 0.0 112.571 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.08 154.63 38.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -95.85 -10.67 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.72 2.28 . . . . 0.0 112.972 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.35 139.54 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.389 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -65.53 -45.25 84.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.853 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.24 -18.5 65.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.611 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -40.92 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.77 HD12 HG23 ' A' ' 165' ' ' VAL . 24.0 mt -69.29 -37.87 76.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.217 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.11 -44.17 95.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.42 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -75.45 -46.9 29.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.753 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.676 ' HB3' HD22 ' A' ' 159' ' ' LEU . 6.3 t70 -70.18 -43.45 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.574 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.8 mm? -100.23 67.11 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -16.59 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.048 0.843 . . . . 0.0 112.848 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.44 25.09 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.649 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.55 -69.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.553 179.031 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.677 ' HA ' HG23 ' A' ' 28' ' ' ILE . 1.2 p-10 -108.29 99.51 8.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.498 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.57 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.97 130.2 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.735 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.77 HG23 HD12 ' A' ' 155' ' ' ILE . 1.9 p -64.33 -170.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.948 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.768 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.53 119.95 28.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.155 0.502 . . . . 0.0 111.426 -178.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.4 -0.69 57.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.076 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.591 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -75.75 -38.71 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.82 64.85 1.7 Allowed Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.767 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.844 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 7.3 m-20 -73.14 -124.0 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.859 -0.2 . . . . 0.0 110.744 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.855 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -141.72 -170.1 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.232 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.86 10.1 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -64.63 91.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.149 0.5 . . . . 0.0 111.364 -176.177 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.404 ' HG3' HG23 ' A' ' 36' ' ' ILE . 10.0 ttt -55.04 -15.79 2.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.857 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -139.68 150.58 63.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.055 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.95 -151.92 0.66 Allowed 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 123.497 -1.46 . . . . 0.0 112.533 0.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -153.91 115.21 4.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.18 46.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.333 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.4 t -129.24 105.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.564 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 189' ' ' VAL . 3.7 mp -121.2 132.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.763 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -95.3 71.86 3.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.553 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 0.0 OUTLIER -68.37 84.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.299 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -88.0 0.08 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.414 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.72 -128.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.6 OUTLIER -59.33 -51.17 83.32 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.36 106.27 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.238 1.958 . . . . 0.0 112.371 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 96.1 Cg_endo -84.29 140.56 8.67 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.601 2.2 . . . . 0.0 112.401 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.67 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.2 mmm-85 -97.18 59.31 1.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.473 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.699 ' HA ' HG23 ' A' ' 180' ' ' ILE . 43.2 t -58.24 107.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.117 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.01 80.36 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -99.2 143.45 29.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -84.51 81.62 8.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -89.14 114.48 4.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.6 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 21.74 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -81.03 -99.48 0.36 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.448 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.97 76.22 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.787 2.325 . . . . 0.0 112.179 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -7.92 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.981 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -69.59 123.48 88.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.876 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 35.1 Cg_exo -60.16 -57.91 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.604 2.203 . . . . 0.0 112.287 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.555 HG12 ' HB2' ' A' ' 202' ' ' LEU . 12.7 t -73.79 112.95 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.06 30.92 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.555 ' HB2' HG12 ' A' ' 200' ' ' VAL . 0.2 OUTLIER -66.12 -26.94 67.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.02 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.69 -72.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 144.46 163.48 10.02 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -94.23 -34.21 12.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.712 0.292 . . . . 0.0 111.102 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -134.77 105.81 0.57 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.46 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -93.86 -23.71 18.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.979 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 208' ' ' VAL . 10.1 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.143 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.789 0.328 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.1 171.56 9.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.901 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 mm -92.24 125.71 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -82.71 -171.1 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.007 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -171.41 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -105.65 143.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.156 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.518 ' N ' HG13 ' A' ' 6' ' ' ILE . 13.2 t -75.93 -178.63 4.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 8' ' ' ARG . 6.6 mtm180 -73.12 167.41 21.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.797 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -92.98 -76.73 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.888 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -110.1 132.31 21.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.77 -157.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.576 2.184 . . . . 0.0 112.162 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.35 111.35 16.48 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.7 172.52 5.63 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.63 2.22 . . . . 0.0 112.134 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -33.75 76.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.437 HG13 ' OE2' ' A' ' 18' ' ' GLU . 95.3 t -65.93 -35.67 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.135 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -47.08 70.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.87 -21.18 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.03 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' OE2' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.22 -34.21 61.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.661 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -70.42 -36.68 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.058 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.6 mm -69.71 -31.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m -64.04 -47.54 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 19' ' ' ALA . 4.4 p -64.47 -25.5 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.031 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.42 -47.24 86.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -23.71 61.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.983 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.35 -5.3 79.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.519 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.0 57.13 12.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.81 174.72 16.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -96.44 148.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.756 0.313 . . . . 0.0 110.67 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.553 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.8 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.744 HG22 ' H ' ' A' ' 31' ' ' TYR . 2.5 mt -102.38 174.23 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.744 ' H ' HG22 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -171.31 106.44 0.39 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' N ' ' A' ' 170' ' ' ASP . 87.2 Cg_endo -84.28 125.39 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.602 2.201 . . . . 0.0 111.506 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.62 -154.84 0.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 6.8 m-20 -54.7 -30.1 54.89 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.255 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 176' ' ' PRO . 0.2 OUTLIER -93.54 -118.23 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.18 -165.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.165 -179.593 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -71.87 126.02 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.537 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.2 121.19 2.79 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -112.16 149.32 32.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 0.0 112.062 -176.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 41' ' ' VAL . . . -144.93 169.04 26.8 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.946 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -159.27 -170.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.909 0.385 . . . . 0.0 111.118 -179.04 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.5 t30 -56.75 119.74 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.56 -63.23 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.37 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 44' ' ' LEU . 1.2 mm? -78.33 33.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 111.863 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 1.1 m-20 -111.28 147.68 34.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.973 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -75.57 -29.63 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.305 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.71 -25.68 63.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -72.33 -31.48 65.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.145 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.13 -45.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.496 ' NH2' ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -67.75 -34.92 77.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 24.2 mmt180 -73.64 -35.1 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.1 OUTLIER -67.23 -24.65 65.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.846 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -46.68 32.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.384 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -54.46 -48.21 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.391 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.447 HG13 ' CB ' ' A' ' 142' ' ' ASN . 10.7 t -75.21 -49.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.36 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.737 ' HE3' ' HB2' ' A' ' 58' ' ' ARG . 14.7 tptt -93.69 -71.25 0.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.411 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.85 15.33 34.32 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.697 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.737 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 76.7 mtp85 -118.23 22.91 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -149.7 66.21 8.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.93 -54.94 4.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.575 2.184 . . . . 0.0 112.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.424 ' O ' ' HA3' ' A' ' 112' ' ' GLY . 32.2 p-80 -123.84 24.09 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.137 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.619 ' HE3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -88.55 146.55 37.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.619 ' HD2' ' HE3' ' A' ' 62' ' ' LYS . 76.9 Cg_exo -51.74 148.32 22.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.662 2.241 . . . . 0.0 112.559 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.9 166.13 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.58 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 0.4 OUTLIER -106.92 140.22 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 118' ' ' GLY . 1.8 pt -116.21 171.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.6 t -122.8 125.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.504 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.876 HG21 HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -135.97 -179.11 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.878 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.608 ' H ' HG22 ' A' ' 68' ' ' VAL . 1.5 t -90.0 -44.07 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.79 0.328 . . . . 0.0 110.956 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -163.71 174.91 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.089 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HA ' HD11 ' A' ' 74' ' ' ILE . 5.8 t -58.38 -37.37 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.834 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 1.0 OUTLIER -67.13 -22.12 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.837 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.63 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -80.43 -20.92 42.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.139 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.876 HG23 HG21 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -113.63 54.6 0.61 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 29.5 Cg_endo -62.41 -82.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.834 1.689 . . . . 0.0 111.828 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -73.41 19.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.336 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' PRO . 59.9 m-85 -103.26 -34.81 8.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.755 0.312 . . . . 0.0 111.108 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.456 ' OG ' HD11 ' A' ' 119' ' ' ILE . 2.2 m -135.33 165.5 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -112.76 105.01 56.09 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.415 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 86.3 Cg_endo -102.57 179.72 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.169 2.579 . . . . 0.0 112.619 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 -173.45 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.11 -82.47 0.44 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.713 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -57.64 -26.71 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.927 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.471 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -63.41 -48.25 78.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 9.6 mmt -70.44 -15.81 62.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.713 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mm-40 -66.44 -50.4 63.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.67 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 182' ' ' LEU . 2.7 tm? -61.77 -38.99 90.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.449 ' SD ' HD13 ' A' ' 182' ' ' LEU . 5.1 tpt -64.94 -49.67 69.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.437 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -72.88 -2.59 21.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.368 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.99 -58.88 3.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.295 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.3 74.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.629 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.74 149.22 72.82 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.071 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.72 -148.5 0.51 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.18 -1.175 . . . . 0.0 111.952 -1.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.18 8.74 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.979 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.42 ' HB2' HG23 ' A' ' 35' ' ' THR . 3.9 Cg_exo -80.42 43.77 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.221 2.614 . . . . 0.0 112.151 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.497 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 3.6 p90 -112.23 -177.03 3.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -112.89 139.04 48.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.245 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.17 102.77 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.282 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.745 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -101.22 122.9 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -126.91 -179.04 4.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.714 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -74.86 -166.01 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.664 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -119.28 138.19 53.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.182 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -73.73 -163.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.315 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -39.19 82.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.325 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.576 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -69.46 100.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.688 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.4 pt -80.95 102.87 1.5 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.922 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 60.6 Cg_endo -70.91 138.43 34.16 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.429 2.086 . . . . 0.0 112.248 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.034 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 109' ' ' VAL . 7.0 p -87.43 23.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.922 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 57.7 mt -106.69 -54.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 110.894 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.677 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 6.2 t -87.57 -24.26 24.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.865 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 61' ' ' HIS . . . 69.31 -141.74 36.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.408 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.32 27.6 6.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.437 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' A' ' 63' ' ' PRO . 1.3 t -123.94 165.58 17.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.327 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -113.16 42.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 116' ' ' ARG . 2.3 mtp180 -136.74 163.63 30.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.52 142.28 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . -92.74 149.59 19.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.454 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.503 HD13 HD13 ' A' ' 74' ' ' ILE . 72.2 mt -144.98 150.26 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.41 124.03 12.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.88 0.371 . . . . 0.0 111.476 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.1 t -110.66 83.7 3.61 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.837 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.08 179.5 6.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.589 2.192 . . . . 0.0 112.614 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -93.13 19.65 7.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.108 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.471 ' HB2' ' SG ' ' A' ' 127' ' ' CYS . 66.1 m-20 -82.02 105.57 13.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' ARG . 5.4 pt-20 -57.35 -42.96 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.277 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mm -61.36 -58.13 8.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -58.58 -21.16 52.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.994 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 125' ' ' GLU . 1.8 mtp180 -68.17 -37.54 81.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 34.6 ttt-85 -75.25 -53.23 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.2 mt -59.19 -52.0 65.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.257 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.798 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.08 -27.86 69.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.63 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -51.27 66.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.997 0.427 . . . . 0.0 110.021 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.521 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -75.19 -91.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 177.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.521 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -77.92 144.87 68.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 178.136 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 159.53 49.19 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.185 1.923 . . . . 0.0 111.374 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 t -132.67 152.0 35.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.802 0.334 . . . . 0.0 111.244 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.466 HG21 ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -80.2 153.28 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.4 116.4 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 111.57 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.651 HG23 HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -142.42 140.89 32.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.697 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.439 ' O ' HG11 ' A' ' 55' ' ' VAL . 22.4 p -66.93 139.17 57.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.997 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.06 145.09 46.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.393 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.447 ' CB ' HG13 ' A' ' 55' ' ' VAL . 1.6 t-20 -165.96 46.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.803 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.479 ' O ' ' HG3' ' A' ' 147' ' ' PRO . 7.2 mm -61.06 160.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.8 m -59.4 142.35 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.727 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.07 -109.81 3.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 148' ' ' PRO . 0.4 OUTLIER -127.19 94.31 39.2 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.593 0.235 . . . . 0.0 111.029 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 43.1 Cg_exo -60.34 -48.12 12.55 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.498 2.132 . . . . 0.0 113.389 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.492 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 73.9 Cg_endo -75.07 90.41 1.09 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.802 1.668 . . . . 0.0 112.208 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.489 ' HB2' HG12 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -84.78 157.93 60.0 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -96.01 -11.27 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.902 2.401 . . . . 0.0 112.908 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -141.48 141.62 33.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.87 HD22 ' HA ' ' A' ' 166' ' ' LEU . 55.8 mt -60.19 -28.6 68.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.771 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -72.23 -34.45 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.361 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.54 ' HG3' HH21 ' A' ' 157' ' ' ARG . 3.9 tt0 -58.95 -47.07 86.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.804 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.542 ' H ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -74.44 -35.43 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -67.33 -20.91 27.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.072 0.463 . . . . 0.0 110.37 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.54 HH21 ' HG3' ' A' ' 154' ' ' GLU . 10.1 ttp180 -73.1 -46.31 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.431 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.17 -41.41 63.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.677 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 160' ' ' ASP . 2.7 mm? -111.22 68.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.7 t70 -15.93 -63.35 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.094 0.871 . . . . 0.0 112.817 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -157.02 18.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.321 . . . . 0.0 111.251 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.96 -42.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.909 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 25.5 m-20 -111.21 110.75 21.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.411 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.529 HD12 HG13 ' A' ' 29' ' ' VAL . 29.7 mt -74.71 61.93 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.746 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.646 HG13 ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -78.84 22.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.732 178.159 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.87 ' HA ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -148.21 34.81 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.499 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.501 ' OD1' ' HB3' ' A' ' 164' ' ' LEU . 4.3 m-20 -70.01 -84.09 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.385 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.638 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -86.35 -34.19 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.065 0.46 . . . . 0.0 110.673 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.59 27.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.468 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' HG2' ' A' ' 32' ' ' PRO . 2.9 m-20 -62.19 -177.55 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 0.0 111.214 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.9 t -140.16 -62.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.55 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -124.77 -135.61 0.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.495 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.7 144.78 26.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.9 ptm -70.32 2.4 3.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.054 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.72 151.29 26.45 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.626 ' O ' HG22 ' A' ' 35' ' ' THR . 64.5 Cg_endo -92.02 -136.64 0.1 OUTLIER 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.946 -1.273 . . . . 0.0 112.46 0.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.411 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -159.33 130.2 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.418 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 191' ' ' ARG . 32.6 m -101.29 139.72 36.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.923 0.392 . . . . 0.0 111.607 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.7 t -129.6 117.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.662 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.31 121.01 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.386 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -98.25 67.96 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.271 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 87' ' ' LEU . 4.4 tt -69.29 79.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 -78.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.92 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 185' ' ' ASN . 5.7 t -120.42 -119.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.381 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 2.1 m-20 -69.57 -52.65 13.95 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.97 109.55 2.6 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.108 1.872 . . . . 0.0 112.767 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.7 Cg_endo -75.97 122.67 6.87 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.444 2.096 . . . . 0.0 111.955 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.776 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 3.3 mmp_? -87.28 61.2 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.88 93.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.569 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -122.05 87.8 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.211 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.614 ' HB3' HG23 ' A' ' 178' ' ' THR . 1.5 ptm180 -89.41 142.81 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.057 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -84.59 2.94 39.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.867 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -95.92 -166.53 34.49 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.627 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -95.62 93.36 7.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -88.11 162.3 32.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.403 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.55 124.32 10.21 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.536 2.157 . . . . 0.0 112.334 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.46 -38.12 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.55 134.27 66.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.77 169.31 19.23 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.478 2.119 . . . . 0.0 112.301 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.9 t -72.04 97.64 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.645 HD23 ' HA3' ' A' ' 204' ' ' GLY . 0.2 OUTLIER -85.18 85.68 7.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.8 tp -88.31 -51.68 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.25 1.11 38.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.012 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.645 ' HA3' HD23 ' A' ' 201' ' ' LEU . . . -100.64 -97.09 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.493 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -109.4 -75.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 111.034 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 63.49 -157.2 41.45 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.455 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.75 -14.63 14.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.042 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.76 0.314 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.7 179.81 4.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mt -99.44 100.02 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.021 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -91.52 138.47 31.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.53 -167.96 2.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.01 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 tt -99.0 134.91 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.015 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 p -82.64 -178.78 7.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 98.45 9.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.691 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -109.08 8.64 26.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.049 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -98.28 104.85 25.34 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 35.9 Cg_endo -64.56 124.25 12.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.526 2.15 . . . . 0.0 112.084 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.28 82.44 11.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.99 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 16' ' ' LEU . 23.1 Cg_exo -64.65 171.76 7.86 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.663 2.242 . . . . 0.0 112.104 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.88 -26.53 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.488 HG13 ' OD2' ' A' ' 167' ' ' ASP . 44.9 t -75.11 -34.54 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.074 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 1.1 mm? -69.65 -47.0 64.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.97 -21.21 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -74.77 -35.88 62.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.679 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.57 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -67.56 -37.67 82.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.933 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.95 -35.18 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.647 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -33.52 75.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 18' ' ' GLU . 16.8 t -70.1 -32.29 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.0 mmt -61.33 -41.93 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.17 -11.23 60.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.12 -11.82 72.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 37.78 92.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.13 170.22 18.89 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.584 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.675 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -96.3 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.673 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.675 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.29 135.97 55.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -102.56 152.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.59 0.233 . . . . 0.0 110.586 178.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -160.13 102.5 1.4 Allowed Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.093 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.689 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.4 Cg_endo -82.18 136.3 8.94 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 0.0 111.327 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 -147.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.663 0.268 . . . . 0.0 111.277 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.601 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 8.0 t70 -54.5 -25.41 25.34 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.928 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 174' ' ' MET . 4.3 t -95.43 -120.54 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.586 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.7 HG12 ' H ' ' A' ' 37' ' ' TYR . 9.3 tt -111.77 -171.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.563 0.221 . . . . 0.0 110.876 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.7 ' H ' HG12 ' A' ' 36' ' ' ILE . 1.4 m-85 -63.33 129.02 38.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.778 0.323 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -121.14 177.68 16.38 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.146 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.654 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.6 mp -119.32 141.11 49.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.635 0.255 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.39 114.08 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 42' ' ' ASN . 3.4 p -153.29 161.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.511 0.195 . . . . 0.0 110.867 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.492 ' N ' HG22 ' A' ' 41' ' ' VAL . 5.9 t-20 -55.93 98.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.371 . . . . 0.0 110.346 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.62 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.108 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 9.2 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.086 0.469 . . . . 0.0 111.34 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.91 152.51 26.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.718 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.7 mt-10 -74.07 -19.16 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.825 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.47 -25.1 63.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.55 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.2 35.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.29 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 46' ' ' GLU . 32.6 m -65.17 -34.28 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.056 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -40.15 96.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.557 ' HG2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -62.2 -54.5 40.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.146 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.71 -27.29 39.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.293 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.57 -31.57 65.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.532 HH21 ' HA2' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -73.52 -40.58 63.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.015 -179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.5 t -75.12 -35.05 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.397 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.89 0.32 56.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.401 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 -115.37 7.92 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.604 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -100.42 105.12 16.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.871 0.367 . . . . 0.0 110.993 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 63.3 m -151.97 65.12 6.09 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.014 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.7 6.03 5.48 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.598 2.199 . . . . 0.0 112.448 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -122.36 -14.03 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.018 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 5.9 mmtp -88.16 129.19 50.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 35.0 Cg_exo -61.18 -175.1 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.549 2.166 . . . . 0.0 111.999 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.55 170.64 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -113.62 134.57 54.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 25.9 mm -116.42 159.24 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.387 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.888 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 1.6 t -119.15 141.24 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.153 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 74' ' ' ILE . 1.4 p -150.05 173.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.287 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.572 ' H ' HG22 ' A' ' 68' ' ' VAL . 7.5 t -89.84 -34.15 16.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 110.072 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.9 t -164.26 160.66 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.595 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.53 ' HA ' HD11 ' A' ' 74' ' ' ILE . 21.9 t -57.08 -32.56 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.624 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.35 -26.19 66.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.884 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.677 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -77.1 -22.82 52.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.207 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.646 HG12 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.61 60.11 0.83 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.677 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 23.5 Cg_exo -64.12 -73.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.158 1.906 . . . . 0.0 112.448 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 15.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.032 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 -34.93 6.98 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.157 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.569 ' HB2' HD23 ' A' ' 100' ' ' LEU . 93.4 p -135.49 164.2 28.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.0 110.991 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -114.52 103.22 55.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.756 ' HA ' HD11 ' A' ' 100' ' ' LEU . 74.3 Cg_endo -102.15 -169.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.177 2.585 . . . . 0.0 113.063 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -144.58 -174.85 4.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.06 -86.56 0.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.881 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -29.48 61.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.793 0.33 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 184' ' ' VAL . . . -58.44 -49.28 77.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.787 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.516 ' SD ' HG21 ' A' ' 71' ' ' VAL . 21.3 mmt -72.17 -17.91 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.956 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.67 -36.22 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.14 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 182' ' ' LEU . 2.8 tm? -64.18 -45.45 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.852 ' HB2' HD23 ' A' ' 182' ' ' LEU . 31.5 tpp -75.39 -26.56 58.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.376 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HA ' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -60.72 -40.76 93.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.399 . . . . 0.0 111.854 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -75.56 -18.46 59.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.4 mt -100.4 -11.29 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.525 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -112.08 151.89 43.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.007 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 174.84 50.58 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.904 -1.29 . . . . 0.0 112.202 0.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.32 -173.61 32.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.568 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.17 28.63 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.661 2.241 . . . . 0.0 112.437 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -101.59 143.36 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -106.96 136.24 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.635 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 182' ' ' LEU . 1.4 p -120.11 111.83 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.406 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.678 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 6.4 t -87.44 127.16 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.922 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' HA ' ' A' ' 80' ' ' PRO . 15.1 tp -124.8 178.22 5.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.562 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 1.6 mt-10 -74.4 -170.24 0.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.9 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.64 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.77 138.63 52.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.491 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 176.1 7.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.747 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.57 55.84 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.451 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 107' ' ' PRO . 1.8 mt -89.85 131.04 35.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 110.768 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.631 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.3 mp -66.84 -51.86 36.16 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.781 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.734 ' HD2' HD22 ' A' ' 105' ' ' LEU . 56.7 Cg_exo -52.21 105.17 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.236 1.957 . . . . 0.0 112.445 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -4.7 53.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 110' ' ' ILE . 14.5 p -71.96 -27.01 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.015 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.62 HG13 HG13 ' A' ' 109' ' ' VAL . 13.1 mt -93.87 -39.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.426 HG22 ' NE ' ' A' ' 102' ' ' ARG . 2.5 p -71.68 -23.21 61.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.6 -157.44 50.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.498 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.85 -21.26 71.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.0 m -108.39 -179.77 3.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.533 ' C ' ' HB2' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -112.98 59.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.029 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 mtm105 -142.72 158.58 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.64 HG23 ' HG2' ' A' ' 102' ' ' ARG . 39.5 t -139.93 117.11 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.61 117.9 4.54 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 74' ' ' ILE . 5.7 mt -130.14 150.43 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.8 0.333 . . . . 0.0 111.037 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.8 ptp180 -144.48 149.32 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.478 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -110.5 88.72 7.9 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.739 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 21.8 Cg_exo -64.81 -179.52 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.461 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.25 2.11 56.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.188 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 5.1 t0 -71.44 109.11 5.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.27 -40.51 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.243 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mm -69.94 -50.02 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.258 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 20.6 t -61.26 -18.79 60.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.2 OUTLIER -73.69 -46.79 44.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.878 179.688 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -52.54 60.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.562 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.5 mt -59.45 -55.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.309 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.74 -25.1 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.451 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB1' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -57.37 11.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.02 0.438 . . . . 0.0 109.965 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.458 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -76.16 -85.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 177.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.458 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 28.7 m-85 -77.19 112.32 22.51 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.236 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -65.64 133.33 33.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.279 1.986 . . . . 0.0 111.306 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.72 166.98 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 120.878 0.371 . . . . 0.0 111.771 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.578 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 87.7 m -80.97 125.88 30.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -122.58 95.37 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.68 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.654 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -126.76 113.87 17.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.859 179.193 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.579 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -61.84 121.7 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . -79.08 129.98 35.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -160.11 -43.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.435 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.417 ' HB ' ' H ' ' A' ' 144' ' ' SER . 1.1 mp -80.31 -106.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.417 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.3 OUTLIER -62.41 178.42 0.41 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.967 0.413 . . . . 0.0 111.469 -179.082 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.532 ' HA2' HH21 ' A' ' 54' ' ' ARG . . . 73.6 -152.24 45.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.379 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.34 62.94 56.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 0.0 110.886 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.58 ' HG2' ' HD3' ' A' ' 148' ' ' PRO . 11.1 Cg_endo -60.77 -38.23 72.43 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.445 2.097 . . . . 0.0 114.377 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.58 ' HD3' ' HG2' ' A' ' 147' ' ' PRO . 67.3 Cg_endo -73.95 73.19 3.74 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.764 1.643 . . . . 0.0 112.653 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.4 110.12 53.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.732 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -95.39 -14.84 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.601 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -130.44 127.02 38.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.602 HD22 HG22 ' A' ' 165' ' ' VAL . 45.7 mt -63.12 -37.98 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -17.81 62.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -74.09 -36.95 64.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.015 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.947 HD12 HG23 ' A' ' 165' ' ' VAL . 2.5 mt -70.96 -45.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 152' ' ' LEU . 4.3 t -54.73 -38.07 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -70.88 -48.83 51.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.579 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -45.98 92.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.461 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.807 ' HB3' ' HB ' ' A' ' 162' ' ' VAL . 1.4 mm? -109.77 81.84 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.084 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.4 -40.79 0.39 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.004 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.75 15.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.318 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.807 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 47.2 t -80.61 -83.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.979 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 4.3 t0 -93.83 85.9 4.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.753 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.587 ' HB3' HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -54.89 123.82 14.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.326 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.947 HG23 HD12 ' A' ' 155' ' ' ILE . 1.4 p -62.71 177.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.296 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.629 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -125.47 137.82 53.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.792 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.488 ' OD2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -92.26 -9.65 41.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.232 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.582 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -77.44 -35.04 54.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.571 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 86.92 177.86 49.12 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.827 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 16.7 p-10 -71.32 -160.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.39 -64.75 0.44 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.758 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.601 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.86 -139.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.466 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -87.04 149.19 24.91 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.252 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.8 ptm -60.99 -10.72 6.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.237 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.76 158.38 67.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.552 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -92.33 -156.71 0.68 Allowed 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 124.124 -1.198 . . . . 0.0 112.844 1.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.71 120.24 3.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.815 HG23 ' HB3' ' A' ' 191' ' ' ARG . 69.5 m -102.02 138.18 39.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.32 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.52 98.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.061 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.668 HG12 ' HA ' ' A' ' 189' ' ' VAL . 6.0 mt -108.73 132.96 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.678 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -90.1 71.4 7.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.893 ' HA ' ' HB3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -72.4 82.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.545 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.9 p -83.7 -97.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.181 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 6.2 t -121.92 -63.2 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.457 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -173.56 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.342 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HA ' ' HD2' ' A' ' 187' ' ' PRO . 51.8 Cg_exo -59.57 120.37 8.15 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.927 1.085 . . . . 0.0 110.867 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.893 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 21.2 Cg_endo -62.67 156.69 51.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.811 2.341 . . . . 0.0 112.834 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.417 ' HD3' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -101.92 99.96 10.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.873 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.668 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.4 t -67.75 103.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.78 82.26 1.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ARG . . . . . 0.815 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -102.98 159.04 15.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.798 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 144.13 40.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -86.46 132.76 11.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.498 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.78 -34.32 9.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.922 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -86.0 163.26 36.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.522 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.51 -56.73 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 112.328 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.22 144.15 19.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.61 116.64 51.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.92 139.62 88.95 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.55 2.167 . . . . 0.0 112.261 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 202' ' ' LEU . 5.0 m -62.02 169.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.211 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.03 40.93 0.94 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.456 ' HB2' HG23 ' A' ' 200' ' ' VAL . 0.5 OUTLIER -80.14 178.74 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.939 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.35 141.87 31.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.028 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.29 -159.85 22.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.447 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -79.2 148.21 32.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 0.0 111.113 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.16 -168.57 35.43 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.565 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -87.15 -3.88 59.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.774 0.321 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.0 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.224 -0.894 . . . . 0.0 111.101 -179.981 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.932 0.305 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -37.47 80.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.4 t -71.31 -28.12 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.235 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.425 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.1 mm? -68.87 -48.03 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 21' ' ' SER . 4.9 pt-20 -72.51 -20.92 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.81 -35.05 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -74.21 -40.18 62.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.457 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 20' ' ' ILE . 2.3 pp -75.65 -18.69 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 111.024 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 1.2 t -68.23 -53.87 21.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.744 HG21 ' HB2' ' A' ' 164' ' ' LEU . 4.9 p -63.78 -33.51 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 17.9 mtt -63.38 -30.32 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.8 -29.2 64.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.07 1.02 89.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.378 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.2 53.42 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.634 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.97 172.72 15.62 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.306 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.685 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.9 tp -96.38 136.3 27.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.748 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.552 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.8 131.63 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -102.27 162.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.508 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -167.96 104.41 0.56 Allowed Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 93.7 Cg_endo -80.24 145.46 17.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.477 2.118 . . . . 0.0 111.888 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -123.05 -150.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.615 0.245 . . . . 0.0 111.224 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.736 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 3.0 m-20 -55.41 -22.43 20.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.603 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 95' ' ' PRO . 12.8 p -99.74 -112.79 0.18 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.945 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.84 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -161.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.726 0.298 . . . . 0.0 111.051 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -68.7 134.16 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.944 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -116.45 178.08 17.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.936 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.666 ' HB2' HG23 ' A' ' 139' ' ' THR . 1.1 mt -133.42 139.17 46.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.83 124.53 2.09 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.989 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 136' ' ' VAL . 8.9 p -157.62 165.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.558 0.218 . . . . 0.0 110.814 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.738 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -55.52 100.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 110.646 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.15 99.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.159 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.5 mm? -77.53 15.6 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.34 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.42 146.23 36.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -24.36 67.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.26 -29.2 69.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.868 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.47 -40.28 70.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.188 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 t -65.35 -35.49 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.984 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -50.3 34.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -69.7 -13.71 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -75.25 -49.48 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.359 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' N ' HD13 ' A' ' 52' ' ' LEU . 5.5 t80 -63.93 -25.55 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HD3' HH11 ' A' ' 54' ' ' ARG . 1.1 mmm180 -66.19 -45.85 79.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.42 -52.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.347 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -74.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.218 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.73 40.59 98.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.562 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -112.37 -80.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.309 . . . . 0.0 110.925 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.08 129.22 16.93 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.31 22.1 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 112.487 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.89 -8.87 15.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.112 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -88.13 141.33 31.03 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.047 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.05 165.63 25.72 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.518 2.145 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 110' ' ' ILE . 2.6 m -116.4 156.77 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.062 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 10.6 t -101.0 137.36 39.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.67 173.42 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.792 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 16.5 t -122.21 141.69 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.883 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -150.03 177.01 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.615 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -86.07 -46.82 10.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.674 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.25 175.85 9.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.008 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.48 -31.78 47.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 t70 -67.39 -26.03 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.107 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.563 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 23.6 mm-40 -80.39 -23.99 40.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.394 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.883 HG23 HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.54 54.81 0.61 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 77' ' ' PHE . 27.6 Cg_endo -61.74 -83.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.864 1.709 . . . . 0.0 111.743 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.49 19.89 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.368 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' PRO . 8.2 m-85 -93.17 -44.13 8.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.801 0.334 . . . . 0.0 111.088 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -128.1 -175.45 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.638 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HB3' ' CB ' ' A' ' 101' ' ' GLU . 10.1 ttt-85 -112.75 103.54 55.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.589 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -102.33 -178.77 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.223 2.615 . . . . 0.0 112.584 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 1.5 t -145.98 -176.17 5.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.05 -85.01 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.687 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.442 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 5.1 t70 -55.04 -26.31 36.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.754 0.312 . . . . 0.0 110.823 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.16 -51.53 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 81' ' ' SER . 13.7 mmt -69.55 -20.45 63.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.2 mt-10 -71.04 -41.36 70.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.667 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.741 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 2.7 tm? -60.08 -44.18 94.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.587 ' HB2' HD22 ' A' ' 182' ' ' LEU . 7.0 tpt -74.6 -35.98 62.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.155 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -64.17 -12.5 40.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.741 ' HD2' ' HA ' ' A' ' 87' ' ' LEU . 23.8 mtt-85 -75.61 -55.13 5.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.672 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 57.52 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -132.1 154.51 81.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.615 0.245 . . . . 0.0 111.184 178.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.92 -153.24 0.88 Allowed 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.712 -1.37 . . . . 0.0 112.007 -2.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.46 178.27 28.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.725 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.736 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 99.0 Cg_endo -79.58 32.57 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.673 2.249 . . . . 0.0 112.609 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -112.67 146.59 38.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.743 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.834 HG22 ' HA ' ' A' ' 179' ' ' VAL . 6.7 t -95.47 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.585 HG11 ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -115.66 109.31 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.46 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 8.7 t -98.41 126.29 51.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.56 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.87 -174.9 3.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.714 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.416 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -74.6 -177.82 3.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.173 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.99 138.21 52.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.97 -165.56 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.029 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.65 43.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.602 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -80.54 124.72 29.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.532 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 3.4 mp -74.55 -50.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.948 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.57 ' HD2' HD23 ' A' ' 105' ' ' LEU . 86.9 Cg_exo -49.27 103.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.284 1.989 . . . . 0.0 112.554 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 81.2 m-20 -80.94 -4.57 55.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.176 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -70.45 -21.58 23.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.592 HG22 HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -111.41 -35.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 64.1 p -76.95 -19.97 56.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.07 -167.69 51.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.55 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.72 5.72 73.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.59 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.7 m -122.69 -178.36 3.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.82 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 43.7 m -105.75 51.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -144.53 149.17 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.453 HG23 ' CB ' ' A' ' 102' ' ' ARG . 87.6 t -139.65 142.55 32.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.574 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -95.8 158.86 22.09 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.54 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 120' ' ' ARG . 18.9 mt -142.62 162.62 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 119' ' ' ILE . 12.5 ttt85 -146.63 128.23 15.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 111.321 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.77 81.18 2.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HB2' HG21 ' A' ' 33' ' ' THR . 72.1 Cg_endo -76.36 178.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.493 2.129 . . . . 0.0 112.551 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.38 9.74 35.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 9.1 m-20 -70.47 105.09 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.122 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.54 -49.96 74.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.411 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.18 -53.17 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.212 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -60.85 -18.35 55.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -74.69 -35.88 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -52.78 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 16' ' ' LEU . 43.7 mm -60.75 -49.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.29 -27.53 69.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.279 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.477 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . . . -54.67 -56.33 20.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -75.94 -87.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.159 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -77.0 126.75 85.12 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.188 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.08 154.6 66.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.309 2.006 . . . . 0.0 111.637 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -133.99 161.06 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.344 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 91.2 m -81.14 128.67 34.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -123.65 101.26 7.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 0.0 111.631 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -124.91 146.4 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.669 178.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.1 m -82.35 120.92 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.149 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.899 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.43 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.1 Cg_exo . . . . . 0 CA--C 1.537 0.648 0 N-CA-C 113.554 0.559 . . . . 0.0 113.554 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 64.7 Cg_endo -73.25 118.67 5.62 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 121.893 1.729 . . . . 0.0 112.217 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -85.85 144.49 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 68.4 Cg_endo -95.96 -13.63 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.927 2.418 . . . . 0.0 112.747 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 126.61 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.715 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -63.24 -40.01 96.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.155 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -18.9 62.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.61 -36.78 65.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.117 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.83 HD12 HG23 ' A' ' 165' ' ' VAL . 21.8 mt -68.78 -52.24 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.439 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.55 -27.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.0 -55.91 6.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.71 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.45 -55.83 13.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.33 -179.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.3 mm? -91.14 73.93 6.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.929 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.13 -42.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.883 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.95 14.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.422 ' HB ' HD12 ' A' ' 159' ' ' LEU . 3.0 t -80.67 -78.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.994 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.685 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -100.03 87.81 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.484 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.744 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.06 129.77 43.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.326 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.83 HG23 HD12 ' A' ' 155' ' ' ILE . 1.5 p -69.36 -169.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.744 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.91 154.53 42.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.399 . . . . 0.0 110.957 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.46 -21.9 19.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.3 -51.71 6.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.459 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 97.13 -155.58 20.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.744 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.9 -161.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.763 0.316 . . . . 0.0 111.086 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -146.2 -53.25 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.524 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.92 -128.63 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.526 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -85.64 144.56 27.77 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 120.84 0.353 . . . . 0.0 111.603 -178.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.84 ' HG2' HG23 ' A' ' 36' ' ' ILE . 2.5 ttp -65.29 -12.96 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.215 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.39 155.35 23.31 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.87 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.93 -139.73 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.434 0.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 192' ' ' ARG . 1.3 p -153.41 140.73 19.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.596 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 191' ' ' ARG . 23.7 m -101.44 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.0 111.322 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.834 ' HA ' HG22 ' A' ' 97' ' ' THR . 67.5 t -129.25 112.15 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.661 HG12 ' HA ' ' A' ' 189' ' ' VAL . 58.0 mt -116.71 129.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.65 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.25 65.63 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 88' ' ' MET . 39.9 tp -69.9 89.38 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -80.08 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.832 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.45 -127.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.931 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.516 HD22 ' HD3' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -59.21 -51.06 84.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.516 ' HD3' HD22 ' A' ' 185' ' ' ASN . 97.8 Cg_endo -79.71 107.15 2.08 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.165 1.91 . . . . 0.0 112.403 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.667 ' HG3' ' HG ' ' A' ' 87' ' ' LEU . 82.1 Cg_endo -77.64 138.31 17.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.482 2.122 . . . . 0.0 111.961 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 181' ' ' ASP . 0.7 OUTLIER -101.08 41.63 1.17 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.374 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.661 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.8 p -56.95 105.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.015 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.1 94.63 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.541 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 178' ' ' THR . 23.3 ptt85 -83.67 140.1 32.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.756 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 177' ' ' SER . 1.6 mtt85 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.698 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 42.8 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.932 0.305 . . . . 0.0 112.537 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 29.4 m-20 -72.2 -35.31 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.797 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 48.8 t -61.35 -35.52 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.75 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.714 HD11 ' HB ' ' A' ' 130' ' ' ILE . 0.7 OUTLIER -67.29 -56.51 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.624 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.62 -22.5 61.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.24 -34.91 61.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.006 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -69.46 -34.76 74.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.054 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.67 -39.67 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.721 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 t -72.85 -42.23 63.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.833 HG22 HD13 ' A' ' 164' ' ' LEU . 8.6 p -68.37 -29.49 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.263 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 mtt -74.24 -25.42 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -1.99 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.29 5.52 84.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.64 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.31 41.59 99.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.79 178.81 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.572 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.687 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.46 144.66 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.687 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.88 126.43 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.361 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.624 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -101.85 164.4 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.513 0.197 . . . . 0.0 110.488 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -165.29 103.76 0.77 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 90.9 Cg_endo -84.1 137.5 7.37 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.704 2.269 . . . . 0.0 111.735 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.816 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.93 -152.15 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.206 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 0.7 OUTLIER -54.73 -22.19 13.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.309 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.688 HG23 ' HB2' ' A' ' 95' ' ' PRO . 2.5 p -100.04 -116.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -112.2 -175.17 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.753 0.311 . . . . 0.0 111.141 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.452 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.1 m-85 -63.42 134.09 55.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.906 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -120.33 179.51 16.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.026 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 2.6 mp -122.27 143.57 49.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.971 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.22 117.39 0.96 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.101 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.658 HG11 HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -153.91 166.0 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 111.367 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 54.9 m-20 -56.58 109.73 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.091 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.51 -46.25 84.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.202 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.69 24.92 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.5 148.1 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 -24.66 60.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.83 -27.79 63.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.24 -28.39 59.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 109' ' ' VAL . 26.0 t -67.23 -44.56 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -49.9 72.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.095 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 57.0 mmt-85 -62.29 -42.54 99.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.149 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.01 -25.71 68.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.903 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -30.51 64.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 54' ' ' ARG . 2.9 mmt85 -75.45 -49.9 17.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.309 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.71 -51.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.676 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -79.56 -5.96 56.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.293 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.15 -113.95 6.31 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.36 77.37 1.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 111.002 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -154.89 71.51 5.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 23.28 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.697 2.265 . . . . 0.0 112.531 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -122.5 -8.36 8.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 133.15 50.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.788 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.66 153.51 14.21 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.621 2.214 . . . . 0.0 112.52 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 142.54 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -97.22 148.55 22.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.653 HG13 ' HA ' ' A' ' 119' ' ' ILE . 0.9 OUTLIER -116.06 170.95 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 3.3 t -122.17 118.59 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.612 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -138.46 177.51 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.799 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.83 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 2.1 t -86.95 -41.37 13.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.453 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.405 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -164.14 170.61 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.991 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.92 -34.03 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 21.9 t70 -67.03 -28.64 68.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 67.8 mm-40 -74.45 -23.36 58.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.767 HG23 HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.31 61.23 0.79 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.783 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 34.8 Cg_endo -65.04 -72.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.063 1.842 . . . . 0.0 112.267 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.86 14.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.63 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 74' ' ' ILE . 1.7 t80 -103.64 -54.34 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.493 ' CB ' HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -120.09 172.69 7.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.768 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.52 111.49 41.77 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.933 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.14 175.29 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.948 2.432 . . . . 0.0 112.72 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.56 -177.02 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.896 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.36 -88.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.932 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -26.22 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.999 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.67 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.2 mmt -71.65 -16.22 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.055 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.56 -47.22 61.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.438 . . . . 0.0 110.401 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -57.31 -43.61 83.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.667 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.456 ' HE1' ' HE2' ' A' ' 96' ' ' TYR . 1.8 ttm -66.65 -36.73 83.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -67.96 -10.84 56.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.377 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.64 -51.69 13.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.8 65.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.228 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 3.1 tt -131.22 139.24 34.86 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.598 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 84.4 Cg_endo -79.03 -154.55 1.04 Allowed 'Cis proline' 0 C--N 1.35 0.65 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.548 -1.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.71 160.47 10.36 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.686 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 35' ' ' THR . 91.4 Cg_endo -78.67 42.37 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 112.271 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.609 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 55.3 p90 -112.18 149.9 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.6 m -96.19 141.78 29.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.156 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 182' ' ' LEU . 1.8 p -127.41 109.99 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.577 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.7 t -92.66 123.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.975 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 19.6 tp -127.26 172.27 10.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.599 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.583 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 2.8 pm0 -74.58 -176.17 2.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.521 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.659 ' HE ' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -119.07 139.43 51.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.975 0.417 . . . . 0.0 111.131 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.768 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.52 -157.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.94 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.469 ' H ' HD22 ' A' ' 103' ' ' ASN . 7.0 mm-40 -67.51 -31.85 72.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.525 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.7 tt -69.93 84.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.659 HG12 ' HE ' ' A' ' 102' ' ' ARG . 5.9 mt -80.9 104.48 2.78 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.758 ' HG2' ' HB ' ' A' ' 111' ' ' THR . 59.2 Cg_endo -70.69 154.8 63.85 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.33 2.02 . . . . 0.0 112.201 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.44 -84.04 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.752 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.79 HG21 HG22 ' A' ' 49' ' ' VAL . 27.5 m -81.88 7.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.985 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.693 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 6.8 mt -102.53 -35.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.295 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.758 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -83.12 -27.97 29.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.42 -140.55 37.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.383 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.05 -3.78 72.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.433 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -107.04 162.21 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.448 ' HB2' ' NH1' ' A' ' 102' ' ' ARG . 12.2 p -102.98 44.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -136.74 163.33 30.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 102' ' ' ARG . 80.2 t -139.78 133.71 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.652 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 119' ' ' ILE . . . -87.6 157.31 28.69 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.3 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.653 ' HA ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -135.28 167.98 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' H ' HG22 ' A' ' 119' ' ' ILE . 4.9 ttp180 -154.97 119.46 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.354 . . . . 0.0 111.417 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 121' ' ' VAL . 2.8 p -110.59 83.65 3.52 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.516 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.816 ' HB2' HG21 ' A' ' 33' ' ' THR . 72.8 Cg_endo -76.24 -178.86 4.73 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.632 2.221 . . . . 0.0 112.67 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.02 -4.88 51.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.714 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.4 OUTLIER -62.04 110.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.989 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.06 -46.54 82.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.672 HG23 HD22 ' A' ' 16' ' ' LEU . 38.0 mm -62.03 -54.88 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.969 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.714 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 98.5 m -60.2 -19.78 55.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -75.63 -43.65 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -72.67 -54.45 9.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.654 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.714 ' HB ' HD11 ' A' ' 16' ' ' LEU . 1.5 tt -57.44 -45.35 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.504 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.52 -25.11 62.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.58 -56.5 18.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.024 0.44 . . . . 0.0 110.125 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -75.91 -83.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.145 177.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 3.2 t80 -77.11 128.19 81.61 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.3 155.13 64.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.323 2.015 . . . . 0.0 111.603 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.21 157.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.337 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.604 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.42 138.8 36.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.82 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.02 109.12 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 111.605 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -131.8 127.29 36.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.789 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.0 t -71.19 119.16 14.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 111.152 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.7 Cg_exo . . . . . 0 CA--C 1.537 0.637 0 N-CA-C 113.517 0.545 . . . . 0.0 113.517 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 65.6 Cg_endo -73.03 118.05 5.39 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.828 1.685 . . . . 0.0 112.378 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 143.77 26.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.817 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -96.0 -12.47 0.68 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.885 2.39 . . . . 0.0 112.863 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.59 122.45 27.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.31 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -59.97 -30.88 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.841 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -29.18 60.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.124 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -67.43 -28.6 68.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 159' ' ' LEU . 46.5 mt -75.04 -50.73 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.485 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.34 -33.82 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.925 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -75.6 -58.4 3.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.756 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.51 -34.05 77.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.821 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.939 HD13 ' HB3' ' A' ' 163' ' ' ASP . 85.0 mt -106.33 68.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.331 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 8.5 t70 -16.34 -63.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.778 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.02 22.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 111.121 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.65 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.77 -63.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.939 ' HB3' HD13 ' A' ' 159' ' ' LEU . 3.6 t70 -107.56 100.24 9.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.011 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.833 HD13 HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.61 124.7 25.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.601 -177.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.805 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.2 p -64.02 -166.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.805 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.62 160.04 30.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.01 -25.02 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.289 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.32 -55.85 3.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.456 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 101.18 -163.52 18.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.862 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.01 -165.97 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.413 ' HB2' ' C ' ' A' ' 33' ' ' THR . 22.1 m -144.64 -60.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.628 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -124.35 -130.85 0.26 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.91 141.68 29.39 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.801 0.334 . . . . 0.0 111.465 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.96 -36.78 70.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -142.6 158.79 59.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.73 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 64.4 Cg_endo -91.46 -147.73 0.27 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.734 1.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 1.4 p -155.03 156.39 35.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.609 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.5 m -99.56 142.24 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.157 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.408 HG21 ' NH1' ' A' ' 192' ' ' ARG . 0.7 OUTLIER -129.0 89.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.771 HG23 ' HA ' ' A' ' 189' ' ' VAL . 12.2 mt -104.43 134.17 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -108.28 68.16 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.173 178.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.637 ' HB3' HG23 ' A' ' 98' ' ' VAL . 12.1 tp -69.75 87.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.358 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -77.25 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.66 0.267 . . . . 0.0 110.808 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.56 -126.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.467 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.7 OUTLIER -63.8 -53.42 50.11 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.19 108.22 2.46 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.161 1.907 . . . . 0.0 112.356 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.1 Cg_endo -76.22 139.2 20.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.451 2.1 . . . . 0.0 112.075 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.2 OUTLIER -99.42 49.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 180' ' ' ILE . 8.9 t -56.87 98.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.45 85.95 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.024 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.568 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -83.68 154.77 23.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.408 ' NH1' HG21 ' A' ' 179' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.0 Cg_exo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.855 0.273 . . . . 0.0 112.293 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.0 -34.59 73.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.796 HG11 HD13 ' A' ' 126' ' ' ILE . 18.9 t -59.43 -53.64 45.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 20' ' ' ILE . 3.1 mm? -61.9 -35.98 79.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.407 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' ' 20' ' ' ILE . 2.8 mt-10 -57.72 -30.63 65.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.709 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -77.3 -32.89 55.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.286 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -71.15 -46.91 60.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.57 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -75.84 -17.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 13.0 t -66.12 -53.86 32.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 164' ' ' LEU . 9.7 p -69.78 -27.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 mtt -60.1 -37.15 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.09 -16.68 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.25 9.57 77.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.591 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.27 51.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.49 161.62 22.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.427 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.663 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.24 143.21 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.663 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.04 146.08 21.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.511 ' H ' HG13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -111.19 165.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 178.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -170.9 92.0 0.46 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.815 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.9 Cg_endo -81.55 157.3 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.545 2.163 . . . . 0.0 111.127 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.63 ' HA ' ' CB ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.35 -150.88 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.24 -20.81 45.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.74 -98.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.036 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.2 OUTLIER -131.47 -166.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.874 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.815 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m-85 -72.68 131.12 41.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.781 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -117.2 178.59 17.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.136 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.731 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.5 mt -133.96 144.49 48.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.351 . . . . 0.0 110.831 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.17 131.48 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.292 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.564 HG11 HG12 ' A' ' 28' ' ' ILE . 1.1 m -156.53 163.35 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.5 m-20 -56.57 106.58 0.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.366 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.95 84.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.877 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.53 18.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -110.62 146.77 35.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.24 -23.82 57.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.02 -26.77 68.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.21 -36.92 61.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -65.3 -43.64 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -70.05 -42.89 72.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.234 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -68.9 -29.39 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -67.59 -38.39 83.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.891 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -65.35 -37.73 87.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.69 -40.52 95.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.348 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.81 -57.92 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.288 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -81.89 -70.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.277 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.32 4.75 24.94 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.614 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.2 18.23 13.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -134.53 66.13 69.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.2 -54.38 5.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.79 2.327 . . . . 0.0 112.454 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -122.39 24.48 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -88.29 149.72 45.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.001 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.13 169.1 14.24 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.506 2.138 . . . . 0.0 112.289 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG21 HG22 ' A' ' 110' ' ' ILE . 32.9 m -119.48 162.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.04 138.48 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.563 HG13 HG23 ' A' ' 119' ' ' ILE . 9.4 pt -116.01 165.95 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 41.9 t -122.06 130.45 53.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.941 HG21 HG23 ' A' ' 74' ' ' ILE . 1.4 p -138.34 -175.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.394 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.782 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 5.6 t -88.94 -45.85 9.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -164.49 168.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.831 179.416 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.608 HG11 ' HG3' ' A' ' 85' ' ' MET . 10.2 t -55.34 -35.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.631 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.63 -28.98 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.92 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 2.9 mp0 -75.23 -15.99 60.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.44 58.18 0.7 Allowed Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.934 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 77' ' ' PHE . 20.4 Cg_endo -60.02 -86.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.07 1.847 . . . . 0.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -73.32 22.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 75' ' ' PRO . 27.1 m-85 -96.99 -47.33 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 111.008 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.1 p -129.83 -175.0 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.25 99.84 51.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -102.69 -173.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.284 2.656 . . . . 0.0 112.508 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.768 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.4 m -141.93 176.87 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.61 -87.9 0.2 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.839 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -33.76 64.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -57.34 -46.57 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.608 ' HG3' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -75.02 -25.5 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.246 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -46.99 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 0.0 110.924 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.9 tp -66.41 -43.86 84.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.155 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.605 ' SD ' HD23 ' A' ' 182' ' ' LEU . 6.0 tpt -63.44 -57.42 10.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.529 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -63.2 -11.81 23.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 1.8 mtt180 -67.12 -32.79 74.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.26 60.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -131.2 149.28 73.23 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.19 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 6.3 Cg_exo -78.54 -158.04 1.61 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.101 -1.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.24 162.08 11.31 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.829 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.25 46.5 2.21 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.847 2.365 . . . . 0.0 112.598 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -112.11 -179.53 3.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.066 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 m -115.27 145.62 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.685 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.04 91.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.373 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 16.7 t -87.28 122.56 39.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.756 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.446 HD12 HD12 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -126.67 175.91 7.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.591 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.08 158.87 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.218 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.564 ' CZ ' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -119.83 145.47 46.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.208 0.527 . . . . 0.0 111.184 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.84 174.93 8.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -76.66 60.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.22 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.467 HD12 ' NH1' ' A' ' 102' ' ' ARG . 1.6 mt -71.37 154.01 41.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.579 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 mt -76.32 -51.28 2.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.728 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 16.5 Cg_endo -57.04 101.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.234 1.956 . . . . 0.0 112.243 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.22 4.56 23.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -83.77 -17.63 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.706 HG22 HG21 ' A' ' 64' ' ' VAL . 1.1 pt -113.03 -29.03 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 107' ' ' PRO . 17.3 p -79.07 -35.43 42.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -169.2 46.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -70.47 -14.68 72.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p -117.64 -179.97 3.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.342 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.0 t -107.36 61.86 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mpp_? -141.2 141.5 34.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.564 HG21 ' CZ ' ' A' ' 102' ' ' ARG . 77.8 t -142.88 139.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.008 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.26 159.45 19.96 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.92 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.704 HD13 HD13 ' A' ' 74' ' ' ILE . 1.1 mt -141.22 173.47 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.602 ' H ' HG22 ' A' ' 119' ' ' ILE . 7.1 ptp180 -162.64 131.13 4.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.7 t -110.97 86.82 6.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.514 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.4 -177.78 2.93 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.531 2.154 . . . . 0.0 112.423 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.42 8.97 25.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.068 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.5 OUTLIER -76.45 100.91 5.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.796 HD13 HG11 ' A' ' 15' ' ' VAL . 85.5 mt -57.84 -50.99 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -65.99 -18.34 65.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.714 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 69' ' ' SER . 3.8 ttt180 -75.2 -37.66 61.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.999 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -51.21 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 131' ' ' ALA . 2.0 tt -62.6 -43.69 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.775 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -68.06 -28.24 67.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.97 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.01 33.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.084 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -75.76 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.266 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -77.21 128.93 79.5 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.207 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.21 144.03 32.76 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.337 2.025 . . . . 0.0 111.514 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.54 157.02 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 111.462 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.651 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 36.2 m -79.14 143.45 35.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.835 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -139.19 110.1 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.964 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.731 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -127.53 150.58 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.281 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.67 116.13 17.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.433 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.6 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 40.0 Cg_exo . . . . . 0 CA--C 1.538 0.719 0 N-CA-C 113.228 0.434 . . . . 0.0 113.228 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 7.4 Cg_exo -73.46 106.23 2.14 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.096 1.864 . . . . 0.0 112.291 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.08 155.95 36.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -95.41 -14.52 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.769 2.312 . . . . 0.0 112.775 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.7 mmt180 -134.38 128.86 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.935 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.592 ' O ' HG11 ' A' ' 165' ' ' VAL . 5.7 mt -61.07 -45.46 94.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.066 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -23.52 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.79 -31.19 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.169 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -75.49 -51.21 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.529 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.815 HG13 HG13 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -59.0 -25.5 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.416 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -75.08 -48.99 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.15 -21.77 58.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 163' ' ' ASP . 81.0 mt -111.23 68.05 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.03 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.5 t70 -16.26 -63.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.176 0.923 . . . . 0.0 112.724 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -159.26 23.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.235 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.643 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.88 -65.22 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.759 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 159' ' ' LEU . 47.5 t0 -111.37 102.34 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.575 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -74.49 131.15 40.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.573 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.815 HG13 HG13 ' A' ' 156' ' ' VAL . 17.1 m -65.33 -166.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.164 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.775 HD12 ' H ' ' A' ' 169' ' ' GLY . 0.4 OUTLIER -126.3 167.39 15.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.669 ' HB3' HG13 ' A' ' 15' ' ' VAL . 3.2 t70 -92.47 -39.87 11.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.595 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 126' ' ' ILE . . . -64.09 -70.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.305 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.775 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 89.37 51.26 2.98 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.837 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.63 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 3.7 m-20 -71.99 121.2 18.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.75 123.74 4.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.266 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -137.18 -113.85 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.448 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -85.38 127.53 34.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.506 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.08 -1.64 10.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.122 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.72 157.34 36.08 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.692 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -92.64 -151.66 0.36 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.737 1.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.8 p -156.91 115.1 3.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.1 m -102.31 143.58 31.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 111.499 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.5 105.87 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.727 HG23 ' HA ' ' A' ' 189' ' ' VAL . 13.7 mt -114.31 131.18 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.72 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.6 m-20 -99.42 73.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.718 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.605 HD23 ' SD ' ' A' ' 88' ' ' MET . 0.2 OUTLIER -68.79 81.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.309 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -86.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.321 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.49 -128.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -59.82 -51.03 83.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 72.6 Cg_endo -76.53 108.67 2.71 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.203 1.936 . . . . 0.0 112.504 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 83.8 Cg_endo -83.96 121.92 2.89 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.645 2.23 . . . . 0.0 112.257 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.72 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.6 mtm180 -89.35 54.38 2.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.489 . . . . 0.0 111.149 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.727 ' HA ' HG23 ' A' ' 180' ' ' ILE . 48.3 t -59.33 106.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.8 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.47 86.86 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -89.75 140.65 29.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.605 ' HG2' HD23 ' A' ' 16' ' ' LEU . 44.2 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.599 0.166 . . . . 0.0 112.052 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.714 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 m-20 -67.46 -28.12 67.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.87 -58.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.605 HD23 ' HG2' ' A' ' 13' ' ' PRO . 4.4 mm? -60.27 -42.48 95.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.27 -31.37 63.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.035 0.445 . . . . 0.0 110.485 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 5.1 mm-40 -76.29 -32.11 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.186 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -75.64 -41.73 53.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.907 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 21' ' ' SER . 1.9 pp -71.7 -31.37 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.025 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.532 ' N ' HD12 ' A' ' 20' ' ' ILE . 5.7 p -75.18 -38.0 61.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.787 HG11 HD13 ' A' ' 164' ' ' LEU . 11.6 p -75.66 -29.39 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.083 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mtt -62.11 -42.7 99.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.634 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -4.97 26.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.813 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.76 78.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 51.69 37.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.812 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.17 165.24 22.57 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.427 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.5 148.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.703 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -116.39 127.42 74.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.733 -179.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.504 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -102.71 151.6 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.635 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.519 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -157.05 113.35 1.94 Allowed Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.63 134.26 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.721 2.281 . . . . 0.0 111.377 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.574 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -116.49 -149.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 111.191 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 11.7 m-20 -54.58 -22.08 12.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.194 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 36' ' ' ILE . 4.6 t -100.38 -121.82 0.16 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.75 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.52 -149.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.761 0.315 . . . . 0.0 111.454 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.476 ' OH ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -64.96 129.59 40.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.446 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.72 170.68 15.36 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.959 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 139' ' ' THR . 1.6 mp -123.45 141.13 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.929 0.395 . . . . 0.0 111.263 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.34 111.5 0.58 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.696 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 42' ' ' ASN . 2.5 p -151.79 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.645 0.26 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.601 ' H ' HG22 ' A' ' 41' ' ' VAL . 14.2 m120 -56.42 116.86 3.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 110.493 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.42 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.0 -56.02 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.988 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HA ' HD13 ' A' ' 44' ' ' LEU . 1.4 mm? -82.81 37.11 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.553 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -110.94 156.17 21.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 178.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -31.91 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.441 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.15 -28.15 68.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.518 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -72.25 -35.43 68.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.718 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.0 t -66.17 -48.28 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.446 ' HD3' HH11 ' A' ' 50' ' ' ARG . 11.2 mtt180 -63.73 -45.17 91.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.546 ' HG3' HG13 ' A' ' 28' ' ' ILE . 11.0 mmm180 -65.25 -30.67 71.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -66.59 -46.48 75.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.6 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.89 -18.08 63.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.091 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -73.24 -67.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.701 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.28 -41.16 57.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -80.08 -11.32 59.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.626 0.251 . . . . 0.0 111.292 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 -139.0 39.05 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.416 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.2 85.48 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.82 67.45 23.21 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.88 9.31 2.03 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 0.0 112.511 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -105.21 -26.31 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.28 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -88.12 128.8 52.31 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.287 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 35.7 Cg_exo -59.73 171.63 2.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 110' ' ' ILE . 5.0 m -114.85 150.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.322 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -99.91 133.93 43.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.449 HD11 HG12 ' A' ' 119' ' ' ILE . 10.5 pt -113.94 172.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.505 ' SG ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m -122.07 129.37 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG21 HG23 ' A' ' 74' ' ' ILE . 1.8 p -136.0 179.06 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.707 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 30.3 t -86.18 -42.54 13.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.261 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.5 166.22 20.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.422 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG21 ' SD ' ' A' ' 85' ' ' MET . 26.8 t -57.68 -31.33 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.5 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 37.0 t70 -67.44 -27.59 67.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.812 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 0.6 OUTLIER -76.73 -21.04 55.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.119 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.809 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.34 58.79 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 34.7 Cg_endo -65.08 -74.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.007 1.804 . . . . 0.0 112.003 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.19 15.18 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.5 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 32.5 m-85 -100.52 -45.95 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 p -135.23 159.49 41.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.679 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.496 ' HG3' ' HB3' ' A' ' 101' ' ' GLU . 7.1 ptm180 -119.14 104.16 46.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.012 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HB3' HD22 ' A' ' 100' ' ' LEU . 85.5 Cg_endo -102.23 -166.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.14 2.56 . . . . 0.0 112.399 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 166.27 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.84 -73.47 0.68 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.586 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.636 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -55.33 -34.44 64.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.797 0.332 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.47 ' HB1' HD21 ' A' ' 182' ' ' LEU . . . -64.01 -36.68 84.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.678 ' SD ' HG21 ' A' ' 71' ' ' VAL . 4.2 mmt -71.36 -17.99 62.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.095 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.636 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.6 mt-10 -71.58 -47.2 56.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.934 0.397 . . . . 0.0 110.573 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.23 -40.55 81.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.533 ' HG2' HG11 ' A' ' 98' ' ' VAL . 4.4 tpt -74.76 -46.12 39.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.507 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.83 -14.64 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.298 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -44.83 63.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.4 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 3.7 pt -108.81 53.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 6.3 tt -130.97 131.73 23.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 87.6 Cg_endo -78.08 -163.4 3.36 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.478 -0.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.62 167.11 16.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.95 37.22 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.748 2.299 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.4 ' CE2' ' HB ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -112.17 144.31 41.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.647 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 1.3 m -94.74 148.77 21.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.71 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.533 HG11 ' HG2' ' A' ' 88' ' ' MET . 2.1 t -126.49 102.51 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.24 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.834 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 2.8 t -93.55 120.1 42.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 80' ' ' PRO . 1.1 mp -126.99 -168.5 1.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.576 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -74.83 169.33 18.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.552 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.563 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.17 147.13 44.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 105' ' ' LEU . 22.1 p-10 -73.72 -152.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.314 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 31.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.47 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.738 HD13 ' HD2' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -69.53 94.85 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.725 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.603 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 6.1 mt -64.91 -50.79 61.0 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.71 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.738 ' HD2' HD13 ' A' ' 105' ' ' LEU . 76.5 Cg_exo -50.38 108.85 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.128 1.885 . . . . 0.0 112.316 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.22 -1.53 41.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.788 HG13 HG13 ' A' ' 110' ' ' ILE . 15.0 p -69.98 -21.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.788 HG13 HG13 ' A' ' 109' ' ' VAL . 5.1 mt -105.03 -52.25 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.037 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -68.2 -14.27 62.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.54 -154.75 40.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -87.62 6.25 83.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.362 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.9 169.93 9.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.769 0.318 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -99.0 39.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -136.92 158.99 43.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 102' ' ' ARG . 98.7 t -139.95 147.87 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.478 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -98.99 146.89 18.31 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.389 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.759 HD13 HD13 ' A' ' 74' ' ' ILE . 24.8 mt -148.26 134.98 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -144.58 146.52 32.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.962 0.41 . . . . 0.0 111.438 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 68' ' ' VAL . 1.7 m -110.22 96.82 27.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HB2' HG21 ' A' ' 33' ' ' THR . 50.6 Cg_endo -68.14 -179.28 2.12 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.501 2.134 . . . . 0.0 112.449 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 5.2 47.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.97 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.3 104.54 6.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.35 -49.01 77.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.194 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.493 HG23 HD21 ' A' ' 16' ' ' LEU . 30.6 mm -59.83 -48.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.1 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -20.89 65.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 128' ' ' ARG . 0.3 OUTLIER -75.19 -27.36 59.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.987 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -74.31 -60.4 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.172 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -58.27 -45.5 89.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.73 -28.25 69.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.006 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 129' ' ' ARG . . . -54.76 -53.4 55.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -75.28 -88.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.123 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -77.09 144.96 72.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.41 159.09 47.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.321 2.014 . . . . 0.0 111.603 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 t -133.65 150.25 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.526 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.614 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 m -80.9 140.47 35.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.824 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.7 107.13 8.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.494 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.12 122.24 22.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.905 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 110.54 5.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.017 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.552 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.8 Cg_exo . . . . . 0 CA--C 1.536 0.583 0 N-CA-C 113.322 0.47 . . . . 0.0 113.322 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 28.4 Cg_endo -62.1 129.66 27.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.781 1.654 . . . . 0.0 111.976 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.468 ' HB3' HD11 ' A' ' 155' ' ' ILE . 8.6 p -85.86 121.91 72.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -95.11 -28.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.882 2.388 . . . . 0.0 112.297 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 131.85 18.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.338 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 152' ' ' LEU . 25.7 mt -59.95 -36.48 77.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.255 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -19.4 59.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.98 -44.83 79.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.851 HD12 HG23 ' A' ' 165' ' ' VAL . 11.6 mt -68.29 -44.1 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.17 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.96 -41.27 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.418 ' HD2' HH11 ' A' ' 157' ' ' ARG . 0.1 OUTLIER -75.38 -53.31 8.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.498 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.644 ' HB3' HD22 ' A' ' 159' ' ' LEU . 9.6 t70 -56.6 -39.85 74.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.496 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.644 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.6 mm? -111.37 77.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.934 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.43 -43.2 0.56 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.094 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.26 19.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 48.7 t -80.45 -97.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.529 ' OD1' ' HG ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -94.72 92.25 6.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.46 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.787 HD13 HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -55.57 135.13 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.026 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.851 HG23 HD12 ' A' ' 155' ' ' ILE . 0.7 OUTLIER -66.6 172.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.648 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.55 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -127.42 127.34 43.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.521 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -7.95 46.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.746 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -64.08 -38.21 90.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.388 . . . . 0.0 110.655 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.498 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 102.25 166.67 26.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.084 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -152.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.574 ' HB2' ' C ' ' A' ' 33' ' ' THR . 11.4 m -144.28 -63.22 0.37 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -130.47 -138.68 0.21 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.4 168.43 13.14 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.75 ' HG2' HG23 ' A' ' 36' ' ' ILE . 61.9 mtp -71.01 1.39 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.012 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.17 160.17 26.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 177' ' ' SER . 68.8 Cg_endo -97.02 -149.65 0.18 OUTLIER 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.737 1.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.436 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -153.77 120.45 5.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.484 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.8 m -99.73 137.21 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.398 . . . . 0.0 111.483 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.23 107.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.607 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.576 HG23 ' HA ' ' A' ' 189' ' ' VAL . 3.1 mt -119.14 132.95 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.64 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.834 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 9.2 m-20 -97.88 69.24 2.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.163 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 88' ' ' MET . 3.5 tt -69.44 87.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.408 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -81.76 0.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.493 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.5 -126.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.864 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.41 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -60.58 -52.63 71.35 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -77.27 108.39 2.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.237 1.958 . . . . 0.0 112.626 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 1.0 OUTLIER -84.07 132.45 5.39 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.017 2.478 . . . . 0.0 112.071 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.655 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.1 mmm180 -91.88 59.18 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 110.897 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 180' ' ' ILE . 46.7 t -59.16 109.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.53 88.33 2.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.05 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -90.94 127.77 36.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.819 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.654 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.819 0.258 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.08 -29.54 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.19 -31.77 25.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.92 -41.57 64.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 21' ' ' SER . 1.4 pt-20 -74.87 -19.02 60.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.3 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.0 -36.73 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.82 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -72.77 -40.84 65.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.592 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.47 -17.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -71.94 -46.34 57.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 164' ' ' LEU . 9.6 p -73.5 -27.78 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 15.2 mtt -59.76 -49.42 77.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.113 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.67 -12.96 61.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.57 1.03 89.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.503 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.14 44.26 87.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.9 170.43 19.38 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.362 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.45 143.84 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.428 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.681 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.63 140.03 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.701 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.578 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -105.46 165.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.445 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.2 103.32 0.31 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.779 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 83.3 Cg_endo -82.69 135.72 8.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.6 2.2 . . . . 0.0 111.744 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -120.21 -155.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.804 0.335 . . . . 0.0 111.414 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.8 OUTLIER -54.72 -21.17 10.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -98.42 -117.92 0.14 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.848 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.3 OUTLIER -112.6 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.723 0.297 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.37 131.38 47.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.714 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -123.11 176.47 16.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.482 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.4 mt -133.32 142.99 48.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.741 0.305 . . . . 0.0 110.839 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.665 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.5 134.69 5.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.059 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.664 HG22 ' NH1' ' A' ' 51' ' ' ARG . 3.9 m -152.69 168.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.773 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -56.61 105.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.259 178.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.12 75.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.278 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -79.89 22.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.87 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.773 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.25 161.71 15.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 178.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -25.18 58.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 110.426 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 6.5 m-20 -60.59 -28.82 68.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.806 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.09 -27.16 59.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.92 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.686 HG13 HG21 ' A' ' 109' ' ' VAL . 46.2 t -65.66 -54.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -71.33 -22.19 61.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.688 ' NH2' HG22 ' A' ' 139' ' ' THR . 0.0 OUTLIER -68.01 -34.48 76.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.997 0.427 . . . . 0.0 110.754 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.571 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.8 OUTLIER -74.96 -44.44 48.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.391 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.52 -34.53 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.181 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -66.41 -61.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.439 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.76 -51.12 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -79.86 -70.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.454 -178.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.93 -11.7 0.62 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.08 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 56' ' ' LYS . 2.6 ptp180 -118.4 40.19 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.784 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 p -141.72 63.75 17.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.44 -66.85 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.652 2.235 . . . . 0.0 112.591 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.719 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 53.3 m80 -108.59 24.44 13.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 2.1 mttt -88.41 147.48 40.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.16 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HD2' ' HG2' ' A' ' 62' ' ' LYS . 62.0 Cg_endo -73.8 161.26 41.99 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.591 2.194 . . . . 0.0 112.269 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 110' ' ' ILE . 3.8 p -114.05 151.53 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.8 t -94.16 134.22 36.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.214 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -116.24 172.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.796 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 20.7 t -119.96 136.88 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.768 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -135.86 -179.57 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.639 ' H ' HG22 ' A' ' 68' ' ' VAL . 1.2 t -76.09 -49.67 16.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.155 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.579 ' SG ' HD21 ' A' ' 92' ' ' LEU . 1.2 m -163.93 179.86 6.74 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.143 0.497 . . . . 0.0 111.664 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.712 ' HA ' HD11 ' A' ' 74' ' ' ILE . 60.9 t -52.44 -41.29 35.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.111 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -69.57 -27.82 65.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.905 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.85 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 1.4 tp10 -80.99 -8.22 59.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.712 HD11 ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -90.86 -38.56 0.39 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.668 ' HG3' ' HG3' ' A' ' 80' ' ' PRO . 99.8 Cg_exo -44.03 -23.3 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.491 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -55.22 -59.33 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -107.51 3.89 25.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -118.05 179.7 4.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HG2' HD22 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -131.5 94.44 26.26 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.668 ' HG3' ' HG3' ' A' ' 75' ' ' PRO . 68.3 Cg_endo -102.49 -166.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.2 2.6 . . . . 0.0 112.687 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 177.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.15 -83.28 0.41 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.769 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.93 -33.25 62.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.842 0.353 . . . . 0.0 111.152 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -60.41 -49.36 77.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.44 ' CE ' HD11 ' A' ' 100' ' ' LEU . 17.7 mmt -71.94 -14.91 62.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.255 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.0 mm-40 -66.59 -46.68 75.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.4 tm? -61.35 -38.4 86.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.201 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.476 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 5.9 tpt -66.29 -43.11 87.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.27 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -69.95 -39.69 75.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.058 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.12 51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.648 HD13 HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -131.36 134.65 25.93 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.28 -162.34 2.95 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.277 -1.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.93 166.78 15.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.562 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.9 Cg_endo -81.29 41.72 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.742 2.295 . . . . 0.0 112.482 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.2 m-85 -111.31 156.21 21.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.819 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 59.2 m -94.93 135.62 36.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.355 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.434 ' O ' ' HB ' ' A' ' 119' ' ' ILE . 6.5 t -122.49 98.94 6.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.292 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.797 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 18.9 t -95.48 128.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.623 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.44 HD11 ' CE ' ' A' ' 85' ' ' MET . 2.3 mm? -126.96 -178.6 4.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -178.73 3.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.325 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.546 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.18 137.7 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.322 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.582 HD22 ' HG2' ' A' ' 79' ' ' ARG . 2.5 t-20 -74.25 -168.19 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.902 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 37.56 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.474 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.877 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 1.6 tp -72.11 132.25 43.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.58 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 19.9 mm -73.33 -50.6 6.22 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.665 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.877 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 72.8 Cg_exo -49.77 109.99 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.241 1.961 . . . . 0.0 112.353 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.09 -17.79 45.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.125 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.686 HG21 HG13 ' A' ' 49' ' ' VAL . 14.8 p -69.18 -22.6 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.247 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.524 ' O ' HG12 ' A' ' 64' ' ' VAL . 45.0 mt -93.88 -43.58 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.025 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.691 ' HA ' HG22 ' A' ' 117' ' ' VAL . 22.1 p -81.28 -6.52 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.05 -169.8 50.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 61' ' ' HIS . . . -78.23 -1.5 80.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.365 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.48 -172.75 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 111.017 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 3.4 p -106.22 39.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -136.77 153.1 50.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.047 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 111' ' ' THR . 93.8 t -139.81 144.53 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.468 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.491 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -91.32 155.55 23.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.385 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 118' ' ' GLY . 3.8 mt -143.94 151.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.592 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.3 ttt180 -144.67 126.79 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.41 HG11 HD11 ' A' ' 92' ' ' LEU . 9.8 t -111.14 78.3 1.71 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 15.2 Cg_exo -69.71 -176.32 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.55 6.48 45.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.83 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 100.2 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -57.47 -45.71 84.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.032 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.9 mt -62.25 -53.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.185 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -24.01 62.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 1.7 ttm105 -68.95 -36.49 77.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -54.57 12.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.5 mt -60.47 -49.47 84.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.768 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.29 -28.91 68.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.85 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.68 -56.7 16.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.35 -89.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -76.69 127.57 83.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.095 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 153.8 72.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.28 1.987 . . . . 0.0 111.628 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.03 155.82 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.119 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.665 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -80.56 139.5 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.031 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -143.24 111.52 6.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.882 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.688 HG22 ' NH2' ' A' ' 51' ' ' ARG . 2.1 t -140.24 138.15 34.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.545 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 15.0 p -70.6 126.78 30.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.338 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.523 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 46.2 Cg_exo . . . . . 0 CA--C 1.537 0.667 0 N-CA-C 113.474 0.529 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 40.6 Cg_endo -67.15 106.49 1.19 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.845 1.697 . . . . 0.0 112.327 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.09 136.5 21.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.517 ' HG2' ' HG2' ' A' ' 151' ' ' ARG . 69.3 Cg_endo -95.71 -12.25 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.865 2.377 . . . . 0.0 112.445 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -128.29 112.34 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.777 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -56.49 -32.6 65.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.219 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -24.88 58.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.287 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 2.2 tt0 -72.51 -31.01 65.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.509 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.707 HG22 HD12 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -75.22 -51.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.313 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.03 -36.32 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.54 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 157' ' ' ARG . 5.4 mmt85 -72.73 -51.15 20.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.338 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.18 -24.57 64.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.433 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.707 HD12 HG22 ' A' ' 155' ' ' ILE . 40.5 mt -111.22 79.46 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.143 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.2 t70 -28.15 -51.2 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.223 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -161.65 26.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.74 -92.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.535 ' OD1' HD13 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -89.95 88.51 7.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.795 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -56.26 129.39 40.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.388 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.552 HG12 HD12 ' A' ' 155' ' ' ILE . 35.4 m -66.37 -172.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.21 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.78 156.25 41.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -92.62 -19.6 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.4 -50.74 7.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 94.11 -157.02 22.52 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.909 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.07 -163.26 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.623 0.249 . . . . 0.0 111.105 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 m -150.18 -60.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -123.57 -130.19 0.26 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.6 OUTLIER -86.31 144.77 27.21 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.82 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.848 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.6 ttp -68.79 -15.71 63.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -154.51 160.83 30.53 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 70.2 Cg_endo -89.43 -142.41 0.16 OUTLIER 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.548 0.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 73.1 m -153.88 131.86 11.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.834 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.691 HG23 ' HB3' ' A' ' 191' ' ' ARG . 75.9 m -102.33 142.13 34.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.819 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 19.2 t -129.08 110.4 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.006 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.738 HG23 ' HA ' ' A' ' 189' ' ' VAL . 5.4 mt -120.69 125.08 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.182 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.797 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -102.32 66.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 84' ' ' ALA . 21.7 tp -69.58 83.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.527 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -80.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.447 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 185' ' ' ASN . 4.2 t -120.73 -121.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.166 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.454 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -62.66 -52.86 61.7 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.1 109.61 2.73 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.208 1.938 . . . . 0.0 112.445 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 189' ' ' VAL . 93.9 Cg_endo -80.45 127.83 6.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.615 2.21 . . . . 0.0 112.329 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -88.39 45.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 180' ' ' ILE . 9.1 t -56.87 96.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.791 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.24 84.7 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.149 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.691 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -86.02 140.02 30.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 192' ' ' ARG . 1.2 mtt85 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.823 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' CG ' HD23 ' A' ' 16' ' ' LEU . 51.4 Cg_exo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.888 0.287 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -35.74 79.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.147 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.27 -53.21 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.167 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.3 mm? -60.06 -32.62 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.623 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.98 67.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.788 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -36.6 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.55 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.34 -42.8 53.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -66.97 -30.14 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.114 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.8 p -66.5 -44.49 82.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.061 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 18' ' ' GLU . 35.7 t -65.32 -29.45 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.5 mmt -62.7 -44.6 95.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -17.74 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.86 89.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.98 39.78 93.29 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.51 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.84 171.93 15.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.7 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -96.17 140.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.61 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.646 ' H ' HG13 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -116.55 130.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.197 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -101.68 168.89 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.574 0.226 . . . . 0.0 110.756 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -169.48 102.4 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.413 ' HG2' ' HA ' ' A' ' 170' ' ' ASP . 89.3 Cg_endo -83.06 143.74 11.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.544 2.163 . . . . 0.0 111.888 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.43 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -123.16 -160.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.732 ' HB3' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -66.83 -25.35 66.4 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -88.7 -89.9 0.14 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.257 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' H ' HG23 ' A' ' 35' ' ' THR . 1.3 tt -133.68 174.99 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 111.06 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -68.21 143.16 55.43 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -134.82 177.13 19.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.745 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.769 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.0 mt -125.55 144.38 50.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.87 0.367 . . . . 0.0 110.553 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.57 125.59 2.35 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.024 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.646 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -156.58 178.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 111.105 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.43 122.73 12.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.317 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.84 -60.67 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.05 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' HD13 ' A' ' 44' ' ' LEU . 2.4 mm? -81.07 37.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.1 149.76 30.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -75.14 -18.59 60.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -26.64 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.667 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -74.71 -44.55 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.997 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -35.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -38.87 78.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.671 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.584 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.3 -45.18 70.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.781 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.639 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.3 OUTLIER -60.83 -25.83 66.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.784 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -72.88 -34.82 66.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.27 -49.81 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.358 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 140' ' ' SER . 70.9 t -65.27 -49.85 76.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.588 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.602 ' HE2' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -79.75 -6.38 57.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 111.18 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.43 -92.05 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.64 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HG3' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -102.86 116.05 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.466 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 60.8 p -155.11 57.44 1.65 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.09 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 59' ' ' SER . 50.7 Cg_exo -54.11 -57.18 1.98 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.411 2.074 . . . . 0.0 112.285 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.06 30.32 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HD3' ' HE2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.54 135.77 33.86 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.826 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.92 160.79 45.34 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 112.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 110' ' ' ILE . 9.3 m -118.75 162.51 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 t -110.6 141.15 44.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.97 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.503 HG13 HG12 ' A' ' 119' ' ' ILE . 5.9 pt -116.49 167.34 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.01 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.701 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -119.78 135.7 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.874 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -141.53 -178.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.634 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 68' ' ' VAL . 21.6 t -89.71 -41.86 11.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.564 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.18 170.69 16.02 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.52 -37.63 59.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -67.41 -21.89 65.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.159 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -77.15 -26.27 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.874 HG23 HG21 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -113.48 58.81 0.74 Allowed Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 21.5 Cg_endo -60.49 -84.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.066 1.844 . . . . 0.0 111.965 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.57 23.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.389 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 26.0 m-85 -98.9 -31.78 11.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.673 0.273 . . . . 0.0 111.228 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -135.08 178.31 7.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.083 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -113.23 90.21 16.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 78' ' ' SER . 69.2 Cg_endo -102.23 176.39 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.049 2.499 . . . . 0.0 112.645 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -177.31 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.046 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.03 -75.23 0.74 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.516 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.461 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -59.19 -29.95 67.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.821 0.343 . . . . 0.0 110.856 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -61.74 -47.34 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 9.5 mmt -74.21 -18.63 60.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.161 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.4 mm-40 -63.01 -45.18 93.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.524 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.586 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.611 ' HG2' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.92 -58.24 8.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.306 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -4.0 16.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.321 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -56.33 4.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.048 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.45 71.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.583 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.606 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.35 151.76 79.36 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.997 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.648 ' HB3' HG22 ' A' ' 121' ' ' VAL . 5.5 Cg_exo -78.36 -148.45 0.5 Allowed 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.175 -0.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.67 163.6 12.55 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.723 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.78 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 92.8 Cg_endo -81.6 35.2 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.756 2.304 . . . . 0.0 112.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.742 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 44.9 p90 -112.26 162.86 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.411 HG23 ' HB3' ' A' ' 120' ' ' ARG . 7.8 m -115.23 124.86 52.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 182' ' ' LEU . 2.4 p -108.31 109.01 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.131 0.491 . . . . 0.0 110.982 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 44.7 t -103.72 128.61 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.147 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -126.59 -165.87 1.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.308 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.69 -176.05 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.736 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.7 143.33 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.994 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -74.73 -170.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -76.49 55.2 0.99 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.207 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.778 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 24.1 tp -88.79 129.63 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.632 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 11.4 mm -72.02 -52.47 7.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.778 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 75.6 Cg_exo -50.88 100.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.304 2.003 . . . . 0.0 112.536 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.445 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -82.04 1.08 37.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.8 -26.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.097 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.704 HG22 HG21 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -107.48 -29.51 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 19.8 p -78.76 -18.08 54.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.937 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.13 -169.21 54.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.375 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.08 -8.39 83.08 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.401 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.2 p -114.68 -175.46 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.524 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 74.8 m -111.63 62.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -143.22 138.21 29.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' ' 102' ' ' ARG . 97.8 t -139.94 140.28 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.356 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.35 157.08 19.95 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.643 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.508 HD13 HD13 ' A' ' 74' ' ' ILE . 27.8 mt -146.23 151.74 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HB3' HG23 ' A' ' 97' ' ' THR . 0.4 OUTLIER -146.39 137.71 24.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.459 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 93' ' ' PRO . 2.7 p -110.6 87.72 6.88 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.39 -179.74 3.42 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.411 2.074 . . . . 0.0 112.628 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.29 -4.49 57.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.975 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 7.1 m-20 -62.33 103.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -45.98 83.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.48 -50.8 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -63.56 -20.93 66.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.653 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 128' ' ' ARG . 1.7 ttp180 -74.98 -27.21 60.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -60.6 2.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.9 mt -57.79 -48.15 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.178 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.826 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.09 -29.87 70.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.358 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.6 -54.92 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 110.028 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -75.92 -89.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.26 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -77.04 141.07 67.03 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.09 153.77 46.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.303 2.002 . . . . 0.0 111.577 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.98 156.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.691 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.7 m -80.38 129.97 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.027 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.701 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . . . -128.53 102.9 6.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.846 0.355 . . . . 0.0 111.856 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.769 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -130.28 141.76 50.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' HG11 ' A' ' 55' ' ' VAL . 1.4 p -61.72 125.52 24.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 111.373 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.417 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.4 Cg_exo . . . . . 0 CA--C 1.537 0.663 0 N-CA-C 113.246 0.441 . . . . 0.0 113.246 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 21.6 Cg_exo -65.24 100.22 0.37 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.008 1.805 . . . . 0.0 112.112 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.21 149.25 40.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.994 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -95.37 -18.03 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.858 2.372 . . . . 0.0 112.433 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -136.94 130.34 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.524 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.652 ' O ' HG23 ' A' ' 156' ' ' VAL . 9.2 tp -56.78 -41.92 78.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.139 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.43 -38.01 88.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -58.66 -49.21 78.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -61.16 -39.32 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 152' ' ' LEU . 57.7 t -52.46 -37.66 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.728 0.299 . . . . 0.0 111.399 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.39 86.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.495 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.85 -22.69 55.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.158 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 163' ' ' ASP . 2.0 pp -108.65 43.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -16.8 -58.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.342 0.657 . . . . 0.0 112.535 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.38 10.06 0.43 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.757 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -80.87 -82.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.247 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.757 ' H ' HG13 ' A' ' 162' ' ' VAL . 2.0 p-10 -100.51 92.7 5.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.796 0.331 . . . . 0.0 110.783 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.532 ' HA ' HD13 ' A' ' 159' ' ' LEU . 0.6 OUTLIER -65.42 130.7 44.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.736 -178.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.617 HG12 HD12 ' A' ' 155' ' ' ILE . 27.0 m -59.98 -171.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.26 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.92 HD23 ' H ' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.76 156.05 41.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.51 -7.81 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.609 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.58 -40.12 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.892 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.92 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 89.88 -178.82 43.95 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.484 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 14.7 p-10 -70.73 -159.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.515 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 39.6 m -136.78 -59.66 0.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.262 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.732 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -135.85 -116.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.387 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.474 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 58.4 m-20 -86.13 150.63 24.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -15.07 62.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 6.2 pt-20 -153.07 160.6 30.75 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.668 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 177' ' ' SER . 66.0 Cg_endo -95.27 -139.56 0.13 OUTLIER 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.249 -1.146 . . . . 0.0 112.648 0.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 7.6 t -154.01 146.54 24.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.742 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 69.5 m -101.19 142.96 31.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.122 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.11 97.1 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.714 HG12 ' HA ' ' A' ' 189' ' ' VAL . 25.3 mt -109.94 131.58 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.211 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.637 ' HB3' ' HE ' ' A' ' 188' ' ' ARG . 0.2 OUTLIER -108.43 65.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.004 0.43 . . . . 0.0 110.571 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.76 ' HB3' HG23 ' A' ' 98' ' ' VAL . 19.0 tp -69.29 89.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -78.41 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 0.0 110.858 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -128.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 2.1 t-20 -59.68 -52.23 75.43 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.0 Cg_exo -76.92 108.9 2.74 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.497 2.131 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 94.1 Cg_endo -80.72 134.23 9.64 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.519 2.146 . . . . 0.0 112.037 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.637 ' HE ' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -96.31 45.91 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.274 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.714 ' HA ' HG12 ' A' ' 180' ' ' ILE . 20.2 t -56.63 103.81 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.21 93.26 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.452 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -85.07 149.54 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.769 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.038 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HG2' HD23 ' A' ' 16' ' ' LEU . 53.0 Cg_exo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.823 0.259 . . . . 0.0 112.215 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -69.81 -42.45 73.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.028 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -67.75 -25.22 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -70.98 -52.21 21.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.086 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.637 ' HA ' HD12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -69.19 -14.53 63.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.564 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.25 -34.72 59.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.564 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.12 -42.98 55.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.776 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -75.55 -20.22 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.734 0.302 . . . . 0.0 111.274 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.423 ' N ' HD13 ' A' ' 20' ' ' ILE . 46.0 t -70.35 -48.5 56.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 164' ' ' LEU . 11.3 p -69.52 -28.16 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.128 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 21.9 mtt -62.47 -38.57 90.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.064 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -70.29 -20.54 63.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.82 5.05 62.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.29 38.92 94.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.91 168.51 15.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.504 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.718 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.45 148.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.434 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.718 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -119.1 146.94 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -114.78 164.85 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.272 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.518 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -172.91 103.42 0.32 Allowed Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.79 137.03 12.38 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.769 2.312 . . . . 0.0 111.408 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.82 -151.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.738 0.304 . . . . 0.0 111.161 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -54.87 -20.95 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.606 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.82 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -100.1 -114.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.126 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.85 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.0 OUTLIER -112.55 -163.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.353 . . . . 0.0 110.995 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.86 131.38 47.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.586 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.88 174.68 15.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.067 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HB2' HG23 ' A' ' 139' ' ' THR . 2.5 mt -133.25 138.52 46.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.821 0.343 . . . . 0.0 111.132 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.1 121.16 1.48 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.836 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 136' ' ' VAL . 5.3 p -159.76 163.97 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.712 0.292 . . . . 0.0 111.221 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.718 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -55.25 102.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.01 0.434 . . . . 0.0 110.944 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.74 81.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.938 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.561 HD21 ' HZ ' ' A' ' 77' ' ' PHE . 4.3 mm? -76.26 12.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.306 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.46 150.46 28.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -19.53 60.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.77 -30.0 70.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.1 -22.89 57.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.22 -54.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -63.88 -40.25 96.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 8.2 mmt180 -64.18 -38.86 92.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -68.16 -18.4 64.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.798 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -36.76 62.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.2 -40.69 90.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.7 t -73.89 -52.96 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -79.38 -76.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.902 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 17.27 32.9 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.697 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -68.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.349 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB3' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -136.78 76.26 47.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.852 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.11 27.21 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 0.0 112.597 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' ' 59' ' ' SER . 23.7 p80 -105.28 -21.91 13.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.958 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -73.33 154.3 90.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.973 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 116' ' ' ARG . 75.6 Cg_exo -50.62 154.88 5.96 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.597 2.198 . . . . 0.0 112.46 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.635 HG21 HG22 ' A' ' 110' ' ' ILE . 4.3 m -114.54 151.31 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -96.48 136.61 36.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.689 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 14.4 pt -116.27 172.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.27 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 12.5 t -117.87 135.57 54.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.974 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.754 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.1 p -146.24 174.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.604 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.593 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.47 -47.63 15.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.992 0.425 . . . . 0.0 110.462 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.17 176.3 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.449 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.586 HG11 ' HG3' ' A' ' 85' ' ' MET . 2.8 t -59.13 -33.74 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.764 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -67.54 -27.65 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.156 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.664 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 1.2 mp0 -80.43 -17.21 52.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.217 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.685 HG13 ' HB3' ' A' ' 77' ' ' PHE . 21.5 tt -114.65 50.71 0.59 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.664 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 37.4 Cg_exo -59.07 -84.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.046 1.83 . . . . 0.0 113.182 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.42 12.27 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -177.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.685 ' HB3' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -107.77 -17.03 14.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.969 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.656 ' HB2' HG12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.5 177.22 7.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.889 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 12.4 mtp180 -129.81 85.43 58.05 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -101.96 -175.29 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.059 2.506 . . . . 0.0 112.853 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 85' ' ' MET . 1.3 m -140.4 179.9 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.878 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.25 -74.0 0.92 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.39 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.047 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.586 ' HG3' HG11 ' A' ' 71' ' ' VAL . 9.6 mmt -70.64 -16.32 62.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.169 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 41.3 mm-40 -64.89 -50.47 66.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.595 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.94 -35.98 80.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.6 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 182' ' ' LEU . 36.3 mmm -65.6 -45.43 83.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.279 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.94 -16.89 62.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 111.117 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -39.1 63.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.38 40.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.798 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 4.8 tt -129.54 137.91 31.97 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.67 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 96.8 Cg_endo -78.45 -161.66 2.76 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.351 -0.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.98 167.06 16.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.928 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.82 ' HB2' HG23 ' A' ' 35' ' ' THR . 92.2 Cg_endo -79.85 44.35 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.919 2.412 . . . . 0.0 112.359 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 10.6 p90 -112.19 141.24 46.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 m -102.55 112.51 25.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 180' ' ' ILE . 3.5 p -108.39 123.98 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.0 111.672 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 21.3 t -102.45 129.42 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.941 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.64 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 0.8 OUTLIER -126.88 177.17 6.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.802 -178.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.64 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 10.0 mt-10 -74.09 172.94 10.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.672 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -119.71 143.56 47.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.409 . . . . 0.0 111.477 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.475 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.13 -164.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.481 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.39 56.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.518 HD22 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -74.15 136.2 42.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.61 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.6 mt -80.16 -51.39 1.09 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.457 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 40.4 Cg_exo -57.75 103.35 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.328 2.019 . . . . 0.0 112.418 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.78 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 109' ' ' VAL . 2.2 m -76.21 -17.39 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.635 HG22 HG21 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -113.2 -32.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.104 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 107' ' ' PRO . 5.7 p -74.41 -26.79 60.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.5 -163.56 54.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.61 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.15 -3.06 80.87 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.483 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.9 m -114.68 171.32 7.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.449 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 33.5 p -103.87 59.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.61 ' HG2' ' HA ' ' A' ' 101' ' ' GLU . 9.6 mtm105 -152.31 149.1 28.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.022 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 102' ' ' ARG . 77.7 t -139.8 131.81 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.589 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -78.68 167.6 53.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -147.04 162.48 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttt85 -149.14 125.62 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 111.463 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.03 77.79 1.52 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.706 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.75 ' HB2' HG21 ' A' ' 33' ' ' THR . 73.2 Cg_endo -75.34 -178.65 4.39 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.478 2.118 . . . . 0.0 112.605 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.28 -4.02 58.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 0.3 OUTLIER -62.8 99.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 45.3 mt-10 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.08 -50.16 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.955 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -61.22 -24.57 66.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.819 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 15.9 mtm180 -70.12 -32.56 70.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.148 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -59.61 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 mt -58.92 -49.25 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.567 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.754 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.61 -29.32 69.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.406 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.64 -56.64 16.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 109.909 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HB2' ' H ' ' A' ' 134' ' ' PHE . 2.5 mmt85 -76.44 -88.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.166 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.45 ' H ' ' HB2' ' A' ' 133' ' ' ARG . 27.1 m-85 -76.64 117.56 65.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 21.2 Cg_exo -65.45 152.03 83.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.321 2.014 . . . . 0.0 111.319 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -134.46 169.55 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 111.472 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.668 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.2 m -80.85 138.8 36.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.492 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -136.99 96.54 3.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.277 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -125.72 145.33 50.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.32 117.07 22.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.186 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.559 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 36.0 Cg_exo . . . . . 0 CA--C 1.537 0.653 0 N-CA-C 113.404 0.502 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.441 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.1 Cg_exo -65.65 87.75 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.03 1.82 . . . . 0.0 112.175 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -96.62 142.97 25.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.911 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 67.6 Cg_endo -95.74 -16.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.557 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -132.37 121.25 23.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.693 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.582 ' HA ' HD11 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -58.04 -38.7 76.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.195 -179.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -41.48 85.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.0 -38.38 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.839 HD12 HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -71.94 -33.23 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 152' ' ' LEU . 21.6 t -53.42 -47.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.476 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -69.37 -32.45 71.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.861 0.363 . . . . 0.0 110.77 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -21.69 56.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.244 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.833 HD21 HG13 ' A' ' 165' ' ' VAL . 2.6 pp -98.76 43.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 159' ' ' LEU . 13.8 t0 -17.53 -54.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.709 0.63 . . . . 0.0 112.254 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -160.75 11.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.4 p -81.84 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.859 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 162' ' ' VAL . 0.3 OUTLIER -108.24 96.19 6.19 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.743 0.306 . . . . 0.0 111.396 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.717 ' HA ' HD13 ' A' ' 159' ' ' LEU . 1.4 mm? -64.16 139.77 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.676 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.839 HG12 HD12 ' A' ' 155' ' ' ILE . 3.4 m -61.03 -174.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.508 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.32 145.6 50.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.739 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.85 -22.49 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.72 -52.79 5.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.138 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.621 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 96.64 -160.34 21.82 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.48 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.07 -163.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.427 ' HB3' ' N ' ' A' ' 34' ' ' ASP . 49.1 t -145.34 -57.4 0.33 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.612 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -126.16 -130.07 0.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.3 OUTLIER -86.16 147.63 26.05 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -177.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.85 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.21 -23.3 66.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 158.84 33.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.684 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.55 ' O ' HG22 ' A' ' 35' ' ' THR . 64.9 Cg_endo -90.95 -149.86 0.35 Allowed 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.024 -1.24 . . . . 0.0 112.663 1.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.1 p -154.67 153.74 31.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.793 HG23 ' HB3' ' A' ' 191' ' ' ARG . 0.3 OUTLIER -99.91 141.58 32.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.0 t -129.05 78.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 189' ' ' VAL . 23.2 mt -101.67 131.32 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.209 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 188' ' ' ARG . 6.9 t70 -108.78 61.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.3 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -70.14 100.15 1.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.333 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 -73.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.813 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 185' ' ' ASN . 23.1 t -120.56 -109.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.028 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -74.63 -52.76 3.56 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.486 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 4.8 Cg_exo -77.68 108.0 2.48 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.496 2.131 . . . . 0.0 112.237 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 98.7 Cg_endo -79.46 131.15 9.34 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 3.8 mmt85 -86.65 53.12 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.973 0.416 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.769 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.93 107.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.12 82.73 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.793 ' HB3' HG23 ' A' ' 178' ' ' THR . 5.3 ptm180 -89.57 142.07 28.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.023 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' HD22 ' A' ' 16' ' ' LEU . 73.2 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.85 0.271 . . . . 0.0 112.352 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.05 -28.25 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.625 HG22 ' HB3' ' A' ' 167' ' ' ASP . 82.7 t -57.5 -62.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.18 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.842 HD11 HG12 ' A' ' 126' ' ' ILE . 2.9 mp -60.53 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.366 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.06 -29.61 67.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.482 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.97 -31.9 59.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.329 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.64 56.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.326 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 16' ' ' LEU . 2.2 pp -75.21 -22.05 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 0.0 111.224 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -69.08 -53.15 21.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.4 -28.62 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.4 mtt -57.09 -51.15 70.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.64 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.37 9.15 74.72 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.707 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 39.42 92.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.723 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.56 168.58 13.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.192 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.733 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -96.29 141.28 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.619 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -116.19 110.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.078 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.615 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -100.49 151.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 111.247 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.489 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 1.9 m-85 -154.33 114.12 2.48 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.171 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 68.4 Cg_endo -84.9 139.25 7.31 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.81 2.34 . . . . 0.0 111.391 176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.775 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -119.2 -149.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.708 0.289 . . . . 0.0 111.457 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -54.82 -23.75 19.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.561 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 36' ' ' ILE . 2.1 t -100.48 -114.94 0.17 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.011 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.763 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.71 -166.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.892 0.377 . . . . 0.0 111.592 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.59 138.57 55.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -130.98 168.71 21.86 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.116 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.707 ' HB2' HG23 ' A' ' 139' ' ' THR . 8.3 mp -113.91 143.71 44.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.741 0.305 . . . . 0.0 110.863 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.7 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.13 112.97 0.68 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.679 HG13 HD12 ' A' ' 28' ' ' ILE . 18.6 m -151.52 172.41 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.772 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.87 95.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.233 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HA ' ' CB ' ' A' ' 48' ' ' ALA . . . -57.85 -42.54 84.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.998 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HG ' HD11 ' A' ' 110' ' ' ILE . 2.5 mp -67.38 -29.77 69.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 111.417 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.772 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -86.51 154.24 21.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.026 -177.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -60.58 -12.4 9.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.062 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -60.75 -34.03 73.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 110.262 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -76.28 -49.32 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.493 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 46' ' ' GLU . 8.1 p -59.66 -20.9 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.195 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.07 -57.84 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 179.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -63.17 -25.43 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.721 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 64' ' ' VAL . 1.7 mp -63.64 -54.43 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.768 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -54.57 -28.91 49.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.082 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -67.48 -57.26 6.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.605 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.9 t -75.55 -56.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.5 5.86 11.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.47 -121.85 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.353 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.04 109.24 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.0 111.015 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.619 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -148.25 66.8 9.53 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.82 -7.51 20.86 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.53 2.153 . . . . 0.0 112.306 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 21.7 m-70 -103.79 -19.14 14.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -85.96 132.51 43.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.8 166.22 27.01 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.433 2.089 . . . . 0.0 112.057 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 110' ' ' ILE . 12.1 p -112.97 141.91 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.153 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.74 138.39 32.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 66' ' ' ILE . 1.5 pp -115.99 174.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.545 ' SG ' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -122.23 132.68 54.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.538 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG21 HG23 ' A' ' 74' ' ' ILE . 1.2 p -138.47 179.83 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.731 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.824 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 3.0 t -90.09 -41.8 11.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.63 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.72 170.67 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 74' ' ' ILE . 5.2 t -57.52 -38.54 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.13 -24.45 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.985 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 56.2 mm-40 -76.04 -20.89 57.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.775 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.802 HG23 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.55 61.84 0.9 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.729 178.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.66 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 28.9 Cg_exo -61.94 -79.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.086 1.858 . . . . 0.0 112.226 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -73.25 22.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' A' ' 117' ' ' VAL . 1.1 t80 -100.56 -48.9 4.38 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.954 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 80.7 p -131.38 -179.98 5.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -129.14 101.61 19.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 88.2 Cg_endo -102.4 -172.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.143 2.562 . . . . 0.0 112.634 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.19 -171.86 3.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.14 -82.08 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.629 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 1.1 m-20 -56.43 -26.11 52.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.67 71.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.463 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 27.0 mmt -74.27 -12.89 60.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.75 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 1.8 mt-10 -70.68 -50.28 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.7 tp -63.96 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.833 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.668 ' HB2' HD13 ' A' ' 182' ' ' LEU . 7.9 tpt -75.01 -42.41 57.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.383 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -23.7 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.715 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.1 ptm180 -75.84 -36.21 59.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.472 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.419 HG13 ' HE3' ' A' ' 88' ' ' MET . 3.6 pt -103.61 14.94 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.064 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.486 HD23 ' C ' ' A' ' 88' ' ' MET . 0.3 OUTLIER -130.97 152.77 81.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.823 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.426 ' N ' HD12 ' A' ' 92' ' ' LEU . 71.6 Cg_endo -78.17 -174.38 14.66 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.563 -1.432 . . . . 0.0 112.67 0.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.61 -174.63 32.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.491 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 96.0 Cg_endo -79.87 39.29 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.597 2.198 . . . . 0.0 112.29 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.13 160.92 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.784 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 27.2 m -107.54 131.05 54.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.29 107.34 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.852 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 5.5 t -102.89 131.02 52.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD11 ' HE3' ' A' ' 85' ' ' MET . 3.1 mm? -126.75 177.95 6.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.469 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 177.03 6.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.847 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -119.65 141.09 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.189 0.518 . . . . 0.0 111.429 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.647 HD22 ' H ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -74.8 -167.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.426 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -76.91 37.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.506 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -69.27 116.47 9.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.909 0.385 . . . . 0.0 110.786 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.521 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 25.5 mm -63.55 -48.55 80.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.159 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.5 Cg_exo -49.63 108.9 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.092 1.862 . . . . 0.0 112.483 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -2.62 48.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.858 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.728 HG13 HG13 ' A' ' 110' ' ' ILE . 10.5 p -71.78 -27.03 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.73 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.728 HG13 HG13 ' A' ' 109' ' ' VAL . 4.4 mt -101.2 -35.6 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.686 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.653 HG23 ' HG2' ' A' ' 102' ' ' ARG . 2.0 m -73.88 -30.69 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.81 -143.01 27.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.357 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -89.98 -18.29 51.1 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.529 ' O ' HG22 ' A' ' 111' ' ' THR . 22.1 m -106.61 -172.08 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.704 0.288 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.2 m -113.12 42.44 1.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 116' ' ' ARG . 5.7 mtm-85 -136.63 156.36 48.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 102' ' ' ARG . 62.0 t -140.15 145.52 26.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.558 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -99.2 159.18 20.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.227 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.61 HD13 HD13 ' A' ' 74' ' ' ILE . 9.3 mt -142.57 159.89 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.406 ' N ' HG22 ' A' ' 119' ' ' ILE . 7.0 ttp85 -151.12 124.7 9.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 111.151 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.48 87.96 7.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.71 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.775 ' HB2' HG21 ' A' ' 33' ' ' THR . 60.2 Cg_endo -72.25 -179.97 4.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.409 2.072 . . . . 0.0 112.47 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.52 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -93.0 17.92 9.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.182 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 109.77 15.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.01 -47.01 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.106 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.842 HG12 HD11 ' A' ' 16' ' ' LEU . 2.2 mp -64.39 -52.08 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 95.8 m -59.32 -16.15 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 69' ' ' SER . 31.7 ttt180 -74.94 -46.98 31.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.409 HH21 HG12 ' A' ' 130' ' ' ILE . 5.7 ttp180 -66.89 -48.88 67.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.388 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.409 HG12 HH21 ' A' ' 129' ' ' ARG . 37.9 mt -61.23 -55.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.192 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.53 -26.42 67.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.228 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.7 -57.1 12.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -76.0 -87.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.072 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.9 124.7 87.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 151.63 59.57 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.341 2.027 . . . . 0.0 111.879 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.545 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.6 t -131.42 157.71 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.046 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.7 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.4 OUTLIER -80.75 136.64 36.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.071 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.505 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . . . -129.27 98.39 4.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 111.349 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -128.21 105.13 8.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.623 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.853 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 78.5 p -61.71 128.56 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.842 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.487 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 37.7 Cg_exo . . . . . 0 CA--C 1.537 0.669 0 N-CA-C 113.484 0.532 . . . . 0.0 113.484 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 57.1 Cg_endo -69.94 97.68 0.66 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.804 1.669 . . . . 0.0 112.198 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.432 ' HB3' HD11 ' A' ' 155' ' ' ILE . 1.4 m -89.75 135.19 30.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 94.1 Cg_endo -95.2 -43.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.752 2.301 . . . . 0.0 112.718 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.688 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 4.2 ttt180 -131.69 137.47 48.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.695 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.686 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -61.01 -40.67 94.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -19.93 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.688 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 3.7 tm-20 -67.29 -40.98 86.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.657 HD12 HG23 ' A' ' 165' ' ' VAL . 5.4 mt -70.06 -48.46 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.346 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.76 -31.02 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.318 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ttt180 -75.36 -52.95 9.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.113 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.741 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -60.07 -38.62 83.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.179 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.7 mm? -109.29 73.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -37.19 -39.83 0.29 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.25 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.84 11.88 0.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.606 0.241 . . . . 0.0 111.597 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 5.3 t -80.67 -81.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.733 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -104.34 99.39 9.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.502 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -73.68 127.87 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -178.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.841 HG22 ' H ' ' A' ' 166' ' ' LEU . 3.5 p -65.19 -163.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.841 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.68 143.55 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.976 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.625 ' HB3' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -92.31 -14.96 28.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.489 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.24 -41.73 16.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.425 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.56 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 93.53 -167.67 28.8 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.163 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 3.0 p30 -73.1 -165.11 0.21 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.75 0.31 . . . . 0.0 111.022 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -61.4 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.724 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.69 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -126.33 -132.57 0.25 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.511 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 3.8 t70 -86.88 165.16 16.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.87 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.763 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.8 ttp -70.33 -8.96 54.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.839 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.14 162.17 36.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' A' ' 177' ' ' SER . 66.4 Cg_endo -97.5 -148.97 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.71 1.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -155.27 110.31 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 191' ' ' ARG . 95.6 m -101.46 138.72 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.198 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.784 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.0 t -129.24 109.24 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.746 HG23 ' HA ' ' A' ' 189' ' ' VAL . 4.5 mt -117.84 137.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.852 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.2 m-20 -108.0 67.44 0.68 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -69.5 83.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.354 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.25 -83.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.523 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.96 -100.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.282 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -83.9 -51.82 0.6 Allowed Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -73.84 110.4 3.07 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.125 1.883 . . . . 0.0 112.259 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.5 Cg_endo -82.15 118.1 2.94 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.707 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -86.94 49.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.746 ' HA ' HG23 ' A' ' 180' ' ' ILE . 6.6 t -56.6 104.01 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.012 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.03 77.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.017 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.518 ' HB3' HG23 ' A' ' 178' ' ' THR . 3.0 ptp180 -83.81 131.66 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.493 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.709 0.212 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -40.26 84.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 12.3 t -66.9 -34.01 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.014 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.95 -46.63 67.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -61.5 -21.55 64.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.161 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -75.18 -36.68 61.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.632 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.21 80.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.78 -32.26 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -59.99 -38.73 83.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.78 HG21 HD22 ' A' ' 164' ' ' LEU . 7.4 t -67.82 -34.68 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.0 mmt -56.06 -40.87 74.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.96 -23.14 58.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.21 -2.35 74.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.507 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.67 57.91 10.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.99 163.18 22.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.491 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.718 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.2 tp -96.21 143.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.772 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.541 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.44 120.32 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.543 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.6 OUTLIER -101.58 149.96 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 0.0 110.981 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 1.5 m-85 -153.18 100.08 2.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.005 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.509 ' HG3' ' CD2' ' A' ' 37' ' ' TYR . 2.5 Cg_endo -78.53 134.0 12.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.824 2.349 . . . . 0.0 110.791 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 93.9 m -138.35 -85.44 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 3.0 m-20 -74.46 -72.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.561 -177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.509 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -77.72 -86.89 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.047 -177.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.682 HG23 ' N ' ' A' ' 37' ' ' TYR . 3.9 tp -133.33 -155.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.672 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.682 ' N ' HG23 ' A' ' 36' ' ' ILE . 8.9 m-85 -63.27 131.5 48.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.37 172.85 14.42 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.177 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -118.2 135.85 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.96 0.41 . . . . 0.0 111.113 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.76 114.44 0.72 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.769 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.5 p -158.12 175.88 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -56.35 118.55 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.592 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.433 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.85 -56.24 24.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.03 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.6 mm? -82.29 37.52 0.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.926 0.393 . . . . 0.0 111.45 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.651 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.14 153.98 24.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.861 178.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -71.5 -29.16 64.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.833 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.04 -33.35 75.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.02 -35.99 74.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.78 -44.03 89.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.036 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -66.12 -43.11 88.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.543 HH11 ' HA ' ' A' ' 51' ' ' ARG . 7.2 mmt-85 -70.96 -24.71 62.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.61 HD11 HG23 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -71.83 -44.99 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.985 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -20.47 62.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.41 -49.77 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 48.0 t -75.55 -40.36 41.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.439 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.95 -12.23 59.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.94 -108.0 2.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.533 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -118.19 90.6 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.049 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 m -153.79 70.7 6.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.12 14.98 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.566 2.177 . . . . 0.0 112.594 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -121.06 -19.02 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.951 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -84.26 131.68 49.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 32.1 Cg_exo -60.01 175.34 1.01 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.555 2.17 . . . . 0.0 112.247 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.61 HG23 HD11 ' A' ' 52' ' ' LEU . 10.0 p -112.98 152.07 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 4.8 t -93.93 129.0 40.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 67' ' ' CYS . 9.5 mm -107.98 161.51 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.861 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 51.4 t -122.23 127.44 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.865 HG21 HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -140.84 177.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.575 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.703 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -87.18 -41.76 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 110.462 179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.42 170.57 15.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.799 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.826 HG11 ' HG3' ' A' ' 85' ' ' MET . 5.1 t -59.03 -33.07 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -24.91 66.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.668 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.703 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 73.5 mm-40 -78.06 -21.04 51.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.66 56.52 0.69 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.652 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -58.68 -85.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.033 1.822 . . . . 0.0 112.11 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 18.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.59 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.472 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 25.2 m-85 -92.34 -34.42 14.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.76 0.315 . . . . 0.0 110.958 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 57.1 p -135.37 -178.14 4.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.837 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.835 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 6.5 mmt180 -114.1 83.76 8.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.667 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 76.4 Cg_endo -102.46 178.46 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.111 2.541 . . . . 0.0 113.036 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 3.0 m -129.93 179.43 5.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.19 -78.63 0.63 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.762 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -55.08 -31.39 61.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -60.73 -41.14 94.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.826 ' HG3' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -69.97 -25.95 63.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.279 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.3 mm-40 -57.99 -56.09 26.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.418 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -55.04 -39.23 68.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.896 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.557 ' SD ' HG21 ' A' ' 98' ' ' VAL . 3.9 tpt -66.69 -41.34 88.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.343 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.23 -7.72 44.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.265 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.95 -37.92 61.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 pt -115.06 48.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 121' ' ' VAL . 4.1 tp -131.21 138.52 33.04 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.513 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 97.0 Cg_endo -78.51 -162.95 3.14 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.481 -0.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.52 164.68 13.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.376 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.14 30.76 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.586 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -100.99 132.99 46.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.905 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -101.61 120.54 40.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.427 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' A' ' 180' ' ' ILE . 2.4 m -110.36 135.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 0.0 111.681 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -101.76 130.19 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.283 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -126.78 -179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.744 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.835 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 2.1 tt0 -74.27 175.71 7.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.508 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.628 HH11 HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -119.24 144.77 46.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.417 . . . . 0.0 111.325 -179.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 105' ' ' LEU . 5.7 p-10 -74.34 -159.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.936 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 27.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.563 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.436 ' HG ' ' HG2' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -69.45 113.47 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.2 mt -68.58 -49.45 29.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.89 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 7.5 Cg_endo -49.93 110.08 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.444 2.096 . . . . 0.0 112.459 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.414 ' HA ' HG22 ' A' ' 111' ' ' THR . 3.9 m-20 -76.15 -5.06 44.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.872 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.77 -24.68 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.686 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.605 ' O ' HG12 ' A' ' 64' ' ' VAL . 26.0 mm -95.18 -51.71 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.168 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.628 HG21 HH11 ' A' ' 102' ' ' ARG . 11.7 t -77.93 -0.64 28.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.51 -160.17 51.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.588 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.37 83.89 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.473 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 m -113.82 -171.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.496 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 55.2 m -105.26 47.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -137.05 155.74 49.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.0 0.428 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 102' ' ' ARG . 67.1 t -139.72 138.8 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.458 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -90.66 152.25 21.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.841 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.593 HD13 HD13 ' A' ' 74' ' ' ILE . 42.9 mt -147.68 142.85 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.582 ' HB3' HG23 ' A' ' 97' ' ' THR . 0.0 OUTLIER -148.76 137.94 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.943 0.401 . . . . 0.0 111.21 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 92' ' ' LEU . 6.8 t -110.21 98.09 33.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.025 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.19 -179.1 4.92 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.459 2.106 . . . . 0.0 112.568 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.23 14.01 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 1.5 t0 -76.14 106.09 7.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -52.71 64.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.235 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.2 -49.07 84.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -62.53 -23.66 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.891 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -67.04 -35.11 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.786 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -53.74 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 mt -60.58 -54.75 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.307 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.745 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -58.32 -28.73 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.376 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.8 -55.27 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 109.904 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 133' ' ' ARG . 1.6 mtm180 -75.48 -89.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.02 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.97 134.35 68.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.784 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.97 152.59 76.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.379 2.053 . . . . 0.0 111.811 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.3 153.61 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.204 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.63 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 6.8 m -80.68 137.55 36.32 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.861 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -133.91 108.47 8.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.707 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.91 136.04 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -79.43 113.88 17.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.422 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.9 Cg_exo . . . . . 0 CA--C 1.537 0.643 0 N-CA-C 113.352 0.482 . . . . 0.0 113.352 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 74.0 Cg_endo -74.81 115.81 4.41 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 112.358 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.4 152.69 38.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -95.86 -14.51 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.83 2.353 . . . . 0.0 113.004 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.1 mmt180 -135.88 136.88 40.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.856 0.36 . . . . 0.0 111.109 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' HG11 ' A' ' 165' ' ' VAL . 8.3 mt -65.3 -45.16 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.907 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -27.0 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.145 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -37.42 86.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.146 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.464 ' HB ' ' CG1' ' A' ' 165' ' ' VAL . 1.1 mt -72.7 -34.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.154 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 152' ' ' LEU . 16.0 t -64.17 -30.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.813 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -75.5 -53.02 9.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.444 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.41 -45.85 68.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.814 HD12 ' HB ' ' A' ' 162' ' ' VAL . 0.8 OUTLIER -90.83 64.22 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -37.05 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.186 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -171.51 16.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.814 ' HB ' HD12 ' A' ' 159' ' ' LEU . 47.1 t -80.78 -91.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.718 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -98.41 95.85 7.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.403 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.78 HD22 HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -60.46 138.65 57.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.79 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 152' ' ' LEU . 26.9 m -65.04 -169.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 169' ' ' GLY . 1.0 OUTLIER -125.84 135.76 52.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.211 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -2.16 54.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.01 -33.61 24.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.349 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.439 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 102.24 130.18 6.92 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.505 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 4.8 p-10 -73.41 -175.97 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.674 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.7 OUTLIER -136.72 -171.49 2.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.643 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.86 38.65 1.34 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 1.4 m-20 -85.08 56.89 4.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.111 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -54.43 173.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.377 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.921 ' H ' ' HA ' ' A' ' 176' ' ' PRO . 2.1 tp10 -160.12 -47.77 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.921 ' HA ' ' H ' ' A' ' 175' ' ' GLU . 89.6 Cg_endo -83.45 -52.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.358 1.048 0 C-N-CA 124.653 -0.978 . . . . 0.0 113.495 3.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.96 144.82 22.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.664 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 96' ' ' TYR . 53.0 m -102.41 150.39 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.464 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.6 86.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.343 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.722 ' HB ' HG12 ' A' ' 98' ' ' VAL . 10.3 mt -100.71 131.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.654 ' HB3' ' HG3' ' A' ' 188' ' ' ARG . 7.3 t0 -98.84 64.53 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.953 0.406 . . . . 0.0 110.685 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.3 tt -70.2 75.68 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.419 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.56 -79.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.444 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.779 HG13 ' H ' ' A' ' 185' ' ' ASN . 1.7 p -120.42 -95.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.546 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.779 ' H ' HG13 ' A' ' 184' ' ' VAL . 2.2 t-20 -90.47 -51.31 0.33 Allowed Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 18.3 Cg_exo -67.52 107.26 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.571 2.18 . . . . 0.0 112.314 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 87.7 Cg_endo -84.55 116.51 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.683 2.255 . . . . 0.0 112.477 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.654 ' HG3' ' HB3' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -91.96 67.9 5.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.06 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.56 HG13 HG12 ' A' ' 180' ' ' ILE . 2.5 t -63.71 112.77 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.3 94.08 2.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -83.99 147.18 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.827 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 26.1 Cg_exo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.724 0.218 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -54.52 6.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.414 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.6 HG11 HD13 ' A' ' 126' ' ' ILE . 41.8 t -64.39 -45.95 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.607 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.7 mm? -58.94 -50.77 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.124 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -55.07 -27.57 45.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.839 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 1.8 mt-10 -75.82 -43.75 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.59 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.13 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.9 mm -67.41 -22.35 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 3.6 t -65.16 -58.9 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 164' ' ' LEU . 14.6 p -62.41 -29.65 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 mtt -64.57 -28.52 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.35 13.89 62.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.522 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.05 58.92 9.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.84 162.35 19.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.697 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.4 tp -95.05 140.0 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.721 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.61 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.39 131.99 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.571 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.551 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -102.28 163.2 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.679 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -168.33 102.44 0.54 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.761 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.686 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 92.6 Cg_endo -84.27 155.47 12.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.745 2.297 . . . . 0.0 112.121 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.458 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 40.8 p -131.51 -155.28 0.68 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.553 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -55.34 -19.03 7.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.715 0.293 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -97.61 -118.64 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.795 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.514 ' H ' ' HB ' ' A' ' 35' ' ' THR . 1.1 tt -111.94 -174.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 110.827 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.686 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -63.24 134.64 56.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.94 178.9 17.76 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.119 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 4.4 mt -133.25 138.01 46.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.174 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.46 122.61 1.73 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.609 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.7 p -159.77 177.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.723 0.296 . . . . 0.0 111.281 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.655 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 1.9 m120 -56.13 106.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.976 0.417 . . . . 0.0 110.669 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.14 -49.73 76.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.091 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -80.29 27.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.944 0.402 . . . . 0.0 111.748 -178.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 147.77 34.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.815 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -73.32 -24.78 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 110.593 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -58.37 -30.14 66.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.809 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -65.88 -30.37 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 t -71.15 -46.07 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 50' ' ' ARG . 9.9 mtm180 -65.15 -41.13 95.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.682 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mpt_? -67.01 -53.87 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.077 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -54.56 -25.76 27.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -73.76 -52.98 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 54' ' ' ARG . 6.6 mmp_? -55.49 -35.88 66.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.68 -58.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -72.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.41 17.0 30.71 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.31 -16.16 9.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 110.93 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -140.05 67.65 33.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 -4.59 15.41 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.551 2.167 . . . . 0.0 112.213 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.91 -4.46 17.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 0.0 OUTLIER -86.43 145.36 39.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.993 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HD2' ' HD2' ' A' ' 62' ' ' LYS . 24.2 Cg_endo -60.82 156.98 40.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.673 2.249 . . . . 0.0 112.147 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 110' ' ' ILE . 11.9 p -112.59 147.26 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -94.18 145.03 25.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.2 161.83 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.819 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 10.8 t -111.73 131.55 55.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 0.8 OUTLIER -137.74 170.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.803 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 4.1 t -86.47 -39.4 16.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.489 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.7 t -164.08 174.09 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.56 HG11 ' HG3' ' A' ' 85' ' ' MET . 37.9 t -59.93 -38.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m-20 -67.22 -23.4 65.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.803 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 24.5 mm-40 -80.62 -23.17 39.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.231 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.718 ' HB ' HG21 ' A' ' 68' ' ' VAL . 18.9 tt -114.22 50.66 0.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.029 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 20.8 Cg_endo -61.97 -78.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.099 1.866 . . . . 0.0 113.176 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 9.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CE2' ' HG2' ' A' ' 135' ' ' PRO . 1.8 m-85 -108.21 -13.63 14.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.219 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.657 ' HB2' HD23 ' A' ' 100' ' ' LEU . 60.3 p -135.74 178.11 7.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.622 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.656 ' O ' HD11 ' A' ' 100' ' ' LEU . 3.8 mtp-105 -133.5 62.14 57.89 Favored Pre-proline 0 N--CA 1.464 0.232 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.485 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.626 ' HB3' HD22 ' A' ' 100' ' ' LEU . 65.6 Cg_endo -102.38 173.15 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.784 2.323 . . . . 0.0 113.203 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.5 -177.71 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.53 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.09 4.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.783 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -55.59 -41.28 73.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 0.0 111.211 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.16 -51.6 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.56 ' HG3' HG11 ' A' ' 71' ' ' VAL . 24.0 mmt -71.74 -7.81 50.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -72.28 -54.58 9.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.342 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -37.49 74.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.695 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.491 ' HG2' HG11 ' A' ' 98' ' ' VAL . 3.4 tpt -73.76 -41.36 62.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.633 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -63.42 -13.82 43.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.05 -31.17 61.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.27 45.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.472 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -131.27 147.09 64.82 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.843 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.37 -172.08 10.76 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.953 -1.269 . . . . 0.0 112.14 -0.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.25 179.93 29.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.582 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 36.8 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.782 2.321 . . . . 0.0 112.279 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.405 ' HD2' HG21 ' A' ' 178' ' ' THR . 13.9 m-85 -106.86 114.42 28.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.474 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 26.0 m -96.99 117.29 30.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -108.83 108.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.517 HG13 ' HA2' ' A' ' 118' ' ' GLY . 7.1 t -84.93 124.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 78' ' ' SER . 0.2 OUTLIER -128.13 162.3 27.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.394 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.606 ' H ' HD12 ' A' ' 100' ' ' LEU . 3.6 mt-10 -59.08 174.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.756 ' HE ' ' HB3' ' A' ' 105' ' ' LEU . 18.8 ttt85 -118.57 159.06 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.151 0.501 . . . . 0.0 111.835 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.417 ' H ' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.13 -162.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.343 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 16.53 0.37 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.836 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.756 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 1.7 tm? -69.83 153.75 42.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.583 0.23 . . . . 0.0 110.459 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.714 HG13 ' H ' ' A' ' 108' ' ' ASP . 1.8 tp -59.54 106.41 0.73 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.629 ' HA ' HG23 ' A' ' 111' ' ' THR . 74.3 Cg_endo -72.25 16.79 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.003 2.469 . . . . 0.0 113.431 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.714 ' H ' HG13 ' A' ' 106' ' ' ILE . 22.4 t0 -61.32 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.76 6.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.615 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.588 ' O ' HG12 ' A' ' 64' ' ' VAL . 10.1 mm -95.95 -59.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.297 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 107' ' ' PRO . 5.9 p -87.5 -31.11 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.014 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 -89.8 0.29 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.19 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.93 -84.01 0.17 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.114 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -103.95 -167.71 1.4 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.558 0.218 . . . . 0.0 110.896 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.7 60.4 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 111.188 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 116' ' ' ARG . 9.5 mtt85 -136.44 143.6 43.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.692 HG21 HH11 ' A' ' 102' ' ' ARG . 90.3 t -140.0 138.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.71 151.82 36.33 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.793 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 118' ' ' GLY . 26.0 mt -149.61 135.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.642 0.258 . . . . 0.0 110.453 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.575 ' HD2' ' HD3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -156.46 149.99 24.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 111.454 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 92' ' ' LEU . 2.3 t -110.87 89.08 8.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.404 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.575 ' HD3' ' HD2' ' A' ' 120' ' ' ARG . 22.7 Cg_endo -61.75 -178.77 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.499 2.133 . . . . 0.0 112.721 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.72 7.46 23.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.3 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 127' ' ' CYS . 7.3 m-20 -80.2 94.86 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.868 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.26 -33.41 67.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.6 HD13 HG11 ' A' ' 15' ' ' VAL . 2.0 mt -69.67 -52.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.725 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -61.34 -13.93 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.754 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.65 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -75.15 -48.06 25.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.89 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -59.65 -54.25 48.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mt -59.03 -49.05 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.064 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.4 -27.68 69.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.42 -56.71 15.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -89.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.747 176.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -77.08 124.88 87.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.818 177.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.528 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 25.9 Cg_exo -64.78 157.72 54.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.283 1.989 . . . . 0.0 111.69 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.3 t -128.94 155.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.651 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 8.0 m -80.51 132.51 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.927 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.23 104.29 7.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 111.548 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -133.22 163.32 29.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 t -81.31 131.22 35.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.044 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.4 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 45.5 Cg_exo . . . . . 0 CA--C 1.536 0.622 0 N-CA-C 113.228 0.434 . . . . 0.0 113.228 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 26.1 Cg_exo -62.0 91.24 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.899 1.733 . . . . 0.0 111.931 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.94 148.52 78.96 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -95.48 -15.53 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.994 2.462 . . . . 0.0 112.368 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.48 ' HG2' ' HB2' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -136.53 125.89 24.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.425 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.507 HD21 HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -58.29 -40.8 82.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -20.04 63.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.48 ' HB2' ' HG2' ' A' ' 151' ' ' ARG . 15.2 tt0 -75.12 -28.68 60.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.61 HG22 HD12 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -74.95 -46.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 -179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -60.09 -31.22 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.29 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -74.96 -47.02 31.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.071 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.14 -23.75 60.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.252 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.864 HD13 ' HB3' ' A' ' 163' ' ' ASP . 97.2 mt -111.34 67.13 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -16.19 -63.15 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.077 0.86 . . . . 0.0 112.776 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.18 22.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.005 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.7 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -81.13 -70.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.983 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.864 ' HB3' HD13 ' A' ' 159' ' ' LEU . 38.6 t0 -107.98 96.7 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.578 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.49 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -67.51 135.77 53.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 156' ' ' VAL . 18.8 m -67.4 -164.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.255 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.701 ' H ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.27 161.38 27.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.869 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.439 ' HB3' HG13 ' A' ' 15' ' ' VAL . 15.3 t70 -92.41 -25.08 18.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.59 -57.56 3.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.128 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.419 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 102.05 -161.87 17.33 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.934 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.65 -162.73 0.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.676 0.274 . . . . 0.0 110.915 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.458 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.73 -56.11 0.16 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.705 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -133.46 -133.15 0.17 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -85.89 142.6 28.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.873 0.368 . . . . 0.0 111.963 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 35' ' ' THR . 69.2 mmm -62.4 -25.36 67.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.319 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.4 159.17 42.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.741 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.54 ' O ' HG22 ' A' ' 35' ' ' THR . 75.3 Cg_endo -86.79 -149.59 0.44 Allowed 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.694 0.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.98 157.12 38.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -99.45 132.23 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.87 90.33 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.946 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.719 HG12 ' HA ' ' A' ' 189' ' ' VAL . 22.6 mt -108.42 137.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.499 ' H ' ' HB2' ' A' ' 188' ' ' ARG . 0.5 OUTLIER -106.49 67.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.042 178.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 187' ' ' PRO . 31.8 tp -70.28 90.04 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.682 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -79.25 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.447 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.23 -123.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.059 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -62.51 -52.02 68.6 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 80.9 Cg_endo -77.92 108.42 2.53 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.138 1.892 . . . . 0.0 112.645 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.58 ' HB3' HD13 ' A' ' 182' ' ' LEU . 84.6 Cg_endo -83.25 129.65 5.24 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.499 ' HB2' ' H ' ' A' ' 181' ' ' ASP . 9.2 mmt85 -88.68 60.9 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.038 0.447 . . . . 0.0 111.001 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.719 ' HA ' HG12 ' A' ' 180' ' ' ILE . 32.6 t -62.38 92.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.949 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.55 87.04 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -83.56 145.93 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.722 179.687 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.863 0.276 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.693 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -75.07 -27.72 60.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.48 -49.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 4.1 mm? -66.22 -32.15 73.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.152 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -71.77 -31.3 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -75.54 -38.21 59.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.264 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.566 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.68 -45.44 58.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.8 -30.35 37.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.72 -40.81 88.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.726 HG22 ' HG ' ' A' ' 164' ' ' LEU . 3.3 t -62.82 -31.03 50.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.0 mmt -61.5 -43.88 98.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.38 -23.21 58.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.809 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -19.0 63.8 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.44 36.34 88.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.687 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.74 170.57 14.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.142 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 163' ' ' ASP . 1.5 tp -90.52 136.06 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.597 HG22 HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -116.7 133.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.665 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.517 HG12 ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -101.87 163.01 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.55 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -165.21 101.15 0.79 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.79 -178.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.63 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.6 Cg_endo -82.61 144.64 12.67 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.592 2.195 . . . . 0.0 111.601 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.507 HG21 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -121.55 -152.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.717 0.294 . . . . 0.0 111.291 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.593 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -55.05 -21.99 14.29 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.457 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 1.8 t -100.02 -115.0 0.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.78 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -112.34 -172.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.852 0.358 . . . . 0.0 111.173 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.63 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.8 m-85 -63.69 137.9 58.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.926 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -124.02 -176.66 14.77 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.014 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -127.08 140.98 51.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.33 120.83 1.35 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.708 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.634 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.5 p -165.98 177.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.775 0.321 . . . . 0.0 111.65 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.763 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t-20 -56.73 107.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -62.7 -52.09 64.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 33.1 0.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.6 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.763 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 159.69 17.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.833 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.13 -36.7 61.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.791 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 25.0 t70 -58.49 -26.54 63.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.109 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.83 -33.28 62.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.52 -52.69 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -65.01 -45.85 83.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.92 -31.95 63.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -27.9 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -42.91 53.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.72 -43.37 47.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.245 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.63 -17.9 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.012 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.93 -95.33 0.19 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -118.06 83.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.63 69.55 15.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.9 11.96 2.6 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.609 2.206 . . . . 0.0 112.526 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.17 -14.93 8.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 1.8 ttmt -88.46 127.01 58.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.156 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 23.4 Cg_exo -65.16 -166.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.692 2.261 . . . . 0.0 112.084 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 p -118.68 135.64 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.138 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 8.6 t -96.24 131.69 42.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.592 HD11 HD11 ' A' ' 74' ' ' ILE . 32.3 pt -116.89 169.93 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.524 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -114.75 137.1 52.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.353 . . . . 0.0 110.603 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.662 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.2 p -145.84 173.91 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.591 ' H ' HG22 ' A' ' 68' ' ' VAL . 21.4 t -80.17 -42.52 23.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.958 0.408 . . . . 0.0 110.371 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.51 20.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 74' ' ' ILE . 15.8 t -57.17 -29.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.943 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.46 -32.68 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.225 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.99 -13.24 59.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.489 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.592 HD11 HD11 ' A' ' 66' ' ' ILE . 6.3 tt -114.16 44.52 0.32 Allowed Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 72.9 Cg_endo -76.39 -46.76 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.726 1.618 . . . . 0.0 112.634 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -72.42 -1.03 14.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.886 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -107.78 -56.07 2.28 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.652 -179.27 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 p -114.55 171.03 7.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.347 . . . . 0.0 111.144 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -121.94 108.18 34.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -102.45 -168.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.221 2.614 . . . . 0.0 113.007 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 3.2 t -138.82 -178.24 5.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.88 -83.72 0.37 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.843 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.797 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.96 -27.78 46.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.111 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.66 -46.43 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 81' ' ' SER . 19.5 mmt -74.92 -11.98 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.797 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -71.17 -48.28 52.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.992 0.425 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 5.0 tp -65.21 -35.99 82.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.79 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.444 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 7.7 tpp -68.41 -44.61 74.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.63 -13.82 61.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 5.7 tpt180 -73.43 -42.11 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.651 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 pt -110.55 43.79 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.041 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.907 HD21 HG21 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -131.2 143.5 49.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.804 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.4 Cg_exo -78.13 -165.14 4.37 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.174 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.81 173.33 23.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.588 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 93.0 Cg_endo -79.82 39.23 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.563 2.175 . . . . 0.0 112.358 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.647 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.3 m-85 -111.98 143.87 42.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.518 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 29.1 m -94.82 135.95 35.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.435 HG11 ' HG2' ' A' ' 88' ' ' MET . 4.9 t -120.29 109.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.429 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.802 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 19.1 t -99.66 135.97 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.276 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.572 ' HB2' HD11 ' A' ' 119' ' ' ILE . 2.4 mm? -126.45 -172.69 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.043 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.04 -165.84 0.43 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.733 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.821 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.13 132.44 56.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.97 0.414 . . . . 0.0 111.106 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 5.9 t30 -74.87 -173.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.15 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 9.27 2.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.483 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HB2' HH12 ' A' ' 102' ' ' ARG . 1.3 mt -69.39 -174.39 0.67 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.711 0.291 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 108' ' ' ASP . 2.8 mt -79.53 107.47 6.55 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.283 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 65.4 Cg_endo -71.65 23.56 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.675 2.25 . . . . 0.0 112.941 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 106' ' ' ILE . 3.7 m-20 -61.55 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.683 0.278 . . . . 0.0 111.2 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 m -90.21 5.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.703 0.287 . . . . 0.0 111.202 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.439 HG21 HH21 ' A' ' 102' ' ' ARG . 4.1 mt -96.4 -35.01 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.4 OUTLIER -87.13 -37.27 17.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.622 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.78 -101.35 0.64 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.347 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.26 -60.42 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.631 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.78 -179.32 3.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.728 0.299 . . . . 0.0 110.906 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.543 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -92.78 70.1 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.995 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -136.75 163.69 30.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.322 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.821 HG23 ' HG2' ' A' ' 102' ' ' ARG . 95.3 t -139.54 125.07 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.377 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.553 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -78.92 152.71 37.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.899 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -144.87 156.06 14.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.653 0.263 . . . . 0.0 110.553 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -148.49 124.82 10.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.261 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.907 HG21 HD21 ' A' ' 92' ' ' LEU . 5.2 t -110.42 86.99 5.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.56 179.77 5.25 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.518 2.146 . . . . 0.0 112.65 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.507 ' H ' HG21 ' A' ' 33' ' ' THR . 0.3 OUTLIER -93.28 5.17 52.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.03 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.87 106.99 7.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.155 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -57.34 -39.44 75.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.771 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 16' ' ' LEU . 45.2 mm -63.1 -54.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.873 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -18.53 60.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -72.27 -36.46 69.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -75.02 -52.53 10.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.239 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' ' 130' ' ' ILE . 17.0 mt -60.0 -53.72 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.662 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.84 -26.93 67.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.277 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -54.63 -56.77 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.018 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -86.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.326 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.78 115.29 46.84 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.68 137.75 46.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.558 2.172 . . . . 0.0 111.602 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 67' ' ' CYS . 27.2 m -114.74 170.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 120.943 0.402 . . . . 0.0 111.737 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.654 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 46.2 m -80.76 139.94 35.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.012 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.66 103.71 4.92 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.287 0.367 . . . . 0.0 111.37 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -130.28 126.31 36.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.7 p -70.93 110.86 5.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 39.5 Cg_exo . . . . . 0 CA--C 1.537 0.636 0 N-CA-C 113.178 0.415 . . . . 0.0 113.178 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 91.0 Cg_endo -78.99 103.05 1.59 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.898 1.732 . . . . 0.0 112.148 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -82.91 145.97 51.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 72.2 Cg_endo -95.53 -11.22 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.916 2.411 . . . . 0.0 111.929 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.93 128.88 14.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.04 -27.36 66.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 156' ' ' VAL . 3.7 tt0 -71.07 -37.89 72.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.171 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -55.73 31.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.323 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 165' ' ' VAL . 0.6 OUTLIER -63.47 -42.98 98.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -53.08 -30.1 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -39.21 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -26.79 57.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.257 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 155' ' ' ILE . 2.0 pp -94.98 46.8 1.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t70 -16.03 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.728 0.643 . . . . 0.0 112.551 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -157.32 10.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.77 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -81.39 -75.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.381 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.77 ' H ' HG13 ' A' ' 162' ' ' VAL . 4.2 t70 -95.79 109.07 21.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.791 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.726 ' HG ' HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -73.85 120.65 19.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.99 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.76 HG22 ' H ' ' A' ' 166' ' ' LEU . 4.3 p -61.72 -179.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.779 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.76 ' H ' HG22 ' A' ' 165' ' ' VAL . 1.3 pt? -125.28 149.28 48.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.828 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.19 -19.61 22.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.289 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.53 -48.0 61.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.945 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 91.56 -168.51 31.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.777 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -163.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.074 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.44 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 44.2 m -140.95 -56.94 0.5 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.48 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -129.43 -130.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.518 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.514 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 33.9 m-20 -86.36 146.29 26.53 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.487 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.78 ' HG2' HG23 ' A' ' 36' ' ' ILE . 3.7 ttp -69.35 0.17 5.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.179 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.81 156.75 30.99 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.631 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 177' ' ' SER . 70.7 Cg_endo -88.71 -140.27 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.921 -1.283 . . . . 0.0 112.576 0.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -153.63 124.77 7.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.623 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 191' ' ' ARG . 34.8 m -101.99 131.69 48.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.45 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.518 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -129.48 109.15 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.707 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.72 HG12 ' HA ' ' A' ' 189' ' ' VAL . 15.1 mt -120.9 137.14 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.474 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.802 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 6.0 t70 -107.99 66.91 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.589 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.444 ' CD2' ' HB2' ' A' ' 88' ' ' MET . 21.9 tp -69.77 88.26 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -79.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.437 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 185' ' ' ASN . 4.8 t -120.64 -121.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.9 t-20 -63.48 -50.59 72.53 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 79.7 Cg_endo -77.87 108.75 2.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.24 1.96 . . . . 0.0 112.566 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.1 Cg_endo -82.44 128.6 5.52 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.558 2.172 . . . . 0.0 112.248 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 17.8 mtp180 -87.58 56.1 3.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.72 ' HA ' HG12 ' A' ' 180' ' ' ILE . 17.9 t -59.97 104.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.423 ' O ' HG23 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -127.75 74.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.682 ' HB3' HG23 ' A' ' 178' ' ' THR . 1.5 ptp85 -89.73 139.58 30.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.941 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HD2' HD12 ' A' ' 16' ' ' LEU . 45.1 Cg_exo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.808 0.253 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.38 -28.74 68.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.066 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.6 t -65.31 -57.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.013 HD11 HG22 ' A' ' 126' ' ' ILE . 13.7 mt -62.01 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 20' ' ' ILE . 3.4 mt-10 -64.15 -23.75 67.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.712 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.5 -32.69 58.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.165 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.27 -44.33 62.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.761 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.608 ' HA ' ' HG2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -75.55 -18.37 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.182 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 t -75.52 -47.95 24.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.352 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.545 HG21 HD23 ' A' ' 164' ' ' LEU . 12.7 p -74.52 -26.93 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.656 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 15.7 ptp -73.97 -31.51 63.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 0.0 111.112 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -25.09 65.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.84 31.18 6.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 47' ' ' ASP . . . 67.0 47.53 64.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' MET . . . -130.12 147.47 18.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.28 143.0 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.638 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -117.94 145.26 24.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.766 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.658 HD11 HG21 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.96 167.27 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.255 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -171.72 94.52 0.41 Allowed Pre-proline 0 C--N 1.332 -0.152 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.2 Cg_endo -84.14 142.71 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.872 2.381 . . . . 0.0 110.549 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.696 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 85.7 m -138.09 -97.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.047 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.675 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.12 -59.13 2.88 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.58 ' OG1' HG13 ' A' ' 36' ' ' ILE . 1.2 t -79.87 -104.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.58 HG13 ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -114.68 -146.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.62 0.248 . . . . 0.0 111.048 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.818 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.1 m-85 -81.84 134.39 35.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 111.038 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -116.4 -178.34 18.09 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.086 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.689 ' HB2' HG23 ' A' ' 139' ' ' THR . 4.5 mt -133.65 142.68 48.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.39 132.2 4.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.881 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -158.97 171.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.148 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.729 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 4.1 t-20 -56.58 122.2 11.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.131 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.49 -67.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -176.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.5 37.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -110.41 146.67 35.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.681 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.99 -25.82 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.707 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.448 ' CG ' ' HA2' ' A' ' 26' ' ' GLY . 3.3 m-20 -61.63 -29.75 70.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.625 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -36.11 60.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.09 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.838 HG13 HG21 ' A' ' 109' ' ' VAL . 18.7 t -61.62 -46.77 95.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -48.69 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.126 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.523 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 1.9 mmp_? -63.79 -21.55 66.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -71.41 -40.92 70.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.79 -19.45 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 51' ' ' ARG . 4.2 mmt180 -71.86 -56.4 5.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.357 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -75.36 -43.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.742 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.71 -3.17 46.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.303 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -113.75 5.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.19 90.12 3.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 t -144.8 71.37 15.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.66 7.37 4.58 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.763 2.309 . . . . 0.0 112.721 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -114.35 -14.41 12.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.14 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 122.03 70.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.24 171.47 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.594 2.196 . . . . 0.0 112.315 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 110' ' ' ILE . 10.5 p -112.8 145.02 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.008 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -93.6 146.49 23.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -116.39 154.31 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 52.8 t -105.02 122.93 46.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.633 HG22 ' H ' ' A' ' 69' ' ' SER . 1.8 p -147.51 177.68 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.765 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.633 ' H ' HG22 ' A' ' 68' ' ' VAL . 2.5 t -86.74 -36.32 18.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.109 0.481 . . . . 0.0 110.23 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.442 ' N ' HG13 ' A' ' 68' ' ' VAL . 3.5 t -162.89 161.16 25.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.325 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.767 HG21 ' HE2' ' A' ' 85' ' ' MET . 17.8 t -55.58 -32.69 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.379 . . . . 0.0 111.099 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 2.0 m-20 -67.35 -29.36 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.001 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -80.58 -15.27 57.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.371 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.506 ' O ' HG12 ' A' ' 74' ' ' ILE . 3.0 tt -114.34 47.9 0.44 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 98.8 Cg_endo -79.08 -32.67 1.74 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.778 1.652 . . . . 0.0 112.298 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.49 -11.8 60.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.672 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.59 -49.44 3.24 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.483 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.9 p -114.83 178.23 4.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.602 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -117.22 116.63 37.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.023 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 71' ' ' VAL . 68.2 Cg_endo -102.22 178.09 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.162 2.575 . . . . 0.0 112.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -140.76 177.35 8.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.89 -99.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.966 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.04 -25.49 30.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.158 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -60.25 -47.16 87.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.767 ' HE2' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -67.97 -27.93 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.003 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -57.88 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.578 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 11.8 tp -57.82 -26.2 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.884 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.546 ' SD ' HD13 ' A' ' 182' ' ' LEU . 6.9 tpt -72.39 -46.79 53.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.427 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.35 -4.03 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.273 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.59 -38.52 87.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.066 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.05 58.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -123.97 141.23 36.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.7 Cg_exo -78.66 -161.57 2.74 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.246 -1.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.45 163.1 11.65 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.748 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.17 38.55 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.2 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 92' ' ' LEU . 30.6 p90 -99.96 158.03 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.08 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -110.51 137.67 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.545 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 15.7 t -117.93 109.2 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.881 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 50.4 t -104.33 126.57 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.282 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.479 HD11 ' HE1' ' A' ' 85' ' ' MET . 1.2 mt -126.33 -167.02 1.65 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.559 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.58 -167.94 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.687 178.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.52 ' HG2' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.45 137.44 53.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.252 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -74.43 -173.19 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.084 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -75.54 5.14 6.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.295 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.419 ' HB2' HH21 ' A' ' 102' ' ' ARG . 1.5 mt -69.7 163.38 25.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.911 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.462 HG12 ' HB2' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -65.8 108.99 2.56 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 30.48 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.956 2.437 . . . . 0.0 113.051 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.462 ' HB2' HG12 ' A' ' 106' ' ' ILE . 37.8 t70 -61.46 -97.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.578 0.227 . . . . 0.0 111.559 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 49' ' ' VAL . 6.3 p -89.74 5.6 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.798 0.332 . . . . 0.0 111.618 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 64' ' ' VAL . 1.4 mt -97.87 -36.27 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.313 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.513 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -87.11 -39.62 15.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.102 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.09 -96.53 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.44 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.45 -64.47 1.22 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.891 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.679 ' HB2' ' HE ' ' A' ' 116' ' ' ARG . 0.7 OUTLIER -104.56 176.27 5.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.681 0.277 . . . . 0.0 111.111 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.513 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -92.47 71.89 5.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.679 ' HE ' ' HB2' ' A' ' 114' ' ' SER . 64.2 mtm180 -136.32 160.36 38.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 102' ' ' ARG . 21.6 t -139.26 125.92 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -85.61 161.55 35.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.514 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 98' ' ' VAL . 30.5 mt -144.74 152.34 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.632 0.253 . . . . 0.0 110.452 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.61 120.23 9.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.83 86.58 5.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.736 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.95 -178.02 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.516 2.144 . . . . 0.0 112.513 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -0.58 50.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.982 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.843 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.7 t0 -72.88 96.09 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -43.12 83.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.599 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 1.013 HG22 HD11 ' A' ' 16' ' ' LEU . 9.5 mt -67.48 -48.64 76.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.004 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.843 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 15.1 t -57.81 -29.02 64.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.546 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.8 mtp180 -67.35 -33.95 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.484 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -64.43 -58.77 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.973 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 tt -63.83 -35.08 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.376 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.43 -30.05 64.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.151 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -55.35 -55.36 32.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.178 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -75.9 -83.86 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.296 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.67 110.11 9.79 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.23 147.26 83.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.429 2.086 . . . . 0.0 111.768 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.89 159.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 5.2 m -80.13 141.75 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.14 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.63 109.85 6.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 111.756 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.689 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.75 157.06 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.508 178.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 p -78.52 126.51 30.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.055 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.509 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.07 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo . . . . . 0 CA--C 1.537 0.627 0 N-CA-C 113.459 0.523 . . . . 0.0 113.459 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.89 110.4 3.03 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.861 1.707 . . . . 0.0 112.279 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.37 151.94 38.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -95.88 -12.03 0.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.948 2.432 . . . . 0.0 112.934 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -131.48 137.39 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.208 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.8 -33.39 73.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.717 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.1 -19.27 60.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.913 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -36.79 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.702 HD12 HG23 ' A' ' 165' ' ' VAL . 69.4 mt -67.62 -55.56 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.142 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.2 m -54.87 -33.85 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -59.46 2.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.626 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.608 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -57.45 -43.01 83.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.429 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.753 ' HG ' ' HB3' ' A' ' 163' ' ' ASP . 2.3 mm? -101.3 66.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 159' ' ' LEU . 33.8 t70 -16.87 -61.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.033 0.833 . . . . 0.0 112.706 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -152.15 11.56 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.241 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.651 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.5 p -81.01 -63.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.837 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HB3' ' HG ' ' A' ' 159' ' ' LEU . 40.4 t0 -109.34 91.33 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.477 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.545 HD23 HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -69.67 139.81 53.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.473 -178.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.702 HG23 HD12 ' A' ' 155' ' ' ILE . 1.4 p -74.62 -175.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.047 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.695 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.55 134.21 50.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -4.22 53.67 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.14 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.755 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.484 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 86.71 28.82 25.55 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.995 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.696 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 25.7 m-20 -73.28 119.89 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.842 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.7 125.62 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.591 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -136.7 -138.64 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.216 -179.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -86.26 137.22 32.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.88 0.371 . . . . 0.0 111.598 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.6 ttt -68.83 -5.78 22.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.813 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -149.99 156.54 38.0 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.693 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.63 -152.92 0.55 Allowed 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.864 -1.307 . . . . 0.0 112.633 0.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -155.52 122.25 5.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.521 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.79 137.15 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.471 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.91 91.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.531 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.601 HG23 ' HA ' ' A' ' 189' ' ' VAL . 2.2 mp -106.55 128.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.752 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.881 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -103.01 64.13 0.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.116 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.546 HD13 ' SD ' ' A' ' 88' ' ' MET . 5.1 tt -69.55 94.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.427 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -77.09 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.578 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.22 -123.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.589 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -63.39 -52.2 62.36 Favored Pre-proline 0 CA--C 1.532 0.253 0 O-C-N 122.423 -0.173 . . . . 0.0 111.256 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.4 Cg_exo -75.07 109.22 2.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.554 2.169 . . . . 0.0 112.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 93.2 Cg_endo -84.19 131.58 5.04 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.61 2.206 . . . . 0.0 112.405 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 23.8 mmm-85 -89.44 51.08 2.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.989 0.424 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.601 ' HA ' HG23 ' A' ' 180' ' ' ILE . 14.7 t -58.26 98.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.781 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.5 91.42 3.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.133 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 178.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.783 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 73.9 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 CA-C-O 120.966 0.319 . . . . 0.0 112.663 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.5 -32.51 68.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.77 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 167' ' ' ASP . 58.8 t -60.43 -35.93 66.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.738 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.783 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -74.03 -39.13 63.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -71.58 -21.34 61.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.981 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -76.42 -35.68 58.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.777 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.77 75.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.285 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' H ' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -75.66 -21.35 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -66.9 -50.43 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.774 ' HB ' HD22 ' A' ' 164' ' ' LEU . 8.0 p -65.15 -32.99 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 mtt -61.48 -29.22 69.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.83 -30.54 62.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.01 5.11 77.88 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.577 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.16 36.6 93.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.692 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.9 169.65 13.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.19 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.43 146.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.7 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -119.51 131.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.632 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -102.35 162.81 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.565 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -167.81 99.63 0.59 Allowed Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.633 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 79.1 Cg_endo -84.1 166.62 12.75 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.545 2.164 . . . . 0.0 110.922 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.748 ' HA ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.72 -157.61 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.937 178.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.573 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 10.4 p-10 -63.61 -13.19 39.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.819 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -100.37 -94.49 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.996 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.481 ' H ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -133.13 173.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.661 0.267 . . . . 0.0 111.177 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m-85 -63.88 144.28 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.827 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -135.09 -174.83 13.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.334 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 mp -126.68 146.54 50.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.55 121.53 1.46 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.183 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.595 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.75 171.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.748 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -56.76 123.43 14.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.055 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.24 -65.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.264 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.95 40.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.762 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.38 149.41 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.47 -28.76 59.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -65.23 -27.17 68.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.292 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -75.5 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.071 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 46' ' ' GLU . 20.5 m -65.53 -28.83 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.219 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 4.8 mtp180 -72.39 -46.98 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.824 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -70.42 -27.09 64.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 48' ' ' ALA . 2.0 mp -67.12 -34.57 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -69.62 -39.74 77.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.953 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -65.19 -48.58 72.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.95 -40.04 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 5.6 mptt -83.0 -2.16 54.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.961 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.29 -102.78 0.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.326 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 71.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.036 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.02 70.25 70.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.11 -1.58 11.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.503 2.135 . . . . 0.0 112.425 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -121.12 -1.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -82.98 124.63 76.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.999 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.05 160.9 9.49 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.575 2.184 . . . . 0.0 112.431 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 110' ' ' ILE . 7.3 p -117.28 148.67 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 t -95.38 149.86 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 111.074 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 117' ' ' VAL . 25.0 mt -116.02 157.65 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.846 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 6.9 t -116.25 119.75 36.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.767 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 1.0 OUTLIER -136.03 171.09 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.993 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.464 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -84.59 -38.83 19.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.103 0.477 . . . . 0.0 110.447 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.06 169.52 17.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.398 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' A' ' 85' ' ' MET . 22.2 t -59.2 -32.7 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.07 -26.62 66.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.663 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 17.8 mm-40 -81.12 -19.9 42.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.296 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.596 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 15.4 tt -114.74 47.49 0.45 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 21.7 Cg_exo -66.93 -65.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.832 1.688 . . . . 0.0 113.208 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -72.29 4.21 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HB3' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -108.0 -24.03 11.77 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.571 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -129.31 159.27 36.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.37 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.565 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.57 87.12 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.69 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.35 -163.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.062 2.508 . . . . 0.0 112.83 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.76 -177.67 5.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.5 -77.2 0.73 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.645 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.778 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -56.2 -31.31 63.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.816 0.341 . . . . 0.0 111.066 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.07 91.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.119 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.515 ' HG3' HG11 ' A' ' 71' ' ' VAL . 20.2 mmt -71.41 -17.61 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.778 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -63.75 -50.35 69.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.263 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 2.5 tm? -60.58 -37.77 82.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.304 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.532 ' SD ' HG21 ' A' ' 98' ' ' VAL . 5.9 tpt -66.78 -33.31 75.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.016 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.14 -15.04 61.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.116 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 87' ' ' LEU . 1.2 mtp85 -67.0 -61.98 1.66 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 pt -98.68 57.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.051 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 121' ' ' VAL . 3.9 tt -131.03 129.19 22.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.912 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HB3' HG12 ' A' ' 121' ' ' VAL . 6.0 Cg_exo -78.14 -159.97 2.19 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.28 -0.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.433 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 156.83 163.04 11.97 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.626 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.756 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 4.6 Cg_exo -78.1 39.49 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.051 2.501 . . . . 0.0 112.371 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.433 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -112.3 130.97 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.337 -179.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.17 114.9 26.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.3 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.532 HG21 ' SD ' ' A' ' 88' ' ' MET . 2.0 m -108.87 118.81 57.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.92 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 22.0 t -91.64 131.07 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.218 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 183' ' ' THR . 0.3 OUTLIER -127.18 178.93 5.71 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.426 0.453 . . . . 0.0 111.121 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.75 176.08 7.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.681 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.05 137.14 53.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.979 0.419 . . . . 0.0 111.36 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.565 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 1.5 t-20 -74.59 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.024 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -75.55 15.8 0.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.648 HD13 ' H ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -69.51 153.98 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.679 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 105' ' ' LEU . 4.7 pt -59.67 109.61 2.1 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.24 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 59.2 Cg_endo -70.81 1.93 4.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.692 2.261 . . . . 0.0 112.785 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.13 -93.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.762 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.78 7.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 64' ' ' VAL . 41.3 mm -103.2 -64.93 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 111.317 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 107' ' ' PRO . 8.4 p -87.42 -26.97 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.39 -116.67 4.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.727 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.35 -20.2 42.58 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.019 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -104.83 179.8 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.575 0.226 . . . . 0.0 110.845 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -113.45 42.37 1.97 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -136.64 156.19 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.352 -179.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.681 HG23 ' HB3' ' A' ' 102' ' ' ARG . 58.8 t -139.51 144.6 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.521 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -84.04 160.08 36.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.96 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 118' ' ' GLY . 34.0 mt -149.15 141.14 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -148.91 134.11 18.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.946 0.403 . . . . 0.0 111.566 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 92' ' ' LEU . 34.2 t -111.02 81.96 2.92 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.768 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.549 ' HG2' ' OD1' ' A' ' 124' ' ' ASP . 34.9 Cg_endo -64.38 -178.86 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.566 2.177 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.91 -0.98 55.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.72 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.549 ' OD1' ' HG2' ' A' ' 122' ' ' PRO . 0.8 OUTLIER -64.75 105.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 111.034 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.35 -42.88 82.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.44 -58.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.218 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.65 -19.85 42.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . 42.6 ttt-85 -70.11 -35.88 74.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.37 -51.89 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.05 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.38 -51.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.767 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.17 -29.41 69.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -55.08 -55.27 32.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.422 . . . . 0.0 110.039 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -90.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.114 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 1.9 m-85 -77.17 127.34 83.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.935 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 23.1 Cg_exo -65.54 154.15 75.03 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 111.555 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.55 156.28 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.64 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 2.1 m -80.41 136.7 36.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.777 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -133.02 108.05 8.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.868 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -127.76 118.54 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.582 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -62.43 112.17 2.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.982 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.21 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo . . . . . 0 CA--C 1.538 0.692 0 N-CA-C 113.336 0.476 . . . . 0.0 113.336 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.23 132.21 12.39 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.868 1.712 . . . . 0.0 112.427 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.16 156.56 36.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.897 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -95.06 -16.59 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.718 2.279 . . . . 0.0 112.382 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.691 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 12.5 ttm180 -141.7 129.13 21.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.319 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.512 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -58.07 -31.12 66.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.273 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.614 ' O ' HG12 ' A' ' 156' ' ' VAL . 2.1 tt0 -74.42 -34.74 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.396 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.691 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.6 -42.9 97.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.46 -178.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.762 HD12 HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.17 -38.81 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.606 -178.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -53.37 -32.84 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.269 -177.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HD2' HH11 ' A' ' 157' ' ' ARG . 2.1 mtm180 -75.92 -41.71 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.994 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -22.9 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 164' ' ' LEU . 3.3 pp -93.22 37.41 1.04 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.101 -0.24 . . . . 0.0 111.643 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 159' ' ' LEU . 27.6 t70 -18.38 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.753 0.658 . . . . 0.0 112.517 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -154.64 7.95 0.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.417 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -81.37 -80.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.618 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -104.64 89.44 3.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.774 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -57.22 121.18 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.679 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.823 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.3 p -60.24 -170.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.391 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.885 HD12 ' H ' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -125.95 156.97 38.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.942 -179.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.478 ' HB3' HG22 ' A' ' 15' ' ' VAL . 2.3 t70 -91.77 -26.98 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.8 -59.21 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.797 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.885 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 81.62 49.21 5.53 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.13 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.748 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -70.63 105.73 3.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.337 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -157.54 122.12 4.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.329 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -137.43 -104.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.4 m-20 -85.37 111.71 20.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 35' ' ' THR . 83.9 mmm -65.89 -16.8 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.175 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.97 154.64 39.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 177' ' ' SER . 67.7 Cg_endo -91.67 -149.7 0.33 Allowed 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.681 0.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 23.0 p -158.27 146.35 18.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.473 HG22 HG13 ' A' ' 180' ' ' ILE . 40.5 m -101.87 145.19 29.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.899 0.38 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.98 96.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.59 HG23 ' HA ' ' A' ' 189' ' ' VAL . 12.5 mt -110.64 135.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.395 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.92 65.43 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.068 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 100' ' ' LEU . 18.6 tp -70.14 82.63 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.397 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.34 -75.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.336 . . . . 0.0 110.433 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.58 -120.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.562 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.1 m-80 -67.4 -52.83 26.4 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.0 109.05 2.26 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.38 2.053 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.3 Cg_endo -82.91 123.83 3.73 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.529 2.152 . . . . 0.0 112.162 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -88.01 54.4 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.59 ' HA ' HG23 ' A' ' 180' ' ' ILE . 11.6 t -57.56 104.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.904 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.39 89.9 2.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.074 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -86.95 141.01 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 192' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.656 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 19.0 Cg_exo . . . . . 0 C--O 1.232 0.2 0 CA-C-O 120.709 0.212 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 4.4 m-20 -74.24 -38.68 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -69.66 -26.5 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 mm? -70.87 -52.27 21.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -64.82 -20.06 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.5 mm-40 -67.65 -47.46 69.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.18 82.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.222 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 16' ' ' LEU . 28.2 mm -67.92 -33.26 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.81 -30.71 70.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.974 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG22 ' HG ' ' A' ' 164' ' ' LEU . 11.7 t -72.68 -33.38 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.5 mmt -64.03 -50.15 69.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.025 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.02 -17.57 64.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.252 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 0.91 84.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.2 35.02 90.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.59 165.06 12.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.19 146.59 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.511 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.695 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.15 129.87 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.701 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -102.42 163.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.677 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -163.68 88.42 1.19 Allowed Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.599 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 94.5 Cg_endo -78.22 119.94 4.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.498 2.132 . . . . 0.0 110.749 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.858 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 0.6 OUTLIER -116.46 -139.17 0.37 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.04 0.448 . . . . 0.0 111.961 -176.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -53.62 -47.77 69.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.52 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 36' ' ' ILE . 3.3 t -79.0 -119.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.735 HG12 ' H ' ' A' ' 37' ' ' TYR . 8.3 tt -112.36 -168.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.282 -0.261 . . . . 0.0 110.846 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.735 ' H ' HG12 ' A' ' 36' ' ' ILE . 4.1 m-85 -63.43 127.89 33.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 110.353 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.43 170.58 13.34 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.368 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -120.12 139.58 52.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.36 117.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.869 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 42' ' ' ASN . 2.0 p -158.36 174.63 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.708 0.29 . . . . 0.0 111.331 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.809 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.22 114.36 1.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.653 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.481 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -66.17 -49.75 66.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.038 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 44' ' ' LEU . 1.2 mm? -80.97 28.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 111.564 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.809 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -111.02 152.23 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.71 178.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -75.36 -29.0 59.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.835 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -28.79 68.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.039 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.49 ' O ' HD23 ' A' ' 52' ' ' LEU . . . -68.18 -32.59 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.534 ' HA ' HD23 ' A' ' 52' ' ' LEU . 56.5 t -70.12 -48.67 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.135 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.32 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.245 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.98 -55.78 8.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.276 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -60.13 -17.51 40.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.335 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -51.96 13.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.025 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -59.19 -38.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.218 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -70.71 -58.2 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -83.54 -76.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.18 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.03 27.68 51.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.55 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -108.48 -47.26 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 16.7 m -135.42 82.43 40.29 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.21 -3.39 10.7 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.812 2.342 . . . . 0.0 112.662 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -109.01 -19.94 13.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.246 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -68.0 147.39 98.44 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.44 ' HG3' ' OG ' ' A' ' 114' ' ' SER . 50.1 Cg_exo -53.47 158.64 7.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.52 2.147 . . . . 0.0 112.324 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 110' ' ' ILE . 9.0 p -112.8 153.54 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 136.0 34.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 77' ' ' PHE . 12.0 mm -113.92 148.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.259 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.4 127.64 54.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.759 HG21 HG23 ' A' ' 74' ' ' ILE . 1.5 p -141.96 179.99 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.589 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.882 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 12.5 t -86.32 -41.35 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 0.0 110.529 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.14 169.22 18.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.88 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.686 ' HA ' HD11 ' A' ' 74' ' ' ILE . 16.2 t -57.17 -34.61 45.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.29 -26.87 66.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.067 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.882 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 80.9 mm-40 -77.46 -20.02 55.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.773 HD13 HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -113.31 61.42 0.8 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.812 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.149 1.899 . . . . 0.0 112.421 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.02 16.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.976 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE1' HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -105.3 -49.53 3.43 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.135 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -126.4 165.38 19.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.464 HH11 ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -113.0 96.97 40.58 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -102.29 -179.12 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.112 2.542 . . . . 0.0 112.567 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 47.4 t -133.59 169.96 16.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.45 -77.29 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.839 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.564 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -57.51 -29.62 64.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.44 -45.84 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 81' ' ' SER . 17.7 mmt -74.41 -11.65 60.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.334 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 4.4 mt-10 -72.43 -49.92 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.872 0.368 . . . . 0.0 110.603 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 8.3 tp -63.18 -36.37 83.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.949 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.53 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 3.7 tpt -70.67 -51.21 29.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.92 -14.98 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.465 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.98 -34.14 77.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 pt -115.04 52.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.463 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -131.03 140.56 39.05 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.75 -163.96 3.72 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.625 -1.406 . . . . 0.0 112.37 -1.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.85 166.39 15.2 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.625 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.522 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 5.7 Cg_exo -78.23 35.34 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.057 2.504 . . . . 0.0 112.043 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.555 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 25.0 p90 -99.0 164.86 12.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.969 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.689 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 36.8 m -115.29 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.698 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.53 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 1.7 p -123.6 104.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.444 . . . . 0.0 110.955 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.733 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 15.4 t -101.47 129.92 51.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.86 -175.11 3.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.595 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -178.79 3.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -119.76 141.27 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.969 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -74.28 -174.17 1.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 104' ' ' GLU . 2.5 pt-20 -76.56 43.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.491 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.647 HD22 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -73.97 146.16 44.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.804 0.335 . . . . 0.0 110.973 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.567 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.2 mp -80.02 -50.28 1.2 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.647 ' HD2' HD22 ' A' ' 105' ' ' LEU . 77.7 Cg_exo -51.07 100.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.186 1.924 . . . . 0.0 112.461 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -82.38 1.98 34.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.92 -23.88 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.065 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.52 ' O ' HG12 ' A' ' 64' ' ' VAL . 15.0 pt -96.87 -39.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.151 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 108' ' ' ASP . 12.9 t -76.8 -15.51 59.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.953 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.24 -171.5 42.94 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.635 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -71.02 -6.67 60.83 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.44 ' OG ' ' HG3' ' A' ' 63' ' ' PRO . 4.2 p -106.24 -176.57 3.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.503 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.3 m -111.57 40.31 2.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -139.02 150.43 45.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 111' ' ' THR . 93.0 t -139.7 144.56 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.497 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.583 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -91.77 158.3 25.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.773 HD13 HD13 ' A' ' 74' ' ' ILE . 43.7 mt -145.82 151.16 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HG2' ' HA ' ' A' ' 97' ' ' THR . 13.3 mtp180 -147.67 134.06 19.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.617 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.8 87.26 6.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.551 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.55 -176.33 2.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.555 2.17 . . . . 0.0 112.586 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 11.55 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 13.4 t0 -76.83 97.89 4.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -47.92 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.09 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.411 HG23 HD22 ' A' ' 16' ' ' LEU . 32.2 mm -61.06 -50.98 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 6.9 t -61.35 -23.74 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 69' ' ' SER . 9.2 ttm180 -67.04 -31.85 72.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.591 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtt85 -75.09 -56.19 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.1 -50.9 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.371 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.678 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.22 -26.96 69.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.391 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 128' ' ' ARG . . . -54.58 -56.51 18.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 109.989 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -75.86 -86.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.998 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 61.4 m-85 -76.59 125.56 87.21 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.717 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.45 147.19 82.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.283 1.988 . . . . 0.0 111.949 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -120.52 155.1 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.209 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.661 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 11.3 m -80.22 133.84 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.228 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.71 104.97 7.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -134.15 161.18 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.3 m -76.87 123.33 26.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.789 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 45.0 Cg_exo . . . . . 0 CA--C 1.538 0.682 0 N-CA-C 113.281 0.454 . . . . 0.0 113.281 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 24.0 Cg_exo -64.27 113.07 2.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.932 1.755 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -97.1 137.9 21.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 64.6 Cg_endo -96.09 -12.35 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.885 2.39 . . . . 0.0 112.983 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -133.05 134.85 44.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -43.13 83.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.817 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.04 -18.0 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 158' ' ' ASP . 4.4 tt0 -73.44 -37.03 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.816 HD12 HG23 ' A' ' 165' ' ' VAL . 6.1 mt -70.59 -46.4 70.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.593 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.58 -36.66 78.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.956 0.407 . . . . 0.0 111.403 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -75.61 -49.03 19.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.095 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -72.64 -41.96 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.302 . . . . 0.0 111.694 -177.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.558 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -93.77 72.28 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' A' ' 159' ' ' LEU . 11.3 t70 -15.97 -66.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.057 0.848 . . . . 0.0 112.925 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.14 25.94 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.281 . . . . 0.0 111.43 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.673 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.83 -67.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.673 ' H ' HG13 ' A' ' 162' ' ' VAL . 1.5 p-10 -111.12 94.19 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.413 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.521 ' HG ' HG22 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -60.01 127.76 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.608 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.816 HG23 HD12 ' A' ' 155' ' ' ILE . 3.4 p -60.79 176.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.039 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.684 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.79 125.54 41.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.135 0.493 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -4.34 52.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.67 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.42 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 84.71 65.62 1.49 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.996 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.858 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 5.6 m-20 -72.88 -116.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.77 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -149.89 -171.67 3.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.635 0.255 . . . . 0.0 111.112 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 9.11 1.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.4 94.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.42 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.73 -15.44 0.72 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 150.69 64.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.538 0.209 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.42 -160.87 2.41 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.663 0.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.0 t -160.9 112.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 3.4 m -102.16 136.18 42.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.689 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -128.93 98.9 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 189' ' ' VAL . 36.9 mt -116.49 132.51 65.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.511 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.733 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -108.3 64.41 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 178.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 18.2 tp -69.91 100.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.533 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.431 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -82.42 -85.63 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.352 178.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.75 -94.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.213 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 23.0 t-20 -82.78 -53.15 0.63 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 85.5 Cg_endo -77.75 107.08 2.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.244 1.963 . . . . 0.0 112.231 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.569 ' HB2' HG23 ' A' ' 189' ' ' VAL . 86.9 Cg_endo -82.16 130.71 6.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.508 2.139 . . . . 0.0 112.367 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -90.42 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.982 0.42 . . . . 0.0 110.547 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.778 ' HA ' HG12 ' A' ' 180' ' ' ILE . 94.3 t -56.44 101.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.12 86.62 2.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.008 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -83.92 143.93 29.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.994 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.741 0.225 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.27 -48.47 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.14 -33.75 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -63.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.193 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.79 -20.01 60.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.276 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.02 -46.5 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.06 94.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.282 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' MET . 2.0 mp -72.26 -29.12 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -54.56 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.253 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.93 -26.79 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 10.8 mmt -56.56 -44.59 81.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -19.66 61.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.9 -0.43 64.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.694 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.52 27.23 71.52 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.36 170.75 13.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.36 153.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.74 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.32 151.13 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 111.447 -178.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -108.3 154.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.22 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.79 106.93 0.45 Allowed Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HB2' ' HA ' ' A' ' 170' ' ' ASP . 1.4 Cg_endo -84.55 162.59 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.292 2.661 . . . . 0.0 112.136 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -137.33 -150.34 0.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.637 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.781 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 5.9 m-20 -60.16 -20.36 58.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.725 0.297 . . . . 0.0 111.148 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 95' ' ' PRO . 7.9 p -100.18 -112.31 0.18 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tt -111.82 -179.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.665 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -84.2 128.89 34.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.197 0.522 . . . . 0.0 110.686 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -118.75 -167.98 14.03 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.753 HD12 HG23 ' A' ' 139' ' ' THR . 0.2 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.799 0.333 . . . . 0.0 110.5 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.727 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -144.26 136.1 6.57 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.987 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.697 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.4 p -172.28 -169.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.792 -0.204 . . . . 0.0 110.743 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.697 ' H ' HG22 ' A' ' 41' ' ' VAL . 2.8 t-20 -56.33 103.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.003 0.43 . . . . 0.0 110.327 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.84 -39.23 91.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.017 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.99 24.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.441 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.85 155.16 22.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.775 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -21.74 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -72.89 -23.23 60.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.629 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.34 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.755 HG21 HG22 ' A' ' 109' ' ' VAL . 11.5 p -72.27 -30.25 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.816 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -41.76 61.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -64.44 -44.38 91.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -61.52 -40.69 95.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.13 -28.54 69.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.005 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -64.26 -45.72 86.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.247 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 t -72.51 -51.25 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.03 -78.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.86 7.41 16.14 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.851 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -118.35 11.8 13.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.721 0.296 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 1.6 m -147.11 65.35 9.56 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.104 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 59' ' ' SER . 8.9 Cg_exo -72.8 -2.63 12.21 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.728 2.286 . . . . 0.0 112.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -112.61 -24.33 9.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.2 OUTLIER -68.47 148.67 98.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 177.35 3.12 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.515 2.144 . . . . 0.0 112.344 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 66' ' ' ILE . 14.6 p -112.92 149.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.798 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 134.27 35.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.502 HD11 HG13 ' A' ' 64' ' ' VAL . 4.1 mm -116.12 160.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.056 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 9.9 t -122.62 137.63 54.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.726 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.806 HG11 HG12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -139.35 -176.2 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.663 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -73.3 -50.03 24.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.709 179.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.484 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -164.71 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.265 0.555 . . . . 0.0 111.797 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.606 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 16.8 t -52.83 -22.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.85 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 2.2 t70 -67.92 -52.78 32.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.76 13.77 3.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.658 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.806 HG12 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.17 -42.88 0.41 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 72' ' ' ASP . 76.9 Cg_exo -51.62 -17.42 4.75 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.244 1.963 . . . . 0.0 112.935 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -72.2 -39.01 68.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.433 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 23.7 m-85 -97.44 -35.71 10.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.516 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 74' ' ' ILE . 88.8 p -116.24 -173.81 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.957 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.39 100.7 28.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.719 ' HA ' HD22 ' A' ' 100' ' ' LEU . 92.3 Cg_endo -102.74 -170.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.211 2.608 . . . . 0.0 112.677 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.538 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -126.98 177.09 6.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.22 -88.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.857 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -55.72 -27.48 50.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.128 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.43 -44.12 97.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.918 0.39 . . . . 0.0 110.932 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.526 ' CE ' HD21 ' A' ' 100' ' ' LEU . 6.6 mmt -73.94 -16.13 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.307 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 mt-10 -67.44 -51.27 53.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.591 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.6 tp -62.61 -32.4 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.666 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.435 ' HG2' HG11 ' A' ' 98' ' ' VAL . 6.0 tpt -70.15 -48.12 58.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -65.42 -11.42 42.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.7 tpt180 -72.95 -31.08 64.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.09 32.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.474 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 93' ' ' PRO . 4.4 mt -131.11 152.93 81.5 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.815 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 92' ' ' LEU . 83.3 Cg_endo -77.94 -172.65 11.55 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.555 -1.435 . . . . 0.0 112.512 0.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.55 -177.81 31.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.687 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.781 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 87.8 Cg_endo -81.03 43.45 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.751 2.301 . . . . 0.0 112.239 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.515 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 5.6 m-85 -111.43 136.28 50.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 m -94.92 120.93 35.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.344 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.435 HG11 ' HG2' ' A' ' 88' ' ' MET . 3.2 t -108.86 116.52 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.695 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 3.5 t -104.1 127.47 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.719 HD22 ' HA ' ' A' ' 80' ' ' PRO . 1.6 mt -126.87 -169.37 2.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.969 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -172.63 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.648 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.684 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.9 142.53 47.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 1.3 t-20 -74.38 -172.37 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.207 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -75.82 12.83 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.48 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.533 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -69.73 -172.93 0.55 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.807 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.25 105.12 3.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.128 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.599 ' HA ' HG23 ' A' ' 111' ' ' THR . 65.9 Cg_endo -71.43 2.8 4.11 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.585 2.19 . . . . 0.0 112.611 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.82 -88.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.075 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.755 HG22 HG21 ' A' ' 49' ' ' VAL . 3.2 p -84.77 -0.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.0 mt -96.8 -63.59 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.648 0.261 . . . . 0.0 111.379 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.602 HG21 ' HG3' ' A' ' 102' ' ' ARG . 4.4 p -87.18 -23.75 24.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.59 -130.14 20.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.553 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.41 11.68 60.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.698 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -119.1 169.45 9.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.707 0.289 . . . . 0.0 111.035 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 39.8 m -113.44 31.95 6.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -136.6 166.58 23.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.684 HG23 ' HB2' ' A' ' 102' ' ' ARG . 77.2 t -139.93 142.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.65 155.75 41.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.366 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 100' ' ' LEU . 8.4 mt -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.604 0.24 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.541 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER -146.1 127.34 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.387 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.37 80.13 2.47 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.597 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 20.2 Cg_exo -66.6 179.08 2.28 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.505 2.137 . . . . 0.0 112.713 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.69 -0.9 55.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.2 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 83.5 m-20 -61.98 109.1 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.155 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.43 -56.59 19.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.438 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.6 mm -58.66 -50.79 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -17.24 62.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -75.14 -38.48 60.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -45.01 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.05 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.8 mm -62.91 -46.15 97.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -64.38 -28.4 69.67 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.898 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 69' ' ' SER . . . -54.79 -55.0 34.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.041 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -75.48 -88.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.174 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -77.2 138.55 64.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.88 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.56 146.94 62.99 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.36 2.04 . . . . 0.0 111.849 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 131' ' ' ALA . 13.4 t -125.31 133.32 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.47 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.727 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.2 m -67.35 141.47 57.1 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -140.06 104.53 4.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.856 0.36 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.753 HG23 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.61 125.47 15.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.702 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.62 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -61.18 135.85 57.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.872 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 120.859 0.361 . . . . 0.0 111.171 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 CA--C 1.536 0.597 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.46 94.98 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.847 1.698 . . . . 0.0 112.419 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.6 128.49 69.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.748 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -95.95 -8.24 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.886 2.39 . . . . 0.0 112.951 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -129.19 120.12 25.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.493 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -60.05 -36.31 77.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.518 178.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -23.83 61.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.647 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -36.87 84.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.974 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 165' ' ' VAL . 55.0 mt -68.77 -55.15 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -32.51 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.46 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -75.67 -54.99 6.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.39 -24.08 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.585 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.558 ' HB3' HG13 ' A' ' 162' ' ' VAL . 3.2 mm? -111.25 70.69 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.818 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 16.4 t0 -15.94 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 124.049 0.843 . . . . 0.0 112.823 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -156.85 25.5 0.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.7 0.285 . . . . 0.0 111.469 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.686 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.61 -69.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.573 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.799 ' HB2' HD11 ' A' ' 30' ' ' ILE . 2.0 p-10 -111.29 102.65 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.488 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.621 ' HB2' HG21 ' A' ' 22' ' ' VAL . 3.2 mm? -71.45 131.52 43.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.743 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.0 p -62.98 -163.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.879 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.743 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.1 160.81 29.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 111.124 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.87 -25.8 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.68 -56.29 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.472 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.24 -163.28 16.86 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.792 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.623 ' HA ' ' HB2' ' A' ' 32' ' ' PRO . 7.2 p-10 -70.89 -164.72 0.1 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.829 0.347 . . . . 0.0 111.124 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.51 -57.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.563 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -124.17 -134.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.15 146.4 26.6 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.794 0.331 . . . . 0.0 111.841 -177.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' THR . 71.0 mmm -62.98 -27.47 69.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.71 154.28 47.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.655 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 177' ' ' SER . 65.7 Cg_endo -91.39 -149.36 0.33 Allowed 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.867 -1.305 . . . . 0.0 112.67 1.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.505 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.82 158.29 39.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.515 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.2 m -102.27 139.0 38.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.1 t -129.1 88.8 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.048 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.654 HG23 ' HA ' ' A' ' 189' ' ' VAL . 13.0 mt -108.87 129.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.373 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.695 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.55 66.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.414 178.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 187' ' ' PRO . 53.4 tp -69.71 93.67 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.318 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.42 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -79.51 -81.7 0.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.409 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 185' ' ' ASN . 12.2 t -120.84 -115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.046 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.5 m-20 -66.41 -52.69 35.11 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 185' ' ' ASN . 3.5 Cg_exo -77.22 108.04 2.54 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.497 2.131 . . . . 0.0 112.093 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.4 Cg_endo -81.49 133.38 8.36 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.451 2.101 . . . . 0.0 112.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 188' ' ' ARG . 5.8 mtt180 -91.92 51.12 1.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.654 ' HA ' HG23 ' A' ' 180' ' ' ILE . 6.3 t -58.64 100.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 tp -126.54 86.64 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.43 ' HB3' HG23 ' A' ' 178' ' ' THR . 8.5 ptt-85 -87.06 161.62 18.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.824 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 192' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.869 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 38.1 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.872 0.28 . . . . 0.0 112.287 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.71 -39.88 66.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.28 -22.78 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.074 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.31 -43.62 66.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -75.23 -28.54 59.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.622 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.07 -38.9 69.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 111.018 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.622 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -74.08 -36.32 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.75 -30.0 48.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -68.84 -48.33 63.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.847 HG21 ' HG ' ' A' ' 164' ' ' LEU . 7.5 p -72.3 -21.8 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -48.4 81.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.809 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.37 -13.52 62.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.098 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.53 -2.87 76.57 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.453 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.29 53.84 33.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.552 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.37 161.6 23.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.516 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.673 HD11 ' HG ' ' A' ' 39' ' ' LEU . 1.4 tp -90.89 136.05 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 110.568 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.634 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.74 140.96 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.958 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.421 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -101.99 150.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.053 178.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.661 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -165.99 107.04 0.72 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 96.7 Cg_endo -84.26 159.29 13.13 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.763 2.309 . . . . 0.0 111.837 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.892 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -135.32 -149.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -54.81 -20.6 8.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.28 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 36' ' ' ILE . 2.7 t -100.17 -117.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.651 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.694 HG23 ' HB2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -157.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.117 0 O-C-N 122.198 -0.314 . . . . 0.0 111.202 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.595 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 3.9 m-85 -68.62 132.11 46.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.26 -176.76 15.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.265 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.673 ' HG ' HD11 ' A' ' 28' ' ' ILE . 1.7 mp -131.93 142.94 49.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.88 0.372 . . . . 0.0 111.172 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.89 115.46 0.82 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.595 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 136' ' ' VAL . 2.4 p -153.96 150.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.802 0.334 . . . . 0.0 111.067 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -55.87 104.65 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.397 . . . . 0.0 110.574 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.53 78.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.942 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.4 mm? -76.7 13.92 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.946 0.403 . . . . 0.0 111.151 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -110.48 156.25 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.893 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.589 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -69.72 -25.22 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 31.1 t70 -66.5 -21.18 66.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.09 -38.14 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 46' ' ' GLU . 14.6 p -74.25 -35.86 41.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.778 0.323 . . . . 0.0 110.829 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -69.89 -44.21 70.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.487 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.607 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.54 -37.43 84.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.453 179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.607 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -60.05 -30.85 69.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.898 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.2 -32.01 66.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.762 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmt-85 -68.8 -48.71 62.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.559 ' HB ' HH21 ' A' ' 51' ' ' ARG . 29.7 t -75.05 -51.01 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.4 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.56 -67.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.296 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.06 33.03 82.48 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.446 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -100.4 -81.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 110.959 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 m -149.25 146.14 20.65 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.91 2.13 7.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.584 2.189 . . . . 0.0 112.489 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -1.55 26.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.099 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.77 145.29 50.04 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 158.28 54.6 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.517 2.145 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 m -117.04 163.21 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.6 136.6 46.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.623 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.27 168.32 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.817 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 8.3 t -122.57 133.35 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.949 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.91 HG21 HG23 ' A' ' 74' ' ' ILE . 1.1 p -143.39 179.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.627 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -89.3 -42.99 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.931 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.3 t -164.21 170.21 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.089 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HA ' HD11 ' A' ' 74' ' ' ILE . 6.8 t -56.94 -34.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.662 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -67.28 -29.84 69.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.936 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 58.8 mm-40 -73.53 -19.84 60.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.39 60.82 0.8 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.034 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.625 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 44.1 Cg_exo -56.08 -92.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.972 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.442 ' H ' ' HB2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -73.64 22.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.234 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 3.3 m-85 -92.89 -51.95 4.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -128.19 170.51 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.793 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.05 109.21 24.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -102.22 -169.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.108 2.539 . . . . 0.0 112.475 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.947 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -127.61 170.26 12.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.009 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.85 -111.23 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.933 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -25.53 35.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 0.0 110.985 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.947 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -59.97 -53.63 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.629 ' HB3' ' O ' ' A' ' 81' ' ' SER . 1.6 tpp -73.76 -24.16 59.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.098 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -55.55 -40.37 71.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.581 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -67.6 -40.54 84.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 178.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.492 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 12.0 tpt -61.69 -50.07 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.441 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.551 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.83 -6.26 46.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.529 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.581 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.2 ttm180 -67.29 -24.88 65.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 pt -111.07 49.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -128.05 150.37 73.54 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.18 179.06 32.11 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.392 0.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.15 174.34 26.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.72 39.91 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.671 2.248 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -98.74 138.43 35.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 7.7 m -97.92 141.45 30.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.654 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.556 HG13 ' HB ' ' A' ' 119' ' ' ILE . 2.5 p -126.18 99.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.18 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.732 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 65.3 t -96.7 117.13 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -126.12 -166.3 1.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.63 178.32 5.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.621 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.665 HH22 HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -120.1 143.6 48.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.659 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.94 -170.56 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.19 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.28 35.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.499 HD22 ' HD2' ' A' ' 107' ' ' PRO . 1.9 mt -69.86 146.3 51.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.852 0.358 . . . . 0.0 110.816 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.561 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 36.8 mm -80.1 -49.15 1.27 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.9 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.7 Cg_exo -50.22 94.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.482 2.121 . . . . 0.0 112.857 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.747 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.5 OUTLIER -82.45 -3.47 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.7 179.227 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 t -74.2 -24.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.292 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.665 HD12 HH22 ' A' ' 102' ' ' ARG . 1.3 pt -98.27 -42.23 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.747 HG22 ' HA ' ' A' ' 108' ' ' ASP . 14.5 t -75.8 -14.54 60.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.814 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.8 -151.72 37.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.657 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.33 -26.4 57.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 m -106.29 175.54 5.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 111.001 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.49 67.65 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -142.12 131.49 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.656 HG21 HH21 ' A' ' 102' ' ' ARG . 59.8 t -139.85 140.89 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.786 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -98.95 162.4 20.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.384 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.556 ' HB ' HG13 ' A' ' 98' ' ' VAL . 10.3 mt -141.8 164.31 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -149.8 127.15 11.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 t -110.4 88.55 7.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.892 ' HB2' HG21 ' A' ' 33' ' ' THR . 78.6 Cg_endo -76.97 -179.35 5.34 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.59 2.193 . . . . 0.0 112.533 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.43 5.45 51.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -72.4 108.29 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -57.29 -43.05 82.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 130' ' ' ILE . 31.2 mm -64.16 -53.62 41.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.88 -17.68 61.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 7.6 ttt180 -75.49 -44.68 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -54.61 11.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.531 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.0 tt -57.31 -43.08 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.552 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.36 -25.8 62.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.418 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -54.55 -58.05 8.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.013 0.435 . . . . 0.0 109.88 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -76.74 -83.28 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.243 177.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.415 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -76.62 114.48 39.08 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.62 144.39 72.15 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.368 2.045 . . . . 0.0 111.565 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 41' ' ' VAL . 1.6 t -127.65 161.99 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.845 0.355 . . . . 0.0 111.267 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.606 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.47 139.26 36.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.063 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -131.07 107.48 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.381 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -132.75 141.41 48.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.9 p -80.72 115.74 20.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.86 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.433 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 38.9 Cg_exo . . . . . 0 CA--C 1.537 0.649 0 N-CA-C 113.172 0.412 . . . . 0.0 113.172 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.6 Cg_exo -64.74 104.19 0.53 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.932 1.754 . . . . 0.0 111.862 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.7 t -77.08 149.54 79.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.211 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -95.21 -18.73 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.81 2.34 . . . . 0.0 112.403 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.64 141.41 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.54 HD22 HG22 ' A' ' 165' ' ' VAL . 49.7 mt -64.47 -43.95 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.72 -17.18 63.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -75.06 -39.97 60.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.12 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 1.029 HD12 HG23 ' A' ' 165' ' ' VAL . 7.9 mt -65.3 -56.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.201 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -55.84 -40.86 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.32 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -65.41 -50.48 65.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.666 ' HB3' HD22 ' A' ' 159' ' ' LEU . 8.0 t0 -63.68 -35.17 79.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.771 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -110.88 75.32 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t0 -15.95 -64.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.117 0.886 . . . . 0.0 112.85 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -150.97 11.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.685 0.279 . . . . 0.0 111.35 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -81.15 -62.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.831 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.665 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 1.4 t0 -103.03 97.13 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.847 ' HG ' HG21 ' A' ' 22' ' ' VAL . 2.8 mm? -74.49 129.13 37.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.557 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 1.029 HG23 HD12 ' A' ' 155' ' ' ILE . 2.4 p -66.31 -179.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.306 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.805 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.31 147.33 49.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.484 179.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.9 -26.8 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.951 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.661 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -64.64 -54.08 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.88 0.372 . . . . 0.0 111.343 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.804 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 98.24 -165.64 21.76 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.945 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -71.94 -165.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.431 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -141.68 -51.74 0.42 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.322 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -132.33 -135.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 175' ' ' GLU . 4.4 t0 -86.57 154.81 20.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.778 0.323 . . . . 0.0 111.667 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.694 ' HB2' HG23 ' A' ' 36' ' ' ILE . 19.3 ptm -70.9 17.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.434 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 173' ' ' ASP . 1.5 mt-10 -155.35 157.86 31.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.563 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -95.67 -151.89 0.28 Allowed 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.185 -1.173 . . . . 0.0 112.662 1.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.55 96.74 1.93 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 191' ' ' ARG . 97.0 m -100.97 135.51 42.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.231 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 21.0 t -127.64 104.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.66 HG12 ' HA ' ' A' ' 189' ' ' VAL . 36.9 mt -109.11 127.71 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.462 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.2 m-20 -89.35 74.71 7.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.303 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.645 HD12 HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -68.51 79.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -84.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 3.1 t -121.0 -128.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.66 177.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 57.7 t30 -60.24 -51.74 78.09 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 68.3 Cg_endo -74.32 109.02 2.81 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.19 1.927 . . . . 0.0 112.637 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 84.7 Cg_endo -82.8 120.83 3.15 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.611 2.207 . . . . 0.0 112.157 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 1.2 mpp_? -87.87 53.17 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.131 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.73 97.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.71 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.96 89.41 3.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.269 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.578 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -91.17 131.9 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 -179.867 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 52.2 Cg_endo . . . . . 0 C--O 1.231 0.139 0 CA-C-O 120.854 0.272 . . . . 0.0 112.259 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.53 -32.98 73.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -68.14 -36.67 76.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.085 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.598 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.13 -39.77 71.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.15 -24.79 65.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.791 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -33.93 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -67.67 -37.3 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.835 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 16' ' ' LEU . 7.8 mm -75.11 -18.71 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -73.41 -44.98 57.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.053 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.634 ' HB ' HD13 ' A' ' 164' ' ' LEU . 14.1 p -68.46 -31.19 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 53.0 mtt -66.99 -31.24 71.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.861 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.12 -35.26 64.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.053 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.16 10.32 69.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.661 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.01 58.88 9.47 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.529 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.27 160.52 22.03 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.26 146.9 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.434 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.699 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.94 133.03 64.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -102.58 154.14 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.62 0.248 . . . . 0.0 110.946 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.8 OUTLIER -158.47 100.13 1.71 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.762 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 4.7 Cg_exo -78.01 142.29 19.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.975 2.45 . . . . 0.0 111.299 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.5 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 88.4 m -138.62 -82.4 0.3 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 112.304 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 6.0 m-20 -75.36 -78.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.738 ' HA ' ' HG3' ' A' ' 174' ' ' MET . 0.8 OUTLIER -79.4 -88.59 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.366 -177.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.59 -150.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 7.4 m-85 -69.81 141.2 53.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.05 -177.22 17.77 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.911 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.5 mp -122.7 140.21 53.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -147.22 110.35 0.51 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 42' ' ' ASN . 2.6 p -153.48 156.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 111.099 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 41' ' ' VAL . 3.0 m120 -55.05 101.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.025 0.44 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.68 76.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.938 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' HA ' HD13 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.4 18.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.048 0.452 . . . . 0.0 111.238 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.84 156.97 20.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.565 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER -75.27 -30.32 60.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.973 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.485 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 6.9 m-20 -62.48 -32.32 73.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.093 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.65 -34.1 71.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.42 -44.79 83.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -66.88 -44.52 80.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.772 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.49 ' NH2' HG23 ' A' ' 162' ' ' VAL . 51.9 mmt-85 -67.01 -23.7 65.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.15 -53.58 19.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -65.86 -14.89 62.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -66.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.313 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.56 -38.48 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -1.54 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.385 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.23 -148.57 50.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -98.61 117.6 33.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 3.2 p -153.35 69.65 6.72 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.822 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.25 1.36 5.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.772 2.314 . . . . 0.0 112.619 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.643 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.8 m80 -114.21 -21.68 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.206 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 8.7 mtpt -88.11 126.43 60.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.28 174.5 7.04 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.451 2.101 . . . . 0.0 112.069 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 110' ' ' ILE . 2.5 m -113.06 153.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.028 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 t -111.3 132.39 54.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.463 HD11 HG12 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -111.67 172.74 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.778 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 3.0 p -119.56 135.31 54.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.725 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -143.69 173.18 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.704 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -83.0 -39.94 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.996 0.427 . . . . 0.0 110.426 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.1 165.75 21.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.637 ' HA ' HD11 ' A' ' 74' ' ' ILE . 18.5 t -55.41 -33.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.769 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.29 -31.36 71.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.116 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.656 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 9.2 mm-40 -71.07 -21.41 62.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.152 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.725 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.27 63.73 0.92 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.791 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.648 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 27.9 Cg_exo -62.29 -76.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.211 1.941 . . . . 0.0 112.38 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.21 23.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.143 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -102.5 -53.04 2.97 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.262 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 22.5 p -123.01 177.24 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 9.2 mtt-85 -113.64 88.76 14.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 78' ' ' SER . 94.2 Cg_endo -102.74 -169.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.241 2.627 . . . . 0.0 112.786 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 2.2 t -145.96 179.21 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.853 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.33 -86.46 0.3 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.046 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -54.96 -32.71 61.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.346 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.595 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -60.29 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.0 110.871 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.564 ' HE1' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.5 -17.91 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.617 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 2.5 mm-40 -59.14 -51.63 69.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.279 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.5 OUTLIER -64.37 -32.81 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.273 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.633 ' HG3' ' HE2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -65.51 -49.39 69.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.463 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -70.22 -8.76 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.265 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -75.02 -20.21 59.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 ' CE1' ' A' ' 96' ' ' TYR . 1.7 mt -108.35 13.18 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.728 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 4.2 pp -131.2 166.07 30.52 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.544 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.728 ' HA ' ' HB2' ' A' ' 92' ' ' LEU . 97.2 Cg_endo -78.87 162.69 87.1 Favored 'Cis proline' 0 C--N 1.354 0.819 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.91 -0.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.88 -151.04 22.81 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.442 ' HG3' ' HD2' ' A' ' 176' ' ' PRO . 85.6 Cg_endo -78.08 35.12 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.411 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.633 ' HE2' ' HG3' ' A' ' 88' ' ' MET . 16.9 t80 -92.62 135.35 34.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.592 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 13.2 m -114.02 120.23 39.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.529 ' HB ' ' HE2' ' A' ' 88' ' ' MET . 0.2 OUTLIER -115.92 108.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.224 0.535 . . . . 0.0 111.551 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.906 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -105.66 128.73 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.435 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.564 HD21 ' HE1' ' A' ' 85' ' ' MET . 1.1 mt -126.59 -172.44 2.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 1.7 tt0 -74.42 -176.65 2.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.296 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.812 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.71 141.36 49.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 111.279 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 7.7 t30 -74.54 -177.02 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.943 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.43 52.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.838 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 4.5 tp -79.97 134.84 36.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 27.4 mt -72.27 -50.58 8.51 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.428 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.838 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 71.0 Cg_exo -51.9 109.1 0.29 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.304 2.003 . . . . 0.0 112.327 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.631 ' HA ' HG22 ' A' ' 111' ' ' THR . 4.4 p-10 -81.98 -19.82 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.182 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.25 -15.38 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.197 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 107' ' ' PRO . 48.1 mt -98.15 -43.08 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.631 HG22 ' HA ' ' A' ' 108' ' ' ASP . 10.3 t -77.0 -12.78 59.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.44 -155.73 49.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.455 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -82.44 -13.65 78.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.397 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.86 -175.06 2.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.782 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.411 ' CA ' ' HD2' ' A' ' 102' ' ' ARG . 3.0 m -112.91 44.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -137.22 159.91 40.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.063 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 102' ' ' ARG . 84.1 t -139.79 143.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.596 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -99.33 152.49 19.56 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.328 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.637 HD13 HD13 ' A' ' 74' ' ' ILE . 19.4 mt -145.92 149.61 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.3 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -148.56 137.07 21.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.215 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.26 88.03 6.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.757 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.532 ' HD2' ' NH2' ' A' ' 128' ' ' ARG . 30.6 Cg_endo -63.95 -177.68 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.591 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -92.83 8.11 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.21 -179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.55 115.06 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.984 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -57.46 -56.37 22.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.663 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.488 ' CG2' HD21 ' A' ' 16' ' ' LEU . 66.7 mt -60.61 -48.47 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.444 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.2 t -57.49 -16.95 11.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.704 ' HE ' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -75.4 -55.04 6.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.149 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -51.09 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.652 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 tt -59.62 -40.22 81.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.597 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.75 -26.49 61.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.13 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.45 -54.76 36.58 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -75.98 -88.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.2 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 19.0 m-85 -77.85 119.18 76.38 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.456 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 21.6 Cg_exo -65.64 156.41 63.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.405 2.07 . . . . 0.0 111.605 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.521 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.2 t -134.9 159.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.208 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 29.0 m -80.85 139.24 36.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.1 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.778 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . . . -133.42 106.38 7.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.801 0.334 . . . . 0.0 111.62 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -136.75 122.05 19.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.976 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.1 111.36 3.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.206 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.409 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 42.5 Cg_exo . . . . . 0 CA--C 1.537 0.662 0 N-CA-C 113.69 0.612 . . . . 0.0 113.69 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 72.7 Cg_endo -76.36 121.23 5.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.906 1.737 . . . . 0.0 112.601 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -97.32 147.77 33.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.798 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -95.99 -13.72 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.913 2.408 . . . . 0.0 113.204 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -134.58 140.06 45.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.01 72.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.583 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.68 -17.43 63.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -75.27 -37.56 60.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.876 HD12 HG23 ' A' ' 165' ' ' VAL . 49.1 mt -67.48 -45.15 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.355 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.43 -28.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -75.7 -54.22 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.436 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.04 -43.96 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.722 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.564 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.7 mm? -90.5 66.59 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 159' ' ' LEU . 5.0 t70 -16.68 -64.35 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.062 0.851 . . . . 0.0 112.761 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.35 25.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.652 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.77 -68.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.722 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.652 ' H ' HG13 ' A' ' 162' ' ' VAL . 1.7 p-10 -111.1 96.55 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.676 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -59.68 130.42 46.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.199 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.876 HG23 HD12 ' A' ' 155' ' ' ILE . 3.6 p -67.34 175.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.88 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.682 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.62 124.92 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 111.172 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 -7.54 45.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.274 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.94 73.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.38 123.2 5.21 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 9.5 p-10 -73.25 -166.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.895 0.379 . . . . 0.0 111.259 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 5.1 m -136.49 -168.5 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.554 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 39.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -83.37 46.36 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.858 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.738 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 9.1 ttm -59.15 -17.97 31.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.467 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -139.92 136.05 16.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 95' ' ' PRO . 84.1 Cg_endo -83.68 -151.93 0.73 Allowed 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.452 0.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.419 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -153.69 92.59 1.58 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.685 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -102.27 129.92 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 98.3 t -128.02 100.82 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.378 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.826 HG12 ' HA ' ' A' ' 189' ' ' VAL . 73.8 mt -116.29 139.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.827 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.906 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.8 m-20 -107.48 58.69 0.62 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 187' ' ' PRO . 9.7 tp -69.96 105.78 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.391 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.478 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -83.29 -88.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.242 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.7 t -120.96 -83.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.646 0.26 . . . . 0.0 111.371 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.527 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.0 OUTLIER -89.01 -52.14 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.67 -179.053 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.36 106.75 1.37 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.248 1.965 . . . . 0.0 112.491 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.658 ' HB3' HD13 ' A' ' 182' ' ' LEU . 98.2 Cg_endo -84.27 129.57 4.48 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.752 2.301 . . . . 0.0 112.499 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.611 ' HD3' ' HB2' ' A' ' 181' ' ' ASP . 9.2 mtt180 -90.48 50.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.826 ' HA ' HG12 ' A' ' 180' ' ' ILE . 47.8 t -56.47 105.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.28 83.57 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.132 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 191' ' ' ARG . 8.1 ptt180 -85.95 174.1 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.737 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.803 0.251 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.86 -33.97 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.798 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG11 HG13 ' A' ' 126' ' ' ILE . 26.2 t -61.51 -40.14 85.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.602 HD22 HG23 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -68.43 -34.77 76.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.723 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.09 -26.58 63.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.65 -37.22 68.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.654 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -66.08 -37.25 85.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.814 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 16' ' ' LEU . 22.8 mm -75.3 -23.95 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 t -68.18 -47.75 67.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.57 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.3 p -69.72 -31.02 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 1.7 mtt -71.23 -27.91 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.075 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.84 -33.82 76.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.81 73.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.519 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.35 65.48 2.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.36 175.84 16.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.413 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' ' 39' ' ' LEU . 2.2 tp -96.04 142.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.661 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.69 121.15 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -102.06 165.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -169.91 86.28 0.57 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 73.0 Cg_endo -75.09 118.97 5.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.265 1.977 . . . . 0.0 111.009 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.855 ' HA ' ' H ' ' A' ' 171' ' ' CYS . 1.0 OUTLIER -116.31 -137.29 0.36 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.034 0.445 . . . . 0.0 111.68 -176.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -54.24 -46.56 72.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.202 -179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.8 -122.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.485 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.471 ' H ' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -112.51 -158.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 110.9 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -69.99 115.46 9.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA3' HH22 ' A' ' 120' ' ' ARG . . . -116.16 126.48 7.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.525 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.68 ' HB2' HD11 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -111.17 138.77 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 111.199 -178.126 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.18 160.52 28.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.987 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.494 ' CG1' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -158.95 -169.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.047 -178.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.725 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t30 -56.14 124.0 16.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.197 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.09 -67.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.226 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 44' ' ' LEU . 2.1 mm? -80.84 42.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 111.625 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.33 152.82 25.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.849 178.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.28 -30.28 60.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.89 -25.5 68.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -69.88 -38.88 76.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 t -72.34 -37.63 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -67.66 -37.73 82.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.093 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -75.19 -20.29 59.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.036 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -44.92 66.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.956 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -75.26 -27.94 59.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -68.58 -56.52 7.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -66.72 -49.42 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.429 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -72.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.285 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.64 78.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.656 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.86 -69.31 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.91 98.7 11.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.73 14.72 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.567 2.178 . . . . 0.0 112.448 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -104.88 -7.35 19.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.6 148.5 44.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.978 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.56 165.13 1.78 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.662 2.241 . . . . 0.0 112.319 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.3 159.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.27 138.49 43.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.565 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 118' ' ' GLY . 22.6 pt -114.76 169.08 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.502 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 118.22 27.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.854 HG11 HG12 ' A' ' 74' ' ' ILE . 1.5 p -135.86 -179.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.634 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.65 -40.1 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.042 0.449 . . . . 0.0 110.582 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 166.73 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.562 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.671 HG21 ' SD ' ' A' ' 85' ' ' MET . 3.3 t -59.17 -29.38 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.31 -27.51 67.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.777 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HG3' ' OG ' ' A' ' 69' ' ' SER . 12.8 mm-40 -79.31 -22.87 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.854 HG12 HG11 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.74 56.67 0.71 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 42.8 Cg_endo -68.35 -62.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.857 1.705 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -72.89 4.09 4.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.559 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 66' ' ' ILE . 1.8 t80 -92.2 -64.54 1.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.736 0.303 . . . . 0.0 110.837 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.06 -178.03 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -116.59 116.62 38.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.956 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 71' ' ' VAL . 69.1 Cg_endo -102.07 -176.71 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.203 2.602 . . . . 0.0 112.558 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.923 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 29.5 t -143.4 173.08 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.99 -103.25 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.129 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 86' ' ' GLU . 1.5 m-20 -55.17 -26.54 39.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -60.61 -51.95 67.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.989 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.671 ' SD ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -74.26 -21.01 59.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -63.61 -44.83 92.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -44.65 95.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.578 ' HE1' HD13 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -66.4 -29.98 70.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.696 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.7 mt-10 -72.39 -17.3 61.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.082 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -75.22 -13.82 60.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.179 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 41.95 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 89' ' ' GLU . 1.8 pp -127.27 146.65 58.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.994 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.59 -171.95 10.59 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.37 -1.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.35 163.42 12.29 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.856 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.0 Cg_endo -81.06 48.78 3.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -107.5 159.68 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.57 138.84 44.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.632 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.07 106.58 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.285 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.763 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 14.0 t -103.85 122.48 56.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.427 HD21 ' HE3' ' A' ' 85' ' ' MET . 1.2 mp -126.36 -167.66 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.442 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -177.53 3.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.314 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.769 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.8 147.87 44.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.091 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.527 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 8.7 t30 -74.28 -173.21 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.39 38.38 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.826 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 10.8 tp -76.63 127.77 33.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.79 0.329 . . . . 0.0 110.799 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.57 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.5 mt -75.68 -50.34 3.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.692 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.826 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 76.4 Cg_exo -50.58 108.32 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.267 1.978 . . . . 0.0 112.443 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.592 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.8 OUTLIER -80.82 1.37 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.73 -15.02 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 107' ' ' PRO . 4.3 mt -109.5 -44.33 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 108' ' ' ASP . 8.8 t -77.26 -9.63 58.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.834 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.35 -150.25 38.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.7 -10.52 67.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.549 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.3 p -117.02 -171.35 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.757 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.573 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.4 p -109.67 64.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.702 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -140.42 152.59 45.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.012 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 102' ' ' ARG . 92.9 t -139.86 135.07 38.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.411 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.557 ' O ' HG12 ' A' ' 66' ' ' ILE . . . -99.21 155.99 19.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.563 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.638 HD12 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.06 173.23 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' H ' HG22 ' A' ' 119' ' ' ILE . 3.2 ttp180 -157.29 117.5 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 111.392 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.87 79.38 1.85 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.846 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.57 -170.47 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.594 2.196 . . . . 0.0 112.548 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.11 23.01 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.104 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.69 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.1 t0 -82.2 96.06 7.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.57 -44.99 85.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.602 HG23 HD22 ' A' ' 16' ' ' LEU . 30.6 mm -64.91 -53.42 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.947 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 14.5 t -63.11 -12.78 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.507 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 6.4 ttt85 -75.47 -42.85 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -73.25 -54.46 8.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.518 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.18 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.299 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.13 -26.6 63.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.36 -53.79 49.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -89.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.824 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 90.1 m-85 -77.74 123.16 86.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 20.7 Cg_exo -65.51 163.53 29.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.06 146.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 111.517 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.418 HG21 ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -74.47 151.24 39.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.29 114.87 8.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.952 0.406 . . . . 0.0 111.939 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.52 148.51 50.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.54 124.9 29.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.199 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.471 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.9 Cg_exo . . . . . 0 CA--C 1.537 0.674 0 N-CA-C 113.136 0.399 . . . . 0.0 113.136 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 86.3 Cg_endo -82.26 125.62 4.63 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.924 1.749 . . . . 0.0 112.571 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.08 154.63 38.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -95.85 -10.67 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.72 2.28 . . . . 0.0 112.972 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.35 139.54 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.389 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -65.53 -45.25 84.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.853 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.24 -18.5 65.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.611 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -40.92 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.77 HD12 HG23 ' A' ' 165' ' ' VAL . 24.0 mt -69.29 -37.87 76.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.217 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.11 -44.17 95.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.42 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -75.45 -46.9 29.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.753 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.676 ' HB3' HD22 ' A' ' 159' ' ' LEU . 6.3 t70 -70.18 -43.45 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.574 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.8 mm? -100.23 67.11 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -16.59 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.048 0.843 . . . . 0.0 112.848 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.44 25.09 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.649 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.55 -69.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.553 179.031 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.677 ' HA ' HG23 ' A' ' 28' ' ' ILE . 1.2 p-10 -108.29 99.51 8.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.498 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.57 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.97 130.2 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.735 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.77 HG23 HD12 ' A' ' 155' ' ' ILE . 1.9 p -64.33 -170.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.948 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.768 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.53 119.95 28.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.155 0.502 . . . . 0.0 111.426 -178.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.4 -0.69 57.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.076 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.591 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -75.75 -38.71 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.82 64.85 1.7 Allowed Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.767 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.844 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 7.3 m-20 -73.14 -124.0 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.859 -0.2 . . . . 0.0 110.744 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.855 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -141.72 -170.1 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.232 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.86 10.1 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -64.63 91.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.149 0.5 . . . . 0.0 111.364 -176.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.404 ' HG3' HG23 ' A' ' 36' ' ' ILE . 10.0 ttt -55.04 -15.79 2.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.857 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -139.68 150.58 63.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.055 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.95 -151.92 0.66 Allowed 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 123.497 -1.46 . . . . 0.0 112.533 0.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -153.91 115.21 4.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.18 46.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.333 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.4 t -129.24 105.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.564 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 189' ' ' VAL . 3.7 mp -121.2 132.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.763 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -95.3 71.86 3.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.553 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 0.0 OUTLIER -68.37 84.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.299 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -88.0 0.08 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.414 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.72 -128.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.6 OUTLIER -59.33 -51.17 83.32 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.36 106.27 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.238 1.958 . . . . 0.0 112.371 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 96.1 Cg_endo -84.29 140.56 8.67 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.601 2.2 . . . . 0.0 112.401 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.67 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.2 mmm-85 -97.18 59.31 1.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.473 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.699 ' HA ' HG23 ' A' ' 180' ' ' ILE . 43.2 t -58.24 107.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.117 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.01 80.36 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -99.2 143.45 29.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 179.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.712 0.213 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -33.75 76.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.437 HG13 ' OE2' ' A' ' 18' ' ' GLU . 95.3 t -65.93 -35.67 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.135 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -47.08 70.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.87 -21.18 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.03 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' OE2' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.22 -34.21 61.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.661 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -70.42 -36.68 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.058 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.6 mm -69.71 -31.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m -64.04 -47.54 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 19' ' ' ALA . 4.4 p -64.47 -25.5 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.031 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.42 -47.24 86.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -23.71 61.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.983 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.35 -5.3 79.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.519 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.0 57.13 12.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.81 174.72 16.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -96.44 148.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.756 0.313 . . . . 0.0 110.67 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.553 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.8 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.744 HG22 ' H ' ' A' ' 31' ' ' TYR . 2.5 mt -102.38 174.23 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.744 ' H ' HG22 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -171.31 106.44 0.39 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' N ' ' A' ' 170' ' ' ASP . 87.2 Cg_endo -84.28 125.39 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.602 2.201 . . . . 0.0 111.506 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.62 -154.84 0.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 6.8 m-20 -54.7 -30.1 54.89 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.255 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 176' ' ' PRO . 0.2 OUTLIER -93.54 -118.23 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.18 -165.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.165 -179.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -71.87 126.02 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.537 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.2 121.19 2.79 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -112.16 149.32 32.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 0.0 112.062 -176.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 41' ' ' VAL . . . -144.93 169.04 26.8 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.946 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -159.27 -170.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.909 0.385 . . . . 0.0 111.118 -179.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.5 t30 -56.75 119.74 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.56 -63.23 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.37 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 44' ' ' LEU . 1.2 mm? -78.33 33.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 111.863 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 1.1 m-20 -111.28 147.68 34.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.973 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -75.57 -29.63 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.305 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.71 -25.68 63.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -72.33 -31.48 65.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.145 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.13 -45.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.496 ' NH2' ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -67.75 -34.92 77.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 24.2 mmt180 -73.64 -35.1 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.1 OUTLIER -67.23 -24.65 65.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.846 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -46.68 32.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.384 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -54.46 -48.21 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.391 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 140' ' ' SER . 10.7 t -75.21 -49.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.36 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.737 ' HE3' ' HB2' ' A' ' 58' ' ' ARG . 14.7 tptt -93.69 -71.25 0.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.411 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.85 15.33 34.32 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.697 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.737 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 76.7 mtp85 -118.23 22.91 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -149.7 66.21 8.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.93 -54.94 4.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.575 2.184 . . . . 0.0 112.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.424 ' O ' ' HA3' ' A' ' 112' ' ' GLY . 32.2 p-80 -123.84 24.09 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.137 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.619 ' HE3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -88.55 146.55 37.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.619 ' HD2' ' HE3' ' A' ' 62' ' ' LYS . 76.9 Cg_exo -51.74 148.32 22.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.662 2.241 . . . . 0.0 112.559 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.9 166.13 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.58 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 0.4 OUTLIER -106.92 140.22 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 118' ' ' GLY . 1.8 pt -116.21 171.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.6 t -122.8 125.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.504 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.876 HG21 HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -135.97 -179.11 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.878 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.608 ' H ' HG22 ' A' ' 68' ' ' VAL . 1.5 t -90.0 -44.07 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.79 0.328 . . . . 0.0 110.956 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -163.71 174.91 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.089 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HA ' HD11 ' A' ' 74' ' ' ILE . 5.8 t -58.38 -37.37 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.834 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 1.0 OUTLIER -67.13 -22.12 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.837 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.63 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -80.43 -20.92 42.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.139 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.876 HG23 HG21 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -113.63 54.6 0.61 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 29.5 Cg_endo -62.41 -82.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.834 1.689 . . . . 0.0 111.828 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.457 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 2.0 mmt180 -73.41 19.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.336 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' PRO . 59.9 m-85 -103.26 -34.81 8.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.755 0.312 . . . . 0.0 111.108 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.456 ' OG ' HD11 ' A' ' 119' ' ' ILE . 2.2 m -135.33 165.5 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -112.76 105.01 56.09 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.415 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 86.3 Cg_endo -102.57 179.72 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.169 2.579 . . . . 0.0 112.619 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 -173.45 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.11 -82.47 0.44 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.713 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -57.64 -26.71 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.927 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.471 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -63.41 -48.25 78.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 9.6 mmt -70.44 -15.81 62.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.713 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mm-40 -66.44 -50.4 63.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.67 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 182' ' ' LEU . 2.7 tm? -61.77 -38.99 90.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.449 ' SD ' HD13 ' A' ' 182' ' ' LEU . 5.1 tpt -64.94 -49.67 69.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.437 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -72.88 -2.59 21.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.368 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.99 -58.88 3.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.295 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.3 74.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.629 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.74 149.22 72.82 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.071 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.72 -148.5 0.51 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.18 -1.175 . . . . 0.0 111.952 -1.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.18 8.74 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.979 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.42 ' HB2' HG23 ' A' ' 35' ' ' THR . 3.9 Cg_exo -80.42 43.77 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.221 2.614 . . . . 0.0 112.151 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.497 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 3.6 p90 -112.23 -177.03 3.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -112.89 139.04 48.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.245 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.17 102.77 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.282 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.745 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -101.22 122.9 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -126.91 -179.04 4.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.714 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -74.86 -166.01 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.664 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -119.28 138.19 53.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.182 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 76' ' ' ARG . 4.3 t30 -73.73 -163.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.315 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -39.19 82.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.325 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.576 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -69.46 100.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.688 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.4 pt -80.95 102.87 1.5 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.922 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 60.6 Cg_endo -70.91 138.43 34.16 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.429 2.086 . . . . 0.0 112.248 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.034 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 109' ' ' VAL . 7.0 p -87.43 23.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.922 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 57.7 mt -106.69 -54.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 110.894 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.677 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 6.2 t -87.57 -24.26 24.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.865 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 61' ' ' HIS . . . 69.31 -141.74 36.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.408 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.32 27.6 6.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.437 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' A' ' 63' ' ' PRO . 1.3 t -123.94 165.58 17.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.327 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -113.16 42.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 116' ' ' ARG . 2.3 mtp180 -136.74 163.63 30.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.52 142.28 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . -92.74 149.59 19.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.454 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.503 HD13 HD13 ' A' ' 74' ' ' ILE . 72.2 mt -144.98 150.26 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.41 124.03 12.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.88 0.371 . . . . 0.0 111.476 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.1 t -110.66 83.7 3.61 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.837 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.08 179.5 6.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.589 2.192 . . . . 0.0 112.614 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -93.13 19.65 7.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.108 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.471 ' HB2' ' SG ' ' A' ' 127' ' ' CYS . 66.1 m-20 -82.02 105.57 13.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' ARG . 5.4 pt-20 -57.35 -42.96 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.277 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mm -61.36 -58.13 8.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -58.58 -21.16 52.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.994 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 125' ' ' GLU . 1.8 mtp180 -68.17 -37.54 81.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 34.6 ttt-85 -75.25 -53.23 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.2 mt -59.19 -52.0 65.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.257 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.798 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.08 -27.86 69.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.63 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -51.27 66.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.997 0.427 . . . . 0.0 110.021 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.521 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -75.19 -91.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 177.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.521 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -77.92 144.87 68.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 178.136 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 159.53 49.19 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.185 1.923 . . . . 0.0 111.374 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 t -132.67 152.0 35.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.802 0.334 . . . . 0.0 111.244 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.466 HG21 ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -80.2 153.28 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.4 116.4 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 111.57 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.651 HG23 HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -142.42 140.89 32.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.697 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.439 ' O ' HG11 ' A' ' 55' ' ' VAL . 22.4 p -66.93 139.17 57.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.997 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.393 -179.725 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.416 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 43.1 Cg_exo . . . . . 0 CA--C 1.538 0.709 0 N-CA-C 113.389 0.496 . . . . 0.0 113.389 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 73.9 Cg_endo -75.07 90.41 1.09 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.802 1.668 . . . . 0.0 112.208 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.489 ' HB2' HG12 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -84.78 157.93 60.0 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -96.01 -11.27 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.902 2.401 . . . . 0.0 112.908 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -141.48 141.62 33.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.87 HD22 ' HA ' ' A' ' 166' ' ' LEU . 55.8 mt -60.19 -28.6 68.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.771 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -72.23 -34.45 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.361 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.54 ' HG3' HH21 ' A' ' 157' ' ' ARG . 3.9 tt0 -58.95 -47.07 86.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.804 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.542 ' H ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -74.44 -35.43 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -67.33 -20.91 27.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.072 0.463 . . . . 0.0 110.37 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.54 HH21 ' HG3' ' A' ' 154' ' ' GLU . 10.1 ttp180 -73.1 -46.31 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.431 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.17 -41.41 63.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.677 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 160' ' ' ASP . 2.7 mm? -111.22 68.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.7 t70 -15.93 -63.35 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.094 0.871 . . . . 0.0 112.817 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -157.02 18.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.321 . . . . 0.0 111.251 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.96 -42.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.909 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 25.5 m-20 -111.21 110.75 21.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.411 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.529 HD12 HG13 ' A' ' 29' ' ' VAL . 29.7 mt -74.71 61.93 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.746 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.646 HG13 ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -78.84 22.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.732 178.159 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.87 ' HA ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -148.21 34.81 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.501 ' OD1' ' HB3' ' A' ' 164' ' ' LEU . 4.3 m-20 -70.01 -84.09 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.385 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.638 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -86.35 -34.19 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.065 0.46 . . . . 0.0 110.673 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.59 27.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.468 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' HG2' ' A' ' 32' ' ' PRO . 2.9 m-20 -62.19 -177.55 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 0.0 111.214 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.9 t -140.16 -62.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.55 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -124.77 -135.61 0.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.7 144.78 26.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.9 ptm -70.32 2.4 3.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.054 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.72 151.29 26.45 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.626 ' O ' HG22 ' A' ' 35' ' ' THR . 64.5 Cg_endo -92.02 -136.64 0.1 OUTLIER 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.946 -1.273 . . . . 0.0 112.46 0.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.411 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -159.33 130.2 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.418 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 191' ' ' ARG . 32.6 m -101.29 139.72 36.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.923 0.392 . . . . 0.0 111.607 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.7 t -129.6 117.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.662 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.31 121.01 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.386 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -98.25 67.96 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.271 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 87' ' ' LEU . 4.4 tt -69.29 79.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 -78.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.92 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 185' ' ' ASN . 5.7 t -120.42 -119.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.381 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 2.1 m-20 -69.57 -52.65 13.95 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.97 109.55 2.6 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.108 1.872 . . . . 0.0 112.767 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.7 Cg_endo -75.97 122.67 6.87 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.444 2.096 . . . . 0.0 111.955 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.776 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 3.3 mmp_? -87.28 61.2 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.88 93.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.569 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -122.05 87.8 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.211 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.614 ' HB3' HG23 ' A' ' 178' ' ' THR . 1.5 ptm180 -89.41 142.81 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.057 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.867 179.764 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 16' ' ' LEU . 23.1 Cg_exo . . . . . 0 C--O 1.23 0.109 0 CA-C-O 120.825 0.26 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.88 -26.53 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.488 HG13 ' OD2' ' A' ' 167' ' ' ASP . 44.9 t -75.11 -34.54 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.074 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 1.1 mm? -69.65 -47.0 64.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.97 -21.21 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.57 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -74.77 -35.88 62.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.679 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.57 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -67.56 -37.67 82.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.933 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.95 -35.18 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.647 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -33.52 75.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 18' ' ' GLU . 16.8 t -70.1 -32.29 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.0 mmt -61.33 -41.93 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.17 -11.23 60.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.12 -11.82 72.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 37.78 92.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.13 170.22 18.89 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.584 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.675 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -96.3 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.673 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.675 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.29 135.97 55.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -102.56 152.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.59 0.233 . . . . 0.0 110.586 178.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -160.13 102.5 1.4 Allowed Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.689 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.4 Cg_endo -82.18 136.3 8.94 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 0.0 111.327 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 -147.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.663 0.268 . . . . 0.0 111.277 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.601 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 8.0 t70 -54.5 -25.41 25.34 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.928 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 174' ' ' MET . 4.3 t -95.43 -120.54 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.586 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.7 HG12 ' H ' ' A' ' 37' ' ' TYR . 9.3 tt -111.77 -171.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.563 0.221 . . . . 0.0 110.876 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.7 ' H ' HG12 ' A' ' 36' ' ' ILE . 1.4 m-85 -63.33 129.02 38.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.778 0.323 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -121.14 177.68 16.38 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.146 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.654 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.6 mp -119.32 141.11 49.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.635 0.255 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.39 114.08 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 42' ' ' ASN . 3.4 p -153.29 161.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.511 0.195 . . . . 0.0 110.867 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.492 ' N ' HG22 ' A' ' 41' ' ' VAL . 5.9 t-20 -55.93 98.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.371 . . . . 0.0 110.346 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.62 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.108 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 9.2 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.086 0.469 . . . . 0.0 111.34 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.91 152.51 26.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.718 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.7 mt-10 -74.07 -19.16 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.825 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.47 -25.1 63.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.55 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.2 35.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.29 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 46' ' ' GLU . 32.6 m -65.17 -34.28 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.056 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -40.15 96.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.557 ' HG2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -62.2 -54.5 40.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.146 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.71 -27.29 39.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.293 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.57 -31.57 65.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -40.58 63.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.015 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.5 t -75.12 -35.05 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.397 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.89 0.32 56.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.401 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 -115.37 7.92 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.604 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -100.42 105.12 16.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.871 0.367 . . . . 0.0 110.993 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 63.3 m -151.97 65.12 6.09 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.014 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.7 6.03 5.48 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.598 2.199 . . . . 0.0 112.448 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -122.36 -14.03 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.018 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 5.9 mmtp -88.16 129.19 50.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 35.0 Cg_exo -61.18 -175.1 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.549 2.166 . . . . 0.0 111.999 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.55 170.64 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -113.62 134.57 54.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 25.9 mm -116.42 159.24 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.387 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.888 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 1.6 t -119.15 141.24 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.153 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 74' ' ' ILE . 1.4 p -150.05 173.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.287 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.572 ' H ' HG22 ' A' ' 68' ' ' VAL . 7.5 t -89.84 -34.15 16.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 110.072 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.9 t -164.26 160.66 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.595 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.53 ' HA ' HD11 ' A' ' 74' ' ' ILE . 21.9 t -57.08 -32.56 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.624 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.35 -26.19 66.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.884 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.677 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -77.1 -22.82 52.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.207 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.646 HG12 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.61 60.11 0.83 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.677 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 23.5 Cg_exo -64.12 -73.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.158 1.906 . . . . 0.0 112.448 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 15.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.032 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 -34.93 6.98 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.157 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.569 ' HB2' HD23 ' A' ' 100' ' ' LEU . 93.4 p -135.49 164.2 28.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.0 110.991 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -114.52 103.22 55.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.756 ' HA ' HD11 ' A' ' 100' ' ' LEU . 74.3 Cg_endo -102.15 -169.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.177 2.585 . . . . 0.0 113.063 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -144.58 -174.85 4.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.06 -86.56 0.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.881 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -29.48 61.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.793 0.33 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 184' ' ' VAL . . . -58.44 -49.28 77.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.787 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.516 ' SD ' HG21 ' A' ' 71' ' ' VAL . 21.3 mmt -72.17 -17.91 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.956 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.67 -36.22 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.14 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 182' ' ' LEU . 2.8 tm? -64.18 -45.45 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.852 ' HB2' HD23 ' A' ' 182' ' ' LEU . 31.5 tpp -75.39 -26.56 58.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.376 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HA ' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -60.72 -40.76 93.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.399 . . . . 0.0 111.854 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -75.56 -18.46 59.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.4 mt -100.4 -11.29 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.525 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -112.08 151.89 43.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.007 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 174.84 50.58 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.904 -1.29 . . . . 0.0 112.202 0.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.32 -173.61 32.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.568 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.17 28.63 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.661 2.241 . . . . 0.0 112.437 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -101.59 143.36 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -106.96 136.24 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.635 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 182' ' ' LEU . 1.4 p -120.11 111.83 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.406 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.678 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 6.4 t -87.44 127.16 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.922 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' HA ' ' A' ' 80' ' ' PRO . 15.1 tp -124.8 178.22 5.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.562 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 1.6 mt-10 -74.4 -170.24 0.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.9 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.64 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.77 138.63 52.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.491 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 176.1 7.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.747 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.57 55.84 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.451 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 107' ' ' PRO . 1.8 mt -89.85 131.04 35.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 110.768 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.631 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.3 mp -66.84 -51.86 36.16 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.781 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.734 ' HD2' HD22 ' A' ' 105' ' ' LEU . 56.7 Cg_exo -52.21 105.17 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.236 1.957 . . . . 0.0 112.445 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -4.7 53.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 110' ' ' ILE . 14.5 p -71.96 -27.01 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.015 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.62 HG13 HG13 ' A' ' 109' ' ' VAL . 13.1 mt -93.87 -39.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.426 HG22 ' NE ' ' A' ' 102' ' ' ARG . 2.5 p -71.68 -23.21 61.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.6 -157.44 50.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.498 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.85 -21.26 71.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.0 m -108.39 -179.77 3.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.533 ' C ' ' HB2' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -112.98 59.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.029 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 mtm105 -142.72 158.58 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.64 HG23 ' HG2' ' A' ' 102' ' ' ARG . 39.5 t -139.93 117.11 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.61 117.9 4.54 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 74' ' ' ILE . 5.7 mt -130.14 150.43 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.8 0.333 . . . . 0.0 111.037 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.8 ptp180 -144.48 149.32 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.478 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -110.5 88.72 7.9 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.739 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 21.8 Cg_exo -64.81 -179.52 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.461 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.25 2.11 56.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.188 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 5.1 t0 -71.44 109.11 5.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.27 -40.51 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.243 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mm -69.94 -50.02 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.258 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 20.6 t -61.26 -18.79 60.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.2 OUTLIER -73.69 -46.79 44.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.878 179.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -52.54 60.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.562 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.5 mt -59.45 -55.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.309 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.74 -25.1 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.451 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB1' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -57.37 11.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.02 0.438 . . . . 0.0 109.965 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.458 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -76.16 -85.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 177.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.458 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 28.7 m-85 -77.19 112.32 22.51 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.236 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -65.64 133.33 33.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.279 1.986 . . . . 0.0 111.306 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.72 166.98 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 120.878 0.371 . . . . 0.0 111.771 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.578 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 87.7 m -80.97 125.88 30.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -122.58 95.37 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.68 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.654 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -126.76 113.87 17.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.859 179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.579 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -61.84 121.7 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.58 ' HG2' ' HD3' ' A' ' 148' ' ' PRO . 11.1 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.58 ' HD3' ' HG2' ' A' ' 147' ' ' PRO . 67.3 Cg_endo -73.95 73.19 3.74 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.764 1.643 . . . . 0.0 112.653 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.4 110.12 53.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.732 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -95.39 -14.84 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.601 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -130.44 127.02 38.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.602 HD22 HG22 ' A' ' 165' ' ' VAL . 45.7 mt -63.12 -37.98 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -17.81 62.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -74.09 -36.95 64.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.015 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.947 HD12 HG23 ' A' ' 165' ' ' VAL . 2.5 mt -70.96 -45.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 152' ' ' LEU . 4.3 t -54.73 -38.07 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -70.88 -48.83 51.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.579 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -45.98 92.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.461 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.807 ' HB3' ' HB ' ' A' ' 162' ' ' VAL . 1.4 mm? -109.77 81.84 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.084 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.4 -40.79 0.39 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.004 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.75 15.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.318 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.807 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 47.2 t -80.61 -83.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.979 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 4.3 t0 -93.83 85.9 4.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.753 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.587 ' HB3' HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -54.89 123.82 14.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.326 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.947 HG23 HD12 ' A' ' 155' ' ' ILE . 1.4 p -62.71 177.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.296 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.629 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -125.47 137.82 53.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.792 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.488 ' OD2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -92.26 -9.65 41.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.232 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.582 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -77.44 -35.04 54.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.571 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 86.92 177.86 49.12 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.827 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 16.7 p-10 -71.32 -160.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.39 -64.75 0.44 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.758 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.601 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.86 -139.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.466 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -87.04 149.19 24.91 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.8 ptm -60.99 -10.72 6.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.237 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.76 158.38 67.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.552 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -92.33 -156.71 0.68 Allowed 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 124.124 -1.198 . . . . 0.0 112.844 1.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.71 120.24 3.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.815 HG23 ' HB3' ' A' ' 191' ' ' ARG . 69.5 m -102.02 138.18 39.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.32 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.52 98.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.061 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.668 HG12 ' HA ' ' A' ' 189' ' ' VAL . 6.0 mt -108.73 132.96 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.678 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -90.1 71.4 7.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.893 ' HA ' ' HB3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -72.4 82.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.545 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.9 p -83.7 -97.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.181 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 6.2 t -121.92 -63.2 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.457 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -173.56 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.342 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HA ' ' HD2' ' A' ' 187' ' ' PRO . 51.8 Cg_exo -59.57 120.37 8.15 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.927 1.085 . . . . 0.0 110.867 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.893 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 21.2 Cg_endo -62.67 156.69 51.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.811 2.341 . . . . 0.0 112.834 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.417 ' HD3' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -101.92 99.96 10.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.873 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.668 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.4 t -67.75 103.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.78 82.26 1.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . 0.815 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -102.98 159.04 15.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.798 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.735 0.302 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mt -105.35 -66.01 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 4' ' ' ARG . 1.8 tp -74.29 146.92 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.197 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -74.81 97.66 3.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.2 -179.92 5.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 tt -106.45 153.84 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.833 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.3 p -69.75 -178.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.959 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.06 -65.22 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.989 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -84.71 129.45 34.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -96.26 132.67 26.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.3 129.59 36.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.587 2.192 . . . . 0.0 112.362 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -116.06 99.58 52.75 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.65 179.82 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.577 2.185 . . . . 0.0 112.28 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -37.47 80.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.4 t -71.31 -28.12 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.235 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.425 ' CD1' HD11 ' A' ' 130' ' ' ILE . 1.1 mm? -68.87 -48.03 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 21' ' ' SER . 4.9 pt-20 -72.51 -20.92 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.031 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.81 -35.05 60.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -74.21 -40.18 62.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.457 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 20' ' ' ILE . 2.3 pp -75.65 -18.69 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 111.024 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 1.2 t -68.23 -53.87 21.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.744 HG21 ' HB2' ' A' ' 164' ' ' LEU . 4.9 p -63.78 -33.51 62.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.81 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 17.9 mtt -63.38 -30.32 71.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.728 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.8 -29.2 64.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.07 1.02 89.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.378 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.2 53.42 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.634 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.97 172.72 15.62 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.306 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.685 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.9 tp -96.38 136.3 27.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 110.748 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.552 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.8 131.63 68.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -102.27 162.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.508 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -167.96 104.41 0.56 Allowed Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.536 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 93.7 Cg_endo -80.24 145.46 17.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.477 2.118 . . . . 0.0 111.888 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -123.05 -150.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.615 0.245 . . . . 0.0 111.224 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.736 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 3.0 m-20 -55.41 -22.43 20.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.603 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 95' ' ' PRO . 12.8 p -99.74 -112.79 0.18 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.945 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.84 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -161.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.726 0.298 . . . . 0.0 111.051 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -68.7 134.16 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.944 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -116.45 178.08 17.17 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.936 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.666 ' HB2' HG23 ' A' ' 139' ' ' THR . 1.1 mt -133.42 139.17 46.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.83 124.53 2.09 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.989 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 136' ' ' VAL . 8.9 p -157.62 165.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.558 0.218 . . . . 0.0 110.814 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.738 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -55.52 100.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.41 . . . . 0.0 110.646 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.15 99.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.159 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.5 mm? -77.53 15.6 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.34 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.738 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.42 146.23 36.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.758 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -24.36 67.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.26 -29.2 69.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.868 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.47 -40.28 70.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.188 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.3 t -65.35 -35.49 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.984 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -50.3 34.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -69.7 -13.71 62.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.302 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.9 OUTLIER -75.25 -49.48 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.359 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' N ' HD13 ' A' ' 52' ' ' LEU . 5.5 t80 -63.93 -25.55 68.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HD3' HH11 ' A' ' 54' ' ' ARG . 1.1 mmm180 -66.19 -45.85 79.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.638 HG13 HG12 ' A' ' 143' ' ' ILE . 41.2 t -72.42 -52.17 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.347 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -74.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.218 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.73 40.59 98.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.562 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -112.37 -80.66 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.309 . . . . 0.0 110.925 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.08 129.22 16.93 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.31 22.1 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.594 2.196 . . . . 0.0 112.487 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.89 -8.87 15.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.112 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -88.13 141.33 31.03 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.047 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.05 165.63 25.72 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.518 2.145 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 110' ' ' ILE . 2.6 m -116.4 156.77 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.062 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 10.6 t -101.0 137.36 39.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.67 173.42 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.166 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.792 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 16.5 t -122.21 141.69 51.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.883 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -150.03 177.01 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.66 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.615 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -86.07 -46.82 10.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.898 0.38 . . . . 0.0 110.674 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.25 175.85 9.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.008 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.48 -31.78 47.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 t70 -67.39 -26.03 66.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.107 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.563 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 23.6 mm-40 -80.39 -23.99 40.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.394 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.883 HG23 HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.54 54.81 0.61 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 77' ' ' PHE . 27.6 Cg_endo -61.74 -83.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.864 1.709 . . . . 0.0 111.743 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.49 19.89 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.368 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 75' ' ' PRO . 8.2 m-85 -93.17 -44.13 8.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.801 0.334 . . . . 0.0 111.088 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -128.1 -175.45 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.638 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HB3' ' CB ' ' A' ' 101' ' ' GLU . 10.1 ttt-85 -112.75 103.54 55.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.589 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -102.33 -178.77 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.223 2.615 . . . . 0.0 112.584 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.438 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 1.5 t -145.98 -176.17 5.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.05 -85.01 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.687 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.442 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 5.1 t70 -55.04 -26.31 36.48 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.754 0.312 . . . . 0.0 110.823 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.16 -51.53 68.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 81' ' ' SER . 13.7 mmt -69.55 -20.45 63.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.857 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.2 mt-10 -71.04 -41.36 70.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.667 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.741 ' HA ' ' HD2' ' A' ' 90' ' ' ARG . 2.7 tm? -60.08 -44.18 94.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.76 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.587 ' HB2' HD22 ' A' ' 182' ' ' LEU . 7.0 tpt -74.6 -35.98 62.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.155 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -64.17 -12.5 40.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.741 ' HD2' ' HA ' ' A' ' 87' ' ' LEU . 23.8 mtt-85 -75.61 -55.13 5.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.672 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 57.52 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.701 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -132.1 154.51 81.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 120.615 0.245 . . . . 0.0 111.184 178.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.92 -153.24 0.88 Allowed 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.712 -1.37 . . . . 0.0 112.007 -2.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.46 178.27 28.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.725 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.736 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 99.0 Cg_endo -79.58 32.57 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.673 2.249 . . . . 0.0 112.609 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -112.67 146.59 38.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.743 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.834 HG22 ' HA ' ' A' ' 179' ' ' VAL . 6.7 t -95.47 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.585 HG11 ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -115.66 109.31 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.46 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 8.7 t -98.41 126.29 51.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.56 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.87 -174.9 3.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.714 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.416 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.8 OUTLIER -74.6 -177.82 3.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.173 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.99 138.21 52.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.429 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.97 -165.56 0.39 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.029 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.65 43.58 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.602 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -80.54 124.72 29.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.532 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 3.4 mp -74.55 -50.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.948 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.57 ' HD2' HD23 ' A' ' 105' ' ' LEU . 86.9 Cg_exo -49.27 103.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.284 1.989 . . . . 0.0 112.554 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 81.2 m-20 -80.94 -4.57 55.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.176 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.6 m -70.45 -21.58 23.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.075 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.592 HG22 HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -111.41 -35.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 64.1 p -76.95 -19.97 56.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.07 -167.69 51.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.55 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -82.72 5.72 73.36 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.59 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.7 m -122.69 -178.36 3.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.82 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 43.7 m -105.75 51.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -144.53 149.17 35.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.453 HG23 ' CB ' ' A' ' 102' ' ' ARG . 87.6 t -139.65 142.55 32.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.574 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -95.8 158.86 22.09 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.54 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 120' ' ' ARG . 18.9 mt -142.62 162.62 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 119' ' ' ILE . 12.5 ttt85 -146.63 128.23 15.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.812 0.339 . . . . 0.0 111.321 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.77 81.18 2.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HB2' HG21 ' A' ' 33' ' ' THR . 72.1 Cg_endo -76.36 178.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.493 2.129 . . . . 0.0 112.551 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.38 9.74 35.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 9.1 m-20 -70.47 105.09 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.122 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.54 -49.96 74.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.411 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.18 -53.17 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.212 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -60.85 -18.35 55.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -74.69 -35.88 62.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -52.78 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 16' ' ' LEU . 43.7 mm -60.75 -49.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.29 -27.53 69.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.279 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.477 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . . . -54.67 -56.33 20.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.926 0.393 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -75.94 -87.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.159 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -77.0 126.75 85.12 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.188 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.08 154.6 66.33 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.309 2.006 . . . . 0.0 111.637 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -133.99 161.06 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.344 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 91.2 m -81.14 128.67 34.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -123.65 101.26 7.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 0.0 111.631 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -124.91 146.4 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.669 178.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.1 m -82.35 120.92 26.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.149 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . -86.32 84.23 7.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.899 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -158.13 32.57 0.25 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.227 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.649 ' N ' ' HG2' ' A' ' 147' ' ' PRO . 1.2 pp -75.5 -155.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.015 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 147.64 36.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.425 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 87.63 -138.36 15.18 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.603 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -127.58 66.98 71.47 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.523 0.201 . . . . 0.0 111.044 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.649 ' HG2' ' N ' ' A' ' 143' ' ' ILE . 41.1 Cg_exo -60.75 -48.73 10.11 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.436 2.091 . . . . 0.0 113.554 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 64.7 Cg_endo -73.25 118.67 5.62 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 121.893 1.729 . . . . 0.0 112.217 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -85.85 144.49 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 68.4 Cg_endo -95.96 -13.63 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.927 2.418 . . . . 0.0 112.747 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 126.61 41.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.715 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -63.24 -40.01 96.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.155 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -18.9 62.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.216 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.61 -36.78 65.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.117 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.83 HD12 HG23 ' A' ' 165' ' ' VAL . 21.8 mt -68.78 -52.24 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.439 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.55 -27.24 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.0 -55.91 6.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.71 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.45 -55.83 13.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.33 -179.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.3 mm? -91.14 73.93 6.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.929 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -37.13 -42.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.883 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.95 14.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.204 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.422 ' HB ' HD12 ' A' ' 159' ' ' LEU . 3.0 t -80.67 -78.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.994 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.685 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -100.03 87.81 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.484 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.744 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -59.06 129.77 43.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.326 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.83 HG23 HD12 ' A' ' 155' ' ' ILE . 1.5 p -69.36 -169.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.744 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.91 154.53 42.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.399 . . . . 0.0 110.957 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.46 -21.9 19.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.182 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.3 -51.71 6.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.459 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 97.13 -155.58 20.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.744 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.9 -161.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.763 0.316 . . . . 0.0 111.086 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -146.2 -53.25 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.524 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.92 -128.63 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.526 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -85.64 144.56 27.77 Favored 'General case' 0 CA--C 1.523 -0.061 0 CA-C-O 120.84 0.353 . . . . 0.0 111.603 -178.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.84 ' HG2' HG23 ' A' ' 36' ' ' ILE . 2.5 ttp -65.29 -12.96 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.215 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.39 155.35 23.31 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.87 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -91.93 -139.73 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.434 0.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 192' ' ' ARG . 1.3 p -153.41 140.73 19.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.596 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 191' ' ' ARG . 23.7 m -101.44 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.0 111.322 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.834 ' HA ' HG22 ' A' ' 97' ' ' THR . 67.5 t -129.25 112.15 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.661 HG12 ' HA ' ' A' ' 189' ' ' VAL . 58.0 mt -116.71 129.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.65 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.25 65.63 0.63 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 88' ' ' MET . 39.9 tp -69.9 89.38 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -80.08 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.832 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.45 -127.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.931 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.516 HD22 ' HD3' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -59.21 -51.06 84.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.516 ' HD3' HD22 ' A' ' 185' ' ' ASN . 97.8 Cg_endo -79.71 107.15 2.08 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.165 1.91 . . . . 0.0 112.403 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.667 ' HG3' ' HG ' ' A' ' 87' ' ' LEU . 82.1 Cg_endo -77.64 138.31 17.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.482 2.122 . . . . 0.0 111.961 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 181' ' ' ASP . 0.7 OUTLIER -101.08 41.63 1.17 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.374 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.661 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.8 p -56.95 105.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.015 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.1 94.63 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.541 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 178' ' ' THR . 23.3 ptt85 -83.67 140.1 32.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.756 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 177' ' ' SER . 1.6 mtt85 -79.54 87.19 5.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -91.44 -170.5 42.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.534 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.09 -169.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.729 0.3 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.55 -175.58 18.78 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.479 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.73 74.95 2.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.571 2.181 . . . . 0.0 112.365 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 40.44 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.687 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -59.94 146.05 83.01 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.126 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.58 109.5 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.666 2.244 . . . . 0.0 112.199 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.2 m -74.18 178.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.905 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.1 31.62 5.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 -171.93 1.44 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 109.29 21.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -162.54 103.63 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -107.71 -13.08 15.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -85.51 83.45 1.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.658 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.02 -7.62 55.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 0.0 110.988 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.902 179.893 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.1 mtm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.796 0.332 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.75 178.96 6.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.36 142.9 12.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.8 ttp85 -92.06 104.76 17.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 173.57 6.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.968 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.7 pt -75.07 -141.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.987 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -70.05 -178.82 1.71 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.939 0.399 . . . . 0.0 111.082 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.91 121.4 19.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.94 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.56 -17.86 13.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 3.8 p-10 -98.99 125.41 41.98 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 10' ' ' ASN . 37.4 Cg_exo -57.75 146.18 86.74 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.481 2.121 . . . . 0.0 112.344 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.1 t -106.04 95.46 11.04 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.846 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.698 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 42.8 Cg_endo -68.28 132.98 27.15 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.59 2.194 . . . . 0.0 112.537 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 29.4 m-20 -72.2 -35.31 68.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.797 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 48.8 t -61.35 -35.52 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.75 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.714 HD11 ' HB ' ' A' ' 130' ' ' ILE . 0.7 OUTLIER -67.29 -56.51 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.624 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.62 -22.5 61.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.24 -34.91 61.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.006 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -69.46 -34.76 74.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.054 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.67 -39.67 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.721 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.9 t -72.85 -42.23 63.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.074 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.833 HG22 HD13 ' A' ' 164' ' ' LEU . 8.6 p -68.37 -29.49 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.263 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.1 mtt -74.24 -25.42 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.859 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -1.99 13.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.185 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.29 5.52 84.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.64 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.31 41.59 99.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.79 178.81 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.572 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.687 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -96.46 144.66 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.687 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -115.88 126.43 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.361 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.624 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -101.85 164.4 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.513 0.197 . . . . 0.0 110.488 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -165.29 103.76 0.77 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 90.9 Cg_endo -84.1 137.5 7.37 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.704 2.269 . . . . 0.0 111.735 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.816 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.93 -152.15 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.206 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 0.7 OUTLIER -54.73 -22.19 13.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.309 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.688 HG23 ' HB2' ' A' ' 95' ' ' PRO . 2.5 p -100.04 -116.14 0.16 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.122 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -112.2 -175.17 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.753 0.311 . . . . 0.0 111.141 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.452 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.1 m-85 -63.42 134.09 55.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.906 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -120.33 179.51 16.46 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.026 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 2.6 mp -122.27 143.57 49.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.971 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.22 117.39 0.96 Allowed Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.101 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.658 HG11 HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -153.91 166.0 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 111.367 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 54.9 m-20 -56.58 109.73 0.67 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.091 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.51 -46.25 84.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.202 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.69 24.92 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.5 148.1 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.27 -24.66 60.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -57.83 -27.79 63.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.24 -28.39 59.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 109' ' ' VAL . 26.0 t -67.23 -44.56 87.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -49.9 72.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.095 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 57.0 mmt-85 -62.29 -42.54 99.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.149 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.01 -25.71 68.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.903 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -30.51 64.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 54' ' ' ARG . 2.9 mmt85 -75.45 -49.9 17.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.309 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.71 -51.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.676 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -79.56 -5.96 56.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.293 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.15 -113.95 6.31 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.523 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.36 77.37 1.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.905 0.383 . . . . 0.0 111.002 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.1 m -154.89 71.51 5.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 23.28 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.697 2.265 . . . . 0.0 112.531 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -122.5 -8.36 8.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 133.15 50.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.788 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.66 153.51 14.21 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.621 2.214 . . . . 0.0 112.52 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 142.54 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -97.22 148.55 22.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.653 HG13 ' HA ' ' A' ' 119' ' ' ILE . 0.9 OUTLIER -116.06 170.95 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 3.3 t -122.17 118.59 29.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.612 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.767 HG21 HG23 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -138.46 177.51 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.799 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.83 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 2.1 t -86.95 -41.37 13.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 0.0 110.453 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.405 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -164.14 170.61 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.991 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.92 -34.03 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.82 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 21.9 t70 -67.03 -28.64 68.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.984 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 67.8 mm-40 -74.45 -23.36 58.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.08 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.767 HG23 HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.31 61.23 0.79 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.783 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 34.8 Cg_endo -65.04 -72.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.063 1.842 . . . . 0.0 112.267 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.86 14.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.63 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 74' ' ' ILE . 1.7 t80 -103.64 -54.34 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.739 0.304 . . . . 0.0 111.21 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.493 ' CB ' HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -120.09 172.69 7.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.768 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.52 111.49 41.77 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.933 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.14 175.29 0.22 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.948 2.432 . . . . 0.0 112.72 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.56 -177.02 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.896 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.36 -88.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.932 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -26.22 41.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.338 . . . . 0.0 110.999 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.67 78.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.2 mmt -71.65 -16.22 62.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.055 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -70.56 -47.22 61.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.438 . . . . 0.0 110.401 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -57.31 -43.61 83.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.667 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.456 ' HE1' ' HE2' ' A' ' 96' ' ' TYR . 1.8 ttm -66.65 -36.73 83.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -67.96 -10.84 56.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.377 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.64 -51.69 13.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 pt -113.8 65.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 111.228 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 3.1 tt -131.22 139.24 34.86 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.736 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.598 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 84.4 Cg_endo -79.03 -154.55 1.04 Allowed 'Cis proline' 0 C--N 1.35 0.65 0 C-N-CA 123.808 -1.33 . . . . 0.0 112.548 -1.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.71 160.47 10.36 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.686 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.688 ' HB2' HG23 ' A' ' 35' ' ' THR . 91.4 Cg_endo -78.67 42.37 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 112.271 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.609 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 55.3 p90 -112.18 149.9 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.6 m -96.19 141.78 29.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.156 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.637 HG23 ' HB3' ' A' ' 182' ' ' LEU . 1.8 p -127.41 109.99 21.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.951 0.405 . . . . 0.0 111.577 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.7 t -92.66 123.74 44.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.975 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.583 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 19.6 tp -127.26 172.27 10.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.599 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.583 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 2.8 pm0 -74.58 -176.17 2.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.521 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.659 ' HE ' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -119.07 139.43 51.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.975 0.417 . . . . 0.0 111.131 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.768 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.52 -157.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.94 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.469 ' H ' HD22 ' A' ' 103' ' ' ASN . 7.0 mm-40 -67.51 -31.85 72.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.525 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.7 tt -69.93 84.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.8 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.659 HG12 ' HE ' ' A' ' 102' ' ' ARG . 5.9 mt -80.9 104.48 2.78 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.091 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.758 ' HG2' ' HB ' ' A' ' 111' ' ' THR . 59.2 Cg_endo -70.69 154.8 63.85 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.33 2.02 . . . . 0.0 112.201 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.44 -84.04 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.752 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.79 HG21 HG22 ' A' ' 49' ' ' VAL . 27.5 m -81.88 7.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.985 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.693 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 6.8 mt -102.53 -35.87 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.295 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.758 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -83.12 -27.97 29.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.77 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.42 -140.55 37.41 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.383 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.05 -3.78 72.71 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.433 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -107.04 162.21 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.448 ' HB2' ' NH1' ' A' ' 102' ' ' ARG . 12.2 p -102.98 44.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 101' ' ' GLU . 0.1 OUTLIER -136.74 163.33 30.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.989 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 102' ' ' ARG . 80.2 t -139.78 133.71 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.652 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 119' ' ' ILE . . . -87.6 157.31 28.69 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.3 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.653 ' HA ' HG13 ' A' ' 66' ' ' ILE . 1.0 OUTLIER -135.28 167.98 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' H ' HG22 ' A' ' 119' ' ' ILE . 4.9 ttp180 -154.97 119.46 4.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.354 . . . . 0.0 111.417 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 121' ' ' VAL . 2.8 p -110.59 83.65 3.52 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.516 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.816 ' HB2' HG21 ' A' ' 33' ' ' THR . 72.8 Cg_endo -76.24 -178.86 4.73 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.632 2.221 . . . . 0.0 112.67 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.02 -4.88 51.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.714 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.4 OUTLIER -62.04 110.93 1.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.989 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.06 -46.54 82.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.672 HG23 HD22 ' A' ' 16' ' ' LEU . 38.0 mm -62.03 -54.88 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.969 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.714 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 98.5 m -60.2 -19.78 55.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -75.63 -43.65 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -72.67 -54.45 9.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.654 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.714 ' HB ' HD11 ' A' ' 16' ' ' LEU . 1.5 tt -57.44 -45.35 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.504 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.52 -25.11 62.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.58 -56.5 18.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.024 0.44 . . . . 0.0 110.125 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -75.91 -83.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.145 177.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 3.2 t80 -77.11 128.19 81.61 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.3 155.13 64.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.323 2.015 . . . . 0.0 111.603 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.21 157.35 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.337 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.604 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.42 138.8 36.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.82 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.02 109.12 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 111.605 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -131.8 127.29 36.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.789 178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.0 t -71.19 119.16 14.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 0.0 111.152 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -87.05 97.59 10.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -163.28 30.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.083 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 144' ' ' SER . 1.1 pp -80.8 -155.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.001 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.404 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.5 OUTLIER -57.84 152.27 16.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.024 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 89.1 -142.88 17.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.425 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.18 67.89 71.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.503 0.192 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.7 Cg_exo -60.49 -48.79 10.43 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.372 2.048 . . . . 0.0 113.517 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 65.6 Cg_endo -73.03 118.05 5.39 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.828 1.685 . . . . 0.0 112.378 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.45 143.77 26.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.817 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -96.0 -12.47 0.68 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.885 2.39 . . . . 0.0 112.863 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.59 122.45 27.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.31 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -59.97 -30.88 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.841 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.1 -29.18 60.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.124 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -67.43 -28.6 68.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 159' ' ' LEU . 46.5 mt -75.04 -50.73 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.485 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.34 -33.82 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.925 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -75.6 -58.4 3.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.756 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -65.51 -34.05 77.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.821 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.939 HD13 ' HB3' ' A' ' 163' ' ' ASP . 85.0 mt -106.33 68.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.331 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 8.5 t70 -16.34 -63.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.778 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.02 22.41 0.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.811 0.339 . . . . 0.0 111.121 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.65 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.77 -63.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.939 ' HB3' HD13 ' A' ' 159' ' ' LEU . 3.6 t70 -107.56 100.24 9.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.011 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.833 HD13 HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -71.61 124.7 25.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.601 -177.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.805 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.2 p -64.02 -166.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.805 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.62 160.04 30.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -92.01 -25.02 19.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.289 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.32 -55.85 3.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.456 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 101.18 -163.52 18.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.862 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.01 -165.97 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.672 0.272 . . . . 0.0 110.975 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.413 ' HB2' ' C ' ' A' ' 33' ' ' THR . 22.1 m -144.64 -60.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.628 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -124.35 -130.85 0.26 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.91 141.68 29.39 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.801 0.334 . . . . 0.0 111.465 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' THR . 0.2 OUTLIER -56.96 -36.78 70.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.036 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -142.6 158.79 59.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.73 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 64.4 Cg_endo -91.46 -147.73 0.27 Allowed 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.734 1.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 1.4 p -155.03 156.39 35.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.609 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.5 m -99.56 142.24 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.157 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.408 HG21 ' NH1' ' A' ' 192' ' ' ARG . 0.7 OUTLIER -129.0 89.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.771 HG23 ' HA ' ' A' ' 189' ' ' VAL . 12.2 mt -104.43 134.17 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -108.28 68.16 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.173 178.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.637 ' HB3' HG23 ' A' ' 98' ' ' VAL . 12.1 tp -69.75 87.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.358 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.28 -77.25 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.66 0.267 . . . . 0.0 110.808 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.56 -126.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.996 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.467 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.7 OUTLIER -63.8 -53.42 50.11 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.19 108.22 2.46 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.161 1.907 . . . . 0.0 112.356 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.1 Cg_endo -76.22 139.2 20.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.451 2.1 . . . . 0.0 112.075 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.2 OUTLIER -99.42 49.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 180' ' ' ILE . 8.9 t -56.87 98.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.45 85.95 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.024 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.568 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -83.68 154.77 23.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.951 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.408 ' NH1' HG21 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -84.47 48.07 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -83.92 61.93 4.66 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.459 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.14 32.83 0.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 110.946 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -73.72 -130.24 0.17 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.523 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.8 -54.66 1.44 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.555 2.17 . . . . 0.0 112.259 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.675 HD23 ' HD2' ' A' ' 199' ' ' PRO . 0.3 OUTLIER -153.94 157.89 39.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -51.62 6.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.425 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.675 ' HD2' HD23 ' A' ' 197' ' ' LEU . 50.7 Cg_exo -56.14 159.54 12.33 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.204 1.936 . . . . 0.0 112.254 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.52 147.19 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.09 37.28 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.22 -9.17 58.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.966 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.83 104.77 17.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.892 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -119.28 67.3 0.38 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.407 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -99.99 -40.52 7.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 111.106 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 81.01 -154.34 35.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -86.68 -12.86 47.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.037 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.774 0.321 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.92 178.6 6.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.03 149.6 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 mtp85 -103.06 165.02 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.962 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 157.88 16.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pt -75.1 -27.72 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.036 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -73.89 -166.48 0.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.16 -163.56 1.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -70.04 -71.13 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.033 -179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -110.02 92.99 13.98 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 9' ' ' LYS . 33.9 Cg_exo -59.97 -64.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.581 2.187 . . . . 0.0 112.282 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 t 55.75 73.3 0.87 Allowed Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.099 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HB2' HD23 ' A' ' 16' ' ' LEU . 39.0 Cg_exo -57.65 157.46 23.19 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.492 2.128 . . . . 0.0 112.293 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -70.0 -34.59 73.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.796 HG11 HD13 ' A' ' 126' ' ' ILE . 18.9 t -59.43 -53.64 45.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 20' ' ' ILE . 3.1 mm? -61.9 -35.98 79.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.407 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' ' 20' ' ' ILE . 2.8 mt-10 -57.72 -30.63 65.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.709 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -77.3 -32.89 55.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.286 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -71.15 -46.91 60.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.57 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -75.84 -17.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 111.067 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 13.0 t -66.12 -53.86 32.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 164' ' ' LEU . 9.7 p -69.78 -27.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 mtt -60.1 -37.15 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.09 -16.68 60.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.25 9.57 77.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.591 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.27 51.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.49 161.62 22.78 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.427 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.663 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.24 143.21 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.663 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.04 146.08 21.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.511 ' H ' HG13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -111.19 165.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 178.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -170.9 92.0 0.46 Allowed Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.815 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.9 Cg_endo -81.55 157.3 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.545 2.163 . . . . 0.0 111.127 176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.63 ' HA ' ' CB ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.35 -150.88 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.24 -20.81 45.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.246 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.74 -98.69 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.036 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.2 OUTLIER -131.47 -166.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.874 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.815 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.1 m-85 -72.68 131.12 41.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.781 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -117.2 178.59 17.16 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.136 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.731 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.5 mt -133.96 144.49 48.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.838 0.351 . . . . 0.0 110.831 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.17 131.48 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.292 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.564 HG11 HG12 ' A' ' 28' ' ' ILE . 1.1 m -156.53 163.35 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 111.193 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.5 m-20 -56.57 106.58 0.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.366 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.98 -41.95 84.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.877 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.53 18.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 111.378 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -110.62 146.77 35.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.24 -23.82 57.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.02 -26.77 68.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.21 -36.92 61.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -65.3 -43.64 95.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -70.05 -42.89 72.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.234 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -68.9 -29.39 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -67.59 -38.39 83.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.891 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -65.35 -37.73 87.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.936 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -61.69 -40.52 95.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.348 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.75 HG13 HG12 ' A' ' 143' ' ' ILE . 42.3 t -74.81 -57.92 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.288 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -81.89 -70.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.277 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.32 4.75 24.94 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.614 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -118.2 18.23 13.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.987 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p -134.53 66.13 69.15 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.2 -54.38 5.1 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.79 2.327 . . . . 0.0 112.454 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -122.39 24.48 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -88.29 149.72 45.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.001 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.13 169.1 14.24 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.506 2.138 . . . . 0.0 112.289 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG21 HG22 ' A' ' 110' ' ' ILE . 32.9 m -119.48 162.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.04 138.48 39.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.722 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.563 HG13 HG23 ' A' ' 119' ' ' ILE . 9.4 pt -116.01 165.95 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.011 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 41.9 t -122.06 130.45 53.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.941 HG21 HG23 ' A' ' 74' ' ' ILE . 1.4 p -138.34 -175.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.394 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.782 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 5.6 t -88.94 -45.85 9.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.841 0.353 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -164.49 168.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.831 179.416 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.608 HG11 ' HG3' ' A' ' 85' ' ' MET . 10.2 t -55.34 -35.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.631 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.63 -28.98 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.92 179.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 2.9 mp0 -75.23 -15.99 60.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.11 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.44 58.18 0.7 Allowed Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.934 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 77' ' ' PHE . 20.4 Cg_endo -60.02 -86.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.07 1.847 . . . . 0.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -73.32 22.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.347 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 75' ' ' PRO . 27.1 m-85 -96.99 -47.33 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 111.008 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.1 p -129.83 -175.0 3.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -118.25 99.84 51.72 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -102.69 -173.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.284 2.656 . . . . 0.0 112.508 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.768 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 2.4 m -141.93 176.87 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.61 -87.9 0.2 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.839 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -33.76 64.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -57.34 -46.57 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.608 ' HG3' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -75.02 -25.5 58.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.246 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -46.99 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 0.0 110.924 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.9 tp -66.41 -43.86 84.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.155 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.605 ' SD ' HD23 ' A' ' 182' ' ' LEU . 6.0 tpt -63.44 -57.42 10.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.529 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -63.2 -11.81 23.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.63 -178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 1.8 mtt180 -67.12 -32.79 74.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.26 60.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -131.2 149.28 73.23 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.19 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HG3' ' NH2' ' A' ' 128' ' ' ARG . 6.3 Cg_exo -78.54 -158.04 1.61 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.066 -1.222 . . . . 0.0 112.101 -1.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.24 162.08 11.31 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.829 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.25 46.5 2.21 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.847 2.365 . . . . 0.0 112.598 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -112.11 -179.53 3.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.066 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 m -115.27 145.62 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.685 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.04 91.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.373 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.698 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 16.7 t -87.28 122.56 39.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.756 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.446 HD12 HD12 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -126.67 175.91 7.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.591 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.08 158.87 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.218 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.564 ' CZ ' HG21 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -119.83 145.47 46.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.208 0.527 . . . . 0.0 111.184 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.84 174.93 8.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -76.66 60.23 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.22 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.467 HD12 ' NH1' ' A' ' 102' ' ' ARG . 1.6 mt -71.37 154.01 41.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.579 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.3 mt -76.32 -51.28 2.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.728 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 16.5 Cg_endo -57.04 101.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.234 1.956 . . . . 0.0 112.243 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.22 4.56 23.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -83.77 -17.63 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.031 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.706 HG22 HG21 ' A' ' 64' ' ' VAL . 1.1 pt -113.03 -29.03 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.163 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 107' ' ' PRO . 17.3 p -79.07 -35.43 42.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.881 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -169.2 46.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.634 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -70.47 -14.68 72.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 p -117.64 -179.97 3.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.342 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.0 t -107.36 61.86 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.3 mpp_? -141.2 141.5 34.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.564 HG21 ' CZ ' ' A' ' 102' ' ' ARG . 77.8 t -142.88 139.41 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.008 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.26 159.45 19.96 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.92 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.704 HD13 HD13 ' A' ' 74' ' ' ILE . 1.1 mt -141.22 173.47 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.602 ' H ' HG22 ' A' ' 119' ' ' ILE . 7.1 ptp180 -162.64 131.13 4.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.0 0.428 . . . . 0.0 111.682 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 65.7 t -110.97 86.82 6.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.514 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.4 -177.78 2.93 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.531 2.154 . . . . 0.0 112.423 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.42 8.97 25.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.068 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 0.5 OUTLIER -76.45 100.91 5.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -48.96 77.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.796 HD13 HG11 ' A' ' 15' ' ' VAL . 85.5 mt -57.84 -50.99 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -65.99 -18.34 65.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.714 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 69' ' ' SER . 3.8 ttt180 -75.2 -37.66 61.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.999 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -51.21 24.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 131' ' ' ALA . 2.0 tt -62.6 -43.69 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.257 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.775 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -68.06 -28.24 67.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.97 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.01 33.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.084 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -75.76 -87.61 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.266 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -77.21 128.93 79.5 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.207 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.21 144.03 32.76 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.337 2.025 . . . . 0.0 111.514 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.54 157.02 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 111.462 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.651 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 36.2 m -79.14 143.45 35.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.835 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -139.19 110.1 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 111.964 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.731 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -127.53 150.58 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.281 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.67 116.13 17.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.433 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.6 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . . . -88.17 81.27 7.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.04 33.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.75 HG12 HG13 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -80.85 -154.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.013 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.442 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.4 OUTLIER -56.73 153.52 10.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.837 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.43 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 89.95 -144.98 17.97 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.286 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -127.17 66.16 67.1 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.628 0.251 . . . . 0.0 111.23 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 40.0 Cg_exo -60.46 -49.28 9.32 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.374 2.049 . . . . 0.0 113.228 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 7.4 Cg_exo -73.46 106.23 2.14 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.096 1.864 . . . . 0.0 112.291 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.08 155.95 36.9 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -95.41 -14.52 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.769 2.312 . . . . 0.0 112.775 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.7 mmt180 -134.38 128.86 34.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.935 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.592 ' O ' HG11 ' A' ' 165' ' ' VAL . 5.7 mt -61.07 -45.46 94.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.066 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.97 -23.52 66.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.241 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.79 -31.19 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.169 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -75.49 -51.21 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.529 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.815 HG13 HG13 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -59.0 -25.5 29.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.416 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -75.08 -48.99 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.759 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.15 -21.77 58.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 163' ' ' ASP . 81.0 mt -111.23 68.05 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.03 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.5 t70 -16.26 -63.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.176 0.923 . . . . 0.0 112.724 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -159.26 23.11 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 111.235 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.643 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -80.88 -65.22 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.759 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 159' ' ' LEU . 47.5 t0 -111.37 102.34 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.575 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -74.49 131.15 40.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.573 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.815 HG13 HG13 ' A' ' 156' ' ' VAL . 17.1 m -65.33 -166.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.164 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.775 HD12 ' H ' ' A' ' 169' ' ' GLY . 0.4 OUTLIER -126.3 167.39 15.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.669 ' HB3' HG13 ' A' ' 15' ' ' VAL . 3.2 t70 -92.47 -39.87 11.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.595 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 126' ' ' ILE . . . -64.09 -70.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.305 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.775 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 89.37 51.26 2.98 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.837 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.63 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 3.7 m-20 -71.99 121.2 18.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.692 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.75 123.74 4.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.266 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -137.18 -113.85 0.17 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.448 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -85.38 127.53 34.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.791 0.329 . . . . 0.0 111.155 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.506 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.08 -1.64 10.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.122 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.72 157.34 36.08 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.692 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -92.64 -151.66 0.36 Allowed 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 124.1 -1.208 . . . . 0.0 112.737 1.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.8 p -156.91 115.1 3.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.1 m -102.31 143.58 31.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.906 0.384 . . . . 0.0 111.499 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 19.8 t -129.5 105.87 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.677 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.727 HG23 ' HA ' ' A' ' 189' ' ' VAL . 13.7 mt -114.31 131.18 67.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.438 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.72 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.6 m-20 -99.42 73.32 1.85 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.718 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.605 HD23 ' SD ' ' A' ' 88' ' ' MET . 0.2 OUTLIER -68.79 81.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.309 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.71 -86.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.321 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.49 -128.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -59.82 -51.03 83.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 72.6 Cg_endo -76.53 108.67 2.71 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.203 1.936 . . . . 0.0 112.504 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 83.8 Cg_endo -83.96 121.92 2.89 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.645 2.23 . . . . 0.0 112.257 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.72 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.6 mtm180 -89.35 54.38 2.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.128 0.489 . . . . 0.0 111.149 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.727 ' HA ' HG23 ' A' ' 180' ' ' ILE . 48.3 t -59.33 106.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.8 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.47 86.86 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -89.75 140.65 29.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -7.58 58.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.96 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -95.67 63.45 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.628 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -105.88 -48.67 3.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -79.33 -141.7 2.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.424 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.42 -176.32 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.688 2.259 . . . . 0.0 112.324 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.572 ' HB3' ' HD2' ' A' ' 199' ' ' PRO . 0.8 OUTLIER -145.1 169.46 18.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.444 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 4.1 t0 -73.91 -51.89 4.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.151 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 197' ' ' LEU . 17.6 Cg_exo -66.92 83.83 0.32 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.281 1.988 . . . . 0.0 111.993 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.736 HG13 HD23 ' A' ' 201' ' ' LEU . 1.4 p -71.06 -68.12 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.043 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.736 HD23 HG13 ' A' ' 200' ' ' VAL . 0.6 OUTLIER -106.9 16.27 24.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.498 . . . . 0.0 110.284 179.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.78 -25.56 65.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.906 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -83.18 126.99 33.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.925 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -125.98 -60.34 0.16 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.55 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -96.18 137.94 34.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.874 0.369 . . . . 0.0 111.13 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -124.34 -34.04 0.74 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.466 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.91 -21.08 13.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.843 0.354 . . . . 0.0 110.887 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.099 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.75 0.31 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.4 mt -88.77 -57.91 2.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.71 116.17 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.037 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -72.03 169.22 16.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -75.15 154.33 37.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -94.43 142.45 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -175.16 0.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.024 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.595 ' HD3' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -75.5 175.46 8.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.595 ' H ' ' HD3' ' A' ' 8' ' ' ARG . 27.6 mttt -81.17 132.65 35.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.72 141.37 75.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.13 -164.34 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.51 2.14 . . . . 0.0 112.191 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.73 112.52 9.81 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.006 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.605 ' HG2' HD23 ' A' ' 16' ' ' LEU . 44.2 Cg_endo -67.6 175.71 5.83 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.484 2.123 . . . . 0.0 112.052 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.714 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 1.7 m-20 -67.46 -28.12 67.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.87 -58.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.605 HD23 ' HG2' ' A' ' 13' ' ' PRO . 4.4 mm? -60.27 -42.48 95.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.834 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -56.27 -31.37 63.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.035 0.445 . . . . 0.0 110.485 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 5.1 mm-40 -76.29 -32.11 58.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.186 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 22' ' ' VAL . . . -75.64 -41.73 53.35 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.907 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 21' ' ' SER . 1.9 pp -71.7 -31.37 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 111.025 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.532 ' N ' HD12 ' A' ' 20' ' ' ILE . 5.7 p -75.18 -38.0 61.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.899 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.787 HG11 HD13 ' A' ' 164' ' ' LEU . 11.6 p -75.66 -29.39 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.083 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mtt -62.11 -42.7 99.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.634 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -4.97 26.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.813 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.74 1.76 78.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.553 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 51.69 37.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.812 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.17 165.24 22.57 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.427 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.5 148.9 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.839 0.352 . . . . 0.0 110.688 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.703 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -116.39 127.42 74.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.733 -179.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.504 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -102.71 151.6 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.656 0.265 . . . . 0.0 110.635 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.519 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -157.05 113.35 1.94 Allowed Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.63 134.26 5.48 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.721 2.281 . . . . 0.0 111.377 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.574 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -116.49 -149.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 111.191 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 11.7 m-20 -54.58 -22.08 12.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.194 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 36' ' ' ILE . 4.6 t -100.38 -121.82 0.16 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.75 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.52 -149.7 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.761 0.315 . . . . 0.0 111.454 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.476 ' OH ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -64.96 129.59 40.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.446 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.72 170.68 15.36 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.959 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HB2' ' O ' ' A' ' 139' ' ' THR . 1.6 mp -123.45 141.13 52.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.929 0.395 . . . . 0.0 111.263 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.34 111.5 0.58 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.696 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 42' ' ' ASN . 2.5 p -151.79 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.645 0.26 . . . . 0.0 111.213 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.601 ' H ' HG22 ' A' ' 41' ' ' VAL . 14.2 m120 -56.42 116.86 3.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 0.0 110.493 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.42 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.0 -56.02 27.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.988 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HA ' HD13 ' A' ' 44' ' ' LEU . 1.4 mm? -82.81 37.11 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.553 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -110.94 156.17 21.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 178.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -31.91 63.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.441 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.15 -28.15 68.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.518 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -72.25 -35.43 68.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.718 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.0 t -66.17 -48.28 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.446 ' HD3' HH11 ' A' ' 50' ' ' ARG . 11.2 mtt180 -63.73 -45.17 91.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.546 ' HG3' HG13 ' A' ' 28' ' ' ILE . 11.0 mmm180 -65.25 -30.67 71.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -66.59 -46.48 75.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.6 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.89 -18.08 63.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.091 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -73.24 -67.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.701 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG13 HG23 ' A' ' 143' ' ' ILE . 56.2 t -73.28 -41.16 57.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -80.08 -11.32 59.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.626 0.251 . . . . 0.0 111.292 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.4 -139.0 39.05 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.416 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.2 85.48 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.82 67.45 23.21 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.88 9.31 2.03 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 0.0 112.511 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -105.21 -26.31 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.28 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -88.12 128.8 52.31 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.287 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 35.7 Cg_exo -59.73 171.63 2.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.601 2.201 . . . . 0.0 112.023 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 110' ' ' ILE . 5.0 m -114.85 150.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.322 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -99.91 133.93 43.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.449 HD11 HG12 ' A' ' 119' ' ' ILE . 10.5 pt -113.94 172.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.505 ' SG ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m -122.07 129.37 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.908 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG21 HG23 ' A' ' 74' ' ' ILE . 1.8 p -136.0 179.06 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.707 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 30.3 t -86.18 -42.54 13.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.261 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.5 166.22 20.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.422 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG21 ' SD ' ' A' ' 85' ' ' MET . 26.8 t -57.68 -31.33 39.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.5 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 37.0 t70 -67.44 -27.59 67.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.812 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 0.6 OUTLIER -76.73 -21.04 55.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.119 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.809 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.34 58.79 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 34.7 Cg_endo -65.08 -74.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.007 1.804 . . . . 0.0 112.003 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.19 15.18 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.5 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 32.5 m-85 -100.52 -45.95 5.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 p -135.23 159.49 41.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.679 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.496 ' HG3' ' HB3' ' A' ' 101' ' ' GLU . 7.1 ptm180 -119.14 104.16 46.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.012 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HB3' HD22 ' A' ' 100' ' ' LEU . 85.5 Cg_endo -102.23 -166.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.14 2.56 . . . . 0.0 112.399 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 166.27 20.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.84 -73.47 0.68 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.586 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.636 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -55.33 -34.44 64.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.797 0.332 . . . . 0.0 110.912 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.47 ' HB1' HD21 ' A' ' 182' ' ' LEU . . . -64.01 -36.68 84.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.678 ' SD ' HG21 ' A' ' 71' ' ' VAL . 4.2 mmt -71.36 -17.99 62.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.095 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.636 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.6 mt-10 -71.58 -47.2 56.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.934 0.397 . . . . 0.0 110.573 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -58.23 -40.55 81.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.533 ' HG2' HG11 ' A' ' 98' ' ' VAL . 4.4 tpt -74.76 -46.12 39.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.507 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -56.83 -14.64 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.298 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -44.83 63.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.4 ' HB ' ' CE2' ' A' ' 96' ' ' TYR . 3.7 pt -108.81 53.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 6.3 tt -130.97 131.73 23.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.894 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 87.6 Cg_endo -78.08 -163.4 3.36 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.478 -0.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.62 167.11 16.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.95 37.22 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.748 2.299 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.4 ' CE2' ' HB ' ' A' ' 91' ' ' ILE . 0.3 OUTLIER -112.17 144.31 41.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.647 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 1.3 m -94.74 148.77 21.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.71 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.533 HG11 ' HG2' ' A' ' 88' ' ' MET . 2.1 t -126.49 102.51 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.24 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.834 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 2.8 t -93.55 120.1 42.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.73 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 80' ' ' PRO . 1.1 mp -126.99 -168.5 1.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.576 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -74.83 169.33 18.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.552 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.563 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.17 147.13 44.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 105' ' ' LEU . 22.1 p-10 -73.72 -152.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.314 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 31.87 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.47 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.738 HD13 ' HD2' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -69.53 94.85 0.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.725 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.603 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 6.1 mt -64.91 -50.79 61.0 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.71 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.738 ' HD2' HD13 ' A' ' 105' ' ' LEU . 76.5 Cg_exo -50.38 108.85 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.128 1.885 . . . . 0.0 112.316 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.22 -1.53 41.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.801 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.788 HG13 HG13 ' A' ' 110' ' ' ILE . 15.0 p -69.98 -21.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.788 HG13 HG13 ' A' ' 109' ' ' VAL . 5.1 mt -105.03 -52.25 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.037 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 m -68.2 -14.27 62.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.54 -154.75 40.58 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.471 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -87.62 6.25 83.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.362 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.9 169.93 9.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.769 0.318 . . . . 0.0 110.902 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -99.0 39.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -136.92 158.99 43.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.563 HG23 ' HB2' ' A' ' 102' ' ' ARG . 98.7 t -139.95 147.87 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.793 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.478 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -98.99 146.89 18.31 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.389 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.759 HD13 HD13 ' A' ' 74' ' ' ILE . 24.8 mt -148.26 134.98 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -144.58 146.52 32.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.962 0.41 . . . . 0.0 111.438 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 68' ' ' VAL . 1.7 m -110.22 96.82 27.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.788 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HB2' HG21 ' A' ' 33' ' ' THR . 50.6 Cg_endo -68.14 -179.28 2.12 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.501 2.134 . . . . 0.0 112.449 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 5.2 47.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.97 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.3 104.54 6.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.35 -49.01 77.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.194 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.493 HG23 HD21 ' A' ' 16' ' ' LEU . 30.6 mm -59.83 -48.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.1 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.53 -20.89 65.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 128' ' ' ARG . 0.3 OUTLIER -75.19 -27.36 59.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.987 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -74.31 -60.4 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.172 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 mt -58.27 -45.5 89.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.73 -28.25 69.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.006 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 129' ' ' ARG . . . -54.76 -53.4 55.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -75.28 -88.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.123 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -77.09 144.96 72.6 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.41 159.09 47.26 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.321 2.014 . . . . 0.0 111.603 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 t -133.65 150.25 31.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 111.526 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.614 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.3 m -80.9 140.47 35.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.824 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -132.7 107.13 8.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 111.494 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.12 122.24 22.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.905 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 110.54 5.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -79.79 104.69 10.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.017 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.84 27.3 0.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.083 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -81.37 -156.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.406 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 5.7 p -62.34 174.02 1.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 82.46 -139.26 19.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.445 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.34 72.18 77.09 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.578 0.227 . . . . 0.0 111.04 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.552 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 39.8 Cg_exo -60.16 -46.9 16.62 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.358 2.039 . . . . 0.0 113.322 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 28.4 Cg_endo -62.1 129.66 27.97 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.781 1.654 . . . . 0.0 111.976 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.468 ' HB3' HD11 ' A' ' 155' ' ' ILE . 8.6 p -85.86 121.91 72.99 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -95.11 -28.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.882 2.388 . . . . 0.0 112.297 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.79 131.85 18.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.338 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 152' ' ' LEU . 25.7 mt -59.95 -36.48 77.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.255 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -19.4 59.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.98 -44.83 79.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.08 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.851 HD12 HG23 ' A' ' 165' ' ' VAL . 11.6 mt -68.29 -44.1 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.17 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.96 -41.27 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.418 ' HD2' HH11 ' A' ' 157' ' ' ARG . 0.1 OUTLIER -75.38 -53.31 8.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.498 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.644 ' HB3' HD22 ' A' ' 159' ' ' LEU . 9.6 t70 -56.6 -39.85 74.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.496 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.644 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.6 mm? -111.37 77.01 1.01 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.934 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.43 -43.2 0.56 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.094 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.26 19.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 48.7 t -80.45 -97.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.768 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.529 ' OD1' ' HG ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -94.72 92.25 6.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.46 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.787 HD13 HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -55.57 135.13 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.026 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.851 HG23 HD12 ' A' ' 155' ' ' ILE . 0.7 OUTLIER -66.6 172.82 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.648 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.55 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -127.42 127.34 43.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.521 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.3 -7.95 46.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.746 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -64.08 -38.21 90.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.388 . . . . 0.0 110.655 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.498 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 102.25 166.67 26.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.084 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -152.6 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.55 0.214 . . . . 0.0 110.817 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.574 ' HB2' ' C ' ' A' ' 33' ' ' THR . 11.4 m -144.28 -63.22 0.37 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -130.47 -138.68 0.21 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.4 168.43 13.14 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.75 ' HG2' HG23 ' A' ' 36' ' ' ILE . 61.9 mtp -71.01 1.39 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.012 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.17 160.17 26.62 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.86 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 177' ' ' SER . 68.8 Cg_endo -97.02 -149.65 0.18 OUTLIER 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.281 -1.133 . . . . 0.0 112.737 1.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.436 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -153.77 120.45 5.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.484 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.8 m -99.73 137.21 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.935 0.398 . . . . 0.0 111.483 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.23 107.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.607 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.576 HG23 ' HA ' ' A' ' 189' ' ' VAL . 3.1 mt -119.14 132.95 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.64 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.834 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 9.2 m-20 -97.88 69.24 2.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.163 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 88' ' ' MET . 3.5 tt -69.44 87.27 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.408 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -81.76 0.15 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.493 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.5 -126.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.864 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.41 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -60.58 -52.63 71.35 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -179.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -77.27 108.39 2.6 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.237 1.958 . . . . 0.0 112.626 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 1.0 OUTLIER -84.07 132.45 5.39 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.017 2.478 . . . . 0.0 112.071 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.655 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 9.1 mmm180 -91.88 59.18 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 110.897 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.576 ' HA ' HG23 ' A' ' 180' ' ' ILE . 46.7 t -59.16 109.94 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.53 88.33 2.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.05 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.754 ' HG2' ' H ' ' A' ' 193' ' ' GLY . 5.6 ttt180 -90.94 127.77 36.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.819 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -82.7 3.75 27.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.024 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.754 ' H ' ' HG2' ' A' ' 191' ' ' ARG . . . -89.12 167.66 34.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.379 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -175.01 2.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -74.84 -171.8 28.48 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.48 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.68 84.26 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.501 2.134 . . . . 0.0 112.306 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.75 0.92 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.558 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 9.6 m-20 -79.44 -50.19 1.34 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.582 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 198' ' ' ASP . 36.7 Cg_endo -65.13 161.08 38.82 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.101 1.867 . . . . 0.0 112.357 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 201' ' ' LEU . 1.3 t -75.64 170.84 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.119 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.512 ' H ' HG12 ' A' ' 200' ' ' VAL . 0.1 OUTLIER -86.0 77.12 9.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.958 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.8 tp -90.02 -20.57 23.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 203' ' ' ARG . 3.6 mmm180 -91.75 -24.75 19.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.15 117.6 9.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.582 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -97.25 152.18 19.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.731 0.3 . . . . 0.0 111.047 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -176.07 -88.04 0.07 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.18 -30.17 13.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 110.837 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.116 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.786 0.327 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.86 -172.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.2 -11.82 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -97.05 106.54 18.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -167.34 1.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -99.82 139.56 21.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.994 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.43 ' N ' HG13 ' A' ' 6' ' ' ILE . 82.4 p -73.75 119.9 18.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.971 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -78.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 129.28 55.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.862 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -109.4 137.64 20.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.2 -175.52 2.01 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.467 2.111 . . . . 0.0 112.367 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.0 77.13 58.8 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.64 148.49 87.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.661 2.241 . . . . 0.0 112.139 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.08 -29.54 64.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.19 -31.77 25.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.92 -41.57 64.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.126 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 21' ' ' SER . 1.4 pt-20 -74.87 -19.02 60.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.3 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.0 -36.73 59.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.82 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 23' ' ' MET . . . -72.77 -40.84 65.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.592 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pp -75.47 -17.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -71.94 -46.34 57.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 164' ' ' LEU . 9.6 p -73.5 -27.78 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 15.2 mtt -59.76 -49.42 77.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.113 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.67 -12.96 61.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.57 1.03 89.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.503 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.14 44.26 87.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.9 170.43 19.38 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.362 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.45 143.84 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.722 0.296 . . . . 0.0 110.428 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.681 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.63 140.03 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.701 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.578 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -105.46 165.74 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.445 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.2 103.32 0.31 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.779 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 83.3 Cg_endo -82.69 135.72 8.05 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.6 2.2 . . . . 0.0 111.744 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.545 HG21 ' HB3' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -120.21 -155.49 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.804 0.335 . . . . 0.0 111.414 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.8 OUTLIER -54.72 -21.17 10.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.369 -179.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -98.42 -117.92 0.14 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.848 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.3 OUTLIER -112.6 -169.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.723 0.297 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -64.37 131.38 47.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.714 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -123.11 176.47 16.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.482 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.4 mt -133.32 142.99 48.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.741 0.305 . . . . 0.0 110.839 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.665 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.5 134.69 5.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.059 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.664 HG22 ' NH1' ' A' ' 51' ' ' ARG . 3.9 m -152.69 168.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.772 0.32 . . . . 0.0 110.947 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.773 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -56.61 105.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.259 178.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.12 75.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.278 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -79.89 22.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.87 -177.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.773 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.25 161.71 15.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.72 178.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.01 -25.18 58.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 110.426 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 6.5 m-20 -60.59 -28.82 68.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.806 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.09 -27.16 59.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.92 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.686 HG13 HG21 ' A' ' 109' ' ' VAL . 46.2 t -65.66 -54.4 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -71.33 -22.19 61.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.688 ' NH2' HG22 ' A' ' 139' ' ' THR . 0.0 OUTLIER -68.01 -34.48 76.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.997 0.427 . . . . 0.0 110.754 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.571 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.8 OUTLIER -74.96 -44.44 48.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.391 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -64.52 -34.53 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.181 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -66.41 -61.54 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.439 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.888 HG13 HG12 ' A' ' 143' ' ' ILE . 39.5 t -63.76 -51.12 73.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.589 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -79.86 -70.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.454 -178.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.93 -11.7 0.62 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.08 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 56' ' ' LYS . 2.6 ptp180 -118.4 40.19 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 0.0 110.784 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 p -141.72 63.75 17.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.44 -66.85 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.652 2.235 . . . . 0.0 112.591 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.719 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 53.3 m80 -108.59 24.44 13.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HG2' ' HD2' ' A' ' 63' ' ' PRO . 2.1 mttt -88.41 147.48 40.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.16 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HD2' ' HG2' ' A' ' 62' ' ' LYS . 62.0 Cg_endo -73.8 161.26 41.99 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.591 2.194 . . . . 0.0 112.269 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 110' ' ' ILE . 3.8 p -114.05 151.53 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.864 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.8 t -94.16 134.22 36.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.214 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -116.24 172.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.796 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 20.7 t -119.96 136.88 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.768 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -135.86 -179.57 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.639 ' H ' HG22 ' A' ' 68' ' ' VAL . 1.2 t -76.09 -49.67 16.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.155 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.579 ' SG ' HD21 ' A' ' 92' ' ' LEU . 1.2 m -163.93 179.86 6.74 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.143 0.497 . . . . 0.0 111.664 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.712 ' HA ' HD11 ' A' ' 74' ' ' ILE . 60.9 t -52.44 -41.29 35.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.111 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -69.57 -27.82 65.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.905 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.85 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 1.4 tp10 -80.99 -8.22 59.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.712 HD11 ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -90.86 -38.56 0.39 Allowed Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.668 ' HG3' ' HG3' ' A' ' 80' ' ' PRO . 99.8 Cg_exo -44.03 -23.3 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.561 2.174 . . . . 0.0 113.491 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -55.22 -59.33 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.691 0.281 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -107.51 3.89 25.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -118.05 179.7 4.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HG2' HD22 ' A' ' 103' ' ' ASN . 0.0 OUTLIER -131.5 94.44 26.26 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.11 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.668 ' HG3' ' HG3' ' A' ' 75' ' ' PRO . 68.3 Cg_endo -102.49 -166.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.2 2.6 . . . . 0.0 112.687 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 177.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.15 -83.28 0.41 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.769 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.93 -33.25 62.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.842 0.353 . . . . 0.0 111.152 -179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -60.41 -49.36 77.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.44 ' CE ' HD11 ' A' ' 100' ' ' LEU . 17.7 mmt -71.94 -14.91 62.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.255 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.0 mm-40 -66.59 -46.68 75.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 2.4 tm? -61.35 -38.4 86.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.201 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.476 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 5.9 tpt -66.29 -43.11 87.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.27 -16.58 60.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -69.95 -39.69 75.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.058 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.3 pt -115.12 51.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.648 HD13 HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -131.36 134.65 25.93 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.993 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.28 -162.34 2.95 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.277 -1.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.93 166.78 15.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.562 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.9 Cg_endo -81.29 41.72 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.742 2.295 . . . . 0.0 112.482 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.2 m-85 -111.31 156.21 21.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.819 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 59.2 m -94.93 135.62 36.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.355 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.434 ' O ' ' HB ' ' A' ' 119' ' ' ILE . 6.5 t -122.49 98.94 6.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.292 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.797 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 18.9 t -95.48 128.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.623 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.44 HD11 ' CE ' ' A' ' 85' ' ' MET . 2.3 mm? -126.96 -178.6 4.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.99 -178.73 3.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.325 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.546 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.18 137.7 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.956 0.408 . . . . 0.0 111.322 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.582 HD22 ' HG2' ' A' ' 79' ' ' ARG . 2.5 t-20 -74.25 -168.19 0.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.902 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 37.56 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.474 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.877 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 1.6 tp -72.11 132.25 43.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.83 0.347 . . . . 0.0 111.075 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.58 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 19.9 mm -73.33 -50.6 6.22 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.665 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.877 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 72.8 Cg_exo -49.77 109.99 0.33 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.241 1.961 . . . . 0.0 112.353 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -82.09 -17.79 45.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.125 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.686 HG21 HG13 ' A' ' 49' ' ' VAL . 14.8 p -69.18 -22.6 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.247 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.524 ' O ' HG12 ' A' ' 64' ' ' VAL . 45.0 mt -93.88 -43.58 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.025 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.691 ' HA ' HG22 ' A' ' 117' ' ' VAL . 22.1 p -81.28 -6.52 58.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.05 -169.8 50.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 61' ' ' HIS . . . -78.23 -1.5 80.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.365 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.48 -172.75 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 111.017 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 3.4 p -106.22 39.51 1.79 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.089 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -136.77 153.1 50.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.047 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 111' ' ' THR . 93.8 t -139.81 144.53 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.468 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.491 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -91.32 155.55 23.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.385 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 118' ' ' GLY . 3.8 mt -143.94 151.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.592 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.3 ttt180 -144.67 126.79 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 0.0 110.907 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.41 HG11 HD11 ' A' ' 92' ' ' LEU . 9.8 t -111.14 78.3 1.71 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 15.2 Cg_exo -69.71 -176.32 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.55 6.48 45.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.83 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.6 100.2 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.1 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -57.47 -45.71 84.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.032 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.9 mt -62.25 -53.97 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.185 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -24.01 62.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 1.7 ttm105 -68.95 -36.49 77.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -54.57 12.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.5 mt -60.47 -49.47 84.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.768 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.29 -28.91 68.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.85 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.68 -56.7 16.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.35 -89.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.971 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -76.69 127.57 83.89 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.095 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.63 153.8 72.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.28 1.987 . . . . 0.0 111.628 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.03 155.82 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.119 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.665 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.7 OUTLIER -80.56 139.5 36.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.031 178.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -143.24 111.52 6.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.789 0.328 . . . . 0.0 111.882 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.688 HG22 ' NH2' ' A' ' 51' ' ' ARG . 2.1 t -140.24 138.15 34.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.545 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 15.0 p -70.6 126.78 30.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.338 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 39' ' ' LEU . . . -88.04 94.21 9.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -154.7 26.64 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.949 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.888 HG12 HG13 ' A' ' 55' ' ' VAL . 1.1 pp -79.12 -155.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.03 162.14 2.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.199 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.438 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 82.62 -144.78 23.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.319 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -127.34 66.45 68.81 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.588 0.233 . . . . 0.0 111.058 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.523 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 46.2 Cg_exo -60.42 -46.63 17.01 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.376 2.05 . . . . 0.0 113.474 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 40.6 Cg_endo -67.15 106.49 1.19 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.845 1.697 . . . . 0.0 112.327 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.09 136.5 21.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.517 ' HG2' ' HG2' ' A' ' 151' ' ' ARG . 69.3 Cg_endo -95.71 -12.25 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.865 2.377 . . . . 0.0 112.445 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -128.29 112.34 14.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.777 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -56.49 -32.6 65.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.219 -179.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.98 -24.88 58.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.287 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 2.2 tt0 -72.51 -31.01 65.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.509 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.707 HG22 HD12 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -75.22 -51.32 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.313 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.03 -36.32 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.54 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 157' ' ' ARG . 5.4 mmt85 -72.73 -51.15 20.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.338 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.18 -24.57 64.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.433 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.707 HD12 HG22 ' A' ' 155' ' ' ILE . 40.5 mt -111.22 79.46 1.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.143 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 159' ' ' LEU . 4.2 t70 -28.15 -51.2 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.223 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -161.65 26.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.74 -92.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.535 ' OD1' HD13 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -89.95 88.51 7.34 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 120.861 0.362 . . . . 0.0 110.613 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.795 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -56.26 129.39 40.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.388 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.552 HG12 HD12 ' A' ' 155' ' ' ILE . 35.4 m -66.37 -172.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.21 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.78 156.25 41.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -92.62 -19.6 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.4 -50.74 7.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.121 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 94.11 -157.02 22.52 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.909 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.07 -163.26 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.623 0.249 . . . . 0.0 111.105 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.8 m -150.18 -60.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -123.57 -130.19 0.26 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.6 OUTLIER -86.31 144.77 27.21 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.818 0.342 . . . . 0.0 111.82 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.848 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.6 ttp -68.79 -15.71 63.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.959 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -154.51 160.83 30.53 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.72 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 175' ' ' GLU . 70.2 Cg_endo -89.43 -142.41 0.16 OUTLIER 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.548 0.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 73.1 m -153.88 131.86 11.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.834 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.691 HG23 ' HB3' ' A' ' 191' ' ' ARG . 75.9 m -102.33 142.13 34.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.206 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.819 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 19.2 t -129.08 110.4 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.006 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.738 HG23 ' HA ' ' A' ' 189' ' ' VAL . 5.4 mt -120.69 125.08 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.182 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.797 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -102.32 66.26 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 84' ' ' ALA . 21.7 tp -69.58 83.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.527 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -80.42 0.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.447 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 185' ' ' ASN . 4.2 t -120.73 -121.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.166 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.454 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -62.66 -52.86 61.7 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.1 109.61 2.73 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.208 1.938 . . . . 0.0 112.445 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 189' ' ' VAL . 93.9 Cg_endo -80.45 127.83 6.73 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.615 2.21 . . . . 0.0 112.329 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -88.39 45.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.738 ' HA ' HG23 ' A' ' 180' ' ' ILE . 9.1 t -56.87 96.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.791 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.24 84.7 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.149 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.691 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -86.02 140.02 30.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.006 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 192' ' ' ARG . 1.2 mtt85 -67.8 91.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.823 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -94.91 72.79 1.01 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -14.34 18.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.714 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -75.87 -67.9 1.63 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.39 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.11 -167.29 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.438 2.092 . . . . 0.0 112.202 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.2 tp -137.48 -73.7 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -78.89 120.54 81.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.92 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.29 -37.56 7.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.511 2.141 . . . . 0.0 112.336 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.6 m -70.33 160.59 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -114.35 104.6 12.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.56 -177.58 3.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -85.06 -38.66 18.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.21 173.31 50.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.493 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -104.43 -33.19 8.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.735 0.302 . . . . 0.0 111.069 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 175.54 67.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.554 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -108.07 10.48 28.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.719 0.295 . . . . 0.0 110.992 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.999 -179.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.769 0.319 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.78 178.02 4.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 4' ' ' ARG . 7.1 tp -76.84 149.44 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.976 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.463 ' N ' HG13 ' A' ' 3' ' ' ILE . 5.9 mtm-85 -107.06 168.59 9.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 169.54 14.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.2 pt -84.9 -28.67 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.6 p -69.63 118.57 12.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.08 -49.64 5.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.93 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.11 159.89 24.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.59 124.61 81.91 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.24 175.4 10.99 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.479 2.12 . . . . 0.0 112.41 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.53 99.67 42.2 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' CG ' HD23 ' A' ' 16' ' ' LEU . 51.4 Cg_exo -55.21 168.68 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.587 2.192 . . . . 0.0 112.329 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -35.74 79.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.147 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 t -66.27 -53.21 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.167 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.3 mm? -60.06 -32.62 71.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.623 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 -33.98 67.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.788 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -36.6 68.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.34 -42.8 53.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -66.97 -30.14 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.114 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.8 p -66.5 -44.49 82.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.061 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 18' ' ' GLU . 35.7 t -65.32 -29.45 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.5 mmt -62.7 -44.6 95.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -17.74 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.981 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.86 89.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.98 39.78 93.29 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.51 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.84 171.93 15.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.42 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.7 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -96.17 140.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.61 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.646 ' H ' HG13 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -116.55 130.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.197 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -101.68 168.89 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.574 0.226 . . . . 0.0 110.756 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -169.48 102.4 0.47 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.669 -179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.413 ' HG2' ' HA ' ' A' ' 170' ' ' ASP . 89.3 Cg_endo -83.06 143.74 11.6 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.544 2.163 . . . . 0.0 111.888 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.43 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 0.2 OUTLIER -123.16 -160.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.732 ' HB3' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -66.83 -25.35 66.4 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.133 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.78 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -88.7 -89.9 0.14 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.257 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' H ' HG23 ' A' ' 35' ' ' THR . 1.3 tt -133.68 174.99 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 111.06 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.631 ' HE1' ' HB ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -68.21 143.16 55.43 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -134.82 177.13 19.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.745 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.769 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.0 mt -125.55 144.38 50.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.87 0.367 . . . . 0.0 110.553 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.57 125.59 2.35 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.024 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.646 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -156.58 178.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 111.105 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.43 122.73 12.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.317 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.84 -60.67 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.05 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' HD13 ' A' ' 44' ' ' LEU . 2.4 mm? -81.07 37.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.1 149.76 30.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -75.14 -18.59 60.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -26.64 62.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.667 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -74.71 -44.55 49.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.997 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.58 -35.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -38.87 78.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.671 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.584 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.3 -45.18 70.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.781 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.639 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.3 OUTLIER -60.83 -25.83 66.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.784 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -72.88 -34.82 66.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.747 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -75.27 -49.81 18.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.358 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 140' ' ' SER . 70.9 t -65.27 -49.85 76.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.588 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.602 ' HE2' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -79.75 -6.38 57.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.778 0.323 . . . . 0.0 111.18 -179.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.43 -92.05 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.64 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.404 ' HG3' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -102.86 116.05 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 111.129 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.466 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 60.8 p -155.11 57.44 1.65 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.09 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 59' ' ' SER . 50.7 Cg_exo -54.11 -57.18 1.98 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.411 2.074 . . . . 0.0 112.285 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.06 30.32 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HD3' ' HE2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -87.54 135.77 33.86 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.826 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.92 160.79 45.34 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 112.293 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 110' ' ' ILE . 9.3 m -118.75 162.51 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.4 t -110.6 141.15 44.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.97 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.503 HG13 HG12 ' A' ' 119' ' ' ILE . 5.9 pt -116.49 167.34 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.01 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.701 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -119.78 135.7 54.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.874 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -141.53 -178.11 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.634 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 68' ' ' VAL . 21.6 t -89.71 -41.86 11.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.564 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.18 170.69 16.02 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 t -57.52 -37.63 59.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -67.41 -21.89 65.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.159 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -77.15 -26.27 52.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.089 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.874 HG23 HG21 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -113.48 58.81 0.74 Allowed Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 21.5 Cg_endo -60.49 -84.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.066 1.844 . . . . 0.0 111.965 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.57 23.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.389 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 26.0 m-85 -98.9 -31.78 11.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.673 0.273 . . . . 0.0 111.228 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -135.08 178.31 7.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.083 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -113.23 90.21 16.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.845 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 78' ' ' SER . 69.2 Cg_endo -102.23 176.39 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.049 2.499 . . . . 0.0 112.645 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -177.31 4.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.046 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.03 -75.23 0.74 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.516 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.461 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -59.19 -29.95 67.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.821 0.343 . . . . 0.0 110.856 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -61.74 -47.34 85.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.409 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 9.5 mmt -74.21 -18.63 60.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.161 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.4 mm-40 -63.01 -45.18 93.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.879 0.371 . . . . 0.0 110.524 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -67.6 -38.32 83.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.586 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.611 ' HG2' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -62.92 -58.24 8.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.306 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -4.0 16.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.321 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -56.33 4.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.048 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.45 71.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.583 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.606 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.35 151.76 79.36 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.997 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.648 ' HB3' HG22 ' A' ' 121' ' ' VAL . 5.5 Cg_exo -78.36 -148.45 0.5 Allowed 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.175 -0.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.67 163.6 12.55 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.723 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.78 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 92.8 Cg_endo -81.6 35.2 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.756 2.304 . . . . 0.0 112.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.742 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 44.9 p90 -112.26 162.86 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.411 HG23 ' HB3' ' A' ' 120' ' ' ARG . 7.8 m -115.23 124.86 52.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.428 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 182' ' ' LEU . 2.4 p -108.31 109.01 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.131 0.491 . . . . 0.0 110.982 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 44.7 t -103.72 128.61 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.147 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -126.59 -165.87 1.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.308 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.69 -176.05 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.628 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.736 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.7 143.33 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.994 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -74.73 -170.23 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.216 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -76.49 55.2 0.99 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.207 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.778 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 24.1 tp -88.79 129.63 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.632 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 11.4 mm -72.02 -52.47 7.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.778 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 75.6 Cg_exo -50.88 100.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.304 2.003 . . . . 0.0 112.536 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.445 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -82.04 1.08 37.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.8 -26.25 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.097 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.704 HG22 HG21 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -107.48 -29.51 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 108' ' ' ASP . 19.8 p -78.76 -18.08 54.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.937 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.13 -169.21 54.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.375 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.08 -8.39 83.08 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.401 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.2 p -114.68 -175.46 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.524 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 74.8 m -111.63 62.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -143.22 138.21 29.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' ' 102' ' ' ARG . 97.8 t -139.94 140.28 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.356 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -99.35 157.08 19.95 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.643 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.508 HD13 HD13 ' A' ' 74' ' ' ILE . 27.8 mt -146.23 151.74 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HB3' HG23 ' A' ' 97' ' ' THR . 0.4 OUTLIER -146.39 137.71 24.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.459 -179.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 93' ' ' PRO . 2.7 p -110.6 87.72 6.88 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.39 -179.74 3.42 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.411 2.074 . . . . 0.0 112.628 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.29 -4.49 57.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.975 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 7.1 m-20 -62.33 103.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.21 -45.98 83.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.48 -50.8 78.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -63.56 -20.93 66.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.653 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 128' ' ' ARG . 1.7 ttp180 -74.98 -27.21 60.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.05 -60.6 2.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.9 mt -57.79 -48.15 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.178 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.826 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.09 -29.87 70.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.358 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.6 -54.92 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.951 0.405 . . . . 0.0 110.028 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -75.92 -89.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.26 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -77.04 141.07 67.03 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.074 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.09 153.77 46.83 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.303 2.002 . . . . 0.0 111.577 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.98 156.04 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 111.258 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.691 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.7 m -80.38 129.97 34.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.027 178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.701 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . . . -128.53 102.9 6.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.846 0.355 . . . . 0.0 111.856 -178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.769 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -130.28 141.76 50.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' HG11 ' A' ' 55' ' ' VAL . 1.4 p -61.72 125.52 24.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . -70.61 123.97 23.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 111.373 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 147' ' ' PRO . 0.7 OUTLIER -153.06 58.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.658 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.485 HD13 HG22 ' A' ' 55' ' ' VAL . 1.6 mm -70.67 168.94 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.898 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.465 ' H ' HG22 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -60.57 143.84 52.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.661 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.31 -119.4 5.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -125.83 91.04 49.2 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.675 0.274 . . . . 0.0 111.145 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 33.4 Cg_exo -60.52 -48.53 11.07 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.435 2.09 . . . . 0.0 113.246 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 21.6 Cg_exo -65.24 100.22 0.37 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.008 1.805 . . . . 0.0 112.112 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.21 149.25 40.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.994 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -95.37 -18.03 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.858 2.372 . . . . 0.0 112.433 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -136.94 130.34 31.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.524 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.652 ' O ' HG23 ' A' ' 156' ' ' VAL . 9.2 tp -56.78 -41.92 78.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.139 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.43 -38.01 88.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -58.66 -49.21 78.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -61.16 -39.32 82.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.079 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 152' ' ' LEU . 57.7 t -52.46 -37.66 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.728 0.299 . . . . 0.0 111.399 -177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.39 86.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.495 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.85 -22.69 55.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.158 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 163' ' ' ASP . 2.0 pp -108.65 43.83 1.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -16.8 -58.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.342 0.657 . . . . 0.0 112.535 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.38 10.06 0.43 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.757 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -80.87 -82.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.247 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.757 ' H ' HG13 ' A' ' 162' ' ' VAL . 2.0 p-10 -100.51 92.7 5.26 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.796 0.331 . . . . 0.0 110.783 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.532 ' HA ' HD13 ' A' ' 159' ' ' LEU . 0.6 OUTLIER -65.42 130.7 44.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.736 -178.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.617 HG12 HD12 ' A' ' 155' ' ' ILE . 27.0 m -59.98 -171.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.26 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.92 HD23 ' H ' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -126.76 156.05 41.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.963 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.51 -7.81 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.609 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.58 -40.12 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.892 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.92 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 89.88 -178.82 43.95 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.484 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 14.7 p-10 -70.73 -159.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.515 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 39.6 m -136.78 -59.66 0.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.262 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.732 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -135.85 -116.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.387 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.474 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 58.4 m-20 -86.13 150.63 24.29 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.877 0.37 . . . . 0.0 111.561 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -15.07 62.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.384 178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 176' ' ' PRO . 6.2 pt-20 -153.07 160.6 30.75 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.668 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 177' ' ' SER . 66.0 Cg_endo -95.27 -139.56 0.13 OUTLIER 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.249 -1.146 . . . . 0.0 112.648 0.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 7.6 t -154.01 146.54 24.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.742 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 69.5 m -101.19 142.96 31.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.122 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.11 97.1 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.714 HG12 ' HA ' ' A' ' 189' ' ' VAL . 25.3 mt -109.94 131.58 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.211 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.637 ' HB3' ' HE ' ' A' ' 188' ' ' ARG . 0.2 OUTLIER -108.43 65.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.004 0.43 . . . . 0.0 110.571 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.76 ' HB3' HG23 ' A' ' 98' ' ' VAL . 19.0 tp -69.29 89.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.31 -78.41 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 0.0 110.858 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.02 -128.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 2.1 t-20 -59.68 -52.23 75.43 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.0 Cg_exo -76.92 108.9 2.74 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.497 2.131 . . . . 0.0 112.329 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 94.1 Cg_endo -80.72 134.23 9.64 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.519 2.146 . . . . 0.0 112.037 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.637 ' HE ' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -96.31 45.91 1.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.274 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.714 ' HA ' HG12 ' A' ' 180' ' ' ILE . 20.2 t -56.63 103.81 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.538 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.21 93.26 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.452 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -85.07 149.54 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.769 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.03 47.51 1.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.038 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.19 162.47 46.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.426 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -98.06 -77.73 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.752 0.31 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -89.97 -162.02 37.97 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.485 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.458 ' HG2' HD23 ' A' ' 197' ' ' LEU . 49.7 Cg_endo -68.59 -43.3 4.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.583 2.189 . . . . 0.0 112.346 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.458 HD23 ' HG2' ' A' ' 196' ' ' PRO . 0.9 OUTLIER -151.24 171.22 17.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 7.4 p-10 -64.51 130.64 94.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.929 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 51.6 Cg_exo -54.63 106.24 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.513 2.142 . . . . 0.0 112.202 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 14.5 t -57.75 115.88 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.065 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.72 53.87 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.9 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -33.63 75.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.886 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.42 -11.66 34.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.78 18.46 20.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -80.91 -179.05 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.062 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 127.06 124.75 2.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.594 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -109.63 17.12 21.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.744 0.307 . . . . 0.0 110.866 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.098 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mmt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.834 0.35 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.21 -177.09 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.989 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mt -102.39 141.07 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.082 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.1 -170.76 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -87.48 156.19 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.897 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 tt -98.3 143.47 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.11 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -72.87 -177.25 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.969 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.539 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -73.06 149.28 43.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.055 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 -67.84 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.642 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 15.1 m120 -81.96 -51.08 0.82 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.454 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 10' ' ' ASN . 46.0 Cg_exo -56.52 125.02 17.67 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.192 1.928 . . . . 0.0 112.174 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.1 p -155.83 148.84 18.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.968 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HG2' HD23 ' A' ' 16' ' ' LEU . 53.0 Cg_exo -55.96 166.66 2.86 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.558 2.172 . . . . 0.0 112.215 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -69.81 -42.45 73.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.028 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -67.75 -25.22 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -70.98 -52.21 21.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.086 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.637 ' HA ' HD12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -69.19 -14.53 63.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.564 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.25 -34.72 59.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.564 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -75.12 -42.98 55.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.776 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -75.55 -20.22 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.734 0.302 . . . . 0.0 111.274 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.423 ' N ' HD13 ' A' ' 20' ' ' ILE . 46.0 t -70.35 -48.5 56.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 164' ' ' LEU . 11.3 p -69.52 -28.16 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.128 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 21.9 mtt -62.47 -38.57 90.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.064 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -70.29 -20.54 63.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.112 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.82 5.05 62.91 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.648 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.29 38.92 94.13 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.91 168.51 15.17 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.504 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.718 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.45 148.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.434 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.718 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -119.1 146.94 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -114.78 164.85 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.272 178.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.518 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -172.91 103.42 0.32 Allowed Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.79 137.03 12.38 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.769 2.312 . . . . 0.0 111.408 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.75 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -116.82 -151.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.738 0.304 . . . . 0.0 111.161 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -54.87 -20.95 9.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.606 -179.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.82 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -100.1 -114.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.126 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.85 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.0 OUTLIER -112.55 -163.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.353 . . . . 0.0 110.995 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.86 131.38 47.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.586 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.88 174.68 15.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.067 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HB2' HG23 ' A' ' 139' ' ' THR . 2.5 mt -133.25 138.52 46.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.821 0.343 . . . . 0.0 111.132 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.1 121.16 1.48 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.836 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 136' ' ' VAL . 5.3 p -159.76 163.97 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.712 0.292 . . . . 0.0 111.221 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.718 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -55.25 102.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.01 0.434 . . . . 0.0 110.944 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.74 81.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.938 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.561 HD21 ' HZ ' ' A' ' 77' ' ' PHE . 4.3 mm? -76.26 12.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.977 0.418 . . . . 0.0 111.306 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -110.46 150.46 28.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -19.53 60.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.77 -30.0 70.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.1 -22.89 57.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.22 -54.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.175 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -63.88 -40.25 96.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 8.2 mmt180 -64.18 -38.86 92.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.779 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -68.16 -18.4 64.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.798 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -36.76 62.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.597 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.2 -40.69 90.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 144' ' ' SER . 37.7 t -73.89 -52.96 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -79.38 -76.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.902 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.57 17.27 32.9 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.697 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -68.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.349 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB3' ' NE2' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -136.78 76.26 47.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.852 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.11 27.21 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 0.0 112.597 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' ' 59' ' ' SER . 23.7 p80 -105.28 -21.91 13.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.958 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -73.33 154.3 90.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.973 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 116' ' ' ARG . 75.6 Cg_exo -50.62 154.88 5.96 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.597 2.198 . . . . 0.0 112.46 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.635 HG21 HG22 ' A' ' 110' ' ' ILE . 4.3 m -114.54 151.31 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.193 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.2 t -96.48 136.61 36.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.689 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 14.4 pt -116.27 172.67 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.27 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 12.5 t -117.87 135.57 54.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.974 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.754 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.1 p -146.24 174.19 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.604 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.593 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -79.47 -47.63 15.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.992 0.425 . . . . 0.0 110.462 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.17 176.3 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.449 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.586 HG11 ' HG3' ' A' ' 85' ' ' MET . 2.8 t -59.13 -33.74 51.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.764 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -67.54 -27.65 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.156 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.664 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 1.2 mp0 -80.43 -17.21 52.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.217 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.685 HG13 ' HB3' ' A' ' 77' ' ' PHE . 21.5 tt -114.65 50.71 0.59 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.664 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 37.4 Cg_exo -59.07 -84.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.046 1.83 . . . . 0.0 113.182 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.42 12.27 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.156 -177.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.685 ' HB3' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -107.77 -17.03 14.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.969 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.656 ' HB2' HG12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.5 177.22 7.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.889 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 12.4 mtp180 -129.81 85.43 58.05 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.691 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -101.96 -175.29 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.059 2.506 . . . . 0.0 112.853 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 85' ' ' MET . 1.3 m -140.4 179.9 6.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.878 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.25 -74.0 0.92 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.39 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.047 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.586 ' HG3' HG11 ' A' ' 71' ' ' VAL . 9.6 mmt -70.64 -16.32 62.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.169 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 41.3 mm-40 -64.89 -50.47 66.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.595 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.94 -35.98 80.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.6 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 182' ' ' LEU . 36.3 mmm -65.6 -45.43 83.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.279 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.94 -16.89 62.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 111.117 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -39.1 63.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.708 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.38 40.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.798 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 93' ' ' PRO . 4.8 tt -129.54 137.91 31.97 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.912 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.67 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 96.8 Cg_endo -78.45 -161.66 2.76 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.351 -0.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.98 167.06 16.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.928 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.82 ' HB2' HG23 ' A' ' 35' ' ' THR . 92.2 Cg_endo -79.85 44.35 1.7 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.919 2.412 . . . . 0.0 112.359 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 10.6 p90 -112.19 141.24 46.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.218 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.9 m -102.55 112.51 25.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.094 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 180' ' ' ILE . 3.5 p -108.39 123.98 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.073 0.463 . . . . 0.0 111.672 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 21.3 t -102.45 129.42 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.941 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.64 ' HG ' ' H ' ' A' ' 101' ' ' GLU . 0.8 OUTLIER -126.88 177.17 6.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.802 -178.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.64 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 10.0 mt-10 -74.09 172.94 10.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.337 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.672 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -119.71 143.56 47.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.958 0.409 . . . . 0.0 111.477 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.475 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.13 -164.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.481 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.39 56.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.518 HD22 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -74.15 136.2 42.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.61 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.6 mt -80.16 -51.39 1.09 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.457 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 40.4 Cg_exo -57.75 103.35 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.328 2.019 . . . . 0.0 112.418 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.78 25.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 109' ' ' VAL . 2.2 m -76.21 -17.39 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.635 HG22 HG21 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -113.2 -32.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.104 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 107' ' ' PRO . 5.7 p -74.41 -26.79 60.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.5 -163.56 54.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.61 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.15 -3.06 80.87 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.483 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.9 m -114.68 171.32 7.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.449 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 33.5 p -103.87 59.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.61 ' HG2' ' HA ' ' A' ' 101' ' ' GLU . 9.6 mtm105 -152.31 149.1 28.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.022 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 102' ' ' ARG . 77.7 t -139.8 131.81 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.589 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -78.68 167.6 53.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.45 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -147.04 162.48 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.652 0.263 . . . . 0.0 110.466 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 ttt85 -149.14 125.62 10.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.869 0.366 . . . . 0.0 111.463 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.03 77.79 1.52 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.706 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.75 ' HB2' HG21 ' A' ' 33' ' ' THR . 73.2 Cg_endo -75.34 -178.65 4.39 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.478 2.118 . . . . 0.0 112.605 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.28 -4.02 58.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.139 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 0.3 OUTLIER -62.8 99.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 45.3 mt-10 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.08 -50.16 81.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.955 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -61.22 -24.57 66.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.819 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 15.9 mtm180 -70.12 -32.56 70.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.148 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -59.61 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 mt -58.92 -49.25 83.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.567 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.754 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.61 -29.32 69.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.406 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.64 -56.64 16.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 109.909 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HB2' ' H ' ' A' ' 134' ' ' PHE . 2.5 mmt85 -76.44 -88.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.166 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.45 ' H ' ' HB2' ' A' ' 133' ' ' ARG . 27.1 m-85 -76.64 117.56 65.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 21.2 Cg_exo -65.45 152.03 83.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.321 2.014 . . . . 0.0 111.319 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -134.46 169.55 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 111.472 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.668 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.2 m -80.85 138.8 36.21 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.492 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -136.99 96.54 3.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.277 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -125.72 145.33 50.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.32 117.07 22.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.186 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.559 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . -87.53 115.3 24.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -166.77 -37.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.915 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.45 -110.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -177.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -61.85 162.69 8.52 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.92 0.391 . . . . 0.0 111.51 -178.087 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.496 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 73.28 -156.35 51.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.39 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -127.26 60.91 45.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.555 0.217 . . . . 0.0 111.007 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.559 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 36.0 Cg_exo -60.89 -49.12 8.97 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.442 2.095 . . . . 0.0 113.404 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.441 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.1 Cg_exo -65.65 87.75 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.03 1.82 . . . . 0.0 112.175 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -96.62 142.97 25.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.911 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 67.6 Cg_endo -95.74 -16.95 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.912 2.408 . . . . 0.0 112.557 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -132.37 121.25 23.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.693 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.582 ' HA ' HD11 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -58.04 -38.7 76.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.195 -179.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -41.48 85.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.29 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.0 -38.38 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.839 HD12 HG12 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -71.94 -33.23 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 152' ' ' LEU . 21.6 t -53.42 -47.97 57.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.476 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -69.37 -32.45 71.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.861 0.363 . . . . 0.0 110.77 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -21.69 56.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.244 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.833 HD21 HG13 ' A' ' 165' ' ' VAL . 2.6 pp -98.76 43.86 1.05 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.49 ' C ' ' O ' ' A' ' 159' ' ' LEU . 13.8 t0 -17.53 -54.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.709 0.63 . . . . 0.0 112.254 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -160.75 11.14 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.847 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.4 p -81.84 -87.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.859 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 162' ' ' VAL . 0.3 OUTLIER -108.24 96.19 6.19 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-O 120.743 0.306 . . . . 0.0 111.396 -178.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.717 ' HA ' HD13 ' A' ' 159' ' ' LEU . 1.4 mm? -64.16 139.77 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.676 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.839 HG12 HD12 ' A' ' 155' ' ' ILE . 3.4 m -61.03 -174.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.508 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.32 145.6 50.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.739 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.85 -22.49 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.72 -52.79 5.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.138 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.621 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 96.64 -160.34 21.82 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.48 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.07 -163.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.654 0.264 . . . . 0.0 110.907 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.427 ' HB3' ' N ' ' A' ' 34' ' ' ASP . 49.1 t -145.34 -57.4 0.33 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.612 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -126.16 -130.07 0.24 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.3 OUTLIER -86.16 147.63 26.05 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -177.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.85 ' HG2' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.21 -23.3 66.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 158.84 33.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.684 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.55 ' O ' HG22 ' A' ' 35' ' ' THR . 64.9 Cg_endo -90.95 -149.86 0.35 Allowed 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.024 -1.24 . . . . 0.0 112.663 1.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 89.1 p -154.67 153.74 31.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.793 HG23 ' HB3' ' A' ' 191' ' ' ARG . 0.3 OUTLIER -99.91 141.58 32.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.152 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 7.0 t -129.05 78.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.769 HG12 ' HA ' ' A' ' 189' ' ' VAL . 23.2 mt -101.67 131.32 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.209 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 188' ' ' ARG . 6.9 t70 -108.78 61.63 0.6 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.3 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -70.14 100.15 1.61 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.333 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 -73.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.631 0.253 . . . . 0.0 110.813 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 185' ' ' ASN . 23.1 t -120.56 -109.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.028 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -74.63 -52.76 3.56 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.486 ' HD3' ' OD1' ' A' ' 185' ' ' ASN . 4.8 Cg_exo -77.68 108.0 2.48 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.496 2.131 . . . . 0.0 112.237 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 98.7 Cg_endo -79.46 131.15 9.34 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.447 2.098 . . . . 0.0 112.194 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 3.8 mmt85 -86.65 53.12 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.973 0.416 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.769 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.93 107.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.12 82.73 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.115 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.793 ' HB3' HG23 ' A' ' 178' ' ' THR . 5.3 ptm180 -89.57 142.07 28.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.98 110.1 18.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.023 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -96.2 127.63 9.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.206 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -90.69 -35.77 14.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.746 0.308 . . . . 0.0 111.102 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -79.66 132.22 11.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.611 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.76 -21.44 18.88 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.589 2.193 . . . . 0.0 112.299 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -137.58 -174.77 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.87 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.404 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -62.02 149.02 87.3 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.56 152.68 15.72 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.536 2.158 . . . . 0.0 112.247 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.26 148.17 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.218 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.54 114.3 27.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.56 -26.52 20.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 17.1 mtt-85 -77.27 -10.83 59.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.078 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -153.63 123.48 1.42 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.62 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -96.17 153.57 17.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.84 0.353 . . . . 0.0 111.017 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -86.9 53.26 4.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.414 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.89 -44.49 6.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.032 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.082 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.837 0.351 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 2' ' ' LEU . 4.0 mm? -76.19 -174.27 2.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.928 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.19 131.48 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -89.2 146.47 24.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 175.15 10.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 7' ' ' THR . 0.8 OUTLIER -93.41 143.59 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.007 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.405 ' N ' HG13 ' A' ' 6' ' ' ILE . 30.1 p -69.79 125.89 28.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -69.8 -22.21 63.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -90.75 100.93 13.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.809 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -110.15 89.15 7.93 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 9' ' ' LYS . 34.4 Cg_exo -59.93 103.66 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.545 2.164 . . . . 0.0 112.201 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.75 66.97 74.3 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.756 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' HD22 ' A' ' 16' ' ' LEU . 73.2 Cg_endo -74.22 177.37 8.35 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.545 2.163 . . . . 0.0 112.352 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.05 -28.25 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.625 HG22 ' HB3' ' A' ' 167' ' ' ASP . 82.7 t -57.5 -62.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.18 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.842 HD11 HG12 ' A' ' 126' ' ' ILE . 2.9 mp -60.53 -35.59 76.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.366 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.06 -29.61 67.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.482 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.97 -31.9 59.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.329 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.08 -42.64 56.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.326 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 16' ' ' LEU . 2.2 pp -75.21 -22.05 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.737 0.303 . . . . 0.0 111.224 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -69.08 -53.15 21.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.134 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.4 -28.62 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.289 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.4 mtt -57.09 -51.15 70.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.958 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.64 -9.37 58.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.37 9.15 74.72 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.707 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 39.42 92.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.723 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.56 168.58 13.95 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.192 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.733 HG23 ' HA ' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -96.29 141.28 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.619 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -116.19 110.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.078 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.615 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -100.49 151.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 111.247 -177.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.489 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 1.9 m-85 -154.33 114.12 2.48 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.171 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 68.4 Cg_endo -84.9 139.25 7.31 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.81 2.34 . . . . 0.0 111.391 176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.775 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -119.2 -149.45 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.708 0.289 . . . . 0.0 111.457 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -54.82 -23.75 19.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.561 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 36' ' ' ILE . 2.1 t -100.48 -114.94 0.17 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.011 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.763 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.71 -166.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.892 0.377 . . . . 0.0 111.592 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.59 138.57 55.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -130.98 168.71 21.86 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.116 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.707 ' HB2' HG23 ' A' ' 139' ' ' THR . 8.3 mp -113.91 143.71 44.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.741 0.305 . . . . 0.0 110.863 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.7 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.13 112.97 0.68 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.679 HG13 HD12 ' A' ' 28' ' ' ILE . 18.6 m -151.52 172.41 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.685 0.279 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.772 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.87 95.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.233 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HA ' ' CB ' ' A' ' 48' ' ' ALA . . . -57.85 -42.54 84.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.998 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HG ' HD11 ' A' ' 110' ' ' ILE . 2.5 mp -67.38 -29.77 69.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 111.417 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.772 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -86.51 154.24 21.25 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.026 -177.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -60.58 -12.4 9.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.062 -177.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -60.75 -34.03 73.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 110.262 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -76.28 -49.32 17.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.493 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 46' ' ' GLU . 8.1 p -59.66 -20.9 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.195 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.07 -57.84 3.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.615 179.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG3' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -63.17 -25.43 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.721 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 64' ' ' VAL . 1.7 mp -63.64 -54.43 35.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.768 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -54.57 -28.91 49.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.082 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -67.48 -57.26 6.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.605 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 143' ' ' ILE . 69.9 t -75.55 -56.89 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.5 5.86 11.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.47 -121.85 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.353 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.04 109.24 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.0 111.015 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.619 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -148.25 66.8 9.53 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.82 -7.51 20.86 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.53 2.153 . . . . 0.0 112.306 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 21.7 m-70 -103.79 -19.14 14.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.956 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -85.96 132.51 43.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.8 166.22 27.01 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.433 2.089 . . . . 0.0 112.057 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 110' ' ' ILE . 12.1 p -112.97 141.91 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.153 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.74 138.39 32.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.829 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.445 ' H ' HG13 ' A' ' 66' ' ' ILE . 1.5 pp -115.99 174.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.545 ' SG ' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -122.23 132.68 54.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.538 179.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG21 HG23 ' A' ' 74' ' ' ILE . 1.2 p -138.47 179.83 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.731 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.824 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 3.0 t -90.09 -41.8 11.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 0.0 110.63 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.72 170.67 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 74' ' ' ILE . 5.2 t -57.52 -38.54 64.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.836 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.13 -24.45 65.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.985 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.824 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 56.2 mm-40 -76.04 -20.89 57.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.775 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.802 HG23 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.55 61.84 0.9 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.729 178.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.66 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 28.9 Cg_exo -61.94 -79.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.086 1.858 . . . . 0.0 112.226 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -73.25 22.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' A' ' 117' ' ' VAL . 1.1 t80 -100.56 -48.9 4.38 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.954 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 80.7 p -131.38 -179.98 5.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -129.14 101.61 19.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.463 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 88.2 Cg_endo -102.4 -172.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.143 2.562 . . . . 0.0 112.634 -178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.19 -171.86 3.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.14 -82.08 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.629 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 1.1 m-20 -56.43 -26.11 52.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.67 71.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.772 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.463 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 27.0 mmt -74.27 -12.89 60.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.75 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 1.8 mt-10 -70.68 -50.28 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 10.7 tp -63.96 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.833 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.668 ' HB2' HD13 ' A' ' 182' ' ' LEU . 7.9 tpt -75.01 -42.41 57.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.383 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -23.7 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.715 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 6.1 ptm180 -75.84 -36.21 59.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.472 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.419 HG13 ' HE3' ' A' ' 88' ' ' MET . 3.6 pt -103.61 14.94 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 112.064 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.486 HD23 ' C ' ' A' ' 88' ' ' MET . 0.3 OUTLIER -130.97 152.77 81.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.792 -0.185 . . . . 0.0 110.823 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.426 ' N ' HD12 ' A' ' 92' ' ' LEU . 71.6 Cg_endo -78.17 -174.38 14.66 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.563 -1.432 . . . . 0.0 112.67 0.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.61 -174.63 32.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.491 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 96.0 Cg_endo -79.87 39.29 0.82 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.597 2.198 . . . . 0.0 112.29 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -112.13 160.92 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.784 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 27.2 m -107.54 131.05 54.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.29 107.34 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.852 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 5.5 t -102.89 131.02 52.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.755 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD11 ' HE3' ' A' ' 85' ' ' MET . 3.1 mm? -126.75 177.95 6.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.469 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 177.03 6.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.847 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -119.65 141.09 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.189 0.518 . . . . 0.0 111.429 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.647 HD22 ' H ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -74.8 -167.54 0.59 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.426 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -76.91 37.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.506 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -69.27 116.47 9.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.909 0.385 . . . . 0.0 110.786 -179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.521 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 25.5 mm -63.55 -48.55 80.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.159 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.5 Cg_exo -49.63 108.9 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.092 1.862 . . . . 0.0 112.483 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -2.62 48.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.858 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.728 HG13 HG13 ' A' ' 110' ' ' ILE . 10.5 p -71.78 -27.03 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.73 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.728 HG13 HG13 ' A' ' 109' ' ' VAL . 4.4 mt -101.2 -35.6 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.686 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.653 HG23 ' HG2' ' A' ' 102' ' ' ARG . 2.0 m -73.88 -30.69 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.909 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.81 -143.01 27.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.357 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -89.98 -18.29 51.1 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.529 ' O ' HG22 ' A' ' 111' ' ' THR . 22.1 m -106.61 -172.08 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.704 0.288 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.2 m -113.12 42.44 1.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 116' ' ' ARG . 5.7 mtm-85 -136.63 156.36 48.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 102' ' ' ARG . 62.0 t -140.15 145.52 26.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.558 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -99.2 159.18 20.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.227 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.61 HD13 HD13 ' A' ' 74' ' ' ILE . 9.3 mt -142.57 159.89 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.406 ' N ' HG22 ' A' ' 119' ' ' ILE . 7.0 ttp85 -151.12 124.7 9.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.816 0.341 . . . . 0.0 111.151 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.48 87.96 7.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.71 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.775 ' HB2' HG21 ' A' ' 33' ' ' THR . 60.2 Cg_endo -72.25 -179.97 4.46 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.409 2.072 . . . . 0.0 112.47 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.52 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.8 OUTLIER -93.0 17.92 9.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.182 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 109.77 15.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.01 -47.01 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.106 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.842 HG12 HD11 ' A' ' 16' ' ' LEU . 2.2 mp -64.39 -52.08 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.214 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 95.8 m -59.32 -16.15 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 69' ' ' SER . 31.7 ttt180 -74.94 -46.98 31.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.837 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.409 HH21 HG12 ' A' ' 130' ' ' ILE . 5.7 ttp180 -66.89 -48.88 67.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.388 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.409 HG12 HH21 ' A' ' 129' ' ' ARG . 37.9 mt -61.23 -55.34 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.192 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.53 -26.42 67.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.228 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.7 -57.1 12.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -76.0 -87.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.072 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.9 124.7 87.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.968 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.44 151.63 59.57 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.341 2.027 . . . . 0.0 111.879 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.545 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.6 t -131.42 157.71 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.046 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.7 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 0.4 OUTLIER -80.75 136.64 36.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.071 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.505 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . . . -129.27 98.39 4.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 111.349 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -128.21 105.13 8.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.623 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.853 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 78.5 p -61.71 128.56 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -79.35 132.92 36.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.842 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -162.17 -43.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.362 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.599 HD12 HG12 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -72.87 -117.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.388 -178.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 m -62.26 172.63 1.4 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.011 0.434 . . . . 0.0 111.397 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.491 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 82.96 -155.06 32.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.532 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.38 67.55 47.31 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.697 0.284 . . . . 0.0 110.852 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 37.7 Cg_exo -60.82 -47.69 12.56 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.557 2.171 . . . . 0.0 113.484 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 57.1 Cg_endo -69.94 97.68 0.66 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 121.804 1.669 . . . . 0.0 112.198 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.432 ' HB3' HD11 ' A' ' 155' ' ' ILE . 1.4 m -89.75 135.19 30.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 94.1 Cg_endo -95.2 -43.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.752 2.301 . . . . 0.0 112.718 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.688 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 4.2 ttt180 -131.69 137.47 48.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.695 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.686 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -61.01 -40.67 94.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -19.93 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.688 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 3.7 tm-20 -67.29 -40.98 86.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.657 HD12 HG23 ' A' ' 165' ' ' VAL . 5.4 mt -70.06 -48.46 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.346 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.76 -31.02 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.318 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ttt180 -75.36 -52.95 9.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.113 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.741 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -60.07 -38.62 83.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.179 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.7 mm? -109.29 73.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -37.19 -39.83 0.29 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.25 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -153.84 11.88 0.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.606 0.241 . . . . 0.0 111.597 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 5.3 t -80.67 -81.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.733 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -104.34 99.39 9.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.502 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -73.68 127.87 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -178.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.841 HG22 ' H ' ' A' ' 166' ' ' LEU . 3.5 p -65.19 -163.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.841 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -125.68 143.55 50.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.976 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.625 ' HB3' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -92.31 -14.96 28.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.489 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.24 -41.73 16.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.425 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.56 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 93.53 -167.67 28.8 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.163 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' HA ' ' HG2' ' A' ' 32' ' ' PRO . 3.0 p30 -73.1 -165.11 0.21 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.75 0.31 . . . . 0.0 111.022 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -61.4 0.67 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.724 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.69 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -126.33 -132.57 0.25 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.511 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 3.8 t70 -86.88 165.16 16.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.886 0.374 . . . . 0.0 111.87 -177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.763 ' HG2' HG23 ' A' ' 36' ' ' ILE . 1.8 ttp -70.33 -8.96 54.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.839 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.14 162.17 36.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.43 ' HB2' ' H ' ' A' ' 177' ' ' SER . 66.4 Cg_endo -97.5 -148.97 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.346 -1.106 . . . . 0.0 112.71 1.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.1 OUTLIER -155.27 110.31 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.615 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 191' ' ' ARG . 95.6 m -101.46 138.72 38.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.198 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.784 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 14.0 t -129.24 109.24 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.746 HG23 ' HA ' ' A' ' 189' ' ' VAL . 4.5 mt -117.84 137.56 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.852 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.2 m-20 -108.0 67.44 0.68 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.567 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -69.5 83.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.354 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.25 -83.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.523 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.96 -100.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.282 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -83.9 -51.82 0.6 Allowed Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 71.6 Cg_endo -73.84 110.4 3.07 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.125 1.883 . . . . 0.0 112.259 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.5 Cg_endo -82.15 118.1 2.94 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.612 2.208 . . . . 0.0 112.372 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.707 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -86.94 49.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.045 0.45 . . . . 0.0 110.811 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.746 ' HA ' HG23 ' A' ' 180' ' ' ILE . 6.6 t -56.6 104.01 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.012 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.03 77.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.017 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.518 ' HB3' HG23 ' A' ' 178' ' ' THR . 3.0 ptp180 -83.81 131.66 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -83.09 -47.61 11.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -98.11 133.48 11.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.322 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -90.36 171.5 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.426 . . . . 0.0 110.98 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -87.05 -70.0 1.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.25 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.39 -166.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.67 2.247 . . . . 0.0 112.105 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.66 145.52 27.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.073 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.401 ' N ' ' CD ' ' A' ' 199' ' ' PRO . 2.1 m-20 -68.7 -49.88 26.84 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.487 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 198' ' ' ASP . 77.5 Cg_exo -51.35 132.66 40.4 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.325 2.017 . . . . 0.0 112.532 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.13 134.28 30.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.018 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.09 61.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.0 tp -67.2 -37.01 82.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.977 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.79 170.22 9.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.47 -138.65 5.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.533 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.47 99.28 10.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.757 0.313 . . . . 0.0 111.052 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -144.48 12.79 2.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.442 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.6 14.07 16.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 0.0 110.972 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.098 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.846 0.355 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.643 HD22 ' H ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -110.06 -171.31 1.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 mm -102.25 132.54 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 4' ' ' ARG . 3.1 mtp180 -81.49 139.73 34.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.56 ' HG3' ' H ' ' A' ' 8' ' ' ARG . 2.5 ptpt -73.07 177.85 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 pt -83.24 -29.72 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.7 -67.2 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.054 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.56 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -101.02 89.52 3.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 -71.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -110.08 111.29 58.32 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.811 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HG2' ' H ' ' A' ' 12' ' ' SER . 41.1 Cg_endo -68.11 -70.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.469 2.113 . . . . 0.0 112.386 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -157.52 146.88 15.02 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.843 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.11 160.59 7.95 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.545 2.163 . . . . 0.0 112.275 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -40.26 84.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 12.3 t -66.9 -34.01 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.014 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.95 -46.63 67.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -61.5 -21.55 64.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.161 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -75.18 -36.68 61.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.632 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.71 -40.21 80.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.78 -32.26 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -59.99 -38.73 83.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.78 HG21 HD22 ' A' ' 164' ' ' LEU . 7.4 t -67.82 -34.68 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.0 mmt -56.06 -40.87 74.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.988 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.96 -23.14 58.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.21 -2.35 74.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.507 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.67 57.91 10.25 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.99 163.18 22.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.491 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.718 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.2 tp -96.21 143.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.772 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.541 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.44 120.32 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.543 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.6 OUTLIER -101.58 149.96 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.301 . . . . 0.0 110.981 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 1.5 m-85 -153.18 100.08 2.67 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.005 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.509 ' HG3' ' CD2' ' A' ' 37' ' ' TYR . 2.5 Cg_endo -78.53 134.0 12.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.824 2.349 . . . . 0.0 110.791 176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 93.9 m -138.35 -85.44 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 3.0 m-20 -74.46 -72.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.561 -177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.509 ' HB ' ' H ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -77.72 -86.89 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.047 -177.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.682 HG23 ' N ' ' A' ' 37' ' ' TYR . 3.9 tp -133.33 -155.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.672 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.682 ' N ' HG23 ' A' ' 36' ' ' ILE . 8.9 m-85 -63.27 131.5 48.58 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.37 172.85 14.42 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.177 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -118.2 135.85 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.96 0.41 . . . . 0.0 111.113 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.76 114.44 0.72 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.769 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.5 p -158.12 175.88 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.651 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -56.35 118.55 4.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.592 179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.433 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -59.85 -56.24 24.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.03 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 44' ' ' LEU . 2.6 mm? -82.29 37.52 0.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.926 0.393 . . . . 0.0 111.45 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.651 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -111.14 153.98 24.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.861 178.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -71.5 -29.16 64.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.833 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.04 -33.35 75.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.682 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.02 -35.99 74.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.1 t -66.78 -44.03 89.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.036 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -66.12 -43.11 88.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.543 HH11 ' HA ' ' A' ' 51' ' ' ARG . 7.2 mmt-85 -70.96 -24.71 62.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.61 HD11 HG23 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -71.83 -44.99 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.985 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -20.47 62.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.41 -49.77 17.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.621 ' HA ' HD13 ' A' ' 143' ' ' ILE . 48.0 t -75.55 -40.36 41.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.439 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.95 -12.23 59.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.019 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.94 -108.0 2.19 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.533 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -118.19 90.6 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.049 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 m -153.79 70.7 6.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.12 14.98 1.79 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.566 2.177 . . . . 0.0 112.594 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -121.06 -19.02 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.951 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -84.26 131.68 49.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 32.1 Cg_exo -60.01 175.34 1.01 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.555 2.17 . . . . 0.0 112.247 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.61 HG23 HD11 ' A' ' 52' ' ' LEU . 10.0 p -112.98 152.07 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.051 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 4.8 t -93.93 129.0 40.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.887 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 67' ' ' CYS . 9.5 mm -107.98 161.51 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.861 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 51.4 t -122.23 127.44 49.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.865 HG21 HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -140.84 177.33 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.575 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.703 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -87.18 -41.76 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 110.462 179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.42 170.57 15.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.799 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.826 HG11 ' HG3' ' A' ' 85' ' ' MET . 5.1 t -59.03 -33.07 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -24.91 66.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.668 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.703 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 73.5 mm-40 -78.06 -21.04 51.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -113.66 56.52 0.69 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.652 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 32.1 Cg_exo -58.68 -85.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.033 1.822 . . . . 0.0 112.11 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 18.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.59 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.472 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 25.2 m-85 -92.34 -34.42 14.2 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.76 0.315 . . . . 0.0 110.958 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 57.1 p -135.37 -178.14 4.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.837 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.835 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 6.5 mmt180 -114.1 83.76 8.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.667 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB2' ' SD ' ' A' ' 85' ' ' MET . 76.4 Cg_endo -102.46 178.46 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.111 2.541 . . . . 0.0 113.036 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 3.0 m -129.93 179.43 5.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.932 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.19 -78.63 0.63 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.762 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -55.08 -31.39 61.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -60.73 -41.14 94.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.826 ' HG3' HG11 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -69.97 -25.95 63.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.279 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 2.3 mm-40 -57.99 -56.09 26.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.039 0.447 . . . . 0.0 110.418 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -55.04 -39.23 68.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.896 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.557 ' SD ' HG21 ' A' ' 98' ' ' VAL . 3.9 tpt -66.69 -41.34 88.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.343 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.23 -7.72 44.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.265 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -74.95 -37.92 61.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 pt -115.06 48.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.453 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 121' ' ' VAL . 4.1 tp -131.21 138.52 33.04 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.513 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 97.0 Cg_endo -78.51 -162.95 3.14 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.481 -0.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 154.52 164.68 13.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.376 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.14 30.76 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.606 2.204 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.586 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 0.2 OUTLIER -100.99 132.99 46.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.905 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -101.61 120.54 40.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.427 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' A' ' 180' ' ' ILE . 2.4 m -110.36 135.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.074 0.464 . . . . 0.0 111.681 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 t -101.76 130.19 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.283 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -126.78 -179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.744 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.835 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 2.1 tt0 -74.27 175.71 7.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.508 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.628 HH11 HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -119.24 144.77 46.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.417 . . . . 0.0 111.325 -179.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 105' ' ' LEU . 5.7 p-10 -74.34 -159.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.936 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.95 27.04 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.563 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.436 ' HG ' ' HG2' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -69.45 113.47 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.2 mt -68.58 -49.45 29.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.89 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 106' ' ' ILE . 7.5 Cg_endo -49.93 110.08 0.34 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.444 2.096 . . . . 0.0 112.459 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.414 ' HA ' HG22 ' A' ' 111' ' ' THR . 3.9 m-20 -76.15 -5.06 44.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.872 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.77 -24.68 27.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.686 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.605 ' O ' HG12 ' A' ' 64' ' ' VAL . 26.0 mm -95.18 -51.71 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.168 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.628 HG21 HH11 ' A' ' 102' ' ' ARG . 11.7 t -77.93 -0.64 28.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.238 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.51 -160.17 51.62 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.588 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.37 83.89 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.473 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 m -113.82 -171.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 110.843 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.496 ' C ' ' HG2' ' A' ' 102' ' ' ARG . 55.2 m -105.26 47.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -137.05 155.74 49.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.0 0.428 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 102' ' ' ARG . 67.1 t -139.72 138.8 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.458 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -90.66 152.25 21.79 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.841 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.593 HD13 HD13 ' A' ' 74' ' ' ILE . 42.9 mt -147.68 142.85 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.582 ' HB3' HG23 ' A' ' 97' ' ' THR . 0.0 OUTLIER -148.76 137.94 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.943 0.401 . . . . 0.0 111.21 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 92' ' ' LEU . 6.8 t -110.21 98.09 33.74 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.025 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.19 -179.1 4.92 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.459 2.106 . . . . 0.0 112.568 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.23 14.01 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 127' ' ' CYS . 1.5 t0 -76.14 106.09 7.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.15 -52.71 64.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.235 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.2 -49.07 84.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.234 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -62.53 -23.66 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.891 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.0 OUTLIER -67.04 -35.11 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.786 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -53.74 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 mt -60.58 -54.75 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.307 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.745 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -58.32 -28.73 65.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.376 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.8 -55.27 31.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.976 0.417 . . . . 0.0 109.904 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 133' ' ' ARG . 1.6 mtm180 -75.48 -89.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.02 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.97 134.35 68.34 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.784 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.97 152.59 76.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.379 2.053 . . . . 0.0 111.811 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.3 153.61 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.204 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.63 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 6.8 m -80.68 137.55 36.32 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.861 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -133.91 108.47 8.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.707 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -134.91 136.04 42.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.673 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 t -79.43 113.88 17.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.125 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -85.97 88.12 7.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.117 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.589 ' HB3' HG21 ' A' ' 36' ' ' ILE . 4.8 p-10 -154.15 25.54 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' A' ' 55' ' ' VAL . 2.9 pt -77.96 -157.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.434 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.9 OUTLIER -55.06 160.22 2.14 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.065 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.442 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 85.65 -144.67 20.6 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.285 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 33.2 tttt -127.46 63.47 59.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.487 0.184 . . . . 0.0 111.279 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 41.9 Cg_exo -60.49 -47.79 13.09 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.336 2.024 . . . . 0.0 113.352 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 74.0 Cg_endo -74.81 115.81 4.41 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.888 1.725 . . . . 0.0 112.358 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.4 152.69 38.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -95.86 -14.51 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.83 2.353 . . . . 0.0 113.004 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 155' ' ' ILE . 1.1 mmt180 -135.88 136.88 40.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.856 0.36 . . . . 0.0 111.109 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' HG11 ' A' ' 165' ' ' VAL . 8.3 mt -65.3 -45.16 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.907 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -27.0 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.145 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -37.42 86.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.146 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.464 ' HB ' ' CG1' ' A' ' 165' ' ' VAL . 1.1 mt -72.7 -34.19 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.154 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 152' ' ' LEU . 16.0 t -64.17 -30.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.813 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -75.5 -53.02 9.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.444 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.41 -45.85 68.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.814 HD12 ' HB ' ' A' ' 162' ' ' VAL . 0.8 OUTLIER -90.83 64.22 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -179.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -37.05 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.186 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -171.51 16.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.814 ' HB ' HD12 ' A' ' 159' ' ' LEU . 47.1 t -80.78 -91.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.718 ' HA ' HG23 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -98.41 95.85 7.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.403 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.78 HD22 HG21 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -60.46 138.65 57.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.79 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 152' ' ' LEU . 26.9 m -65.04 -169.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.628 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 169' ' ' GLY . 1.0 OUTLIER -125.84 135.76 52.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.211 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -2.16 54.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.026 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.01 -33.61 24.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.349 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.439 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 102.24 130.18 6.92 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.505 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 4.8 p-10 -73.41 -175.97 2.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.674 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.7 OUTLIER -136.72 -171.49 2.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.643 178.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.86 38.65 1.34 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 1.4 m-20 -85.08 56.89 4.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.111 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -54.43 173.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.377 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.921 ' H ' ' HA ' ' A' ' 176' ' ' PRO . 2.1 tp10 -160.12 -47.77 0.01 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.921 ' HA ' ' H ' ' A' ' 175' ' ' GLU . 89.6 Cg_endo -83.45 -52.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.358 1.048 0 C-N-CA 124.653 -0.978 . . . . 0.0 113.495 3.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.96 144.82 22.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.038 0.447 . . . . 0.0 111.664 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 96' ' ' TYR . 53.0 m -102.41 150.39 23.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.464 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 11.9 t -125.6 86.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.931 0.396 . . . . 0.0 111.343 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.722 ' HB ' HG12 ' A' ' 98' ' ' VAL . 10.3 mt -100.71 131.92 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.654 ' HB3' ' HG3' ' A' ' 188' ' ' ARG . 7.3 t0 -98.84 64.53 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.953 0.406 . . . . 0.0 110.685 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.3 tt -70.2 75.68 0.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.419 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.56 -79.32 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.444 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.779 HG13 ' H ' ' A' ' 185' ' ' ASN . 1.7 p -120.42 -95.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.546 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.779 ' H ' HG13 ' A' ' 184' ' ' VAL . 2.2 t-20 -90.47 -51.31 0.33 Allowed Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 18.3 Cg_exo -67.52 107.26 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.571 2.18 . . . . 0.0 112.314 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 87.7 Cg_endo -84.55 116.51 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.683 2.255 . . . . 0.0 112.477 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.654 ' HG3' ' HB3' ' A' ' 181' ' ' ASP . 0.1 OUTLIER -91.96 67.9 5.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 111.06 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.56 HG13 HG12 ' A' ' 180' ' ' ILE . 2.5 t -63.71 112.77 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.811 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.3 94.08 2.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -83.99 147.18 27.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -85.07 53.92 2.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.041 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -97.01 125.19 8.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.59 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.96 -10.68 17.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -76.01 -167.78 24.56 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.473 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.1 -176.85 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.596 2.197 . . . . 0.0 112.171 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.4 9.5 2.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.976 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -78.96 138.3 57.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 202' ' ' LEU . 53.0 Cg_endo -69.45 -141.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.471 2.114 . . . . 0.0 112.227 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.429 ' H ' ' HB2' ' A' ' 199' ' ' PRO . 4.6 t -63.76 -97.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.173 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.38 67.06 0.7 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.805 0.336 . . . . 0.0 111.154 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.645 ' HB2' ' HG2' ' A' ' 199' ' ' PRO . 18.0 tp -95.14 149.79 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.918 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.08 111.15 19.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -179.16 79.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.512 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -100.88 -177.14 3.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 111.078 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 169.18 -28.09 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.433 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -102.91 -26.02 13.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 110.858 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.011 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.805 0.336 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.99 -172.24 0.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mt -89.73 -101.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.978 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -75.25 128.61 35.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.0 -175.56 1.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -92.38 144.45 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.018 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -70.13 121.53 17.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.72 140.81 48.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.68 -74.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.01 101.3 44.11 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.933 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.56 56.69 6.18 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.523 2.149 . . . . 0.0 112.434 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.15 71.3 4.56 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.827 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 26.1 Cg_exo -63.3 140.94 79.83 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.662 2.241 . . . . 0.0 112.374 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -54.52 6.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.414 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.6 HG11 HD13 ' A' ' 126' ' ' ILE . 41.8 t -64.39 -45.95 94.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.607 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.827 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 3.7 mm? -58.94 -50.77 72.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.124 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -55.07 -27.57 45.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 110.839 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 17' ' ' GLU . 1.8 mt-10 -75.82 -43.75 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.05 -45.59 70.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.13 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.9 mm -67.41 -22.35 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' GLU . 3.6 t -65.16 -58.9 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 164' ' ' LEU . 14.6 p -62.41 -29.65 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 mtt -64.57 -28.52 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.35 13.89 62.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.522 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.05 58.92 9.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.501 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.84 162.35 19.12 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.462 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.697 HG23 ' HA ' ' A' ' 163' ' ' ASP . 1.4 tp -95.05 140.0 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.721 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.61 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.39 131.99 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.571 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.551 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -102.28 163.2 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.679 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -168.33 102.44 0.54 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.761 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.686 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 92.6 Cg_endo -84.27 155.47 12.66 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.745 2.297 . . . . 0.0 112.121 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.458 ' C ' ' HB2' ' A' ' 171' ' ' CYS . 40.8 p -131.51 -155.28 0.68 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.553 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -55.34 -19.03 7.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.715 0.293 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 174' ' ' MET . 0.0 OUTLIER -97.61 -118.64 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.795 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' H ' ' HB ' ' A' ' 35' ' ' THR . 1.1 tt -111.94 -174.44 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 110.827 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.686 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -63.24 134.64 56.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.739 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.94 178.9 17.76 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.119 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 4.4 mt -133.25 138.01 46.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.94 0.4 . . . . 0.0 111.174 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.46 122.61 1.73 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.609 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.635 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.7 p -159.77 177.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.723 0.296 . . . . 0.0 111.281 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.655 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 1.9 m120 -56.13 106.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.976 0.417 . . . . 0.0 110.669 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.14 -49.73 76.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.091 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -80.29 27.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.944 0.402 . . . . 0.0 111.748 -178.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 147.77 34.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.815 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -73.32 -24.78 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.888 0.375 . . . . 0.0 110.593 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -58.37 -30.14 66.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.809 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -65.88 -30.37 70.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.4 t -71.15 -46.07 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 50' ' ' ARG . 9.9 mtm180 -65.15 -41.13 95.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.682 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mpt_? -67.01 -53.87 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.077 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -54.56 -25.76 27.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.936 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -73.76 -52.98 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 54' ' ' ARG . 6.6 mmp_? -55.49 -35.88 66.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 HG23 ' A' ' 143' ' ' ILE . 54.5 t -70.68 -58.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -72.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.41 17.0 30.71 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.31 -16.16 9.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 0.0 110.93 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -140.05 67.65 33.97 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.75 -4.59 15.41 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.551 2.167 . . . . 0.0 112.213 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.91 -4.46 17.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 0.0 OUTLIER -86.43 145.36 39.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.993 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HD2' ' HD2' ' A' ' 62' ' ' LYS . 24.2 Cg_endo -60.82 156.98 40.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.673 2.249 . . . . 0.0 112.147 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 110' ' ' ILE . 11.9 p -112.59 147.26 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.943 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -94.18 145.03 25.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pt -116.2 161.83 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.819 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 10.8 t -111.73 131.55 55.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 0.8 OUTLIER -137.74 170.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.803 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 4.1 t -86.47 -39.4 16.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 110.489 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 2.7 t -164.08 174.09 11.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.56 HG11 ' HG3' ' A' ' 85' ' ' MET . 37.9 t -59.93 -38.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 6.7 m-20 -67.22 -23.4 65.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.803 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 24.5 mm-40 -80.62 -23.17 39.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.231 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.718 ' HB ' HG21 ' A' ' 68' ' ' VAL . 18.9 tt -114.22 50.66 0.55 Allowed Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.029 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 20.8 Cg_endo -61.97 -78.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.099 1.866 . . . . 0.0 113.176 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.4 9.89 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CE2' ' HG2' ' A' ' 135' ' ' PRO . 1.8 m-85 -108.21 -13.63 14.87 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.219 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.657 ' HB2' HD23 ' A' ' 100' ' ' LEU . 60.3 p -135.74 178.11 7.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.622 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.656 ' O ' HD11 ' A' ' 100' ' ' LEU . 3.8 mtp-105 -133.5 62.14 57.89 Favored Pre-proline 0 N--CA 1.464 0.232 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.485 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.626 ' HB3' HD22 ' A' ' 100' ' ' LEU . 65.6 Cg_endo -102.38 173.15 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.784 2.323 . . . . 0.0 113.203 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.5 -177.71 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.53 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.46 -58.09 4.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.783 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -55.59 -41.28 73.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 0.0 111.211 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.16 -51.6 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.56 ' HG3' HG11 ' A' ' 71' ' ' VAL . 24.0 mmt -71.74 -7.81 50.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.97 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -72.28 -54.58 9.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.342 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -37.49 74.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.695 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.491 ' HG2' HG11 ' A' ' 98' ' ' VAL . 3.4 tpt -73.76 -41.36 62.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.633 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -63.42 -13.82 43.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.05 -31.17 61.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.27 45.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.472 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -131.27 147.09 64.82 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.843 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.37 -172.08 10.76 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.953 -1.269 . . . . 0.0 112.14 -0.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.25 179.93 29.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.582 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 36.8 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.782 2.321 . . . . 0.0 112.279 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.405 ' HD2' HG21 ' A' ' 178' ' ' THR . 13.9 m-85 -106.86 114.42 28.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.474 ' HA ' ' HB3' ' A' ' 120' ' ' ARG . 26.0 m -96.99 117.29 30.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -108.83 108.84 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.517 HG13 ' HA2' ' A' ' 118' ' ' GLY . 7.1 t -84.93 124.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 78' ' ' SER . 0.2 OUTLIER -128.13 162.3 27.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.394 179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.606 ' H ' HD12 ' A' ' 100' ' ' LEU . 3.6 mt-10 -59.08 174.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.756 ' HE ' ' HB3' ' A' ' 105' ' ' LEU . 18.8 ttt85 -118.57 159.06 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.151 0.501 . . . . 0.0 111.835 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.417 ' H ' ' HG2' ' A' ' 102' ' ' ARG . 1.6 t30 -74.13 -162.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.343 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 16.53 0.37 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.836 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.756 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 1.7 tm? -69.83 153.75 42.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.583 0.23 . . . . 0.0 110.459 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.714 HG13 ' H ' ' A' ' 108' ' ' ASP . 1.8 tp -59.54 106.41 0.73 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.325 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.629 ' HA ' HG23 ' A' ' 111' ' ' THR . 74.3 Cg_endo -72.25 16.79 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.003 2.469 . . . . 0.0 113.431 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.714 ' H ' HG13 ' A' ' 106' ' ' ILE . 22.4 t0 -61.32 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.76 6.96 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.615 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.588 ' O ' HG12 ' A' ' 64' ' ' VAL . 10.1 mm -95.95 -59.49 3.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.297 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 107' ' ' PRO . 5.9 p -87.5 -31.11 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.014 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 -89.8 0.29 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.19 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.93 -84.01 0.17 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.114 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -103.95 -167.71 1.4 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.558 0.218 . . . . 0.0 110.896 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.7 60.4 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.392 . . . . 0.0 111.188 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 116' ' ' ARG . 9.5 mtt85 -136.44 143.6 43.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.692 HG21 HH11 ' A' ' 102' ' ' ARG . 90.3 t -140.0 138.05 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.71 151.82 36.33 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.793 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 118' ' ' GLY . 26.0 mt -149.61 135.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.642 0.258 . . . . 0.0 110.453 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.575 ' HD2' ' HD3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -156.46 149.99 24.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 111.454 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 92' ' ' LEU . 2.3 t -110.87 89.08 8.88 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.404 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.575 ' HD3' ' HD2' ' A' ' 120' ' ' ARG . 22.7 Cg_endo -61.75 -178.77 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.499 2.133 . . . . 0.0 112.721 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.72 7.46 23.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.3 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 127' ' ' CYS . 7.3 m-20 -80.2 94.86 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.868 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.26 -33.41 67.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.6 HD13 HG11 ' A' ' 15' ' ' VAL . 2.0 mt -69.67 -52.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.725 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -61.34 -13.93 23.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.754 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.65 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -75.15 -48.06 25.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.89 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -59.65 -54.25 48.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mt -59.03 -49.05 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.064 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.4 -27.68 69.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.405 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.42 -56.71 15.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -89.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.747 176.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -77.08 124.88 87.31 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.818 177.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.528 ' HG2' ' CE2' ' A' ' 77' ' ' PHE . 25.9 Cg_exo -64.78 157.72 54.65 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.283 1.989 . . . . 0.0 111.69 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.3 t -128.94 155.59 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.274 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.651 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 8.0 m -80.51 132.51 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.927 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.23 104.29 7.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 111.548 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -133.22 163.32 29.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.77 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 t -81.31 131.22 35.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . -76.78 119.02 19.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.044 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.507 ' H ' HG13 ' A' ' 55' ' ' VAL . 1.2 m120 -163.6 63.06 0.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.656 HG23 HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -76.7 179.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.975 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.9 t -62.3 145.23 54.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.53 -125.58 7.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.622 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.81 88.86 50.35 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.595 0.236 . . . . 0.0 110.957 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 142' ' ' ASN . 45.5 Cg_exo -59.99 -47.6 14.84 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.588 2.192 . . . . 0.0 113.228 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 26.1 Cg_exo -62.0 91.24 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.899 1.733 . . . . 0.0 111.931 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.94 148.52 78.96 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -95.48 -15.53 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.994 2.462 . . . . 0.0 112.368 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.48 ' HG2' ' HB2' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -136.53 125.89 24.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.425 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.507 HD21 HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -58.29 -40.8 82.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -20.04 63.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.48 ' HB2' ' HG2' ' A' ' 151' ' ' ARG . 15.2 tt0 -75.12 -28.68 60.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.61 HG22 HD12 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -74.95 -46.84 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.18 -179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -60.09 -31.22 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.29 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -74.96 -47.02 31.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.071 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.14 -23.75 60.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.252 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.864 HD13 ' HB3' ' A' ' 163' ' ' ASP . 97.2 mt -111.34 67.13 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -16.19 -63.15 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.077 0.86 . . . . 0.0 112.776 -178.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -160.18 22.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.882 0.372 . . . . 0.0 111.005 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.7 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -81.13 -70.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.983 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.864 ' HB3' HD13 ' A' ' 159' ' ' LEU . 38.6 t0 -107.98 96.7 6.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.578 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.49 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -67.51 135.77 53.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 156' ' ' VAL . 18.8 m -67.4 -164.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.255 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.701 ' H ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.27 161.38 27.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.869 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.439 ' HB3' HG13 ' A' ' 15' ' ' VAL . 15.3 t70 -92.41 -25.08 18.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.154 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -84.59 -57.56 3.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.128 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.419 ' HA2' HD23 ' A' ' 166' ' ' LEU . . . 102.05 -161.87 17.33 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.934 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.65 -162.73 0.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.676 0.274 . . . . 0.0 110.915 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.458 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.73 -56.11 0.16 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.705 -179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -133.46 -133.15 0.17 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -85.89 142.6 28.75 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.873 0.368 . . . . 0.0 111.963 -177.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.545 ' HA ' ' O ' ' A' ' 35' ' ' THR . 69.2 mmm -62.4 -25.36 67.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.319 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.4 159.17 42.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.741 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' O ' HG22 ' A' ' 35' ' ' THR . 75.3 Cg_endo -86.79 -149.59 0.44 Allowed 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.694 0.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.98 157.12 38.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.75 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.405 HG21 ' HD2' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -99.45 132.23 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.87 90.33 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.946 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.719 HG12 ' HA ' ' A' ' 189' ' ' VAL . 22.6 mt -108.42 137.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.499 ' H ' ' HB2' ' A' ' 188' ' ' ARG . 0.5 OUTLIER -106.49 67.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.042 178.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 187' ' ' PRO . 31.8 tp -70.28 90.04 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.682 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -79.25 0.2 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.447 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.23 -123.13 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.059 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.0 OUTLIER -62.51 -52.02 68.6 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -178.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 185' ' ' ASN . 80.9 Cg_endo -77.92 108.42 2.53 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.138 1.892 . . . . 0.0 112.645 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.58 ' HB3' HD13 ' A' ' 182' ' ' LEU . 84.6 Cg_endo -83.25 129.65 5.24 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.499 ' HB2' ' H ' ' A' ' 181' ' ' ASP . 9.2 mmt85 -88.68 60.9 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.038 0.447 . . . . 0.0 111.001 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.719 ' HA ' HG12 ' A' ' 180' ' ' ILE . 32.6 t -62.38 92.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.949 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.55 87.04 2.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.088 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -83.56 145.93 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -73.17 97.48 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.722 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -93.78 125.47 8.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.646 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.27 -28.5 12.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.999 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -86.66 114.36 4.06 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.499 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.4 ' HG2' HD23 ' A' ' 197' ' ' LEU . 42.7 Cg_endo -67.72 -12.91 37.07 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.513 2.142 . . . . 0.0 112.363 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.4 HD23 ' HG2' ' A' ' 196' ' ' PRO . 0.7 OUTLIER -155.92 171.63 19.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.008 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 19.8 m-20 -76.54 137.1 67.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 24.3 Cg_exo -63.9 -178.16 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.652 2.235 . . . . 0.0 112.235 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 202' ' ' LEU . 46.6 t -68.12 123.28 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.983 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.94 37.41 2.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.531 ' H ' HG12 ' A' ' 200' ' ' VAL . 0.1 OUTLIER -70.72 172.19 9.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -72.05 112.89 8.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -117.18 48.09 0.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.494 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -88.12 34.64 0.74 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 111.173 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 137.07 127.98 2.65 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.389 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -101.64 -1.07 33.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.841 0.353 . . . . 0.0 110.959 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.147 -179.786 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.689 ' HB2' ' HB2' ' A' ' 4' ' ' ARG . 13.6 ptt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.829 0.347 . . . . 0.0 111.244 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -107.78 -77.48 0.6 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.28 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.501 ' N ' ' HG ' ' A' ' 2' ' ' LEU . 9.0 tp -84.41 -7.33 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.999 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.689 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 1.0 OUTLIER -84.63 137.12 33.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 177.68 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 tt -95.01 137.27 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -78.85 125.72 29.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.07 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 169.51 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.016 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.04 99.98 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.79 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -99.05 107.26 43.11 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.85 106.14 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.568 2.179 . . . . 0.0 112.323 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.516 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 4.0 m -101.05 -51.09 0.18 Allowed Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.355 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 12' ' ' SER . 52.8 Cg_exo -56.22 151.41 43.76 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.213 1.942 . . . . 0.0 112.287 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.693 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -75.07 -27.72 60.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.957 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.48 -49.25 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 4.1 mm? -66.22 -32.15 73.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.152 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -71.77 -31.3 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -75.54 -38.21 59.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.264 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.566 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.68 -45.44 58.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.68 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.8 -30.35 37.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.72 -40.81 88.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.726 HG22 ' HG ' ' A' ' 164' ' ' LEU . 3.3 t -62.82 -31.03 50.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 28.0 mmt -61.5 -43.88 98.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.38 -23.21 58.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.809 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -19.0 63.8 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.44 36.34 88.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.687 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.74 170.57 14.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.142 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 163' ' ' ASP . 1.5 tp -90.52 136.06 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.597 HG22 HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -116.7 133.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.665 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.517 HG12 ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -101.87 163.01 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.55 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -165.21 101.15 0.79 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.79 -178.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.63 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 89.6 Cg_endo -82.61 144.64 12.67 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.592 2.195 . . . . 0.0 111.601 177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.507 HG21 ' H ' ' A' ' 123' ' ' ASP . 0.2 OUTLIER -121.55 -152.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.717 0.294 . . . . 0.0 111.291 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.593 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.3 m-20 -55.05 -21.99 14.29 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.457 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 95' ' ' PRO . 1.8 t -100.02 -115.0 0.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.78 HG23 ' HG2' ' A' ' 174' ' ' MET . 0.7 OUTLIER -112.34 -172.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.852 0.358 . . . . 0.0 111.173 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.63 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.8 m-85 -63.69 137.9 58.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.926 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -124.02 -176.66 14.77 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.014 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -127.08 140.98 51.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.86 0.362 . . . . 0.0 110.935 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.654 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.33 120.83 1.35 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.708 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.634 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.5 p -165.98 177.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.775 0.321 . . . . 0.0 111.65 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.763 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t-20 -56.73 107.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -62.7 -52.09 64.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 33.1 0.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.846 0.355 . . . . 0.0 111.6 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.763 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -111.15 159.69 17.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.833 178.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.13 -36.7 61.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.791 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 25.0 t70 -58.49 -26.54 63.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.109 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.83 -33.28 62.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.52 -52.69 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HD2' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -65.01 -45.85 83.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.92 -31.95 63.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -27.9 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -42.91 53.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.529 ' HA ' HD13 ' A' ' 143' ' ' ILE . 48.1 t -74.72 -43.37 47.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.245 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -79.63 -17.9 52.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.012 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.93 -95.33 0.19 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.451 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp-105 -118.06 83.37 1.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.63 69.55 15.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.9 11.96 2.6 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.609 2.206 . . . . 0.0 112.526 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.17 -14.93 8.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 1.8 ttmt -88.46 127.01 58.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.156 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 23.4 Cg_exo -65.16 -166.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.692 2.261 . . . . 0.0 112.084 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 p -118.68 135.64 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.138 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 138' ' ' ALA . 8.6 t -96.24 131.69 42.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.592 HD11 HD11 ' A' ' 74' ' ' ILE . 32.3 pt -116.89 169.93 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.524 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 0.6 OUTLIER -114.75 137.1 52.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.353 . . . . 0.0 110.603 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.662 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 2.2 p -145.84 173.91 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.838 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.591 ' H ' HG22 ' A' ' 68' ' ' VAL . 21.4 t -80.17 -42.52 23.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.958 0.408 . . . . 0.0 110.371 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.51 20.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.604 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.555 ' HA ' HG22 ' A' ' 74' ' ' ILE . 15.8 t -57.17 -29.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.943 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.9 OUTLIER -67.46 -32.68 73.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.225 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.99 -13.24 59.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.489 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.592 HD11 HD11 ' A' ' 66' ' ' ILE . 6.3 tt -114.16 44.52 0.32 Allowed Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 72.9 Cg_endo -76.39 -46.76 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.726 1.618 . . . . 0.0 112.634 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -72.42 -1.03 14.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.886 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -107.78 -56.07 2.28 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.652 -179.27 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 p -114.55 171.03 7.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.83 0.347 . . . . 0.0 111.144 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -121.94 108.18 34.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -102.45 -168.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.221 2.614 . . . . 0.0 113.007 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 3.2 t -138.82 -178.24 5.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.88 -83.72 0.37 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.843 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.797 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -54.96 -27.78 46.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.111 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.66 -46.43 89.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 81' ' ' SER . 19.5 mmt -74.92 -11.98 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.797 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -71.17 -48.28 52.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.992 0.425 . . . . 0.0 110.585 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 5.0 tp -65.21 -35.99 82.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.79 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.444 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 7.7 tpp -68.41 -44.61 74.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -66.63 -13.82 61.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 5.7 tpt180 -73.43 -42.11 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.651 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 pt -110.55 43.79 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.041 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.907 HD21 HG21 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -131.2 143.5 49.59 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.055 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.804 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.4 Cg_exo -78.13 -165.14 4.37 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.174 -0.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.81 173.33 23.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.588 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 93.0 Cg_endo -79.82 39.23 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.563 2.175 . . . . 0.0 112.358 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.647 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 1.3 m-85 -111.98 143.87 42.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.82 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.518 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 29.1 m -94.82 135.95 35.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.606 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.435 HG11 ' HG2' ' A' ' 88' ' ' MET . 4.9 t -120.29 109.76 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.429 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.802 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 19.1 t -99.66 135.97 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.276 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.572 ' HB2' HD11 ' A' ' 119' ' ' ILE . 2.4 mm? -126.45 -172.69 2.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.043 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.04 -165.84 0.43 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.733 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.821 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.13 132.44 56.34 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.97 0.414 . . . . 0.0 111.106 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 5.9 t30 -74.87 -173.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.15 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 9.27 2.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.483 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.5 ' HB2' HH12 ' A' ' 102' ' ' ARG . 1.3 mt -69.39 -174.39 0.67 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.711 0.291 . . . . 0.0 110.838 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 108' ' ' ASP . 2.8 mt -79.53 107.47 6.55 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.283 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 105' ' ' LEU . 65.4 Cg_endo -71.65 23.56 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.675 2.25 . . . . 0.0 112.941 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 106' ' ' ILE . 3.7 m-20 -61.55 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.683 0.278 . . . . 0.0 111.2 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 m -90.21 5.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.703 0.287 . . . . 0.0 111.202 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.439 HG21 HH21 ' A' ' 102' ' ' ARG . 4.1 mt -96.4 -35.01 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.4 OUTLIER -87.13 -37.27 17.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.622 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.78 -101.35 0.64 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.347 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.26 -60.42 1.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.631 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.78 -179.32 3.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.728 0.299 . . . . 0.0 110.906 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.543 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.8 OUTLIER -92.78 70.1 4.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.995 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -136.75 163.69 30.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.322 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.821 HG23 ' HG2' ' A' ' 102' ' ' ARG . 95.3 t -139.54 125.07 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.377 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.553 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -78.92 152.71 37.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.899 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -144.87 156.06 14.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.653 0.263 . . . . 0.0 110.553 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -148.49 124.82 10.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.261 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.907 HG21 HD21 ' A' ' 92' ' ' LEU . 5.2 t -110.42 86.99 5.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.694 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.56 179.77 5.25 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.518 2.146 . . . . 0.0 112.65 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.507 ' H ' HG21 ' A' ' 33' ' ' THR . 0.3 OUTLIER -93.28 5.17 52.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.03 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.87 106.99 7.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.155 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -57.34 -39.44 75.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.771 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 16' ' ' LEU . 45.2 mm -63.1 -54.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.873 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -18.53 60.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -72.27 -36.46 69.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -75.02 -52.53 10.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.239 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' ' 130' ' ' ILE . 17.0 mt -60.0 -53.72 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.662 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -60.84 -26.93 67.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.277 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -54.63 -56.77 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.018 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.35 -86.06 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.326 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.78 115.29 46.84 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.68 137.75 46.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.558 2.172 . . . . 0.0 111.602 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.466 HG23 ' HB2' ' A' ' 67' ' ' CYS . 27.2 m -114.74 170.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 120.943 0.402 . . . . 0.0 111.737 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.654 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 46.2 m -80.76 139.94 35.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.012 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.66 103.71 4.92 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.287 0.367 . . . . 0.0 111.37 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -130.28 126.31 36.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.129 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.7 p -70.93 110.86 5.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -82.1 96.59 7.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -154.25 25.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.041 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 55' ' ' VAL . 10.9 pt -81.16 -154.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.251 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.1 p -59.83 170.39 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.921 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.449 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 75.98 -139.64 24.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.293 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -127.55 62.91 57.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 39.5 Cg_exo -60.53 -50.19 7.36 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.24 1.96 . . . . 0.0 113.178 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 91.0 Cg_endo -78.99 103.05 1.59 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.898 1.732 . . . . 0.0 112.148 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -82.91 145.97 51.11 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 -179.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 72.2 Cg_endo -95.53 -11.22 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.916 2.411 . . . . 0.0 111.929 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.93 128.88 14.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.736 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.04 -27.36 66.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 156' ' ' VAL . 3.7 tt0 -71.07 -37.89 72.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.171 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -55.73 31.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.323 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 165' ' ' VAL . 0.6 OUTLIER -63.47 -42.98 98.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.741 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -53.08 -30.1 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -176.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.56 -39.21 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -26.79 57.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.257 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 155' ' ' ILE . 2.0 pp -94.98 46.8 1.13 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t70 -16.03 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.728 0.643 . . . . 0.0 112.551 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -157.32 10.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.77 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.2 p -81.39 -75.97 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.381 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.77 ' H ' HG13 ' A' ' 162' ' ' VAL . 4.2 t70 -95.79 109.07 21.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.791 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.726 ' HG ' HG22 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -73.85 120.65 19.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 111.99 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.76 HG22 ' H ' ' A' ' 166' ' ' LEU . 4.3 p -61.72 -179.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.779 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.76 ' H ' HG22 ' A' ' 165' ' ' VAL . 1.3 pt? -125.28 149.28 48.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.828 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.19 -19.61 22.05 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.289 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.53 -48.0 61.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.953 0.406 . . . . 0.0 110.945 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.606 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 91.56 -168.51 31.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.777 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -163.41 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.716 0.293 . . . . 0.0 111.074 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.44 ' HB2' ' N ' ' A' ' 34' ' ' ASP . 44.2 m -140.95 -56.94 0.5 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.48 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -129.43 -130.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.518 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.514 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 33.9 m-20 -86.36 146.29 26.53 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.487 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.78 ' HG2' HG23 ' A' ' 36' ' ' ILE . 3.7 ttp -69.35 0.17 5.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.179 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.81 156.75 30.99 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.631 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 177' ' ' SER . 70.7 Cg_endo -88.71 -140.27 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.921 -1.283 . . . . 0.0 112.576 0.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.5 OUTLIER -153.63 124.77 7.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.623 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 191' ' ' ARG . 34.8 m -101.99 131.69 48.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.45 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.518 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -129.48 109.15 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.707 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.72 HG12 ' HA ' ' A' ' 189' ' ' VAL . 15.1 mt -120.9 137.14 55.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.474 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.802 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 6.0 t70 -107.99 66.91 0.66 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.589 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.444 ' CD2' ' HB2' ' A' ' 88' ' ' MET . 21.9 tp -69.77 88.26 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -79.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.437 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 185' ' ' ASN . 4.8 t -120.64 -121.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.861 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.9 t-20 -63.48 -50.59 72.53 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 79.7 Cg_endo -77.87 108.75 2.59 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.24 1.96 . . . . 0.0 112.566 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.1 Cg_endo -82.44 128.6 5.52 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.558 2.172 . . . . 0.0 112.248 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 181' ' ' ASP . 17.8 mtp180 -87.58 56.1 3.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.72 ' HA ' HG12 ' A' ' 180' ' ' ILE . 17.9 t -59.97 104.96 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.423 ' O ' HG23 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -127.75 74.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.011 -179.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.682 ' HB3' HG23 ' A' ' 178' ' ' THR . 1.5 ptp85 -89.73 139.58 30.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.941 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.81 89.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -87.2 168.46 38.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.61 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.24 -174.61 2.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.331 . . . . 0.0 110.802 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.91 -66.8 2.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.49 159.85 30.19 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.692 2.262 . . . . 0.0 112.209 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.7 174.21 10.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.35 149.68 97.74 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.56 143.45 97.01 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.518 2.145 . . . . 0.0 112.271 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.2 m -71.32 -179.94 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.248 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.88 26.03 7.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.984 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.99 172.3 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.58 -56.34 4.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.007 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.29 -127.11 9.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.464 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.49 149.44 45.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.769 0.319 . . . . 0.0 111.063 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -124.76 20.33 6.84 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.559 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.51 18.76 19.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.046 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.824 0.345 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.13 -178.56 6.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.024 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 mm -78.9 131.5 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.941 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -83.97 157.93 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.011 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -75.0 -166.36 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -110.38 -68.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.027 179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 p -106.24 -79.15 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.173 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -102.23 175.82 5.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.929 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.38 -67.36 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.014 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 11.9 m120 -94.12 131.17 32.14 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.017 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 10' ' ' ASN . 33.2 Cg_exo -59.61 -66.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.583 2.189 . . . . 0.0 112.075 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 m 55.18 83.89 0.22 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HD2' HD12 ' A' ' 16' ' ' LEU . 45.1 Cg_exo -56.59 149.52 57.72 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.466 2.111 . . . . 0.0 112.233 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.38 -28.74 68.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.066 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.6 t -65.31 -57.31 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.013 HD11 HG22 ' A' ' 126' ' ' ILE . 13.7 mt -62.01 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 20' ' ' ILE . 3.4 mt-10 -64.15 -23.75 67.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.712 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -76.5 -32.69 58.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.165 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -72.27 -44.33 62.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.761 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.608 ' HA ' ' HG2' ' A' ' 23' ' ' MET . 0.1 OUTLIER -75.55 -18.37 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.182 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.4 t -75.52 -47.95 24.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.352 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.545 HG21 HD23 ' A' ' 164' ' ' LEU . 12.7 p -74.52 -26.93 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.656 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 20' ' ' ILE . 15.7 ptp -73.97 -31.51 63.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 0.0 111.112 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -25.09 65.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.84 31.18 6.36 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' HA2' ' CG ' ' A' ' 47' ' ' ASP . . . 67.0 47.53 64.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' MET . . . -130.12 147.47 18.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.28 143.0 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.638 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -117.94 145.26 24.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.766 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.658 HD11 HG21 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.96 167.27 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.255 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -171.72 94.52 0.41 Allowed Pre-proline 0 C--N 1.332 -0.152 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.2 Cg_endo -84.14 142.71 9.9 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.872 2.381 . . . . 0.0 110.549 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.696 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 85.7 m -138.09 -97.99 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.631 -0.428 . . . . 0.0 112.047 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.675 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.12 -59.13 2.88 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.58 ' OG1' HG13 ' A' ' 36' ' ' ILE . 1.2 t -79.87 -104.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.005 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.58 HG13 ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -114.68 -146.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.62 0.248 . . . . 0.0 111.048 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.818 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 2.1 m-85 -81.84 134.39 35.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.854 0.359 . . . . 0.0 111.038 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -116.4 -178.34 18.09 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.086 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.689 ' HB2' HG23 ' A' ' 139' ' ' THR . 4.5 mt -133.65 142.68 48.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.778 0.323 . . . . 0.0 110.988 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.39 132.2 4.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.881 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -158.97 171.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.148 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.729 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 4.1 t-20 -56.58 122.2 11.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.131 178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -57.49 -67.03 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -176.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.5 37.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.6 OUTLIER -110.41 146.67 35.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.681 178.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.99 -25.82 60.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.707 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.448 ' CG ' ' HA2' ' A' ' 26' ' ' GLY . 3.3 m-20 -61.63 -29.75 70.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.625 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.39 -36.11 60.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.09 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.838 HG13 HG21 ' A' ' 109' ' ' VAL . 18.7 t -61.62 -46.77 95.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -48.69 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.126 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.523 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 1.9 mmp_? -63.79 -21.55 66.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 0.3 OUTLIER -71.41 -40.92 70.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.79 -19.45 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 51' ' ' ARG . 4.2 mmt180 -71.86 -56.4 5.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.357 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -75.36 -43.13 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.742 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -79.71 -3.17 46.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.303 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -113.75 5.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.19 90.12 3.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.857 0.36 . . . . 0.0 111.05 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 t -144.8 71.37 15.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.66 7.37 4.58 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.763 2.309 . . . . 0.0 112.721 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -114.35 -14.41 12.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.14 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.01 122.03 70.27 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.966 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.24 171.47 1.74 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.594 2.196 . . . . 0.0 112.315 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 110' ' ' ILE . 10.5 p -112.8 145.02 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.008 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -93.6 146.49 23.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -116.39 154.31 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 52.8 t -105.02 122.93 46.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.449 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.633 HG22 ' H ' ' A' ' 69' ' ' SER . 1.8 p -147.51 177.68 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.765 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.633 ' H ' HG22 ' A' ' 68' ' ' VAL . 2.5 t -86.74 -36.32 18.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.109 0.481 . . . . 0.0 110.23 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.442 ' N ' HG13 ' A' ' 68' ' ' VAL . 3.5 t -162.89 161.16 25.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.325 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.767 HG21 ' HE2' ' A' ' 85' ' ' MET . 17.8 t -55.58 -32.69 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.379 . . . . 0.0 111.099 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 2.0 m-20 -67.35 -29.36 68.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.001 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -80.58 -15.27 57.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.371 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.506 ' O ' HG12 ' A' ' 74' ' ' ILE . 3.0 tt -114.34 47.9 0.44 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 98.8 Cg_endo -79.08 -32.67 1.74 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.778 1.652 . . . . 0.0 112.298 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -72.49 -11.8 60.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.672 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -107.59 -49.44 3.24 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.483 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.9 p -114.83 178.23 4.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.238 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.602 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -117.22 116.63 37.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.023 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HB3' HG12 ' A' ' 71' ' ' VAL . 68.2 Cg_endo -102.22 178.09 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.162 2.575 . . . . 0.0 112.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.6 OUTLIER -140.76 177.35 8.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.89 -99.75 0.04 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.966 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.04 -25.49 30.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.158 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -60.25 -47.16 87.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.767 ' HE2' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -67.97 -27.93 67.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.003 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -57.88 11.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.578 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 11.8 tp -57.82 -26.2 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.884 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.546 ' SD ' HD13 ' A' ' 182' ' ' LEU . 6.9 tpt -72.39 -46.79 53.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.427 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.35 -4.03 33.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.273 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.59 -38.52 87.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.066 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.05 58.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -123.97 141.23 36.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 5.7 Cg_exo -78.66 -161.57 2.74 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.246 -1.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.45 163.1 11.65 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.748 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.17 38.55 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.606 2.204 . . . . 0.0 112.2 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 92' ' ' LEU . 30.6 p90 -99.96 158.03 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.08 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 m -110.51 137.67 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.545 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 119' ' ' ILE . 15.7 t -117.93 109.2 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.881 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 50.4 t -104.33 126.57 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.282 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.479 HD11 ' HE1' ' A' ' 85' ' ' MET . 1.2 mt -126.33 -167.02 1.65 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.559 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -74.58 -167.94 0.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.687 178.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.52 ' HG2' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.45 137.44 53.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.252 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -74.43 -173.19 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.084 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -75.54 5.14 6.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.295 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.419 ' HB2' HH21 ' A' ' 102' ' ' ARG . 1.5 mt -69.7 163.38 25.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.911 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.462 HG12 ' HB2' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -65.8 108.99 2.56 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 30.48 0.25 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.956 2.437 . . . . 0.0 113.051 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.462 ' HB2' HG12 ' A' ' 106' ' ' ILE . 37.8 t70 -61.46 -97.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.578 0.227 . . . . 0.0 111.559 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 49' ' ' VAL . 6.3 p -89.74 5.6 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.798 0.332 . . . . 0.0 111.618 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 64' ' ' VAL . 1.4 mt -97.87 -36.27 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.313 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.513 ' OG1' ' HA ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -87.11 -39.62 15.39 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.102 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.09 -96.53 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.44 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.45 -64.47 1.22 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.891 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.679 ' HB2' ' HE ' ' A' ' 116' ' ' ARG . 0.7 OUTLIER -104.56 176.27 5.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.681 0.277 . . . . 0.0 111.111 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.513 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 0.0 OUTLIER -92.47 71.89 5.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.928 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.679 ' HE ' ' HB2' ' A' ' 114' ' ' SER . 64.2 mtm180 -136.32 160.36 38.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' A' ' 102' ' ' ARG . 21.6 t -139.26 125.92 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.428 ' C ' HG13 ' A' ' 119' ' ' ILE . . . -85.61 161.55 35.31 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.514 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 98' ' ' VAL . 30.5 mt -144.74 152.34 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.632 0.253 . . . . 0.0 110.452 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.61 120.23 9.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 111.219 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 t -110.83 86.58 5.96 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.736 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.95 -178.02 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.516 2.144 . . . . 0.0 112.513 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -0.58 50.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.982 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.843 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.7 t0 -72.88 96.09 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -43.12 83.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.599 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 1.013 HG22 HD11 ' A' ' 16' ' ' LEU . 9.5 mt -67.48 -48.64 76.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.004 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.843 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 15.1 t -57.81 -29.02 64.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.546 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.8 mtp180 -67.35 -33.95 76.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.484 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -64.43 -58.77 5.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.973 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 tt -63.83 -35.08 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.376 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.43 -30.05 64.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.151 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -55.35 -55.36 32.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.972 0.415 . . . . 0.0 110.178 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -75.9 -83.86 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.296 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.67 110.11 9.79 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.23 147.26 83.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.429 2.086 . . . . 0.0 111.768 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.89 159.51 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 5.2 m -80.13 141.75 35.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.14 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -138.63 109.85 6.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.871 0.367 . . . . 0.0 111.756 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.689 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -132.75 157.06 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.508 178.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 p -78.52 126.51 30.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.055 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.509 ' HA ' HD11 ' A' ' 39' ' ' LEU . . . -74.62 117.92 17.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.07 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 147' ' ' PRO . 6.9 t30 -161.47 47.46 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.63 173.86 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.3 p -58.9 148.97 28.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.92 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.23 -126.95 8.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.475 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.46 90.85 50.35 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.596 0.236 . . . . 0.0 110.924 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.403 ' HG2' ' HA ' ' A' ' 142' ' ' ASN . 36.7 Cg_exo -60.48 -49.48 8.9 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.477 2.118 . . . . 0.0 113.459 -178.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.89 110.4 3.03 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.861 1.707 . . . . 0.0 112.279 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.37 151.94 38.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -95.88 -12.03 0.75 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.948 2.432 . . . . 0.0 112.934 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -131.48 137.39 48.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.208 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 64.2 mt -68.8 -33.39 73.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.717 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.1 -19.27 60.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.913 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -36.79 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.702 HD12 HG23 ' A' ' 165' ' ' VAL . 69.4 mt -67.62 -55.56 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.142 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.2 m -54.87 -33.85 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.297 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -59.46 2.73 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.626 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.608 ' HB3' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -57.45 -43.01 83.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.429 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.753 ' HG ' ' HB3' ' A' ' 163' ' ' ASP . 2.3 mm? -101.3 66.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 159' ' ' LEU . 33.8 t70 -16.87 -61.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.033 0.833 . . . . 0.0 112.706 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -152.15 11.56 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.241 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.651 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.5 p -81.01 -63.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.837 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HB3' ' HG ' ' A' ' 159' ' ' LEU . 40.4 t0 -109.34 91.33 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.477 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.545 HD23 HG21 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -69.67 139.81 53.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.473 -178.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.702 HG23 HD12 ' A' ' 155' ' ' ILE . 1.4 p -74.62 -175.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.047 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.695 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.55 134.21 50.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -4.22 53.67 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.14 98.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.755 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.484 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 86.71 28.82 25.55 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.995 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.696 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 25.7 m-20 -73.28 119.89 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.929 0.395 . . . . 0.0 110.842 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.7 125.62 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.591 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -136.7 -138.64 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.216 -179.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -86.26 137.22 32.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.88 0.371 . . . . 0.0 111.598 -178.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 2.6 ttt -68.83 -5.78 22.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.813 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 173' ' ' ASP . 0.2 OUTLIER -149.99 156.54 38.0 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.693 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -90.63 -152.92 0.55 Allowed 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.864 -1.307 . . . . 0.0 112.633 0.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.1 t -155.52 122.25 5.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.521 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.79 137.15 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.471 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.91 91.05 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.531 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.601 HG23 ' HA ' ' A' ' 189' ' ' VAL . 2.2 mp -106.55 128.69 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.752 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.881 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.4 m-20 -103.01 64.13 0.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.116 177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.546 HD13 ' SD ' ' A' ' 88' ' ' MET . 5.1 tt -69.55 94.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.427 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -77.09 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 110.578 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.22 -123.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.589 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -63.39 -52.2 62.36 Favored Pre-proline 0 CA--C 1.532 0.253 0 O-C-N 122.423 -0.173 . . . . 0.0 111.256 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 3.4 Cg_exo -75.07 109.22 2.89 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.554 2.169 . . . . 0.0 112.183 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 93.2 Cg_endo -84.19 131.58 5.04 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.61 2.206 . . . . 0.0 112.405 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 23.8 mmm-85 -89.44 51.08 2.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.989 0.424 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.601 ' HA ' HG23 ' A' ' 180' ' ' ILE . 14.7 t -58.26 98.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.781 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.5 91.42 3.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.133 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 178.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 98.58 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.35 19.47 35.56 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -97.03 -60.27 1.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.029 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.43 114.18 5.28 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.414 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.0 161.47 35.77 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.569 2.179 . . . . 0.0 112.366 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.91 8.59 3.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.95 -49.99 55.02 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.487 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.34 154.3 19.5 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.189 1.926 . . . . 0.0 112.318 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.08 145.07 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.052 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.76 27.31 3.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.31 -42.29 13.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.984 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -173.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -149.55 113.67 0.62 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.589 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -90.95 14.87 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 0.0 111.084 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -150.59 58.92 0.43 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.444 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.87 -10.63 41.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.8 0.333 . . . . 0.0 111.041 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.4 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.102 -179.917 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.799 0.333 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.88 -168.84 0.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.75 134.37 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.205 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -109.86 90.04 3.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.52 173.15 12.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 8' ' ' ARG . 6.9 tt -110.03 143.81 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -59.86 2.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.076 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.451 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -97.65 -173.15 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -50.23 8.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.765 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.478 ' ND2' ' HG2' ' A' ' 17' ' ' GLU . 22.8 m120 -84.4 133.71 44.19 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.81 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.546 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 48.0 Cg_exo -55.64 -79.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.482 2.122 . . . . 0.0 112.181 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.513 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -173.5 -52.12 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.49 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.783 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 73.9 Cg_endo -76.4 151.72 33.68 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.225 1.95 . . . . 0.0 112.663 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -71.5 -32.51 68.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.77 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.478 HG22 ' HB3' ' A' ' 167' ' ' ASP . 58.8 t -60.43 -35.93 66.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.738 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.783 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 2.0 mm? -74.03 -39.13 63.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HG2' ' ND2' ' A' ' 10' ' ' ASN . 36.1 mt-10 -71.58 -21.34 61.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.981 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -76.42 -35.68 58.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.777 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.77 75.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.285 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' H ' HG13 ' A' ' 20' ' ' ILE . 1.7 pp -75.66 -21.35 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 t -66.9 -50.43 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.774 ' HB ' HD22 ' A' ' 164' ' ' LEU . 8.0 p -65.15 -32.99 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.098 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.4 mtt -61.48 -29.22 69.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.76 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.83 -30.54 62.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.01 5.11 77.88 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.577 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.16 36.6 93.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.692 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.9 169.65 13.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.19 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.43 146.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.7 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -119.51 131.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.632 HG12 ' HB2' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -102.35 162.81 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.565 ' CD1' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -167.81 99.63 0.59 Allowed Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.633 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 79.1 Cg_endo -84.1 166.62 12.75 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.545 2.164 . . . . 0.0 110.922 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.748 ' HA ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -138.72 -157.61 0.78 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.937 178.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.573 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 10.4 p-10 -63.61 -13.19 39.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.819 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -100.37 -94.49 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.996 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.481 ' H ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -133.13 173.17 15.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.661 0.267 . . . . 0.0 111.177 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 5.7 m-85 -63.88 144.28 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.827 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -135.09 -174.83 13.57 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.334 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 mp -126.68 146.54 50.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.55 121.53 1.46 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.183 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.595 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.75 171.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.817 0.341 . . . . 0.0 111.132 179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.748 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -56.76 123.43 14.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.055 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.24 -65.71 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.264 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.95 40.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.762 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.38 149.41 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 178.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -75.47 -28.76 59.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -65.23 -27.17 68.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.292 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -75.5 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.071 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 46' ' ' GLU . 20.5 m -65.53 -28.83 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.219 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 46' ' ' GLU . 4.8 mtp180 -72.39 -46.98 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.824 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -70.42 -27.09 64.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 48' ' ' ALA . 2.0 mp -67.12 -34.57 77.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -69.62 -39.74 77.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.953 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -65.19 -48.58 72.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.95 -40.04 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 5.6 mptt -83.0 -2.16 54.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.961 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.29 -102.78 0.57 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.326 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 71.29 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.036 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.02 70.25 70.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.11 -1.58 11.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.503 2.135 . . . . 0.0 112.425 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -121.12 -1.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -82.98 124.63 76.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.999 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.05 160.9 9.49 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.575 2.184 . . . . 0.0 112.431 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 110' ' ' ILE . 7.3 p -117.28 148.67 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 t -95.38 149.86 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.979 0.419 . . . . 0.0 111.074 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 117' ' ' VAL . 25.0 mt -116.02 157.65 16.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.846 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 6.9 t -116.25 119.75 36.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.767 ' HA ' ' HB1' ' A' ' 131' ' ' ALA . 1.0 OUTLIER -136.03 171.09 17.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.993 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.464 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -84.59 -38.83 19.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.103 0.477 . . . . 0.0 110.447 179.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.06 169.52 17.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.398 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' A' ' 85' ' ' MET . 22.2 t -59.2 -32.7 48.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.07 -26.62 66.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.663 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 17.8 mm-40 -81.12 -19.9 42.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.296 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.596 ' N ' ' HD3' ' A' ' 75' ' ' PRO . 15.4 tt -114.74 47.49 0.45 Allowed Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 21.7 Cg_exo -66.93 -65.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 121.832 1.688 . . . . 0.0 113.208 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -72.29 4.21 3.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.508 ' HB3' ' CG1' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -108.0 -24.03 11.77 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.571 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -129.31 159.27 36.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 111.37 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.565 ' HG3' ' HA ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -116.57 87.12 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.69 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -102.35 -163.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.062 2.508 . . . . 0.0 112.83 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.76 -177.67 5.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.5 -77.2 0.73 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.645 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.778 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -56.2 -31.31 63.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.816 0.341 . . . . 0.0 111.066 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.07 91.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.119 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.515 ' HG3' HG11 ' A' ' 71' ' ' VAL . 20.2 mmt -71.41 -17.61 62.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.271 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.778 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 1.2 mm-40 -63.75 -50.35 69.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.263 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HA ' ' HG3' ' A' ' 90' ' ' ARG . 2.5 tm? -60.58 -37.77 82.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.304 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.532 ' SD ' HG21 ' A' ' 98' ' ' VAL . 5.9 tpt -66.78 -33.31 75.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.016 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.14 -15.04 61.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.116 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 87' ' ' LEU . 1.2 mtp85 -67.0 -61.98 1.66 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.797 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 pt -98.68 57.47 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.051 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 121' ' ' VAL . 3.9 tt -131.03 129.19 22.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.912 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HB3' HG12 ' A' ' 121' ' ' VAL . 6.0 Cg_exo -78.14 -159.97 2.19 Favored 'Cis proline' 0 C--N 1.349 0.598 0 C-N-CA 124.008 -1.247 . . . . 0.0 112.28 -0.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.433 ' HA3' ' CE2' ' A' ' 96' ' ' TYR . . . 156.83 163.04 11.97 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.626 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.756 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 4.6 Cg_exo -78.1 39.49 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.051 2.501 . . . . 0.0 112.371 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.433 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -112.3 130.97 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.337 -179.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.17 114.9 26.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.3 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.532 HG21 ' SD ' ' A' ' 88' ' ' MET . 2.0 m -108.87 118.81 57.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.92 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 118' ' ' GLY . 22.0 t -91.64 131.07 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.218 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 183' ' ' THR . 0.3 OUTLIER -127.18 178.93 5.71 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.426 0.453 . . . . 0.0 111.121 -178.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.75 176.08 7.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.681 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.05 137.14 53.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.979 0.419 . . . . 0.0 111.36 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.565 ' HA ' ' HG3' ' A' ' 79' ' ' ARG . 1.5 t-20 -74.59 -153.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.024 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -75.55 15.8 0.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.648 HD13 ' H ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -69.51 153.98 42.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.679 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 105' ' ' LEU . 4.7 pt -59.67 109.61 2.1 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.24 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 59.2 Cg_endo -70.81 1.93 4.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.692 2.261 . . . . 0.0 112.785 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.13 -93.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.762 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.78 7.33 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 64' ' ' VAL . 41.3 mm -103.2 -64.93 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 111.317 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 107' ' ' PRO . 8.4 p -87.42 -26.97 23.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.39 -116.67 4.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.727 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -90.35 -20.2 42.58 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.019 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -104.83 179.8 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.575 0.226 . . . . 0.0 110.845 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -113.45 42.37 1.97 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.891 0.377 . . . . 0.0 111.153 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -136.64 156.19 48.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.352 -179.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.681 HG23 ' HB3' ' A' ' 102' ' ' ARG . 58.8 t -139.51 144.6 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.448 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.521 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -84.04 160.08 36.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.96 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 118' ' ' GLY . 34.0 mt -149.15 141.14 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -148.91 134.11 18.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.946 0.403 . . . . 0.0 111.566 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 92' ' ' LEU . 34.2 t -111.02 81.96 2.92 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.768 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.549 ' HG2' ' OD1' ' A' ' 124' ' ' ASP . 34.9 Cg_endo -64.38 -178.86 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.566 2.177 . . . . 0.0 112.747 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.91 -0.98 55.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.72 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.549 ' OD1' ' HG2' ' A' ' 122' ' ' PRO . 0.8 OUTLIER -64.75 105.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.889 0.376 . . . . 0.0 111.034 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.35 -42.88 82.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.217 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.44 -58.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.218 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.65 -19.85 42.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 69' ' ' SER . 42.6 ttt-85 -70.11 -35.88 74.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.032 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.37 -51.89 13.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.05 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 mt -60.38 -51.78 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.15 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.767 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -61.17 -29.41 69.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.193 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -55.08 -55.27 32.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.987 0.422 . . . . 0.0 110.039 178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -90.14 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.114 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 1.9 m-85 -77.17 127.34 83.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.935 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 23.1 Cg_exo -65.54 154.15 75.03 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.341 2.027 . . . . 0.0 111.555 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.55 156.28 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.64 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 2.1 m -80.41 136.7 36.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.777 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -133.02 108.05 8.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 0.0 111.868 -178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -127.76 118.54 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.582 178.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -62.43 112.17 2.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.982 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -88.41 81.48 7.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.21 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 7.8 p30 -156.34 25.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 143' ' ' ILE . 0.9 OUTLIER -81.27 -145.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.09 162.52 2.51 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.866 0.365 . . . . 0.0 111.146 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.464 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 76.04 -144.96 31.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.362 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 7.8 tttt -127.47 63.09 57.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.633 0.254 . . . . 0.0 111.23 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 42.3 Cg_exo -60.65 -48.69 10.38 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.323 2.015 . . . . 0.0 113.336 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 142' ' ' ASN . 73.7 Cg_endo -77.23 132.21 12.39 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.868 1.712 . . . . 0.0 112.427 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.16 156.56 36.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.897 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -95.06 -16.59 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.718 2.279 . . . . 0.0 112.382 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.691 ' HG2' ' H ' ' A' ' 154' ' ' GLU . 12.5 ttm180 -141.7 129.13 21.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.319 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.512 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -58.07 -31.12 66.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.273 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.614 ' O ' HG12 ' A' ' 156' ' ' VAL . 2.1 tt0 -74.42 -34.74 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.396 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.691 ' H ' ' HG2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.6 -42.9 97.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.46 -178.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.762 HD12 HG23 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.17 -38.81 49.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.606 -178.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -53.37 -32.84 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.269 -177.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HD2' HH11 ' A' ' 157' ' ' ARG . 2.1 mtm180 -75.92 -41.71 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.994 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -22.9 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 164' ' ' LEU . 3.3 pp -93.22 37.41 1.04 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.101 -0.24 . . . . 0.0 111.643 -178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.487 ' C ' ' O ' ' A' ' 159' ' ' LEU . 27.6 t70 -18.38 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.753 0.658 . . . . 0.0 112.517 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 159' ' ' LEU . . . -154.64 7.95 0.3 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.417 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 163' ' ' ASP . 1.3 p -81.37 -80.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.618 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.777 ' H ' HG13 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -104.64 89.44 3.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.768 0.318 . . . . 0.0 111.137 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.774 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -57.22 121.18 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.679 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.823 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.3 p -60.24 -170.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.391 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.885 HD12 ' H ' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -125.95 156.97 38.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.942 -179.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.478 ' HB3' HG22 ' A' ' 15' ' ' VAL . 2.3 t70 -91.77 -26.98 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.196 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.8 -59.21 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.797 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.885 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 81.62 49.21 5.53 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.13 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.748 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -70.63 105.73 3.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.337 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -157.54 122.12 4.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.329 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -137.43 -104.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 1.4 m-20 -85.37 111.71 20.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 35' ' ' THR . 83.9 mmm -65.89 -16.8 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.175 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.97 154.64 39.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 177' ' ' SER . 67.7 Cg_endo -91.67 -149.7 0.33 Allowed 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 123.934 -1.278 . . . . 0.0 112.681 0.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 23.0 p -158.27 146.35 18.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.473 HG22 HG13 ' A' ' 180' ' ' ILE . 40.5 m -101.87 145.19 29.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.899 0.38 . . . . 0.0 111.125 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 59.9 t -126.98 96.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.59 HG23 ' HA ' ' A' ' 189' ' ' VAL . 12.5 mt -110.64 135.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.395 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.92 65.43 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.068 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 100' ' ' LEU . 18.6 tp -70.14 82.63 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.397 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.34 -75.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.336 . . . . 0.0 110.433 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.58 -120.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.562 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.457 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.1 m-80 -67.4 -52.83 26.4 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.0 109.05 2.26 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.38 2.053 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 85.3 Cg_endo -82.91 123.83 3.73 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.529 2.152 . . . . 0.0 112.162 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -88.01 54.4 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.59 ' HA ' HG23 ' A' ' 180' ' ' ILE . 11.6 t -57.56 104.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.904 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.39 89.9 2.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.074 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -86.95 141.01 29.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 192' ' ' ARG . 0.8 OUTLIER -79.0 -21.19 47.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -92.07 -153.4 29.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.532 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.3 128.69 55.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.822 0.344 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -74.63 164.64 54.65 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.512 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.712 ' HG2' HD23 ' A' ' 197' ' ' LEU . 59.7 Cg_endo -72.78 -6.31 18.79 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.569 2.179 . . . . 0.0 112.36 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.712 HD23 ' HG2' ' A' ' 196' ' ' PRO . 0.6 OUTLIER -149.22 29.06 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.523 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -77.64 -50.9 1.93 Allowed Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.415 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 198' ' ' ASP . 50.6 Cg_endo -68.27 -46.45 2.13 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.213 1.942 . . . . 0.0 112.503 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.543 HG22 ' H ' ' A' ' 202' ' ' LEU . 14.7 p -69.18 142.25 16.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.076 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.18 35.57 4.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.543 ' H ' HG22 ' A' ' 200' ' ' VAL . 0.1 OUTLIER -78.06 -71.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.055 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -82.3 178.77 8.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.081 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -164.15 150.85 19.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.527 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -80.95 112.31 18.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.7 0.286 . . . . 0.0 111.107 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 154.12 85.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.468 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.27 26.39 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 0.0 110.951 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.086 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ptt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.805 0.336 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.438 HD12 ' HE ' ' A' ' 4' ' ' ARG . 1.1 mt -104.65 -175.58 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 tp -79.75 -6.78 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HE ' HD12 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -75.07 161.76 29.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.859 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 153.74 37.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.923 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 pt -84.56 -30.03 7.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.222 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -71.99 173.46 8.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.015 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.43 150.84 28.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.003 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -77.59 149.24 34.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.606 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -110.0 94.83 18.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.215 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 -45.05 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.386 2.057 . . . . 0.0 112.06 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 53.27 70.78 1.64 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.176 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.656 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 19.0 Cg_exo -65.6 142.48 71.19 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.559 2.173 . . . . 0.0 112.008 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 4.4 m-20 -74.24 -38.68 63.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 t -69.66 -26.5 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.3 mm? -70.87 -52.27 21.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -64.82 -20.06 66.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.5 mm-40 -67.65 -47.46 69.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.18 82.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.222 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 16' ' ' LEU . 28.2 mm -67.92 -33.26 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.81 -30.71 70.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.974 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.521 HG22 ' HG ' ' A' ' 164' ' ' LEU . 11.7 t -72.68 -33.38 44.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.5 mmt -64.03 -50.15 69.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.025 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.02 -17.57 64.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.252 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.29 0.91 84.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.2 35.02 90.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.59 165.06 12.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.695 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -96.19 146.59 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 110.511 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.695 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.15 129.87 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.701 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -102.42 163.04 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.677 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -163.68 88.42 1.19 Allowed Pre-proline 0 CA--C 1.529 0.139 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.599 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 94.5 Cg_endo -78.22 119.94 4.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.498 2.132 . . . . 0.0 110.749 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.858 ' HA ' ' HB3' ' A' ' 170' ' ' ASP . 0.6 OUTLIER -116.46 -139.17 0.37 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.04 0.448 . . . . 0.0 111.961 -176.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 95' ' ' PRO . 0.3 OUTLIER -53.62 -47.77 69.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.52 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 36' ' ' ILE . 3.3 t -79.0 -119.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.735 HG12 ' H ' ' A' ' 37' ' ' TYR . 8.3 tt -112.36 -168.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.282 -0.261 . . . . 0.0 110.846 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.735 ' H ' HG12 ' A' ' 36' ' ' ILE . 4.1 m-85 -63.43 127.89 33.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 110.353 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -115.43 170.58 13.34 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.368 -179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -120.12 139.58 52.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.36 117.28 0.94 Allowed Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.869 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 42' ' ' ASN . 2.0 p -158.36 174.63 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.708 0.29 . . . . 0.0 111.331 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.809 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -56.22 114.36 1.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.653 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.481 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -66.17 -49.75 66.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.038 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' HD13 ' A' ' 44' ' ' LEU . 1.2 mm? -80.97 28.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 111.564 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.809 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -111.02 152.23 27.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.71 178.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -75.36 -29.0 59.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.835 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -28.79 68.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.039 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.49 ' O ' HD23 ' A' ' 52' ' ' LEU . . . -68.18 -32.59 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.534 ' HA ' HD23 ' A' ' 52' ' ' LEU . 56.5 t -70.12 -48.67 60.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.135 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.32 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.245 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HD2' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -69.98 -55.78 8.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.276 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -60.13 -17.51 40.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.335 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -51.96 13.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.025 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -59.19 -38.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.218 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG22 HD13 ' A' ' 143' ' ' ILE . 44.8 t -70.71 -58.2 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -83.54 -76.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.18 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.03 27.68 51.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.55 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -108.48 -47.26 3.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.319 . . . . 0.0 111.095 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 16.7 m -135.42 82.43 40.29 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.21 -3.39 10.7 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.812 2.342 . . . . 0.0 112.662 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -109.01 -19.94 13.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.246 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -68.0 147.39 98.44 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.44 ' HG3' ' OG ' ' A' ' 114' ' ' SER . 50.1 Cg_exo -53.47 158.64 7.39 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.52 2.147 . . . . 0.0 112.324 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 110' ' ' ILE . 9.0 p -112.8 153.54 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 136.0 34.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 77' ' ' PHE . 12.0 mm -113.92 148.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.259 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.4 127.64 54.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.738 179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.759 HG21 HG23 ' A' ' 74' ' ' ILE . 1.5 p -141.96 179.99 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.589 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.882 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 12.5 t -86.32 -41.35 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 0.0 110.529 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.14 169.22 18.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.88 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.686 ' HA ' HD11 ' A' ' 74' ' ' ILE . 16.2 t -57.17 -34.61 45.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.717 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.29 -26.87 66.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.067 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.882 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 80.9 mm-40 -77.46 -20.02 55.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.773 HD13 HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -113.31 61.42 0.8 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.812 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.81 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.149 1.899 . . . . 0.0 112.421 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.02 16.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.976 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE1' HG13 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -105.3 -49.53 3.43 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.135 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -126.4 165.38 19.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.001 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.464 HH11 ' HD3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -113.0 96.97 40.58 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -102.29 -179.12 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.112 2.542 . . . . 0.0 112.567 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 47.4 t -133.59 169.96 16.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.45 -77.29 0.23 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.839 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.564 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -57.51 -29.62 64.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.029 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.44 -45.84 92.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.101 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 81' ' ' SER . 17.7 mmt -74.41 -11.65 60.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.334 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 4.4 mt-10 -72.43 -49.92 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.872 0.368 . . . . 0.0 110.603 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 8.3 tp -63.18 -36.37 83.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.949 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.53 ' HE3' ' HB ' ' A' ' 98' ' ' VAL . 3.7 tpt -70.67 -51.21 29.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.92 -14.98 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.465 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -64.98 -34.14 77.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.025 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.2 pt -115.04 52.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.463 ' HB2' ' OH ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -131.03 140.56 39.05 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.75 -163.96 3.72 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.625 -1.406 . . . . 0.0 112.37 -1.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.85 166.39 15.2 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.625 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' HG3' ' HB3' ' A' ' 34' ' ' ASP . 5.7 Cg_exo -78.23 35.34 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.057 2.504 . . . . 0.0 112.043 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.555 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 25.0 p90 -99.0 164.86 12.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.969 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.689 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 36.8 m -115.29 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.698 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.53 ' HB ' ' HE3' ' A' ' 88' ' ' MET . 1.7 p -123.6 104.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.444 . . . . 0.0 110.955 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.733 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 15.4 t -101.47 129.92 51.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.715 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 182' ' ' LEU . 0.8 OUTLIER -126.86 -175.11 3.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.595 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.52 -178.79 3.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.307 177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -119.76 141.27 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 110.969 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -74.28 -174.17 1.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.005 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 104' ' ' GLU . 2.5 pt-20 -76.56 43.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.491 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.647 HD22 ' HD2' ' A' ' 107' ' ' PRO . 2.6 mt -73.97 146.16 44.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.804 0.335 . . . . 0.0 110.973 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.567 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.2 mp -80.02 -50.28 1.2 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.647 ' HD2' HD22 ' A' ' 105' ' ' LEU . 77.7 Cg_exo -51.07 100.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.186 1.924 . . . . 0.0 112.461 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.707 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -82.38 1.98 34.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.92 -23.88 10.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.065 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.52 ' O ' HG12 ' A' ' 64' ' ' VAL . 15.0 pt -96.87 -39.95 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.151 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 108' ' ' ASP . 12.9 t -76.8 -15.51 59.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.953 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.24 -171.5 42.94 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.635 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -71.02 -6.67 60.83 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.44 ' OG ' ' HG3' ' A' ' 63' ' ' PRO . 4.2 p -106.24 -176.57 3.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 110.885 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.503 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.3 m -111.57 40.31 2.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -139.02 150.43 45.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.271 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 111' ' ' THR . 93.0 t -139.7 144.56 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.497 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.583 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -91.77 158.3 25.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.773 HD13 HD13 ' A' ' 74' ' ' ILE . 43.7 mt -145.82 151.16 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HG2' ' HA ' ' A' ' 97' ' ' THR . 13.3 mtp180 -147.67 134.06 19.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 111.617 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.8 87.26 6.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.551 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.55 -176.33 2.22 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.555 2.17 . . . . 0.0 112.586 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.67 11.55 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 13.4 t0 -76.83 97.89 4.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.052 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -47.92 80.62 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.09 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.411 HG23 HD22 ' A' ' 16' ' ' LEU . 32.2 mm -61.06 -50.98 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.027 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 6.9 t -61.35 -23.74 65.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 69' ' ' SER . 9.2 ttm180 -67.04 -31.85 72.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.591 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtt85 -75.09 -56.19 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.985 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.1 -50.9 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.371 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.678 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -63.22 -26.96 69.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.391 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 128' ' ' ARG . . . -54.58 -56.51 18.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 109.989 178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -75.86 -86.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.998 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 131' ' ' ALA . 61.4 m-85 -76.59 125.56 87.21 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.717 178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.45 147.19 82.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.283 1.988 . . . . 0.0 111.949 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -120.52 155.1 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.209 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.661 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 11.3 m -80.22 133.84 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.228 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 39' ' ' LEU . . . -128.71 104.97 7.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.204 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 39' ' ' LEU . 0.5 OUTLIER -134.15 161.18 35.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.3 m -76.87 123.33 26.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.789 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . -67.87 136.0 53.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -163.37 51.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.823 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.491 HD13 HG22 ' A' ' 55' ' ' VAL . 13.6 mm -60.96 154.14 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 m -54.04 142.67 24.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.993 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.06 -109.28 3.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.462 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.45 94.92 41.93 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.25 . . . . 0.0 110.948 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.453 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 45.0 Cg_exo -60.26 -48.7 11.08 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.58 2.187 . . . . 0.0 113.281 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 24.0 Cg_exo -64.27 113.07 2.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.932 1.755 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.5 OUTLIER -97.1 137.9 21.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.767 179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 149' ' ' SER . 64.6 Cg_endo -96.09 -12.35 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.885 2.39 . . . . 0.0 112.983 -178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -133.05 134.85 44.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.489 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -43.13 83.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.817 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.04 -18.0 62.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.17 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 158' ' ' ASP . 4.4 tt0 -73.44 -37.03 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.816 HD12 HG23 ' A' ' 165' ' ' VAL . 6.1 mt -70.59 -46.4 70.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.593 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.58 -36.66 78.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.956 0.407 . . . . 0.0 111.403 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -75.61 -49.03 19.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.095 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -72.64 -41.96 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.733 0.302 . . . . 0.0 111.694 -177.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.558 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -93.77 72.28 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' A' ' 159' ' ' LEU . 11.3 t70 -15.97 -66.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.057 0.848 . . . . 0.0 112.925 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.14 25.94 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.281 . . . . 0.0 111.43 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.673 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.83 -67.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.699 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.673 ' H ' HG13 ' A' ' 162' ' ' VAL . 1.5 p-10 -111.12 94.19 4.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.413 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.521 ' HG ' HG22 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -60.01 127.76 33.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.608 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.816 HG23 HD12 ' A' ' 155' ' ' ILE . 3.4 p -60.79 176.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.039 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.684 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.79 125.54 41.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.135 0.493 . . . . 0.0 111.168 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -4.34 52.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.67 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.42 ' H ' ' CD2' ' A' ' 166' ' ' LEU . . . 84.71 65.62 1.49 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.996 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.858 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 5.6 m-20 -72.88 -116.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.77 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -149.89 -171.67 3.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.635 0.255 . . . . 0.0 111.112 179.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.88 9.11 1.29 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.4 94.7 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.043 0.449 . . . . 0.0 111.42 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.73 -15.44 0.72 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.052 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.57 150.69 64.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.538 0.209 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.42 -160.87 2.41 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.663 0.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.0 t -160.9 112.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.77 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 3.4 m -102.16 136.18 42.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.416 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.689 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -128.93 98.9 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.743 179.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.778 HG12 ' HA ' ' A' ' 189' ' ' VAL . 36.9 mt -116.49 132.51 65.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.511 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.733 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.6 OUTLIER -108.3 64.41 0.62 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 178.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 18.2 tp -69.91 100.71 1.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.533 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.431 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -82.42 -85.63 0.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.352 178.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.75 -94.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.213 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 23.0 t-20 -82.78 -53.15 0.63 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 85.5 Cg_endo -77.75 107.08 2.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.244 1.963 . . . . 0.0 112.231 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.569 ' HB2' HG23 ' A' ' 189' ' ' VAL . 86.9 Cg_endo -82.16 130.71 6.5 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.508 2.139 . . . . 0.0 112.367 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -90.42 44.34 1.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.982 0.42 . . . . 0.0 110.547 179.468 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.778 ' HA ' HG12 ' A' ' 180' ' ' ILE . 94.3 t -56.44 101.55 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.805 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.12 86.62 2.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.008 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -83.92 143.93 29.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.994 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -160.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.964 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.56 135.88 16.13 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.53 -52.64 2.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 0.0 110.852 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.04 121.16 8.29 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.433 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.57 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.438 2.092 . . . . 0.0 112.407 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.88 -50.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.973 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.55 124.33 82.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.04 -35.38 14.89 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.438 2.092 . . . . 0.0 112.316 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.3 t -66.31 117.93 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.91 27.93 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.03 -64.49 1.04 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.949 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -79.08 146.18 33.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -126.34 104.1 0.71 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.48 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -106.94 137.03 45.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 111.172 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -132.92 -46.29 0.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.421 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -89.02 -53.39 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.795 0.331 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.128 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.789 0.328 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.2 mt -73.38 -82.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.02 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.3 mm -96.61 145.37 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.194 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.22 127.64 43.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -86.99 -169.48 2.65 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 tt -88.26 140.31 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.028 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -69.95 115.99 9.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.38 125.76 51.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.15 109.27 5.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.023 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -108.01 117.13 55.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 52.6 Cg_exo -55.63 152.68 32.98 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.561 2.174 . . . . 0.0 112.188 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -86.33 110.42 31.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.02 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 11' ' ' PRO . 50.3 Cg_exo -53.81 153.69 18.91 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.49 2.127 . . . . 0.0 112.291 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.27 -48.47 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.14 -33.75 57.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -63.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.193 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.79 -20.01 60.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.276 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -73.02 -46.5 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.061 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.06 94.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.282 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' MET . 2.0 mp -72.26 -29.12 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -54.56 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.253 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.6 p -64.93 -26.79 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.202 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 10.8 mmt -56.56 -44.59 81.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -19.66 61.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.9 -0.43 64.55 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.694 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.52 27.23 71.52 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.36 170.75 13.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.36 153.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.74 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.32 151.13 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 111.447 -178.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -108.3 154.41 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.22 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.79 106.93 0.45 Allowed Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.623 ' HB2' ' HA ' ' A' ' 170' ' ' ASP . 1.4 Cg_endo -84.55 162.59 12.62 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.292 2.661 . . . . 0.0 112.136 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -137.33 -150.34 0.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.637 179.093 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.781 ' HB2' ' HB3' ' A' ' 95' ' ' PRO . 5.9 m-20 -60.16 -20.36 58.16 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.725 0.297 . . . . 0.0 111.148 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 95' ' ' PRO . 7.9 p -100.18 -112.31 0.18 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.141 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 tt -111.82 -179.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.665 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -84.2 128.89 34.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.197 0.522 . . . . 0.0 110.686 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -118.75 -167.98 14.03 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.753 HD12 HG23 ' A' ' 139' ' ' THR . 0.2 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.799 0.333 . . . . 0.0 110.5 179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.727 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -144.26 136.1 6.57 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.987 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.697 HG22 ' H ' ' A' ' 42' ' ' ASN . 1.4 p -172.28 -169.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.792 -0.204 . . . . 0.0 110.743 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.697 ' H ' HG22 ' A' ' 41' ' ' VAL . 2.8 t-20 -56.33 103.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.003 0.43 . . . . 0.0 110.327 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' OG1' ' A' ' 137' ' ' THR . . . -61.84 -39.23 91.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.017 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.99 24.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.441 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.85 155.16 22.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.775 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -21.74 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -72.89 -23.23 60.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.629 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.34 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.755 HG21 HG22 ' A' ' 109' ' ' VAL . 11.5 p -72.27 -30.25 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.816 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -41.76 61.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -64.44 -44.38 91.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.604 ' O ' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -61.52 -40.69 95.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.049 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.13 -28.54 69.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.005 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -64.26 -45.72 86.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.247 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 t -72.51 -51.25 29.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.03 -78.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.86 7.41 16.14 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.851 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -118.35 11.8 13.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.721 0.296 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 1.6 m -147.11 65.35 9.56 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.104 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 59' ' ' SER . 8.9 Cg_exo -72.8 -2.63 12.21 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.728 2.286 . . . . 0.0 112.231 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -112.61 -24.33 9.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 0.2 OUTLIER -68.47 148.67 98.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.019 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 177.35 3.12 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.515 2.144 . . . . 0.0 112.344 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 66' ' ' ILE . 14.6 p -112.92 149.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.798 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 134.27 35.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.502 HD11 HG13 ' A' ' 64' ' ' VAL . 4.1 mm -116.12 160.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.056 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 9.9 t -122.62 137.63 54.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.726 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.806 HG11 HG12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -139.35 -176.2 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.663 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -73.3 -50.03 24.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.709 179.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.484 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -164.71 171.07 14.81 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.265 0.555 . . . . 0.0 111.797 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.606 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 16.8 t -52.83 -22.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.85 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.614 ' O ' ' HD2' ' A' ' 75' ' ' PRO . 2.2 t70 -67.92 -52.78 32.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.76 13.77 3.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.658 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.806 HG12 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -90.17 -42.88 0.41 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -177.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 72' ' ' ASP . 76.9 Cg_exo -51.62 -17.42 4.75 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.244 1.963 . . . . 0.0 112.935 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -72.2 -39.01 68.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.433 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 23.7 m-85 -97.44 -35.71 10.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.516 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.467 ' OG ' HG23 ' A' ' 74' ' ' ILE . 88.8 p -116.24 -173.81 2.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.957 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.39 100.7 28.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.719 ' HA ' HD22 ' A' ' 100' ' ' LEU . 92.3 Cg_endo -102.74 -170.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.211 2.608 . . . . 0.0 112.677 -178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.538 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -126.98 177.09 6.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -73.22 -88.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.857 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -55.72 -27.48 50.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.128 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -61.43 -44.12 97.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.918 0.39 . . . . 0.0 110.932 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.526 ' CE ' HD21 ' A' ' 100' ' ' LEU . 6.6 mmt -73.94 -16.13 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.307 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 mt-10 -67.44 -51.27 53.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.591 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 7.6 tp -62.61 -32.4 73.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.666 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.435 ' HG2' HG11 ' A' ' 98' ' ' VAL . 6.0 tpt -70.15 -48.12 58.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.415 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -65.42 -11.42 42.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.245 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.7 tpt180 -72.95 -31.08 64.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.09 32.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.474 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 93' ' ' PRO . 4.4 mt -131.11 152.93 81.5 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.815 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 92' ' ' LEU . 83.3 Cg_endo -77.94 -172.65 11.55 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.555 -1.435 . . . . 0.0 112.512 0.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.55 -177.81 31.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.687 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.781 ' HB3' ' HB2' ' A' ' 34' ' ' ASP . 87.8 Cg_endo -81.03 43.45 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.751 2.301 . . . . 0.0 112.239 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.515 ' HA ' ' HB ' ' A' ' 178' ' ' THR . 5.6 m-85 -111.43 136.28 50.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 m -94.92 120.93 35.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.344 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.435 HG11 ' HG2' ' A' ' 88' ' ' MET . 3.2 t -108.86 116.52 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.695 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 3.5 t -104.1 127.47 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.719 HD22 ' HA ' ' A' ' 80' ' ' PRO . 1.6 mt -126.87 -169.37 2.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.969 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -172.63 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.648 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.684 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.9 142.53 47.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 1.3 t-20 -74.38 -172.37 1.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.207 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -75.82 12.83 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.48 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.533 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -69.73 -172.93 0.55 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.807 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.25 105.12 3.16 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.128 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.599 ' HA ' HG23 ' A' ' 111' ' ' THR . 65.9 Cg_endo -71.43 2.8 4.11 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.585 2.19 . . . . 0.0 112.611 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.82 -88.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.075 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.755 HG22 HG21 ' A' ' 49' ' ' VAL . 3.2 p -84.77 -0.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.0 mt -96.8 -63.59 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.648 0.261 . . . . 0.0 111.379 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.602 HG21 ' HG3' ' A' ' 102' ' ' ARG . 4.4 p -87.18 -23.75 24.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.59 -130.14 20.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.553 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -85.41 11.68 60.59 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.698 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -119.1 169.45 9.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.707 0.289 . . . . 0.0 111.035 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.488 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 39.8 m -113.44 31.95 6.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -136.6 166.58 23.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.982 -179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.684 HG23 ' HB2' ' A' ' 102' ' ' ARG . 77.2 t -139.93 142.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 119' ' ' ILE . . . -78.65 155.75 41.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.366 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 100' ' ' LEU . 8.4 mt -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.604 0.24 . . . . 0.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.541 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER -146.1 127.34 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.387 -179.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.37 80.13 2.47 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.597 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 20.2 Cg_exo -66.6 179.08 2.28 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.505 2.137 . . . . 0.0 112.713 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.69 -0.9 55.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.2 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 83.5 m-20 -61.98 109.1 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.155 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.43 -56.59 19.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.438 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.6 mm -58.66 -50.79 77.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.06 -17.24 62.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -75.14 -38.48 60.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -45.01 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.05 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.8 mm -62.91 -46.15 97.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -64.38 -28.4 69.67 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.898 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 69' ' ' SER . . . -54.79 -55.0 34.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.041 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -75.48 -88.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.174 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -77.2 138.55 64.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.88 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.56 146.94 62.99 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.36 2.04 . . . . 0.0 111.849 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 131' ' ' ALA . 13.4 t -125.31 133.32 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.47 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.727 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 1.2 m -67.35 141.47 57.1 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -140.06 104.53 4.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.856 0.36 . . . . 0.0 111.65 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.753 HG23 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -143.61 125.47 15.18 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.702 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.62 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -61.18 135.85 57.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.872 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . . . -78.95 137.19 37.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.859 0.361 . . . . 0.0 111.171 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -159.41 49.32 0.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.86 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.648 HG13 ' H ' ' A' ' 144' ' ' SER . 5.3 tp -68.22 166.84 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.99 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.648 ' H ' HG13 ' A' ' 143' ' ' ILE . 2.3 m -55.01 155.64 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.971 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.25 -124.38 7.44 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.407 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.04 90.3 50.85 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.638 0.256 . . . . 0.0 110.932 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.535 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 48.0 Cg_exo -60.23 -43.65 33.78 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.653 2.235 . . . . 0.0 113.866 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.46 94.98 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.847 1.698 . . . . 0.0 112.419 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.6 128.49 69.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.748 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -95.95 -8.24 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.886 2.39 . . . . 0.0 112.951 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 151' ' ' ARG . 0.1 OUTLIER -129.19 120.12 25.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.493 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -60.05 -36.31 77.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.518 178.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -23.83 61.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.647 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -36.87 84.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.974 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 165' ' ' VAL . 55.0 mt -68.77 -55.15 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -32.51 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.46 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -75.67 -54.99 6.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.63 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.39 -24.08 63.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.585 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.558 ' HB3' HG13 ' A' ' 162' ' ' VAL . 3.2 mm? -111.25 70.69 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.818 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 159' ' ' LEU . 16.4 t0 -15.94 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 124.049 0.843 . . . . 0.0 112.823 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -156.85 25.5 0.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.7 0.285 . . . . 0.0 111.469 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.686 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.9 OUTLIER -80.61 -69.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.573 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.799 ' HB2' HD11 ' A' ' 30' ' ' ILE . 2.0 p-10 -111.29 102.65 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.488 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.621 ' HB2' HG21 ' A' ' 22' ' ' VAL . 3.2 mm? -71.45 131.52 43.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.302 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.743 HG22 ' H ' ' A' ' 166' ' ' LEU . 2.0 p -62.98 -163.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.879 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.743 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.1 160.81 29.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.799 0.333 . . . . 0.0 111.124 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -92.87 -25.8 17.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.68 -56.29 3.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.472 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.24 -163.28 16.86 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.792 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.623 ' HA ' ' HB2' ' A' ' 32' ' ' PRO . 7.2 p-10 -70.89 -164.72 0.1 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.829 0.347 . . . . 0.0 111.124 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.51 -57.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.563 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -124.17 -134.88 0.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.15 146.4 26.6 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.794 0.331 . . . . 0.0 111.841 -177.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' THR . 71.0 mmm -62.98 -27.47 69.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.71 154.28 47.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.655 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 177' ' ' SER . 65.7 Cg_endo -91.39 -149.36 0.33 Allowed 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.867 -1.305 . . . . 0.0 112.67 1.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.505 ' HB3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.82 158.29 39.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.85 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.515 ' HB ' ' HA ' ' A' ' 96' ' ' TYR . 1.2 m -102.27 139.0 38.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.1 t -129.1 88.8 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.048 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.654 HG23 ' HA ' ' A' ' 189' ' ' VAL . 13.0 mt -108.87 129.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.373 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.695 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -108.55 66.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.414 178.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 187' ' ' PRO . 53.4 tp -69.71 93.67 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.318 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.42 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -79.51 -81.7 0.11 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.409 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 185' ' ' ASN . 12.2 t -120.84 -115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.186 -0.206 . . . . 0.0 111.046 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 5.5 m-20 -66.41 -52.69 35.11 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 185' ' ' ASN . 3.5 Cg_exo -77.22 108.04 2.54 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.497 2.131 . . . . 0.0 112.093 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 91.4 Cg_endo -81.49 133.38 8.36 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.451 2.101 . . . . 0.0 112.26 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 188' ' ' ARG . 5.8 mtt180 -91.92 51.12 1.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.979 0.418 . . . . 0.0 110.88 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.654 ' HA ' HG23 ' A' ' 180' ' ' ILE . 6.3 t -58.64 100.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.066 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 tp -126.54 86.64 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.43 ' HB3' HG23 ' A' ' 178' ' ' THR . 8.5 ptt-85 -87.06 161.62 18.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.824 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' A' ' 193' ' ' GLY . 0.2 OUTLIER -64.69 169.52 4.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.869 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 192' ' ' ARG . . . -85.2 80.63 1.8 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.592 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -109.82 -87.8 0.51 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.724 0.297 . . . . 0.0 110.789 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 194' ' ' LYS . . . -90.09 134.71 12.51 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.305 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.451 ' HB2' ' H ' ' A' ' 197' ' ' LEU . 24.3 Cg_exo -63.01 -82.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.539 2.159 . . . . 0.0 112.133 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.451 ' H ' ' HB2' ' A' ' 196' ' ' PRO . 0.0 OUTLIER -157.21 -85.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.808 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 145.0 59.37 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.924 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.22 131.05 40.88 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.541 2.161 . . . . 0.0 112.083 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.58 137.83 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.043 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.6 mt -105.82 43.0 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.015 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.461 HD23 ' HB3' ' A' ' 205' ' ' ALA . 0.7 OUTLIER -75.93 -172.62 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.7 8.86 29.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.94 49.57 2.25 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.546 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 202' ' ' LEU . . . -104.72 -51.65 3.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 111.091 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -135.11 85.72 0.26 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.422 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.46 -69.81 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.984 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.091 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.12 176.3 5.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.428 ' HB ' ' HD3' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -71.39 121.85 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.013 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.08 35.9 2.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.982 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.428 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -98.72 159.59 14.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.021 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 tt -82.84 134.45 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -70.45 -82.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.075 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.72 151.57 26.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.89 103.09 3.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.821 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.13 -51.49 0.78 Allowed Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.444 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.12 -71.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.149 1.9 . . . . 0.0 112.177 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m 56.43 79.15 0.34 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.544 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 38.1 Cg_exo -57.42 158.3 19.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.662 2.242 . . . . 0.0 112.287 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.71 -39.88 66.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.28 -22.78 16.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.074 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.31 -43.62 66.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -75.23 -28.54 59.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.38 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.622 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.07 -38.9 69.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.781 0.324 . . . . 0.0 111.018 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.622 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -74.08 -36.32 64.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -63.75 -30.0 48.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -68.84 -48.33 63.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.847 HG21 ' HG ' ' A' ' 164' ' ' LEU . 7.5 p -72.3 -21.8 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -48.4 81.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.809 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.37 -13.52 62.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.098 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.53 -2.87 76.57 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.453 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.29 53.84 33.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.552 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.37 161.6 23.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.516 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.673 HD11 ' HG ' ' A' ' 39' ' ' LEU . 1.4 tp -90.89 136.05 25.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 110.568 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.634 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.74 140.96 36.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.958 -179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.421 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -101.99 150.27 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.053 178.763 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.661 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -165.99 107.04 0.72 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 96.7 Cg_endo -84.26 159.29 13.13 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.763 2.309 . . . . 0.0 111.837 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.892 HG21 ' HB2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -135.32 -149.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.03 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 172' ' ' LEU . 1.1 m-20 -54.81 -20.6 8.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.28 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 36' ' ' ILE . 2.7 t -100.17 -117.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.651 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.694 HG23 ' HB2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.58 -157.85 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.117 0 O-C-N 122.198 -0.314 . . . . 0.0 111.202 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.595 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 3.9 m-85 -68.62 132.11 46.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.855 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.26 -176.76 15.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.265 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.673 ' HG ' HD11 ' A' ' 28' ' ' ILE . 1.7 mp -131.93 142.94 49.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.88 0.372 . . . . 0.0 111.172 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -145.89 115.46 0.82 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.595 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 136' ' ' VAL . 2.4 p -153.96 150.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.802 0.334 . . . . 0.0 111.067 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -55.87 104.65 0.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.933 0.397 . . . . 0.0 110.574 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.53 78.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.942 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.4 mm? -76.7 13.92 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.946 0.403 . . . . 0.0 111.151 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.8 OUTLIER -110.48 156.25 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.893 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.589 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -69.72 -25.22 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 51' ' ' ARG . 31.1 t70 -66.5 -21.18 66.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -75.09 -38.14 61.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 46' ' ' GLU . 14.6 p -74.25 -35.86 41.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.778 0.323 . . . . 0.0 110.829 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -69.89 -44.21 70.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.487 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.607 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.54 -37.43 84.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.453 179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.607 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -60.05 -30.85 69.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.898 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.2 -32.01 66.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.762 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmt-85 -68.8 -48.71 62.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.2 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.559 ' HB ' HH21 ' A' ' 51' ' ' ARG . 29.7 t -75.05 -51.01 22.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.4 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.56 -67.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.296 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.06 33.03 82.48 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.446 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -100.4 -81.23 0.47 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 110.959 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 m -149.25 146.14 20.65 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.91 2.13 7.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.584 2.189 . . . . 0.0 112.489 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -1.55 26.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.099 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.77 145.29 50.04 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 158.28 54.6 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.517 2.145 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 m -117.04 163.21 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.6 136.6 46.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.623 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.27 168.32 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.817 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 8.3 t -122.57 133.35 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.949 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.91 HG21 HG23 ' A' ' 74' ' ' ILE . 1.1 p -143.39 179.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.503 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.627 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -89.3 -42.99 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.931 179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.3 t -164.21 170.21 16.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.089 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HA ' HD11 ' A' ' 74' ' ' ILE . 6.8 t -56.94 -34.59 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.662 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -67.28 -29.84 69.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.936 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 58.8 mm-40 -73.53 -19.84 60.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.09 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.39 60.82 0.8 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.034 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.625 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 44.1 Cg_exo -56.08 -92.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.098 1.865 . . . . 0.0 111.972 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.442 ' H ' ' HB2' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -73.64 22.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.234 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 3.3 m-85 -92.89 -51.95 4.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -128.19 170.51 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.793 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -126.05 109.21 24.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.748 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -102.22 -169.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.108 2.539 . . . . 0.0 112.475 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.947 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -127.61 170.26 12.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.009 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.85 -111.23 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.933 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.38 -25.53 35.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 0.0 110.985 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.947 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -59.97 -53.63 55.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.629 ' HB3' ' O ' ' A' ' 81' ' ' SER . 1.6 tpp -73.76 -24.16 59.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.098 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -55.55 -40.37 71.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.581 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -67.6 -40.54 84.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.294 178.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.492 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 12.0 tpt -61.69 -50.07 73.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.441 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.551 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -73.83 -6.26 46.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.529 -178.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.581 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 4.2 ttm180 -67.29 -24.88 65.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 pt -111.07 49.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -128.05 150.37 73.54 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.725 179.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.18 179.06 32.11 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.392 0.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.15 174.34 26.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.72 39.91 0.89 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.671 2.248 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -98.74 138.43 35.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.004 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 7.7 m -97.92 141.45 30.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.654 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.556 HG13 ' HB ' ' A' ' 119' ' ' ILE . 2.5 p -126.18 99.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.18 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.732 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 65.3 t -96.7 117.13 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.697 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.645 HD23 HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -126.12 -166.3 1.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -74.63 178.32 5.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.621 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.665 HH22 HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -120.1 143.6 48.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.659 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.94 -170.56 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.19 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.28 35.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.499 HD22 ' HD2' ' A' ' 107' ' ' PRO . 1.9 mt -69.86 146.3 51.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.852 0.358 . . . . 0.0 110.816 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.561 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 36.8 mm -80.1 -49.15 1.27 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.9 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 106' ' ' ILE . 72.7 Cg_exo -50.22 94.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.482 2.121 . . . . 0.0 112.857 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.747 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.5 OUTLIER -82.45 -3.47 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.7 179.227 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 t -74.2 -24.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.292 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.665 HD12 HH22 ' A' ' 102' ' ' ARG . 1.3 pt -98.27 -42.23 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.747 HG22 ' HA ' ' A' ' 108' ' ' ASP . 14.5 t -75.8 -14.54 60.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.814 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.8 -151.72 37.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.657 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.33 -26.4 57.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 m -106.29 175.54 5.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.338 . . . . 0.0 111.001 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.49 67.65 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -142.12 131.49 23.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.656 HG21 HH21 ' A' ' 102' ' ' ARG . 59.8 t -139.85 140.89 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.786 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 99' ' ' VAL . . . -98.95 162.4 20.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.384 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.556 ' HB ' HG13 ' A' ' 98' ' ' VAL . 10.3 mt -141.8 164.31 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -149.8 127.15 11.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 t -110.4 88.55 7.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.892 ' HB2' HG21 ' A' ' 33' ' ' THR . 78.6 Cg_endo -76.97 -179.35 5.34 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.59 2.193 . . . . 0.0 112.533 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.43 5.45 51.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -72.4 108.29 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -57.29 -43.05 82.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.958 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 130' ' ' ILE . 31.2 mm -64.16 -53.62 41.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.88 -17.68 61.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' HG2' ' OG ' ' A' ' 69' ' ' SER . 7.6 ttt180 -75.49 -44.68 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.187 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -54.61 11.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.531 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.0 tt -57.31 -43.08 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.552 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.36 -25.8 62.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.418 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 69' ' ' SER . . . -54.55 -58.05 8.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.013 0.435 . . . . 0.0 109.88 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.415 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -76.74 -83.28 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.243 177.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.415 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -76.62 114.48 39.08 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -66.62 144.39 72.15 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.368 2.045 . . . . 0.0 111.565 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 41' ' ' VAL . 1.6 t -127.65 161.99 34.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.845 0.355 . . . . 0.0 111.267 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.606 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 4.8 m -80.47 139.26 36.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.063 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -131.07 107.48 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.381 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -132.75 141.41 48.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.969 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.563 ' HB2' HD21 ' A' ' 142' ' ' ASN . 10.9 p -80.72 115.74 20.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.86 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -83.51 90.21 7.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.839 0.352 . . . . 0.0 111.178 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.563 HD21 ' HB2' ' A' ' 140' ' ' SER . 0.8 OUTLIER -162.07 33.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.942 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.58 ' N ' ' HG2' ' A' ' 147' ' ' PRO . 0.4 OUTLIER -81.13 -154.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.779 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.421 ' H ' HG22 ' A' ' 143' ' ' ILE . 0.6 OUTLIER -56.07 155.6 6.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.741 0.305 . . . . 0.0 110.887 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 82.1 -142.1 22.05 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.244 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.14 67.46 70.53 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.547 0.213 . . . . 0.0 111.114 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.58 ' HG2' ' N ' ' A' ' 143' ' ' ILE . 38.9 Cg_exo -60.29 -48.42 11.8 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.265 1.977 . . . . 0.0 113.172 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 22.6 Cg_exo -64.74 104.19 0.53 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.932 1.754 . . . . 0.0 111.862 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.7 t -77.08 149.54 79.86 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.211 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -95.21 -18.73 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.81 2.34 . . . . 0.0 112.403 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.64 141.41 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.54 HD22 HG22 ' A' ' 165' ' ' VAL . 49.7 mt -64.47 -43.95 92.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.72 -17.18 63.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -75.06 -39.97 60.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.12 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 1.029 HD12 HG23 ' A' ' 165' ' ' VAL . 7.9 mt -65.3 -56.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.201 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.432 HG13 ' HB ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -55.84 -40.86 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.32 -179.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -65.41 -50.48 65.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.666 ' HB3' HD22 ' A' ' 159' ' ' LEU . 8.0 t0 -63.68 -35.17 79.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.771 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.9 mm? -110.88 75.32 0.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.829 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.6 t0 -15.95 -64.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.117 0.886 . . . . 0.0 112.85 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -150.97 11.86 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.685 0.279 . . . . 0.0 111.35 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -81.15 -62.07 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.831 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.665 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 1.4 t0 -103.03 97.13 7.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.847 ' HG ' HG21 ' A' ' 22' ' ' VAL . 2.8 mm? -74.49 129.13 37.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.557 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 1.029 HG23 HD12 ' A' ' 155' ' ' ILE . 2.4 p -66.31 -179.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.306 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.805 HD13 ' H ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -126.31 147.33 49.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.484 179.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.9 -26.8 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.951 -178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.661 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -64.64 -54.08 37.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.88 0.372 . . . . 0.0 111.343 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.804 ' H ' HD23 ' A' ' 166' ' ' LEU . . . 98.24 -165.64 21.76 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.945 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -71.94 -165.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.216 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.431 ' HB2' ' C ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -141.68 -51.74 0.42 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.322 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -132.33 -135.55 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 175' ' ' GLU . 4.4 t0 -86.57 154.81 20.78 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.778 0.323 . . . . 0.0 111.667 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.694 ' HB2' HG23 ' A' ' 36' ' ' ILE . 19.3 ptm -70.9 17.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.434 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 173' ' ' ASP . 1.5 mt-10 -155.35 157.86 31.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.563 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -95.67 -151.89 0.28 Allowed 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.185 -1.173 . . . . 0.0 112.662 1.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.55 96.74 1.93 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 191' ' ' ARG . 97.0 m -100.97 135.51 42.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.231 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.495 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 21.0 t -127.64 104.49 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.796 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.66 HG12 ' HA ' ' A' ' 189' ' ' VAL . 36.9 mt -109.11 127.71 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.462 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.788 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.2 m-20 -89.35 74.71 7.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.303 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.645 HD12 HD23 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -68.51 79.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -84.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 3.1 t -121.0 -128.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.66 177.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.504 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 57.7 t30 -60.24 -51.74 78.09 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 185' ' ' ASN . 68.3 Cg_endo -74.32 109.02 2.81 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.19 1.927 . . . . 0.0 112.637 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 84.7 Cg_endo -82.8 120.83 3.15 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.611 2.207 . . . . 0.0 112.157 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 1.2 mpp_? -87.87 53.17 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.131 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 180' ' ' ILE . 21.5 t -56.73 97.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.71 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.96 89.41 3.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.269 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.578 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -91.17 131.9 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -83.63 -20.62 33.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -82.98 84.09 1.57 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.59 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -93.46 83.05 4.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.311 . . . . 0.0 110.969 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -80.69 162.37 45.11 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.542 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.05 166.99 27.98 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.586 2.19 . . . . 0.0 112.264 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.02 106.63 4.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.855 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.7 -51.36 21.53 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.403 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.19 90.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.14 1.893 . . . . 0.0 112.263 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 200' ' ' VAL . 3.2 m -73.52 153.96 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.012 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.655 HD22 ' H ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -107.01 37.51 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.89 -46.23 62.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.001 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.85 3.23 33.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -135.17 73.8 0.44 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.531 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -102.31 -24.65 13.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.729 0.299 . . . . 0.0 111.054 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 131.29 -78.55 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.593 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.86 89.48 3.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.071 -179.902 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtm . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.87 -71.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 mm -81.51 107.01 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -109.77 172.46 6.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.737 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.25 -176.94 2.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.965 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 tt -76.63 140.25 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.004 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 t -70.22 -176.41 1.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.83 172.27 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.945 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -82.91 112.76 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.526 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 1.9 m-20 -90.76 -52.12 0.31 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.403 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 10' ' ' ASN . 34.7 Cg_exo -60.04 139.28 86.88 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.14 1.894 . . . . 0.0 112.101 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -161.52 107.18 1.2 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.058 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HG2' ' HB2' ' A' ' 16' ' ' LEU . 52.2 Cg_endo -69.15 171.36 13.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.534 2.156 . . . . 0.0 112.259 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -68.53 -32.98 73.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -68.14 -36.67 76.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.085 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.598 ' HB2' ' HG2' ' A' ' 13' ' ' PRO . 1.2 mm? -71.13 -39.77 71.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.824 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.15 -24.79 65.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.791 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -33.93 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -67.67 -37.3 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.835 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 16' ' ' LEU . 7.8 mm -75.11 -18.71 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -73.41 -44.98 57.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.053 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.634 ' HB ' HD13 ' A' ' 164' ' ' LEU . 14.1 p -68.46 -31.19 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 53.0 mtt -66.99 -31.24 71.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.861 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.12 -35.26 64.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.053 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.16 10.32 69.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.661 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.01 58.88 9.47 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.529 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.27 160.52 22.03 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -96.26 146.9 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.434 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.699 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -116.94 133.03 64.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -102.58 154.14 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.62 0.248 . . . . 0.0 110.946 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 166' ' ' LEU . 0.8 OUTLIER -158.47 100.13 1.71 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.762 -178.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.539 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 4.7 Cg_exo -78.01 142.29 19.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.975 2.45 . . . . 0.0 111.299 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.5 ' HA ' ' HB2' ' A' ' 171' ' ' CYS . 88.4 m -138.62 -82.4 0.3 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 112.304 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.559 ' HA ' ' HB2' ' A' ' 173' ' ' ASP . 6.0 m-20 -75.36 -78.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -177.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.738 ' HA ' ' HG3' ' A' ' 174' ' ' MET . 0.8 OUTLIER -79.4 -88.59 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.366 -177.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.59 -150.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.215 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.52 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 7.4 m-85 -69.81 141.2 53.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.05 -177.22 17.77 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.911 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 138' ' ' ALA . 1.5 mp -122.7 140.21 53.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -147.22 110.35 0.51 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.509 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 42' ' ' ASN . 2.6 p -153.48 156.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.674 0.273 . . . . 0.0 111.099 -178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 41' ' ' VAL . 3.0 m120 -55.05 101.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.025 0.44 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.68 76.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.938 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' HA ' HD13 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.4 18.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.048 0.452 . . . . 0.0 111.238 -179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.84 156.97 20.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.565 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER -75.27 -30.32 60.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.973 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.485 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 6.9 m-20 -62.48 -32.32 73.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.093 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' LEU . . . -70.65 -34.1 71.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.42 -44.79 83.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -66.88 -44.52 80.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.772 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.49 ' NH2' HG23 ' A' ' 162' ' ' VAL . 51.9 mmt-85 -67.01 -23.7 65.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -69.15 -53.58 19.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -65.86 -14.89 62.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -66.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.313 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.68 HG22 HG12 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -75.56 -38.48 38.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.76 -1.54 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.385 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.23 -148.57 50.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.494 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -98.61 117.6 33.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 3.2 p -153.35 69.65 6.72 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.822 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.25 1.36 5.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.772 2.314 . . . . 0.0 112.619 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.643 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.8 m80 -114.21 -21.68 10.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.206 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 8.7 mtpt -88.11 126.43 60.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.898 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.28 174.5 7.04 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.451 2.101 . . . . 0.0 112.069 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 110' ' ' ILE . 2.5 m -113.06 153.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.028 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 t -111.3 132.39 54.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.463 HD11 HG12 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -111.67 172.74 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.778 ' HB3' ' HB2' ' A' ' 138' ' ' ALA . 3.0 p -119.56 135.31 54.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.725 HG21 HG23 ' A' ' 74' ' ' ILE . 1.3 p -143.69 173.18 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.704 ' HA ' ' HE ' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -83.0 -39.94 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.996 0.427 . . . . 0.0 110.426 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.1 165.75 21.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.637 ' HA ' HD11 ' A' ' 74' ' ' ILE . 18.5 t -55.41 -33.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.769 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.29 -31.36 71.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.116 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.656 ' HG3' ' HB3' ' A' ' 69' ' ' SER . 9.2 mm-40 -71.07 -21.41 62.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.152 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.725 HG23 HG21 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -113.27 63.73 0.92 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.791 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.648 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 27.9 Cg_exo -62.29 -76.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.211 1.941 . . . . 0.0 112.38 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -73.21 23.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.143 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -102.5 -53.04 2.97 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.262 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 80' ' ' PRO . 22.5 p -123.01 177.24 5.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 9.2 mtt-85 -113.64 88.76 14.17 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 78' ' ' SER . 94.2 Cg_endo -102.74 -169.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.241 2.627 . . . . 0.0 112.786 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 2.2 t -145.96 179.21 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.853 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.33 -86.46 0.3 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.046 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -54.96 -32.71 61.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.346 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.595 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -60.29 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.0 110.871 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.564 ' HE1' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.5 -17.91 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.282 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.617 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 2.5 mm-40 -59.14 -51.63 69.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.279 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 90' ' ' ARG . 0.5 OUTLIER -64.37 -32.81 74.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.273 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.633 ' HG3' ' HE2' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -65.51 -49.39 69.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.463 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -70.22 -8.76 52.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.265 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -75.02 -20.21 59.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.444 HD12 ' CE1' ' A' ' 96' ' ' TYR . 1.7 mt -108.35 13.18 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.728 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 4.2 pp -131.2 166.07 30.52 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.544 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.728 ' HA ' ' HB2' ' A' ' 92' ' ' LEU . 97.2 Cg_endo -78.87 162.69 87.1 Favored 'Cis proline' 0 C--N 1.354 0.819 0 C-N-CA 124.077 -1.218 . . . . 0.0 112.91 -0.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.88 -151.04 22.81 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.982 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.442 ' HG3' ' HD2' ' A' ' 176' ' ' PRO . 85.6 Cg_endo -78.08 35.12 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.411 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.633 ' HE2' ' HG3' ' A' ' 88' ' ' MET . 16.9 t80 -92.62 135.35 34.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.592 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 179' ' ' VAL . 13.2 m -114.02 120.23 39.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.529 ' HB ' ' HE2' ' A' ' 88' ' ' MET . 0.2 OUTLIER -115.92 108.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.224 0.535 . . . . 0.0 111.551 -178.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.906 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -105.66 128.73 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.435 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.564 HD21 ' HE1' ' A' ' 85' ' ' MET . 1.1 mt -126.59 -172.44 2.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 79' ' ' ARG . 1.7 tt0 -74.42 -176.65 2.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.296 177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.812 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.71 141.36 49.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 111.279 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 7.7 t30 -74.54 -177.02 2.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.943 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.43 52.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.838 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 4.5 tp -79.97 134.84 36.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 27.4 mt -72.27 -50.58 8.51 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.428 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.838 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 71.0 Cg_exo -51.9 109.1 0.29 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.304 2.003 . . . . 0.0 112.327 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.631 ' HA ' HG22 ' A' ' 111' ' ' THR . 4.4 p-10 -81.98 -19.82 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.182 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.25 -15.38 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.197 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 107' ' ' PRO . 48.1 mt -98.15 -43.08 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.631 HG22 ' HA ' ' A' ' 108' ' ' ASP . 10.3 t -77.0 -12.78 59.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.44 -155.73 49.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.455 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 61' ' ' HIS . . . -82.44 -13.65 78.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.397 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.86 -175.06 2.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 0.0 110.782 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.411 ' CA ' ' HD2' ' A' ' 102' ' ' ARG . 3.0 m -112.91 44.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -137.22 159.91 40.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.063 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 102' ' ' ARG . 84.1 t -139.79 143.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.596 ' HA2' HG13 ' A' ' 99' ' ' VAL . . . -99.33 152.49 19.56 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.328 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.637 HD13 HD13 ' A' ' 74' ' ' ILE . 19.4 mt -145.92 149.61 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.65 0.262 . . . . 0.0 110.3 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -148.56 137.07 21.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.362 . . . . 0.0 111.215 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.9 t -110.26 88.03 6.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.757 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.532 ' HD2' ' NH2' ' A' ' 128' ' ' ARG . 30.6 Cg_endo -63.95 -177.68 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.539 2.159 . . . . 0.0 112.591 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 33' ' ' THR . 0.2 OUTLIER -92.83 8.11 40.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.21 -179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.55 115.06 11.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.984 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -57.46 -56.37 22.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.663 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.488 ' CG2' HD21 ' A' ' 16' ' ' LEU . 66.7 mt -60.61 -48.47 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.444 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.2 t -57.49 -16.95 11.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.704 ' HE ' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -75.4 -55.04 6.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.149 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -51.09 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.652 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 tt -59.62 -40.22 81.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.597 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -72.75 -26.49 61.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.13 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 73' ' ' GLU . . . -54.45 -54.76 36.58 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -75.98 -88.01 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.2 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 19.0 m-85 -77.85 119.18 76.38 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.456 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 21.6 Cg_exo -65.64 156.41 63.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.405 2.07 . . . . 0.0 111.605 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.521 ' HB ' ' SG ' ' A' ' 67' ' ' CYS . 2.2 t -134.9 159.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.208 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 29.0 m -80.85 139.24 36.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.1 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.778 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . . . -133.42 106.38 7.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.801 0.334 . . . . 0.0 111.62 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.583 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -136.75 122.05 19.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.976 179.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.1 111.36 3.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.111 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . . . -81.55 103.71 11.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -160.23 29.14 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.68 HG12 HG22 ' A' ' 55' ' ' VAL . 1.1 pt -79.09 -157.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.047 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.8 p -57.41 163.34 2.37 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.931 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.416 ' C ' ' HD3' ' A' ' 147' ' ' PRO . . . 83.35 -144.18 22.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.344 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.21 69.38 74.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.681 0.277 . . . . 0.0 110.914 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 145' ' ' GLY . 42.5 Cg_exo -60.7 -47.48 13.36 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.562 2.175 . . . . 0.0 113.69 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 147' ' ' PRO . 72.7 Cg_endo -76.36 121.23 5.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 121.906 1.737 . . . . 0.0 112.601 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 t -97.32 147.77 33.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.798 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -95.99 -13.72 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.913 2.408 . . . . 0.0 113.204 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -134.58 140.06 45.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 -178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -43.01 72.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.583 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.68 -17.43 63.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.0 OUTLIER -75.27 -37.56 60.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.876 HD12 HG23 ' A' ' 165' ' ' VAL . 49.1 mt -67.48 -45.15 86.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.355 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 6.4 m -66.43 -28.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.057 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -75.7 -54.22 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.436 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.04 -43.96 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.722 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.564 ' HB3' HG13 ' A' ' 162' ' ' VAL . 2.7 mm? -90.5 66.59 6.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 159' ' ' LEU . 5.0 t70 -16.68 -64.35 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.062 0.851 . . . . 0.0 112.761 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -158.35 25.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.434 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.652 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.77 -68.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.722 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.652 ' H ' HG13 ' A' ' 162' ' ' VAL . 1.7 p-10 -111.1 96.55 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.676 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -59.68 130.42 46.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.199 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.876 HG23 HD12 ' A' ' 155' ' ' ILE . 3.6 p -67.34 175.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.88 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.682 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.62 124.92 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 111.172 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 -7.54 45.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.274 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.83 -31.94 73.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.019 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.38 123.2 5.21 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 32' ' ' PRO . 9.5 p-10 -73.25 -166.02 0.29 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.895 0.379 . . . . 0.0 111.259 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 33' ' ' THR . 5.1 m -136.49 -168.5 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.554 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 39.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -83.37 46.36 1.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 0.0 110.858 -179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.738 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 9.1 ttm -59.15 -17.97 31.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.467 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -139.92 136.05 16.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.021 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 95' ' ' PRO . 84.1 Cg_endo -83.68 -151.93 0.73 Allowed 'Cis proline' 0 C--N 1.349 0.556 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.452 0.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.419 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -153.69 92.59 1.58 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.685 179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -102.27 129.92 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.323 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 98.3 t -128.02 100.82 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.378 178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.826 HG12 ' HA ' ' A' ' 189' ' ' VAL . 73.8 mt -116.29 139.22 43.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.827 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.906 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 1.8 m-20 -107.48 58.69 0.62 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 187' ' ' PRO . 9.7 tp -69.96 105.78 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.391 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.478 ' O ' HD23 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -83.29 -88.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.242 178.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 27.7 t -120.96 -83.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.646 0.26 . . . . 0.0 111.371 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.527 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 1.0 OUTLIER -89.01 -52.14 0.36 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.67 -179.053 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.36 106.75 1.37 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.248 1.965 . . . . 0.0 112.491 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.658 ' HB3' HD13 ' A' ' 182' ' ' LEU . 98.2 Cg_endo -84.27 129.57 4.48 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.752 2.301 . . . . 0.0 112.499 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.611 ' HD3' ' HB2' ' A' ' 181' ' ' ASP . 9.2 mtt180 -90.48 50.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.826 ' HA ' HG12 ' A' ' 180' ' ' ILE . 47.8 t -56.47 105.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.123 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.28 83.57 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.132 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 191' ' ' ARG . 8.1 ptt180 -85.95 174.1 9.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.26 109.66 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.737 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -88.03 81.41 1.6 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.607 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.85 110.42 22.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.73 0.3 . . . . 0.0 110.822 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.518 ' O ' HD23 ' A' ' 197' ' ' LEU . . . -83.56 -108.12 0.53 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.68 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.17 118.27 5.53 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.519 2.146 . . . . 0.0 112.555 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 195' ' ' GLY . 0.5 OUTLIER -149.24 171.26 16.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.789 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.403 ' OD2' HG13 ' A' ' 200' ' ' VAL . 6.0 t70 -74.56 133.4 77.08 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.031 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.415 ' HA ' HD13 ' A' ' 202' ' ' LEU . 85.3 Cg_endo -82.22 45.25 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.65 2.233 . . . . 0.0 112.368 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.566 HG23 ' H ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -55.31 -74.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.308 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.566 ' H ' HG23 ' A' ' 200' ' ' VAL . 0.3 OUTLIER -114.85 48.31 1.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.992 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -67.18 -60.97 2.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' A' ' 203' ' ' ARG . 8.6 ptp180 -72.95 143.1 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -170.5 176.89 43.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.544 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -106.91 150.43 26.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.721 0.296 . . . . 0.0 111.002 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 151.56 -0.99 0.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -105.77 -22.73 12.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.754 0.311 . . . . 0.0 110.916 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.073 179.89 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.82 0.343 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.71 -175.74 2.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.0 tp -85.83 150.54 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.408 ' H ' ' HG2' ' A' ' 4' ' ' ARG . 1.6 ptt180 -104.69 172.63 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.006 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.99 161.28 20.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.965 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tt -102.99 141.31 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.05 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -71.09 120.62 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.003 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.65 167.96 11.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.976 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -98.22 53.78 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.929 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.53 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -76.24 -50.97 2.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.49 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 10' ' ' ASN . 43.6 Cg_endo -67.91 -52.18 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.091 1.86 . . . . 0.0 112.439 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.7 122.05 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.91 128.55 17.99 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.523 2.148 . . . . 0.0 112.32 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -74.86 -33.97 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.798 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG11 HG13 ' A' ' 126' ' ' ILE . 26.2 t -61.51 -40.14 85.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.9 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.602 HD22 HG23 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -68.43 -34.77 76.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.723 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.09 -26.58 63.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.944 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.65 -37.22 68.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.654 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -66.08 -37.25 85.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.814 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 16' ' ' LEU . 22.8 mm -75.3 -23.95 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 t -68.18 -47.75 67.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.57 HG21 ' HB2' ' A' ' 164' ' ' LEU . 7.3 p -69.72 -31.02 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 1.7 mtt -71.23 -27.91 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.075 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.84 -33.82 76.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.81 73.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.519 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.35 65.48 2.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.36 175.84 16.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.413 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.68 HD11 ' HB2' ' A' ' 39' ' ' LEU . 2.2 tp -96.04 142.01 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.661 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -116.69 121.15 67.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -102.06 165.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -169.91 86.28 0.57 Allowed Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.604 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 73.0 Cg_endo -75.09 118.97 5.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.265 1.977 . . . . 0.0 111.009 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.855 ' HA ' ' H ' ' A' ' 171' ' ' CYS . 1.0 OUTLIER -116.31 -137.29 0.36 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.034 0.445 . . . . 0.0 111.68 -176.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 0.3 OUTLIER -54.24 -46.56 72.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.202 -179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -78.8 -122.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.485 179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.471 ' H ' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -112.51 -158.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 110.9 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 32' ' ' PRO . 1.8 m-85 -69.99 115.46 9.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' HA3' HH22 ' A' ' 120' ' ' ARG . . . -116.16 126.48 7.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.525 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.68 ' HB2' HD11 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -111.17 138.77 47.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 111.199 -178.126 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.18 160.52 28.07 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.987 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.494 ' CG1' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -158.95 -169.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.875 0.369 . . . . 0.0 111.047 -178.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.725 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 1.7 t30 -56.14 124.0 16.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.197 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.09 -67.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.226 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 44' ' ' LEU . 2.1 mm? -80.84 42.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 111.625 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -110.33 152.82 25.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.849 178.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.28 -30.28 60.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.8 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.89 -25.5 68.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.878 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -69.88 -38.88 76.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.9 t -72.34 -37.63 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -67.66 -37.73 82.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.093 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -75.19 -20.29 59.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.036 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -44.92 66.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.956 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -75.26 -27.94 59.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.249 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -68.58 -56.52 7.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 143' ' ' ILE . 17.4 t -66.72 -49.42 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.429 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -72.79 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.285 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.64 78.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.656 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.86 -69.31 0.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.98 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.91 98.7 11.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.73 14.72 1.97 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.567 2.178 . . . . 0.0 112.448 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -104.88 -7.35 19.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.6 148.5 44.2 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.978 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.56 165.13 1.78 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.662 2.241 . . . . 0.0 112.319 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.3 159.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.212 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.27 138.49 43.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.565 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 118' ' ' GLY . 22.6 pt -114.76 169.08 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 111.502 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 118.22 27.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.854 HG11 HG12 ' A' ' 74' ' ' ILE . 1.5 p -135.86 -179.85 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.634 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -87.65 -40.1 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.042 0.449 . . . . 0.0 110.582 179.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 166.73 21.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.562 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.671 HG21 ' SD ' ' A' ' 85' ' ' MET . 3.3 t -59.17 -29.38 41.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.752 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -67.31 -27.51 67.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.777 179.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HG3' ' OG ' ' A' ' 69' ' ' SER . 12.8 mm-40 -79.31 -22.87 43.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.036 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.854 HG12 HG11 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -113.74 56.67 0.71 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 42.8 Cg_endo -68.35 -62.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.857 1.705 . . . . 0.0 112.143 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.8 mtt180 -72.89 4.09 4.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.559 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 66' ' ' ILE . 1.8 t80 -92.2 -64.54 1.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.736 0.303 . . . . 0.0 110.837 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.06 -178.03 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -116.59 116.62 38.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.956 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HB3' HG11 ' A' ' 71' ' ' VAL . 69.1 Cg_endo -102.07 -176.71 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.203 2.602 . . . . 0.0 112.558 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.923 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 29.5 t -143.4 173.08 11.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.232 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.99 -103.25 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.129 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 86' ' ' GLU . 1.5 m-20 -55.17 -26.54 39.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -60.61 -51.95 67.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.989 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.671 ' SD ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -74.26 -21.01 59.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -63.61 -44.83 92.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.311 179.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -44.65 95.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.578 ' HE1' HD13 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -66.4 -29.98 70.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.696 ' HA ' HD23 ' A' ' 92' ' ' LEU . 3.7 mt-10 -72.39 -17.3 61.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.082 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -75.22 -13.82 60.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.179 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.5 41.95 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.875 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 89' ' ' GLU . 1.8 pp -127.27 146.65 58.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.994 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.59 -171.95 10.59 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.37 -1.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.35 163.42 12.29 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.856 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 35' ' ' THR . 86.0 Cg_endo -81.06 48.78 3.01 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -107.5 159.68 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.57 138.84 44.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.632 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.07 106.58 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.285 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.763 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 14.0 t -103.85 122.48 56.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.427 HD21 ' HE3' ' A' ' 85' ' ' MET . 1.2 mp -126.36 -167.66 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.442 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -177.53 3.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.314 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.769 ' HB2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.8 147.87 44.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.115 0.483 . . . . 0.0 111.091 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 8.7 t30 -74.28 -173.21 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.39 38.38 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.826 ' HG ' ' HD2' ' A' ' 107' ' ' PRO . 10.8 tp -76.63 127.77 33.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.79 0.329 . . . . 0.0 110.799 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.57 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 4.5 mt -75.68 -50.34 3.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.692 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.826 ' HD2' ' HG ' ' A' ' 105' ' ' LEU . 76.4 Cg_exo -50.58 108.32 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.267 1.978 . . . . 0.0 112.443 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.592 ' HA ' HG22 ' A' ' 111' ' ' THR . 0.8 OUTLIER -80.82 1.37 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.986 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.73 -15.02 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 107' ' ' PRO . 4.3 mt -109.5 -44.33 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.115 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 108' ' ' ASP . 8.8 t -77.26 -9.63 58.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.834 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.35 -150.25 38.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.459 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.7 -10.52 67.18 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.549 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.3 p -117.02 -171.35 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 0.0 110.757 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.573 ' HA ' ' HD3' ' A' ' 102' ' ' ARG . 4.4 p -109.67 64.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.702 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -140.42 152.59 45.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.012 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.769 HG23 ' HB2' ' A' ' 102' ' ' ARG . 92.9 t -139.86 135.07 38.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.411 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.557 ' O ' HG12 ' A' ' 66' ' ' ILE . . . -99.21 155.99 19.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.563 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.638 HD12 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -135.06 173.23 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' H ' HG22 ' A' ' 119' ' ' ILE . 3.2 ttp180 -157.29 117.5 3.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.751 0.31 . . . . 0.0 111.392 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.87 79.38 1.85 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.846 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.57 -170.47 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.594 2.196 . . . . 0.0 112.548 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.11 23.01 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.104 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.69 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 3.1 t0 -82.2 96.06 7.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.57 -44.99 85.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.602 HG23 HD22 ' A' ' 16' ' ' LEU . 30.6 mm -64.91 -53.42 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.947 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 14.5 t -63.11 -12.78 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.507 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 6.4 ttt85 -75.47 -42.85 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -73.25 -54.46 8.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.518 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -39.18 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.299 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -71.13 -26.6 63.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.36 -53.79 49.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -89.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.824 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 90.1 m-85 -77.74 123.16 86.51 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 20.7 Cg_exo -65.51 163.53 29.55 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.06 146.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 111.517 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.418 HG21 ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -74.47 151.24 39.6 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.29 114.87 8.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.952 0.406 . . . . 0.0 111.939 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.52 148.51 50.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.54 124.9 29.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.18 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' TYR . . . -69.75 119.59 14.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.199 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.463 ' HA ' ' HG2' ' A' ' 147' ' ' PRO . 2.4 t30 -162.61 31.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 55' ' ' VAL . 4.7 tt -68.37 171.17 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.3 p -54.04 149.18 9.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.014 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 89.75 -136.74 13.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.557 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -116.72 90.26 31.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.554 0.216 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.471 ' HB2' ' HD3' ' A' ' 148' ' ' PRO . 33.9 Cg_exo -60.55 -50.57 6.56 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.423 2.082 . . . . 0.0 113.136 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 147' ' ' PRO . 86.3 Cg_endo -82.26 125.62 4.63 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.924 1.749 . . . . 0.0 112.571 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.08 154.63 38.82 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.664 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -95.85 -10.67 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.72 2.28 . . . . 0.0 112.972 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.35 139.54 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.389 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -65.53 -45.25 84.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.853 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -67.24 -18.5 65.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.611 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -40.92 76.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.77 HD12 HG23 ' A' ' 165' ' ' VAL . 24.0 mt -69.29 -37.87 76.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.217 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.11 -44.17 95.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.42 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -75.45 -46.9 29.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.753 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.676 ' HB3' HD22 ' A' ' 159' ' ' LEU . 6.3 t70 -70.18 -43.45 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.574 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 158' ' ' ASP . 2.8 mm? -100.23 67.11 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -16.59 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.048 0.843 . . . . 0.0 112.848 -178.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.44 25.09 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.649 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER -80.55 -69.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.553 179.031 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.677 ' HA ' HG23 ' A' ' 28' ' ' ILE . 1.2 p-10 -108.29 99.51 8.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.968 0.413 . . . . 0.0 110.498 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.57 ' HB2' HG21 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -58.97 130.2 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.735 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.77 HG23 HD12 ' A' ' 155' ' ' ILE . 1.9 p -64.33 -170.7 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.948 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.768 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.0 OUTLIER -126.53 119.95 28.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.155 0.502 . . . . 0.0 111.426 -178.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.4 -0.69 57.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.076 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.591 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -75.75 -38.71 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.82 64.85 1.7 Allowed Glycine 0 CA--C 1.517 0.212 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.767 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.844 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 7.3 m-20 -73.14 -124.0 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 O-C-N 122.859 -0.2 . . . . 0.0 110.744 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.855 ' H ' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -141.72 -170.1 3.04 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.232 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.86 10.1 1.34 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -64.63 91.81 0.09 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.149 0.5 . . . . 0.0 111.364 -176.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.404 ' HG3' HG23 ' A' ' 36' ' ' ILE . 10.0 ttt -55.04 -15.79 2.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.857 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -139.68 150.58 63.65 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.055 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.95 -151.92 0.66 Allowed 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 123.497 -1.46 . . . . 0.0 112.533 0.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -153.91 115.21 4.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.599 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.18 46.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.333 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.4 t -129.24 105.92 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.564 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 189' ' ' VAL . 3.7 mp -121.2 132.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.629 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.763 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.5 OUTLIER -95.3 71.86 3.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.553 ' HG ' ' HE1' ' A' ' 85' ' ' MET . 0.0 OUTLIER -68.37 84.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.299 -179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.13 -88.0 0.08 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.414 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.72 -128.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.842 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 0.6 OUTLIER -59.33 -51.17 83.32 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.36 106.27 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.238 1.958 . . . . 0.0 112.371 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 96.1 Cg_endo -84.29 140.56 8.67 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.601 2.2 . . . . 0.0 112.401 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.67 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 10.2 mmm-85 -97.18 59.31 1.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.473 . . . . 0.0 110.587 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.699 ' HA ' HG23 ' A' ' 180' ' ' ILE . 43.2 t -58.24 107.65 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.117 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.01 80.36 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 191' ' ' ARG . 0.0 OUTLIER -99.2 143.45 29.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.996 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -84.51 81.62 8.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -89.14 114.48 4.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.6 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.45 21.74 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -81.03 -99.48 0.36 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.448 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.97 76.22 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.787 2.325 . . . . 0.0 112.179 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -7.92 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.981 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 0.2 OUTLIER -69.59 123.48 88.59 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.876 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 198' ' ' ASP . 35.1 Cg_exo -60.16 -57.91 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.604 2.203 . . . . 0.0 112.287 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.555 HG12 ' HB2' ' A' ' 202' ' ' LEU . 12.7 t -73.79 112.95 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.06 30.92 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.555 ' HB2' HG12 ' A' ' 200' ' ' VAL . 0.2 OUTLIER -66.12 -26.94 67.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.02 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.69 -72.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 144.46 163.48 10.02 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -94.23 -34.21 12.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.712 0.292 . . . . 0.0 111.102 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . -134.77 105.81 0.57 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.46 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -93.86 -23.71 18.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.979 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 208' ' ' VAL . 10.1 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.143 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.789 0.328 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.1 171.56 9.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.901 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 mm -92.24 125.71 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -82.71 -171.1 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.007 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.98 -171.41 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -105.65 143.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.156 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.518 ' N ' HG13 ' A' ' 6' ' ' ILE . 13.2 t -75.93 -178.63 4.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 8' ' ' ARG . 6.6 mtm180 -73.12 167.41 21.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.797 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -92.98 -76.73 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.888 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -110.1 132.31 21.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.77 -157.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.576 2.184 . . . . 0.0 112.162 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.35 111.35 16.48 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.7 172.52 5.63 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.63 2.22 . . . . 0.0 112.134 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -33.75 76.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.437 HG13 ' OE2' ' A' ' 18' ' ' GLU . 95.3 t -65.93 -35.67 75.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.135 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.81 -47.08 70.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.87 -21.18 65.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.03 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' OE2' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -75.22 -34.21 61.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.661 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -70.42 -36.68 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.058 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.6 mm -69.71 -31.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 m -64.04 -47.54 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 19' ' ' ALA . 4.4 p -64.47 -25.5 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.031 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.0 mmt -60.42 -47.24 86.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -23.71 61.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.983 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.35 -5.3 79.66 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.519 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.0 57.13 12.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.81 174.72 16.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -96.44 148.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-O 120.756 0.313 . . . . 0.0 110.67 179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.553 ' H ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.8 116.82 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.325 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.744 HG22 ' H ' ' A' ' 31' ' ' TYR . 2.5 mt -102.38 174.23 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.484 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.744 ' H ' HG22 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -171.31 106.44 0.39 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HG2' ' N ' ' A' ' 170' ' ' ASP . 87.2 Cg_endo -84.28 125.39 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.602 2.201 . . . . 0.0 111.506 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.62 -154.84 0.56 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 6.8 m-20 -54.7 -30.1 54.89 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.255 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 176' ' ' PRO . 0.2 OUTLIER -93.54 -118.23 0.09 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.762 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 174' ' ' MET . 0.1 OUTLIER -112.18 -165.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.81 0.338 . . . . 0.0 111.165 -179.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -71.87 126.02 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.537 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.2 121.19 2.79 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -112.16 149.32 32.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.259 0.552 . . . . 0.0 112.062 -176.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 41' ' ' VAL . . . -144.93 169.04 26.8 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.946 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.553 HG13 HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -159.27 -170.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.909 0.385 . . . . 0.0 111.118 -179.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 2.5 t30 -56.75 119.74 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.303 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.56 -63.23 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.37 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 44' ' ' LEU . 1.2 mm? -78.33 33.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 111.863 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.67 ' HB2' ' HB3' ' A' ' 42' ' ' ASN . 1.1 m-20 -111.28 147.68 34.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.973 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -75.57 -29.63 59.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.305 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.71 -25.68 63.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 137' ' ' THR . . . -72.33 -31.48 65.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.145 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.13 -45.23 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.16 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.496 ' NH2' ' HB3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -67.75 -34.92 77.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.139 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 24.2 mmt180 -73.64 -35.1 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.019 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 139' ' ' THR . 0.1 OUTLIER -67.23 -24.65 65.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.846 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -46.68 32.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.384 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -54.46 -48.21 72.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.391 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.447 HG13 ' CB ' ' A' ' 142' ' ' ASN . 10.7 t -75.21 -49.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.36 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.737 ' HE3' ' HB2' ' A' ' 58' ' ' ARG . 14.7 tptt -93.69 -71.25 0.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.411 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.85 15.33 34.32 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.697 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.737 ' HB2' ' HE3' ' A' ' 56' ' ' LYS . 76.7 mtp85 -118.23 22.91 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 111.087 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.4 p -149.7 66.21 8.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.93 -54.94 4.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.575 2.184 . . . . 0.0 112.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.424 ' O ' ' HA3' ' A' ' 112' ' ' GLY . 32.2 p-80 -123.84 24.09 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.137 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.619 ' HE3' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -88.55 146.55 37.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.619 ' HD2' ' HE3' ' A' ' 62' ' ' LYS . 76.9 Cg_exo -51.74 148.32 22.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.662 2.241 . . . . 0.0 112.559 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.9 166.13 7.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.58 ' HA ' ' HA3' ' A' ' 118' ' ' GLY . 0.4 OUTLIER -106.92 140.22 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.741 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 118' ' ' GLY . 1.8 pt -116.21 171.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.241 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.6 t -122.8 125.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.504 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.876 HG21 HG23 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -135.97 -179.11 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.878 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.608 ' H ' HG22 ' A' ' 68' ' ' VAL . 1.5 t -90.0 -44.07 10.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.79 0.328 . . . . 0.0 110.956 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -163.71 174.91 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.089 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HA ' HD11 ' A' ' 74' ' ' ILE . 5.8 t -58.38 -37.37 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.834 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 75' ' ' PRO . 1.0 OUTLIER -67.13 -22.12 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.837 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.63 ' HG2' ' HA ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -80.43 -20.92 42.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.139 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.876 HG23 HG21 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -113.63 54.6 0.61 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 29.5 Cg_endo -62.41 -82.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.834 1.689 . . . . 0.0 111.828 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.457 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 2.0 mmt180 -73.41 19.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.336 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' PRO . 59.9 m-85 -103.26 -34.81 8.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.755 0.312 . . . . 0.0 111.108 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.456 ' OG ' HD11 ' A' ' 119' ' ' ILE . 2.2 m -135.33 165.5 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -112.76 105.01 56.09 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.415 ' HB2' ' HG2' ' A' ' 85' ' ' MET . 86.3 Cg_endo -102.57 179.72 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.169 2.579 . . . . 0.0 112.619 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 -173.45 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.11 -82.47 0.44 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.709 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.713 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -57.64 -26.71 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.927 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.471 ' O ' HD21 ' A' ' 182' ' ' LEU . . . -63.41 -48.25 78.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 80' ' ' PRO . 9.6 mmt -70.44 -15.81 62.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.713 ' HG3' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mm-40 -66.44 -50.4 63.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.67 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 182' ' ' LEU . 2.7 tm? -61.77 -38.99 90.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.81 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.449 ' SD ' HD13 ' A' ' 182' ' ' LEU . 5.1 tpt -64.94 -49.67 69.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.437 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -72.88 -2.59 21.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.368 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -73.99 -58.88 3.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.295 -179.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.3 74.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.629 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.74 149.22 72.82 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.071 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.72 -148.5 0.51 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.18 -1.175 . . . . 0.0 111.952 -1.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 156.69 158.18 8.74 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.979 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.42 ' HB2' HG23 ' A' ' 35' ' ' THR . 3.9 Cg_exo -80.42 43.77 1.6 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.221 2.614 . . . . 0.0 112.151 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.497 ' HB3' ' HB ' ' A' ' 178' ' ' THR . 3.6 p90 -112.23 -177.03 3.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -112.89 139.04 48.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.245 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.17 102.77 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.282 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.745 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 4.9 t -101.22 122.9 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.462 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -126.91 -179.04 4.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.714 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -74.86 -166.01 0.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.664 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -119.28 138.19 53.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.906 0.384 . . . . 0.0 111.182 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 76' ' ' ARG . 4.3 t30 -73.73 -163.11 0.15 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.315 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.19 -39.19 82.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.325 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.576 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -69.46 100.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.688 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.4 pt -80.95 102.87 1.5 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.918 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.922 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 60.6 Cg_endo -70.91 138.43 34.16 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.429 2.086 . . . . 0.0 112.248 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.034 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 109' ' ' VAL . 7.0 p -87.43 23.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.922 ' HB ' ' HB2' ' A' ' 107' ' ' PRO . 57.7 mt -106.69 -54.41 6.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 110.894 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.677 ' HB ' ' HG2' ' A' ' 107' ' ' PRO . 6.2 t -87.57 -24.26 24.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.865 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 61' ' ' HIS . . . 69.31 -141.74 36.12 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.408 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -88.32 27.6 6.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.437 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' A' ' 63' ' ' PRO . 1.3 t -123.94 165.58 17.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.327 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -113.16 42.86 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 116' ' ' ARG . 2.3 mtp180 -136.74 163.63 30.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -139.52 142.28 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . -92.74 149.59 19.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.454 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.503 HD13 HD13 ' A' ' 74' ' ' ILE . 72.2 mt -144.98 150.26 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.41 124.03 12.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.88 0.371 . . . . 0.0 111.476 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.1 t -110.66 83.7 3.61 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.837 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.08 179.5 6.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.589 2.192 . . . . 0.0 112.614 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -93.13 19.65 7.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.108 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.471 ' HB2' ' SG ' ' A' ' 127' ' ' CYS . 66.1 m-20 -82.02 105.57 13.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' ARG . 5.4 pt-20 -57.35 -42.96 82.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.277 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.6 mm -61.36 -58.13 8.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.274 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -58.58 -21.16 52.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.994 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 125' ' ' GLU . 1.8 mtp180 -68.17 -37.54 81.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 34.6 ttt-85 -75.25 -53.23 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.2 mt -59.19 -52.0 65.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.257 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.798 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.08 -27.86 69.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.63 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -51.27 66.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.997 0.427 . . . . 0.0 110.021 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.521 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -75.19 -91.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 177.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.521 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -77.92 144.87 68.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.777 178.136 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.34 159.53 49.19 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.185 1.923 . . . . 0.0 111.374 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.7 t -132.67 152.0 35.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.802 0.334 . . . . 0.0 111.244 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.466 HG21 ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -80.2 153.28 28.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.4 116.4 8.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.407 . . . . 0.0 111.57 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.651 HG23 HD12 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -142.42 140.89 32.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.697 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.439 ' O ' HG11 ' A' ' 55' ' ' VAL . 22.4 p -66.93 139.17 57.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.997 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.06 145.09 46.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.393 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.447 ' CB ' HG13 ' A' ' 55' ' ' VAL . 1.6 t-20 -165.96 46.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.803 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.479 ' O ' ' HG3' ' A' ' 147' ' ' PRO . 7.2 mm -61.06 160.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.8 m -59.4 142.35 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.727 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.07 -109.81 3.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.463 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 148' ' ' PRO . 0.4 OUTLIER -127.19 94.31 39.2 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.593 0.235 . . . . 0.0 111.029 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 143' ' ' ILE . 43.1 Cg_exo -60.34 -48.12 12.55 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.498 2.132 . . . . 0.0 113.389 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.492 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 73.9 Cg_endo -75.07 90.41 1.09 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.802 1.668 . . . . 0.0 112.208 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.489 ' HB2' HG12 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -84.78 157.93 60.0 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -96.01 -11.27 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.902 2.401 . . . . 0.0 112.908 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -141.48 141.62 33.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.462 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.87 HD22 ' HA ' ' A' ' 166' ' ' LEU . 55.8 mt -60.19 -28.6 68.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.771 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -72.23 -34.45 68.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.361 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.54 ' HG3' HH21 ' A' ' 157' ' ' ARG . 3.9 tt0 -58.95 -47.07 86.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.804 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.542 ' H ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -74.44 -35.43 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -67.33 -20.91 27.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.072 0.463 . . . . 0.0 110.37 178.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.54 HH21 ' HG3' ' A' ' 154' ' ' GLU . 10.1 ttp180 -73.1 -46.31 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.431 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.17 -41.41 63.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.677 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 160' ' ' ASP . 2.7 mm? -111.22 68.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.661 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 159' ' ' LEU . 1.7 t70 -15.93 -63.35 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.094 0.871 . . . . 0.0 112.817 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -157.02 18.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.775 0.321 . . . . 0.0 111.251 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.96 -42.35 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.909 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 25.5 m-20 -111.21 110.75 21.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.411 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.529 HD12 HG13 ' A' ' 29' ' ' VAL . 29.7 mt -74.71 61.93 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.746 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.646 HG13 ' HB ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -78.84 22.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.732 178.159 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.87 ' HA ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -148.21 34.81 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -175.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.501 ' OD1' ' HB3' ' A' ' 164' ' ' LEU . 4.3 m-20 -70.01 -84.09 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.385 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.638 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -86.35 -34.19 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.065 0.46 . . . . 0.0 110.673 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.54 176.59 27.26 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.468 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' N ' ' HG2' ' A' ' 32' ' ' PRO . 2.9 m-20 -62.19 -177.55 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 0.0 111.214 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 1.9 t -140.16 -62.91 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.55 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -124.77 -135.61 0.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.7 144.78 26.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.768 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.9 ptm -70.32 2.4 3.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.054 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.72 151.29 26.45 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.626 ' O ' HG22 ' A' ' 35' ' ' THR . 64.5 Cg_endo -92.02 -136.64 0.1 OUTLIER 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.946 -1.273 . . . . 0.0 112.46 0.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.411 ' H ' ' HB2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -159.33 130.2 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.418 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 191' ' ' ARG . 32.6 m -101.29 139.72 36.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.923 0.392 . . . . 0.0 111.607 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.7 t -129.6 117.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.662 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.7 mt -120.31 121.01 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.386 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 188' ' ' ARG . 1.0 OUTLIER -98.25 67.96 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.271 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 87' ' ' LEU . 4.4 tt -69.29 79.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 -78.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.92 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 185' ' ' ASN . 5.7 t -120.42 -119.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.381 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 187' ' ' PRO . 2.1 m-20 -69.57 -52.65 13.95 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.97 109.55 2.6 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.108 1.872 . . . . 0.0 112.767 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 185' ' ' ASN . 72.7 Cg_endo -75.97 122.67 6.87 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.444 2.096 . . . . 0.0 111.955 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.776 ' HB2' ' HB2' ' A' ' 181' ' ' ASP . 3.3 mmp_? -87.28 61.2 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.276 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.7 t -61.88 93.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.569 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -122.05 87.8 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.211 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.614 ' HB3' HG23 ' A' ' 178' ' ' THR . 1.5 ptm180 -89.41 142.81 27.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.057 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -84.59 2.94 39.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.867 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -95.92 -166.53 34.49 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.627 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -95.62 93.36 7.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -88.11 162.3 32.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.403 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.55 124.32 10.21 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.536 2.157 . . . . 0.0 112.334 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.46 -38.12 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.55 134.27 66.08 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.77 169.31 19.23 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.478 2.119 . . . . 0.0 112.301 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.9 t -72.04 97.64 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.645 HD23 ' HA3' ' A' ' 204' ' ' GLY . 0.2 OUTLIER -85.18 85.68 7.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.8 tp -88.31 -51.68 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.25 1.11 38.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.012 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.645 ' HA3' HD23 ' A' ' 201' ' ' LEU . . . -100.64 -97.09 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.493 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -109.4 -75.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 111.034 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 63.49 -157.2 41.45 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.455 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.75 -14.63 14.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.042 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.76 0.314 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.7 179.81 4.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mt -99.44 100.02 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.021 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -91.52 138.47 31.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.53 -167.96 2.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.01 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 tt -99.0 134.91 36.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.015 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 p -82.64 -178.78 7.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 98.45 9.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.691 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -109.08 8.64 26.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.049 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -98.28 104.85 25.34 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 35.9 Cg_endo -64.56 124.25 12.98 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.526 2.15 . . . . 0.0 112.084 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.28 82.44 11.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.99 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 16' ' ' LEU . 23.1 Cg_exo -64.65 171.76 7.86 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.663 2.242 . . . . 0.0 112.104 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.88 -26.53 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.488 HG13 ' OD2' ' A' ' 167' ' ' ASP . 44.9 t -75.11 -34.54 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.074 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 1.1 mm? -69.65 -47.0 64.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.97 -21.21 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' HG3' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -74.77 -35.88 62.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.679 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.57 ' N ' ' HG3' ' A' ' 18' ' ' GLU . . . -67.56 -37.67 82.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.933 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.95 -35.18 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.647 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -33.52 75.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 18' ' ' GLU . 16.8 t -70.1 -32.29 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.056 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.0 mmt -61.33 -41.93 97.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.17 -11.23 60.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.12 -11.82 72.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 37.78 92.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.13 170.22 18.89 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.584 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.675 HD13 ' N ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -96.3 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.673 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.675 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -117.29 135.97 55.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -102.56 152.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.59 0.233 . . . . 0.0 110.586 178.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' HE1' ' HB3' ' A' ' 168' ' ' ALA . 0.6 OUTLIER -160.13 102.5 1.4 Allowed Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -178.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.689 ' HB3' ' HA ' ' A' ' 37' ' ' TYR . 84.4 Cg_endo -82.18 136.3 8.94 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.489 2.126 . . . . 0.0 111.327 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 -147.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.663 0.268 . . . . 0.0 111.277 -178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.601 ' O ' ' HB3' ' A' ' 172' ' ' LEU . 8.0 t70 -54.5 -25.41 25.34 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.928 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 174' ' ' MET . 4.3 t -95.43 -120.54 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.586 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.7 HG12 ' H ' ' A' ' 37' ' ' TYR . 9.3 tt -111.77 -171.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.563 0.221 . . . . 0.0 110.876 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.7 ' H ' HG12 ' A' ' 36' ' ' ILE . 1.4 m-85 -63.33 129.02 38.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.778 0.323 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 140' ' ' SER . . . -121.14 177.68 16.38 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.146 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.654 ' HB2' HG23 ' A' ' 139' ' ' THR . 3.6 mp -119.32 141.11 49.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.635 0.255 . . . . 0.0 110.728 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 137' ' ' THR . . . -146.39 114.08 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 42' ' ' ASN . 3.4 p -153.29 161.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.511 0.195 . . . . 0.0 110.867 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.492 ' N ' HG22 ' A' ' 41' ' ' VAL . 5.9 t-20 -55.93 98.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.371 . . . . 0.0 110.346 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.64 -25.62 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.108 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.42 9.2 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.086 0.469 . . . . 0.0 111.34 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.91 152.51 26.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.718 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.7 mt-10 -74.07 -19.16 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.825 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.47 -25.1 63.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.55 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.2 35.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.29 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 46' ' ' GLU . 32.6 m -65.17 -34.28 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.056 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.72 -40.15 96.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.557 ' HG2' HG13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -62.2 -54.5 40.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.146 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.71 -27.29 39.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.293 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.57 -31.57 65.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.532 HH21 ' HA2' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -73.52 -40.58 63.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.015 -179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.5 t -75.12 -35.05 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.397 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.89 0.32 56.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.401 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.24 -115.37 7.92 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.604 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -100.42 105.12 16.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.871 0.367 . . . . 0.0 110.993 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 63.3 m -151.97 65.12 6.09 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.014 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.7 6.03 5.48 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.598 2.199 . . . . 0.0 112.448 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -122.36 -14.03 7.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.018 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 5.9 mmtp -88.16 129.19 50.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 35.0 Cg_exo -61.18 -175.1 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.549 2.166 . . . . 0.0 111.999 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.55 170.64 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.854 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -113.62 134.57 54.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 25.9 mm -116.42 159.24 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.387 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.888 ' HB2' ' HB2' ' A' ' 138' ' ' ALA . 1.6 t -119.15 141.24 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.153 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 74' ' ' ILE . 1.4 p -150.05 173.24 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.287 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.572 ' H ' HG22 ' A' ' 68' ' ' VAL . 7.5 t -89.84 -34.15 16.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 110.072 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 13.9 t -164.26 160.66 21.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.595 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.53 ' HA ' HD11 ' A' ' 74' ' ' ILE . 21.9 t -57.08 -32.56 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.624 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.35 -26.19 66.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.884 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.677 ' C ' ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -77.1 -22.82 52.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.207 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.646 HG12 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.61 60.11 0.83 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.677 ' HD3' ' C ' ' A' ' 73' ' ' GLU . 23.5 Cg_exo -64.12 -73.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.158 1.906 . . . . 0.0 112.448 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 15.79 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.032 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.19 -34.93 6.98 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.157 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.569 ' HB2' HD23 ' A' ' 100' ' ' LEU . 93.4 p -135.49 164.2 28.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.0 110.991 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -114.52 103.22 55.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.756 ' HA ' HD11 ' A' ' 100' ' ' LEU . 74.3 Cg_endo -102.15 -169.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.177 2.585 . . . . 0.0 113.063 -177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -144.58 -174.85 4.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.06 -86.56 0.28 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.881 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -29.48 61.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.793 0.33 . . . . 0.0 110.998 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 184' ' ' VAL . . . -58.44 -49.28 77.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.787 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.516 ' SD ' HG21 ' A' ' 71' ' ' VAL . 21.3 mmt -72.17 -17.91 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.956 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.67 -36.22 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.14 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.497 HD12 HD22 ' A' ' 182' ' ' LEU . 2.8 tm? -64.18 -45.45 88.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.651 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.852 ' HB2' HD23 ' A' ' 182' ' ' LEU . 31.5 tpp -75.39 -26.56 58.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.376 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HA ' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -60.72 -40.76 93.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.399 . . . . 0.0 111.854 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -75.56 -18.46 59.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.4 mt -100.4 -11.29 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.525 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -112.08 151.89 43.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.007 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.96 174.84 50.58 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.904 -1.29 . . . . 0.0 112.202 0.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.32 -173.61 32.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.568 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.17 28.63 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.661 2.241 . . . . 0.0 112.437 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -101.59 143.36 31.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -106.96 136.24 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.635 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 182' ' ' LEU . 1.4 p -120.11 111.83 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 0.0 111.406 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.678 ' HB ' ' HA ' ' A' ' 181' ' ' ASP . 6.4 t -87.44 127.16 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.922 177.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.756 HD11 ' HA ' ' A' ' 80' ' ' PRO . 15.1 tp -124.8 178.22 5.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.562 ' H ' ' HG ' ' A' ' 100' ' ' LEU . 1.6 mt-10 -74.4 -170.24 0.96 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.9 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.64 ' HG2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -118.77 138.63 52.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.491 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 176.1 7.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.747 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.57 55.84 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.451 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 107' ' ' PRO . 1.8 mt -89.85 131.04 35.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 110.768 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.631 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 2.3 mp -66.84 -51.86 36.16 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.781 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.734 ' HD2' HD22 ' A' ' 105' ' ' LEU . 56.7 Cg_exo -52.21 105.17 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.236 1.957 . . . . 0.0 112.445 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -4.7 53.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 110' ' ' ILE . 14.5 p -71.96 -27.01 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.015 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.62 HG13 HG13 ' A' ' 109' ' ' VAL . 13.1 mt -93.87 -39.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.426 HG22 ' NE ' ' A' ' 102' ' ' ARG . 2.5 p -71.68 -23.21 61.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.6 -157.44 50.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.498 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.85 -21.26 71.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.0 m -108.39 -179.77 3.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.722 0.296 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.533 ' C ' ' HB2' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -112.98 59.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.029 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 mtm105 -142.72 158.58 43.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.101 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.64 HG23 ' HG2' ' A' ' 102' ' ' ARG . 39.5 t -139.93 117.11 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.61 117.9 4.54 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 74' ' ' ILE . 5.7 mt -130.14 150.43 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.8 0.333 . . . . 0.0 111.037 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 8.8 ptp180 -144.48 149.32 35.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.478 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -110.5 88.72 7.9 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.739 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 120' ' ' ARG . 21.8 Cg_exo -64.81 -179.52 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.461 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.25 2.11 56.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.188 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 127' ' ' CYS . 5.1 t0 -71.44 109.11 5.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 111.005 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.27 -40.51 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.243 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 30.2 mm -69.94 -50.02 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.258 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 124' ' ' ASP . 20.6 t -61.26 -18.79 60.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.2 OUTLIER -73.69 -46.79 44.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.878 179.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -52.54 60.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.562 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 130' ' ' ILE . 8.5 mt -59.45 -55.21 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.309 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 68' ' ' VAL . . . -62.74 -25.1 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.451 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB1' ' HG2' ' A' ' 73' ' ' GLU . . . -54.92 -57.37 11.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.02 0.438 . . . . 0.0 109.965 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.458 ' HB3' ' H ' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -76.16 -85.58 0.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.265 177.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.458 ' H ' ' HB3' ' A' ' 133' ' ' ARG . 28.7 m-85 -77.19 112.32 22.51 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.236 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -65.64 133.33 33.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.279 1.986 . . . . 0.0 111.306 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.72 166.98 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 120.878 0.371 . . . . 0.0 111.771 -177.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.578 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 87.7 m -80.97 125.88 30.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . . . -122.58 95.37 4.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.68 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.654 HG23 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER -126.76 113.87 17.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.859 179.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.579 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -61.84 121.7 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 147' ' ' PRO . . . -79.08 129.98 35.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.797 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -160.11 -43.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.435 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.417 ' HB ' ' H ' ' A' ' 144' ' ' SER . 1.1 mp -80.31 -106.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.457 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.417 ' H ' ' HB ' ' A' ' 143' ' ' ILE . 0.3 OUTLIER -62.41 178.42 0.41 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.967 0.413 . . . . 0.0 111.469 -179.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.532 ' HA2' HH21 ' A' ' 54' ' ' ARG . . . 73.6 -152.24 45.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.379 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.34 62.94 56.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 0.0 110.886 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.58 ' HG2' ' HD3' ' A' ' 148' ' ' PRO . 11.1 Cg_endo -60.77 -38.23 72.43 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.445 2.097 . . . . 0.0 114.377 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.58 ' HD3' ' HG2' ' A' ' 147' ' ' PRO . 67.3 Cg_endo -73.95 73.19 3.74 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.764 1.643 . . . . 0.0 112.653 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.4 110.12 53.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.732 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -95.39 -14.84 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.601 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -130.44 127.02 38.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.602 HD22 HG22 ' A' ' 165' ' ' VAL . 45.7 mt -63.12 -37.98 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.93 -17.81 62.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.764 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -74.09 -36.95 64.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.015 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.947 HD12 HG23 ' A' ' 165' ' ' VAL . 2.5 mt -70.96 -45.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.077 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 152' ' ' LEU . 4.3 t -54.73 -38.07 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.31 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -70.88 -48.83 51.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.579 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -45.98 92.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.461 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.807 ' HB3' ' HB ' ' A' ' 162' ' ' VAL . 1.4 mm? -109.77 81.84 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.084 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.4 -40.79 0.39 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.004 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -155.75 15.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.318 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.807 ' HB ' ' HB3' ' A' ' 159' ' ' LEU . 47.2 t -80.61 -83.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.979 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 4.3 t0 -93.83 85.9 4.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.753 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.587 ' HB3' HG13 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -54.89 123.82 14.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.326 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.947 HG23 HD12 ' A' ' 155' ' ' ILE . 1.4 p -62.71 177.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.296 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.629 ' H ' HG22 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -125.47 137.82 53.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.792 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.488 ' OD2' HG13 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -92.26 -9.65 41.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.232 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.582 ' HB3' ' HE1' ' A' ' 31' ' ' TYR . . . -77.44 -35.04 54.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.571 ' H ' HD12 ' A' ' 166' ' ' LEU . . . 86.92 177.86 49.12 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.827 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 16.7 p-10 -71.32 -160.3 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.39 -64.75 0.44 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.758 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.601 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -130.86 -139.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.466 ' H ' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -87.04 149.19 24.91 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 35' ' ' THR . 6.8 ptm -60.99 -10.72 6.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.237 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.76 158.38 67.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.552 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -92.33 -156.71 0.68 Allowed 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 124.124 -1.198 . . . . 0.0 112.844 1.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.71 120.24 3.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.642 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.815 HG23 ' HB3' ' A' ' 191' ' ' ARG . 69.5 m -102.02 138.18 39.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.32 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.52 98.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.061 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.668 HG12 ' HA ' ' A' ' 189' ' ' VAL . 6.0 mt -108.73 132.96 55.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.678 ' HA ' ' HB ' ' A' ' 99' ' ' VAL . 0.1 OUTLIER -90.1 71.4 7.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.893 ' HA ' ' HB3' ' A' ' 187' ' ' PRO . 0.1 OUTLIER -72.4 82.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.545 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.9 p -83.7 -97.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.181 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 6.2 t -121.92 -63.2 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.457 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -173.56 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.342 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HA ' ' HD2' ' A' ' 187' ' ' PRO . 51.8 Cg_exo -59.57 120.37 8.15 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.927 1.085 . . . . 0.0 110.867 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.893 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 21.2 Cg_endo -62.67 156.69 51.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.811 2.341 . . . . 0.0 112.834 -176.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.417 ' HD3' ' HB3' ' A' ' 181' ' ' ASP . 0.0 OUTLIER -101.92 99.96 10.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.873 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.668 ' HA ' HG12 ' A' ' 180' ' ' ILE . 1.4 t -67.75 103.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.78 82.26 1.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . 0.815 ' HB3' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -102.98 159.04 15.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.798 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 144.13 40.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -86.46 132.76 11.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.498 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.78 -34.32 9.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.922 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -86.0 163.26 36.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.522 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.51 -56.73 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 112.328 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.22 144.15 19.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.61 116.64 51.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.92 139.62 88.95 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.55 2.167 . . . . 0.0 112.261 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 202' ' ' LEU . 5.0 m -62.02 169.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.211 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.03 40.93 0.94 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.456 ' HB2' HG23 ' A' ' 200' ' ' VAL . 0.5 OUTLIER -80.14 178.74 8.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.939 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.35 141.87 31.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.028 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -176.29 -159.85 22.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.447 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -79.2 148.21 32.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 0.0 111.113 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.16 -168.57 35.43 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.565 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -87.15 -3.88 59.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.774 0.321 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 8.0 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.224 -0.894 . . . . 0.0 111.101 -179.981 . . . . . . . . 0 0 . 1 stop_ save_